From 067a8aca6661033d5fd6f07b51ffdab6ef443ca1 Mon Sep 17 00:00:00 2001 From: Matthijs Berends Date: Mon, 10 Mar 2025 17:04:35 +0100 Subject: [PATCH] (v2.1.1.9192) fix fluoroquinolones and add bleomycin --- DESCRIPTION | 2 +- NEWS.md | 12 ++- PythonPackage/AMR/AMR.egg-info/PKG-INFO | 2 +- PythonPackage/AMR/dist/amr-2.1.1.9191.tar.gz | Bin 10095 -> 0 bytes ...ny.whl => amr-2.1.1.9192-py3-none-any.whl} | Bin 10280 -> 10280 bytes PythonPackage/AMR/dist/amr-2.1.1.9192.tar.gz | Bin 0 -> 10087 bytes PythonPackage/AMR/setup.py | 2 +- R/sysdata.rda | Bin 93624 -> 93568 bytes data-raw/_pre_commit_checks.R | 5 +- data-raw/ab.md5 | 2 +- data-raw/antimicrobials.dta | Bin 468187 -> 468998 bytes data-raw/antimicrobials.feather | Bin 132530 -> 132674 bytes data-raw/antimicrobials.parquet | Bin 105167 -> 105270 bytes data-raw/antimicrobials.rds | Bin 43492 -> 43436 bytes data-raw/antimicrobials.sav | Bin 372940 -> 373428 bytes data-raw/antimicrobials.txt | 93 +++++++++--------- data-raw/antimicrobials.xlsx | Bin 75870 -> 75989 bytes ....txt => gpt_training_text_v2.1.1.9192.txt} | 22 ++--- data/antimicrobials.rda | Bin 43488 -> 43456 bytes man/AMR-deprecated.Rd | 2 +- man/antimicrobial_selectors.Rd | 4 +- man/antimicrobials.Rd | 4 +- man/custom_eucast_rules.Rd | 6 +- man/eucast_rules.Rd | 2 +- man/mdro.Rd | 2 +- tests/testthat/test-amr_selectors.R | 7 +- 26 files changed, 86 insertions(+), 81 deletions(-) delete mode 100644 PythonPackage/AMR/dist/amr-2.1.1.9191.tar.gz rename PythonPackage/AMR/dist/{amr-2.1.1.9191-py3-none-any.whl => amr-2.1.1.9192-py3-none-any.whl} (86%) create mode 100644 PythonPackage/AMR/dist/amr-2.1.1.9192.tar.gz rename data-raw/{gpt_training_text_v2.1.1.9191.txt => gpt_training_text_v2.1.1.9192.txt} (91%) diff --git a/DESCRIPTION b/DESCRIPTION index 447740bce..9ca155bc8 100644 --- a/DESCRIPTION +++ b/DESCRIPTION @@ -1,5 +1,5 @@ Package: AMR -Version: 2.1.1.9191 +Version: 2.1.1.9192 Date: 2025-03-10 Title: Antimicrobial Resistance Data Analysis Description: Functions to simplify and standardise antimicrobial resistance (AMR) diff --git a/NEWS.md b/NEWS.md index 8744f4fc5..3696aec4c 100644 --- a/NEWS.md +++ b/NEWS.md @@ -1,4 +1,4 @@ -# AMR 2.1.1.9191 +# AMR 2.1.1.9192 *(this beta version will eventually become v3.0. We're happy to reach a new major milestone soon, which will be all about the new One Health support! Install this beta using [the instructions here](https://msberends.github.io/AMR/#latest-development-version).)* @@ -59,11 +59,13 @@ This package now supports not only tools for AMR data analysis in clinical setti * Added a new argument `return_all` to all selectors, which defaults to `TRUE` to include any match. With `FALSE`, the old behaviour, only the first hit for each unique antimicrobial is returned. * All selectors can now be run as a separate command to retrieve a vector of all possible antimicrobials that the selector can select * The selectors `lincosamides()` and `macrolides()` do not overlap anymore - each antibiotic is now classified as either of these and not both + * Fixed selector `fluoroquinolones()`, which now really only selects second-generation quinolones and up (first-generation quinolones do not contain a fluorine group) * `antimicrobials` data set - * Added "clindamycin inducible screening" as `CLI1`. Since clindamycin is a lincosamide, the antimicrobial selector `lincosamides()` now contains the argument `only_treatable = TRUE` (similar to other antibiotic selectors that contain non-treatable drugs) - * Added Amorolfine (`AMO`, D01AE16), which is now also part of the `antifungals()` selector - * Added Efflux (`EFF`), to allow mapping to AMRFinderPlus - * Added Tigemonam (`TNM`), a monobactam + * Added "clindamycin inducible screening" as `CLI1`. Since clindamycin is a lincosamide, the antimicrobial selector `lincosamides()` now contains the argument `only_treatable = TRUE` (similar to other antimicrobial selectors that contain non-treatable drugs) + * Added amorolfine (`AMO`, D01AE16), which is now also part of the `antifungals()` selector + * Added efflux (`EFF`), to allow mapping to AMRFinderPlus + * Added tigemonam (`TNM`), a monobactam + * Added bleomycin (`BLM`), a glycopeptide * Added over 1,500 trade names * MICs * Added as valid levels: 4096, 6 powers of 0.0625, and 5 powers of 192 (192, 384, 576, 768, 960) diff --git a/PythonPackage/AMR/AMR.egg-info/PKG-INFO b/PythonPackage/AMR/AMR.egg-info/PKG-INFO index c4630b60b..3c2d263c5 100644 --- a/PythonPackage/AMR/AMR.egg-info/PKG-INFO +++ b/PythonPackage/AMR/AMR.egg-info/PKG-INFO @@ -1,6 +1,6 @@ Metadata-Version: 2.2 Name: AMR -Version: 2.1.1.9191 +Version: 2.1.1.9192 Summary: A Python wrapper for the AMR R package Home-page: https://github.com/msberends/AMR Author: Matthijs Berends diff --git a/PythonPackage/AMR/dist/amr-2.1.1.9191.tar.gz b/PythonPackage/AMR/dist/amr-2.1.1.9191.tar.gz deleted file mode 100644 index 3c78ad49a0c1646fd44fca94e8ef0173037cd333..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 10095 zcmch-RZtvE)Gdm;yCk>@RSPF9Y8O@KpygVoj88S2W<%VUGT$pQSg ze7ED~le|D%&DNw>9@iQ3R%gn{*!6YhhL?bCWGGEbCpzKUInBvty;J`-h^8I|j!zEG z%wu1k&WNonkm|NtvM>;4Q1Ye1=kW#A8AMG>_eAcOR844T7U0vn$KE~m=S^2x5vNNbKh`MB)-+v;|J+ z7BPG6Hv`pQOc@u}dGs!yTtHIhD*)h^1fP^a9SAw*Ucz6WKVV4QIwbREU1x=c64{c- za_U)6Z0VGxQ6%P^*^vcjp`bN)$~^q03!KBx+%Op#3HuC>Tpp`sCLInhXn`f4|CXxf z!|E~=>PjFW^GA=K$+3!*0NL~vy0rqkt1lGJV$qzY|trL07-OE9}RGLlze*Y zR*fGTiBCOnp2)=S>;v5(Wvx5sI-BjD@Bd&+wL*(kXg|bU(a{#FKtBwE2~L(nX~{Ub z{@JWpkgcPNva)wh|AV<9v`;9;R~19>I3bgQHLAgVcUzYtPInty7^}Fq>o?wyElbgC z>{It-&fq!3apw){LX^QFER(Q@p!odoa~_=pOF(a!N;HxJ1fo zW5$2oYr%A|^-x=zR~S8{_|RC6l^x;X`xojU<}K2flC^RXVt&o=X_j_ec3MuO1<8Wn znNxY<54+s+sVY-Q&EiK#VV85G;t|a_5dtorMoJE}zKB!l>;{?DYBAHqk3p&_(A*Rx z=RWLr6d9##1(+TFugsX{O?4ro#om$`Ng4`SoRVvw+Qrp5R`joT{h5!h$5hY#nX9)F zj##h9nub2KzHcR%g)KIuqPTXZP?RbStDbW+SG$=a_eLvZj!amU&Fk^`0rU6P)s7u` zSn`)UlW;Y%?=zSqVPNU0lgV&!4b)BhQ%^L_3@09#nxfR#VdAG`0Lt0T3-7BoMM)Ac zSXQRLtM5KrDrC^7`Di^7Ku+U1%mjfypbcpmb8k4wQSjs$j-&}z`TXeD1&Csu`Jim8 zq#Rt&B^b@Uh+Srbt->^~50FvhCZ`zx=%5wm^^@=27^v=Id0BXr5%Y6((B1+l?wB*zHl+UskQ3&ItvyPhCkO z5B6Yls;QH2o#*vyFAAWJ5=|J`8ER}@LINdQrHOgaKs`EsndGtMJ$*vNHxJo%mcJ4N zEX?mX5C5jmj2V3YE?YlzI2lrs6=o zj3ap@6=PG?;Me+}NMz6vo-@5$Ds-ri{UIvx@ZmT#A$O)2iDvDi2CB9HG za@V`Jzb3cq0xd*bSR zX|>py)_R*dj`en5UX7rQ_an?ENaV}?pc#6pHii{ok zGKsz5^`E?x(EWirjpUQ%Rmt#?C`|b?52gMxdP!U%Nm#P5*Mw|xj4yu#-@oR+IwNMK z3t?Z0yR_oYV{jjF1*A%Qv7WXQ_bXNwB-ZjHZO}zJJ5nbk(C~GPI{v3XDfysOqJ(hNQ1Up73uVB$XeAJI~;HQ->MY zE691A&sa97UuMi2vLdB7K6za5TY+8USKqErwS=IWV|l+C_0*ATN{Q<+0v8<)nr~ZJ z*#-7N)|6G7>KFuwNP;@Bf*NHOG^x(;EhM0qn+0srXth#CDFHw7e%QDCrUVMQXY3BQ zXIBUYek8vdOEbp_I-Usf3ev~}2mQ>hK51VKx!R1{H-=g`9;jTYhFJUV*Y6iOt{}SX z@9)m1)l0dn2FB!s#jw^5v@RxNw)D!EpgaqzT)NOl`c9x~F=cHJ!EstjQ1W($%jJ`| zG%sN8+ivxWLdFv;5wZL5Z1m@Zc(9TQ!lqDk-cP)!7M?}H+czzq=Ayau;s^l+7x&9m z1%6V#h!q&1p73`0bI`6)jRbm2C%i$qS#3+^g^NLQd!!XE=xWXXMg3ic&xmpvJX_fI zLV0kyxa}{y*tf`9X@L#<9V$zz56ERAqpFXFk>5Gs?E=2 zs4H@N6tvvE$1_+KOpltu^h%>nbTlVc-4e$-|#zEgWi1XY|4?tWo%1mOu4;jW>35H zA54)&(K%%sPu(#3I?F$6@xoXxGtn+d#mozp69@-$lFD;1;vzkSDGaW5SVe`zbt&AV zso{L7f<@>f0}p5uzIzYt`)3({X^U!j*}P1A9=%~0l%AO}!nUh&7YF@R3|+zzaMpx3 z7-n*MeG)ne?u2cYc`XLA9Va&0KVQM7vsGwh3!t7ivs>}4DmaZc^-@eIN+97*{O>Em?R<4vX8ot!V!WX0iC5Z4WZ(Qr@)P!NqzM6g-{OO-67 zFm9e33tx7Mg{SOK&w;pGaqh&l={M{5U+*k_+jf47NjMC27@u|u7RKB0zWS+qm-MtA z-D%Tmw*l-^%iSQ;tM?+E*7?x2fbD&X2Tr-2dSj~frRYF@T!@{6#N7PMF2v5>ASXId z$#sy&h+zo_lMf5DL+g)|y}tp`@`CKBX*Iyq+GAU4{d>g+#v}Dp$dDRF3!$%h*1Pvv zs8#q;@}sOE@s8DzTvPC&bX)rn%@`990pB0m&^pV>f#QbxFj+n~H2uuyut;b}GJSfs zehNV5G+Dw0O|@iP^{G3`&d{THE=ID^F;O?iXiqe7!nCTDt<}|_ekA#ZrY=~kz!5Dg z%`;JCeO!+>KO9>D#wk2wdHN!*aL*b}?p?n`GGAywg!CbhP!)!2XFHPnSs|3r>Nn+- zn43i+vY@ZJXhhlax>IS^*Yw>hR~pA$1!^83UwMiS=}+VwR#=^%mLB-HS6Ay>ug$8; zuP{Hkm^Ig-8uQ3VI_w8u@CcW>gW+$t7wS5Yg$iTRUp#T#`*;F$Y;aNEv0Q#z3h=a^ zeYxmU|CI{0>YA=fJb~5v_iI@0Z-GC^Qc1m0m#FL{eaad=FKlyFNM;FUV;*+nT^R>% zg-XnY!!dz7%t%F*QOaem`rs5bsWb1+(7}jf!KO-5(Og-Ay9dGKm2g5p6GpjFkdE&6 zqcZx}ny!xwpo=3exmaJ{pb)gVgTqa<>U5m%Rk+eCOuZ29&nA9bTzaa%nQff~ z+!lLOS?-yW79>*~XLcUg>jbHJh;3E~o%5GzzbW~64$23AL2Q9^e0wCX!H~6=6 z1*234c`vvpwNPO#(zhC{ml~*$`K|3`B_Eeqbx=v$x9Hif)-!1!mN*HZSkg{abvu!X=QfW(l&%(_ zE+sM{_#V>TdH}bku)a5EmH^5<7YSKEaa)16yB{u;*hgco!ObZvXxc6L+_mNQ2) z33C|8DT$aK+oGWmr-Kld_+bPodiwWZ?`!1Oq!`Gm0`X=-5c=^-upzGj!OMy4R7NvH z{&ecd2NBj3A(cOGDg<=jpa@5l^JIfH{P}hDOLUNlKYmdMDY@=fj>mqCADeLrwM9f> zG4+yo9tS4X45Nlo45KetBi?YQ<|zBhj@U7USms@soE>bajZkd}H}+)|U}mO9@q6fr zY{m#5=fsA70-xSW&JHosMvA7@`{~qy-doha%>}RMM;``gfT@#sSWCKx7ZVEeKF>J` zuGfA(%tj;Arri1=pO}sO-)@4{=G}7^IbEj)nq2B6O-J{R9 z<~61HK!B|9QeNx#p7FZ&>5w{-H-F%)QZ zmxDdia7NA2{iSzp$7te${%)Abv^99E{F6-??<7LSv}zsiqJO6 z_3HpxO+SSjI*x_a0~M!P__Lnc+i5A({++Bg=1wLGUXf=KOFV=?49k(2w1tr74ZRQR zC&^Nj>Qn4&dY^WVX~*fT`r0jIAVTxL&_r3I4zf?kk64;{Zq}oW_C^LO1@6T8?}x!# zX2p`}EFS3kZMM>ueZ;wvxvg0g$~}>TY!(W$yC=z|Ok}(VxF-o4_v#OPxtv5!8ywb2fOD)t%2y{LTqV zN8jBoO$|eER2dvFgXQl?ZJL9^I7GvmtP(@r5RYaF^)>FB*??(>nQ9LdusNv2dIHB9 z#{X=x)c#F7_VA~c$M zrWT(6+ov^vubs;r8ztnG0@>-!3Zx;lvfZIHePD2jBw&oyPc=t6ev+FQlR+j(wyE#( znFTSk58dN5PDx~U-F9H|7Nw!c>^Sczyh{^wTjN{+Z|+E?3d)qB)fmJHDGpZWp!Gm);oMHbT~^=dAwj0; zb?n+!5F<9Azk6yelE~0O<|bHInyjd~At+}X-W|uysLztB++&EvJTJ+NCvmZRfS~)m zVw&X7slJf~b|vY5<5;Z0;__(Y7sU+bP2_e z9`y}qML>;#$1U>;ZTN*DPL_r9hsaF47i(Ul!Zw%&PsQsEbgOEV63M6c&PA-{6lz7E zWHKev#q>iht~9i4bng!d7hn~Fo~N?7!)qSY3T0Y+(1o6`M-L_Sjh{AFt$b9mi3A;P zM9a#1%%=XW`FuD|m8Vem&34N}WhXC$a1j4s``HdoTgddQ^oQUD&!|y&tO{kkzXv+oy7_J z8Y=K~Qu@ha0_BbP$)W_!jF&&0#&#%BHJ$6Ce>t`HLGyi{ks4Wfz_W>-uU9*!RCEGV@ZOD#I_>Ua{O4_909O(Tcl}Rg-#kDcV)EAy+S}J2o?#e@JD2Q!x(; zvmswE`DEI*y%;-3hyQJ4FQ64dCig~(vt+y270{@Up?YaSqh<}i|1BMfSuaIYqDu() zm=S0yE7zNV#304U+fTozxbG?Cwtd4YoAvcF490w_qys%15ul%}gXp@7-_+n?gsq<+ z@lxwng3dUDu3^9%mY&|tzKCZ~rQKeW}FR6v|~bYo|QqChuyBCVt^Mp+5Bb* zdBWJ;j@)}YpVq}g7+5STHX@}Sweis%Xe z%ttc`Zio#apHT(nc~rNXxVfadc<$z~Ztt>NVt*x7NTr#MD5leT7Tr;aMGPtv4R&DZ zCLjEcV5W|IYFQQ(7PbvzZV?ansmQ7*Yn*%0vB&eqjw~&;@~7Hp=F;1rOSiqAV=uY$ z{(dT%R7gI5n2w=H%-XQ0CVAzM___iC#Q@`K{Xm<@AIlNHTJup%XFm_~NT`dxzc0oN zr#$rtxSU4VM1+CYw4-m;VzQWB{kD#hG5GyWumx7Ur?4Oxw`eP7Fe^oRFtt1WpsSF2 zc<$I9*f@c3{LGGh@cwvp^$B8!DuK2!6f#Il{_rZmI?B2*S^T6Ff+)NdUS%JdV4+p6 zY;sj+hRrsB6VUapO|!<^B35$g_tGw+klE<<5}vsSvk>2XKw~ArF-2Vxr~5f{&Dsx9 zpY~Coi?hSK)gPw%o)qb>eQ15TbQC7eGS5fqL)%oMx`SYrLE3V%mv3%eMFz1csx`Q! z?wM0sUzbxw7rl$nl2TW4Ej83LT9C~K`tzuyc{2>9SuILSq5hRDRFgC=E~zA8iBq#< zE9pvqxHZwA-`Y%Ay(%HFSK-$2KCtTIrP9s%`I7cTcgjsI9d;>F4JtnKZGAB#6lk+y zi3pmlFIRvTFQx=H{Q!R&K^#7tT-FI}8oE41nsKv?49A_gz)p6259`s+nj)ysA+Gst z)3`ytfIyX6bxl~<<2`HYWPwykWBVzJmNeLDBkd*OZ|veh{sqK_^R*iN)%qN^)-?gBBkMFYJ!}>v2y+sSmUlHu?Scxf9 z&&ggP>EJ(Z?o~>dc9Gl-;e`btDXZK8P_4T}1tu93Ez(pCP>RZp2(}GA>w|&s>M|YC zmpqbqIAFz~bwJ>cme263K_&hIhDKM@(`9(hmWX&*>o6;07SwCSu8GlQR1tsi85LL5m=MIV>-=2_vNL zu@`PvJV0!-ZrtQ7Wpq#A5|xhpk-FA_EICD>QYg$NCxwr|TK7wMRYbQZAmjL52tj5aX%utN@*6@e{zA1p^JiIP?}G}z6D zTs|3!ouPZ8m~U}fK>RM$CUYc8^Va+jmiuox7SLhND7x}PJV^v&K8c3Hbw?pZ`?f>g zYG)W#QOJfNZX|zl&kb*{+!kwWkl^?lZKw6k6ALY zzd)!ghTq}MC@Da8%CK$qC8jzhcG^HzU#Q^~+i(n-3KnAwEb{!wUdWwb#h8vzWGuXU zhsZpM52EAbQM3mG1u#aZJN>Q;(S?MFZVnKs>4X=DQQ`ZC(f5-G=Dnk0PVp*YQR1iI zUi+!$xx=x9StH?AVZ z70P#NJW69>tG~6jsAagepX5|cRk1mv=+d=hOh^1l+O0{SG1b~LhgKhNkCIne>FGz{ zYC8gAHaA7h*^zhs-fb|MB{!c;BFzz@R>06B}Kp zwq5B>hR|gEh&lHg%S?LV*0J^vBkpe+B$4W7bTlRJya*V5c<=5Fv zwMLf-kg8TtZ!y?%PEIvE!DttIzqvNllkKRB=O1@HjczID^3hp=J zygahF(G>n8SAbf$Y%#c`+2ByDE9+zq$($-yMJb;4IewHrw4tc*O~2?{_UpUewvmw6(DA7yznseV zm>!r^c9VqQ7O2Df!wRuWj|Hku*94I4$D+SQIaMX1L4^Yst`kf)@O|D&%)~dCK{>uK zOU{BX6?MfN1C_fr_6}ECAn()X7k4w?+L43N(-%b9TSE&U+6(SZs`kg{vn?MGG-MUO zJ!>~3d=lO2XI3wdJUdG>TsKj$kWO%JmtPny5SmCp;n&=)QhXIJkwQG3RH0^h1!IZ? z#L}4)$9qud-jh=_EB1|aD~&J{;3siDpZHSFVL8aodJoJH+Yu5ZEBSiwJ+BixYV);C zhb`Ch7saS#U)>M$%W@``0s;kDN1~y%L{fNUXwNbUVNO)?NMe$it5zlwgaU28we@jB zom%=1`y^f2NI$1+Hd^CPKu`7qP`2Lf^nvjw>u60p80IE+)iTz{pl4mDfHj9iRkXJR zMubzSt_4BQ--qii64UITEg1T1XHnR<5(s^o@R2gU16?t26HWEmWq75O=@?=|H<1~| zzb~!2qx!K#8CU%_ByZ(!A?U~F*t{j^k5*>5HF!bFZ;3K=#5~FpRHzrVW{=awLG1^v z{q&8JaiD$ch*?yfPgkk$UkT{&y?;|2k`!{Tlh{;hM1_Y371MG%f_gJX@D#M>bL_b6 zL+sghI)7miZb;DNUQdR2-XD)YOb+wS1~3GEE1tFebBG$;;psyQo0Kx14%;~Yi8#{q ze*M*Xdj87&p))MsOrM)}-M?F7%DgZvRSTydymGPP@EFrxpD%e`&$JO{{3(}sg${w% z6&2~%t^&DURWQw4@4>v~lGtAHywM!_6Jj?XVqgc5WBe=DcChvj3N8&NW_UT5ocQ>$ zkMYBJipQApemw#SPa4kEg^?&guEeG`hY40Xn?Vm_@a?#5_~MQmg&`CG73%IH;3JV| zjJ&$jrXGzXl~1UWb{Vn`thtWc^k zVvtUkRo1xOA$ta_@6xJj$xz%k+>rG#eVMid5AsuIF;N29M*8~v-BepnK}7&uKStEF z2vrO*6A)97j!W$RD3Je4!fpSE3*4G&uV)0xe+QLIm||E6f7`JAI! zkeDPo%rXtv?h0Ji*bt$)EIWkbw!{Sd%xw6kGo1d{+bw7_mn{F&3xY@uZza#|fSEkg z$5d-y*S`I!XQ~`9%B(1WU8-w)r}P+{epTSO9yu zXl$?!cSUlt{+qbTEQ{qD#hz2~Bf0@->*=pjcwSXuk+;?t;*chCFPMs_^mI!t(8uDz z;+^BC_6xQt#QMCExU9jn??C&jw@KZarw*|*WmROz{@YZb@ipd3kr%R*A6J8c${IFy zFOnbTd|mN&n|s(J3l4bYrALDZLDs4k@=I;SL(fJrGCyg>&`|WiejS-8Iw|qCzJNK3 z?=8&Q?~WOwAZ#gK4@bDheA;MAyjRz{zmZbTYOjF=bbc4RYjs>Bt!Y}BXeRdbCqRd> zDJ6av(X($&trxZT+nZi_tAwXc9yV+#b!fSJ>f0*{@yPB$K1sqlPGZw&n@3jQBS-{} zEJF9~7<>-DrW}Yd%$zkkr`>5tv{N4_b6F;|cCX*C)B*4+KfTig?{*v3 z{EW=d_;s>C`Zxz3oHdoZ|8S-e`*={=YG&shXG zVBgorS9QJ~^!{D&je*1JP5l#O+>>7g)K9+OxnEq z9r9t=bQtBmD_JO089x*UX=HxE=Sses8~u*he=WFL^3MaeKi*B>CD2#BP_{X3_o=)y zjDuLeYaT$_?gFyyz&Hm1_3gZ1Oz*LfJ`xD|zN)_d|IGK3K$e01qTmyedbTsj3qnXM zI6#;vZW#!{B81rTgO#*=iE7?L|5MeE2DtfM9Q=FtF|2)ttQ)0&;@@9k{3`b2X1&f`dtG}lsb}s$ZYUR>sLa`~q%{hP>B~28fD^5LaWoU0p%qFrj(PA0lEPv14L2HxP1k`Y+&z5WSmI-?{@U z@*7>s%!|cH?K1beJ94@izL{17d2JXTaP>{V(u>&n8}DdA(HmXAP9(dx!MiQd}r#sNUy^_jHMHpZ5ze;`4o6S)4+12!-P@?_>1bE zl#}M%I0(o{&K<>bK=FDAo=6H?bz&&wIwy3KxvhiF(%nG0b(kS`RDo{J`k%4}`c(yY z*m7PetRsB`4csEXQhj({^kU4yose_RA7KDi#TK7EgmI+s-sHp+lKTT$i-USlue+_0Lt)yOv7--@-S9ItXU8TA(Y` IE;Q8t0(4sgGXMYp diff --git a/PythonPackage/AMR/dist/amr-2.1.1.9191-py3-none-any.whl b/PythonPackage/AMR/dist/amr-2.1.1.9192-py3-none-any.whl similarity index 86% rename from PythonPackage/AMR/dist/amr-2.1.1.9191-py3-none-any.whl rename to PythonPackage/AMR/dist/amr-2.1.1.9192-py3-none-any.whl index b953412f02a97a0d351cc429ed180a8f611d9995..60e956858c37c2fbab3493558fc418ed40b1a369 100644 GIT binary patch delta 647 zcmZ1xup)pbz?+#xgn@y9gJDI(MxF*%rWFmF`&h+TK=d-sx7-}78nU8Rp6`sAJX=(f z(P;8k(JIE=%?4ssyiBVaCa+PJ2a26hE>i+2lh^nr#0E5r1&GyvI5D?K*GSJ02rUgQ zjV7;EmzZ3mB2W)fnw`ij8P5o`mWhEu9z&^KN@j71Zf0IuzJ8Favwx6F>6wE?iwqbT zF6_Q9lrt&Gpj|E?P|Q`NmsMXf>`+rghg!gs*RS9781J=s|1ZbB=JB2tTxWj<+-p1~ zY@;N9d9}^jsMG54Q4Y73=k0k}uipDQ_voE{Rm%>YoppbX-nlIKh-=m|H~Q6mOBS_+ z?VtB_%ejzAt~Heg4|P(qBs+bU$eo&dd(A5GpEf;x%l)0-CpB*UYLN`RdBoxmhgzuK$e8PuZH)B{bv6p^6DLcX@1F_(cM3e7NhE z_AWa0%KZM#+s4)T_OB;Z>wZ>$?-RA{s^o@NqmPHztUa>zxAWc7b!YxqYjxi!WoRnk ziN8L7-QzX$-gEdrOYE81GGpp|L+r@Fr* zET(PO<@0xyr2WZ(NhVguQ}vZk?9JaK>ZR+qOV}X({z7BkLy`>5 z@&VqAOd`y%lrULG%^H{jCTBvZWokBvbnr?|UC9V3hJ0N^997*OO-zNxMblxNgX2LMCH22}t6 delta 647 zcmZ1xup)pbz?+#xgn@y9gTX9nBToY>lUdZ}K2|Xn5WS4^EjNdGR92Mx;Wy_e&lZ(r zG@QIuw2D!8vw>I@FOzxHTvbvQy@i1S9hGV2CYoqt!1w2;*w;W~gx8Iy{TJPEZ`k%h%>l4?k(mr})$IC{Y zU>nu^YgyB~Xhe&wfDY&uJ;-Xlc!gWFYig$}H?bFTLs5QNAN{ai6Z-xh0&eqLYwAMJZ^Ot?f zg2P7(yp`;uI(9v%n|O-j_uZOTJElxNQl;;ob^FTfZC1^k7Y*f>#+!E>e=)I<$K;%L z{mO(;@kd8D^FKReGh_djbBi`OtFu4qNjpAkx%CT`0N|>ypW(`aMlQSXIGBq1SI(Vg~u4IT5L%yydjxLTNj>skelZLUnE-+~% ds>^`VNj;deR$T>b3@Gv^-&9uz$}?)H0|08)0E++s diff --git a/PythonPackage/AMR/dist/amr-2.1.1.9192.tar.gz b/PythonPackage/AMR/dist/amr-2.1.1.9192.tar.gz new file mode 100644 index 0000000000000000000000000000000000000000..5cbd2f3d9627cb77378561424f7cf413442182f4 GIT binary patch literal 10087 zcmcgwRZtvYlf>PFJHg#uc5w+3Ah=6#3+}tP1$URA!JXjl!4?hf?hu^4{8#sUZ+G=g z*K~Dt%{)zY)khVBg3^OIZ4C!Cb980r;o$!Fgt>)zINZ%#Va@|=y;j>AOhJpaTOQM* zX|4`>l@u@EFMW>L)_nwH;@8(7x~KN)Xz-F|4m^L2YBLI3zYo85J<)3-24~X+H;G;+ zpf1NS7odD0Kx+n@7J}vh&(r9xFCXX`?t5N7E>U-nzhfcoe)EjqALz3YdR6UsyMV1> zLW#m&2R%3%|M>75D^q1Uf-!mf+Qywn?3_xi6av|u@;Z5b<}`na`0)WT_5s+Cn07pq^YmBs?Yy5U_d=Zfl)iUt(vV$&POTjc2Ij z9dy^|8N?$(DXxvQwF-f%8JkcBBtC%z-vCJJU!I}av(O*A|Ge7&?X}T_=HDSJ-GU~b zO_nkTq>L{8PNxN-ePv9u(1B!Frk9=9{5WJBC^n_*JLtzV=%S-#QBY9=5|L-4>cD084vXiI8d^egjSm*!7ON!WN^+}f_^D)B8Lk$ zS3VAxXK9Qy=QvyzPA>q+ZWmg^3EM|1Uff!UFiazmYSyPrf@MGAvDkv~dj|POOztR{ zu$#;$$rq3G=1*Ig8AU-N!f3E$;=N^7X{UBPuzHl~>(pB67x`}bihKX1AAxNgh_DD4 z8E0H4qV%q(umeSdJ*%|8Bs^6yeW>m!Y0z0Jq9f{G&8RJg*TU4!coN76iHob|$_l5C zqEE<`9#HsXq)*blY>J*=7(lUJG4l$l%GDkDTQ&fXV{;yrg*O z1(8O`2ntx~)J3063uGFJ2lH_YLY0tmeLtE1f_+U$&<~x9kktL)x|hLEGZJVts@PVA zD$E{{V~}{-0gW>)XJ29_LgL_{yqC%x1b=O(2emK$`AH-285s^miotfqJkOxgI=h#z zxfrKrU`XwwZUJh57v)ni`EiDX61)ucNNA&B%E37#;C0VOy22=LowI_^og6=mDaM;*Y*Ljj;6W*nS{zXNS2x9D z!S-W~4R+q7-+%0xDYD}r1=6Pm0aGtjkmpVyK^Ve1;n@Z?jJ@_Dx@_Da(25hcpNs^aaDpCYfi3#b5Xf`1BW zU=>Sncxp;vrT+I6BurM@nYy28i3F1@JQjqk5t*{+>v!9raQo?ufuW|gN;g`@D(!u4 zT^vLt5!xgYJa}WRFFh$sI$9>sAtv_#4o6cFMuENh!}AlMzTmcuK+vh|emuh#fFt>Xb-eRga@sRdJgkHfM`% zy)A9;eeOJP!uQEwxXrKkxEaJ0L<(zjh1NK_K^BCc#pznNI9E^6MgjIf5v;l!?9amd z7Pc`{10B6D4)vW7_}kHj3plFJ+3SduA?qEzCJ>MH5)5D`<(|i01kU;=xXM!v+a{IG z>Wod4BF>MIturlYEM_J2q7LK&p>04$)`UIE!DE zEPCMbnVX7y&RE`^xEx_!sU{>b4&y|PlSKE&81CDzm>KEKV7p$!1-PHEnio&BjN|r_ z-M=3ll@LQ6h7`dH;Q%u21Rgsc+LS^A*rcbm)L0`3Swxya<;?xvp9?k zT2>P$dR1@`YX8qJ8artEA85&6P{pbJIyCj{w@<;FNyzb*r5|+3z2GlMd@!}s0ZSw* zq@M6S__A8QqHJsGy+AIb@|aP!;t+}Q1FD?FDlFt7@|y}FpFzbg=oLN|5$7~)uz`Ay zg|E1;$5@{bTEAT73`r;en+LdV9{bn6Dg2tKF(bxM#pyBO27He!QAfTo92o{%A_Bat zs&Z*70$f@T&Ik>>kp!_8IQWl-8Q(>m(7Xb;7@e>v&mTp;Fk-eT=(U~gq8SQ0J^@!d zWXerzk$+2g1&@|>2E~>hvkN6iB9qpS@e2h6&ivK~L{@q{Jil54io^%6N_0+8s{KNJ3lI(Xo>Ul2flN^^CVwF?gB)x@LmkS z&5CY)Xmp#GXxTZA=5+j2eScaDtk+pwOmC zcp*^^1w{#3?Io2Q*3~$&afUl$0yK^ollNDLZp5c0#aT%OV&C7nw0XHRCg@p0#3Q`0 z!fJ;$Cip|6cOuupw%P%>g73qaCO|GniHCrtbiR(B_(-F)?LB8OQE>`FfQ6!eH=v4@ z^ij(+0={8nqz2mpS&fjsZE02Q>tM6^&aQG_MO(HkY_vRXdQa{pH4_8h*S$3G>ke%E zXEC&fqxqC*PI{8%8sg!@u^T~EIen=iO~D3b34@Qt5qY*$M`f7)qG60RHlt&4Vy14Y zF>YzJoEkb`V_b*}8Ovb{s3c+(@!JKsW@j*#6p<|C2FR2sxWoIe#6kp29$%}y?I6!G zO$+<%&W`aLY%qOed9s>E)g8hlYslC9hvn3Xla18}lTRHFy7su!jf+NZSWQs{oqnqj z377X^8;{J!VhQw+i}N5W_XijcH2>ueZ@>E+6Pk_Rs80HDzf|)2E4g5uc7tAv)zQxs zkle|Lyd>@seuC$N{@x6Ohe_^fXn6Y?joC56Lq80#U&_U2`<6?&02^u9?9So02%vI4HesZR{N%i z+-W)%t+rw}#W6#$$(Ju>9QIz@xd-&?6Nl_AePUE*WlJvxXjpeHjwf3pjzu{*$I8a( zL}Ie+z;(~_9nJzJU)H$O=s)&sYR`5dpQ{hHFl93(JlUEpS=C!Y`AhRe6@ z5EOTeLi;mBd&S9Oz=9gVR)L+k5Fs91^pg9|3WxCC=XvNB$+?ho%QOPcL4mBKBo6kuIdY)r$}Ex%~=9V1CN z8Rz3KYjUDNG3gK9xT@W;-ukC_=sP%WxeCJk%_}0=-C7PQ)O8dbC1NRN^DCAFs@ezC z^cZ@785%f&wvQ5ew<|p|)gME}4=6U9>9ft_mLeqT!zi8M0vo9#tr#RS`|qFBurRAn z_sPSFvnEDc93I_q^#-RW6pTrYaVA7^f{;$mY*H)p_8LzvXm>cNmHqFIo{=sQc>MhQ zbW-e`_Ur}Shl#w`f9Wo&rWGd*nPm&%)=xE^BbFedr_WYR8(!FQjTE=OeYG)|@ujSH zcJl|mXf;3)gGu|lI5kRdjl57K;a|hAev#0N`x20LkmBxk~PD>Duwq=9%!lu zTMFn5N^~D+ejMPVXMD-2ctRNarlPo$O_!~v!kooSL&uk;CWo5j^HGK)R(s}SpGS7F zdW-_8qT)_Ixj=rF2A`&sawDQZDZ-c-?loghHFXL3LJIX-{D!~&c%AZCq<`hpmlWzu zyhMjfX9;>9WklhxPf_iyu|=}MR?3ld&Kk)f4IKqt{N_VM?8>AWDvRaSQ<(-X-D`NA{b@tg=k8IhUromyiSJ^TkJI|XAw4% z;b;&(l+^9bp_M)E1%$R6hS3=%K1WR%~ zgb{td-`8~R@>;xj9?4XkX43wY&w#!3s z%2Ut$b=z_7XO=^w+&yU8Yq4>;Rm3kQ$gCG~BdXfU{rft7(H*n($pnzvPy&cwojEVO zyC}&uQF-LbX9eE%e{0f1GhjuNy;_rTL8&PjG*1Zo=X(R<%nGBMqg@-?lxz9lGjR2s zo;+Q*j33eG8jGLUOWuqT1_ux0;B6SMA84r=y1i#4MUQ&~F}cz8ospo?*Po`#Y?zN9 zfF?M3c^$JFRW zKu1{#MjIn4H+;(!y&dC+cQlf*4y$h$8iHN+j|Tgsk546?( zb$joKnpDxhe~$@i<5u;-hlG@qOLM-#D^AX|I=dgMO|QzED_mvhKJTOZ;X;3w;D z@njrqjU?DqZ;72(YHCFpQpR)qp%Hh>fhQXtMTn;#^^4kT;phC<%Jzy0?P>+1mY+&S zEq2l;4O+7QV6Ty0eNxO}(9Gnq^3(XAAo@>W(M+%YlhE#ZG1ey#g>^q&#}3&jwL8RKvlxFYqhymOrptVJo))lY&eGM zy#j}3tfXiIi%5WA*a8mz#Ei;b091vkuR2JsLszU1OW>Ro^fA~{MYyFko$Byrk!b|% zrdzO#MkTY%jZ(uBkBr*=^_vzs8V)4@W}Ulg73x!uy2C3|C|WsED+X6lpAf3a%~4nk z-;oSVk9Q6CWLL&EDung>^LED3cKR5N`{Dv_{xHCJ{;7f z`AZw#6zWvAl9n>?uTHQ43fl<6s;K(UNIwsI|4B?_CjNt6i)mpCoY{5OTB`w%HbDm3>@AV%CmFRk zTan~Dm&L4KbR+z5@lP0JY6}0!l?_)%SK^|AxQ&Y-rW>WAsxm#4`0Uq8s8q`(O&*RsV4B|oZgkp$}%Wwl4QBGF30p`eN ztPFAZ|MG^=1-M>_j@O`texOeAy>&FkE2Jq(jAYp7W-)~?(9Zy|)W_Ac#LE%>8~^nb z`NAqc6S>V~Q6L#%*NIsUmEsOgH0RED?eF>ctCKRK90womyQ4UUc+(vnHvC1D5|pE; zaeH6buQKT(O9#P$4w6Uu{|V52ME0w=@w&;y+9%lkDGzk*8u|>YxYO^=rrqggnYPv1 z-y==KZ9QH}35G zKQh5z({$UeD^$i4Cl~$xB>pLe)BN^mvfCq{6c~vhzS?wb;*d_u{FgV0q#5p8@h1e* z8kKzNb&99E46voVVq-iC(}0FUpxRva;FD)o=cZAdZCX7MX$EidjsS5Uj+ZQH?o1)a zxYTBloO?jtM(b>*K(V(|;!Oj4Q)iX5vVlzn!~Re9Cc_1qQud}V$#dZt%pNnpQ#{F- zl6IIo;dV0Gc=Jit!EcJITQCc9;X3HdW|1)v3$ zq$t+o#S~w(OxrUnis-*ANb7!I;P3iov+FfAHiK{0d3wzL^0S3wykfkd5R2kCEyj9^ zU+f@tH!G(=H3udckH!XqT#2@1d?@Pi2I_p4fBOOLq;3VMn`=NP?zkgs8+tjHb#qain%ns*pPD017-EVRQ0!E+mvpVsFV6vxE z-=QC$LGGQ^&=DmlAo88c@e~>~_o@U9dGC1~iI3pi?DT#SK7d|ZY7{}`caJSKp=z^+ zHX;8$RX5AuK`PS0r~MH<8dTUT;t;tv^+U}1<4mOfnK1%JskvX#4%v_PFf$z9b!F?1 zgSX}R!^u~cgkL=aT^)Uo`iuxoqwD5e&e;}awok>jMRli}mgq3j&*FhEG&T4H5%UZf za9SNycS9CXl9l12OWjm;W%YA-RM{E)EbIWb6kd%2V@3$mtPS zCu8(`B|-1!{r#}`<2MguL)X1kp*(pqLaw!a#PXyNWJi1;yT?M#x4W+LWM>KjjHKOWc>(!rL2sUDxP5TB|Kt84QAE7pDdA)xRSgB5 z$Dw=gwP0GJTlEOS^(D--ixGnh`?&DT)7!%);87nqFe*BeVWFEC#d^V+*V*nH2xk47 zNPzUYF1|}<Pm@

8JwkXNqAHt> zsh&{CKTI>^?1?FVX}gpI8fG+zYVGFesKY34rQD#*_ykK-j_jfAz`@ltmOH0Zz`fns0L@c~??L<}Xt_|pn? zdk>Vicyqth3GQ>J%CW;QvVu#4gGRyyp5~W;R{?R4Kjh=GZ+LATM})+E-3twPWA$mNI3PX|IFzNwAIY*wzJDc`BlOGf0&r#$E_SUvbBrV%Xulw=Qp*VR3 zJ5faQ?g6f8l37z?VV(FuHA(i)E|K=vv zkZgy9D;ab~=~u^@GnzKynQ=TTEca2hPfKW=a^9QXPT9lQ4h!bpU!^p2D6Q9IP*}$u z)(~hq5%HO(mB&Aa21QpAQ|07QNXSn&V_#=SEIEgC@t&{0-%98swtx!G0X@FYcjv5~ z@X+3U`XE^EtLF#gYqx0_&G#)$q&1m>GEUB`X%J?3Z9axvCqkuDW+Sxww!&hnP;>eW z5OQJim~o7RdrafmgHTT<5>M_V73|9v%&>Xh6Ikgs`t~p*7A~Wh_oIzx8ML|UGW{6k zji|sgL0wNO2}|bEB^Fa9d>U4G4wiJ0g25-e{DH)7KX$J^P?r3HK%=q>Ga3!>l%PDQ zji-Mo37Y{kASt`|>akxu**s0^@+5&#z`yo4@ZcRtox#{{!8G5EqaA-EeHP)t8*1A` z4f#?v=bMoB2eVgZ@Ch}9fXa3GSPbqr>oD|emNu4bMy8zajzxJVL>jHJl1axfr<@EbFEIi`JFmS3KRCj;a|UXPny0NMlNrWiT+1Vl?SgOH_a73q#CesiSf8+2htEfv zMEFU3%@S8M2b+j392&oPOC4VmB@rD!O*&>)w-j$nnDlxyOR}s<=1}Tfja~3d<0b|x zk(%nQ<-2#j?_&}Kl^2UR4EAX5y$D<3+Dy__GW04QCp7fRQr9bqJyO+WH-k=vfr2Kn z+%@W}j5c}Mx9XM>Xq|gH%Xcko6OO2RS62#~`uA~`fkjeJdZ5`MM-;&WQ;?9QETs0xXiE9$}6Z5hpiE0Jti z1Xt^i=6-ZC+Ubp=?>7Es8nc>NUrWN>`!diTid?_!HW4<={4G%i>i)wEGx;6W;7gq( zcZeL_Z1oE5=%kmQ01@tRJB~7&1hgbh3<|7(xr-R&z+8gEyo<*t<7oNz!%g zAOm>E!87u3<0T*-fpSfs#;3r|+(WG1ng-MyZ*8K01_ z+m*!NqkL%UZ?5>Wi&RSfdiQAK&qC_`N~|&hPBIqPr+ zMGRMt33-GNSspUd)szgeV9JV%FNGjnj+A}o5f;w6=)Wnd#YOXs6?Ou;s>C7dB@e)+ z#X|by{iicpPVrR!OdcNIAa(S8;9->C-9`9ho2&z-_dZik5CDIXkRXkV=xS1&T2J1d zy>ef!T%fzBM!R>k`j`h~kN~-hOrikf*r@V>f+JnNx*SH?!fZ25JpEL(X^`C?$&yC> zf^uS%-?v@d5uo>;UJamOU=a7K0nOqBY?uIjmWU$PA& ze_QZkiT{f@SOLAd6kC*lf;ZzelfR-V_{r}UQLsGV!X_+r`d@zyad_F}vG*TTYGEec zyz3baf?#y|%g|kbNgjQ~jlyy~l6`nL)Wu+pkHakn8TN`;n$@q*L1&d9-`RaO!_;XHp~x|VQS>5t!x{Y;#Mp5FqyTdo=%qDz4t&VpGhPEDWj z+;&=_fp5>Tf!BZUHOt=|9Xm{ixih{wntzt^qL#$CyQ3*)aWNMX%2Z|;7+E8Yl^Ymy z`2rGxiHgZj(wFHs;9*6x9A}v-p(crgjE%W_`}@n&-Nlsk7!xL5DOlE}#>5TgCbl)2 z4l5XTdtaAEhN>O7xq}38pWqZaVdw&1E~y%~AKkiK&YLAeZnj5%#}Oqqnr0gX-Eswp zRmBd5$Fh>H3=SufNLX|6E{&_wBA23l5KY;}!f1Af@FlN~nr*@R&o3*b^v5!NkUO`a znD~2r5zg_jYcU%w?(>FV)UZ2d+t2Xmq2NG?t2e1T0OI1#d`jd*9@O)ZdCetCqp9sId?2PoH_4y~f?8}Tj=Y}h zb>GJZah~6wz*UHf`}p$^W7e$}FZG5bu%F-YK0Kd9M-)O7hqoEiqOSYMx8as76Mx5S z2D=gWD6j2s%ap!d>sC&0FF}C;KCZ5>y6!Q!$Q`Ou=uIFqM@@qN3eXIb37y4!OX$s68%X1%5PX?*pA1rB*+l=wd3NCIViUl@zO>$q&x3C)u^7kd|P93h0^Jiw8E(~XZ|(UIX6>u)Yg?VHJc*ebC_?yH5*jffzMQ1D$;>)Pq*Q_%aZZ+ z`Ish=AS;5u@O%EFe%l$Q_KN-f6ZuC#3{p_@BE~xW%HQC>$94`zF%fQfmS=} zS#@DQ8n%Y!8_qv?1*n1u?!1;9T&@I*4EC=)BBU&vTPDz=tHOa)4yLZ2+*#$Gujhsv z1iJSWS_Ik(MV0Y1_liSVt0Fa3PkhMMo56eD;( z?G}wv?FzHbud4dZP=j-*_Dj#g`=!xKPwmFL>(kwn7N8TeXY2j4&s2=uX%f17>|OO2 z1Q_&qdL3(Anto|n*?y6F*&yA$qBTM`5ud-`6U^c_EQ%m3*JgEDAO2@r zd$-36^w*+JOIG?5K>U;${oqBVQ z^%tb`-pU=!`T~VXABUFS^i;e$vp}=|AL#RY<@qKkxBRlFd;M+GR-|rP9C{7BOnTe= zu|4K(@veqskqX_H{-B6hhBg?XY2V8gd|fVb}{;=9K$ zc<#T`O>bH9=8Dd`Knr`Ju`k`qohMmZvol(c=#f2t*9HOoZxmY1NWKdaV^YYsu*UA-pAhn;`Vk*&m27?ub zg(@@i8ZHqrx(S{xe_5iN3RO5iOkKz@cnj~$yx?bo-sVYI%A3Gf9enLZVJ=9!II%oB z>;DQ_qy}e~!ND$RDZv27CHV>-=1eNpZJ!*2!-ptHcDUNyrqX+ksYWMoz9LInRS+T? z-sAAb-bm_kl5+CguS~b*3QUIq6Bbs)oS;u!*yZGqzwnZ`e;yYYZxi0jgSxNXJeqnn zx@u5e+3r7-?>0~m&NV9i*O&R;AUZ0x0$ArGS{R;9C7OBVk;>H~JV*n@>^9VTjwo&0-y^ptobRy!(qS;r11FvWump4D0L`WwR*KZNiZ;_7Syo|1o#J(E$WuYh#2%QQ6)Dqx=1fB z#w0-2gWoJ51*s+r8ME~2vOY%QSh^rBDLf5^B`!_9NhS`qp*EXw+^Cfs#*&Z%!oAdZ)DzXexFKC z?Q3kAf4nbctPn%oNc0Q1t)LT`3hT1k=f}a%35~ZzEUHko$pscVgS?EL2zZXRU@aY= zeVCn7*)p-$Iq9|(J{q4d>V+9V4@%$X4nhU?AaYC6y_x2trL2fXDcarl{N$KI>LVD& z6n#66D4FOWG2N$N-4))G{mV0z>A6Bu7 z%B(9v0Ujq@vVy^-wGSL6jjf>9J(8j;$eBr>L+G-I`|9sja0i<0L-H6ZMWCBRyjJdQ ze|pfHk=;U&zwDHas_ca_Nm->=k{lmziCrDYC4WRhbzeJkPm4a3eQhuW2=!0p*6AUL zW4_QB)vVGQpRsa7yAoq|C^p(ylv5mCr{nUs%A296?8JXOp$;N5_GX})39 z6IHN#=QvkDv*K_U*SHeXH)dr_7bowAVik1RE?YJr<1$Lzw-SQ&_g3s4;I#@%TFq1cU2;dz6@B zQo5*|>U{6Gjn)$Lw5#~0!m#2(yX6czU}eC5ClWZC8ww`k3o;|Vr|7~Qe>gIoQOSuj zrfJ)*;5|T0q zT`woJD9Z2`xR$M(f~rhbjnCF94{~w2@p#(`p_Gr{Ay{AEZ(|YGckv9H!e8Y+O!RFN z1jG*I@0k8M}7sTCP|J;C$wo@C?JZfM|CK%5TAhLjhu=p24)|5Oapep9o~zP zx8!>&$Y>QdQ-auq=va-)fIb;fXFm0M{)?qnn^Btx97lJZJG5WKrtEQ@3%rQCo7ST< zEXO^?@-vySI63?qf9B&c5TiCME&K_0{HjT zveyma9@+;@VO%TY9r6G$?Ye*6m^Xa^y+8dQw;Qg5o$h~vd*pA}iNzettIx@}vQW1e zHrmMXZub}3__eq!_xw*1xvLta#gj9@i5ONG)CJrcPNkU;f7FA71akffyInF{k4x%B zovapT{LQ)y?;n9QiIZ}aI4_JX7Tteu4Rvv#ouFU7+2mlfy0obO0tK&WS(6xcU1-El zXn9e-A;i7y*Vr8(t^u>JZQ=^iJYq$Riil911Q6!Zs(iHEc>QX&r0^+r(`K*Yd3r@8 zT18E>6GV{+f5W8-7MkP~a1=Mu_~54M%r26dX;-D%>zrg#yOiPR!Q?;W5t@jG^tg={ zhAxK#uMWele(Y~OBzPwp?sWQgyoXa}bFFS1t-RfclpulVFPBV!@P!h z#|gdPb81E!eK3V8Dm%f0uPLff9~|$r_idR-%6O^r$c3-Tdd*h6RLsP-!jZ#;ns*@} zM(yV5N%|m8me5b*DlF{2qDuP+p~M+AvK?gLODPKDx?qlwf!tXYLJ8NMQ0K^u&VUr~ z;3_xfe`yuqPc)fmnGYo|*N zH9kKyS3xF_ov}55d@cp;Cmaw|W4xt|*h04Se*~OY{S+ndR3g$pb*yd zI4+KY{q&NE)hYXXw!$H!l3Q?er<^QQUHH=(J~@F?fGvAxUml%Au)!?p>C>3@r{v=> zrLM@F_eBBw6`m&_jIRR2IHWk-;U2#LOD-S#jDPAi9jUC|lg-8c*ca~G$LdT+Re9Y% zeV8VmpJ~%@ZXb<@!13vex2-IQ6LVs0X_d7f3ci7v*yVEZ42HZGe=WXPd`h+_sWC~eR zIIk;TceqLqVEuMI!o9cfF9qE#z>;*Pr_+6s15LZsBKB)xPKxWuTO*M}Hu<}@y8WLF3`v#3{;;~R7?=xPDgvp!Q%us<&{E`S2o4P8U{aW)w}r-e#!%SUNJL;7Z!Eu}u=qISkr|Tuou~G3{NeiJITTSB zM8+@*H=t^ykJ~CXh#^}gc0Cw*uqwH=VZF)QV;MJ$dZ%`RYqY#|e~A+!Kfo1CY`2)YCe3QGzIKD{3H3pRFXR=Pv+Z^cn= zMsO_~ZNZcDH#j&f_Zh;CsYf z>wK&oPVYOEijX8T{`fNGc+jlz#$%n&H>on_xy|0-ycdivoR%<n7x zqdIIwl$nw8*1h?yvLpArgz6u@mf@e9i{%v}bQK6(40PGtNlfCUt%-hG*$P{w)Cg_T zfZecqE7MKFu+EdEDsBc?c1j;GL+ud}TdF6C{5>YEf+2%&#wLm7bm~! z)DcUotAVg(*8LXDzY%F7m*Mw$^mMCMq&W=*5ie0;1RDBbuBH6jIbs1Ns=*6{(3Sz; zM8Uove@go5<3Wy1;S$SO3liB|xfVz^G}S9OW9!8(?%)rRR6^* z;hOjHT_t0id7!`2sy@uIa&Mc&4b0gPf0PBBv`(kvYb$ZuX}vM!tPyZ#!YnusHh$J#(zTF1TQKaU@EQwz?$b{j?S=NCIb~dLzcBtrJt&zy`$`cp#y&4Me`K7D zQ@A?X*VH*J7KG9nzFo`-xjg<}< zc}DdAEp~hdDNPsR1LS>3zoO*O=QS-;-}|seFVtb0?UKSa-^s+ zWr~8TGHW6<@o&B>(?u+)R4`&Ee~;XmPWbBm#NXORn*8ph1OG(Ll_&l8vZ+^lLV8bd zfYwY)#&d2gDXAW#FD82f46DnqbD|iNI@K1|mMuC2V@e<tfJ{$Y%Rv zTm_>jy9pO=S!XShf^h`d@R#{ zR3kwt`X|h~2v*3tv+y*!fTwSb*IC1a#%ywuB{O0-80)<&b=1y%R0fo17;PCJT6YgG zr5Navt-lTROFD^lt;jXxe{gP?x9y!x^%xcbEP#BF46h`S%^KEkWl^5=jxB+854V_g z4cB_U8Fcv-OFX3^hNGZi+1X{vuzcYp_?E-8XadH-)GnKb0k?Wcc4n#1suEA75X^a5 zZI3{CZP&U9$VIDrrs~{~pq_&oqA~i4BHG^~%%)>s9!vazfNGSseOwk?3`;?RU<*>qvsVJwR8{hy(AC=jQ$!K_$No=1`|? zY%(wZBbe6qd{Rbcf3cGHtEo62=o08$8cE(LeV(u&y^1sxtTfNKDT35YU>V}^M0zf3 z?;^-1-PG4hqm?c)(5qav8hYzb*^WR!K9&5x^SG=sZOYuJ+|c_!3F=z1()dwxXYIHP zxSGRKGCq}@rpoFT92RTN_{49nX4U+HD(Fnd{hZ>sYXB0zf8_5~SHrnI1rk2hA)C=2 z-SP%`ZV5eC2lkV-gfodPw_k z|9BorKJQ7(f8luQ-#4?mle-Qy9d{MK#A|(n6`>@6rtEIe$5G;XGNkJz6lrpsM#3Vw z&i)~u?;I}&8$TAHKznq0T)WrfB@=KKTpM2DYIkWq&RjVQVu0rmpMhEOMo4%B?FI-e zanWS&is*52CYu?Qz68!^?fmdDbwluFKb=O6n(vwee=L2?9$jHbn|Lh4V&Ng3z~J%+ z_i6?lh`ahEHQ1xb`@m^E0eC>9(v`166d)Mg9&Fz#2g2uxhwF`aYT!Wb-_q3jS7DUr zPIMH5FOMc&3{D2F1q7KSoLa0W@ggBE`c<`_7>v8PZK5V|y}N^t@Ob%lBe`pHgV;!X zB!>+*f2M(9W||@EMcAc5?_Kh!G4k|r5JX5mkDoe&w*Hkfz;qNXf_brr=dZEiO<6g) z8-M+UT9;K7+H5^>Q|v1-{>0xjaA@H!ACBZL2xN(qQal&)`7Gk$Il=Y{Q$O#5g{Q_v z*+_%xQFnrQ)XUed$re9)pG(J0o|YRh9niFIe9SNr7dkiRzbcbU~!wLw%7p zf61ZqGW2AT(D_FMgVGHq#X$zgM!;H#&!{2!PWS$N|p+10B*w>+UfGov@{xvolaR*k9k!@s0N>$@=vF; z3q~}RC5kQs0Fgu6w+-!NlP|)4O#=a4f2czRFNg1f>~=fWd%ruX7mA64_R0jvDf& zQB7@8P4d74GOBJeMK=fwARV`bMg{8Ii8X9(Z4UxoySsJ@c=K;nSln3neUs7-e;Z)K zW4-Lh*@b(XapmS6r{#+^XvSM++d4ir(BRSPM85K4tL+3f>%*NL_k!Yw_9 zhn)M#r{Sx5GwIzFVs10Cd0KgHQY7CTeLF|pSa0ZoE`nC_@l&j zzZ?N!!LaxwicNutfOcGa(Ew9^4Z=;kXY&Z!G>u&48oqe&_#12f7s}Qsf4ebrh)MkY z82}~t*_H{*VX9Fkm?U6y9QZcW@Pyn`tMNM7bGHh`xaYMy&fKJ7)|09h`od-tZG<}^ zS;CiEyA=`luwsn-Zh&SK54$i{#Hr~V$O1N1$Azx{$#*!Ty^N$UvMLR(%jWyfI($O+ zLQ{OQy>pp9nT&qv1Qq#Jf6T^*e046&7&Hp=5!SjUDHAT?PL~`4HK%}rw8i_a`%$*g zB#Cv3TfZZcyuUL>fhm^v{uSC1ANPEyJlimI(L4M3UbBtbv?O710Tq=J$9uCU#12UZ zRQkbQu+F%)ukNDoWe=gsyP-K%TP6k<((<@-f8(%47g5wR%URS}f9j~n;Vn2TgJ*NH zl-7q4TZi?J`vml1YN7^^Zowc7!!D&T*xXFqJjX#}=_21r|1=Fpw-{7uw~7!+=KxqZ zxCwfd$97EgC)G*$E|@k6LiiR=rv{kAMXWM1`dQg>RR@lFn-ZKMwINC@eDo^A#qlMq zEs{!D{#_8lfeq5oRK9eF+%0twp^tsNf3x2`-a=D#6k2zAJo=hN5Y?0k z_Y%2)QWh=Bs!N#klTca=g_X65^VcKV->njsmls(|qx&|1Gl)kCJ8dtCF z=8jx+D>c}RRLAm^v*Hzq^a=?<>Y0MdQ0Nv+}47hZ| zSG6}RKAcs-e+KYJoC5MF`}l=;`yxcfRwF@DM(JDVLyH!t@38Eo*FMz9Hi z4dHcX<<-BmX#sQzqu~6XW3-kX;NHIZ3!9m}JZcB7qMLD!E7mkYn;sK-gpq|)-t`JR zH%juGVd$ngk$t{}DszN$jM|oNfooV=Ch~K`XtSide`mfGx9pr>lDgXU zfvoxPd-`?$UyQ7(>&=nzNb7v!2@k9zee2VZ-cmOe*p9cUy$H|#enbWup{ahOq$Ycr zzGAfNAb386y8tv?{Lr7#>k6a0!^Iytv$8L!L!YQ)3BRuSn9^z}Vo96%%?of82FQSt z{j=d0f1>$fk^|?-6IuD#I6oE1+pO%X-4T9*|4!9Ie}dscvJ~wf?SL0zWim%H2Fiy8 z?p}67skD(PtPal|Az^Do=wwF&YnNd28zqNrxmNGOc5sNvkwR|o`3_|%XkDwTnZpPE z$@y0c3aKO5(|)Ki)GEDG>BS(AxP{&XDZ?(U-vLKbJiZtrnM6c-S z==uYu)%I9-@`;vdi`EK~OsAzuT4TiPM%0EP2cPK#GR}z?8dA_Mq|aJKiYjASy#mJG zf7gGm&~UvMG)LSdwWV6q_=oA6>K(DJbw>H=$_@ASCP zW3v{5lLxCvZtM5je-h1fT#D3HHm91BepK^U2AWNzlZ|xGC;w2SUUBnw}2Ku#E5w&Ts@7f zDGE}n&Pj%vP^3OM%)t&Ra>f-6Y<%?;!gJ}W4kLW{7jL;F?tH3nVhVQAMiyVO5w_*D z$zay^%}^Y1cguoFyb!6?XKuJzf9O^Ju?tLUfA%#bG2ZC+I!#e~|7&XZfre z3DiIu;}O$E*X=vkLwXNcfdj7;*JYkZ;-I?jIs|!7Dgcoe+J4R8-Q}GEDHS&<*|IJfOcDG&VaEf*^R;pU@c-(_atZa zJ}d(8CMKC6RvWmfjBKe5*~GaT_+W1*cKT6aMggW84AU#9pySe}tuXxC)d1kb(S}&j zuB~4bQWqbXLtb+g>A}P>)kBc>`D7(;k;g^$kCgc_{idfalOZyKfBvd{Lg~cu5haL; z`;n5*M?~4oj#?t5A=ZZtVJWZ|TU+-n7#%j2=^dF{Txak zX_iJk*YY&m#E90vGfz%K^*=^|tbbZS^;O-QtjHU>CHa_yA_X%<7TK<5)^BJZuTb6n zP*NNT#JUp2UocrZf7?)3TdVczZ9nrf!SYo$wd&9{6qV1Mc+?5zMWg=;!YeQWe~wtGIrRDPHwvhf)t2xd zr1;EX(*UoWX=dEvWCbS?hRvqHhgF#Zllz7$a$~1dcso?^fSp)g|@Gh4!21%_RcM!U8$- zCkkmUMga-5e?j4vTBu!60{xuzDQldeHeKt((H71QI-MplkMT|Uycn63L% z2Pt=Qd2^-f&o{=CvOyAy;Z+3!!~)iD0^$(pE)M&+3RuCLpwo`QEAlv=wM+EmH5DkY zgBf38f7zw5D2DmjP&pdfRy-c2GB^_S-b{W2JZkuv3!qT0g4|u06gg%{QB0-Kcfm>< zjiswISQ1X2u%9}(+d!wb2X{>Sd!_ZUK1kAS-_@g)Gini!ngviABTa}5R-`Q-`#N4os1ZGwpB{wYoMI>+Qq$IbObG-_#c;C2tO&w_OnM_HVD?sO# ze_evkP6MK5$^mLNz#f(~KmeX3PEH?l>zF9r{2{;^wURjF$V?lB(fx@3O5n}UZ69KI zs1$p$B`~vk$Z&7`LR{;wAC{q$SAQZ{Ot(TK(rKG!vUZXqZkT)=Wj<|HLz4)*%I}G( zzB8Ptob>DegRGXNleie!)XgE9%ni$df1b0MFPaN3V@_VLV>B{q+znf^c-YdybRM*& zm=e23u{4sO-bujPT;HMk(iVi|*RP&ZrGZVMssLVuiaITZMulvTNgA{z z6(;V)X&zWqWmWVVPHjXU1Cg2*WL0JOg@tNYhw78>*N~?2E)iUUN!q;bjRD$@l z11a)a?|e`jq)D)x=g49*%u)+ge^8Q@;9UH2z{#5YKslL`f2*+-Cz*M3cOvhwpk6X)B_>V9hl;VO%NsqK_;dK2nKpz? zRA0ahdN4mD?O&!+X4D!w|XEf3ppUq?)tq1}&9 z8f^}D$!<6@x-v2quW(jga-|*DEx`?tza9J z+64%wYBQ@7r9juuC8kXIKxS;}d)_u&2>WKyL8+aXkwVeVHdc zo&e2nin+%JWXa8kRd+o(&Wo{^B)`@XdUkw~!HM>z&yLS-vTUBomv?X-MAO!_fo;~~ z@Q#gURvybfM-Ww;e~=suf!UeK2`7)a5gS4Z)?%Q;DaJT$m=;=JGi_H6fRrsfwh#bj zk<3thAjxOaiUAe=<|UCH8GV;I*cv2BF}g zNEHVV6U^rxO~DeQ5Z7STq^J2I-(S<)@@c>0LXr=OaS1^|A-~Q>Q`rp^_~#(=HmIum z*%2?oH$=lsr@C$v-8yA%y@1d375b(h zCo&58Ph^Uif2X*8eKe$(ey(#og=#uUq{%pIfs|#kc#@0L6IRGdwATrChROWwzQ6U> zcsBbe*F0^XnNl@X{%u`2WIr8VrL+-T-hP)UhWN$xjnupBHy5wJBz`RcFD#WEcN(F% z-Ed3rVdYcb0Iq};fcI|0G*H5}1UF=nMl6_W508G?V(= zULyLo7)n>%$9;@S>(lm!g{o9Zo)q);u$pP6JKDEcX*sn0#?nO~5Q>N#9?r>~-q7u% z|DI0UDH;ndUm>s6LB8FKiT6OqAPHumCkyf2f2U9#J2YKf767e4d#ket?4TH^#=o~I zcCIofE&=);%J#ecF;9_#7kaK(C>dE-J1TCXps-UqwO*YtLj=7K4e}Lm&if)mz#qL_MtizDTsk@=7VLN0Wq?vtyi&RCah9<*x{{U%97w zHmf~7u`h;`t-x*IN|1fl#iD))1=#;R-~8S(1fdww&slXw)zTC!-LhCVbVq!yO>DZN zLGz=_v``^>lA(eSv#|4QD=Fx!5iko#e|)x1l|fPOhZ%;*)t#}m6@+B#jw_6z7Z6RM z7Z!LKlF?QcTXFb6Ike$DdWKmh65?{Yie7vv&3zJkmJvHJDy%)#TXB&MWas-baUH6* z$TqfB&e4E_zu~KHTo+8qpKm#czht|{7qS?Vipk35rh18%c92&q5YRDfi1Ddv%FC)} z=Cr3s7>9vg`^vl~?{@kOx-i*We_rOK+-jRSgRge*>h?ivj%b z7D6!tZk}$EswVoX4z5Hre)*P&AP;YLGLSBCUvgF$K*`meTpMT8m=6Z{4y<=SzXf2{ zfhfC%W!%T@5b?p1%TzmtOO6|eZH{1K_eZ+mWj!1a@dhA(1{IU_dvi`5H)0Pm6{v*J zY)-ISIbKwzOv$Nsw=w?VMQzdI%?r3}Om!yJJ)k1KN zcJn*iQt}MpR!i1K`m7*J({@MVS1f$T0EGpM?_c<9QcE#~J2FN9cHW{rD^a(}@Hf1ygr!WsVZM^M5j zt_5!u{Z+QDp7^sVW;0(7EnlMz#=xGNfxy!|^q8Ftv7@Sn>1LXt!bniD z8PNmgSM>4;fnWrHHr?CJv-9_B*#a&9s6yKrOCn84ceN2 zbr@Q}0Cm>3V7~g;$U+NmkfOz4?X5}zvSR(&-E`jgU{Cx2VGt+WZM0Re5Knu*(ejkR z*d5W%8O2o&spg_fc$%bYOOvePmJ+_Pncc`ocJo|$?LE63e}|qwea_iZ+K~5| z)M9%xr_$r>wlkqL3&?+2o4AkO=ep!uVi0IMY?L2>>lj0sV^wR&`pCY|)nisP^uoQ? z`FSbF-&&VRmZKLj4qW{za_h^KJN4v_2AZBu&I=b3#;U0It$K%6=D*RA<*uoE70IS9 zHajVxGpNNSf7SQ7T%(63oxH2zSsy;M_J68VGrAE??J^ z;I8ac|R2>hDeYJ-c_D+FsEV?mV#jYG8XS@oIjj^2I) ze-b5c8}&>Q{MYkVkeA?_D^+~-gTE%o#Xk!PD6QU++~R+-BLMgr(~pR%aq>yC>?zL; z+uKA|S1gX5131;vAw2B`EGE>dSksGoqm9-YYR zTabVbvM~b85-ee}i4p%PFE(@$f3IzN==TwZ^uef6S$gjwMJ*~Z-ud+z6ksMUyhOme zL?f1J5r%c>K(;+>4xtIn^r$w{SX|t@b>VUi#5m|VlwR8r#?jg3-3(YCQuW{`0>SUX z?mP1sJIbQX(%l(hx029!={Q+l+iosd(5JL(vba|fv1ohg=uWyB*3i*fe<>+AFL0pY zfRxn&{YR!rc~jx}8gy$V%6xl)ny%0hEa)KQ$&n`935iu(uSr>obzW(Vtz*|Wz_dRC z6d2Lv(PR%00ok78s?R2Ziv#?|UukfXUx%%;LQNhP%|TWW0bN`f@{%yGFWH)9DK(Pu z(cO!EEleaRc=&lmafx_Te;{~#9_i?uZxqt|ob}P5ae@sU`ZzZ$p;RH$YZf3VftX&i z2U`Hawhd43vxHYuiT+Ahb9e1tqG42(ihU6_7l3ky?Jt?87>@2BzG$8``=GAtj31(Pllj5m=JEze@9w01SGo+hqI(T zu#7NYNjh_>&^e;i=to!>PrWHriC~HeP(G)0aVn5cyEh$?&G#MA$g6+Nk#HF+oG{?bafiCg`w*khixunQ?Oj2!d_;#3y!H_-t}S8F8AP^088yeaj6gQi*}dwvHYYEx=R9zuQ?E5Khh2%bMs+u?K_zuKYDoxAdo8piedC_-+`Ua~ywWMt7&$2ek%l`&nA=nF>qZhflnla%gt<}3y|<=7Mv z9Zbu|7`GAyfAN06S3k1B;DZA(Lk-_{N%#<3;go2#MlG-Tf${&R{K*`aU0lw(tqhJ& z5eY-Y-J;5^gM9c$xqqT0nAB64g8Rwz-t(2RH5b-1vMLlUDN-xo{Qa9CRac|{3PI_b zgO=ekC|^3Bz$)u|i3RMiuS{Dj#Rz=ee`Ni*|CZo5WILI-1=2gts`Rwbpput*O*V6BI#~bMH!E?N!(|_mE8pZ!LsdTInZLIXx!&Ud8yJnqYPtWt>A4PZoUHf~lmKho|L5Q( z6uPBle_mT)#uNG2iYT9F^h;8E$fvT^|5GNzp0M9MISX;$C=NI-wbd-{wyu_~I$ik; z-JC=HF}Uv%tG=nvb@p?~Q~#!BLly|Qw<-6W@v!_SM}Q0O5%NUoUt-HdslmVu_t3PL zpIInCL7WggBLa}x96}uIN=;YE1M0Ygm-=K2e*?2Jzbu^rAmcD&E=2?Zx6Y<)Bo-9U z{NJ^%E1~0h7cOF{H;>zT3v+yiL;GFVmOGN10Z%E$jiKNJA-&($vvP0l>ionb7Bm;w zucO3-g%V0LWn`~p{5NEB?Y$PD7V9l{ZXV4x3XQNL7HM{Wn1uOZU@y^lGTOt7@|_wO zf82gazXx>M!Ul=LC)P3D#nv)tK|Vq?e%$%EZ=`0{3DYrpB&vPY%%-Rvi5eQtZRa=D zXMqgVR3NqQMdFBM;ja!?5U_|6Jp)R#uPbpQ2rc(c4Csdh#jkH21%RV9Bn~A z=?U)-^95lT^#_ihUo?1=fr?U(!S}U%e}Sp{yo439K)k)rL;(kOx5xb3_q#Y&5}^Sw z4Kc{1T_nL7XHN4@`>`wWS8bSf7gml`E;1X#HAf1jU7Gq$1KlSuIIw;WLn1Hb zp$&(Grb)-mqFq6U>pcum!KsAK@VHoJ`?~sUrz#jQ`({_k^{P9TQXp|M^OioDW|^R-G?QB3!WzpAjy zW&-kG$|*6_QiBK=wO0A+(n+|tA#Yvk(vXP4y7Re7G+s5d*3>c|?2>&%s5-=I09!=_ zbln}R_G_8-l|GBQ+F4C0gr(&qf2Om>N#w@4m-|r6Bt<@0z_HPeXWO7zDW=?bN#2mm z@<@C2Sb#P~XR+-V$U4-A;iLO=e}+<8s2qLH~oiE^_;EI z;2)1C#_11%j>fwjyetk0LZ@o~fs11Dnavmed;*OUS}3*RLyDqsrZTC>f07IG&>>=O zC8r%+*j(OOHlbocSgnDo~s{HkO8e-4Foz~9$pptotSpyJwf#mP9(vn+!-r zlt~K+QP^-f-w>SR_?mdpUmwuM%0x}kChSbKFCWqD4VFscfBmdNQM zCS63=7|DKbF}ps91xjF*6x)XAbZUXD{blBV4f-CRxFNTzx5ypKo@~6Gho6)}YGrBw z!8%t?awHn`f9_M7NML+np9xuy=i?m#rV4dFy$Qq{)E?8e=o6VOnHN?IHJHn}^t`&L z?1-{YC46O4T0b2TR8a#U)jU2yKypT!d<35f|DhB5xQfAd@mjHf3gygHkyoF76mz4Y zQ58G048K!S9#HB~As~V-!8t=Ok&q2DQ*PGExNiflf7~R?e$gav_&C}q&2*aX&v{rc zrb?Wr48FVdoYD9$V5-UUM;N;q@i=vJS`&vssr=M%It33TA~B{YY?Bobsy@Qzh2@xx zS1TovV$rE>IFazhtqfeK1d|tW77){8ytcPl6&UO2kou&MKw8enLXw7fO#o$aCV#FZE`cP#+NoiXN(0R}7b z=F%(u5nc1!g4) zMe6nVHh)B;vEDVt1v?B)?WK7HVT_&JVQ}OreCF9gr7PUGTV5@$HDaIjcy244E&zG`+zWH#4o^~o0VU<s0hMKWOXFoboHDja9)9!~Q-9Qp$Po7dmgKe)2l?-(p4S&BWdN=J zR}t-hSLV#!*7=K$JKk2wP1a=}F;Ldsh>&R^^4$RL?aDZA%bH`~5()OCr{Vla&Plo; zwxu)Kg$3y9LI!g(xwvMK=8x`Rf+P`G0xTaoG1I3)zt!aXIf(1Ps@G!=mN9EyM%{0Z zv41xX$g^4PYnDONWyTRAuZVo$Jt(H#PPNTT9Mt3mQ|33|^GMj#B8NvuAH3H7fNO2Z z%TkH(A$$|q1b#c#*delygj>qW1hs6Oe+mTOB^9f+`Z@h(NQbk#C{6^~-aV5rjN+Q7 zRe|oT3rxmHT3bMQu<*-H17}n&0{b;MTYpz__!5X+Clq|c zpEd7`1ujK&ZeWqmZK?SO?)NJmDt-?9sUHTlX&1qA3@iGuzf`R4b$S0)v)gW%i+|RR zH}=frnY7%EG+_MCf&nPfDD-eIT3u@4Ao}Zws6vHnK92_MBV- zIu{L2RIg2Sb?Cr4Qx8}RGT1I}AAgDky)gQhE>M?=EuXc1y}T%2en@=*xC;he-kFZG zoeo_v&!-EKqgw0(_h5D@HTTFYW2%BvjiWnQ`i2EUfM#7||K!HQEs(!Tv7X~I<6^|> zv%A-%T0gnCfB6L2-_;#Zrgzm^D}ndB**@y82-~rI0U{bYCGCwR@t~IW>3`9wety5- z`Y&;6pSJmEm$^L+ZMJJZ#S#}X`VHPIAmUc1#GzTU+ zmB>^{8w3=~h+zwQdt;Ap0P+XygXCQ*4bLDw+hlHC_=44(L1_=}PU!GGT@N(~bQ!LY(D z%KJ0g{mK(cW0e08A$q+mRfQV6q3ZfG8d!$*7GqYWlpoc+YNv#{ADlssOC|iO2_G>D z27u6U(=J*26%aS_;I=>0=}3=<_`e!V;O*Pl6=PYzjvd`1{LAcNd*rz)*^ZITjq#U~ zS5b5YB;rf(Y2id+B7Z5K3^IVW@Fae3Sm3G0;3m!gl04wVQGs^=ECgdXOnW7N+3v_2 z>2zpi2=UxJ7jQ8%f`S&+^uMryVJ}po*LGw%S0DRZWG|WgQ|Lz|;eK+weem^Q=Vl8& zEOzap$6xji47Ob{*0#G0=vr-lWCNtW zE7|u-jQZ))YTUCQqn-n|wj7Kq^gT8hie&%c&j+One)w1zSU^@l=%!G9OqR>^Ugjtz zI*o`5Tt8ub)PJ7TGOM9hdnz=xr7xr6ZSLk8A;-|M?&>B?`nleX-eVnNG=p1fSy?^1MuxP{V)0Y-uwM-|FG=Px2 zXWXNB+4D-T#}7TqK^4a=FcXt^jF`FArbA%5YkC2n_>;8qDseULLQtsX#0#Xo=YLQ- zzo+YP-S?VzVX~hn z_MOPi5Pzd4xPR0&9}@d(jL-vZCQltqGjo`N;aUxWCB(JINX8%MO- z9|+{aLt!@oyzaLjv3 zNfAI~z6g6eK&&W|u103x6-T{$6x!wyOkH#;7xSYa%{qEGLTA=cQqd8$dp{XGW~mN$UPv6TmKSZ$?*sr@g zOCLiH0ivD|=M`J@+$f>X$2j!AH84ldCmjw<5b{LCrSnWowIn{lVHM?XMfMJ~s&Ao5 zS67$QrMJ&{2PGP^MLmq zyakA|1A%=3AVN6Y`Uh!np?{2guB8SO);{YEF4pB>n+`JRBR`M5C>a;smkvPyi-cVwlL@D>*W+%Srgh%YT2r zrtLG-0M|GKztmr^1R2mPG!!boi;ZZi^Mp@W0z-K9U>jEg7=^>~+7UO71sCFXf$2+2@nG2zi)CRy_9HIsD!U zunp`%4^9?Df%Pe2)Ri;&&R`a76phYAFTKr^H~TQ)u!nM{s*U-g=a!T7;(xU*aoOd_ zo>|(YCAufmL>LzV)H}tMfGE`kf0Fh$F#Xz2iKNH*$n#7dO2gi;c4@rpJzc%QeIkA6 z{sniqUpPQ7@;3+Cdp6(O)Y;;W+c*X1PAoa<5hh?2qWeD&VkP|vYeR2Nhp5L_XBM`E z{zBIfu}879Lib~A+Y67hGJlHI1-uVT(|cY-7Z<9C(=w@wEm}c#)C)2LrGwS{V-7fL zkn2OS>=@Z#*F--e?ntojP7r1)2kH)4!L=kr&%e-?FekxB9>l!!&%Hw4Q2CE(c|2>O zM_^JEtOZ>oV=*O$nI1Cz>YD^tno}Rt?`CUDvh4?w%~C^a;->6WD}Nc8YUg+g7lKq4 ze5WZug|SqVYr0cWQuETP_2Jw1Q?(bF*&f=)*lnu_?bqLDs!BTbqYQXZpv$?5d?y|>`f{o=!d+WH*sSjb951c8fp=9>Zs^PovuNf0+GfkFAhK9 z1XUXOV#EUmf6!pOUw^gRe9gX^8^vo@M3U;+U!FxwJV`v%XEc3<4dht_p( zQ~ya|7aAY1*Ay@YIVeH>6&>MYEmC^zgNXBi3a?yM-JnIu*)nrq!MY}XNOopV>g5sI zY-!)%ZLb+l;dmMcmSwqNsDg&lSV)dPmep3NX0s_na-ta>Y=3NJqNvK$clEv@zN-*! z;mj;M_jy#n>pK|=lg=jCUN)lhdApmv%BmbtsK^pB^2Ms$d`l#^nLl03^#bfkwI`24 zk`XiAmURTx{0_a>h8RMJeL|S;+i}~T@h00Djqx2Qtd~Q+Y4Ump1fv&Iw{mW_{70w# zFse}To^7F6Jx_EM4dNe!(=t331a)^myz?xx315d>1%Fv^i>-O$Xt(VDrE2&jd%y+v zCmpa0ta<+5pIKy3nqub%95G*#+w$$0GqF{%E`Z2bt+GUmsgiIRc3vrKk;;%}^|?3$ zs#6f<5it@P*x@Z0W0_HG=xJE)ZbvRMavt9+_~telhK0A2&Pz5O^} zgf0E)eqPyA9b88L(&L5Woy7DC*3oK{*;k7eGRPQjX zwY3ps-R(c+9{c21F#LOF&wPkY3r-xG(srAp%=IzYZ5b1OiL;X_1rT^|kFzI7mWR_f zI-sVyRD9pa68R=E*YV-YxZiMsBigau;H0V`^p=I;Rx5lj{^E;Ma*xkd{VneN=awu& zh<_ZnlP|*MxS2CNC55v(!SpAfY4d7ZST+MG8lNN-KjQVo2Dzed-*6=q-MK;a4JW70K%f)zxXdN0+ z?xW}v+1^hORq{c#VX#2P8G@KhZGYKK>6Y7kC0-M79FCjOASKl|t$Qx(tkzuyH5Y2| z=vU?v52&2`$%yM;$__<=?65T-rng4U7OR!&opQD|<3g9n>1n&kePOdthIZZc?G!qH zIrgO*v?Zswahm@rP=rnxGNUOa7GHbbKy;f@V@fa`q{u5})OGxWwnU2h`+xkQ#RGr} zWgX0}(vpnAtLAmcIwDvICFG)v#fg-C;C5*lU@&c2EX`1BY%2%(|CZxAwnfdeTu;=_s&Z07)82w=WATS7%6c<$}ijE zgYSs{)!Bh4tRir{T&E-`*c;li<(SMbFpNIoLw>XmgA6S|Mq6BHc!j2Yd6q|~7^Oz!YmtK_e!wmn9iW5dwkoK2b+*D!xO5Q6(Ir_J?9 z{tuv+NOd2Vs#UbgH88T#%(kB?36LVE`RJ#%=nt#g4uyR4fXT*WN`?ezM zp{p+?^^%c%!_dGY?)RL!@Eb)iI3p~O&%%W>T(@%XV{P7*piuGYqP&5QtI69j%iRIU z;B>FagktFg^P4jv;w3a6q_n9dRRw6Z)#zgI7q1KGC=!pcv~a3m#DsYgeLnyL1{}oz z1O$oAZ62AIzJE&j6F?zJkW7zxJN8^cl_frFfk7n5=XT7l z8wV@*QcD003W8_AX_5EiVuf=Lb9VEQ1u8&GmndBsN%yQE>`= zYXnA}rOD%Rzf#FVRs z&kNZbBsh2A89WYqpLj(qkSUHUoF1TbT`S3lcW+augXCMB)8W6Xe@R?+qauDGO12|ElK(!EyeRYSEFAK>%_I1EleCP25 zco{PxD-81P;Q7}FpGkD)5=*TyNNtgEVP#z?s5D*;+HEhoE%C*+w5Jj=Uo{Scu|MKv zaYMaQI*fZ1W5qqHaGC!xg-aHRpv8^A;(t*P0SjwztF@Vj{aD(C$&I!eT%x!1s4fhA zr(ONf$DiS{eEiMLlRtiPBthW8z*|x7UMRNqgY&~cjL`Tca<5%-f_*unW|BD1M}Kdx z&$T2DgY! zx$NM^l8youKD!RK%)R(!4O|&EfPcuMFnI5GJ&&nAh2B^CT+P_2Q5MFFPM}U2#bujO z$Wb+>>yINz5R13mmZT+wk$l59#xwQpox5E@L#_3dz%n^-q?8t5l-ihJqG;*?C6DQ$ z=>qt)HS+R%K~a98Ic!J6srjy2nuhOk;)27aQ5IBCYA19ZTUmg? zT87EI;CcC5!m~d*+w%GFRkc%XYT)L|s*b+nzv~G}wt@fg&o;cvB2VkyMM;sPRtK}6N#gg zDbr;Cjq15vL4;W6hfhpiLhE^V8!iBsU4B-q76y)Acoa#En>_*4ePU>!BxuN3$1B3? z@Y8b4OUXTbW2*9EyXSbXtvBi)lrk-~@@oYn;5|^nDLD7S6WO4VAI2U-7{W=>Bzhj> z<|qr*XPjwP)Qb#T9e;tijsLAB%XGHyu{#!#b%Eed1lIm+1?wIB3u7zjZ)Mj%3YuFO z2@D9u!qCUr@TIF2M+-TIHQR27@V8z4J7hgX84qUCtbL%FyxC|YwoOL+%tiJlbdfXw zqpU6aOg5RNfNdK`i26Yb!NAN`ZSOx>=)qCHmKln4blS=n{THj`d@|wFaSeQQ;NsWt=pF3<~E? zCKsCA|6N3l@98gUbN^PD>aFvKD{wPH#d*0T;$M4=Silf{j(;P#=5F?C$8}=$cPPlw zO4JDj?pL>qXMa7yAOQXc(YyVFiG}`7lq+Q|n_}M8QVN`3O>aY&vIB3tU$9hCfl2@M5V$$1vZxI3}E|k7BF#9 zv>*&vY=86ux${2Oass3}8o@~iK>zfld_*)+X!IVE;ASV$NqebtBVx~snNBrAcj=ya zG#M7-=TLp$oY%mhjl;`Rw%tz0mGizs(Ag~1;+n{*1#Mq+%kmugC_X(3RAd4=uKHx~ z(@$jH?V5%ptw&u;7S90~Fxhc`$f<>BQcz0jCx37k-XHPwAHu<6K2npdQI(0y?#zk` zKiXHfFQll>*t{)|HdxX#{d?T8{5|4$is{=wmvY%w5wS!C?BW%~8I{i(e5lKS!#k7w z;Dz=Ktx6?nj}I8Om6WzGL;+2SJ9fsjTvN8q4uyHn|Bh4yZ9((}0_NFlb4%+Np5n6K zoqw;1)yB{bt40ecZ2BWJxh%=fm-4i$+)7sW{z^!oCgt2N=2W`E>M*(8HW?^>_o@oh z1I9&mzEDjm*siAs9IYvzVORyuu*Ao5(@MRhTlR(NGA(ak?!!I>M=bpmKVAJL1w#8R zAdL9)(<4So5LCqrd@Z;)9Vhplr{$;Lxqm;lwKgukI0hiYO|qDqmQ_ak%_OfEITm!9 zsczjQHWPh_N1I^Dywj=0MT6t?)Hy_MJ}o4N6HcebAa+Of;Yc~zQ^aS^NPG=u0m~U@ zd6yTv|DBNarw2}dZLK-~+pu+N+EaVfOzKBH$lOsu{IKUBPR(IKf%5(SM(fjSK7aa7 z<3qb?25Tppbn@c5n#!_KryPUEf+W(01HoHWpE6FUfX&l<3|HQYoR}u_S$c@;!FY+F zFgt0)hUJR85bRI316-5qkSRDRyG3@d-m`X~Qo;EQ%bCveXd|d| z!+At6IylL{jDiLp&9QFEcuX~Hf{=4{S!#tv&E#KJgez|hqm;-qD-vAx4mn2^h$j~I zqP1$!t?_818J%4}%cYvszJL7Ih--<1iArB^Kr8G7EqGN%uF&S_1+B8XA^5BW=iT^o z5@TW#!Kz&j%{}`0GM;&RZZfF(D$j_{&u6rINaQT3Xcj0oboF;wy``I9=gmjuhGM=o zl}q6H#JhT^!PE9KJGlzB{}ou+dgX>)madNM#q$v1G3sf5Pxy@hI)AH1kwbF{1N23= z+{qArpMQowysXo!v=1?9F18W~nm$y9_~ zp@BYP8YJQ5$n}Z11OLUC=$Xcgrrl8&^JV7Z(|NSx^_!s}9r-VA8;*p#AlV3r5_Vu- z8vK=nO6z_xsOonRRDaN%A(Oji2mFVe3dQBmGZM|@oAc>u1@?JWzmlywWnkdK?q(f1 zju09m{t^zZMxDtWUtSU)igQ8QNPM$@vpdb)=|5%aZsI6vBwI!;rJ>(`>@h(L7*v=( zojY8?7IYsNNbu^~Zp@ojd94Kg@5$TaA)ENd;~l_sB4lJ}uzxJB8e>Gml@^VE&h;t$ zNqiK`<6H-BIMhjXbKoxN7`~tHLSRgDDZp7GT0a^+QCgJxWc9gQI2Y8QU>o_%n_GwLd68<)1XSh+wyUlm!J6a5GM7Bm*dI%{#s_3 zKjnlm)=qg@UwNm*4aQ&AWL(`zh{8FkFoF#yA?`F}8^3JI5)eOO>+D@rKJb5&VO zN91Ck4>kXyJNg5oUSCd(*P_`B8!5P;E;ve+E9?%s#BW?%YySy3a0kU8=c$S>aA~Hz zSspwY5xI{R_eauv>qe=860~cgh?P1llxB~H&VU}DugqP43`8}}|A9CrFoc&aY0nx+ z@4gkCmw%jkllB$jCm;eh`efcr{2|0C4u!|5wLzTKQ=15yBT_n)i7DrB@jG=C;%~q$ z0dl6*odHCsNxytO3bM@*e}yA21y)zd`|)e1CtL-E@2`%4Ts zIBj0N04C?!hjRAN5*Bgz+nDi9IK3Yoh8?#@8pB+k?+-Bpf?t;mlJ{bc`1 zTjXg;cnWV=_LtF`Yp^mIuk8u^&UIB%4biZniynvJ^T4C&ExXzSg9F%C;#{zCHu9Tp z_kT5StqqZ%8Lpsjf%GleGg#c(?06D!B=)cspobwQE{?^=uL*&@VXZ)I&DFI0@lxY% za!$Ma*w^6VuINNue}|7X1&vp0DF}1bZqaW^xOC&G=JC8oBs>(GtFu6B21R|dS*hi2 zO8={a^&dCMHdRt5Sk}EpEkkC6os1etVK`HYC%S4iuY0+WOjM)H(o%8f;G|f2iSa%?_#TZhMu(EqM%Ilfs!BzdHvQ$YJv44Kk zK76@H6DZ2zx!Bb5g8IY1W%zkt7$#&q)#hB|0)VFByQxc2He|J8iAzo}M4pCwf&DL7 zi4Tq5T`G$3y-YR~jpz8VE`9k5w*7m-sIOAJ3&D?S?s7=uJhWH$2MPla+PuSwyJRnY zMe$vR1VNl2qE1)%%?QGRHvw2ZZ-0X;X4+{gNwINB`+q&uxWln35C_e7wu0L zVGTZ$h~=p-j6nX(FtV5zt&zn(G*f8)x}3}Mgf4YS;1+yT;FHJGXdi_8T7Q_*7AqnN zoO_X9G`aw&exA$OewBN}Ee{+#J4Zy1*1bt7{&ox;c7;+!X@nSgugA~TgqeI z1UWKr#?lXfNF-=Po#laeOPe(^DADW{yTJ*s@^5xdZ^ONxv4?Nx^<7XS&qo}l1p(c3 zJB+IqLVj0RvPzpYiwSf4M1QtVhl@Y35uvUv4z4kpV$Nrl)JojP4tWyo=OW)36bR?) z^wLmHgSizvPYSWsj4`hCvD3JjZc?Rve-+&E(PCLep=5jA@qNHuSa7~ z@6>Kc6eY>(7Nfwu%O1G^J3IN`p)rtSWBtQdIjm-NYc*rSQMP%xsk_=dx}XrD9LwF$ ze;0XPX1Lm@QGed{#ywg+%=WQ8^=2olid)>SiS|?_zY)}1pK)4F#ule2e<6Et#z?nE z{ZRX$mMHQWr7SAK2UM}bhguQ*>FQ3c4wci?-9`GK%GQM2ZBP!(_UBOH_{s;AM4tZD zFRoAy=gBHiQrgG+9j!Gi+O^i>N?=-R1=g^Hz5!OhUw;)Z*+8p05xQ21p3m1FPl46a zL>?;_Td@&e1+?dVlvCr=2y1n+-Hwa2K2!awT;vQ;{7|Xrg=mb^58@PubU+j5)r!3$ z7vMlyb9MbO1bS8MX#pm9J$zL!sY4{c1Fps9UfRtcXJaMvPpy8&{pzfTYPByOaZ|ey z=B`bYF@N^2h0b^3v&oT9pjs6i4n`4xmY8M+rl}avYzBBsJa+kmOCO9?M7`MV1s;qK z;Fb6Nd>AfE%HM8M_H!RWFkDF}>NPRW-gdSv%BW2%{%x3u8mhnCn^dwgAQq=OFV7C6 zYKbFq^|v1n2eAQGGoRu*Qy6dLtIqeFfdtN85`VO{mJrzaU6!z$&u?p7V~mkr^+6b* zJn*Zr?lfCdQe=^(@;pQ@ScJW&R6Jd>rylGQJfm$pJCo-iD5qkvp>E1@Kq7~(Na6E# zTF?C-HP%vFX_(QFNjfbAa`7V&sy8W%BHq543A198=g&e$W@q$C4!W9I;-nebF(7Y% zaDTB2YZoV1V8?zYKhAzEo*4J?mN`Uzed9l@X2i4EhaEAhsY?*hdbu2Ph3Q)XP z889AsjmNK*-}9Qd=F_w)1y+3~CbTilM1Qa+)-o$`@$9EH%^2ZhgDrsHEG2A!wJ+{UgnIp`j%{eRz;J(_7v>dM_wZhR0~Ja@^Ce&I-0jh>4KyjO;wWzTaJXkt zKEB@}p!rl(wKi~tib3f}T}ca6bhG+jIe1#_6IW|Da(jBg$7T_Ov<8ABRo#oBR+Oh` zpNHdp%K)Q7!IYwp@mWM%5 zC-0GSzc370SdU*?>G&}_Tzd9g{0Gdt7G=Hb$}u$mn1p`p9Surj6v3evV~6Q8!3$eq zE>MxBIivnZNz#aSN`st*vCgb=mkkOL-Q5}073-DhF*cvF9 z-wbI(Z2xgTUF)}es(5Eh?|3*JzPH&5grdqt(}g zggR7{C$`MDZ>?J1$A3kxfqUS3l<58&CvSifdGV|^{cq&N@Di%o`#l;6)^t4M41^py z$Am1~q(UQP4RSyDf&p34)28p}Cal0Zm7FOp0*4P*Jv^nq+cjDah5|8*u0^3RBH$*S z(-AEG?kyN}(|_^2*zB|lI-9@r<Gt5dMX}IN@~{6Evd2Jz`Vjn0`50S%y;~?3`mQLKOOS3H zh9H9=!g&F<^VX`Od;b)|XZC`d9m4Gqbaggh%T!YpbgVgi;7f$ zh}7F)D3~SDqfE0#u#L^PT;R!Et!7j4b4u)H#bH2JA8ihsRg*eOYTY_30|Go-4hEy$=N4z2x!AR z`u-}id3yT{K7*R`w1-?^-YrOA^Qc{h>Q0HGW+KWY*){x_v=-y=<}sNnN{u8)0Ag~i z6!h0%_+bvsk;RUV{rpcE^0~a)z4AH0c(vuBXn(zU$yyt?`+BuXaau8~PFUzQNa#RS2mJ@*Caqq{*%X0+I8tMcg!!dq?ApoXuWq&b8 zpP3Z=?HTp7!8veshN}O6+uy6o+(GjQ=+efLhr3YRh?1!Z{=LHty37x zEq^J-Pyy1dt^_BaqPE0hxpz&4M1+nMXjewRE~|GzpYX}zaw!d0z>*ve7WmKi)5%CV z7N|R>xVQZc5wEk*Pz>w9Ksui!C_Jg7Nrd94Q(`>Dhn?V}pFwjcMC|`C_vz%3*d?u= z*Pd0mXg@bZ!M3koH_$gr#IlqjIQP}7U4L|{lRBkcJLBhyihe5sd^I-z3z33_x^ZMB zs%x~NP!3-AU_^6G0CMmUR&~gwWbz?+g4mF1LDQ4s!E}BtdNr~f5zRFbX!(;A$N4FX zwsXViC2Qi%zYYL~H_peA#j$N(2el0PIXT>ncpFBMr#LuA%r)26ah>ibMhd|UgMYc6 zMQYyRFu{NEgJFBag5la|^GE1B<=2VluvX#8QCMTYBClRB;_X<7gjg$CcTm}UQG;SD zUnZ#CJeeg(lq)_(-UbAgn<|goW5QIaNQ%o2e8jk_k!%mHd0+8*ruiW5f{z{25Ag1C zuj1jn2sZS-G`k<_Z6t5JmiFAi2!D10a2343?xVPi!pv=*eJlFb1M6X0S0%d>xBT0h zl?hG0i4Hd>6^fLmzWR@a zNy+Q7%%?B{h<^3P8)b{Wq<`_+k%~qa?Mz{x8yVT%v{+I|u#o_9L3&afii7 zG=PkBpj}ujZ}1a5c}6b5RNDO>b5(^NY>Fu=v&al-*kr+z#L?oRS#dqOR#STQ^FsCO zR($AbT%qG~VZ&|oo~%yE?RI~#2Eb%lp+3mb{&_t|EobW>0y`7uzJEi)D@d01CuPjG zDJO+NK|Zf#YsKaF)rC-2FH-44va{6W0`uiIMqe$|y2=k}u=YLb_+5Yr!SrBysA{Mo zjqDmS^RR^=1+nhl%sLP-xfocH_h>8J*>Gbs@;+GuKh<&G$lOLEaq zhz(g4!+LvGtl?%+6MyMqo+rXvIUgu8-qyzsYG+EiKek~Z)y4*wh$#SEn;*U<`0|Nr z%>lJUliK+L5Slbm^Pz-%Nm|R5IV&iFCoKZ}lo&k5;vvvxV|Hs#G(%oD&Z**O4&$8* zMfwSIb?vh@T;Qa-k_EF~9g$@!-BoUi<5@|Hp~-@_%UlpRU7Gws^VdvR-}u z^oiabQYOp}#WCg+D1H=>?=Gj(Fn)7v@ciW7O=KHC(Me7)7wo${VY} z+SX#^uYutdgj9iJ)>>|(6t7Ln1rP4t{WY{>1NZtH(jW3ZmCeoDxmFwF#p~jx{S>yb zCR++`4C5-?^nZ9Z|0>?;p&d<`LRa8%x@GY^af*7x?E+=qEO9*EHHHq)krV$g1a;cl zq7V~xM(jo%Yy(VMyou`4N`=Q3)*XG@yhsOg7a4JpRv@Em(w{%HV@uue6} zR|h!Ngnn2iC)1Xyb`B!+SUV`e)@Blmxucl^!(xjxFkaV-XK%9D4pBdvjgeFXCe%-p z*LMtymX!&cXjQRx4*k8w-_1GikB0~zt@$~_;eR%zm#8gOzJ5-b+cPRMcQ?2^IK@g9 zzfrL01j5`^@GxV7ZuL(u+Q_Vmp|njF%k%)@2p?cUoyGMB3VVy_P4$t+R(lVYLitqu z1H%~1nBB^>3nZO0O+C7$n1#I1-I`lE&?^^u4NnzF%UXF${oZe)6BnqG51>U{0k1jI z#((GyO}Mm94W5^4$fuF70%e-FD%n)D}UU}!KVmrKnCBvb+FcXA*RV95jo3S*jM~ma+2FE2C z)g6K|GJd*4p*iU(+qh5tfrWOjQ0ods@PAiDGu)0B0+S8t-2}FJH}@Ej6wcWYw|O$8 z^je3tN~enKbL@N^IZ+ZRXWEnBiAdVb3~#31wBlUfT+`_xu1R||!P3EKze@&!&ntV1 zna7(;p-SNW3=x@CQ7>>hJ=7XEH3-?`V6jQc5E_vVaDR=lQGNajMU;~DORYP*W`A6P zS`sIJ|4KHNr4wUYAqF&;U&txVFqmVF43ic_XpkN?@7UB~pv=c%_}wJIhm;7L*l6Ab zL9FAfany)(s-Qb=KAF60NosF8Jbp-~E7t3}<$P3V4h}Wkp@-iR{=el=YE#|+M}iTd zI~kIFnoi2h(JPoy{qVt5JY-xA*?$vx>7pC{*crpT#Jncy(%p+&ovUIv&+6a4P!#k2 zs5o?UH84KSSL}uzcQg)Dv59`mh#os$7^QP(8{W8`NMRFNyBlt=%Bk>(j55k3zcmV; zHV+Hg!$9r~BPR9Wxd!x4)a|`FX~J*5y|x_?l72We?QjMdxE%E^yDE?g<9`JUA=Wvf z?Hosn5K8eAHcxu=K^oqA;tnoz9t0om5_n3I-{Y&8-YE1YSfhHzY2smBB0RUn}u0p*_B;RtPxr z(GI`Qmusc6ndE-?I!8t;27gI(wP%3{xSniQWFu;KI(p7!`(68UY1Oa-buEE~HLisy zM&#q(ZpUvoM+$j8tFLVra&4?(J%i_pxDCi-6Vu-d zfI~zap>sXc`A_$*Nyv;~z3bwB;QTd)8rx%@$u-`nI9j;Lu*>7sI&A815G?2EnXbhu z!Hu!O^PoNMEZ)0{h08rSNG-_NR&sqKYmn&1azBIrk(bddlz*HwBNL3sZ2v?+L*EYj zfL`JF&dJ{XpOi(GQ)MU*ts(E(o&S(m!@k{Og59Y4T7N({y072^cslF-*Fc`)K#`?b zVhUk0tQKxijiM4tIUcI%ThL+*s*Lem;C?#$?=Jq5Gk3l-pq*mKBty)ec21XBu&{{&tOkv zvCaU(xJ$Ng7~$DCzuJ679%!f#W+bZrz^Pl)jYo-2U;y5B8F@I?N%J|wEQ20|Zm;C0q67OAB zE;f;ryFXgB+#`0K;P|>oQ4z zi7yVVtr*(<^xS_%>^u+o3#X0WOc?Uyt(2(xz+iAY{C*N7k#tn@CAWU=Z;HgrB2P9u zAoutjP=65~bmb*g9mX(`2{~&i+cgvX3>C21ELU;RtcYwnJVT3;jpY zFL9Kfzv7-&Q4?`!*3GgX%ic0PKNMlZNJBB7W2Bi0Vo@<`0=3jP$gTHJ@eW?k z&j<;Fub7kwcRRJzQFT#Gm2xD9>S>-?QefRKf?Ab7nEEkykOZU93z#9MJO}jmI zHGhI1x*GIG28ExcGTWkCpV!efaXGt}PXEJM`pBj4e4q; zb?#u5X+oqabG)kws*Gj;Y(1zU*a^lE$bVn5ZeA9ymsNR@=yx7AiYA`r<$yqF6hV|- zOCu%>Kt8Km5cW+XMn1=DBL1Tk)3V7MjFOQn#Kt*vI$>Ca*I+)%U^>|FVqK?Q>ezp+ zE8>Z&1@%8)`JT&{p(H9fSN|BmP$L<*7LLv9?*HYd&E_7stP38%)=f``N_xfO_86*zX`4@0e@gHK6?_snSfYr|ELsZxLC-nfuPG56?z}E|N zXIQ2nNPbW<8He!2{e5Al_G5ZI<(a4NWoDVtHVNG_8+`IA)$@n^2{2zk?NW3T=_a+Z zMpRFRya*lpQ1K!nbO3_kU*PX(-Uqi0TQiDvD;6U&Tl4FuN!H{K(dvnCxqo7!Ma2J0 zE_j&xPe?s3Hh#hnOT8SRF7DY?&KU&wgW_E|j13uaucuigQOO-usVq+_ds)J{GY9(i z&A2g>?J6#vG7{oiR!=cGFfY)7C57Q%w{U%wX<{z1h@I&1!dK34<9p>Vh zbwSfvA_IEf4NiAN`;_OE%i>lSR7>(!@XQS?;O>1tfWEyVK^F-*YQpf6%v0xd`}cQ^ zV&%rjuH5M|RGNS2D!ZIXjB&c*)s~S8N_dKY)3pz=r_1S ziIimIiouEVAIv2Ln}6^%bu8gm(x=5~{rvnjTG7yP=P+tmu9471FdjB7{l_(ZEd2JZ z3~{j4wG%dr?8_6*j)#^t1V~uat*oboD~W6S@aTrP0;a?=A})ngl@H-20iE;)CZNcJrvUb=9yZ4G8hPIRf}G@+64mENgnueJ_Rw40Jq4`Htt~LYZ_~N-r^1r6ZysZCS zFNQ7T^$yn~# zoA2ikgJ37X-$)fd%y;v8C%EUqP@EMQEX>ebV4=EH$QMf}!rO{h#C_u)WR$s>W2MYH zEZIM%DhVbTo-6hgxqT~)FZ4-vGj~Q{1#yzg%R?vV$On`lLGphf{UkYPjg$2WofQO*PD|o;(;!nWDDD&hHR6^x3)A`Wl?_bUDJprgF3p!DT}+Mw zpjLgf_|c&(OV_$hytf`1Ep4$R(C9lfh~0QFYg^Ch91il$3Hi>m-r6>M$t^>|95PF3WyVO?E} z-Tvhvz8^xu`uhc@lhj`G04>{ z0h19*V`V~(n)Wfnw3spCn-TyXEuI;M5{mI6S4{-Fqm3SNA-vw?mY4ojUNmh|^2M){ zZbdPDgg z1S=8|D29JCZkr}-hsdDg{((PTNi&?DriBCTPVP1RAf2NPH&o2U2FTk z=_H~uKD>Rapc)&}oYr3X0=fD?tt!%^H%PrLNBNwJZ23y!9agWd+hIQ#cZWdm+$~!1 zNx#b&83NgFpz6sC+wNqtEq1kfc>aeGV;t{NR|-1V`fO%D;!6!Popq4r(i77sc0iTb zza4+H90*H!6Y31OyZ58K{AJ(KY%*E&{%$M*-AhdQ3_s6QNt)kP58Eh$)6*lWeE73A zuy$o_IQ_q%A5wFCL+3F8#QxGHk(&$|Ef+85vR*RZNj&5UnQw=*ev33?;)f3LlS5OV z=X2RYD!4|NMUDNYfb#|~MkM%&AwBYB{i zrmxgthzYia_wOsU`~TKS95Fv8Nq`!#1oX6r)!s}Ji@i{4&Y%oliJ%gd^R|$gIAq-i zH)GGd1xYyTL}FD`JV|)}o}B?_Yo9i4YyQ@*rF~0CZBrHo?Di$FK^yPUOgz=4MfiU} ztJa$TpQY=5fpZvnj^6vBn+kyp@;$h|s1{J4bxC?Cf!vUy?C&Ns1#s(6AXb9<=sX+r`w9y;A~P2j0*C-ovL!XkJWf z99-D^8AG+* zPeZZ>3Nm#mKEO@m?2Z3cIe~xh_lg6fAoUl{BgVT_o(tzC%O8PBQ;J-dXzc|W0}zuB z)zYLvt%_*x2dil`n({s4E(Qo(dk{w88M}DYnUnpGv2g_GqrkE@U&qHR4$PHM7vJJQ zlkF${RU>$g-D}J;Uw}q2yyF?vT3S=AiI%#J4u6BMi3W!w!06u@Lsm5czsTixKQN3IFC59TN$n zldKjiKQ$)?r%qb#SNZR*0e$qi%7xD(DId<=Gh!9zvZlQ<^mpp;?4ncHgbD^=aUy>r(1--ql%YaE(2%|5fF49?s!CGqhpTbEN;5M+A%~iag(&3V zi6QC}o|t6OBIaQsJt-7&lKQE}V77pdlk_17Z}f37SQ$vM;pIQexL4XoFxx>-!h9pm zbJ22UZ16;tQt!XxxR!vr8YG*D-)6XC!vA1fPql~Iw|3jKsZoDYm@lR!o=gZU0FmXH zu}Xm3lzIuUWnlDVbtsA;@yX%Q3ku~$#B}55H&MplqX^v16eZ-Lhu)QFaCGdu z*RD!i6uf4By6=Cg>Rur52plt+%3!MQ@DOh0?P@HAOv@~iUd5|qh;l=tu zbm&!hUd4>eRG{wIEmbxJpk~k&;Jf*d*5?3Mh9)JON}$)jp$uVVaigBFYg!1McgWFq zI%B8#Bw?S;ZxT4+|IUSg&Sl#;da@12qdDc;JVa84Kv91Khh~~*vF-$i`*JoOyJ0k5 z#_w_l^oeKQ!_j!g7%CzK0wpQ!D@ivv&6Lc+^q(Re*|->{ZdV3|E{H@iP>gS5>o;sU zR0XDVjif$t+U`TY#koU*6P9>J@8VL1cYk8Xe8R~Y6BfX`d(34GGVefy=LS6J-B3XM zo!O=|+mL@bl2J?N$LT>w;RatgZ8N8yVqAm4Kr*rkj7p4AjwXLDDpI!I>7erM76r0D z91A{3qg?nxOtZO3ai&bVif~)i_?9V&dX7#;;9@P?p0W=>otrac@FM7Y3Vh?44yc;d z^Q|IDSlUh!=eb%yRQoCe5jR#m@B~ea`5RsRr=G&UCZF_7zXkKyK)4SvDK{AE+vY+oP1qgqu z#~1ZT)sm-K{@Tx74C+3QB|FS92PH={yf)Edy|4t%m_njw9S?sxTIt)} zy7=YN$g85g6^et8m>rpEmSA9blr@sa7{*U&RJise=-BGIA1xpHPe$0eC}hlBty$v4 z@Itl8q*Qy#&lI|HVohV}XUJ3{I^j>z!?@(*aDT~l6nKcuNOPl_?V)*YPvxGUIo$ug zi-M-2xc=%%L@b9@wGLOeQmB7`8@=KZVpThPF3GK}u^{iz#rmW%Cc7QI7AX*us_!ct znfQ`x1MQI<64{IRwuB*rDp2W=SVLubDS5PpAk;Gt${P)jSr~cwS1P@+if|twu{YMp zfuj+xkR6PwsZN8L@zO=$)Y(b)q$+wMJgqHk0?QSLJkOEvY{l#rdqIEB{*GE^JfBdk z0mFQ9`2A{xFN%pkJo$WK$&f%_h)hKxOL3o{rYb{(s1$P1ImrTMjwX7y2r*Q>{EMjGky}a;hSp-6vljBLmam-(r$IJLi(^}_ zR!FH=Jy%(mq$ZWyhU9XzriSQmQE2yt3koS-kXHEeZH*FG)jH;0#=Z@UZA}TOmaFDl z*0p`{oQNm&4pNYXcqPtAU$r4`&8UEDE8uAmz7sO2y6=C`f$uMf{gqS{+Mk3(VPg{$ zpUzf5n692gqiKkN*fx1yQX3P7q3ihhA{8;{t@l#xBwF_|xF4TY&)Pp3E{D=^RqCQ0 zj>ippQoin6*N(i%!eN9WCa^P_J1 zxa(mAYjq|Y!RlRFxeplATC>9?0pfbdVBj);#FZY*ok(neV)DYUfS|;0M)11h zM)An(cCzo;*_0M^4=K^k{qY+C5p>O^`-ZJ|wddacvrvn;BSh*0%#GRJYboF(tsk<`4GXo}+GK8TG>_;N)t5 zy4*)j4g+u9$|D0$6gCseLzamw7x6s8yYu8!XvBX(Ou59C zKwDGwK2#4%cfnu24?xbGB%T9tamTp*UC(4XJX1T!CE%(RC+SJd8Nz95TZ0fQ03{#w z2tP8U4eJl&bG|=gFZqn3#OutW>$fU?1p}l_PIvQEx;8*n`iKWiNekk{Q5CiwYGu(^ z7*d??vy_pomtG^{U)$_6*~Ndw7uEEShz-wvAfAq8%PBXN*>5VaysZ>fKsJ1ruuS|k z;{G-a3+daZpT^{@A3biHXfHJl;gX?5wM`+s#mys^ThijWc(d9l&WR{~7iF~3riIa! z0S224{npqnMX5;O;$Y4*%GeEA174BXuKrgF)Pm-b2=d)oR^9qW+SY$N$0z7>J@_|@ zuxm+3*!sg8TE2m=b6k-D2)+Csuv<+E=YIHu<4km5M-aV9Psq`Cm?UN}NYJ`v=MMn& z;F*W?9-@E;_MB;2r5_l@>-cs;YCR9Z8GXQ+)MCqXe7-zRS0OHHHT>Rd%NDLiCudXQVy^{j8>J!ASA5zt+a0jVhp0%f(%)Pz z$UGlM9$cH^hTqCEQuRC+L`(Y)a$!yIIc=< zozOfea7qZSQ~+?P4j&Qyr!LMEQ*eN$#a0~-2seeH8?8nbuhM@vaitwWtN>RO(kfAcxY)G$F;raFZet ztfR+{hWE$n)4qS9ZZ$%EE{~2wctiSOh_b@T>@l>>CXb(z>R~&UA1SPd(u7OdF+uzC z(wif%y9cEkg3!@aj0tE3aY`Ao%Z>e7RV-WEpmK74XXX@ z-cU>1oM6ac@ZF3c(&FyDv5tQBs|+g591ohtFH)Ti{uDBev-w~B5p56h z06XrRQT{GaRbKG6;$Nx`>$ms25?Aj4vsVKm+tM%^j-T_8Cwr?(87m}rrMba!7t7p* z&sUtXOOSsTX175Ak+82T=53!3oNL~+U9mm`h0ALsDeyPiZWJbGDzl6X*q6|re4}?7 zgWtGZ>tjsOq65&znk$nAL1Y8O(Uxz0q5-nc1^|@poHy`Unxie*O!U2lpC!v%s)nPH zi>w8}g;UYc+FqZ`ii#MdTIt3d|8K=#9(nObH7I{9%S40LIf{m>@kg{?_0rkUu{}6l zJV0bjSRnP%K@frdeFgggjU8um{EdwZu@-%6tkEr~2NE9|#dsR>eIPs+C_bJUP&7zi ziViub72H@ZR&n&3f~gvsHGYtZlre6XNV7bIo(zk*wCpP9QW@V5Im;C9 zv-0qeX>J!rS-VNd7@+s8(yBuAdjrzyd3VPwr#5gc$R~(kk1!jDAu#-rc2`BW@sk*I znS#&LBQF1uOp1$T&D`w~W4!;++?((7Xk>r0a#dV0dvWX~SGq>}6UUJ@+5|nX`!>IA zg9f2KKkU~s>l|g{C%1{wJ$!zi87ZwMaPpKleaRzqoMIv>?FNbHg~XI$_d10q(oT;5 za$>{Wu$DkWc8G)nH`*_AO@O>RWjaww9(dh@<{#4hXBzh z0Rh2MK?pG1XENMUWZn573pqB#G56oeYALY9^`jGF%~UsZd4YdnvRzzNhOg4U!;(S{&hv&86WCk3I3b9cU?Lhz zs*f8x*jxg{PIx}Tp`LB&X25C^T;6&LQTe*$(5OzJ1pZzwXrp`m^xd--x|O_D2_Y6n z(+KYu#}X`rz%=Z5&1keyP>~ujT-5R-TYt~rGC2?tv>_^ zWd}+tX(`C88Z%I`s^K$dWR!m`uS9>=_YKCcXEuHbH?KhT4kX5k4X#I1$r-IwALZf4 zsDH=m{wlY2@;u?GPmXVtF+7n&3teB~H1jIaA$h#_rx{9s^lqa;?6XuIETgUJnGKq! zdez~6Se_&?p~f4V;soA>=xD?;QUqH#%TTAkLvM=> z@Nmz<2&3D=?dc6pp0@&MpMMQ{oMtPKMQ&NLwxKGB>|=G|Dx|cO*0q^P4BD(2eH`=h zPd7E4|3rl=L0bBptdY#W=ECw%FQLj`nh8^_4pqp331wCXB^lW}Ur1{e*z_q?SDHP7 zEZzf!#DuvkWRpVR(*%F+ZEbmgI6fVMBxBgAn*y#Sj+sdE2aVUb@CfHR;;p`g74*4A+4Dw;suAZo-&gnCG;A96MJS7{O8q4*{Qz2+F{M z1?VCR5kuQ1uaB2ew3a3E3t4{PWA^3%GiPt@UJwH#>27n*$vb~t{YpLgpwpV^dn1D* zS`$WIIrvM33DJMZMBWpEEb?-(uUZF_jgSIrblQfvbZQP46LP^NhFO8lQ(W4{-R6>| zvlRj4ke%nw0{h~0i!*u^XNb{h#l1Nv6O)HCbMxwIiB-h)i9VD$lDwwX2a%YH!uehc zfrCv%%}Cr#5^$GZ z1krM+)>40ai-$r*bn2JYi%yH)pwEF#AS>wyAs^pKdXGyZSc1@cSbKHJJwzY>fClF# z`^-JVF`OxvUbL8disDG?naYZ8ZUZQd;Lr^m2tWboPA5%q;$QUqMOkBXtc6A8RKNoc z#>2P)QH(dT&6E@UTlJ?7cO%Uw3~HJhsgB$x$s>Q}RMhaqLJvYIIRv1W-s$a9C4Jwq zE0s_lqgp({ZR!AgRbB$@x;x!Y7C1hc_`=muXUV#QejL7$omh8?2S8$SE>CCYic0VS zSP_+K3xfb%@UEZp@UEC-lm}be79B*i$hlUp@-Oz|2Iljv zFM5Ah3a}KuXqha35@6&@+U;>r*~fR|OQ5DhP6tii3hFN5nfo5;xLa``h>vq$hyZxF zRCZd_FW&1K9{?6X6Tag@6B%Qt`ox;4W+)nmK{1_(tQAE`1{}Ue7*|FiS6;L-nqs(c zr7jI&1)3TMcxB5L3?4UInuRa1Vub|u`7D2FuwF?_92x{QR)@d-Wncpa2oDmnLh?s6 zg6GiqC=7?>Zy7op3Nus8xei*!sN&@@Cw~%KtgZFdxu5;Iw@MJWQBV=Cv!G(6I)r-*o4x2SOg@L^DUIcb9FGft1I>T>U?PkGzcnbA$(6k41nv7(U+o#+&=#DJ{u-H4 zI^Vf25ANJsNnf3@F&-3wL_T)Sc&BvjP|PH^s3~1zFuqn-HQO|c+i7K)QQR0zx+U8L zA{g3C>fOM`9&OBLWF%9@(Tgmx8eJ4xV!Cto#M8^|JfB2+P@wWH)CL7{Co_L-^-2tZ zJNs2yoq@mQ5j*}sHy1p_=~G3HdknIEC5sAt(feMFf(CYLgPdWg#FN8FAf+_O{OBPc z-vSCFKV6IYF?2yB{u!(EXSAYdut%}u9BwpHIujl!v8h+l1a6I5!P6s1^EZIS4nud| z><UguQ&%X)`MALPl*@u ztWQAhctv^1TbhXBgt(Kg$koJ{r7#tRFQb18CLADy-riLOW5o+u3KSwm2RYN!1hi=W zg3=4y9+Wy6F5Ef2Q{%j{O+U@HQOO$~;E`|UE~lvM>f9ex%x82c^#gy7_LU7x6xHsr z-#xC71pkRZue?mRXHe+P0b`)0Fm~IwV+>7DnKX6f23quB=~FwbH_Oci<`83Q28wh{ zs`}&?(_0NTVL=l8ax^=(kYtrmC59Z@+6rX->A;49+LBon+{@;|UL;w>?o~#vMXb-5yAHvgK5kIg1=0{8_DzJ3LuH7=v*3@S#SC>OdjdJCG!j|*drWcUzi~Eof z!B#)gc`bWc3z*5nJJ^pB&C<&MxtDrMJ@J8`7$>?Nqg}4|52}A`(% zl{^1)RRTct6smtAT7zw`Im12ru6ZZR=yP154@KD0!ov>yN|2{?Cw$4t0uA0RpKV%# z1a%BQ^krU4x^L%L@ITJ1FDgc*W-Xd8;AgYxZ zC8?|HD&mr7^)7_4$L!?6F?URI_cA_Cc5QAH(6_T+8n=J8p<2Jj*uta`)$?<{3e+NM z(^M@U0@#acP}BGo^6;%Bz<6zx)Nvos(=*&RggsyHkf(l#4*BhN**Oj?^fibLNu82| z4NKN7zr`MaLS)U9mBF45cXES|AQ7AQ3wByS72kP7@BX-ihi}3os!dBA!iTUV!X5yU zrO-c5`xJjjsmrvdi%4HQ|6_7xR6=sZW>#|j5rD0nMjYzGVdIM12RWHaZsWcnV;?sI zaZDX3?dh-#>_~#G9%>9k9F4^56C%wOJF8gJ((y-$?y$2_d)l#J9CCg!d(G0)54{(o zqdI82fSFi0h}Bt_mii+J5c&tUT*_G32XUL`hbVt6y*|j88cCaDuNGSX5H~!DnI{Jr z;I-VW^Z{hc_*Hc2NF(7#{}XJzInJ) zQqg~|T@+h=!S4d4)(yqYo4+;ZPRLz!ICMf0)@x&j(-mG*@`yWs5C#Dt#pxxaweBc7 z20daNdkeTM;SI=hhJ2MReLS>a44_WpF8>DsnQ=nd)v%BSJJv0PQUe+#gK3GeWYys@ z2GZWbeTEI7)>ij^J4J7KdF^ysQKW4}PBnixBu=a$RV#V!n`0@kg;IomVl}0SSU~l6 zTXw*UzSyL80363O&hPIZgEW#}aN5l6iJH5GC`!rjM~!$7+*t3MGcIWHG%H3>LyJX4 zq)W)P4wi{PNx|Swuboj7^-xyDcZ(v``6njoPWqc131S^P`d$kI1NYN%Kh?zt^uvEA zn0le`*d5j(I1`C1Y>}G4C#4yUkr!5tLb!rq*&zsyUn+htp$h|l0AfCt+NI&hR5g7U zil@oy^FF|>BTu+yL&OmmDhsZ{c<0@s3-sJ>}MHV`tI&+f?6)i^8gFt`Te)Jqh-%(P@AmY-i`;c4Sx= z7*H3kAqQ_y>}2@2n-QLHYU)Z)b@!$T$Q_F2?YTQ#ptc>&kzY4gYdl zPF=mdnZ$k8l|lA)G<J z69~{U8_L@!|F)M}Ks$EbjZc3*@Z8Go7#;6LAX_Y*O<-o=;=Q?T5Tu*`NQ!1!FX&i8 zegHANNW`*QIhB+pGd-H z*Q29lPKnK>i)Mv|)Q>$Aoik9(|RTEjUVAOxzD0RFNb>C_tVBCPLfq)|{FHY~0Au=d=oXY2JvoDcv7FG5b zk;`)(Xmg&j=NEXDJn|ns&)ThK+FGv-zkFF#Czd#?1k4+MTa7nldp|2Jhh9+?M0EcN zds+afI=gy&!s(3wOACu4+vN=`oZHG=qn!e0=HvcX$<)L~E(d?Hox&Gnkvhcae*k~i ziQ8if7XP+9tjASugWTB;y^ODm!Ok-^%`0bK3sXAXR2@gTeb>#a_sHb#UK6L3eRTg?9wz=4v0qN&9jj2WiO<@f6s4*?oY$Gg( zOG9ohD|H>Z7%zY9TMY#Cl{N22>=+GIg+u)3_B869e^iZiXZ|A@Agt1nzWK{xGvAZP z^Jmtl@jCKqen;;=zhjp7kk;Z%E-|u~v6z`1L?Q(#eKJe9u*82Iruh+6XFN|+0tmrvHlu8_ zO}RPy3Q6kbTK2P^TJ)xPJGU_%#IoN%{;n^B&W9^trVn=6W|WVA7hV<)(Y19!TFUK0 ztwwq;cX^U)f%>Jz-eCi=b6kC7dz65dMPo$nGx|%$?R&Bg7*hwSMb4~{9i?ETLcC3oIsR|v(_0aHGmBRYT zDQIUDhE^jZ66^~RWxScr8@)j|%b05tTI+RJ+zo74tr(PSDk%L+fYrX&-ge;R$d7DF z;NRWoq6C8xH=ihp1K;pZ5N=5B08TMsJj!iESNMPBA3~_J6gi{kRZL)4lE{A%c)GUg z^-57cC-5@voaF0mRrH$9fhR58S}&p>qHkjvR*t%Gdb!fh@XXpOcps>Ulem~A<7F6x zILpKP&d?yEJIt%xt%n9BiahOVEybZY;E3TUE=IvO{-_p|0=x^_2x2CIZ(j6lk zk4l3NvY1?bVzeLro3?qXt=Ff+JGXkSAsH2jK-m6img`1sIBy0TNQ^r<~$?ISs*m)Df3 z-^t5`r)X($gtvt6j)i%n}^S~|5Z zFxmk$K0#IC#gWMMm1gHHLotJ;2-__wUUS0v_&CcP!eq&G7JK@&`0fUo2`+s8k zr38qOg$$(Mger5#faT?j28T85Xup-uRFlrXEtiw(qsfAWU-y;iY3IQ}mxF;)$DfJh zW5{H&Sw#fKVGspjr+mZ4! z7j(|RiZ+zd;u`*TIFdD}u#p`|<%@AzWRBL(38n2W2?+Jd9_Tfcw__(lJt!{=f|iM( zr(_>)Bn4xe?y;fAh!2oiHg#9NVb^{({|j^bVd*~c+qV9V-c5Wbo_OD4=@rDwOZb3- zvDd&Acau#hms>sgZwJ|otQ>!_FH>7qRhAOYX#TB?pjCh=L@6>w+QokWmtr>3ZltX8-;&>NTBs3S1Jc# zEcc`~&HZ2=vlu#TfXH6o(t{i!il#^pJQ&>Wd}T9g&tq~EPpN;edpR|WKU6{glJFl8 zBHuMC3BM7SE!A9jL}|@W8iMMK-L@i^%dn)qw1xBC=@avIPnzz6apCXlUjGznt5_${CYgHHthxMyB# zcl1Br1ZN{9dTLUxChztQI_q<S9wP3f$86 zCv`?x$V=YpDV0&p#nEFV>Rq-#?Q4U}CE%*k1shTUijsfWL^yh$((zXHG+I2R&l0MS);i~ID+ zw>%?r7?)Xq5$Kf?z!Ie_Ia_7j%krz>vfbG}m`uuC*hBB8R(h#z}uBW#{DS21DzYXNC^(D;Hk_! z-zq=lK+l~^I5zLPFS`lGLBS1_Hj1+q z>7swKXw2;G2|pt;VZ*?tWHpM;->IEr9RKVSxQrype?6Vxq`#vim-mYR?|?Ed(1?0f zn)3V$AgLn)RJs4stbN#*mN@iVv@`k5(3sm7N7iu21~6mGyP95cy0d-2j=Xudt;M;d zWX4YjFW+ccxt%i*uF$(2BP~Wlj8&<5<8yz+rRl||;jxu)r{Flkv+XZ_{=JOru7+=G zn(b)&3jh@!I#5o@UGYMy7Bg{Q6BGI5tcgbB%93<);NK}>ipe9kxkCY>fxiU~I78%* zp$|oFD}DlI9fNM7x^c20?u8wR{Hu$oB7$!tB;@RO2+3IhJf{6imVcXNjv74b7fgS- z!dbnq0l?VjW&O^6j&|>~`Y7`Nu3bV$05n0ENZ<{Q_PD-rCQXq)UUjK(v5Qx>yFV%Z z1iFYmc7m`(=3;y{KhW4o%t_z~9u|_Kz?xp|gXy5VZMIs(%Cn05B=-A~3ZC`$%R5xm zhx3Q0AQy)^j}TO}$c-;EDq`GN7h8X<_KE6K2TnM6=|KLWTVp*$79YJ99c=c*wO+lG z66)DV2rO2P1I&X5T$2|O$}FqThT8voZCut(=BDQA7OKzfB?8W#*=;pg8OlNhJr6RL zIvR$}mefJUN#Z5NR|fQSN1+J)$`nuPwUjN{f9}UFzg{Z0W7t@>$LnH|3}b)Mv0QMi z-ddgls8$j4fwAV#(TOP5xTfa1MoUQFPWYAw{mm=&;NAs5PL!Ej4$qB)pg=(xbw~|X zJu2x4J&sZJXzMl}kIse#^K5^LS$htTnp^= zN7O1GEIn6y-($LT2vut7g57^nt}~5`b9vuiQg#CR#yuAyQM~&9ux_CAY9yHf@4Gg? z=69co{;7-9uHT>+z3Eia=p^ZoX;)M%1GWjVd9H>;>c=KehCswxjjnON8N$mhOym#?h1UhSZ#-wuagJ?*_nQ=xb!biRv%e zFO=H2BW+^(Q#1cn>UA7swN0%+epf`24Q`N&kDwlZUaC_GjR}7($~Ycp#k2}9A|VOE z^ZrF4b0%E-+kp?nNwOmBrg70U^Z1yj!LcfWBz}wtYv9GX)I)POGv}TKd|H7g#tbpY2}i@>svGkc2aP0MN!>znisKc zFIjWn#@ZJ$C>YucMAxuz9V&e^wrq8*kzx7tz;p{wljXAv)Zez-#C?1&75Wk$~2PdwFmnmm<9k6{((9GQZ4 zoXyeEsEvPJFK|wH7{}=Jq?~Yy(XtiRE!Wb)c!?n!Tu@m~c&7Z>7~UW5L8uI?6pOJ} zA89*3&P-ilH4ym>rA5c&~{PJNtic@4S9-t3fdXUKxGTs}*XEzGj}~ zWba-io9uY4>AZj*pX9jaCUBR9G}P?ql7M(v-XQEfMK4CmOl$l@OnD3xjw`PLUEPt_ z)P_HIn&5cahoacGWeWP_i&0<;?E4Ct#c0`!yY+@C_>PIhh52vw#2JUNw9yq*i-ad+ z!A4E}YemaauaM0Y!~B=(R-oAo!6ij$0(yVAox zG8rUoe-aUSVmw??pkjgCW^l=zGv|HkkObiCfB)<4Xk)i^cQ&5;`{1}K$O!Svn%RGo zBQNEw?XwNI`lrL zopJP3w>o0p`K(F|h<)Yjde9S543Dw1!3dIM9S8Hhm6!-16Nwz~{b5?D8z6v{oRJ5} zlHpk{t|E)c2D`e1plRc){b+wsxr!VI81~nIUN7cZ)SIwevX5>j!ATeM;6!zc=;^~- zr+EDuSIJtDi(E=kwVLgE8&3z-P?h+H=Eu_+Rz@gRO#1g0mCJ?AyZWriRr}$+MOJ)- zxo#Rn@rA=4KSm#Jl3I?QYq_%?O^8w1#h%Ux5M8(aW|Q#Acs#G-~|Hsz;m>33m$ zSAva+=${!@2QpU?^d&0{;6TL^NnAq^Wt&M=tMZd2@WB{b%wJGe>?hcGwmBOOcGQda zYg*ke$Za>0NWOnfGUnQL%&)nN``8>pi4x*rRU50diIIq(fNJibe^aRT#e3l?`AY_$#>!qF9f<~j7W2N)xTvS?L3=6 zG^yst#yuy-U6gCn={@6|&b<=%JlcAPljlX>TDVJ~0nmSI8&{GHVLyskb$d-PCc}%2 za?QaM>FNk>o5Cr5bh{){MtB7ux*6l8)zPdi}%6T#6>I=$HH9ec&%PS+3@ms4!{RBR8q8fqYLPa zH?6WD=aYYg4J|5y+if`(PYS=ecvpaghK>a6soggBFs3F&!wY0zw#(A#4}8-`9T6b^ zPH~I)IoZ?)9)|cxL80Suges{`(<_%Exs8FoF7yiTmCo?$q9Ty&pB728MTQ#e>A;#* zYA;!ru)&Fcy5^2PVH%K{11|Yfn~5gAwAJ!q$+~~c1QJ(H8*3W+2$hJU*?m+g2+NV6 zkFrJ{jI*l3^L}{yIhAFGhbz14d1USs9isYFf~YV<%8737^OAdaCAA-sZx`4Nzw-eWVGUSD^>br)ovD;t?}RMA;S*G zK`(!6@tR9>WsZN_m|4`-z}xOI>9E5`RbG|!1SG(`e9PQ^zt2v;R_-26FKE@D)0B0(ss)%Rl>pe;LdO7boz%Q1i zl8RVERJvD?LqNsN*Zn5_g;ihs;pOxbj4OYuKKq@b%^a+yD9X~1JSImUpG{#d744Kv z(rP9}%zZz58H6IJakp)YImJd4`)4=$=(!oo-q%hep6-@yO3ObQ1?hbu#*j%UdkMBzs5Pt{5Y2z8 z;?k5WV{sZ-Q_*$9nm{?Wbs+DjM^(KlkZB2O_oN%QJ&OL`&o|6cYdO#ne5qw!ONj=Z zWAMgKS1^Cur1I}k$~}IMo*W=@l!2ZtTTR?MzFhf&2?E)x9!=!~8zN_JNcCe$PCSes zO%V5CcR+tPh_yD3jdBb1KJ?<6N&A1j{^B-ny0j(2>9~->&B&Pm5Zk$(N96|=YlK6p zT1y57;Rh({(7mI-i&8SHmo(lh%V@=n-NCH9ojay2QUxF_ol4z+TTK!8@DVybZvhd7N+C$ z(HWU^3FN}o+q$Y~~1wdRK1L$DCM%zy;zi7cKmod|gG!W;77 z_XT8${fOEbpnH~0g4eooS-*eC0l-Ij2KLX8#UI|_R`vnB5JT@x5Fx-M0%au9rZ^hI z06W^F#+@L*)lnb9athspnCK;JW1;vWZTy}wfQEsVhqTBcDrg_{Wf1Hm2|D>Jjim9HkHaS9F4G~JA-(ckh=WS>6mhHoTt{UpF zM!Z0JMYyOXgveuv0peI2r1dgPmar18ijYFDWW0ec`%wEscl$V$Y%^%$8E#kA z!FPKp%gz8l(Xpzq<#X!7av(m|2Zh4s24u$f8(7~IlTaFL59{B}+U~1?B;43m29c=U z#L2I^OiB`e-udAHF_c2Ebs~X(%;n3keS{yhZ0EV5nbYX|-;4|KS=1O&07^wEHqQ4l zQnAAC=t?h~@aDKl8&Qc;tVpOPi0N|F{Z_ob0~#Q z<&=;)-AWJxD+tZShaT9Om?J@MjJdpP9-5wg>R;((H*pIqggeS5ft|m>H@$ewh)nGe z5y=l&jJN;UFuB&2P|_%W(cq%wXH%TS!bFo^rnbl^eMWmNt~hQe;@xS;&38P4Y#f%{ zLpBs*`^nt?5h1AAvXnTuQ-yCit16u)>@|+pbJ_m<)0Ca$UWvchnYyxL-UVlpVMNV! zN7c6WJv(Zh+`nOdeQKpgA3<7>LZ@i&c;!rMF+gr63WbQG|Ht}&Ep#w{JpHG!Oz!t| z+}hD7pLd;ev&KvPa411}H$NRXe0DMW7`De75u`|`9h#wO!g8Q{&>}BVKuN7r7YKO? z$!+eLQ0ONt1OHrA#z8F{>QW}j((oTdS%o~_Q~VWU21l5;vGt)6!4?^OYY-}=8H89- zt--_DcHS+=Ww0!NF;V9&?X%oVE-`#p0guZ#MS`Y(E$BCBJ5njE? zKH+h%wh(8J;6hz0;SV2D`cdLLwo_beU!k@KZ+caJE>4Np2W0fls2k^rL69g0wk^fn z%ZPIYocIFGviw|*$9!0*9+;ipnZ`W>Nk_`h8D{#kM8Ls+(k2K?`x355HlXO4uz$IT z9*yJ-BxUqqRZ(#Nij~F?@u6%6Z}8Kik7ht$N$m7kZUh#6}SdaveL&6do;?Aci-THP{~W%?VUoqlyGm)k6{&YJ3<*NJ&SwbE%RR?f5{=9M#%$!$1?( z+BEZtzhE1Go%^m^vPsS4r*A8820Mw{z|_<5S#h(qI-;2 zWPpcg1;hH_xbNd@-O?^NM__gU)71zd{A8_E{3AWFwOP`;&F=>c;S*ol(i6MLZ;Pt- zy-G>>5)66I6vV3YK8Sgp6C2byiG{w8wsJv*2i%ikKEpIvHfD{IbAsp*PQH?hYcM{4 zU}t{T52?0Ls(dH~|1hz;3WW6eJIIIpGljuSWp7s2ao<{?#7!CAIR*YzMAgjg2mbP- z#kD`z`t??qA6iptlyZ48*~oIBo1ZrxP!?e*vAOu-JaGkXF5sc)>eO{RN2-sqTzZ?Y zdBiKrwv?9$Mmr_mE><~@D&!wc2|SR0>~Sfka@MIh&B8Z5-MHOY3%}NYGy68H*Z^sl z%%OzNX`})C>MwUW`1QhCD4|iLfUh(y)xunkPQ|2=i`q!>vC6Sn6#Zom^TMIJ(Ysph z_ixM7b82X}C2*5Rau%zx55JC2FF8$cEu5U8P8HflFA(K(L52O4?T zJ&L#%>ou=Qm4Hz>FpTBeO!OoP2Cb*>m&*D3GNPF%Z7vSNEIl-0wOx8`s9$tbHfR)r zqtNQ;pWPa9tzz;-S6n*_@=)o2f11du`kBe=m=U?6^pvaQDx}z7F^6-`f7Luwl$P|7 z<+l|vDEk(ghZ)*C0)&Wq)-aKFNvq(o&k}F`{r5Ec%9PhR>4gsz(xIs+H~P@j#fd)J zS1j6IaW6fHkIb%S2qA{^5SMSW@w-k6BuTl%EzVB}Vc;Oie7J#!iM5G;awe3^zG}gV z`vDao_pa^;yO2r_k^4x|-R*?t0$|aPyi72PS>*Gf)-1aOx4YMLy3#$IaXl;-fBf1_ zi)@vI@OxcOh@@KbNBH;I@0Fu@u^LmoI^*zJP8|1EJ8A8ULQeYQ4425yy?=5cw6#UD z+pmiu|JHlhS?lNr3Ke31gtB>ht;G=5#YA@#*gPWjES5{>HJuBvN=*B+4A`olc-ioV zx+cW1*pJ!Nwn?AIOu``+ncD`m^#$g{*?!3G@`?3lPSa;~d9?z-gEikOhalmO3U2F{ z*so~QUp3CR9*<)qd3@hI9w*z7BKsHLEUI?5V}?Ltwg4ko(FoFi8bh)!=|j?=cUma7 zwTcj>-{pZYX!`edvh`FFX#gC5E)WQWa50`X_*T+puy`R=zulcc;)bOVjyb@AzUl- zL@tc}(c&wt7p`(nF5uMu0bCk^4-Wkhj5>9LgnXl$YK;R+`xGqLyUF8>7WY){1w++Q zRJc-R#`7}OVuCLo{HG{|%@nb+Yr<>56q=PolL5BURpSqTP;3sj2OqZ%RcC5TehX}=I1f0!H0cy0QGOH5Va^=yMOItW#ko=?^s20 zGl4m9@dDC+qOMN7 z+Y^hWD_HQSX?za6;v3G{LmuKNDik#%>Z}Ap-E1|@qyDXfK*b;HlUDe;134PwzK>YH zR5G0OEW}UMkwP=i2& ziX+>$5mFBxVa9CX&^Og3HF!42T$%jmXYF*_2STK50N((T@AZlEd11*-JfdaY@mK>x zr!;(j)*jSFKVcan5H1?JQ3b6s=M@{h1_x$;;DO>ESRirsIZ%J^S>IZ*(J)sQ7F+ujZ+f-*qiq zGR|ay?~@LBQ_4yZF3uR*h}d374-8F=IbBcg-4MJLYaK*?b?C;5#a_u3~5pdGY- zsN579?*URJDH5swt^nE%p+iNVf;*xkR20~7OwD*wg1)Bi>dm$$C0=2h;xUeV5gv5@<16d_cN zW22JTR=l=7g{tHgjsLJw)Oltd*6C&}$tmveuo8gm~gJuAKrU%?n zgJ@dw=JmyO-WF3FlQK&>sHN+GO24D;>P$oR{eb$Vs6{grg`DalAX6D;he$;5KD12ImTYi{zKg zy*Zi3aOjNB|=0`hpMpsyHMI$LX+JPkes4E3A|MeW|gds zJukrhJ*Gr&Zu-1pjj7$rJ3_b{^8#)e9oHsIT2SYDgC;v-T{9-0C&Ss|nOXuoU~T{D zrXa|5<+6mSOU16F+I0M$)xbT#SbDHV(9@T{CaCeK&JoxvBuVUm1r#uU1d-ku857XT z9|U@Mdawz!4lwV+`Ga^Wr;jzcg~P8xq##=n!gh0DM-U1T!M1WygyzNh9HDLFDH!9V z?BoxhD^9U6TpNv5utfd0v=PVuALX$RbL;W|rJ=Ee^lgJPUomv$j*q6e9D)}&?xGv6 z@W|D#zkI(0d%Du68gavag9?PX;NArs-_nC+4?N`Gr%~At85QYwz|q+tB@FrbeYnwG zave-y1G!{1jA1~DY8Z^k@#*RKeBNmSpARqhquj>d3E>m+s3AGUw^t*$ROKEN#bEDhIOd0abeaa`|$qe9C+JX z-yBCv#j~Vdh}s^6;r@R69a?23x@WoXm};h@;-4~O`#+o^OyEb69*_Ss480YieX+!e zg115qTI8-s)Y@Wy(hA5~aOLc*4QTS)Xkg+>iqCAX!rW=p@Xk<4j%qf}%zvlImk-EI zxei$`n~c~1h^`CFQia}=^XQBg$pHyibRo0Wix-iRe|e3YrnYZH*0kO;(P_9NR$%&@ zyS2Omjk#~2QX}bsb=GzrvJOg`!k9u}Oov{}2H9NI$?57#8+YQA)Z@{Kan83HDz0{l zf2j&ldzFO=&>}l^vQ;<^vd-D@8LfpKBK48ju|mMi&1+uo(7sCoAdd=GMiwkS#2n zE%J6%T#eQIhZVFzulQj8rw04#D#MG~Oc3l;y6IWD;fC}AXih^IddY~5SSJ~s4{GAx z2BFy9Wfm)w^U7H;LRxh)JgVjyaL+E=6+DrzkUB;HkR4NF%x*FXX#9H`$hr+JfBVO1 zJwE7_Hyd48+V=5Ll57?Du#-|8NnrX&+CU^jg_WDpCy=~{D&b3`{%Ncpqv`c6xHVYf zb`Ehqp~73e$%d|xGVYm!izivS6SPNEjH@8{UcvWjX+6bFD>_l9e&ZWl0ErtTh3K|V zZn2D-bX{6lR}cz6g|4}h)7Nzpe;o{w0qOrC;M<#S-Hk9|q2&pHK}#RjR?BASJpozQ zF!ZC<(aRO}CuTWahU~ORubL|Jz4D*wVU{YD$H7B!UL#;Psgpziu)}gmytmel_Vnyx zO$O7=;o$hzCQP>B&<{$+=`Q?O_FCz6NpXLoX||JVJCJVYaTkCZ_82%oe|OtBFpsr7 zMX~>mdRMg7Mb}z2y^7|Kw7?tnAR__?iGPJ>mI}or)e^YNB&jtCjA5U~* zx=Q^rmhxF^SNx(}NVrP{`us9%>4lzsq;<q%c6F zU5vIyb6Xt+Z~VZbxiuZ{fAO0M+r@_)2<&^&MR126O+|%gjn*ikoU~qUowbZJiDqLq z_0^gE^jReT+~Cyd|*b6Mq^HseE{9= z=y(MYCFp*@{0bC8rWs=ep3hf5qof&`eRz&%=t(KDE<~X{(`x^cfAQbUgvn+BKD2C{ z-FFykIc6l{AZ~@5B1BL!%*}^vm_09DP*s z!Bz9m;}#mMjhV|Gf7f@RBf9ya5hoM5+C8oi_!N$)Go8tG{waMT7wW1F9Pm$%-rx4= z?IvI*y&>Ech1@hkZhZOR0JB2plpe-bKWse=5R9NhMrX)<)@NjF3+srYI_f8g)Jg&@ zsJ>Groi`(Q?qR2BeU3KRoej)3BdqE@G_<9REnRAsqPM<`e;B2C_c+Gv^*uah7;G;j ziF1dGaRyf$I|>(A4PRWk7MAF7zR?5Up`$JMKxOa`TBUh!>RRCp)!IK22%U{eo*Tdg zM9)B!t)N>-HnmE32gww^Zv#Q-K|MOEY@ECuWgWvHlb4gB0rVRUC>qNMZQwm1V) zUs_e$7EK`??%4qQ;Q{wlaQI;sC<;^}M;YPO@D?11YE5crL&=?? zP)Aj%IiQjTSniG>^L@sTI8Y)=h)fUmBi4rfhN|=1VJ7u_2@|t^ zWCpi~P?GesZ{_yc00zLkyO6Q=!H6~ZXsya^9%zVk-HEB9%V4^Z@ZCo<@$R3|ma43} zmW||ve+sJ=H}8w*Q0cl3e=N%@JxHzz9Hdw!=!!cr0NKGv)5g95wVNY_ec&0i&NTmK z*UTD+OhK^^;F`8IzikUs45AT z$|AJ*)a;rI{r2Uv{!hJLyjV@xPG+YcY60Vxe}{hE{-#O^pf1_u&0D{|wv@b0z3jo1 zI@t4yhJUIc?p-)xbwO`IokUrhakSqwfeQ`UtztOD1N@7p ze^wgrow^0PQi2;cWhZ9grOf>FoB_7kPHlVPAHn~s6=K%epCGkW;oD11DAm?evnNQB zw*YC~gjRbs|4d$(L;+M`Lg6)kM?bbyxR*CwJkugg=J_i0@b7MK%fLub=5=-z<#IlR zB5I20_@6lIT&Ah=b#tG>f6YKt>m}ri zD|LY_9?BsObfp3mwQhq5yMb%vE?iK_e^oK6+z?gC+G#jvH!~K3N(wk_v>cGqy@ysy zodv}T_Yoc#mO|rFpJ#mR_t$D@gp&LEQm_C!UsAxw2$di=y%^-$f!hG4MU1}Mf6bqE zUJZ+x}obs>u(P14C*C9&L(?6*FFbRp3u4tjg2t*k;cw<7hLS-1(tdi?K zG=r2$o`vn>+4X1uL`~2vwl(3;f7tl#b*MKSzfM!xnE3>8tC`3mrQQ4$IW-n`ol#7H zGYr|){jHWl`f!YGAp!rw*xO6NW_QK>;Y%}Qgo0Fi3x&s4O6s*|+>U`GuNkRm1}CC- ztBL#6Tx*D-h;WviClS$C!zfc)xCBF&4jCa0huFjD9%{5)%mITS@V?Asf7&&1q$^Iz zE#EmSdOGUun^=?e$v@oBx7dAQxeiErGVBDi3qR}&OXb84@tnZL!8_@Va_>rykzBuQ zduX2KF>}^!-ubCDLG3a6gzair(DkhIh%HI?O)`UcM-? zQXViJ^OLr&x9(jS?Ha)+STq}-qfwnKL@;Km@ro&Znc(t_`QN1m{4G?LGaj>m_U0#t zV<&R_Y~`yf9`K=Gl0zSdwR7?rl=5F1pb$9ilvK*ZUZGbMe`X3Ke^zwT$tFD-7_L>g zd~{{#$I@|Vi4GYV0GPKNT;FRddtSZ2)6}A)LH)P9*3J!C3txR~btlWT($&&m z;ho~qRe0zve>Yh`_+`qD86C`{WP3wEql4nsDET>UnVfb1+Vhv+vSroC?`1^NAHc8 zR_WMQ<;hpS{IF??X>s3NbKb{saKaX*GHzb#zFYa;e|&^;y}ISIqQ*P?q`GD>*Y3h_ zaNSiSP^}~NQ(dZI4Tk`W(g(vt-rm+mm{Tn2EeV#9ppjMCff|S6glRvgk9}FEW{w!d z-&ioAr8C&+l*ZDt(p4B!3IP}G3}#1E%+S!KR*xLwC-&nLRgg4fC^}JO6V;BHOBLFy zOG`~ee^w`qncx?fTdsadCdb0;*6=twOl15a#MAJMlF*%LFmvQZ$r~k1bSM7TNCLTl z=k+0ijwgQlE8eay{~bLyN+7p;=D9S8BWclb=A1JqUMIe{KT}U^=sr zWjcu8Qj1-V^Ij=w!~RXIZs__UEt_VV^5KTWf8ddnkS7#i&nYw~xNl*4!fHRq---Ty zldWhhKI0>?N1LP@z`bsGi#T-y{~rhXFhN9{G`=(-MX>WloxeJ8W;3UG%Zl{BMSASU zb+eX+!b|NEX(xqqW^hr%vCN z7}X|=Ca>Nm!oB!@^_r1tw65*m1yFq%Z(E0Y+^J_<)sw768j`3O$!_$M{}c(WV^8I{ z$?Dp}j=bWWquj#;l`mi+)LkzdP?0Tee+l9>$pRd>&=a_FPk84yBqFlZkv_qZb%7kz zXaFUi_9ltq3moKjZ0rp-m= z?IKw#wY|Ls>(fWdD1EY|s#b-kQgVq#`J7C-1{*yLgJCTxLFx~um`krE=Qrtof2%NG zNk?NMDJ`)Y{2iC0!rEb2Wq%mSZA{~*`@v@S!klA26J=XrXD%h9AHWws8_vj;iWZbe zDSSR}Z=dOeco#rF(JHmz$>;~$5IVBZc_#^!}XM5*TR3D`A$Mx+!YpI=qE&llbHB? ziJd?(Og5j;*;gN}h43&VW~Jgm-X}q&_A@9hjnOa~!-4^p>tI`H{=jF^7_nMaD%sf11PpfXn0orfSin$8&86ZtdOm+G7w%6XO{yg?5zpgL|GQ zNcVc5C_Z4b_*n0YiLEysSN9=US-L$*m)`2*{if1R}F?E=)EP;Au{f2P}HH*$!_b^BCG zw|h2l>px>oYPm8|k-$yf)Kgy`@k5fGB9y`U=H)?aS_weRP32H4kd#)akVRZPTMM4w zpfy;b)p>Cj&`xbtmuT@VSJ9T)+kdlnD1;B|fhbNmHHT3UwyHF@t~VQ3{{(vQX6 zVrA^o!>Y$CIEzlkpBZ8zIXvqA;ha1FY>|v<$J5|n0K%S@Xz@rZ0*EVFSP|9)A0{1- zfU6&?5XP^J7anXvUj1!(kY8hKy4G?Z6!hF}d{C z0PNH?ZasvRFQ!C6ga=zAszP^5s=z1%>EZK!n5Kz5V1}EhaPQlC2h>F;*N^&i7c-u) z9gnY>U07D7mxA1CZCsJE{8$RRg^>r?m38iL>8>4JAE*R{ zO?Rvqt9$-Qcyq@e9rn#-CO}e&7$p-qew5=M86W2T|9ZdZ*Xt%j3J9jO_S^oK?`7QS zr^d71h<$!OgOcq%@U*^gKQDbDU9TT+_X4{v^9!~=~yoz ze_+{-{4V3#pR!vsBMGGzO0$N-iOUQ)Yi-D9!PjSkUI|+m1{&0suGx2A5f9Z;_O>m7h-}>JkTC6LwG1 zLAH~6;lZ7`3}O2E@R^J^UF{mp^TT<0wof*tf7=D;>o&!+si}(b@W%tG$m@XY2c*wqA^o61z zouN2pn(+8EFd7HlcebVpI?ciBKs9{S!9LoQ~ul&5Jjf1fR@O_ax5mmp+s;!=u^QlIGy6UZBj3rUjM zuSZRlNLEbQr}CUq1|sg>F+=Qep@9T50U6S5A9BTCLdf571$@_O9ajdg907FqejDO#(+{y8>pq~wX0q@>LG zNIrDVOme?tH8#)f*ne+P%h0~V<}u7ZRfcS1YVKi;<{Ai$!1?Ek+?pXTd=%9o;xCdB zLbdjZQxb$D7v$(|ID*Vk4yKV0lCSeuC)dJOJvEqFT+poA^0e$|NWy}{e{!}qI;Ua( z&dq2tvkuc5>NT>u9X2UaljL7<-wE%_ali(DuSbhIV`s9eR9GMZj5YxE?YFB$TR_^6 z0g_-l_eKmHLevwcxc$x{E-|1q4ltD0y4 zm*;$gtSF0%@>Txs?S76xfA#lyRx>H1MB;S}IqcWS6F-?wKj>zt@vY|T_JY7%GLT#I z15DGF44@XI6eC!LHpYY7%1EuyyORJ}g_s%{S++W;6e!eWPR_N?@^@TO%Wlkwl8J#zON4ANTe=SF%>79s8%~eGO zF;2uYLx^v6^MPA_=&K&38yG%JhG9&HzIJ8HO)|`kV2nLW%CnZ|e^1-kE?)9qpiheI z2O0)B=_U9YG_Siso79l{nR=+t1^MoXebRLFe~Eo?|NIiX@h$sAoPJcF zm)4`_^mDS|m6>~tW0laPBde9ge&Dwkwqbs_#wUihwA8l?q;LYIDbih*I4>~Nj^5Vd9KB{n1 z=#M&q>TEF{FZ>dKW&dVMc##i=7HzDo5G%e$(c+bCe{CktHz2*@*lnqeCL3$bHeTc# z7TBY_^?=so#$!Dv*UngT$V6REo%vw|X&yoX9JZfeY(RSFHHFz6B>|M*dr*MWPAASv zw2I(bLAjCrj7hU6?8*Lifc8uF{}0UQin3EdTFUJ6ptD=y4-iK@>#h9-e}sZmkgEW_ z$>89!e~~AATtGcs%$I9|P~$ud$Gr`_UCGharZch{kf_M{vu9-8C-|OjejcdL2fb1N zj3o9*@s0qDit)GW{s8&X=tp??(9m!Fr~$~}IbV^n)FsZxPVv`IFl*-DHH#l^9zOqm zlx0YZOf)IkBSHL(jIlkyUH}dC0>hsO-fRGQfBwvfJ#FQEBg=*PziTP6e;bxFoan&B z>uPpjJprE;T!f0Tbp+TUMn44-E)-=@0JI0% zT598{E0u8EiaWv21AnlLf~Mlp^I4!xe`&6k?r1<2JvY8SXHptfKY{YpMg0rnu2yVJ1|gpvGLZroA!t)672dVE}MDPe-wT9 zUp&e$g0@CWJLPtx4bcq|Blb6O2-gemmf2T z`n)5P(jZP!<12Q#mCPjwR;r+S0#}QT!<)XsI=94;5nx@o;H|0PVgR(4XPOosP`1B) z0pmNmgbI)+Th`t+p((AdFJ}5=f5Uhv@>_ooVSM-<+p{&P1_ymHz&)GXwpB0-iS8tws$3av)u~$7{HR&a~!-9M~dbB zyjK(xlB@-#HRPh|1rZ>rNG_*DA{;@MZQseWqmZ+GBWvXKQP`Hfsbhq`f4M3NH*PL| zb~9>L^LdPjA=@UG@3qLi4K*YLKO3U)@EXXq2jXd zN0(&8Gpr=zYlSMriGCJf0%=Vp)$maT1RX1MB0Q0E!RJ<_0~EiZp&J+S_{G~H5c{ZN+MQE-y?8 z-P=q!WZduLsU`3MQ?cQ}tY}94b|OsQmB&77Vu+r{h|!C$q649%9W_V%M>f;{3r_Agu=TJurc#)qIo^kC~O7=;%`p0(mo8 zlZN9>Qo@g`9+`DDe;zlSO*_F^Y1+>J!MC3Y_HD%vLsAdiT#3R!8b^YW*psu_DS%VZ zgIrwb&f2U$-9d?<#FBnYjq6xA6{wMEQ$85M3iS5hxf6RV9(~T?OS?>}Il#gy>2w(4 zdB2eliL_R6qR{fs_={B?+c0~5{7I_O>|k3>0V!1*Tm>cEf0bUNZX8xXWbWv8w8SFk zLvzzyxz6WRakukSujjVSEww>P=UM~mo>o&BkqF@*V#n` z;UmY5uT`&^`w!}%glZ3Y;Y|frIRWNUStn}Bb@|9d`0SC$wIl4_<#*V9`Lyf&yjkYJ zk3C7@lear8f220#lVenz5S*HK1DnrYp}NgB`GR&I5Y$n6G<<<^Az|v`yat^eeek|) z_m4a9j0sQvK1~+9Gs4FD&t58NAjG=f-%lLdvX@obYjg%PqepZv{RerlTBvPtUJ4F)BuWQ;#AMN#vO2uI~jG zyGDO7dF9@g{+2=?N)iBCqbAFx2hHXjwKd}PFdRGY{uEU@Tg-8npvwl>3jOh7^((hB z@r2qby>EWct-IUcJ4D>K@BxF_-flXToin$Kj1O-_v=X` z&$It3LGwKL0-;ZazGL|5f=TS6VDsy}&}{z`j2-Yi15YwNzoCm`5Ge%^h>m_T8f z9EQZH@H}U4`;PixvV!GToOD~*Y>dugNFO;ae>-hhO8V~O0lkDF&vILic%1i6ki?r| zx=ii=snt&sn704 zNN^Dn`wrIFF>4h_gHwfeprZK>4J>Dy7PVy5M6lhJZ_GCW-aI0nqweqP;y-A-&%lWB zf6oc*n6{C;wl}z{4y9k4CD+_C>rdaD<;~H`k zmrBzGSs3ygokHIa245Cn`tE};-{{w^gu!d9W>s%`4y z{t-B-n>Q`LYJMDmVem)x;ZDRffpjWM)O&a`joH`cYT{4_f4>a! zFFpa8+zgji4f{Za18bBu!FB^ZoJPi-an9l^rT}$3tIU$Jl33EJaFA3`VH-p( zX|N=JncSGh-vG!S4pjx3VJaaNEIOK*X&eJtsc5k_mhf-e{||u{iF#%b17W%jtaU6%yH4V2nXJ!aT#GANvZ{AnKeO}*R+`v&`h%(t6`l#~)(nt#j*gbM_yf7NvYCnYun zZVcuHpZUKF&-{XWl$d*`Y?|+CK(S?+YW9NSbs6GkBwTDMGGYYV!lB_Q0G#cJS@>wc z?>u-qM$ZWA;}Q}Xs`kpVnp1*=xd99IDm?BqOj>~jJ<4LgG}VYS15d!Apr%WxqA^X> zJB=}5!eJ@Ej*ifK&b@Oxe;v^oJsAyDN<9bZnt?WSgK+zTQE-=_&@=f&=|ouHY)NkE z1GnJ72s2M6C{NaC%l%zJJOd@%1NN2XWyiYB0+oeUKVq%>NI&wP4=L0Xs_B1GHi?76 zNE_hSFC@YBr6wMivK7V7i0i!zk)PE48}*H&m-!IyHy3g%znm_Ne-Dn=Sf-2CT?(3{ zVyhrvpc*B~djhPL{rU>$^U*(~;&6B_VK-&xq|lm>x>khs{ zNAGTUC5cGxg;yn0e=IWxk$Kzt;O+lX^T(YAjU9%oFKo8(!RCbdt0Wz(Wyr;Zo(%8qu)W&zhXH z$-6J+IHg-s>m!Ze1t-@}iFp5|v4?qkQ;L|bN*`02zH&C|e>v6Dfe{TQ;HVyy+Vtqs zNp)O)!ZHl95$6XT1E}6jHJofJKk0zsuIwCXjs*}GZRpG($Xb*I=Sg(J^L+0NUW^rj z5y=jk59jgq-%pUx+OVfa4vx{{ci~?Jp5J!P6D0hUVX|*tFHgu6)bT{Gu?%oXw-xJ# z>k`<~&GNB$e@O?bDp%$n9Z<%AYjl||m18xcMdqr-;A+DJ>FTITlxm1wPx0WNcPF3i zhx!UqjL~jcJ(-F>Ebp&d%~5=7>3gN%#xD6NR1Ns9M~OVl);A=1dkC zfKQhgt!`CiO0<6`n1wEpM}`tF+U17wckYn67fwVee>iJ{c%Co;9y)H1rI&=F3oce7 z2;tF~C$i%0lHJ%+J1uxvhR@y?eOJOkwsiOR440I!Wu)y)gL3tTkDhq?3N%m#XB?iy zNl;;4DwIN9RuN)Swd^<-F)hLF%|lyn401BpGb#CRb4sBH~ZYCEpbNHKK~*{A!wiXYH!}?tQi1ip*>$0=TIHz)XJsK}5Nme-*hGy9c8Y{O!uM{Z?Zcnd5Rkxh=${`L<*DzHp^3+uu5e%7({Qd-f0_02ts&@3ETH8MW%XVY{J4EK-9UE1 z+m-~u@QqjA89E{i2tQk$yU6&@tI#tWbyFZb;%kqBM}4YNc+T$SE_G-UyMCmMl72a2 zObe48pO(i==L*b1OpP>3@cS$WluymnxY66*0V)f400ve ze?IXo@sBE)L%lb?r6JrECK=Cke2M|>XMdXR@>~0D9AXscxWW-sIa`H;t{(S$Opdlj zU!SxWp_zqs<}K~dSHN*q25mk_up1}>QU$~8Q&8n1CB*2gmzk^=iBr`~2^dv61{Gu) zBNwL~3wC}Hp+v>h=v`!Gr|#Tn)pK|cf0Cge*hj5=m6yl8$MJSY5B618TTUEQi)7jk zQ{3&YYy$;rkwF7jg2^XAfgO4eV!w4fC{RsFV6;;?OI^ILK!YAMBa6Dj;ekP>sZ&19 zb}H)re;Za@N6NY0^dHF*>)p>+V93Gy%xZn)lVt-9wy>rAcvz9IJ=DmsBPBD+f5-_` zN|>joW>2iZ3Ml`5l_?A`sEDlr-ZBN8{E4SWrPs1|s)8U5d*Hag#l@nbEd2eE?1o%X zR`FjOjT!zAqE9kMdlIkHAbkBin$Z){Ji||IqBW>5$sUXtJ@zGCgc1OZ=n1d;4j3X$BDdhf5GE{642^5cTsgU$>oIxA~(X$33}?oKixdP9SkAa z8xFd32c^lI4U2cl>dENAbmS-2!d5(;dZ_ED3uCltDXIn#9<97J=h028s~pzc7c`XK z`-U_>m*S(uq2PnglBB?S8>{gWOdl>(PCEohIxBxuov(+#m6SLF_lcbXf7zjBoR-Y- zW_91*ZbMjt-`riQNNl&I|B`2fta2=_I)ua;PNJRwxpVOa=3Z(U!G5y%G)HXo{2-U@ zk6Tg8LP>;xDqM7+Gui#nZq%r>4t-HOido;h{WrD;!DN^N3z|{=x%ZJ_f~Bh{SnfEl zHF$yQNOl9l4hHdeQm=sxe}i{wOsu*c5@+%f+$0^L z1(}^mCK1h~mdqmv(6|c+{}{HnAK*N{+7u z8jht#lGOHBg(7n^&^5Yb3s@OfTCFPe`^RPiLYp^&PX-#ohN&87X#hoXn`(r_Y{?%x z>f2P_yX_K)(>N=Vi|>l=ubNaDVyO( z=49o$zipP-QOMLKYn;{=YL!~5g2{KpMg!ZrA_qq7ZfRE&=W<}M`XSuoAze_qE8Ls}L_UgYO`Zj+T@ zILr=b?&Fy7VA55IXj@>lE8<*o6m$=cM}SG)aD|Uev|}2XF3Tqb95@=j9>WKa&yjiB z6gJ7q_EG(QYxfVZ?QXxHQW}HgEhGpkggzR&gYVC{=eFeDw>!O-r@maT%T};7)iQ@( zlR^@1?YNB*f0T{ogpw(et%Y3l6?%HlvoZ;na_MK?;m%y@W;`WnQqn(KN^C(kg)o#4 zJO(Yc7Xrd-PCxwrT!U04d=AJAI$9yj)i<1jiqPZul}rG2iNz8H^3ls!F;}pvj5^={ zxA{?e6J9?n#UACckTKj84^pt3LrLwr9h_`dk=Ytqf8s`TGS8Yio!aFPv#RsPz$$Qu zJmL;QFJcq2>1tzDGVa|m#G0SV!bF0qOE8_470(x9jUsr8shS!JM6QE}6(=+{| znUc}$wAZ1~JrfwFYo;aFC^Z_|;utf#yUPl36~CweNJ61dAW0ekpgtF1sSQ5~+;cD- z5LTrbfBI`s0b`1F53i6stx(Nr8-Ve0IeiNp9wL=ITK#lp$xaUdhg)29U}24KQdF15=;)0LhFN z$eO(&bX>j+TcT6U9Hg`G@^%eT#Cbx|j>DNf&)I9(l1oe$7ku|y;lRLhBnWHvkNAPn ze~%;y>f&t)Lxt}FyM^~zJI^CJn|e56#LA2u>>+?s$j>D;pgZQ3hJj=64qmEc)2>52 z!qf`;!u?;sh!e8G&g*!xo1pt) z>Y-6hAKHvEIDhCeR-gginmMIA#c!?eP(^QO${5mTzR#wSm~6LX^Xj>lip&5^`_qz} zjiO{(##Hab&9V*?Dsjr|dzUQpIPb7Wu0A{U6I85u^-O!wj@r^6eoq|wGAwR8e|-Hf zKCm?-nrA^@h=Q7;wE<)$O$eT+gyIvT3yT)CLdUT#HwR1*#4a@h&`avdU@nAl6+QNXD2RchO^+%l zfK->CvQUW@{Z5w?2s8Vv)P{k;?@rgQa>4t?`;{*y6+z0OTf523r5n2j-rPCWE4D^0 za|=fQ67k-ELZBE#d)A!d9EECIZCjoUI61pG6e`fc2O=mT5UH@YAdbS7f9fe$q0MU# z2~aVgT>grh-etSY$I=i-z;bS|qfoQrW`9O6s|Iwei8qR%EA~LpTsp$k0^d@{x1c2)IUI2uX&{TAp8C@Z5FN-ns9)F z&JEWjzju0 z>I=HN-w4a&sASnfoFmd;yBj4Sc-IqKSFO*+;&4_j6+D-%e|3?gj)RdpGp?Y=78VmW z6d~GLDn3a2b3$RyT-r)6-4`69bxd`TLTlpr zD^qOZ&5|u+T9{1(A%;V1Q6yHtJeapSMN#NrhdIa>wZ>Bf4u*mpFxg{U{K$n~I_79mJg|e+m18$9Ga`LK}i=6V< zEouX(f3`ZBiS?Ot!UdSPCdwZkfaK)xH|AkJ$ak+82Y_(iXT6LBoy8Y5)+dN?Zy3p~ zf=`(1Rv*vvTpIVfO__KBh2z$-<^jji#p3G{OYCaI@Nv*eUn9HmS`?!;*=D=5kfd25 z>AL`}kc(DcpE*s5av~8h*9q~$m}k*5Yy6ZmfA(l1=$w_BKK@A-C9aLm^h62XVwr)$ zoDcpVlok)m!E>o>e<*hbr1z$n8so}crbBMzZREu$^!Hn)rfg3TU&RH0bz234ceV-2 ze2W`&Yjz|B@#a$10-loHpTp8c`3o3vCM}~AhV5n59Hp9jsM?apluvq!=PESg1gT}2 ze?ci`P-^A>Aifk+Rs340-+&k!nzbCd6{Dxi6sz7BwzPpzFm9z4R(hZX#QAY8*ph^=lo{XkoD?D?yZQXO^e(aQug^qj@<-^z zOmb&vwi8&wcfKe0%nUJAcyJH>dpY^)e;j??*7UVoVo_~3>S_5x@OLKJRtdP|YvJ$( zm*?k3UvYqbvmy`JNGN!UAPx5xL)3ZFx;%_ErU+d<#QQdQ9q}(Ns_nUr#3>h16MyC~ z#C5w?eL94?O$3$LL#CvzokE%Q+HDV|?yi&Y#`ZZ2KR}H_XxI$;0sQz93c+otrXD zSENj>YZ(#e;{3Oi#kSp4$zM?(f7jkoVzL`|!W;?<;iEp^N9n=#**Ro?0C+f8%{?q2 z`eMA-dX-yEvDJN|32W0WKIN14y$bsz$0bT|pFT$iIv31Y*}#lwk-*SjUYFjnM_`Eh z>`op&v$rFg!!9HRbT5*%OQ!l&47(+&0B3e^O-)5KiT` zj7yH>M%&59z1K8mk>`qv;ax* z%rVP>;O@Vnp47{|cV3cTNAJfvLuhFi_EdBB=k}-dGjUdDkjm{{I%?s=wd<^5I=mhW zRP2f6z8z5JQW(>WLbkfpA;>3_1m9Xt^8UVdyql(zy?d^7$ z1-forgp@tnI;&)N+GjvOH?1feYUbe~FB$)FT7M!xK@d>NvB`&blIt-&r#N^z=$~w; z6UL8e*n6PY$m6?mX2@AXX+16LefKQ(@h{gq+a;>m^FcIKNVw zNW*KdWp;mLxLBjaf5+NNg0H{M7<>jIW}>Y0=f{A~K| z>vEILIJ;erwjfhGds3#99D5vuiA@3)jHm1aC}W9c4wtE@<_hgH3=x-QbW zca~{e+Hk7l*IW6^WZeq1Ek&xV3{#r7JM*3MbALnKrLhg%mpx03i8$K@brztgU$M^l zp%a<7O?|G6e-Kz!xu*qm3AyHQ*7bZY$+0TEyy|2h+UF6$;#B_omLBkoxy=Tbu~}sE z{7+&?GV*b#)u6D$e}XkzMfw;1t{7}0#Nv00_0fo><(j6-#CNf$4Zm!Al>^W+R4NTv zf*{mkdqwQAuTH&9ymJ8-uj7L_DqeYZWh`CV5tRaMf0N(%2B2mrtA6-v6|_AG?%8_k z5D7X6Eg9dta;Jn?1$vSJC*H89WvYfa91BVclJ6fJh+lsvPLkM3A&sixOs6#ajtt1c z(CPR;k_!yuR-{e5uvf!R{?k7X6)&Q?V)gx%J!;aTOKN_ zK#0raf7R_fNmO^J#`P0oM<8ln>hW0$Uy2piF0~WO%e$>J8LsNQp@i+)Y;POk~` z?sQyS<>$?sw%i5u5g4F$&*26->4BlQqWi?BWxP(INuFm|1zpX)X}8Ixvzb=ge&@Q3 zeUaY_>572lHykMkh7V1(zYERk!yEXD=BUW|fA0-CJJG@kwL&=C6FG1{=Hymed^4O4 zNVWFFw@&6fye)#cj2$v}##kr;0^j+5X!HexK{44eRawY#s{zZ0Db;%AC&oAjXc466 zhah1;H`-V__FxN|SiHMdqziL0)i6@Y{U!HHpfn%(jE&R7WDr+|3;$1Nn2ZKi<+Z^! ze*w-K+Pl*lj9>)_xm$Vg*tbzY(LK*D;RAy7{UL2;TXa)CSLd`Z#EhP$17O^q${vG3 zX{Uj5u)lwOauyREf0`1_Et~w8@mcHZ_Xc8C%9)Eq+gy9%-)+y1 z*_R525i>PcB%9HVq#T;6=m`dnpX;z4F+%uC;HJPw4v}9UkLLiYL%T`^OzXw3ZOxx1N;XD5S8k zz<(hl*?<9Drk6v8fw|EaQNzaiXc8f3Mkz0VGtM zTpdvX_RXA9vG#Q>jKyJl3`Mvg61Glfp1VIUk;Y<_N2n%Ino~8S9I8M%>la8QGI5WH zOVT|r-!B$P-EFDP4x9N4hX*1E(!GM`=~7)W3zc1mu$2f_?JGL8sJVamh+c?p3nUTM zsvwv2k?-TY(*F8uAi@?2e-@O1-4W!CI%sL!NUMSWc7M@yn7)XoB<|;QujoY-E1vUT z#4oFsbVwc?CA5(cCQ!}DwW6z|DDsAbs(l%#q-}1Ix{;8fegA|Qlu6*=+@{JuVtf9| zP|&7!G=@%mPvt7zuw}d6Ue*qL? zwv3}#UeE33K1kC%*3y#_l&+j?OU+MpygL{=rkM9|80vs%r`e!-D$OY` z+I~()IC0-Mb13d+f8m2fG4tXXF}U~%T{HYstkCK@E4IVSOD^mlDx2#hNN4gf$vdC; z1xJQX7mMe{2_=aF82+S@WpEvETlaDtyaQip+n%vn3%NPL@8;QASz*sIpnvQ-NJ-j0E23*D*aCp&9cc+mCDk*4+vC}AVtej4_)PG|K z$GdP8ghv>xsUUyqU$UK5UPKeXX6cQ^SMFdM$Jux*Q`0zgAZE?U0Y>f533%}SUaEB` z=wb9`)1Q1&jCR*=wpOmAj?;lYFxpXi4r&?^5LN!Ue?)H{ackRPb#65Zhh|xt2IO8l zKra*(UV2`Fx8eG}g@R$-7vc6X&{xAJ3u$)|J@RhpzEYsbC|GO8#myHUzK{?s3rA`2 zKb_Dt#^C*I>EB65V~P3&qcEWVblpxOC8>E&fIFI%sr!l^6;vZpDkV`FG(AcJzPd|n z?(%ttfBMF%xU&R0I4s2><0!Agxr_66&+GQ*Qg^I=vZ&t99TfMOMXm}{@g8VUv=Mg% zNa@7NlSO#S9uB+4)VB#y(-$8O5fRYHfSJ0}1Z&g+C%(30@t(j=BdYZWG&@8c3W3_( zT#77eY&MDxZqAq%md#~@@5G5r@{2jTM0vQ&e-wpKJxEZKi?jeWK+3;+JDE9PJJTAv z;r0{u^y^;X0swc6^wKatcT6=vJGh=R;kVCTzl)SK8`G{8by48YHyH;n>tq+~>(YtjGO zT2{*%@PFnAt7ArwX~?7fRe6lCC?gJDohHvXm@E8ME(kcM(wItC)Rl9Imq;Du&HXF) zAa`ByqR5vClD1C+6zGmHMa=BK)iqB}O?LK=BHZ4XOF2XygS&ZxjDEW84I}L;Wv8(# zA(Q|un-iGIk0DD_%(}!tLLLc1pW9}9@WF3O_zj}&Iz0F^rZrXH)#iacL_9vv(UiURsQ|AJF@Hz?)*eUe0@KZLFTSoqg3)oa3H|EN zJntLVfhUcF6mRU{)m7)Zl?l(o(@H|Dqbsk?uj;HV z%YSyj=by<-AFe=)`L4UnbmDzSfvXs<1hUQhur;+(pczT{c}JRpm5}zU#KHo1VgY8b zch_V2K>mm9wTtExzS-DU9{A-?NC$szO%31tSAGmBtlT&*imgsar|Z<9u0e8@juAp(oS?fDLr#Mz)7-9@7vuUNLbm|jH(K^zzt34f6h zu53LPd~TGraOffK2%&PSr-sZ<&98DMxX>ic0aqBJ<-^1$k%6L5eDz`+MQ1bH>)mpM z;GxOUGfLPL!n*>k#aZ!;PEJB;|*Ae(#b#<4{zOv!bXzfy~;g{okwxxdaDA%z@${Pd^R`((lP! zxWwlc$#E4ko=M>@qmb@_PzQW=W!u`W8E^(N*~v7+I-o3|NHBA7FlIEJdw-T$F!}vs zu&{=(ya=p6HF%<>@bXlI3CY>o{oYe_P-^qkM03FL`tjWD!R+{b3*HZ+396%{uP?DN z3{e%!M%>PNos|*-6*t35+j9k)^vtrzEl9T@!-#%ktD((i8;$q2;>{S#+x&E!$SGKT z3!S)X5Lw84frghW+5YxE+<(pjJs7|03~7N5s@C5hn?!U39h_Q-rxj?CT|yZ9CyTd< z$SUVa6{UPTMGo*oj5}^F-&&;vNV>fy`w?-7vLCm9ojOUPYIuuoxMg6E$jfiETyi7l zNj#(k=vsecsd1}f>j72h2$)%Laf^`Uso40cM|uEuB3dWhyfjt8F@GqVA!Rgy81Ty0 zgb;t#(h=%`DDx%^tUa=r!(TzOpH=2IOq%xtFn$HlfE}pfxz}3(4$8pmoe&Hj>$&J; zV`+3=YeAH`p(6nuY^Cdd{@l_I)5)RE31)C|RS2njTjcXD3$v#VLGzG!I|5G{A5Bx# zqs|O}X;7jP4MIAHgMU+J12?12YpzCx2c0ifl^}FYRL-Jv&texf>Eev&YlAPRYT~(n z#Mj(;Wj0Lsb_H^9C+Bj?YBI-8g|_jrEbO_^02_al?~@A(%X;6LMR*Zl>XTq)p|gL& zVP?4!SXu*WEH8slCHMgnlj(&A0z0Y^?g`R`sX%eMc-34_DSyRJMyg`?LlR=TKvQbG z91ewqfPgY;_L4sSl|iAP*xUe|ZlM3UmEO<2t%j3ptmTF5djIokBRt??=^`DT z(>n?i*}6i5vV11THEfUYE~S#M zxv}5kRG50j?SD1@IZO$GLn0YG;MVu@rG_@IBz}CPryZuSlegPO+@diEYJe=z#jDL# zTSLyEH5P&7Nc2dz`2T@x zxOXeDg>0Ud&Sbd09f)R^(j9=mB4-d(yn&qPG)CakwzrrG6O9jL`*JMa zih8-+K>vpgw5KmjtC?YCF+S%Aa_!{SDa@kxxP7n7S_wH*{~(LR#B-k|Hdkc9@a zD}i=-mVefQsLh$1=^XuY57)it;t;41#=|h<+13<*P&9z`1OA<>WHtGA8TYyN98Nmw zrh#zAX>ryrbHIuwXCPYhbvD5&8Z|>jfgg6nwC!d{41|~!z!rM0wy4I;m?7)A- zxVQfS8mII*eKQp}h-EoTp6L{PM(qSTUVX;g?te3P>iIKI%Bvgd+(yUWx+f}{b=GQj z6v%NU7B)L=O|?U*h8w^r6uY^qkdJY#jREDWMiI#Spg*;r)p-cWYZJc+X-%=72_|FU zv^N++E**6x`>B5fZ86KJi@Yih+XN$Sqt+uQCQlM1Qew`;5@KfkH1pos3&C;jIP)s-kOqb<3 zcnVAR99nzeG6&x@DWv&Uzqhy&oyQQ~FNFi2MSR($zgRaH)-An|ryS|6Wto0;VB`6B z6@=&;XK`vbFKuKzza(bY!{9Nx8Adx^Za;6ERM+a&e1^KV?Rzb5bDyY=PpQq=M}L;) z@$Owx<`k!w7on*kSVY{6dKHZee1^Ir9svg@d%A}N{ZwplK(-g7RNekF_EcWVHIzr# z`u^bS09C-7Ks>}68fZWB1ORk~{bmugjIoc5sx*a=Esp`RVma#Hva0T30{$Ay zX2$1J&n4WH9-Xfw<;yZ@=)>Y@mVeU*8{u}BXw-${4{ugGK|0&TCHCa=1unn(P50!L zD`5n(q9?)Owf}M183g!{V0T-%=5tS{`{2Fji!t{xR#kKUMS^LzRF;4s41#+w2Mz!~ zp`1pFBVG;;A)%%_8-&+WUNt8&hh6mOAkiF88Z6!7LAl!RZR=BnEAn=y34ez%^Hxm% z&jx;}1%Jv+o4Zt+C4snh66F>t-t6&v9ogOeI{{I9EVzN*GZxP@f?zD^jQz+28#Rnr zohZ}t9#SX_s2 z!XdokdXxdlRwhyf#*@6wPJh~+oC@}-e}LEJN_%z{e!vb7h1$CPZxEk|U7#w1$EQ7u z9KED463|)(G`~?xrzFMNl|2(cILSb|I~`8;@R$4g!Pw2qB97GTr>Xwuah+Myq|N>) z6(|%*BZnV~>BYt#xm8o=blU>BW6&xRzold@Oy5BLk@nox9 z5`vHwd_-K)1*X6vjm0&&lJTs&vdLR|T}zwB#CQH|#Tw4Z*6E#Hs~L2OwtUwu;o>pY z0i}Yu+I&^%XzHF-~1DuEJ6eAhfh z!Ft2Z6kM=tq}-sw#%T7G3aKZf>!TEAf3KJ_EE~uk3q(K@-dUEJPLNHaHpgI>ZyP&S zNv1fb41X8ArS#~rsY2g~5YmTsG1BhPs}E(uL_OV(FV7Gi&41MJnzqC@Y-qj_$sv#N z@BmnqfQLqmn=D<-J!=}3YgwB7Iqj7=N3I}K$Iyp1@(vzbM~ z`dR7~=23D4dQ~nS9rAWVO;@d%VjZBQv;-m39%llHgc};vcmI%SMa3o~^KVfCJN<4Q zApiO-iJOx0=1$)?7k@mdJk){_PKH-YL2Zy46*X#gvcYqKE$a;C=Ek15w*}Rp;`u@~ zXnSB5H-BWUKuqN0uS)v1LpBY}70`~|3-jf310F7D!NS?svdn-pBmlz`{5oQA((7Wo zu6BGAj5CvvA890TzL=iXrC5sTn*m!Kd;UJ&2r9B!M*#J+G~wS){LwSzA0W+l2lAz& zjio5%b^3*&H4l|^e!*I@PSZ(bOBF$z)9yGF=YNX@WXgs$tek+PYJnbC z9DkjKx~`}@JhXuV9!A+BZB}Ams(~zwi@Mp<%~h88!MOk-FL!-pbFEXV+L}l>+Rdv_ zXU70{vdsI6gqXVh=eQ(Rf)5JpT^?w^>aQ=wL0vp>}AeaGN$*sz;OR|v1?bd+! zx18()*+2rDM@%TlkqM@Y_~5Xl1u-?V$(6wmfvv5QL|DDY#Cn037`RID-;rxls}y)Y)TKX=G?U@yW~`8rRxiGN4u z5<`>0Jv0#a*DJiE#iQcj`L9v|lqiU~A}wt3t&6xX2xMS`-lXeOtVBH1gINHXP# zfqENZ)jWPN=;dCukPooh*6NKQX_#cKGB4&-aWk9|UuVY|1N#Cqa}&e&fqx)LA5e{M zu|lnT#*T$~#A((EYgs|3`F%pJ$ah=7R?IzgR=GXo$I%QhqU|kLdHLXCH|peiKN%I7 zQqS7v@_&9ovH3#U;!1s{ zSZbL@rjHaAX!o>{-DghOUCvHYr8NSa9jf#-^S|#63f^>Bs0OIw8R@soYgM-fTyz-9 zrLOQdkCqe{*RiL)3a5Ujw-iWuAqf{#+sWi#60d4V)FPA`zo8QgqyYHyu!G{mMgLmt z+aI-`WqGo4uz(2{oqyxLF^ZeSzD&9%mK)R|e#pcb0dfkC-Si#%a5TK(_nq~e#(}#> z(Ui78dNgl+AhR0NCBhn+0$=^8#r+0TIZv~J$y#QO6I^)&op?lmpZ&+mf3!_MmKj;2 z7(z&KOylByVbj<4_Vov7&Doyr@HpDAUvxThi(NbsIA92W`G1yH8owvFvL=fv-UUfx zB;Oer77NE`wLK!mMF*2!Fm&w)(`Yr)lwwNa^V?4SXhqs8Wx1!>=yFgiLQ^ui+-wk&zAFhh299k&lmLQ)KaE!9==JX z?|NH2awzk{VeJ&3XSpF6<(!RI>x~ME&(4R^EC%mbLqaQC8P-_7nTIAjjzW{f=XUXI$bBnd(6=e2KR3a6BU-G9BoF5}b2){cT4=QcB1!h@!G($(pz5w!xM<5=8zl{{cIpd(LtDcOahh35&HPCSGm zR=|o+60m|6i&l)$PF*G6h$se(lhyI-{M8B!!VlhWITZT!^TWXkTjuWs-XwM2FVaY< zA8`@W$A1lkBNhO@0q%@oPo~%Jd2&C0agvI3%lI|ev>CtmJrM4Ziv|}pL}`E|UTVb- z1};P2_`bI~Xip`fx3 z*ngrbiaauF;sdk&?owE*xYFr<=FO#o29Sx-qpz({_;_V8)d!Aqz^1f|Mb+z#qw<G5wV&@E-j8t%8vCBzFHG078$7=$hmDC z?i*5jWYJ`6$}ne%0M;a+Aw$A0{C|oHKxm!Q4IE1+h20w2h575VJDSLIOYS)eqAGv8 zOTQ>6M%RZd?u&)o{)n~J6y`J=x4DYOe%zuC&Fs2a`>?XDDZ%2^;-K?H24G%Z&k$U5 zx41E2j^NCq9;P0;6FJHHg&TE!J$uNn^yQfoC}E-)Rsoymg96ZEXbwiO6Mq6ITZpoD z@E1F!1@PdmVV54NUK^PbXLn95-d^))*0}9q3D61t3M?Ev=q7K<+`hBukI%&gOmpT< zEj=-NDV9}C0)qWLZ1t8ajm@{}gGXfvN7f~!L@Q-LydGfPL6fA9sTs09)MVLuT2OdC zm+G-TK3pkJCc)&d_fq@#zJG~ed)n(FKCm9vVSWhYouQYIA!q*kiyTk?8eu9PZn#M! zDw#q-VOvH)whQSX%UC^N_-R7rX{fl+8hB(+J3;PXRAZov{;>xmS(PdvSdN6;H^K?W ziG`xpJq2~kd;!!()qj%&7bIK>!0`j%)QH*>8>2wLQ5|cch?suv@_#ADU$TE9MJV|) zgN0fd4SrVjFM^M4gK?ayn9Bk>JuWSqnt`ft@Qq~wO7Qe` z1N8Wq)@(SEP1rOz$P-|ccLv(lw_GAlCMMAA`WSX-C~y+FcMa*O<$=H16c524Y{60j z{8qtUD?y6ZLB#!;Oadz^d42MU0-;#iLMg|uCmibwB zGH$4xfcrS>sZSilW{Az5opkt@^*!u!A7-8`nAkHv{Kz?ZcnN<~{-hw3N9il?@`9R^ zax|wz+Gp0BZ+}JdDdaT48;aq=3X`Ji=O8<;DBNn~hD*mbY?pVCU<36&J5MfQ9j#3# z#y%E;FEED@#lB3lM~kzZ3-x!JZ-Zsb%oxKUA5zdhZ#&|pP%WVBUlOlfQam7dqcFr; zTY+QgGQBqxMvox1Z?4~usn|!xD_*AQxnvy^d4mpu(0{etb&a~k0{(;yX7|?n2Q2X# zAXKEk!QNgUlPdrH@9nRb5r4)?TXQ1>JySD`a|G*i3L}OT#nnP{sVN72l(=rbUEZw|&numqmlKFTlnl(n5Ru)= zg&*Kvh<~2p(t^UUr%}ia?TWc@sV^jD4AuGMam zG43kk()SST51T84T9TI3p&&EDQ?KJ;-w!wQ{>L>mkig@SQa%~x)@U@iBR1ct%Hoz` zB?tnp`8EVbyl>B-8G82@@m&7ig6m``*P?v(Vt)o1M_T#(S!!Wr7CH7OO@D{%u5@L+ zyE5;#zI-Poz}vHb)g}BHzu=)0qwCAM?%1yu51llQB8Zt3%b1_DhM1nEF+0o z(!&>EfWi$H*0P=iP}@j6ED^3tg{oZrD}{792T{eH2dou2HTs=Z@4Czcit=v|mTdu! zOMm2ABU#0dBx2j<7>V@U>aQP6$!!=k?^{nsU&~C1cb}AN<5`V1sDf{_p~E13ZdZ;G$EspSQ{k=e=p_ODI`j_p|c!~k~PMlNK$k!9bE&4b4+jtye74u@2<-6Lp$EV zDqHdpB8$6j_YMCb#1)3YkLVdaUN04N`RJhCc$#s|G(3d@YDlVqM%g<+`t*oXFn?ao z4ZOsb(QthH^#B1qw-V@PKpHSIZ9p1LQ^G`P$HJjpvx*2l4Mw2bz3Z7n3ZDYD$<&ygJoBFs35f0ehayU4% zp?LJuL&DfT^4ZUskzm^(dr~y&o zqvL|3c+kv_NhXTbH+%f`l410Hr6rQ&12E(t#IM4$9Fw9Yb-5*s#5HH;_kSi}|6BgQ zMmt>XQMDj7?EAk}WYuA+E#ujsa25;>61P}*uWx?UC$bYFA-NiWO@V54+J2gD8)dOS0;u4$JK zK*qn=tja4WQYX0jUGK}Bme3n;XF|<}3WJj7IG1>bJz#0KAPKYl5XJr>FfwfjRa8@h%n5|G;|=nZGYLfxexSP_|%NT)T9( z&EM~Ar^+GLC0f`||JewMPn;bsUEYyRJXN~3!8y*0gXtfPt*l$K3KS!p5In4$<*Yl0 zN>!WhFu<@ClrFGI?|*E6$8#$%DjijZRs5aHJ5t{G=GQbJXF~&;ce)E?jl1Luk*_ z)IA+Z=6FTQ=Iieqdw=uVY{0`bQl&E=0ats5s`d1@?~+if6o0tCNf9yNd6{Kd)i5Ny z4m(vDoh+^Ecbf>jLLSs;rrS{&(C=k&bOlIO${1}cV?gU1w4)d8IXQn@*PZ9(^|i59 z?z;@5);61yztqIC9?Ek2)Sr1Ic~V_BUDYcxfHf7NTXSIi{w;BQ6|X^mhXAJ-Xe=zZ zdLNR&~KEO!t<9AEDR{gjSTzTf2adfRGo!GBw}exz%AOUF`T0B&Jw8C-{2 zK5ur_uEKt~)XP$THDVK`*`h^xAXiAP7G5BsqX(?3e&_g|`b1yOQn%nEnj`EUcY{`O zI%s6&59edloQ!fqlzh+!s4(0ou0P?Ar*QGRUB)R&*fLv(%{eDfKTsY!rV>NLtFmy{1|48m8&Eg-D*USE^y7g z27j}WtVqhqxty%o|3Ol{Xlgo_l-4o@l~)TJDw+zIZLhp>NNiV7%a?6M7 zx$;`lU3&VqE>7juo!Rtp8rpII0Of9`HJIS;HqXbRlq?G84RUm|U6dNA!y*CgIf!A< zx8z#g@Tq zxDr)|oIk(`*8S`k!6-EmamdH(2h0(Sn|v87e*)<$t@Mtzh|9{v$)~q4P6)WL`0#<6 z5JpZB=uvO}T>8~+cx-2WR3RdZ)TAL*fjkSl%4`h1+RB|B9tc!uTr=5K3Z$4MC)@O{iMI zL)CMD3j91=j01+GWdzGAG)*@)Il1(UwLHdpGxqz&LrNXKgxITN!!RJNj+aZ#5aeJ( z;No<`E~q)8W!!ZKo?hbs((j3L(YAi>C3c0=?y`3LT*vMdT^O@#oPRhjXFuH91qg7O zd~z>T!=*%5M;dABVVr-SuWv&Nk%gtP)3!Z4at&tAcON0HUUVNmM1-^}tkxRSj0#7g z-x^f$n#QZ9&xKoFl8VP(G66_VA6mD}sf_#Ktf%hj7(7%(aq5_$V+EF2(wA5E$b2J?f_0Nl;clAq0t=u^tLZmMM~Y{j15#dug30yuMUSC%Cyw z+CLdIRbA3$&$9+80Rmk+W z9javE^Vyqrg{4>H1Pai}D%gajjVPv-iM0el0D*fPr()55|8fWUwU9v*DVe%Cq${^aueUdw4L&vW#vu z8#A2``5bVjlYg&VeLbb;xLhQM9(DU?qY7b-N6dmUX|&+j!#qLepHa+L-|v8y|Ck*b5RHo&mjr5u=rYFT}_j>7koqO&TJkUSqYG z*<1esiOw328=Wz;uwlKYhKp~T7JEqtTI3$UFAZ$C{eOU0d5-L$LCi3V_W^m_;;G@4 zB!yZO?Inw!_($&U4WO5oCO3zhq2PQl^@8X!IqGZoSW2@u-~|R==)8JiC&pf>I+w&| zilW2nmdM=K9J9Hij;V#$0ck1&HwbeTE@7YzSY%3W^!CcgIUL5GxjwXDCtv!&_BbbBijse8;1gsA4n5)CdE zEj=O~9$ahNW95KlTmx;bOYrJC@QiT~_>5#jWPGTKg3sOA7}DoyHq=%muMc zGvUX0Da{(1Qazsa$~7|aLYJa$YQpH$LV1~j;ll$;b*6E-jZAIpPKAI&i2pC)2a7XU z?9k%%qfBxV#GYl<>3iR&)xI_=8|=R>3xAe~jvTGjhR}A*bPGTH{9C8m877CjIx0&! zbSfm!H%aKjZQmNt1i5fMSA;*!BT{9ZC0!!<-|KtxTFAuDYdvSa1r?7V)>rtWjdH9i zt`wB|=WbE3zGa{qRMufF?fs974v$yiB}l#I2DJkP-IrR$d9C+!w=%D=y$m7A%YTTP ztL0SP{WRST_nDG)C2L!8mL4_!s)tzZX`BU=mE5X{d-!R|F1bguWDmu;Nq)6DwR#6lBRV^e4 zBy=&=6%B=i+KK(E-mZ!IoxIMB&3_m1iVJe4)ESRvJe#QdbPhWvwiCF%nzTLVX!JDW zhpwdmB8hAwRM;y+5Jn@0f-Ki=o{d*GOITXlMas7xe~>DdS>(5d#~y^*dqlEXy5?^g zTbA3hQa>AP(t6rxXH>2NmzIEYLXU3e?*F8FGQ-{*nv1=^!T~`8R=!*t$$v+aM>Bg< zqa{9isUX%VnXaZn?c$*c1W~8~ynsQF)r65-;Z0I7@pW>bwtdetlOCv=!;k~?$s%jB zgb^Qp7C+P%CP;6nrq71$JTzf4#j~sY5^bNauwhKFbcd;@ERUOnz?)F_s^BIvxiZ2B zi3#`ggHv6^Nn`&@BzgZ8^M6IsAuS}xt_Fy^YU;w6+-U^YbDnt|*$VXE>wRTUJ~0)e z)wTe}r^w_0)YHyJpeeQR2>_k*r;F42y6bpFqGZA!bp+0twu$eMx#D5yxss+7vtZ<~ z%V9sSfD8HP4;j^B6(*7A>d?}H5rO0gYhqLz^s?igYdHJPOv)pZ6Y-COs(M$e z_Rmg#xracIX8j(FkriB>_3XiL$c|_2M&o3j2U_eWhB9f#0s%o$xX0T!4}S z#V(uQPM>yoUYqQ5jyi0pmD8a4mUH+fKO35OuZMeZPIgx4+J9lD7FhMm$1Ep7rUPDH zl&CFvr7e0_tY~R0FVUmY%_?p6|3;oF5K3jM@Y^0oV^yTtb%!9Dh5YwP2=6w#p9-+f z?d8PRQI>n=LNT`!pz=%#x|m{CDQHMH+H(9lm;6%Ir~?dhkH$dvIehw~J!yZtyzYaB z-}62VU6--UhJTsikFs0RxKAe-GxaTp2P^oCsaiViYS7|`*ynuT@)cx(1-Wi{(RzHA zPb0YUIUM-|q5RVLWCdNEYj98&1mT%1I3Z2?@(U}e&M^7!+br|#8UqT$&#(Ldk)5Ik zT%%;!nCCF-PX)>*^HYsonJ@o*Wk_au?re?$osyHFO@BhFM_qmS1;p z;XqitsWQ=+rAbJtH|^nI@?z5UD6FctG&_&N;SlQxfZ15uWu3{Z;(UOB$1+41SY?3C(>(^bpaX3fw>; z;bu?({eN95ga$EDW=_55@DZY?_Jm=pTFg1ekqYvu;GD5AIxPywO`(<*Q*2Jo5ib-# zdm{p0ky{ksgUxMcSZ@;W11Y5&`1Vw-9!BVpe^@bV`DO?;?JxJ_3 zTfZRz_Y5EJZ({K`H~Q+sM`$1=cKsY496Cd{^p%OBqqX=9kkgOd#7*Mb-Lf>JjQH4m zJKAn1|7y|uEYx67=Z)nk{ER}}+?L!d6VzwxSY zDR4hkLmB$JWa3LejQ5y~0yQ&+u#B#NBkyH&`NFzxXN}#BUk9fMclH*oApq9?en9l6 zTE1=p7ti7F9q4LEWx1K}N>!OIcsH9 z!1i$#_y}4P+aEvrdb-(&+HW04S$`19084yog$LPwqfz0pua4(X?SFW$_NqMRBSMUG zT+#cIgobt{5Epy_t8^6*a)zyDJ+nx3DgR15ld@z9zmcB=j@y*VwsUzgU9&pFNd5s& z$m}A1=fGq;&Ja;U?+~3ixdZ_?ee^!_FC4#;04!7-GFpk~Np53$aS1R1Fu3CEN^v>wr$V!sB{!!sav3>RZ6(}SHZ^PJ2k7s;djMG(#=KQ z%)_E;D$|WItMsbx?7IJL3E6M4${Tv{XB`GVHq&oB6Ki-kI%pr_j(>_Z9Yai#-(GuR z`iXH$@xliBjO@L8Ilhm)!1+2XDgJ1N(Hn+$+4MEdQCp2WZob~|?lPClZ6dX1Q0$A@ z7E=fmn?2I7Q1NXdrfW%^iqD1x1q9{Eo0#Fn=dDUsY(oze1a4NtZxLjBbyhFM0)Lgn?OM0b|d7r(sJj;4RS+ zO7t|;=gF47?v&Kyvt~gA0pxx%qY-tHU*TOHjf5weV^>KK!YxFoUm#j?Gh|)ht0?WU zY4TJEN|bF<&@dint^ia=7P7e^DPMa!yyLrDRFV0Bmu&gXrhgKl-ULaJQe&Ie(&B2* zH&asFY>(i=Rq2e>`r@kis_fzU$0M3cMV)e2j>de_p+Sqzf6v+l8vu zAcc^ZOR|miMH$5t5=ELNnaZd%f!L$q*`Po{ zj17MdPH7bj8yiNccm+zQ-pVk@!XZ?++5EF_asPhioyQm(aJ!>MN zX9oKosY3FeGfo*dd0VNsV=nL@UagDu;-878K{~~n_CMld0kS>UL&bN1>_V5C?$@LJ ztJf>2wSRXw!HHeQKpfF_qa_+W+6zt7Ua%!6p-K~#jpZ^l7&?1m7$TXjr(ktX>Rq%NhqeB9$C53#%?v1wSi8P~6I%ves5^0 z*z;X=jABZ@U5k}bb0PpJ8T@vyHQ_XO^Gp$z`AJ(_&l_;OAAiW95if?eLhaIhJrCz( zSeyp#1e7NXFkp2(3AnUTj1yg)a4v&&pCxyJ*`QHn${m9YdT##h&)Ji#{caAdOYF4~ zeSg5NK^@Dtm0SbL+L?J?LZwIfUT^B=4U!}2JfL{OZ)Bf-b`ig=A38*PT&uEF025yG zW{BLtR*PqGnOsUS!=NNj{utfZ>EF_!ScF|l{M~X8se|fPZZ|N-0BnKQ!*CLj$dRkn zu1lx6A?J@tlW#A`Gc=X`eVC_{MKhw$fq#HMg@9_coD2d6Uel*^cARI9uwj|y)9C?t zfzT^2*X-?DyXrj+3dijX8N!!}BWi%YQ=w}BOkde1><97gJ0EAEJ3%I&hgrs|s`1EB zF}C1$pV*cXZdW|qS9QzZu+8#r#|6r(E6J($pGSZ2WZ+_Vo8hM4Z2^&i^=N(4kAGSX zF<`F@g0K2ZM=A|IaDie}sO_0XdM|pe&}?W>6A6P)-fM(1D0tnZT68F&UQAV!?6{ZE z1O~K_qWy*{yI!WOsZHh_o#dH#sv(l9HQQ&WdT>pt(2H(KSP}?LrsLwMGH={!0F3#& zs=)ZHT#f4vxT!gxu0s@>GI^yFBn@ z4t&f~T9YAlqYzx7f7vYWRGJu8zN}lfIi>qqm00w$rdBgVGZ^Y3u9NSo6e!j}J^gIG zpa3lU3Do^Hm2zhEsM>A-j>mvXm?96Gr;h6=ojR9P{C_>q43vyf zz!c@xzBRH(G{@4&i(WK-VA-@WHTd>}nI*;K)ZGKJ&v3W7_Px^>)n%9Wf6X?zsbs2I z*3>-siNu}LIPqk*`X5Qs9i`7Uhzh)lO)&(&p!!=2R?C_g(}RK$o!Y}i!HR@Ti0AQ# zN@@BTp!44`gohk&Ow2WiFn^bU{KyhofFIz3FelDT%oIfBNt95r18Y60Vg)-+Y_mW<9&bH)ZqMS<**K%{HL zsFq(*(vZs-064p;x4L3|(3*Ecm>@FR(N6b$K@R91!a)ky@rZpxK7VAVo*=J8{b{47 zqn1amt-6fT$8K@|*<6_gfr+_qY3>MZ0a&m%Ge>4ZkDU`;!MsT1cb)K9S>joGl?-Rl zh>Sju2oUitA)v==R-s5!k!_BzRP+S-d%5p4XuPhb%R7?E;_7DC`C_k^o>4hS$&&9C zk_*Zp4)kFM;$X(CTYuYdL@Zmi+6W8s7DD=j9fp3{UQ@6? z_kWb1$T_{Bo$yr14S%mP&Syrw0QqyCWr&hdZIFs0+%l`5(wsCX9hbHOFhqMJN#p~m zUS|{xr3dy8rhi_cT&#eOr+^S|v`!TN+pMK7CoBi2VG$Hw#N1**7r; zFU(TKylJ_gAyBLxxCMYi2wnUYef#Q%`f8p0*ZRDtCr?wuzt4pDi?OT+cIk(Fdp4J% zDmX*(rLooL*G9=MqF+sO2$41Q@wCaX4%+G^{5u0?c7LEbNI+8vo5a9wW2{Pgtqd%7 z6`V(Hef`zeKDWFiOIKZ&mK+$YNdJ~>2i%V0>T!b7h@eI0wmIW?jfkRed;NiJOoo_x zz<%W1uqm?MhJptXM%{pfbs<*721Ul@lAwn3XCd-Q64+T5u$0FLI-wfUv7L!xH2dZXO<`oJB zv1?}XO!2v7IB9WSCMuT3L1M)+!wo49q1+J^fSs+3qG(VGRXvjXXi7uDGm)20`&=~5 z7JpewNqDM>?v!D5zB$2gCFk9PF#cT*zj+Zi$ZYYz2Vm5FIqb|{B`LytF*DBO_@8s) zQVRMV21IiHDDf#UZ&{TlwSD@XR zha-ZjAa+=J84ax@4?2>?$sq33vdty>RexyUCM2NcdosTV3lW5t0u-BxZ?F@WC)rsc zAk?uGK|R)=plvfhINFEw8I!+J_#!^N<#RSRF+R$yWvo!1X(Y1Qh(SG>=%4vJHT0o! zn2b#&Zj_bkZU1m^R`xWO>Es0Y$E7EZxg=`?x4jNNoD1l|ExXw==@obe@^+-(7H9)w(srMe)SyAaPJpcC++$Ct$og5WJbNw5x;1dR_ib= zFaM>uukt3V;zfQ-q|^gvTMlawxi}bYH&sBSWEpK#r<=prYm$~MjQszfmw&yjP3Pzn zujumF)S4g)cMj`;S3?qS(*0t?Z8CVJSG$*0NL1;#de%-}N&YA5F4POjrZ4k70N^Qn zf&kgZ%3+)Y6h^n5wfHIzj$4SPS$P-0qh1b;gEA95j{6bQbvo1s#iDjXG?xZ7mPxVs z+KP~w`XT7#S<=VXmG%S7(SPB+NgjnR?6i~C=9hUR*_d~s&^$V{$G7DbiUZ8xm>(y6 z8#(gkM+K~o0BPQr!Ic;NuyN2E#2hMmE86W2>%jdH@5KkvDu!0o)6O_%6mKmS3O&Cljz^1;?V2OMt!nbmafJ4#& zyO}B0poPE@87$(#EoGU36D>U=!v~(Kp%?$e-S0vq( zpB6IVhw#!&MgRu>iGM=!DZOCv@;_@ENDLq6vrhzP*wPK;{hRi!6JUt5Q(Fv*@G^L_ zB_CnaI~9%LGo#51_78p7PNIo+w-ftorm{DrxO4WA`2~N<^t+!f5L6i5K>{1JUm$0< zzUARY#vGlB{nX}j{l=1-7Gi#xp)QHN>NZK5+JByF;Dmv7PJah|Tatf0G5T2s)gYq4 zYr{0r_0Z3`aJ#5{8Y>&Ql(4H}X84^FWC6>)MZM2>@?Co`?W4TTiH*3qF#Tcc07pQ$ zzoHq=>6&h}Z1sx%tBbx5AB^3IoA6ka&P=}^#gINX*iC1n%z;XX#Ty;J0L z%iGXwqd)3Sm380sAJOL+i7@e#_Dc&VO$;_{{kXlZS-M(6!w+}gYX1DGhfQbE9D;1L zjArZ4QsBcWTn_gdFE{_oDDJH=2^#V1%%%Wa(9^ZO&p2HFNRNMH2?ylhNR4?cPhB$T zkBh%>;F9hzW|c>Hts`!X%5JQ_NyA?+or7|)$x{3!a4tIFl9Suc;5W&m4| zZ7uFEm7-%a6y=nvS8DYIhwT;e#Mo5L6-J4B%O!ZyNFpUEqR2dd7QmB(ZYPdT^rvlp z=M#}aMbAQTdWnC%(jSfp$#TI9_#xek5EYj!xAT(cYbiapqvv1Kx7!i_L}2Qnvi+@F zhHE$jk?=qGn8p*uvhvLHe^URp07eBZ<+=-mT4SaCAAqE^CFf-I#Q>awnWg_CJiHftl;lL!jic&NEA2|U%Y$7DQk4{b%KU)*g)HY?#@4e=#V z{I9Z3SziZ<5Eifr)@x7HLP_Fonp&x$lkWhcBcOi)NDtS+4+epioALx;#Pt|EH*?XW z5k}*B67+j5_`(e3K%3G5rc zeFE?J>C?RGfGh9%B){zsGPC*Mb-qatIo!XW1vb!snLNWw~N7hoJ<-BWy zas__@&gm`$dWWbL64tVit8TpNha_t50<+={D@7fKg+fr$9QB`dC&jg?acid)6W5&S znw;!1kQbYm?A#7BItzyrO=l8?q<&)r7v+>ciu-U60JfKh+E>{LojGrik1HTCG1zIp zE(X{_9@#Iy*25;{1&D9A3;t#I_`hYD7?AG9E&pb*-6y2UQY@LY=Z`RX{8uNa`d&;-fE`_;tgtc?yP@lmT7YocrYHsQ=zN z=>I}FJ%|fpO$B0a1Zj(9#9-(t^c~kQQEXYHfCCKft}))2gkzq!NIZ?U1JQCb;TP%6;(rZ9_J@Az-u{B9BO<-s{kr7dw2ta zN-N`~R;a&O*dQ-?h@>@?JfW3&B$e%L4I4IROdj6GNv$11kLlhQ_zj!EEs_JymY)8X zigiu8k3$Hi=6i5corO~RkhW)nxA%XEl}c`SMy6EbwT|RO!o9m^1pB1~neiH^S7Z)F ztWG?nnxh0?^$+=P>>D=H2mV1>^_3}r(RPYh>=OS)PWAuf0!s;pk)P_V2Sj|U#c8iOng?-{9u?Z!(k z8NCw*ZvKd#YrxZQ5uE9gajP`|q zsD+3_^bbLg=U-tT6w(LNXvTk~E_0M|oW5UH|E^5J`p@!@Ld}EaK*KCiA$%i7vog2=mOaWc9hDa#!o_|rv(L9nX$h-Xi8W0&!CJGXK@BI zP9w0HQQN8?lk-A11jFr9R=WLLOilN2d>1ec@xzu~K16qPbGA^Z6S{v9ELn;7>GUb} z0xjX~&Rzaf=)?$n-R{R_yu!W z>$zjMI(9!~n@M&VwqNNfiGt_&{HX!KA*KKIO5?`psu!UFz<4r1QinwF)XZmN!>o0z z?o$^Db``_J8s~}h(~*CLCCB0k%XZ%~NoZMJU-s>+re9`=7Kv)5zNv?QC*?() z70~u@PMHuEARhXpCyQHhLm~zp+&99CSDz8b8(>$9P@v?1%x-@Ny*~rmie2d@j;4LI zm}ht@&ST;DgR0p>94eF}4H{OjENl2~GP|dwRz=6!V_OBv;A7z>cAD_N$te7h5PQkY z`(u$pOjdRm`fLOI&6ZVM8$GAu`+P$3d7I=wg&Nwu^+HP?FTJ~90K-AIYd$xb*^!dL zy=JJ}%B@JQw{d?K((Me1UP9zGd*EGeM(4GXo1rFI&^e^##hpoMP0;54#lBz$$uY7+ob8r5@`@XEh(0*hgQp8-l zzvFI$bcOo4Ce-^tP(bneg3}tnC7I2RHxzese$l#kY5))?UQQ2jyF?E8MGSD5tkU%$ z>F(6+pbCKho_a=AhXq+%BZ20xP3uV}SBaeG0Ay{peT7$C!Z#!pQJaW{<>OtB{86Wn zt!5lCv@?I^y%-4}_4(01;DZ0DABhR~xf}8(jO4=u&kyoCinnk~2V!OrFqdh0y1#$N zn&Sf|A5k@wro-t+P!xWZuj5N-s9kBM-Oyas_fkMDF}4%Lf8K@pDYpW;PoE!2+JdBjrsstG7MC0Zyt`#=zqNyO@+xmY)p1_yW^B@Xf^`}#ce!={(@s+buY?G>6xD179JLAidrS$ z74Zbor)O@Gm%#K)g;JMijveMc=!||>Y}Gesb%FXg%&F9mU|!j$ysKllReV+^0NHcd zK>Q{tk~0DN#o1zP?EcIUAo{hhv)Mbrzg~au=mn~1P%G{Ab|#j#F^A^0V*-F)Zt{yK z*J@Q~0fsBf-i6S>45QUTmO0KH$9UOOON4*NQuq@p&dTQ||C&Nec(EG;k`GwMWg1j6 zA!?Tn1-e&(+s}(d*V32m{+p<8Jo>7fscJAS4ml{eqYH5_L4u^aOv+ z5QZ5hD|D1%%!rz!!!@CSqc!b8Mv2=2Rf zIWTn_D!d*E*uvT^-ohGu#Qy*sh@O9zuB+`GM4y7<|Jt?muCSUXi=4#UHWXVj<9hUx zr8FSC=uj3Q8*&fDFQfWFY{NzkKgcW3I%SAK&qX+#$-r-&Mdx=i>3nvJMUFk=Ob3_9 z?ZOOs+x)guZ15pzymix3)O|f8YV`!_JOau!)e~c zYnL&j0x2E}55!E;gbGS3LumqXug!S%)E(^NZtKjSYW121&3*L&^o#CU@wV`7hJHXAW9i$)f$E`1I<;!Asd2 zxsGQpO^*s#E~6HZIkgsp>7l4oR%a*2cr#9GuW^HkGH;5{4h{m%kUD?yHghi8Dejm( z>Tc63TEZ4)RK z0oCP!OGRJL8rDj@67qk3;b(M#M@Q`Zod_0M#DGFgc{|~TY4sYddJ-CCS!L4`-c)>1 zjtPmYZ?fP_%SPNI-)huXj&}E-oiWB%U)#k1D7`#0#?vOt!{l>=>qurOtTl;rIj6Pl zer9fjCv}GiR-U0+T^!8&IU`Dn;v}N2faHtw1w29IIc@&=2}^%`&JuA=^f@Uz+vSNV zC^p&(ba5gi1V}Kcw8QbnWTA0u*d4F>Gp;_QeWEccJb1qH52eR-xt%Ud!(P`D?aazu zTa?93puFnt%gCn07`a5 zR6x#4%k!$kO+J5mIJgKATRP^jsp0aIHq>;(65e2Z=*yyua9Ev(Tc#x*agh_y&%mR# z)P`A)=>pK44dmyv;$8rGPTra(yFyMQBR+$1S9t=$jprlCUouAL-=zPy6ZmXTpx33< zvJ)2Nu0qB`PqiG-z=g4#$$t$jWx$q~p0gPN7y(3u* zjzOn^w10npXpC$Vo$9cpy}$v8PDbL8xnGNw{64q)&JKGaLUZsB@4oNOtjgnX_c?}TuSn*BtBE+(nDVP!sr{BX=8>}LY5?%(v@#@yHnCtSpCw}M4(g?R< z83YO)#bju;?G$~#A$>pVa9F9>?YsMyM0wMgGo?$90kAkUW;W}fyAr&XgvvVBJeF@1qK#_pXn&`o3$lS(jBkn>;!Xr z@<-(Kn#z2F^~2mHy#a8@w;Pio2)8b2Ly*3E!5f$JG%2p)-P+9`hGnK%0S_mrd!W~^ z8ee}%NlLnbfE%2Zcd4d&VLN^%$}$p>0_G~P0PG@y@UfbJdnqO`>gz|lN@Jn_1#jMP zFoqL7`WIR&8vyeNDI|it3RI!>@i0Rx_5I~M19?A9e{elS6uvR~K6CpdTiKJYiml|M zz>7kqgffgPRz_s_Qi!{RYqOX70mn4ZQiOke+s;4Zol9@u*ST-Jo_2=C00wA)<1qHF zc4Gx`43)apF+N`#cLpKqC~YT0o)r=-Yww=j1b-)~w>7O%JSaGGsKc+1*slq=LNOk; zf5wKnu9t{du!b45?=%+^mWQsC6kfox1%>Q@6Q!OUmV(MjP9<1lzK*H}*6{O0!0LYh z=Ms$Hdm~+%ukSMd&hC``H)A3~FvENW&Gv@i324*A(I_A z-`5j3DU23JlSRS$6@z)e?(aEirB~@lGv6m-a;pPNe>bvspq^4IkVdtR4TIrW&-aru z&9|emG#z2Q%9X2ENK-!0NsH&>!bv%TKs4>mHHs;0c)^dyOJ{+dCu-pXf8E4DJGcUB=DtGXeTKy*C(R6j#6j`vM4lgqBQ=M)=PDtfokd8X z&OBZRCeBhUNC3Weq&ftD*)7l#!o}FfFh_*&p!1MS`yp{CP1p;5*5H4Z+_4{*kdPx@ z#itz4f89#P5e~e4)jU$V1Prrj7|3Vx$O7P8ijvL`^bo}65D^jGKMj+ ze(=@AImU}7Fkg;4mfHX(-RocZiGj`c{IsY#ROKBcm3^20FzA}b3L1tOl!wf6L+3Et-yg|eJuKqilDu_KqHAFBSQN>6QH=xOs%;EOV%tnt(gH6BtSfy z$7My{)qG*?%6gl|%+0}C6rEL|TRMoM;CGO9icEh>)OIpxsYWudEix1xK2pps>i<5WI>CFW1k=P!?!Wp;}QukvI*>)seY?9hSVig`USDU}R$bc##61n==7$f3b_CYa1}$WzzmZ_~mpA{VFA0%}f7Pxm zz{P*H>?_r5-59ywPU`hTo)80#EFCU{Rh1x0yS(9uGcS94JL?AUwS%&V^5u7a!^ zlJ)eXx5MAOgqpY4vq#sn=>ys_U+H^VoZ_i->kqnPQgQLM6E;Gc`r9fj<>`!$UrTxa zZL$yAME5L<8=P+mTARoUl4i);gxD-h46=VvEy&TA#&Efe_o?r%yF@X=HnXF35(?49>upI1WK@ z*0v=Y8VfA+-2C9qCcaoX3*=IjR?^STi%gGNVbLNUe#B*E02n}q0YrY=#bQslFVTN` ztq11n(;{zNoALx0R5rvZW8VI&D2xqwGwNmO-3hr%O?E#%YY@wEdrLY843N%$2W)64 z6j0P#atC=ev|1>5;%GM!3|ib=X3XjRUTle}CqSUL6j6nG8P)A(nsR-g?ukL69f4#vePls|!+e1k&@y{tHn_PXdap z2)SgOukcd1Tn_HQk_=UZc+xRyE4j|*eqdoCkc9kWY(na#gHkT10`DDCN{|gz&z1zj zR!ZWI$o(&pJ`+4Kbb;Q%rf5FbtYaxa7&1-EG8AHL4LbQ+a_f5H=RUVR2Y-JQm`ikF z{04OJj2zSq0bnp#8mbynT8qR_zN?{$YzbUoodts0`UAdW69QQc-k-Yc)kL`#iRf-a zAr^%3PMP{){~S-c@9%jhX(F>2x~Vay}w1_`nQ{e6K5Kl)P#`YLLMzih{Sc%7#ITC9rC+%GwD>u zwNLJ}!2e*a(a$}QaW$mO8#iU}&hk&Ky$o`^u4`FtH z92Q)j;^%OnMkhdu{&GOLSoZl4caDU%*% zB?|JQr^kVLp{Rcbs55n~ih$n^=#Ku#yWdlVx4hj&YLUNMHE;c#eM@XlRcSm;5=6HXW; zH}$CcK(V65)DqOsN&N&wDqX*J=c>D_kwQ(T2gp=ZsXu?v@YuAL*~v$-X(1V!z=eSp zUW_|Z?GAZF-8{yT8x-{Oo(mF{NfrG8b?nE@`C`{urYBJhMBekM8O;T*WVY+IN-7cV z53oGeixGL=#+VjTjF#M8tK3`l;^gve+SN#3ikr>pCb2i(C(xKoMo-*ydi~9kn^B_0 zKAj$bHW`1)X~<7S3&-9Zn>BGYO1j`ygFLp15v{jlq``yx!ls2SlINepoXNo`ronW!0Z!G0rKecZ$1R zVo$1b>TknZn0B3;oV%AQfPI1ZkLxes(@qjIe0uo(87?41pI$Dr)R~t)m{cE&DOCxH zzQliiQR#0ZlDm=0fcGM9p|@cN^zS;g#zxf&6~to>*P|&rUM2@f=>rissd=K~_l#4- zp6kQGmC8^qiX}v!PQ%7bDlimKc41A9iA78>!US4#g~aio4MfJbopc;QT(LX?BLrv4 z>ZVu!!aD08GrF|c;phYlGi%p4VQR8~$ya|g-JL*5g_0yXW+cXQ59Ws0M3N$L}PvyslFnF!>`CUWhyjD@dun7URD zaXIAeSe6tU$#M1L?!hB8_Ue#HQ)wypPOE73uiwrfU8XbuX)>uD!&E68N^67e(G7nc zQV$E1X{ehqAjuJlVARGgdDG&iCKzE806w*qbID!Y=4(Rp^Xp@*q`|-doYtfuGK$;W zNgmcAXOdzah8vbcNrmF1;y|AJF`{b{?&h4@t5AkI)IyK)Z}TP8F4Yv^?0wm!0PC}J zvZ+jQGn0iqQp=xcwmr`m)bw66XOVy4MK*ne01gn-#}y3u3ANIvUIY)JHNz>OmBiKN zA?Mg00Zsma1uzn7{|jAK8^yN4dMV*XeiROa;X#Re#p!TXxIdmyE>N^C1Ymt!I#)2noUrUe}Hr}=-r5;^b1 zf8qx)LwUbuXA!nFbI|NzTRp=*Wl>NyfJ#8U+Z+ni$B&mDM5_&3<=UaYgr|cwK3(sl zPyb6o&|3*kB?C==SgJ_&gFt+L!>b=FXNIy!zh|AQ>X=j4zaHqcPB1J0yYa`gAUH*;Y zNL}8T%-%Jkk&xXX!d~dqb}6=dL1S_2`A{hA1t~8Q+JV`uF=7{Eo!qm(XyBRb7VHiE zKPl$bGHG_h;T+Mr%zz%(l>5jx^tV2wDmvmRh0Vr$4yufN!ayoyYM*}?0DHVpbMMqX zpNyXlULq}1&UiY7g5gbChUIfdvfnC0E-(T(jM!suA1@nFiKm&p7F`Vfq2LT};-KGw zgaPQ^TYP~NbXD(Hjgml5GWwc$7r2cP=NKWM008oX+sP4Bk~fkJX8{5`yRIY3U= zYU8k1TqQi~4W@k7IrCZI!dPBA=ihAoOaMW9jU>KE$N*I~@%>&?5=VPL%+%r4zLcUF z6>-AZD4qhaABZPw^(Du`*zC)&qC?dQXP-dc0TWY?H7qwt<@kSBX94}0N-yt$A71iM z{w8makDpay$P?Tm0fh*aPPmW<;+F~~?5=;`0McWS>;|oCcZuQHulXe#tSav$?4oC! z#(*BqvQu$VEE#8Q$_zFg<@j4QUjKUoKvS{OKjJlT%MO z4d2{eV$YI)8N#{|A)#7j5WuYDlHW2Uv40g)Rw59y$77xySN>He_RRLem3J)<@{2{m&#z3wu13Xf!ZtHS31x^(!y=-#|w#e357aH?_V8jlAln6w`e|D_2Qf^)8e4je~)65ZwbhnVy0glY?SNNtFUX`Wb5%nxBmrw4FT|}b+Zwn)<8iruQQi`EJV`)N zbUOz@EdboI_!bCqEE3vA21f>pWAx-%@P87a(?>seZ<}&KCy&RR4oBy#Igq(v;~>C8 z=^i%^gImXIdj@N#SRG%5>#=uomf6e^?i%*TEg+g->S1dDc1ADEoAmkfpJZk5PVx=eo33y`P zZ`H^)*x;gKh!kA>MFX`DU&7>@9;dH1S7)l!#pvnDQ}Otm7y85gGk*c<4QClydiQ@L zFF>fA<)bbE>ZP&NA^{iOYM8qL^i93bC)}QOCT4kIf`kEkOb$uinv-tUpwFFT-d~{L zQ)ddcA`@h7w?XX1Js<=iA9?#9kGNdYF^^>$h3|#Kw(oV3DwD6snfGC}ATW8s5)W0Q z(m4z4*qHrzD>jJcS_asjA^o8+T8)2}NxylIf&*6IYi{$g1v%%_5PJofv0|?VYt~0i zb(PJWF+qHUtxT~}Hj2CRMLh}Zw%_5Xw5r2Xu#gR6wG77LhOBo^7idF z%ql_zJ@^Y#16o@>5mhfD@%f;PRJ!6}i;=edl(TMI_XDW>H>m|YU=oU=kcWR7N1$*^ ztmsjKH>u>&2#`gFuL5{+4gNrZah>U4{(J-r6q# zo7NIV=HK<&e0oI8JY;{_534h>jpD~$+Jc_TgLW#nZQT=QMvC_G? znE)i*UBz9BO0~XjnD-7tHZVPo ztB}(F$j7xpAT3iQNtccgk!#G7~6Zs$`=Q+MD5?r9vWMF?ONvh0whvSWDb9#j%kfd)!Mgy zbd`0TjFI;l3q27M3khcvfIH2_gBs&rUYZ`CVUr!cu5^t zKUR%6C9&8>G+(IFdCNEPEnL}R@(wGTZOJ!p-Dp590X02Bu)kU17L15^C!47+Q%&R_ zqnYsb$-${4L)~VM51o=?&G=KTk#Ce-=PE5?)X=2KDIZ z!F4rd4UB*ZE{7?8H>lxtrvNojY+H}cz`&$TU}Vv(z0`jUD})OO6?+OR!?++Xhh;cG z1m%4$jP=fAEgXHJI#h6Aw0HoVw^$nOk`2|n$XQ#3m=dF@+Mb05eKV~tb1D(a80pK9 z>dn(_+vO190_xxOJ3uIGVoenXX^=U1OCa6LxDT|6fH<9MboO5 zQ)Y^x1&4nTamFI8`_GUx%e3fxZNqBre9*a+(i4_SImRdv9pUS4iiOy4q!*;2Hw|U&_+JHQ_xP z%rU3JyY)U4da1x#{42(dH# z#_pG-ky5rw$Jy(tilufLdaTQRo^cy@1-!=x3C9ok_ zw;^6|HQ0%ps$%;*B|SdK&sTal=WyDZE7Bao@VmLFyywwb!$z0F_0`%ozOau*D zfM~O7jGyvPl3WMfWdlN=MTzNd@gP4N{KB0B3469z4CK+-Y)S)*j{m5uBL zfF!QtMFIK;h?XMwsVuQ{Nlf>kU%G$1e2X8sH-0Gx$O+6R0;teMnXhF!KtUxBm$p=i znTCfu14juX|B3zTRP;k=mhNE)htQwKN*o=w?TY^3Soll^O?HM5V?YDf92jv@>L>K{ zTsTJs)nw~jfdk1}7!J#?QKFc=;53q@CW|=Q*Sd884{sSHa{|YFs6)eq_lfj z7+phDr8mbHJa!U~Nbd ze`FPrjVMb}_KxzOhUC?r+)heSxfiRBrKCcZVPd2Z(>EWVVJJr=ISIU>y6iAZ{3!0C zG$Wl6!gDBCyEuyz9Lax|0|aB@C^sj=MJ7k$-whdD65v>2J*7N%v0T)B#zZ1aX zpq!13%s z8)~=_LhOiFT%42ok(p^F*?VBk{S@~ZYAJQ#&6s48^^DiB-d4Jy=d{tg$JOa%p-0lP z*n|PaMy9+Os&Vq`?RYW$Gcj;FW{P4fYZg;kgG!wD!Dqlt`L#+B?|mkBhN3E+m!I4+U_z}Yw+ZX9)=#5$d&l+iz?mUZ+r$%4`%v@cHet3AKpZ<-55Vj24@x6=R zVtEj$lI%aM^`be^Q$+O+>5@HGaqi@}YCdD*^l}ZgM3sN^T+r@fZg#h@okUBUHK?t> z=0TovQ?pPw5xI}$(Trvj$l#1%P`9ih!qj=Qryhsc*chmJ|5r88_3Pr-34 zUqOH@)u;bj>{C(uM8VBe)6+{=u7kEX(j3$1?&KN2@Yi%VfrAwdR5m7HiX8_f*fQYd z%>BE$?tXtRTHrhHjSIE8Qy>5z_GDZy>K<;lw zn^h18pxzK`-XfkH-`R+fqUP-?^j_&*R{aHyi{hO{^|4ON+U!oqtjp-s1^MRQUp^^U z*9=VXF#Q|1sTE`OC<5&0$rzga_sPjH=b(AtxYU3D&mH#in`nYZZKj;*96|$LjXXqa z4;C8&gl*TLU~)pdtOs-Rs}reR$7yLd7QBf1vXY{APOuZmVXDD7ADzf!oDi9gmF@)? z3lHK6!?f{5_~9oWNQT4pkktbPk10a4|F(O%Og?o9Y<#q4mZ5SP}lF?cRR>k|b1RgW$rEraS+rNLK&y=PFckkN6-Ea`&7+LS)J);$D>-E6^M)(=fqJG;E}zLJ60eXR(qkN?D!p<5Lf$V&i{B z6qsQZ?;cI@BpLe}Hzw6qD(n+zGpscssGcIxY#+9J+L<2do}GzX0B$_O^?O=Y1C#bG zbHU7!;;>7~@<|XYk?1(Q2Db`^kz?$@d@u=rvPshr@~J4apY=I3qlQahk{M2GEv6fx&!uUO_2 zJuKS(A*qa>9mKvtL)8VJ|FM9MNQy}c6^R*LYV_tWD5~D(Ixz$<_BVcyhTIDS z9~uRhG}_e?#}A3%)5>S=;-!E5_Ova_FtaLiAd4vpssn*GOMceABIxqsFO$qDsS~tW z>KKFuRP5jdm2lIM;?L_djL|0-D;K=G2CPFN;e~Sv!6}YHFyrdZn}7SvB3ILwBVE3^ z8;u3lr07oqF2>D4F#m!?kT47IFO|jz&d&n@5kDwX))s^B5RQK%GiiUi#G)KbgQ3nQ z|A)ij4aW_T4IR^QoKRkKsHRRG~aPhMU$3hDT=AxdD8BW-Ug zNZh(?^7Ogluv1+T8%BRlB>@OcCOn}QFt{(BBIb7{yt)bwPx=JKR?jk`%}D4HuKy*F zw8S3>?iwC=eI4uJBKX`-^Y{-YusV6_=yqcLK}K~T10d3V)wur0fK1E=9q9?z z0{b1NmJuA`^4=zP=)@yuEV2RISXAA3Gr7H7%@u07>vqbdvnu_gcP0>)P7%3Tmp$aQ z;Bh^?!&u(*Pf4}=w1Inb%7BCFv=F+`yFYVg&yVp^apzrj_tU6v)O8#g1}mRfuP;|z znFb3BufG6E~^DG^&E`0+lNCvN?aBL@&EFyv**Mzs@WmE@rl* zK1XzO#LhZ5eY;vr>egg$4)4ucMabEjEQ+c5N~~Trm+$%|APVD|)c(}8wXE+hrUM7B zLgN82%sIKDHjx)fEreE}UWV9r!=St&<1|_kDWF>F+gn$3qN~f9db_ZXY?)-(% zU9O{=Ll=Kjcn)KzRFQ+Fn|;lD5;^t;0tfa9evJ3Wv+*Gc2Q^b$M{`@QiNys zUHyNX8wD>KDj)LBz1y|7Jl0ZYmTzu(2_@l5PNd}i=uwVOSIx#t1+WIWniJN|nIkAH zi~cJj9_llUEK;;l=zAuknFxNXK-2S1wwiYCLzxE+frxRE;<5&zA|~GQmmksgeZG`a z^g3{jsPYGI(o-sE@S~gOIC(yiOrV`M@_>JBX%gLSjF!+O3JzRj;L;Ml%4TkKxml;9 zV6{0+3Fv9-r1bXw>9V@Zlh$Iv$Y+q(HGCZn>vW`@N-7G7OoXPu1aLIWo_!YA*C;mO?CL`3Ko43yt5jHrLW zE$ZH_tVPGBPh`EKF4*76tDkZ1U^r$*y~$De)&E9wnnKQ9}F7D zh@HsaXm~U}+#oebf@Nm&EDEmC9a5bvCODEm4vEK`%{ zlsPENaGjH~uop@fCSQ)h$C?jBYbO^lG)F(8NRt0ph)o7FvdA^(-dcoEDx)}mnM~^q zrc)kd7Lv?!jl6?Gzy2h?cZM9Uu-!-xH&L#No?YwWMbE7(&r~97rtaeO17GQv>R1$hP6Iyo)pY;QH%w;zxBZRz;)~x z;izFiNtpz9d1yW`I^AhAvhv*68x4y{ zVHtxL_kXHtoK)LQo72I@EFgb#=znHL3TAFW-L(B|cxTCChZSJH2@fo#n0x&7hbnTT z8u-1w!SjBuwjE6rWX6aKC_X7Mrj$(kq`b3VmqeydLH+3!Mnq!b z*AEYU+<}kJEUD}oO8ZuZN?TOyfx!9W6-&9og$vLFO@$lAWMDs1O-p~P2d@NMmp37^ zuy<&NW51YjoCz6{YPaOZ1EO%nIimXsnEdug123=b{bRJOHjkG&XX^n#M)mBG0Ap4w z54Xz)QTsG!<`!#2-cB&tqkiHE`39RNn{~ykr|{X|0@G%8e&;v4cNr7;ZA^Qp%2^*$ ztB)jE*wlbs=??NzH^_g<;J%=cUuo}>7HCrI0G*HI# zRAmCX%7nz~MO*1AvuQWH##;hN6np2ZxFm1NWPts@eb0GC+Xa6+g3nAWbyRP_i+4p? zjebweBeEj2pw$?j(BVaq8n^ZM2NM_Bx-0ib`J~r4h;YXs26KB3;q-rl=2N6-aXa&t z5lCh`H___{a!c!RqOMYfYHOqFYsUY}T6 zIO>@O(wwE*xUhd!D=S4?WDONW|2WH9C0Xpj!W&1CYhxf6YG7)brBth$m*em{sh&a3 zBSVF*!2}`$VH@uh6jJ}5bU%3xxl|n}oXK|=dEu#p0}rRH74Kp}mA)246eSzIrf~`D z)+0{py&4eTWOt;J0IspEbx+;kgZ-4OHBGfvr?!w|)lXhUBMdJBV2>7?S(NoPNq~?iBI&q{X3MvF zMd~Wv00rR@c{l#9SPR$C+BDGAokO5?Y8P3BD))Xfl>HO7@=^1c1NCf~6dPjX01!VhmfZA<(#LRyS z)k~b_pJ>tr7gYzTOcxh;CvdFQ%eq6G=>c^Y7T*xm-RyiI6^jzMBt#iYDcE!Bo2?l; z1K&e;DKS2g{C z*=yUM;-^qQyoCF>IcOrR^eqtv=^GQZ60>I32s1rdeb`SI_+U0YT+0FGdAz7Zo?s&oEOKq^=O;+JrHA{tSfxF}3iAU)?(d$bidqK$`-@PfY_daqAap%5#Pw>`s{iZW7Y7Q~neNQq%)b6M4L8fmb+n$z6F` z?hi;ojW>rgl}c&BS~|?uNos!;{je6)0sjyH?}a&Ah;x~gFZCZ+&pVB*O9XjF23%iX zqf5H9mRmo!210|A_y8Q~vI|}dtFbyijaSxbTPrULW^Jkp(*~jT2sL>f%-)>7?p2l% za5x_a@=~xX@wudPISCCH*;6KO&**S+*P6H$h+Gu3Q*58?B-WPwPUo&SHNPu=ou`vd zF^cWF!4{ktguSsO^93%Emm!w2>+95dd0y~y1*(jIBUf6k(tM{3gvS^M;)QK<7Q&Ev zeUdFox4H?6dHgQ96ovA@!cPa+D=N_O73S-8O)?eC9!56g5iA7j{#K`4wt%edg0fQz z)(X$oAinGh?w2dcMv2#+QB_8N8+f0Ko8v}m)Qkj$<5rPq)`Dj`YKP6SNj(tnl1*-< zbm8uTE-RK-#iXkavx%x^1;s{x-aEJEbg1(PfWo((UcLm}1)@2X2V6FWDdTc;K`^L| zN%yKO%HO4{=$(Y%xyN9Pij|Q>omQ_w#W|QLcELQIjMKH?eYk+H`hh`zCh?iwW$&3( zGEyK~6^*U_Tc9xi1ZA<42a{O7)erEPMc2D%r={uD_`EZK7q2~bpGhVGL_yC#V!bKG zQ^UOoUHr`l0U)2I@YB~f=;Cp)*0T1iz{JvdHM@{v%Q1IzP5!d=2M|ax=B(OO;m3qo zN3<4+ikZ1jNMQ%Kiq@ZhLBHHky~%^oy$CU>lCRRmbSN}`0@a;94fE$FL6<&m5d2Of z*zu#M80NdM-8Hp9PFf&n^j<7W+GS)*0)9VLFbPpkeANThfNakkX=Q=X{v!O$*$1G~ zDtJ+#^14S(dY{xRj>Y|uIkc^6D=W1OCvU20O_lp*osBI3;LW0Qj z6>yyZ>xPf$7z_Dlx*l{P@u`Ox>_L@i$sEMMyw`QUokN;`Oo$k#l)OZ>Z*}=Gj_K0U z*6GLJIg+%hIJc`Fod69Rdl@6v_Ihx}C8o6HQp!+cH{C}B@iyGaA)*y`*0`tJJD>w28Ezb5uuS5)S;h-G>&DXV__QfRt? zl6&!iy7e`G(*G3i_Ke{4IsG@`xtmjs8)I{zlD+wzC5k%vJ!eeHY2d<6>$sKg9CL&~ z40wh|uS)mGBu>XjM#z3bWVrG$P8iFqy=#-l;U8RLnrh5h+b7e96ks%C-@ZB)Z(pjb zdH9@fbUOHe^5yMqs3<9L+Qyy7){Rk3`AsvOR*tHF=Va@Z=Jabg=@P#LGn!p3PRkfT zi0Zo6s^E>XWXfQ9YYfqm!1%Sp>H39%te)Ax)Mj4Y=e1)IO9fpZOsI#Uv1^LJ^BHAz zH{Da?)p#ZpME@(}i?vQC#1Lv1N)|pinaC#XdDHr~3kL^vI9;#3+yExWqo&*&_x$^` z`2&@I{#7#avL~^qzSQ=nX>H~4?wDNK0MRtFO(Lp#alZ2B)21-OP6N&jfh*ke2HDvF zuufugIvOlKFJy>={c|~jrQJsQo|9jn@H3)axyAI{R!oZDE_Hypr8p$ff$(-l&;Fy) zs{PzRd|fvDL8U%XP^B#z{DT5K`|GDlqUsTUoHzqFk2n+!!(a@R_u)d2^?-uPoSAVv z03a`8BH_=kcCq@c@8|TphG4C1$@lmY$FU=n+k#F-jbzWOAmuGClGGPPK;2eKbw)nj zs1l|^^%aL_0K)?h38Q-rtwa22y)7H7GLfeIl5od)wLVh2M)x%?On)=Wv9jLfm^v4K zoi?nVGT|bF{Ahx^btjh!Qu0sK0DKsxy?tT2_b+?0a=9f(Cqy#}S?yfvqV1S-`*o(D z$uK<;bExj|eZ^uf%I&Wrx3_(E^D<|Lv4Xo)Z%TnUz%T){Z0lI19X$n-5dSsQfg>)j zQKa57;a?=9180C-J~+Ur0^E!XLHwtG0b(@VddAh?jxwkZo>g?!MjwH~r%*E6j#z-E z`5P^cwX6mrA7Wy3Q$Q|Je<4nl%iW?45Ne~%5-Q)Q3PV95$lYsmz6E7X67}x1@LzOTDxvLexV8rH3D(HTecT}!M)bg ztrunyPW88pU}{eLqz;m~$_D}<;;p|FH`K&6Ro!ux;ukvja?X0WHXEI3s%6#bXx@38 zN;;@jPGL>ONcQ)>)4d+rYceFxNftfwLw;>k0=`3L{GJ^4(sn#B7gPwy>R?&j(ZsHO zZj3SxTkqBesVshv6ujdsBZ*U`|}dTk8?#?odcW3+0miK2o-Wn6yx8{ zj3)98DxwX&dF#S*%kl+Tt+`b)+Ry@yE$#&;ml0!k!CX*l0|@o8 zl{I3`bZWMtJolZem)Ti=k>KSWWD9lE<=vPr#0BsNZm+zF`P0kb=0wX3Wm@G=k1^_^ zarJ*qZgb&i7D(ZDSK1Lj9dOCslMJF~QJacgV9z2%8L+^JIcy|9aP@5Ww-pJ(+DR80 zs&jc30U}Kin9fExZiIOYeZ_v38qlUF0oQd&6H3gc-?i?Oi5bQP>y5NKSpUyA`*t^+ziQOP>Uxm1Wi( za6wmGVEqq#tq{jtP0TOYe9*6&CR7R+1k-R+K#Xhbv$ayo-IH~oT3=HH(Ma#?+wqY_ z=61EK4b3^vz(`Vm8Tt-@BLQf@rkBef#$&cyQ6;VB_$JpP3faG>c%R$94Wm=yRXbY0 z?dwTQX=f4A`oKtf5X+1bm^x~nWrY5z2fO8TH-)!#jI*L-`T9Q61 zd#510UEN`I@pTyjQSh*VZRn%U+o91!hkOOwI$#WeX!a}i4dssuicob*{9gU%iKnhx z@vv9O3mQC0(J-ys`tWhC0{hTl){h=^(@c&?!-~xndM&b?05ChKLPu=Cri8#1y9Ydt zROe?}PilH>JZEQ(h}TX;f#^fjb#}5+4svw{fGsn7j3lw{_}Yo8WeF)J-2hkZHQdAu zf%3$crjLKSUU19`H3L^=XIQtsg-i$Ob|A~My$Gy-9(`7f7{i9xd1}i9C__>F(mr}z z>@jlcT20!*Zez!?ydl<0){0_>$Fe(!osRb5QMP$P(sbYNTj#m&Pjtzu=~n_C0}&26 zYwW@ZUvrn;ZvOE6!My+(Nk~iN+pgG3Z+y3^ty?|w*HkxrV$Tkg z1LmTPR9E0kpqSlW;KPe0R$K&gByGEYy&(R1tSM}khwJ2^!_uY|VXRnSE3yz6^jI+U*}u22 zEMlbplC6gjrGzbvuJdvCp1fCIc;lFJFu(2meeMGr(PHnE5OOj$5}KWV9z~pg`&&Za zV<$!Zh$sU>(RI?`+|esxX}i?_%px1bg~U?NT#U!)AZ`dRbK>sWnTpt(8uC9BvR+Jl zqnLV0xja`k8NQOoe&0ai!Gi z*-9$rgXtn^pQq!R*OB`@e}Nw*8z!b00+ z{XU$!xsK;31wt=t3}}c%x>zcN3R#R_pch`MLNcPqm1e-tmmAW_G{|;_pc;?&HsjN~aWnVXy$Rqm;M7ljQc|#s;Tqx0iDYwCr|&Z_y79h}Fgc z%;TLQ;KRfYMy=u-&>PO3nWtR!uagS%6^Wn86Tj}6-gKgF_v1-Nky!O#86 zLeic;81R~%q~BKl_`7?OgA+ad9kHdOT7{M;iXH z;w|wOjvk`ECTrLCr>DVx666|832k@efXB)RpcMYi3aHWlrFjSz8P^?P02DnEsI>}C zvg_TI3(}GXxqwJMlHS|svT`&#tLrl64G%B_QT}3Gi~(TFn!&`Y$>KXtRQYT<5?>w!;IgOb00)y2C0Gu8_tW*t$2 z*JO=Abo4s^9q~`*<4I=eItPeMP&3af!A6?h3~>9P+UY|T3*3kHS(-nFBrcqeKcgj+ z4Q*A#*2=B8JWSA=gbpy+?8YMg>r0<#& z(GUQhCM4dLj~|YB=_i!C?Rl2fpRe?ob^4=wHTuoVusQQU7fgPbxg~&M_zD;ss8!PB zAuM`%J<3M-nLpn7kUMCrS$V3elaRd_`lh`FIsmOJxjdkM-L`VB*D>euSzuJlXM>1MGyD7!0L$WBGEa^W-_WifRPO&DI5o-;C=40 z@t>QPtb$AyN13{re+KhF;z6(VzcUMIC7Zq}dT@E%0002qQ0vS90g~GVtne!qVPY~q PFb#_W0000400CKAt;k*2 diff --git a/data-raw/_pre_commit_checks.R b/data-raw/_pre_commit_checks.R index 70c97a659..7b2bd7d47 100644 --- a/data-raw/_pre_commit_checks.R +++ b/data-raw/_pre_commit_checks.R @@ -397,7 +397,8 @@ pre_commit_lst$AB_CEPHALOSPORINS_5TH <- antimicrobials %>% pull(ab) pre_commit_lst$AB_CEPHALOSPORINS_EXCEPT_CAZ <- pre_commit_lst$AB_CEPHALOSPORINS[pre_commit_lst$AB_CEPHALOSPORINS != "CAZ"] pre_commit_lst$AB_FLUOROQUINOLONES <- antimicrobials %>% - filter(atc_group2 %like% "fluoroquinolone" | (group %like% "quinolone" & is.na(atc_group2))) %>% + # see DOI 10.23937/2378-3656/1410369, more specifically this table: https://www.clinmedjournals.org/articles/cmrcr/cmrcr-8-369-table1.html + filter((group %like% "quinolone" | atc_group1 %like% "quinolone" | atc_group2 %like% "quinolone") & name %unlike% " acid|nalidixic|cinoxacin|flumequine|oxolinic|piromidic|pipemidic|rosoxacin") %>% pull(ab) pre_commit_lst$AB_GLYCOPEPTIDES <- antimicrobials %>% filter(group %like% "glycopeptide") %>% @@ -432,7 +433,7 @@ pre_commit_lst$AB_POLYMYXINS <- antimicrobials %>% filter(group %like% "polymyxin") %>% pull(ab) pre_commit_lst$AB_QUINOLONES <- antimicrobials %>% - filter(group %like% "quinolone") %>% + filter(group %like% "quinolone" | atc_group1 %like% "quinolone" | atc_group2 %like% "quinolone") %>% pull(ab) pre_commit_lst$AB_RIFAMYCINS <- antimicrobials %>% filter(name %like% "Rifampi|Rifabutin|Rifapentine|rifamy") %>% diff --git a/data-raw/ab.md5 b/data-raw/ab.md5 index 14ec09840..66dcae4fb 100644 --- a/data-raw/ab.md5 +++ b/data-raw/ab.md5 @@ -1 +1 @@ -f946ff259f0e2cb1313508eab84bfd4c +5e69630cd8a73eaaf33145af0cf82601 diff --git a/data-raw/antimicrobials.dta b/data-raw/antimicrobials.dta index 879e710f74091732f6b1978e4ec40938ca283483..bed1ab784edf30ef74443471df589d366d4a231c 100644 GIT binary patch delta 7920 zcmY*ed0*;iUfkR?TGl`_l1OzH4;@fta^ggj?$_+fvS> zLr2?y<~vimw`iF(6kD7z>R@PB!xgW*0zc@0>1`n1Qqpsa=Ir#IwIp#qSg&VK1X05Y zrxoe`)}05(fc5U0i2yaNS8t|+wPf8q7t6G*u9nh77i&g-iGaG+>01rWl2+(v&7u-v z$=vB@U0ui@8en#7Fk3h8yeBLx_PJuwY0cf5zvrQ_tT`B9rG5Nk{b5%M)btr(jW{$B zEV;-0th*1hje?VY)<**;fVJrfeqD6h&wBJETWn&@JH{Ti{h2*%>V)~HHGdo!tQ*#= zXYUBh@k;>|^#zOtYmbYcf#u9)KTNKwm9sv$bXP#Mr6kdplGngzV2!)_8Hnai_*1;@ zk5lsullA4bTLM}zLPLX=7~!Rvt>W%u!}3>&pEcwqPnq`kGl14Ox)uam{hk;VM0@-4 z)KG(mf~q+~I#8~Oty3*mSOB!u1(>u>R?pY`P~--wI&`)?yl^C}`{1wY!_#swKs^M}#-?l$23kUA`_lSoWpa=$ zUbL+xI|zeqd=<5YSLJYL_cC)Ic4Kq6uNS*vqmtV9WXOa`I$7q*C|pJ=6faW1)B5;kD$tBi z)heScoxe7d-x$ST`6*>%!zc1sF~$i$-DZSP%_;D}fN_dxoStXs)OaS`5?J|*G6Wmu zC_*MEbew7&uKamy8|$RooDQINX>eO$!%XnAyd7qu4(STRBs;!tneehacFX3aIk8-5 zS=4ikS8nlk_z)a334*t^(D)_VQ4{!6-YEuiq6*rzRD$tTGDhhM# zAIp>aIIjp?DPudl6qvD#$EmWRHAO1Tmh6QLpx`|)0WfPn56jvGvw*7X;};_BUj;#h z`(YEyb(!B@j z_ow$2(#O9u1co;QX#67;mgU4*!I@C{XBj`Kvjx+CV+S)!&U6kMw?&0w z-xK~IHaX$Wenue8t|4;&y~@Y6)GA}@3VWh{S(_JuTwB#X_(Y!o+vE8V4$lottfSdB3V*WH)XodgXkiPD zqx3RDW4YD=>w0PS4vXH@*BI~A#+s`otBDIOXsB_*OG<6bKH$7&nu8Y4C>}-`$_iF& zuGuQcR$<(|IVjI#XdA?U5nez_PcSnGST+ zSYF*}b7!6^Jb>b=Yn&o2dT5+SyZbOZ@67h3lRY)N!j`S&MSJ=vb}G=pkJUtPu!PMH zqWc52JA%#)RUiirVH3jFVG)NW*u4$6Z%0QHn0{^|E)P@FD>4=7U?xb?%Czs?Xhrq2 zv6>&f9i>30j!~oq*l?)b*O`3ADIjLB&e)m;ls<(=i6HgepTbf#M`q!b6t2k9X_~(d zN62S3FNYytYBDEeuBOpD3lx)^(*Db2IF)>=@y2aUX9!T4YA#e*t6<(~trE4jXsmMY zU}}+WrtV7>xm6wR_gk(x_5rGq#qL8j`;`7)|Kp7<_aav+@b6-AKi)h(S*4Yh7c~K& z{LTza+o`+>6&|*6UWw+{CJYRz=E@i z{0C~&Zu+xI&!Y1@;K4}lTF#v10ip?5pCmH%Z7*spD95jH^75fTiHIxRyR6+5(2P!8 z`v-_k-1gpJAR^jcCboSF2i?{j1+BIM`tdf8z$^DTMpy1=8nmFR_cbqP`s=w$t7*?T zCiMD+`u+LeD#bo>c=2Va^1?&Y%UX)1ptIDpBTr3dT4Ef-zA>q{?aAz{-gdA%66vZx zH$*4fYE_Ev(Xy7sHeZqs@8>?2l5Q)itJ7$V&WeP(e2+gd_G)R?vA7D>!FlV zMQ3T~LA|T#+z|ERBs(DjX?iXFKYMuZIy&#+$@TSMnj4|plc%i4`Vbr91^cR0t3(-% zbk>)T0YA-SLo1uIPoh6qx_s?JE24E)ivg70lE>rnwz@<8L))-JxT-y;h&DmY1*{sQ zJD9e`VnK|~Nfk%g?bSMiae9kI*cDLN}bbWeS@i4G6aneQ$GbykIw@odkS zqJII@YcRi14SqZu5F`Ex>T?5<=z5Z}%DsKEVj#K9;EV}u5K>4^Q=i9>>r6Fwtc}P( zs{OgnX*s@Z@W%OSfe9*D>`PvT!c%9lE_3Q+>KZmgJ&ZapRzy$2h{eo$Pt^ajl~!M_ z5Kgu+XgkW%p)6&iO*S`m16Gs;gX*l(xm>5J(1lP!w$A00N}blQ<1k(24=;XugU;>L zOzgeE2%=fJj$nn`d&oZdYMohX3hTxTtMYm_r4%TLpWChCcKv(DE^kZo#6mS?4smdm z#P8MZ#iI_aw0f7$D)0qz@tA4dUZw=Ij_3iD`=d&_G&|4vM|3`#S%1;}Xx|x50Ninb zf7Y01aJ@D^&nRj4uPSP7E-7!gZU0pfy~sv%Fx|SsAnB)DYDAx#JOa<%)!iuRdp?WP zz&q-Nn{GH7)+cw>x=S5OJK_;DL685`7XnRus*ks|?SCq$UpWYv^+GL~MVwGf$GlhS z>1(x_F^}nQc{ba!>2x*S;Jv+)i{WZX+v-lWOzJVjjc+F==ZOjw>0&Ss+_JkF%ux+* z?w#!pTD=T5xki0p{|kMLsX9iPc^a#eJ86IDTQtVZ;B*9frX37!h&v*XpO#yG%!HQ2E25SIL|@-MEo5kS$N2Dgm& zYO)!@akXh`YHfpsViOIktK4ORT(R_b-Xqf*FbvfX+ax|S()is_eR-6@bz!v?bTDmf zWjr)Qfy2_)cFGd>-5uDHAizf>x#;)A@>{W;#~k9PgIx_Sl|tJLGo9(pYvA4ioSf(T z8D%14%e37724`BaeY?3lfNkLMAq;79E%xnJoT7Laofx8gzA%EJJxWk0uZ(1Fih3B_ zG$$k}wz>Tt$sXgA@jPZ#a|M6mI0b*d!)f;k%Jl0g98A^2xJ@$njC7C>*gXu6ds?cI z%JMwN@S~7f`~`jIv7PF3)LMb_4NnZ2W4KVAdHl@hGj2`-squWHz;P7v$Ta)`Yc2U_ z=>m%iVEtu`H)e@i_x&t}WYg=;%hYr9N`6*t5OEvC^2q)4N`^@7*K*3>nQx5$H%}Ow z!yB<3(uHr8-Ci5mA#U+J>C+s8#o#P)+5e}1?2>D6M{yo`Lk^<3Rz)JW+1nI}lZ(sp zC1Zy|bICygI`6VC8g4%(B=6$5h+iGSUAbF%z2E=?TKfb46qg;eZaBbk##JW_hpJaS zZtym9jj~UuXyl(`N)G(2*174};hJ4g18yPrRzY<3qRPG7j!!XH324cD&4;X~M_{qk+eR@=s=`a*mR+Mew6TDMVw!t)iHX7+KyTdS??=RzF zIF|U!#gK@fSCT6s39AIiW-t=t17t@Sh4}%pGbE!3WTd09d7x|oDL6Aw&Vn&0&9Wwp z!}?~PFdkFPvOY|}b!OQGKEuDwatlnvjX|;%?}U$oWHO|3YbXO@8cq(DPhkcohsYx^ zlRgOLK*4NG43n*SXUY$g4`B|j4Cj^R($#Re!I`(6w3_lQ%)_)=vJ}3gxwWMWKpHNp z!|>))ScK%`(L(aCFB|i1P)?VI62O988_7*vZVb0vB>TG*=SRvIKs*;ICt*=ze&4sT zjN=QQ;>I$DcM3E$mB)FDINMY@1FXO+Q5^D>c)po5!zz5%j48{em}nW#`j4AiFm>Nx zg_ewc4R&eCz}Di(mhAht*teBj4(sU8R?-6?2ldvn7JP^GTFXhW9yhg?(R{)3sI`0v ze8FZytIO8}^YF_z@5H zkxk(c%DxQ!Fh1?eS$u?|`pH=Wj^f__vMU@Tp8+zDZzkx#AQiWhcq&ddf>UT3ELX!% zxPGu41*geBUVa7e3t5NA6#~v-mjo`g^SC2{Q|AI!AI7zL5!VmneEJn14da;nhAzX| zz%~4SxE#Yb0-+-q$qgDbLcTSz)(lGFDBQ-EDY6&b!LDOu5!^@jvGPlJh|9;a?cWi` z$;t2-r;g+3mEiJmO#TykF;3nDc!rlJ$UX2JSA8bO!QbdRQTBirm^e`mhnIMEB4=Oh7dkszcGICeR-ebY;f8th7_2)TpT}H+2ZpA}4DiIf zH2E03FnhjijztSNLGI0$r@ zg9tz^laZNeVy4QDAZ)OhwJQ`CEtZ)OhEunK*&RE7h*L&H(N z)Uehn=}bvka<9gx%G#@#?RV+WD$aGNiO;jyyIOR6HFL;k#GEzKTZ0HJS|=B|D;c=6FAsrJw~)%#$PFL%f+Mr{m^)W@ThP>&Qo#o6k{bi#PM-Ek1r7 z*&?}nh{0A{WeMwag97=Sb-Knj7MD&~jbuv}=n=&F*9Er|f9s05+j)!WhP8Ld87$Iy zJ7fTh^wAwMmZdqckeBF<{R?GXR_KgE#?}|}3K`VLbgYmy8v5g3Me_HFZv#@n#AY2(l zd@>{WByMDK($F#(IaL3VyraW+6!?dn0DP%#dCI!UnxFhk4p5qZ;<+3K-&5pYvK#m2 znD&ALpNrF8$`z20L8V-{R_s;E%}fEVDdmLOhWAQk6(Dqf#ev?AQLkhMmcC+Q&c5QF zq6lBT;_N6!|JMw0Cysh8KgRZN`16_9oaei-!y8WCJ$UpDi_BgMcq>2AVIR)WOds(T z^&!oa%~#Yk++@lGzMd{EXZk{8L7(kv8qb1W>T2rG7tnp&OlH>e@ouKi;W)l>Gljzm z3~@IFvYIz>H}!>6wA9^HneT|P(8DwbPGbvCQ+GInOFd2P%|Dk>rZ%flVEYMPhHU62*qtuwcj7MMb>mpd|JZjs2n% zK@?+26cjN<4fanoc9N*E`_6JvZ+@SDT+TVWJLQ>~XLi>)XZ(v!_%CS>w^BQN;8wd) zaCFR=;5xPI)DI4;-MC&@>il88eToe`^>0rVQ|aG=vcE-DEY2VhL*q0D9CaLgEMe(; z>@By~CxZCM4#QVy-j+o>62S6c(?oz8mXf%IV0pA9*%3l5NtuRbo}TH1FCOWR6fjMj z0G0~-d0H6u-^7wOX5AC!~yyb+GB|HDQFz?LwqSei`M6g5_CW3iyffu%~04B@% zv$usg`)uhT>;K~1L=a8va7LCEV7YnzmVi$!yYd%-rPn21b*jkMa{n@0^~+^1%fo9W z0>Uj(-9^DRd;~JK-tca2vo}n76IkD!gL+lQ-mk5%#L_6 zKLvIS1Ya5*0`~-V58%pETS5ZTKs(_a{Ww$-esIFcIR0l6&d!88314q?jTb9;V z635l%?=A^SyF-2c#mRN8DjaA{1Ng@t`dDZ03Rjl*H3!e~q@AAu!_be`v`_}dm`mb3 zOMx|?iPkAU3jVT(fmRpWc4HSYrwb_PSVhO4O2v`xtnS499B!_>=gdN7<@rl=|9rm$Z-^9)A{n-2F37>kT=05zGdgpRYCyKBBOxAHs|7M`rkn?SV}EAv7Z zgT#$3pdxijRl@40T0yd>o@wyBoS15dF&}Dyl&}VF3hcaw1#l=B>mf_q8GBW%rtSqN%Zs=fK(1Ll3UkmkNqExgY!-s^v%!fn z4#IPRDF@%qt8|3t(Xzvk0`$>wm;jh@6r3>|{X7zj29p%|_DtVw%e!_i~fVc0eQkYtza^&Fyw!i4As6g(2vly|W z3?ZM#3ZWN|z-hDdQ;_ft?rJXrspf0ACD8dbIGJC>Insw9_PzJbhd>kFfbJl?C{!1W zqK__|sD?>A7qEt^ISLyj0;r;s@Bmm#HJyc_iFKuv=0{(+3a)_lc=4tPqVDeErhpC9 z%!{XBQ!n9!*=My16yqay*eVY5W5r^V9X9vV189i9U@P1B3uo#bB%TRuA0(X3FXJ32 zt`b`XTc~$cmIqsrOUs|8eIWMg@1PB!p0(I6vCR%UuH#%u{`kMDdevrCu-&?JNf;Z8 z31RGTN6JsSM1{YS!&30rtqcua~Mi-(hi%h)V(QSk{AoLa{&)Sp4G0; z7b>;+<|R!$DKbSIu#IKaH09N4WPS;x9?OJni6WP%J%yrh1#GlTxKjIcao|0A0Ti~9 z7h`z3kej12geD5@u-|qgnBrH7eI^^|+H4ZOI{bzmf*6FPt;(9;Y1A$i`G0q?p)_>6 z;EH>-Tlq9{7bmf5s${ls)Zv1)Q0;#Z({)i~hokH2{PcqO{jI(auBSNjY(q zq3>$=(T{no0ypMyI_+!$E_CuV=exLWhjF!aKRR6~9vX1N8j?TGDfo-+FvOV`Uj0Ma zcGJppS1yT{_HdiH&^TJf`<^L#N8VMy-sQ~XYQ8V_*urt)fpYV{VtXG;K>^aLH*{ba7M06NAiCuvTcI3_mviGf=3i+ zudzXosY*Gm@cpollHowXu9^$Lzf{|eCt;|YCb96k?n_-gG;Rs?Jv3K*HHP;*T`Ou_ zfX^+1sx1UM?WeWi$!|AOR6j^#x_DUzc3iN=U`GdQuI7H6`|UBfpMW4x14Ic*P%Cc`B!LQzJJG?zHOp$RvHb}CmqbGO+3i_iN=6T{X}!( zCZU&CQ#g$!;OJW5&G7O3iV-{?=Qn#R69Xc(_a$lNcv{q4TLM(MB~Jwhj96v((+{mQ zj(chG{`6Ox&3|?FENcU9R*%BfA!TeX8H&vgZ*(7NY!A#9thZE#GSGgWU!3$KL1TD}c zJs!>8p=GhHxupzAl@}?D_ouQ`CVP%rGl3A`YU(1syl}09`xqE_S9ZPg5|F`ZXUCqvMu!Q6V5tHexWk()id>+`dZ_D*os^= zomabPx)a51)7kiSCY|Hfrfm6lj{L?)1cuv(wztq#A92>XVxz1^HFeRsgGZOXAip?K zS5N(pp^gZCN^rQ}JHcmzl&Fr>E`$d}Co2h9MP8}OBB3*ms>?f(an*H>Wf$uEk_Y>AALyo*J!lgIgV?OT2bd_|VZW zbZ#Uu)|5Ehk>P*=bY_6g71^SvKFb7y%HFzv#ZJo#Wy&#gLLM( zp;kzFQ^a-+iPL!}9!GzUWV?V*7GoFb+9`-q!0{ z->}y($qH%wCY1*TtCZZy$bk-`!E5ww@8|na{dF89Y_*2tIc&Ycd@A6TV(=zj%i)+# z{kN&;&cMFgxhUuF(QS$@fcj*zHr}{IGyQsNKF<5|{R$;kfi!jU=3%-PCJ ze_C^p74r#&dr<&wKFm3R^AGDzo4K_}G2a&K5As#GGfr|(%s!=a^(-nK<$b1!&iu|& z(DJ+PMFkghF6R9g_;KVGwuYiFtKUNxRY*HuQ}(4&{&i*FQp&xk;?(b!no(G+X2jm% zXFT_(UfRlC>G@qH`O;n8_R4`qm8ifYF>Mk0@~|lj92Fjs~7t{SUlEnH~4T+)!?mWZbf6NE;f`BwFmvylRFQc3@{kPrv5A= z@1o9=3WJqVkwFG~aG^5G!#0(y64ddcD$ldh<@FEM!mb|}zBH}|+lResSY^xvDhV~X zsl|NEV>7~(?b~QXJ%dvn%lJCAp~1%h&YsdffQ^j@e4uy-3K!!ZRrvw5v!xozEaUO4 zb_S;g9~asySxl>Ie-?gpyp#IMhlj2P=jMKEie2c%3i#l_49EwEzJ^W13Lr~=gUR4< zUsiA54TX9fjlsEk|OgVUA82eMu!{D@zAE}_d5^wO9 z=O8%Ji%|v}{UcqCH#mK!C#uoE#`AQyNxV`VwYug$RfX==6c&FsUIip|hQW0H6S>Y| zhtOq?;YBs(t2v(Yd2RiLN~_;O!_{2S*_oQ97&eDDAM#8yyaDpdbY?GCI%_R6e9hr= z4eFF`@WHTdI=k2{LpjwbgSAGjQVA2jiXS_!V?^oftfZV@>DC2+< zG5Nq-7|`XgjrIUaILzS@MP=dL@S_UvMHSXy+HuTau3L1B-P-lD!E||r)|^(@tv=16 zC_OMADO4$Qy-abzIaZ9j&l%RuI(>eTvsT1vxkkJ-gYW;Ic*-{T*i*V{1xFAIO!8F_yBLCsLvz3+PNti*gl{tVg6PH(!Ex0LNtRnAW zQ59BJSe2E{p>oyaRtK1i`$FX#n1}mn%NH=8_Jm1CfCZRShn-BOc6H?w!Pi%j4df>R zmTaE#2_K=B;?zcRJEUQa#xfa}AvKn5VL6H>auOg;Z6b$4I^Aj_+iI`^>x9cwuyS97 zbO87U9h=Lif#1FjzKZq0nBn7NMhtit`&AhHnd}0qY20UW0N*p=h0ht%wb--;qp=RB zv|v})V|ojD4>sWJmU0Dbq@Y%kx6zw0v^D3$X6)0N4fzhwx0d02Ipp0&J_o)Wa*vX8 zU>mNClILJMj%mk{-GOJ@F{-<;O0@h6cH`V=8R5R?t##`DJ~4Jo%=j2Q6fHenhK^uE zC%w(lOnMzH&*-oh3pz;)Q}fKuGE2Y@*sL3?&BAHjWJ|usIo3^%haCL0y9~!B-5LE^ z-Q{GQte)(9$Pf53Caec%)nOdgL!M@GZPZg92RO34mn?##c(Iq9iABA5@{ryP^>KXE zTYd^ZVOSq_|7Q&BE8FnlXh>f_E z{h6Zb4`&%y@!W8k0M{@oo}Il;$?@`yi7zRV$8kK0vFdo)o$n>4j+fbR8yiiK3*asu zoxnoxW6ebNzeb{T@USn%cf|16u`zE!eTYXBIW8qsWg-_bJVJ-bG8Z1>$;omY{EHD& zWLJ2K%cpRLJzGANv;8?fnkuitOZ;sbbHgiaJYCM^!#*CFE|>6Gze|z~<^Ob;RR} zX@wk!k581%h)g-r#j3Csa zvzw&5#$f_a|>~uq{`@K8} zpU~gmGnYdn8oXUL)tKxz?vi!jQ#`+m$*?Jf?3P=AIX-U>CuTT$T9`y4aDzn-V-|PG zlu1}VlL1Q4l+7_kJzdXas%wQVdu1`SrpJ3F?-JYK2$CfjPdq;O2l)V^u-kqnr)cby zB|l?^UzWv0+5!9hAieNe7Kgth{*lcstP}P;AZIYu7ad@Py5N%ovORRemN~LHbjNu) zGK_gXD~BELiA6cgBfaR~9QhGIZ>)4kZe+gy`4DquUo4+1BhfjR^?#Ym&7nUxZw_$` zbvVo^2Ltf)BeETHe(DifgE>Fvh-?)wzVaO{wzm90$%-DUT4-naza*S*1vT^CNb*|ImsUrF)EL1ZzA5$ z<1(0pk@?J%lQBJC_J=9>EMJcm=n6)kRhjyi-Q%9Oj#}U6M#ZGx z`XO7k5u26pK4la2Es?i$*i0=S%LxGA(ZMIooJ{*GpUS?9_MbhIL*RS*>bdO9TXfv_ zl0&!yx4x3!GViy3%_X`Azkba-pG-XcTDHJbuNfx)H(c-gu+bY15aEzFY}bB#%5MQ# zws9UFJAVAon8den&R!O2>Iw&ztuXb5oMlf;NpKJ+fN2^W!Y5$*0&=N^Fb&fAetnxX zwZ!kG$$=3Lbu!hVk4>gnzGJ5}M^h@mF{YU&es;;m}cHpdQ) zj~y{~=!mzvPvTlv(`?Ac>Tae=a0=VHnf#de2f3NPgaSJ3W~vO#{KXYabD$81yPLXT zoV&>ZPq>>R;TLrFF!{o-^nr)z9`L@_)63Myfb*2#XX1W;fwqO1`~klY;RS`2Oe44% zL{#Pl7qM4mUVaHzS2p#7EBL0eDTrG`P!&@KT*vGxCWQZ^&Q(o&fm?$^bq1ms=kcHa E0dE-)wg3PC diff --git a/data-raw/antimicrobials.feather b/data-raw/antimicrobials.feather index 22aee240c4bc9c99fbc7bb4a9f6c8b528dcfb22b..1a8128a5dacdc6cd41692973086448cc0e842a4e 100644 GIT binary patch delta 40234 zcmb^3dAv>4|2Y1A?qJR(^E?xou9*h&n0ZX*d3I$U;)sNj=#XfjLZl)xm9bJ9sU%5> z2BiThL*f3OJJ;v;dB4BE-{bes?>-*SwO;!S`|Q2fI(xs)UW<(nXLxg7hOG75w{O!W zIS5kyWhk*QYsEry3I{<#5Cjpz`pDO*sl(GA>#-#AU1WNs){^CaMRLD-woP2DR@}{7 zPyG-XQXmp+Z4-&>nh*(MSBu{o85}EHqDI;e2m$%(?z3zCu z3bJKQdpzUydVij@C(^1L%Qx0Hr^xju{z-e^oQl_%Z%upsw(HB$;Kmy!*0}!6@O0Pf zpKeckWm-+!z{(>7j{@*LOH*F85rG3tg=Rf%WSiZ4Y1#YbP`u_i)8}L`I8!x?H z-}r#)X?ybjw%q2wp8xOV8*9y;*5~rxcwlAP_dlU{tGvDI%~-i*k#hlnvWos7NB-+aB>|`%*v!4%QXUj$-no+ zipI5UwdtKogA!wvtLJTdJT_TIYU;J!7mue-z3~b4lCDQ-AMkAKiRypUN)FCu+YnT#w{vv8 zpxE^HvIX^mpyH{@L9@Xx<(<_wsGp&5*%kGI%0cHtMZ>4|T*weqnO^?cMPoKFaDE95`8zS|BQN>e>2FZJ>KT_0_&z9a6R6g40 zo_axY@7=H-W}N=n^p6+$felcnpGovVt>`#<&oEFm8~#6 zp~|<_R;)?LF=|_U*92gSPYJ`&4Rdtziw zY-a5Rkqxn&b*e-r#+uey7FiKHS!c-28#2@{|96I`dPj-}jq}>wzxKp>+%`A&o{ZV@ z){CT{6C@tVSnTYg!9jA+yT+(ZS8i()7pWI(d1pQwHSo^Qvi*0Dj7;on zL3qWfL329Ni$UDWWFF)xRu}tGJp5_HMu${L#$WgxMS1yv6$@zu?l%gv2xhs?Q?;_~KP{uQZM_I;d zHnM{cILvpP;SzC~oy^Eh32vn-_2@uvhBA(6Y+wib_?Tmvwf|Yc71C$1l@y{hmAIW| z^dg1(c#ubVp7m_!Z9d^Br#QzyBuE{W0Mlg{@ zJi|I(V=o6e${8*ZpUqdAe3YUNt?9uK#xgaV_J2t5EHAQ+w>io=u97~x3l+twL~R<; zlc7xD0p{~K&$EMf`Gl`I%>|O=KKUt01!~=_{Tm2cayR`M!2}-XMGkY3AcyZUIVnU1 zYSD~#^kgt&i1H9ic#iG7$;W)pIj)i^n$rp?Pi-30nc<9M29NM8FSCzt_?>^qB`qpW z6>g&m9T>qB=CYLa?BXCl^Cwwy+t7T95+rjct?9;K#xb3_JkGPc!gk)`Lq6wQE)ww* zC@c9XNhRvgh_(!2EYo>}WqGv!tAg#k&2dh1o>Vf+#&S`FvfM^PTG54pjAj~7vX-s9 z%_kh;Bv(nFPqR^qs??=vz7pC_(1ZW^yRnd#XnemZL(|of_Ej4UACNKlesoIzAtO>o zjUFiA&`sWDJ z*N!A+3DRwj4~hqENB0>yq<@Y`@02kEh7ZvzON{L^GlA8`CWDLeVPzliSIplc*^KLBMK#E8_2uaOwp82jn23VBwh3vLP$^F;a#PZ{ely_4?d zhFQ}E$7AJN=Ck@HElWij#)h}dUtoLsY>lQxg2&SZbAnuro=;b%(U7u{`i)XX4|z5A zY|9Ff5wQa;^G9xuoo-n#vN(2Ys|u0FV_jPn>hx}gAZrkRZ_puS%!ncVvjmYg8AlBm zJ7i>&aib3h@fm~4DZ_`3pT64?f>~LzxB4sAu}zIgYV6@Q#d55@ zsd%d)hvOTKY&B$L{=}-ShNQe3+ui1t$bd~hwTVO`M`NekmTs~&sZ^zrg(K;61&M=_ zf}BC}hykP0WqoYO$N_B!j2t^;%&NGEi%9XLAWyJ);*ddoM)n!mcJP3arQ#joqzPGr z`fZ1d=yM^~xm~TeAbV^K-jl9q2{6;!SS`li|j-kvX zOzbxEF=0X%{&LAln8Y=q7ZX{?i@cTSEOJcn7kXMyhI({mG>h260lwo3x$H%lh&7-a zVea(^s|j1o0&V-4H*kYk+XGT9{tWvS0yVHVL>Fq!#0$E)n)OMWB4)juaC zsYXNEGm!Cw*~8Op<|B@AihoGw;-8&@RHGr?2or@UOTsMT6~RtEV+uBoiwK__cDhV&#;!AywAxni?~2mSM?j&K$r>iWIXd( z&1OF27-1F=xM=63G&N{JUqU{vosLbOFK(_+9j4R6gw=6~uUf-F(3rE|WdK z&O&{xgO2oPB6C>G%k1SdPVxr{QFpuxa4U7`%upr~-XUMY zTK4iK=SVE#`%4kZQ=2Aqpf@9!%xo6%ESq_g103ULE)b0`>bDbxC`U~i(T)L(CQ6JK zc!SS4MJhRp*?4Nuh<5a37&CZ`7kQJT{K{o+D((bST>DoN)S?C58O0n{@G{%j&v7o0 zsf6z{m8nNZ`Z1arJjzpS;$6PrcM?l_AC9)-u@kxaviNSk8(t)^0xToo^#wV4JWJqe~ z1=bjDMCLzkN-A;vtx3-X30Z1I?Bh+*%#Q_`lWdi(Y#$`GiX>*XS7jWp9g%dI-iS|M zH%M9>MADy%OUfL?r>_@ed@*~{YPnb4Ak*Lk+Y_Hu$Va{yNysue$b9zSb@fX~Nb2sG zm54;LY>Q;+oIdendIu?zv|6^^DM-3qXseU<2Zq0@+A${xV0jg?uk#@ zBs;$pm(<7xy%=OH5=pA&{U2NDGeM^9@mcN(l4^MCuR&s#+k>QAf@osWvq3_--szIY zIRZWWsECAzqk+vU>2*1SvRR%B+rEG2`CeI4Vt#H8jn@t#PKsb4~tp+VN< zAnD!UmVdt+YlFB~Un6ZCC(!fZrOuqz) zb#IRC>6b71UEwS>B1t_W|9&TvmRaSVAV-#ofu0kWbUGnZmIgu6sD$)MJA=GoXS@F8 zEs%7~rhFO~eonnej-Ygqv?MWC=IMU*4e2v{%)e(F#eXO3>4WLvQxW2bXH&QSQvRN? z1p~@NhQ_uHs2iCQyELF`ifPsucar z@)^$Z2Y>Px7r4k}{^lyzNG0B}F)SP;lAa9QL{^f>#?9m)H+jfQKJsH|IVecsh&CxA zC`xfkP?A!VrYz;SHFkDTfk^dOmca!gcf`&vsu}AwI9u0tp6N^%?xrif=uIEOk;?%L zBpj3+%ut3if{~;U4lv$JIF2}m`(pbC7s)qEG@CihJ!}F|U zRqXa5y&}6}PYoH9@wnyh`5~5fXt&7K*w~>}+hx|JZXzp5WaDOXkdwURBR>TwNFfSS zgklt@1SKgI>%FAFO%+5HsYK;i(P2eysx7*W+qomwa@cK++le~TiOzK4ZtkHQJ?Kd< zdeeu#go7Ug7|5X5l_e#jdcgI+HfeR*CEMckNf&pushfKIYU=R^FQpFs<;u|Iy{;Zl z-EJ6b_b4HJX}wG4;%v z-%}49FY?c>erfC9?>Axicl~qXXC!8b4H>>MYpjZcTbp_b!TCC|vLhN7val~9=Jtf$E}Fd@j%f_7dR9swgK9R{gKdTd-mu;e~*ILz~qH>F!B zSjw}kWdmEia2Nl6lw}`vG480~1V3{Q<16RWr3%tHgWN<;3S?6h_tvsh_KN(mrXx#b z@ZePI$R8U!vQ+r8_Y;EHC+Z^@xICXb_VP&g?n?>pEN_3R#=aVP>!ABZb6LO=o?#U) zvB?_3IR|g@p3gEIdj95cEc6?G;8)J`H?oL-hk~*t1YPoo3x^vP4s@2MT5Lp0!EhvW zgu^seJtZNya9eC?O3}#cvDZ^dCVMF2K1D2pTLwwwPLO!3!*QTnsp6227lSAsjO*Kykv` z6%K2MaO|kA-EKmwgy4&gmcv^ZeHjwIG2bZB1g0^IdBnmEihVq)Pz?+2?|t^A`dd!% zyC>uR5?mqPEsgNDM|Pi;SM46n#nPo?#qOc5GlEsT#3r=NA9-Sv z?=2RNs7EqdNk(1V;dgM>-CMT0h5i=eh6zS9iRsKv2nx*i>cwKWfI2*{e$g(z>O*qJ zGL9~GhX?*WLhAIHJd@R?Gl}WpgR=$UP|^~X^MZ{FhmNT!kxyt#Va+Boht%AtkLH%m=8&s_u zM8Z2dx?51PQ4`nM+L2<78uSf{HEQ^QqQR`N=ol1j)Sz5oH4R$nreWgX(SM6mLFGmb zD*qJ}Z`7b}kiFqfi;a@wBSjlEninJ|$2V%UHumedB1KOH_3Bqm?yxJ8Ejd%9c%z1G zBiS3yjg)BAC~J^ll|^H>jxSvKc%*8hMzwRx0E3$wp9pSlR9k&P{b4YwVRGemO{*t& zh>O(mV7|CwjT+~RO&Wh&r|dN*MUopKev`^o z6XW83j^u3M)OUwmHvZlYm8;gTU%6J<_@Hroa*g`+U-a#ak8}%)SFUnTe70&$g1GUq zOcQD(B*h0uVvQ!0l8+3XP&LQw_&67se38hp_+pi7Uk$QVc{R3SLaxZ&v3DlazA1e| zwpKYKZL8I9RJrQ%SeA*&ZnWPyv0dhZi8r?zl$hMAe)4OvWfSi&ZrpiFLe8dZ5{p); zHY>2n7pON zPlvwy>8-gHy1d@>p95unnQ-lRYJtypjhVeLbMlQ2`d{hns@N^lT4Y(?-i2rqPDh)j zPP->z(~%j?68``Gtmk8+W;f5WJj_)Z(A#IdJ-b`NrlRw1N%w!wthoEJ-I0#5Q3LWc z?q}NvGKj$pWjG@kNebf_&jcnim1%_8$b-y|jg6IP9;V{|oqB7A;3=Nwc~-KD)r9Hy zjnw-;((TxWfqA0)Jo`Q$@F54dkwNOz{LUG|Jo_ABu6-l7 zj+3VRKjhQ{gDjr---&g0%ena9Np+a>NTmPGqr<%U7XBx17MG_2Ze0XbsYW;v}Vc;e>g1IDR*cnY_Wf9Oest;%9y%k8C*1w~JDY%7poLGg{D& zXh+3_Fkm_hSjd}x!G^I6dXh&DV#5$axHH2_{@JYg} z&^lgWM|$la4jBHzS&GSet5B8d)TJ?f=u1EP6JrTavyvBB!&<@#TVX2w8k-3xZ|$O= z%(p)y2vg^&Ov|YKqk=g+LX1U(1CLL#oIUL2P2S=FUvPwDoa7u=xJsNnI1`!4K~8d$ zmtr(z3J>y7R56e52ovaE_?1Li@=X+?D3z&29U9YyZgi(FLkK5pJoTR2>^)^E$E}1zt+x|S>S|3JI@6yN#xQ~V zcz{_v$Ro^WDNpheFSCK2QN`Qr;~ft1Ifn^ngnh%e{6dLr&JR?iH;Y)zDI(dO9mz{o z!eQFM%;YIv=Pgcfl0P_4wE4|e##9!uls$YzksOWy#%97{+s9eM z%e=y?Y-JnUd6TyYhj35vJLhwixIUZfKPJc@=@MQ#Z`@Uyv1-$T4e!Qf3MX>>`}h8) z9-C?|*A?V^!xdwg#w_L&_QB=6KsaeIoH7tj9DJ9LImB0-;8)J`4>#r3S13R+ zDo~9(Xhs|ErZ>YGn_K(eCz!z;9%U)dv4(J>;TFQV2mASqqCUy``Li~`=_=+Dn%im%%BaX{vGuchQb; zLShdFkirxmU;)c`mKRvh7IsG!@9`Pm@FRb6g>?DcfFnOexrH0E7F&ut(w%Su#0bVR zmDwz21uwFha6ZI7KIRDDa+>HxMI^txlsuH60=1||Gg{Myo(y9W4-(@kRRS)F{)6jfc9@7XhvJQ(wjkyAe?P6PSSHe({#~nmhmDRd7JRQZ^aXW zp9tq)M9ibeMm~yDmSk#EmnO8NJ$D!M`Ms=R zg*w!?3;CN0TGNg2Uq4RZejZ{WOL>vk+}_TyOR%5M!dWB7_<=KAAeD^n_@2KfM-gWd zDpQvhbf!B4NMRgNX0d>0c$w|&<{duf1V8aRm$*jyqEW3?^xu2x=kF;bC`C=0(vI%* zWhkSV!2Qf)5znxe&Fo+w2li-m2AbG1t~)^HK|7vTGE9c^p7fraxYW3pLsmN3f9=x zit7d2*~bx1@*CF(C$WT=|6-J-GIeOcT^Iy9Kcl-KoY^v*@jSo+mW6{|s{|X^%1++q zQ@-Q`r#Qo3Tp@Ew`$lofQH9zx;x5|Jm0k>FIAfU1{mkYOTNP#@N25zDt>#s>vYY*U z!U=xi5B?!*DajnAsX#UAP@iVBrw4<%mx;{aAs%BHt9XU2>@KDK-xqws*PP-HE)!SU zu9A;ZBvYUE^k5+OGMU*t&T2NWowqo^34Y;Eu9Cit)PMrqQpWMGE~rOKI@6DljAuIY zSj=;5;0^Y1fTNt^0@uiJi|Z4GDMJ-%(}=e8U@)V(k6BU0JRV~?Ygo_g?BxSK{ zhQG;B)}@{zlp&ehX--GFF@O~AVGj()Tad<=th5rGoBed z%G0c213P$+FZhn%_=~HgEAP}m0m_hEUi;rBXh3t?(T)C$WD+xYh!{`uGQ0VJulSB% zIL}oQDmZEs;1;TKJ56ar7kV*>(NV=zW;36~Jj+XLXD=V~4X62=prT%k88tyJic*$J z+({GK)0KXVU;;Ck$0D9&715Uzn|Xu1yw9f`;ag7e8-MZ-@s)fn$xTsiA(^_gq8mdQ z%_Qz;E-{{AHLtLR-IcWee!&3_bByo#l|Q*cVr9t@IVeDJ%2I_o)Tb$}>B0a;FrI15 z=FuCnTtDqy{{e8CtjO0G%vV`Tlz_v7d z)E{z~ll&f4{6k_@KOe|NAxfsHtgb_2+R>eU3}Z46@F+`I&MUmZeh%{kzYe852bfPB%7|A52GoL3}%|>=}kgxfHb2YU8 zC4uRgK?ZVAkP6hKFP#O+(rYM(}sH(z`ac5LFTiVXIWQA`)?NP;C;U21i$hZ zsbsv(b%{chp)$2;NGp0Um`O}$HVat6dUmj%&-spXB;0P}DR#T|FC(Z(O`6b}PV{6r zQ<%d-o?rzp@Cv)w$A=u^IKOa>jCa^@@==_!BvXq9bYx&uF`7wCXEsZCmbGl+4c=rw zpKye4_?h!uc$!tLV-tJoMfGsOK@Rf`-*cL?T;wY0>uX0!QiK+a#r&aud#!D ze9V`e;Aj3Ml?)ACV<=2Xq7@W1xsw)jpga9ZVSJjI>bX415?1g6>)Fh1KHv*Z@duZP zH1ZpboD}93Dp89DjkJGDL1%h0j4@2+0p_uYCwY!_Y~pqH@*baZloOohEEl*&hQ`i> z1RB-&N2*%^39*=CXh%c$Syg%3FM#=D7MS|B$YU4oX2vQGpuVNmJT! zH$555NG9=6RPh)qS;uzvbA(^{i>o9w)lbMxAxcx8s@z6HTF{oe>B~5#Gmk|)%_?4I zGj9;xtJu%Se9kdWa+>p8CYAKf97=Lih?3k&6>8Iz_H<_;qnXNF9%m)%*u+lubFi8A z|59**Q~b_VvNV@Oa4WTGMq7F@fMMLnEFNVUtJut5KH><+`H??~YoQ~OhmusGb_?xa zU(kxq^ko=hiSjT{@I33-!n=INSA55>{KZug?vkBzGX*J41*%eqhBT)=eHj*2OyMDx zv67eB%3eO?FvmH=MXr&)rT#!(icp41)T9B;XhRozGL&)L&wQ5f4AE7Jm)ONVKH?C^ zIL+UrYvlq%P6|+rTc|>9n$np;Okx)Eh_Q_4c!jO(=6w!vtd;ivUhq3t$k^H*QIuP# zL4BIhfu0OxG*g+yV=QHPnsw@J?B+v`bDDEpCep^yBNqkRX#e7ZvQ(!5ZRkNihB20@ zJiuaB@FJVo&R#y@7^nDyYh-9E$)E^js6;L5(~8dYi7JLL`oB!F{2-6<1k2gLHumum zhd9P5&TxTiB((DlA{Rxtg&NeOC0*#jP@)qQ53rc$d5LZ8;R8P7YkuYo7r91adwqi3 z6r>E*xr0{pWF%4MvWVrZV;g(fw7{FMj@gVbA z!n6Nnt>sPZ;yu3N6z8}~Vn^+NQ%8G2QOZ$=1~jJ~-5A6O#&I9Bc!Vc-o|o9n4&LD- z4snd{IL%oua*c#ePDb1uRTQK&6{*H;G^8c%=|p$>GL(Cn#Qi+P0+#YDFSCj5?B!h! za+L2m!`~!!w&O%|DhhK8b!bf|dNP<%j3>%$9_0z1teZ$TiY+ z(J{$IK}vSf{lbFSPo@5p4d4u=(jPE%|TrU?PN>GWqwBsHF5XJlU z^7*4IP2&+3^DJxF$PV`NDc^9)yR!Z+_>1(tB~z56I=9i#-1_j2UTW&tRu((ao8gQl z%EK(-1zzhNHQpjP$Wc!6Gk+5F(b(jr43(%)b2`(X(ad5I&#{r$d7ndk%}@Nv6%zW& zVkksOszwzJX-8N3FqlzH;vpVm73GYyWoz zpK_ej{7EXA1~^Soj9aNrU0TqA9tVXg)QvhP2T5Iz8;|czZ3k- zA6zDGpsNHq$WIB9sY!kAq66LN%TUHKmDw!hX>0@l0hl3wfH=tY;g0c!vWV;ah&@9G3~_!Dk@qUpWW4DMA@4QG+{Z zNNaj9gvre2u{6un&$5t zjX6BVa$e$f-r^%Z<2a`{$KRwI>WoHVZlwx!Xv|%7q{mS0KS*#dQ+SYh#CVG5d6{kO zWugG@vD&>B}gl@i0rHiWhj5UA)I(zUK@V3IDA^I>xJlJeA`A+71gFvc^D z*(_igt60xAc8>|KKZ1iC`F*0PB=*vA15^9?`pI~TZ0;sob2 zqPZ1CxP^+;q9Lv6N-qX7g0W2FAr`Tmb!_J?KI9O`IK>$*l1loCjxssPPbn%*)c&;v zjc7|Z`Z0{rOko!DS8ALOkc0dbryNzN#ho;w1s&;5KZY`9N(p^f@GuKm%1YL= zmA&kb_5Qv{H10l!lAILg7OGQ^rnI3G-RQ$$Mlqgg%;FIi^CZu*h7D|GCvWpHU+@h- z__>k)H^IgGd`}}&^&kpx3pKcd=Cs34njC$+BW|#T6ecp0hdg-wM@j0dG0V^J0-(8e&Z79r#b6Tf@Grg6)kAbJ@jQLqnJpPIm~AfPqBtq*upOM@ezkO%1KUhmJ3`X zy*&;8IYT%zw*(cb>Hqc$>I=f#)t%|dKqfPj`7GucRjiY0hz(ga_;Z1-XT)G^8!v z8S;SkA1`>|e|bc_h^JZ0YrMs0e9LeAL%Lbce`yM<%Tbd?bf7n*n8qVK&RRCIoj2J( zOZ$H!_>vzu!#|{d(8?)53CdHQ+i6H^x-y9IOlLNa@f6SVGMm}SK0e|wU-Khpxg1r* z&-T?I4@D_QRqD`)j`U+JQ<=#_EaVBEV;$Sr#Xdgd5MObEQ=H=}33D_zg@~3@+`(P+ zU>M_>#sfT@<}vkCJkOdmo7B5_pM!kM8G^ZvAlb-6QOZz}S~TV^+RfGeT?M@v$OtAd zm&aMjCU)@&U-Bd8iGN5Fk(Uxwpe7B{G*@?_FC!Vx4Cba;s9yGv_FpMj&rUwzDBtoc zmkAzrAtDdOC{Jyg(wW{2W(?Dq%R-*#6*jYr_xPNX{Kh2`qVt@&$WCF(Qd}<8bfE`>82PC7A1{dVAPabs=UK;AcJUsE_?BP!lWSyJ zpc7J%;*_N_wWv=s+R~MNj9@HNn8`!YuwWrihB5@_$3G`n%O-a79*6jfll;O3u99t` zuK-0TOEv1zf_8MFC;b`D817>hk1lllmkL(0j*Yy|Ufv6{i+7KRe&J94A?`6pnf#QY zGBvrA*7Ra1!rX+lf7(4Q2hFq21E z$|^Rpll>gxTYlm%;ubk(y6cyY;74D=FchNpgcl7|qGL1Pr!SlSxCU)`;AM-6g zagIx*lDJqmp$Mh8m1^7(CN~WQE$K)P1~7v0JitPhv!2bo%?EtRxBO1d}G@^k5L9nHK(sHM0e^9#K5bGrYtO-sTg&;TQhqrX{Y1l%bNl;jw4W{XBMlqF#S;`t-<#pcVP*m|X-*b*s z(l2xFqY$@HmAW*h6+IZr7^X3g$5_Vmtm9R-vxj&2grl6`Xa3*{(fB8whR9Anicywi z>d=4|bf7x}xtAyp@+gaWisxC!YwYABKI0hQbDo5!{8*wm$xk_f)DyI#GXoe&lvzB? zLZ0FUHu5$f@)bXGhHGSe+LwgFl%hOUsY5f`(1l*~=Uyg1t^MZ;7V{iic#{Ks&CgsQ z;Tc_+{FI>vjc7wJhB1*@JjN5OW;1W|8OQmJOT;gC-3~<+IVea;Do~q7w4x*38Au8< zn9Bl|u!0wPjh(#1#~kJxe&l!lCc_HnEecVZ%0z1_?xZCh=)nL+GnpC8Wg$yh!D=?L zhy5Jn8-C<0mq>h8bC93nRN{7;(V3nMd{+CX2=3zn=COp8Y-BG7`I=w2OyoIxLK1l> zN@*%kgL*Wl4V~yte}*xd$xLT9^Ph|AT!OW1VLxATia$st%k#b&l&22OXhRozGlVfr zVm1p{%8P8|4fgQ`zi@?YD;*iiM-{bbKr6a3kkL$HI*;%qFY-F?@;S#j#ThPejdZK@ zCkj%Us??<=_b{Bv%-~U?VX=&tc#XICgfIA!bNo%Z)xH7bqyWXKOik+2l$La*FZVK) zhj@k;*~&gX;TwKkt^NNJ#J!+BDNK24(v%MLW(1R&&U~KcCEnm&KIdD0;XGG}U*qdV z4vKLLm8d~O+R}B6_8%x1$NkJ>5l{0Hud#!7_?)l#f#11AWUc-|P6|?*3fx8u+Hp61 z8Nwvy@&s$y9#wqASNy~|;$HOCp#;g)kqrCiJtJt_Ky%cOrv|E45Ws7HGS zFqQ|H&oWlCiM@QrN&X^u*%ncd;%UmMYf+Du^kyjIU)GbR3TCr_B|O6_US&IP@)3vl zitqT1i=>kA6_-KsQ;Lezpe~JR%iZ*66cd=vY#w_>PkK_Ynhoq?KZiNaFZ{_h(y!OR z6rebjsY3%=(1Gp@VI24IAoF>G=Xi-N?BM`Mql(j9AZ~+hNlpqC9m<&$F35ywB&H;CHT&dNPbj%;X^!vXnJ!<2^p(Yrf}K z{^AO8n_c$EMj=X5i-xqOYg93S(M)G9F`i}>+jyJ9e8Xuj5x>PDCoiQbPfhA`7oF(M zP)0MEnapPyFR+#9e#KFK<8RV!bu=hQDJoEd2DG9xJs3a=6M2}&Sjr04vWcC%!vVhF zIHx$nMdG(<|LoheDW$1IZR*jKPIPA=BbmZX9_BHY@f>Se&l|kQCw$2%&TyH?c1Mf? zl;BosZP)&d1?}j?AX1pfEFNJoD|neVc%Lu%kw1xhT`o>`@=}ztRH6oV(wKJiU?>xb z@?coZ=kYYpt2d_Et^SB(X-=yz5WJy7k(XkWr5bg)i_Y|ABvaDNQqLpCldNGg(YF-u zbBN=d<^tD9+~K4_E{aou+SI27?deKCQkcjC|5s^u9v4;FH-7y3o*4#2z+ng3W^zpviY;h@XtH&%Y zTlM$Br{C{+Ua#Mu&%AnH=W4)V=3MK!=A84zDm;M4u@$f44IIQVoWxmNc!To)m5gaO z{WxNgfqV?WaNLY3m<=ZaScqjSA&4m+?12XGW0;~XwSy+aE^3^GuFVJN{YR3d;zEX69UL9-@#99!@bcHtn} z@G(x~J6!t9?`$mx*o8^mE#192lJU@9E& zq6sUp4qLDtuVXI`{txeyKY>qi8sFd|uHa8t4)fuVfK+rvcQp4Q8H`bwi0N>^g&H(r z3GT-Ocnn+cJa%9g-o{}Z!$=q2#U30&8$QApIEM@P3BSX9lw)qhBNf>wKyM7i7?fZJ<~Ea5!HaqYrtOyr>_24N(|VG1hX#X_t>^G1@F@H+P5F#d&8IFHM? zhK?Vw3t>Zd48l#Ah^d&3O89UGnsGPogT^L2gBKCRZXEi6@^2&aAI z2{z=S2l`?d#$qPQF&_)ih-J7JYw-x4#PisV12~2=_y(8TDF16@LXJ^M5QkKBMFIL? z5Jq4Ero)9AEW!$`fyO30i(S}@Blsu2#JBhn*I*o{exNh5no0670Any64pid~+>H%* z3a!|MxA6f!!`HZgpK%qI|DYcHr8C=16rc}^F&@)Vfq7_NNYZWv*5F}0k5;^igJ{Di zIEC}Lgg;<8LAype^3V^XFa-|y(S#PP#zS}#&moAtCn*0TWd4P-_yN}t^-qcdDab}Y zjKn0&LIvib1`Dy`f1o{Ff3!c>{`jvr982z5%xuo#ad~}yM<7f+QsZ#D${XFmIbkxj zW8p=q^OU)r{O2qCuYj=o45B)iBUGX@NmcN}fX~xe*{ZpRi>=PPTYnNOspdyToz%a@ zN=lW7+Mu#X>T<58B-YhnM zqeYdLUk@hRB*sW(id3e)$`YmgbsnCs^L%Sk9hKGV4z<=i9~t9w>xFTWo$_-BDdbG{ z@?}wl<<80lkv5m-WJs~w>8+fncgIO$;{Meym15F{yxWr6e=f_KC^R4DhykZ6aj7_qoh;(WPHB(7nDIqGX+d0W< zbx#yE(K6QWb~gBwVWV^JD07v>DqERrDVGH}0^U_(w2H0FeT!*$rK7^}4~eNrU|j8_ z5)?6a=hwujLbtPKe54Ui-B6Zr)qZ+)jvA$p#!JVz$sr|`?V)BDEBV?Yw<%kt<8%F8 zyd?Lz5?fm92$Vbhmy{e<#@6;IsOB!p6s|(eVvgku|Bm#Yoc~(w@V3ONFGFnAj_>ur z1nDa0b!mbm%MH3IL59c2MOxh_BTD%QZb#)4redet5h&Gd2@=;lJ)+3%^WUM0y&gwJ zy1J2#XQa`SG+No56)JkO)9dujcUF=nD68YoSP55lpMR&c$Bnnp+%1I-zCbSyV8cx- z4Yf~M8z#rw+^(M@?0(13F)_}bF~ci};Jezo#^v@mI%;Yh-Yl{Dw{+O!^jGWhM2V5J zx;|0Tv)!R8iG6R1_NPUte_Pj-v)3BE&T@Bgg0*3PMCN?gNtT-QKN2N1a(%4b@2(6t z-ZZR%e0?TS@?@=!N)mg1TIdv4r7uw7Y2TCaQ8uq*r&&F#Zme=U8p2hv%Uc^LiLeD+ zC5HU0XC+B`@13D)kr18S@2w|BvAgO>WU;T_S3LhEEC18-N|B;Nd32DNtZA6wqz+A^m(MM(iNTX znzNF9+2nJ(UG*(i<0ZMJtj_NYEQtuC$#|5JqHIl$+oJ8x0RNw>3Z1pS6MAfC8JoEz z#@MO~D_pgeVkuJ+tz@=P6HFe9Op?3w-D#56FEw>?!0GliSU8E>;jHkPVpM_h zdz=l<${N>`3F>sD6or*K0!@UjUX&JHbJFBwf08-jmSY)vTeDbk{m7-Hxqvtnq3L z(`LOeT~d2w#EJ@4S`f!FgrME7$NnXO-1Zzc7q%nx|r>j%KWNTQV%U%A1_S>Xy)ECL6o+g*q>nIAb z*5&FQHklhWJJVVjs;o5QOz>PS0>!SM$?p zQ&MA`_e9X|TM`s4<GZnhCn{^@wnS4Fo2Bh> z?9BBl#c5ThKT^sZo*IWEkg8&9ZdS%j{i$6#=TAyC(_kM_R^QP$>C4cS8p198mvA_s z`nbI1395*6Y>51u(N5blWn65}EV{U!HLj|%aJ4d`sNCh>qwmU;8>O$_n<=^Zb2`hB z#L$kkiwb9AisTB-xx)8as@le}W|HYWu{q1FVT4YwI`7c&Su#bYYFCyllqUUkmaLQ{ z?du}bQwC;P%Xg<)xv8by>20T-YV>1WB}2Z~ySvJ; zsHW7cn%XT%Hi!FGQN49|wxoqm$Tf{)vZ&-+U6d_3VdYuHcQn?!-qxkrk`R71ix#4$ zhbf8m+Zyr*k2YVil0^?pZr{adQgQ}0^S)!G!HtO2{I4xHv*=XQ8E z=*itAQ?~26ZZbn&)gN?|yxe6u#WlV%uCugOmu1B?ZR$j?Lr<#acQn~J7zl}VM=;X3 zXKQ;N_40rolqZYi6TLG}Cd&>Taf5s$+4`#+=-}hDHDAWZOfD#4Sg3WJD=4gWR=wR> z&DEZKDU)8hEnf-}U+)#|>cL30FOn`GCcuatuA&>~>bL?KFa30Bf!O7eUQ!@g32*c> zEGotks^s>5+%-M3(OtyMPVXw93bg8<3dAc%bwzi{3c0DbwV_q7?k=MT>U?Dh%XHP< zs(Lxy^N$)fx3j{cZe^c18%Bo3I7Y6;<;q?X9+WAJaOTFuo-c(4>HCKOJC{^YiJ&D9PvPd!$Gy8C-aJj3! zdMk5#xXR&mp4z%3y{L%7wd)Uyq(|t2espOJIFUVNW5|R-(SdmVa!(nQFnwT{m4hoL z;Y#w9>{cOBbd}oZC4b7U4ZUS%Z1e#2T#=d;ZFQV6TOAfUI6SP)RlpmVzGd7Z)Q9 zMjsx^XuehF43j~!J6JwUMoRpi+t_oa16=G^YgHj{USBlsuiq$^&2oEi&TzR!0tdN3HZwr{TJuWpjMaIU*Aja4h6sg@O^ zr9ht7Ye&n#%%a(aHS=BnIn!9cH#aKNSATbs%~wAsQ633)x5bzO%yCkzo{6U7`8AID1-8n%RC(zD?8&( zm8wC}v5vANyCbkf71st__51X&any~H;4|asb>u63c)T>pB0XvX&wj68m>`o3%WQph zf=r`BnR>IlAxm}aL}`?6`fn4ZNM6uyO_X0`jedO+dv%$fSt5Ni-cYG> z?;SnzWe)3_oZ~V?wI-;i60MGb`jrwH&2;Iv68Xg(7f>z1pKp=1hU5kBxs|FYqxHVq zWUu7u)aXgwCvU&%#bhXthUdTP4c0>WfsH!Wc}bQ87J%XnOVHR zbe%SvPHMj%Hk+X@Lob;v-$>7(=XPn8^l{B4E`Pw~wj{{GP;1j=r_g;>DuY?Mw<%N? z&y^AKfL=CNevp&8zEpNfP!~ERO;YtlhfJ4c!Dk#2D>5Rut4t=FyKrjpyWQmZ^>kyL zF4&r;(!)xi;(QMnEQrJQM6t zE3t-r7fh>{XhYWP9u4xKIjl#t$U9Q4J1mxi{MBQN@*}lI`J#M8&^5U70!X9HoY_ zl2oe9Y1Ska-e1LDtky?XF-^DXA6C&Ye$mPI$_gd~o9>nB(3K%ZuCmy4r`1vu(-x}C zC8|@HiZ{Z9ocZ6u^{Zv1@xOkfTXgdMbT#JSockruRI+Eq9oFKj&Uu^0{dmhtb9S#0 zL-yRa#?*G3t>}r#ukrnaZS!%JTVho)OVqf^7O|>5*66#}g#GvDW;kkp{IvveUVpS! zR!)dWQpSUP+%HvpZmBYonEh>6@ne%zM6ohkl~Jh7EfQ<(ugukAxv0W(mAO!5s8SUb zUac&A+NAc6-ql#cu&ZBMCu3uajR>1Etje-RnWwkEqQ$Q}u9q7+9WrH{x0x))7!@_$ zY*gz}>t(34>1FH1p5ZrVPz>fUj-yrD$8E~I^7_$yOGsLmF=8I0_phf5em!V^K%Nur zUrROk-|mhrx|?RC3=1yRvfTLpLOP>kUig_|&1SdSV*W;~{VdF}OJy>r=?q7q&- zf+J+L6wAOu(DmTDo7ujARh4siQWPZUl7zXQ+ zup<*)&=uLpLwEGY01U-2jKnmwM~j^gH$3p77Ij#PRk#g5|D__=!Je5h`}hvNX*9VsD>L$u>yBvE!JVZc?#dMklBC-@erQI zGuVn}u^p`7w8v#tdvE|p@E(q$4aaaCU*eRuJuVr||4H^Tu0lfiJP1ceL?9ALNJj>2 z=#Jj#gT5GwVJOCM+=y|Qjv1JVS(pPSs^CU#h$>TcWa@DT?!r>6#X3BMNAWl|<0)*# zHoSmVyoR^12Yay(hwv`m#|PTBQF2_LlKmc+@Ed-|Ra}FaIcf;P5rbGHBL(TmfDK*H z71_u^F7hxC!%&QodizF6Y@R@tg+DbLw_^_Gq7=;HRXHkAg=)CqMJ<|eCz`PYOR)^g zu>z~{H{6H6V*?(=6L=C^EGk>=B(ocD;%)51e!PSC@d4Vjdz0jZd`k9n{UF)qpUM7$ zU-1Y2L`W!IDB=*01f(DpHrUYxg(yNF48Tx~#AuAcSWLmKxDC@W8@FQ)%GyJ$)sd;k zLM*~vSd8Vk2di)|R^xs=i|4Qn2XGu8;v<~I=QxeC_zHjEPnbAHWRO!)VAxcwhN$Q; z7To^dV@z=GX8FuuT-vxrvcu%F;DK#2jFso0y1B2!pj#Y8SDBR cF~M_Ri7Q1^aFQ4^%;AN+`0&Y-CrvB*Kg5%png9R* delta 40184 zcmb^3XOt9G+bHbnNiYP5oO4dX3_0hV1qn)4(vWkO1_VV^QmcR{B7&l#BnhID#4MtM ziWopqk_kltCCs^6hIhTsbI$kgo3*aJ@7>j1T~&Km)!kJE`ya}<<-v@%H0jc%Q;(D& zNb`5T#FASo7oJcg2;zbu2obG+{w6K0XZmaHmfdqQG%HkV$Mut;K`}cfo(iQF+;Jil z(=#rTuVlGU#z>QrWkaVUsU@p~cVzHce>>Cb3-LGFo3h@hZ@*Cm8E?4}Y)-sU@6DS& zA-%fUzB#`sMQ=>Foc_5nm2b2wroVsnjdnP=`GKA_Z%nx(;YPi)e)>DptDEhc?;q3r z#)LuX(~qXNb7#Eq!uj?$>Ne>M+_?LV_RSSq{%<=R1g}N6p1+>GZq$|2+w=R~Xy5$6 ziS+iX>C;yayfM9G`U1Z@>_+=$d9!_UfoF}oIps$EZ`=0=G3iS@f7*=+ucpti_3Z!r zz|Ho}83qsh=k%NH?LBV1zVpP5`myx+biOM(R)XN>3a!_Uet)neeT^Cq`Oh~jPj6?4 zjlL@gRu8)|z3q)=a6Y|#bB3*l-1(+bz;(d$WD>TW+?~*Ybbfe{=en z^u?X|U!Q;f|J@G%Uo$9hbI$+uftz1&A@|MbMtyUEs;95W|5v-?e@(y9t{VJb3y>{+ zgx&m_)#*EXT!{|(`Zu1ldh7bK4~9ZzBh||f$v??Vr!s>ubC|~ikypysD*TFQ2fNtK zKHlP8K8$3n5DwiMnO~t+sOQ$b6)uHBha)>Ht<2rVcxX>2y3ma~B13N-9(ply8DazX2%8}iL-9W=>Ur2OjI zUh96OSkO2K_Fl{wRGn4n!urVfHOsYG95e~89xZ74-haNyXTt0Woz3Ll)j{zS_1A|Q z2V+X46$?`K)_Ay>iBFd~A0!_eaA)HnrT?D8{X;2@uPrPV)M;Gk^t+L+wR(p3MmE%{ z7djs~Q>$8NXQWW=-Cp^scKKVU#8o{}ef8?NoMSe{CI@+*8{_ju-)KQkB62=66>YrSf8;;rGGL$ z(LYooXpt`{KI^ZYk-7CA$g?vsTfWAj4D*Bdj}wcZe`IKo67;V*bZg1_oni{s&RXKR z)5!@XR(G5qlo)gAa%}R)YiiXFN(4`wk38J)@XeFbe-H4;m_{##2icFuGL0oX!Sifq z5AX9C-*B4qTqWM_n~nUGqB6B;P6zrjm@&*@0V~ z4pz~Vco8a6i)M7BJHwdBEFL1llRVEB_F}&YKIa6#U^j6vlL=%Z8~G?jWopxewsfZ- z!Z(oU;rbS$a8Gvb>8AIr!(vS3xexp$Pxs(C`=iu(TMI0W<2+B zACL1an|O_P`Gjvd!yjBBNy1o)D%7PFUFgjqMuipAxsR2sVC0foFpYUE<_TV42m3il_>|%*iH^8ADM%@zN8sjkrY8d#&4WD38eU{4 z@9+ty_>F%^$YxAYh!k3IJN+5X1ZHQ`|H}nWvys>Mgfslfb+Tl4kf998)T0{%7{zqv z@i33GmEF9{5x(OW5^^{mP>@nop-v9{-%QYnUJPUu5A!q!`ISq=wLzK{6QAy|cd5w2D#FzZZ zb#mo57^y%_8qzv{L8DUe@88WJJ?Z#vYjUe+L!JH%nvNSiFm>eUG2>E4Hk~+O^rfJ9 zvjG=^^YT$tWq0XX-Bg=%k zG#fB}%;2<@!5mS#bV?01qlf;@i~L069!Bhoj>wXn^Nso$INLq zXmIMlLE}c}2}-0+c_s*D460WdJ#JS_V-rSJiHRu^6dO5cb`X;%*pfPG^c1gJ%xQ&# zY@$WSK~pCw4x5NXi1NT^n%ciVQMq{#ZVtuh^s3r&iN%N!(Biu~PnTBtx| zLc6;8--`>b#`YgNV)VEHBXh-POU)D;Bn8DL3>p-9r(KcCrQ;K`2ASsui3NiUePa{z z1*IpXz7o_NVOlxi=DW zG>cCNKF`p(+2|3e<6FeWW(*cr88dps)bXRo-SuUBP#`k4ed(H^gc{8Ujd)Mj2iZpE zi5u8_(8xh|k9Z&`**tYqhHTAehJuF^g84!2=8q?oZJt^_)TH_7ajEMgAGW_WG%)f{ z`vRfFNbU}eLk~r|ceu6P!x@9j!QQD8MvqS&HK^r?i6aNijSDgb85)FYwH!TucgEnB zAa-ofb@cd=sROeFp_Ykb22DsE)pFvv&x6>+AlY&@%Fwmt#PO*EPenfJP%Puz#Dq*i z=D)TE3iAy2_{`p$xf$_`XR&t{`RPpfT67F12c% z2aTGLI(}VD$QdVpQjj;;HYIh)fKdZRbsjosROwj#kTmL+ph@S{kpq5-%)YI5%%yCR z*KR8mnin~GTh%-hviIveZuH#)UQ7yA7fg-|We!3cBgMMZ4?P^|)8&cKg~&f$3df(% zk*90Ut%bT43WW|u>fHWP=+&*KZ?7JT6ziV9?Df1s!E4!q{?Q9DX^ql%C%dG?CHi;s z7geNx_ou?y<$HxlrUBi!n~B`dQ|w?r$GAWi`CK$FY)B8r@BnLwUa5%wHu{C=Z=M2F zqdkL|$uc(aUc3X&_kt_rlAGO1OZqXJXLy~DIZHHm%R@A0Ys~BcDTXEpnYrcZy8RfbcBMntouu`J*jUgtA@C4=Op z7`osWnnCg;fzO*o25Dyq?n?hIolOL?BHyumws&X4>}tR$i!6==$xq%wi| zL|Dc1?Biq3@DEw!57DHfUNqroE4YK9%wicYvW<`Uo_~mwB;=z6HR(VvMl+SAJjGUa z^DZa2M2!3(EBUBI9d2V#G~u|1C9Gs4?{J(;BuNg6P=iLa=WZtR01=*J5AX3EmvI^j z@=%N_G$fi!^kximiRKXD4T|mTY%vyHxF+XsXY{e`*)o4OTdNGtR5AZav@(Cw7 zPh4?(0%eNp|0;qebY%!(ma&$NyvoO%<_cL$7?@O~5gqBn5GF92f+E46Z{yHp?GZ8iLpt`gLwNze1@T+pkI)5 zJ|;4tUsdVEBmF)NcgtL7^oa3!f~31L#wYd27@trfF)34!JE=#edMVO3Idw|vs4AIaGG)q?cwgp(pM#_g zK`1F#5K5@(2SbqQe30otkkmO#&V~U>!r5XZhik6eLZzlr61l zC_ZzGAgQcvwKkNHXY=*``Vy)~+&q}!(1(~YGS)SOWcwf0R z6qjXMkokP{l$2C0E-tCJZB{ZAO4t(0ay}t`MuwzXzIt^iKA}^PR8wfFleXK6my?ou zgoDgk4g~RkWk@_0m()B61+Ru;p9>{C8zh~w950yDz?j$!y2qL)J{}~E^=cjSs1)Q+ zI2GB}cqS%DngQR31Jz*2o z43bKi)1yH+E}>44G};!hRM|t(Rj6e?SKm-vV&0gfQ9j*0NLmrxlGMoOUNYnOm}oax;Gk8I>Askxn7Awnt^b|Z1XJ?` zg)==KWNMg@6c;w4jFO}YLE%97mnG=pyq-*xn7E{Vp|Y9R#3nqICAt_FgQSG8^H`9n zWK7bQ8v`>bTc~j6J;5#EAZcY#EU7|FC~gQRc&-IlqN z3dH8uZ7CU&;*yT!$e7qY`dccgM5WlcghyhN*4Zo{__};SVx}SSiCyB7`iF97`Z0)K zl0A}nVE*tgg%grPNwJh+=hMUaj64FjK6WD`M3P<6g@*QEBbnf7-F}s9#|_B>K{2e zsBCEX(!q^F_e2^GuGZl}(;nhs7P5%NEMX~+@F>kdHXT$9%$JK8w^JQa1EmWZ;l0eSX#cjo-Pz zpZvu|F7r26xyE&3Y>rssNFW1Q$jU7wk)0gmj+`G-FkDzvgrXFu1SKg&Y06Qa3RI>F z$)r$~YD8~z)ua}+sY6}rQJ;o1qA^WrMsr%Yys%*Ctu?xdyVHZ7^ravD8NfgWF_~7+zVqg(R|*gPi1zWEoyGcQH|MN>Gwgl!-JRUN)2x z89KaZ*1FpDs87?#Bg5+z?kc*SZgi&ycW@`YBR>x>m^e@rz2h-B(s_AFhZKJu|1JOL z#H%@L>ZRSC8l@e-o;JGK)$q27Gq)Yuc>TAuuie8s{@3xVUO)84g|w@eF7|4$C+*uE zX-{3bz9a2)&R%J~E)7jJj*l!GRXU@26u2kaI54VouDBrbzW5W|w7ih#cyz+G zQ6)29Xc+w=Uy16GilZwInInq+lwZs;RcO9uQ!IIXUE{L2RT`crkB-5Bu$-XV* z_kKp)h&r4{U6@i-v_-3`>(JOoi$rhyMEZ>>uNyApaG5Ju!}DxnCwqB^kNC{ozE+1eXo6l8b_rz((zwqONVF8__Z@_@aaM?eyZV=m%2;WAZ5`Gn08d z6kVR^m5E5Pv4v~;-cQ9}ass!;F2wvQ_=~H!{uX5NUD?(7tX7$#g0hkEW0NgGWRAuI z=#~pH%LJ=f#|HGvg*>kbA|H+|9^I-j#lcokZ^$ zrAE4suWdkIsQjr`@Iyf?& z)A*gsxC$3!;1+!8l}v>MrKm(TqW6cQS5#VCsZMG)J}<=d5e#HF}y91dUrXNv`^HklZq* zM#~^{A!t&)Nz-bzgU~G&+9(T3HE;P-^wdUuFpj5+6sd^xFJ_iQz@#58H%EV*jlP`0XlLOHq| z2{pA;b-KjNs@gmyxk=09YVk2KXG6J~I_A}k38lr1?V4PzNt5K-C1Qhyu_-m1GwMoKf=KO=g6VO&T0I?KtZManK}xga+Kqw%DJiX!t2P@W>xmB~N1mA4AW#1Uosc`2 zZ9%IyO|H=_K2$8F=jO<7Q|pCVMk-DlTylGcn8^txJ2Z7^R0m$nkRzpdDAu*n-a*q= zJ}@FfOw-6K)2f8#M1GidYp7%-$MlJ}mPjn#vgJK-**mN>;4*q7AXl>{u{l!~B?bpV zC3-e(n^3h$O6~Yij+D8f(Avl=(^EnfBd4ZU2#t+opV2b(PNe6Iw9xoS&wKVROIZ{u z(Cy1@!Be&WxL&m2{wr0-78vyRu<*36zI||JiGJ_DH^0$}FS|DARdB+&v44Jd;IWF| zJag@IZzok7q?D(s1zB@19zvEP~+R{h=(ueHY$gG)dGq3F8l;n4=Gsf1>XWkjN zwaUG1;yVBT{8eir@7~`g^U5N=rYZg7wice>D{kxLhsq~p`>&;19oe*WPoM4^&D5I3{vQsT1Q$eJUGkLJk#zmwz|Cf!Vw>qM$Q zS~3zIS}xvix1dX8?xWROL=)b-i6*&2i6*+yhxEoUmT`<{0+X1`6rvA&O=Bi=B3BI(2 z|4#dRZl=hm#b-IkPyEa;oR1V+Rx)dvD2S2k5FhEhEN|$R$k1hFLxm!Xmo-aC@oH77 zQ-``Vqd6^TNh?~@hR%_=<+Vb0N9r$c6q*p3vAkXW`Cfg9hgrxXA}ouXSl%hLA(FhJ zU+BHa;uR&!M;{6LoG&=amqe4tulSl1{K%Qe*DK0)zbN{fe+XoPj+{XvZZZa$$wD-{ zyoDrkkdtV(nVY=iBl@t>|2#K1A~N9dUqivx&MS{*{l9m}+Rwije%t2yh(mnLCmiJ~ zzUEs_agpdI9n5{)OqZV(Z(;}Ua*&Vsn42peeJ<(;qAPof)12XKj2-1?!LR&A^uej$ z30a32q8atgZ4h18JUHb9B`HeJ8UI+oG$qC`BJv46-nQlQ`z z#pA6RC5b+b)tNr@C6!@}V-ho%&8xh{5kBJ-r}>H839@C1P?XBlB6=gQHJyk)m=&I= zxQCf6B*HS5^CYWznrQxhm5k0ci8Q1MO=&@UqA7SMdTO9Zjv1Nue4Ih(5j5kNyncE|%~pD_KJ{;f~%ue2z_QCi*njR$k?G21u6gBARKB zVLCIoCsF_3CwP!0EM++>c#_@hVK4hQ$Y*@cF;4Is|8NC&&V!63lAY)iUAf3ZQJN5a zfNL)ESrAry#~IFYj_4CxnJGvSDpQl%G@}D|5Y5E8hOLHrgNhXD=M6>YP$ku}9^e38MKTh<4tlb>tD^7BTvz+61 z{^TN;h`mMsNAGi1rV$)6aIe8Ew^ z<{Q4{1See@4So>(%r9J`RFbu)EafOqb?VZN_H^KO?qVcknaDKea4&OtkcU{t3SQtv zUgkCSyTl&6$pJp)Fh@Ab*L=%aif40tpb~wF-iVD5z44kx&g=#mDO6=Jvxz?KwUg-0 z*5jPuJipT_hyL%Yn9fq7H(7V{0flqg0+gcy6{$@0iLR7AH_3(@B_hHZUsYwfu30bBZG zzTqstagi8XGb;s%-ujL{gI9}2bi64`;HmDkw3a=*FpzP~ViAwBlJ#uoEu#0vk8+ae z!+Dpp8?14e7T(bfPv{(HAzbjW>9U4>`hd&T@g9k0s{y3$-Yfs7ds(#I|&%JAE0-1n%JhB0Ns?QN{Ia zWGDLxf2jC^(AV5leoGQ;F!K3N7eBH+nOekxU}`_`*U~@C+}rlij>S^l^qS zImvnc$*=$83%J2fArzH|S@sNXpl%N7t zsZAqV(2m=10X=+SR6o%m#xR42S`9gs*f)pA=p9^UwXhSD@(3ioCV4@4Q!)6NRvy`V<&n8~w zO^$GkU${(S2?s)oQGsOY5PgWG1)b?m^kI^_!-`={U>fsS!U~>_j_>t?E$rqKzTy;@ zh%ITwC_o9yQ;p~&C(UVV26MUzdNYX8+`|JzSQWh)_Pk&d+j)Zz_>^Ou;0(X=7jdPm z8wDvzMXJ((=Cq{?J?Y0FMlhaf%;G*v70nusE!GG>rFel&>|`JBbBrJOi9g9u+O+_R zQifZpMqQfFj_wR#7-N~vy*x;SRXoQgcJgLv{r|q;b58IRe{hAkG7cmZp#pVjM|b)$ zjPcB35l`_vTX>y!ImQqC!bO6zvIBBaoXTZw|2l#ebfPyy7|m4Xv5=KK&nxWaT@G`C z-?&7mobw@hDMm%A(ttK}X8^;Q$V}#i6%VqUr&-Tdc5#3Y_>6Bj!v#X+o$bj-F)C1l zrgY$T`ZAP>%wQf7p5$3Jv4ilNibEXZBjqQiVFSpfkM~z);38o!LCZ z3f8iT*LahUIKnZ0-Rzo@X2T`IxUc z#jji>jl@d&o?=v>dL{i|PtcUM+)f{cFplZm%R@ZEv+U#mNBEi__?e4bBjc^UgyK}9 z290S=XL{0~;Yf{9aT4|04+1GRVnI8Ioy8 z7X~nv8O&oL%Xyy7yqfNS`a=%$6+iMjS4pUC^OK(vRK$Jepnh1k- zPw^a^d7XFpm}C6Nd9D&u$5EE-6eF3&+{PUYWH=L;LHIt!LLOrkYuU(7_VNLrahy|} z$Ia#-3q>ePWvWw;rnIIjeHq4B!rae79%n5t*VX^q1aI;w$M}(7xlBww=Oyw`jPg{a zJ}v3a0LC$uSvBvzWy&ONTw03=tvI+F@f1EU@AC;?@I60siG+p* z7kMd4d8*Qw)^y?yhNc^>p3E%54=5gG6>E8k?d;(_4)GaZ@jd7Go$F+7WJFVpiqxbj z?bCHv4`B?`n8zYku$C7Z>HkfFS9y~U_>}KC&)4vVm9G+c<131&8>8Z#c z-$xKNf(gvw0haJM>)6EWyp!&z`YeBvM&_2z9TcGqRj5T{+HxB`7{Cz5aW4;s6;HC3 zE$rhHe&km!a*YhFj1%%ul+sk9I`wHr8*ZZ)qnOG(9_BGt@hmU%3cI*9mkCpwT!y=w!EgRU*KHlR~j&Xw1TqM4Ygn?32r3r25 zNnZvsk(taV(#C*UC3u-#yv-*Z+HRjEr$I?;=PjAROPS;7;nWg~m} zkRyD}kNn!!fVn8RMqE1`Pi~4*hDubUK22#yF9tG!dx`KQ&$5YKyu~4oa)$F(MWxmAH^s~3Uz5oC+_4fhX0pw+F>4K3Cnq&&FtoF4)Pf%I1_#IZ(QOU@wZt+@==^B z)S(5P>CWAZ;T{(91nbz$s~q4%KIePRaGpzCC!vddpWK9tDJoNwmh@lgyv;#A<7-ZGmh)WV8nN9RC&*1v z%5p2!sZR^q(UETS;%11t?I9_Lv$u!UXhPbwG@uoo=}A9^ zFp3FGXATQk$_k$1xgPp|qhJSnd5=#y#tF{w8yC4oLQe}pUW!wW8Z@Fcx6zY+3}z&g znaO=T%ww!#9UFS;|5pUB@eT($!q*PP_1n_QG?cu^zhV;?0a1u0Dm^=U;H`Z74I z7{w%J@gPfC&Qm<=>i*2Fg1vmi=bYs{e-q!=H<5z^RG=#LX+;eP4V?#8ve2`x1{atDJL$rR?YnAN<*8@$J1zT$g+;cqexFq9}pIqK4sPV`|o zGYLPeSjmfQ>)FJ1cJnp|IdPZm ze^&4te{qetyX|>orvT-tOMCh=lu6vrVwUkd8`!}pp%7)MLTwt+ireTx9|kdk$;{?Kma~qnyw2Nv7*-tR1n0Ow8kvU~sg$B3)o4g_ zI?$c|3}XUe=J61Z@&wPanVsz81HRx}PVpPzi;8Q+4YzxchjJuSj}~;I7pY8UE=yU> z3+!M&hxmpwoab-Sh#%qDK~C~hluA?^q5ta&n$VW63}75nxtE7o&eLpSFYl!LNc|OO zxX4vvN7@6(Lurz!MH5=3>#iQmq>=i6p5QT7v5pPA!t1=vAwK6@&hZy%WE^EYP>4#@ zpegORlc9`bDzmtsg*?J4o@GN=v4vgi=Y2lqOOA7jpZSx22uAy2ZXq8vW!(c#};<; z9-r_H=lGq!3C6h+FwXePDkwxLDpHj?G^QOr=*uuBGMk00WGyeVjW;;JK|bd=r}&*K z#EjQ-WFrrSDLvl!t0JgRD{f~XqnXSs9w5Rh*0Y(N?BzWU^A+E7h6`LHVS)oB`6)^{ zDpQjtbf8CAF@T|rV+M1W&ob8W3UBf`r}&Laq>*8w-I_v_q7v1qM-$p`8$IdAAVxBg z>4fJh9%KnCSjQ%IvY&VPgfBVCPh8+1LX#vqWTyb7sX|Q}(w5ul%@9U2nK1XWXp;V4 zAy~r(UST)ya)>WD&S`$*BG-wZY}1mD;*=$Y`m~}8J?Y0_MlzXud6?y_Wy@s!|GMBU z4)Pf%IKz1^6HKw0$x2R&P>!lJpbfXvn}G~x0yDXvg*?WStmQ?vu#*E}#m9WZ5B$Uh zt`Ixbd5G-fyD56x`Ng7I<)}tITF{L?3}rlF=ChP1S{4>Kw&Tx;zD#fWnO`6gczi4va=@T&nG=?&k z8Qkl|^ydpUKcu~k)x5x~9N-XNaf;swX4*9y#d6cJl zj*aYKH*a&0!+ga_&hi_Vuqy`{$VMTe&q5_rH*88XLG)Uq|1c-$NA$QG-7NRBkY%i5 zJv-UYCmiQjt`j%QP$4%3DNQoAMh#Pa+V8RC(~?e zKt4)vD>bQ4JGwG}@!Z3`Jiro`vzq7G%q|XaD6II5uQ|!jT;MvH=Gei>OEJn)odz_c z9bLGC{tRV0_pyi-tYs7XIml7I;}$nO4O$f-MEXvzxa$#OEC6EPrq{tjKV`%};(xQi*CbpaZ=b$s}fQFAG@0O4hQO9qi^U4swKJ zoZuW6xkloAX$~a`*Hkp8I|CWbWbR>Zx(C&d@&r$(+o0aTo4m)DoZ)YR2YdIze{TR#`=CFt-*}x9o=TnaJGgryHz}`V2%8*RGbWPQr>BSI6Go3l< z7N{dUxj_G~7i{MMhxw8p`Gdbnc+i?qfYMZ@F`c-B0gPZWb6CI=JjcuIU_T%66{q-} zYs7^gvYU{X(o~`r&FD;T1~QTfOyeOUJi)VU=5-G60Y^B-_nhSq(#ZI*9|{zvJT(Z{ zS2Uv?UFpX#CNr01Jj07@=2iCbE}!uYKc@Rt{TIPPhvWYxr?>zmsYYX3(Pg3j?;{w( z1ZJ~{6+Dyf1@%^5=PeF#l<)Y7zX%rDi%235g(yohb!bc*I@6v03}N&l{Xazz<^dkz z3D&ZS9qi{IU-BcraEaK(1|hjAND0c5LS35BhA#AGFe9134DO8zD;DrbRL0=Kq?Lj- zY+xt*Imi*d;s<`?B8f}v0_39vw^D~@w52mW=))jJFp-(eXXz5#|4G4GUSun~*dNU< z-uXoI1HbSmSIDqbLPjyllT0mI(UZFw#Z+dqfCx|V0^8WjI~*eXh2l78xxjVeBYs7b zo03$e5iRIUABHl48QjNGR`DX+*~dY?S>OX4ywGecmJAE0qNp z>`G@2a!`O0RG=F5XhwUw(T`zFAPGlEaExw4goR>C14&Go3js zU@0qjiWhm6eZ0pP9Oo>*bDhjj+hP=?95rY{CwkD2@KD7>?qME_d6E~|#e00t5B$MD zgw{ww$VPsOQidwjp((BDNH_X0kl~DHDzmtMjsAaBu!fE7<5N!X6PJm9#-2fGs?mhj zbmk83Vg%!u#RDwm8D8WScJnbm@E3_|Z5c|h4LfiO>d}%e^kX>Vn96-T!ZU1TFCTG~ z6P)2UE|Er-b;c7#sYGpB(3L@qXFBtv!ios%c!}3}pN~1tIWCY!!n5{Wa#4`-BvYHl zw4e*U7{(;-Wf{+~iQT-<7yL;0SH%@FK4;&hG|4okJ$Epe@l54@9%CJ^u$Pbck{|e) zzqm@=dRv166sH_js81WZtk?hj1f!V7JRasT*6|YC*uzJB&bOTAcm5&%d0U0t6r~K+ zX+~RaqZfBEjyWu04O^bq|8EP9@Ezy4Lgp8wo>U;2S~R3J9qCSQ1~QDXOd-rXB0SF1 zyu>!%;9U;!B|q|0^aB^UPSzLY78Iuf$<(Deo#?{|X0U)2JkKU}vWK@h$PvEc2mT<~ zV8m0HiqxSU;l7HI+{67uc!~||;zPdTSN-K#VlhL zFR+EzUef<>3l4IGuQ|neE)(;zGb1@ELRqR%n})REHu{jt7^X6d2YH02c%B{X;}A#r zfnQ$M|Ca>O|CB2;xhP0^s!@+-w5J<)F^Y+Vxt}GhWE~rMm3KMJNq*xB@tbTta#NJ@ zR0}H_(w5ul!$3wemDw!h30~$^-sB^Wahkt~-)!M2MmZ|ekQQ{JJN-yy0`qv3@Ux1Y z?BO7v^DU?NovUQnq6;WYC92b$cJ$&dhBKDQ%w#T)u!i+)WG5eRgm3w2i~heLNF&Qu zClkt1gI3(Z2&S`u$9R(Gc$sbN=4}q~1;;tVUj(n%c_>N>^=U;H`ZAoU%;6y(V-=fuBdj>Y7o6mGu99K9 z?3SXGCYic4rz3Z8H^Ujv4DKhwYBsTt!<^y*X=L4D08)f9gsUj((UMMdr!PYp%Um90 zDJxjR2DY<@clns3oZt-Sxk{#;x|E`nqbhZ1Oh>xyj2{05Lzut}=JFsBRUn(x0J>WhVEr@Kyc4LhvlF@Ft&foL{&?>@I6UcJfn# za#W!f4QWev?q)1g2y;J+(mkR6Kc(GyTvX-$!13ohGr)j=!;S(nh%BP$;BJaSZs3yO zzRLiEj1Duz3pG2 z_!a7Xat%>PL^^WN6Zsg5QJ9KKcrXhOzEAl-O5zE;fQ|SYcH8L?H7UNm0!3Mm6?bw4u_!8ga zGOokCht)&GAsspBjRK6sR5;g;Gj(bs$d033)c&>rXOL!gIuoEBQGn~Rt_ydLynV=vZ>F9w%jKWmR zKn><#0T!bX8mq7Yo3RTA@EN{A!w+mO-SG?iTQGk_2Lvm!kb~YRz-UZ{167!fhtP-@ zu?gGp!5yEn{}Lzh1Fqmt1npxm+DG|EldvKK9nc2@FchOO0cEJg{dgElu^Jn(8Smjk z9KvV#7H4n)zu*Rf_ETI)MHdXfJ^LyDu_Wx6fqPMh`B;W$@e*FgX1tHRID}(3jf=Q~ z>j*eNPltF|k%`Xeg#j3j377^i9%x|mC{|%3-oke5`Y-!PAI2B>24`>qSMVEdA?P5r z9x-Tz40J$O^uZt$V**Oyf)@?5*(}22cnYhq7O!J7-o+jq#8Di_5BLec;s!zvQC|=T zD>7k258RER7=iJy!-*QqK1BJ?C$R*}@ibn*t9T23?7{&Y!%3XQCHxCF5b!Y-2?qdW3Z zh!Gfv5=?^!v#|in@C?>qeFK}fu?@R%2w&kGuHX+CKA}k>3JFL>J9I%V`e7(0V;X9) z7*AsZ-oke5!Ke5d-{U7VTw`PUlq^IGWS|TBVi1O7G^U~w)u_WfJd8#>gVk7%H?b8T z-~f)`Tb#v@_!s^}@Db|F5z4;>i4)Uu7Y||yR^U0T#a8UZL41od z_zBl=69GqggNQ*Zq@x46G=2P_H;Dl#Mk!pFi3Ti2Bc8#F*o^Jii%)O@XYnJh;ZFp9 zMo}RVspy1!6k`JHsKz`jZD8{}HeoZ~#eRH=?{E&6@jGt8{P|y^*e4(z9ncf~QH;qb zL+u?6>=)w+ti>kyu?r0c*nEz!@jWi#SKLC#7qn@l!iGK=iV1MSi+U`?ay*BZ@Fuon zFFwUdT*Ng59iu1^jpSphpR$q2MFB=(GRojWEgJrdy8UQ+rs;9#28j*+cg*5y*3ej6 zRr*)>*Y^y>bTEagI7hsaG!&Lse<5&tB$n6T#KxAngfNLCsW3 zZPk-P42UbiZm-W?Gs97CuOw1xg`Rn}> z0_AU_mbD292&4TO0u!iGhTw3OS6emBF;J}4^?`h*{&tL6uRa3cN=C}%`wYsYn<#N z19R984^|VDbdw^Y!MYp;7K`g1Ay9f@waZcGQ3k6r?bSD9q(#GEV}6Cb+`e5R%VQZr zo2yuLx63iZ8>wtAhqr&2A%?oF0z*{bbh-~UfFNTIB6nTjPa}o|6jd|@m3=_TcY!im zSu5;ch37dcT=qa_5VDNZ@XU1j${YpCQg$V(gnTb^R9{tcP#M-V1vfRd;a6I*5))h> zrA`D`EA8j?=2%Hf_&!wTGqIHcZlA+tR;#@P-z{s32wTxc{}L{}v@7D#cU1 zP1LAB#p#|1wAFcPI&<|JVq9cUdz7VaNQ~9x{5dqG+I~4Q($Ow5zue<>EVMK_UDfq= zuh;HQ6-)K1;9ZXD%5o>QsFbHxNQu{8L!8@_(GiZ-qWTzAuCnOsaS}P)5u~WF-HZ{{ zv7zd;rLm0st#>z-daR{xM`-IA&TmhDGjkfBb^nVn)0fqLI@AHy6xLcYNNV)n#*1nqVk+> zUrk}CwZ>Uwkjs$--bwS+1k>tOebZXx%G zL;s_NSS3&gwUkzJLZ`Qs(q3PMSu30&v0EJ#6bbFr<(ye>F}xwgrM1;dv69#6FA`-ytf7^uk_!eQI~?~!8a^@^2rBWW?wBMU!mcD4 z^37JaFM$fQPESvgwyj=>F|}0l$eC(qm2=k401j_VO$v-q#!#jX`mH1xF866pCaHT& z;)oiD%TpJqimUC8a?kY$m946)9CeNguk*QB^?jJ+m`m(6vxtH{GbzIRi_ykmTk6rR z#1;}3#gU1urh@d+RuXS{Aj+6(u(>@|XH`yxw>C}tTS=N@Tdc+H3Tm`hIbFV{rn-SX zI7SsP!;X$9Cm1w`@GE081~rveO&IK_LJfgR;-f?bsZ=g^OilMM-7E8E)|c65&9cwD zU^JvKu(cwS)N|1?M5R>tKGFHf(nG$|vy!EgT+^>7OPlrwTdKiL|2aO`!mT)sqr}im z6%h%#+H)(p$j#3CZAi&12f-EVHtQS7LL3X--zpBt)~{G4D|TG0r93{2`>$Ail?i6q zV7573Wf%2Dt8@!L-lC*xmecLF=LA@4Q*?(EnHoO2wWT76kBUo>)#vG=SEfi}!_}mm zQcuOHL`x;%K)NNUCsXoW_A2kdD2qL-*>XA<`@OaHs(Px(H%Xn#oUUN{2v^(42wzU5 zsX*Dv?7m}>*0Rc>iII-Qp$tKRv5KblWI|4r(;cMp>gjWW6@B#EMztw{BUL!uPGYTF zD%QmrQ>mlfT1$BEUlU4sO}o7&QAK%&DZ|KAiDvXv60D4;l_86z+ZeS%86Aw8i6;7l zl|&Lh94*}#G4;IG(o%Bu%GNSCs$D95XeY08T4{({6q-}!tlp-twU)c3qwbX|neE56 zl)Z6`eKtqA!;&DGLO)RMc_Xpuw*_tEjUS8EQD!j{*39Cl)=N`mqzu<*Qe}>Kbx9jp zBoX>T8yT0-In`3OHOb;hV)$~`rR32sxa&iS&@7$xq%`R%2K`i;%oCT6OP6Fhue+y9 z->%-oRIhJsyw&a+B`Q1BRFXiY61NHrc z%t@(v_tnpIzMIzk>BI=`l5Z=wyPqKshK1+UO>_L7N^?`=%&JoVJ6&2u4Nm61Y9SXA zbG$yMGu&`*s1)jU8PcQKXUWx`Iy-}6b)0r*h&3v?jf6K1u*x7d8d7zhzeH4GizOT_fq|F zTWKvD_2srQUS89MS&|hxHzUvMDRoR%mdc5`Axjcuv|gDdEo7(Ok|lHHbKSX}jF8v$ zL+#|aBS}(x~t0D9L>bdm18wqN^7&JGhXc2Buic9Xr~K zxu@FHo+$&b8RMX?PnC4L&%&aRp_wtedWOBa+U|44#mIO1wT@B{ccYWFygpoHXoz}Q zWjWkLz1%`LNZrgvj`Y(RHYul5c+|!zZ`7M?(kpso7fE8uk*dZ7sVuXl{EH-&qi@(G zk@wUxhpuRx9+@N4Os{uRX8nE+8K0m}=P15^l#nds_fPmyGue)i@R;EGEbgAvf0XH@-Abuqy}*rsy{MymZ0ll)U3>?Mb&Q&07l`Q%KCT*;2zmuIt= z`C9j^c2#*QYF#sD2U=@gK0PT{;;CV^xzw=jdUdXxrgY}_kty=CKHWzKx5yuCsXAv> zOT%q7r8Uepz2WLdmE!cC(f#|%Bw3@^^p#$+)qk?D^p}`zqschqM=I4xxd*(jj4bQs z=x+J4M#lJ$=S#83*E*{o`!0G;KN%)(=!5;FAhFd1wLdfi_%TJ^N~fplt^T$;hdVc3y#DF^#b_|x8m2u1Whrg&)>jC?);ego6erF1?ENsrYT5((5_jPP9Q@EI8N|UR$#Hw|17JFyizL+*ytbN6D z%@kIn>iyLtWVu07{l?L>V#(9FW8?!#)wjlQUf2As$4Y}i7U>tq%geG=7fz557Cj6WUxG{Cr{!4#ad6I_3hBxCeh2q>+6%`qO|j$n=D&|7P@LGd8G9A zsnSm#*EgriKjoOdQX<>rP5p{pk|aj&x63%0>rW|_D3RX&u4OX9)P|18`J zU*MA{gZ$vvGbO?xkLitd^0cJsyX$EO59_LWc|o%LVY9?8a>DPKO%chndd(auiQW9V zEK>bEHLm*J%35tNTO|LqO0Yj}t~8gXvc8`aO!P0gUvdnxNAH*?ABtTsctG~?szc_> z+eVq`zqwFu8u{iMi)F|}E}Z|m68_JnFkjAF9HSOQF7MIbc(=0Vg%r%I95{W**u~@0 zr(S$I@2qm}JC(a#Q-03Ovu9Ai3JBL#}^qNQHffS4N z*=Iz>94Jzz>ZTX#%VNVgWlFNdtB@Wl>Pm_3w}d&hSv!}|0Iuj|OXMMXm-t7eGH70a zAyWm$>xUl|Z{+?UWg@7wS;ZL4LdtZ?ANrW|H{}0+Pjt0jwv_He`M+E$S;nH0J-y7< zTb;TVrTvlF-|)mUYg&~I+Ars`8sm%GPUKJZ8;hJOI@7Fz^Ho~sU5w8qix%}Oc<_JU zH)C|uLkk2Lzzk> z@VpAiR3@8BRwXK&Y%}DkK;CeC)4NYI6mco3+pLhns2+w;t1?(rV52hKK4@U2p0`5U zHQ!}Sz7TH=G!&@tB9oy+Z(kvOWWWAng`^}`n&LQQ(`#-}Nhgjd)1uo~>U9B0Z3@U& z-SbI$);Il6Jt?ng;G3J0oChdG#!1z3saz(u%v4V&=}w&MT};$s}fC-@5giT(8h=^ybE ze#URYLgMcvZbA&K&B2Nkq@oSd&=%R~jvmMbO8~cne~n>37Sk~UE>yt_ALe5*9>EeU z!+LDM#s)U8U?+CrLmb1GIEB;r9%pbKS8xqYvAzP03=arHb3~yj##KD5XoC*OL09y| z02E>{MxbE~o3R*&@tAYjK>5_MmZ`l177$7RH>>Z zF%xq!AIq>DPh%xkVKvrbJzm9Y*o-ZBA3L!NyRi@ZaTuTAsBU~gGMqn?{1^Vfzi|UM zVdQ$ugkVG<67gt>B(y>@Qqcx!NJj?RqA3_~AM`~(4Aj=u64$^&j+%%`n2afyiV~E< zfeK7RC92>BtGQ|x?#Ba|j|F%T3$X-`;xRPhNvy;gyoi_ZPM}Ix?~&Mn53n11uos8% z2|mS9{q1VW2sladk~XiAjE3JyUc;Zb4pR_aD54OJ7_>wJl3_(EI>Lr7=z(1H!$1r| z0Y+dXMxiNq+C)skWN@{od_gp`S`xD{2XiqG4`LA(;}I;uXLD z{I716+V{0!YP`OviCjGG!05A(aXpZ)6#=Ep3yDHC%7X3EOfswquhe)~Cc u|KzP(3vVEKNdgHFYJkvt$4cl$6cD6X)&KzlX(j;yR{<5of^ERq#e%(I zRMfSAy|-1@zV_}auI}3RPVoDF-*=zq-aqbh-{;9N^~{;m=FFMl!Y=~VonxZ zN>9v6m_$#^A>2UH^fUN35+unsgCy^PIDY``HOYoM5JmTf-6)D)2w7+eJ-~JdJw1+C zOixb{_2Psv2@Dlwfb{3}=sw*IUP1&h1_}+u#9bO58%O5Ci)aby0xuf&lb$r|Pk&-s zcZc$hyAR>*G3}%EJ@mKv6MJGV8FN6xh@#h@BG^m-0-nMkX4z)jMi_*8Ed+2bVlur3 z%_YIt>%?^?=>B{M+LHARIz|S)ehQlV^Ker7FMIJtRnyG^4N0_(Is_LYmE|zF z2OYBP57p?4Whu9e>GzpjiWvzK7`F8K569Lc9eWZtg9Nt0w)D5H1kR0(-~tkvaFp<) zLBkP1jAsjX4fH}GR?jgB9judRe|sRQ^$C+@{Y5B{H`8R!-A(8K&(=gO1n4@iz;|oz zFSXyyBQ{^}EIzY%;LHgB5xXjG?5_O6SB~1NeSU4%1RK?u0~0>|_2J8JXf)s6Iphgi z6s|G_#t$>)^AyP2n)E*!@Xes-e}{GOI~gmNGFZfR7mcb|rckLhGKL>nsZ#~VLqB?) zL=D-vN%kcvRLAMijhxhDiy*h zu#p`n(W+G`g@mQMv_w)Q)oEmMDLhM9l5&+ssDMoCVmFPdS|%qFY;gyE=rVJREl~w80(@@|9(&OpP6AsaQOb&W32d!YF4J=C={gCV z4g{mp}f3TI~lqCt~_aEyZ5e zWte&rMNbD)R-}?Q`amnXPI})Qy|s5T>pUhD246aicn&V6aU^jzLWcS~#KVuM-htbzo5-7UT*g}#B3njz-2kml`8)_ zMlMhZEVvEf4(TeTRH>CI1@F<{E>1ATz!#cBNFkwX6g-X!ToX7N?m2(!45?Bl)7DHR z*wi(&-POU|%!+tI$`lgrJ9N!89NS5zn~J^AIw78}QFY#8vnX&-3QJ>&)iS2`q?w$#7e@NE|>BJXuoJMjqYIhCeqNbnNWN6 z|KBWa6Ulo)4B-X!8QLjy^wekhplpdk%fe1;5IR)LrJBwR3g{%0I!+g%_sbfyDXb$$}`p1r$BcH0FKh$$3aWn`yCCM ze18XVa+(HdfRLgUes*<-y>BPH_?B)=njY9U#xu{{j@;4 zb=T9|+Vi_kILx{f{nSBwey{Cn?G{GQqt?cZscdsvBZ!~3CcBf#rNL-(^Azq(Hap>@ zH2|@s``m?%Y(XIXQkV%}$uSlIz}(;hjJUQ-wQQvuOU(E2(Unur&nG z#0%X6>}Yt2AZCrVJ1f~GpKeRi-6z`?)n_$l@XYmNylbIkC`!RRbe=7P#Uau1N6(sf3>>hhc#sSb(^2Z!$hUI3XAE zK|JR+n|~;z*=3rh?&Oz_B1h#p0C6#@3i; z(-1q@ja4S92GOELrEoLAr;Q#7^9)fzTgs zD%^LljM)K_&--Qz0Lfgh#+9Xj!-#{(-27 z5-|ZjK;DtTa3~rX`IE`_?=FS|k;iDXGiHXV{W_t=ztzeiVgZU7FnD0mil|55 z21iW&TlygE^t-Fy-|s$P^DX{hE8^6J7}nM9j(B$E;j<&t{d4yveYxQIa{Tw-tsy6I z*PGjtN3qP+`v=hf8=`(wDoj93G5h}ytRY{VXP*7UlDF2V{xyuw9AqW(n>AwnT>rLY3}Sa82;Qn?abp$^gD$;AytPbnwd|IsDGv|-MJ>u|OXc+G7WPc?@@x|2*-0Jz???Ic*8INM1) z!(GPhNQH*$lIL6xuqe#?#?cK{c*uZ>G+yczudEKRuwRE+j!({}yj?WVebpCiFFduF z0ANeOZsq;cIq=@wiTkR0Up%$|^*;@*C#)i7mAGQ;Z|Cpy zukHmWO~6>EfdIUK?L}{#4*vZ4uU?ajMjH(yuity)++7aDQbF!Ny|aOhwAm4y8rT;Npe==sIiO6&ok+Z_PU%(dBj zx!}wK3|jq(TQX!(s0_2{o+N!qR+A&*b<0U#DYB33k@{>;Kq6O4N(0C=ypTf*Rv zDh101)|omMye|W5(v}Qr5rFzD8*>e&MCbqj)+k?p4u5rhN9nIy6<;DC4^<6|7(4c<<;+5j zO2G+f=%Sa^zyYw6Ua6$gnOqg=RamK$6seTh?Ug_FW8#vE#cm9=v!qul#AXTcJ=d+3 zTAf5w!ELc2izQ_O4b!?rs=!s;{%mGxjZ#(D;42=+m02(~l|?#=W_xZ8T`3Xzff}L& z6j8fK?juf1n;j>M3mVsjxP#|6>7`QPCHRW2uE7rDVe2A^1|J2)b#|jz9LYGi!p^N@ zqHr@CS63=lj+2$)4$2}~F<-)<23r9YKhIoT=TP*oBLct6s?LrQ?XBCgJw#KXi(sK;C;cD=Ns9BX`vP?l(9H|P>MQNu_h zi{vWqG%hG2%;`nN4avmB1}mVXE?Cl4mE2w{4$noVP*-YXx|*Vun>akCLZwtex}Siu zL7&F-tBa*1E0{*NANGSyy!Eh}UaX-wR*W&A1X6Uh7P{Nn^8#R{olW?7hM2$092CI` z3=SiJt}bI)N~o1zjR>+VfQ)59O(cy4*a0djQx=PfF@%5cHJI8d8^?H0`2(8wQe{QGC{HTKZJ#yt5Y-&+A!tP3N2q_!Jz0`tzZz7Vadc!nFQ0B z$`l4aBQ`f$^4$4%nS`ZXB|d5CavZ4T44!~lB2h}YdL9!aA?Kgu7?BZv5SBm-dXY4{ug zVa|QcW>(%LnNA=Xqp>w1SdzMO)YvvSO8-ui*eW6=MrzjOV0WqM<(8 z3Ad0~J~DrS5BW3!RxANsrKHB9bV*cQ6q8DDAcCNRRH=1v8axeD)N+pW5?!UCb}|xX z0#!p+!f>jMl5OX1V9{0D1O?PF)e^akO5sYJ>1ql0rT|F!`|QYKl~#10n`gs6%d%G2 zNVHmss8!g7MdJQihB+vv!Uf#z=A>4l6ps>`*lHyjol5Ji;(xQiCorX04kWLmfi|U= z@T3SXTmk3NwK8uX208BM+y@3vNaIiX0Os2)NIf zL=vgel`%9diY`-fXEW_6EN+DwZUl#Cwf74?##3`BILWBIjbz9)2=n=CSpFrXPNt;h zv+XDha9L4&|C<(4Pr5`w$@xIqXb;OlF+YS4EvSR`q6-YxO2CR25o0JiHY~YDDXZmwwk74Vs)#%rqsmO5 zZCz4Wsg`QEJ2>eg9w&GogG;ZK2o5+HC7kD$;6&3!4i8Oi>{V& z2P26znkjLDz1U3jHg2PQ&|0aNlirew<$8}`N~)!5{%9+zm`UQGMrJEy?mA38MX#hH zw{|YQSW4|-k*ew%YK}QuC#jYxxY;(aiU=ky@UtAKuPCe}f=1dPd5K@$9iCvHfL$zA zR!O*{EJ&ra2%9#17Oddk5U{nCYRt#S)JFRaLTriv11N}n^g=0h!=|IhXdD!L5f7TP zrAi!{;m>8;S$dlgY@m~j5Ns96Mq=%3cBR*-meU8rFdUXpRr4qk$4@8+8^r(y zg=|Vk!Vsjz=__=hG!O^5{wcK)H29=+F$N1LbBf`LV<+5ZQlcjuAcs1Sg35gDp)1oE zA`v7y(IraiG6M@z<0DuDs;O2~RpvK%ojcI*JQ!ij5=@QOCtz`oD zm zqZ!oekJwN&@%SC+f^49*ojabbKZ#=+PQ$s>KQ4HtD&$h`3Vl#qxd*I6<>g+?Cg0%G z1gmW<&~f*o<>dq2U;Ft#VA*iT3t$k#BfT-g9Rzo?-0jZ7F#cr=>Sq#2xtGvC4UI$$SEqcT}!wMxm&MvWCNIH0+%gBpOQD|}!q+Np5Ip3Dt}mvd$SCGxbDC`zPCS%o0gip8a> zg$x}faG)znsBOqa=}IF5QM@wH^Oif8=T5{*_H5|K@TPv{aC;&G*x>Ov(Q6(*WEcn^ zM&gZtKL9OOdN5{%umb5d)qEFpN@>sD5iD*dEHQ7m1BBQSIfULTec?;wq7vdjZ>(y7 ztE&hos6j&U?~aySMRA+T3=zsUhDYRr=bmh-MkkZ=A26v3bYC?HPDd{4VjS{qRC_@uv{gMAa?u~^cxJwr z=+B-2)-Xm8^)nhYuEruXkgUQ{G_5c7CptW?AJn05<2+$85^35zHb#>&otAMGvLs)G z=QvD0$9v^jI*u4!cP5xzPjgaIRKr!Gdm0yb3PG)#=>#vK2~~`Iv;x;JkuX&d!@&lA zxTjOJGj%iyIxy-9OF?r4Q>iMHQ{z#IHpu);Fg!<&uc@LWs9oyqD1IT-Fk-IX4U zrvY@G4BMvP(VNNyEMMVO-mFK_IOeJ=OIQPgTo0g%s$p;#`lV{L>-sQg4r-w_7uZuP z>>!I>RVl~nJSd(zYYBOn6QfbT@y+l%Ix;>QCZTWRBkeW)I3)zN;q`rArwcLAhF&6N zB*RVAHe10AG^~0&j+LIMehp`!T{R-B)zS1aDfhJ-hig4vrc`77&Oongu29Y~#P3*3 z{F7iCWs-m{)Y{TaQ_=HU35|$BLna*MgLFbbR>@Vu8lXzZwxc=*vMjl8kjKwH=3mp{ z1BN;46U9LVKl?_*p~Pf>9litu-l}^C!pra#!NOkZbqj(?coG6^GYex+30O=}i-Y|N z8I-~Y)TTiGR&?-Zg;mrLdS$T_GlMcP1qMF7sFJ#h22B)U2`ZjA3vy8JL@NvRAVHHA zSu88`Nkf*CY;4aD;@%6ju8^qJ5*?Qs$PY^*egkUiS2Spn82X|5Ne8*qFyYY+HFQ-q zH<%LILnd}wGV1tNc0&lJq5;~77B`gI;Vr9(T8e7w2GdMa(7rk`jhTSH)n&mID5L%$ ze`j)fA>Kvc)rN=nn?NylTMp*N9OT{*2M3_ChGfp)ak3hC4is|jVhC?>AvF^9Gz8(8 z=evf1IQ$VbIUjbS8Ixo1{l}TfZqR_Y zC~E@Fh0n-x>BMn zm+^f^Q|Ak~h9bcP2GzD+KS%`81AtOyPMifw?y&KVGjOF^&Od=ztx8yrer_GZAtpczL0dnjPKur8ZPEN+ z(92d4EJvKSLbw{~+T5TmTG&nva#AGFUZ07Sj!hUhOMsQQtsTvgRlznf2rmB zGN`Xiy#M;R0|h)zmrJ?zDccb5Cvj+~75_Z}a5sf?Q8;$$|HU50OPiun~txMB{z zndn@R0Nl~ z3UzKAfPH{JHumD1lzW@P@f`<$b2Q#wGB&rvW2kqtD>rp5_j)M45h{^LRA!You(#boBTSVf0>rw(07Sgj+_%4NpP2z*DgK&Xi<(^ImZ=>P+IR`kBR8lFXpo;nzYUiX~FbL}}CM}z0lx5GE#T6F!$ zZm2TMIr_5+yk=mYyhOvKynA{pbThP^`3B)D!_0Fm2piF&^Et4~@aB9Pgey`1i_3BJ z_U6UKIG$U1X(JqMaJf9p1RgS|ukL{`#^C+iB?!l$FV`K&&yR(VSr*)L$oWPk#=Px@ zlE!+5h@18DC}W^aA=Aiejn_@m$^kh1QfSs!S7odtvHMj+SO6(xIw++o9X|icp&Rz( zD>(sjrK(C&p^|fOcV#6Ga4033QsZ@$QYKMCU$$DJ)TkJ-4r+-8$AFYl^ya1w$;Q?| zB4^Yi_N^(f0=3>+jRVe6x5v<=Y{SCaOCfDbjv?yq1#|cUkv`sr6{gTN`4`$(igRRQooFh-Xgc(9pKGHhy!3A+a%}t)2Vo;)SzN zLr7NB={!5X)zYaz-y1SE@$6i?&?zNXm`gac*lzUhtrt-*$aJG4=U#8yT|E)8F}KwA zDih^V*52UAXNh;V+mFYMV|xSL*E=k5qff18tD}RGo?LWTGDWMSF7!snBt2t0uAZW6 z#hxb(8G56M(?vCSNxi*F=yW-C)O58ib@YB)_xwE9v>8*zMNuau3ogztC`_Aw1Wo)? z&WK;}3bEO=Sb*OBnQvEOp3Z>b$JXAqUOIoc?)1?6-UE-V``XF|sQCSQ)5!%{X=H|h z`+`pmAP9k99`bm_00ZXfce7 z8cIGhRQ;`l#P_HFOazrh6#*lT2`z?O+baB~#~w{j#UMy6AW~t|r;C zu^wY**#F4}nm%`5xrRL#-T3V4=lRY32x!H0CR1Z&UYw3q#jUfsS*fWZGLK7Z78j$| z%UOk~>8HF0c3{*!zr^{@A9FLUkBJAb=)Ye6i8iDmC5Yv5IC~-US4r%U=_$ef9>=dN zbojN%9HO=_QNE|v-ms>X4Oi?)?_xwg_PDciN%e5myYxehsK)wx?n|4j#`z3A{ya*! zjy>1#@k<`GS$2AOWBo8FI|q@zvr2zm8WlEUqq9?$I&mm?ipw}^<51aH@4gJX?Ts@ZLx5> z$B5HI^2sRadcU>}J93VnE?DF{LAu>uGs_*$$)X%>Z<*r!NH7?X&9i&IC+ zwoKErXi(%3*Rme7Amhrco0)OtDd`*h!`EKBvh?QgDdj>J{ZJa5PA!r3R|vtbj@`em zy&2oBe@ugZE_)m!+na9BU!obQJiBFYbk|cpt$m~pDSvI*mlOGtPtymRz(%jMaXta` z%~AZ{9*i1=l`N1tek{r^@?qI1EH07MiN{fnT@R~Ak zm<~ft`=#bSkFD2N)8PoN^u(*!7=yOz0(CQ?zbx`~EYRPhLm%RgKkhUDy(IxXgpLEI z+R(Vm509*7Zo417f0|jZ>++*Zs;##@$lpKH2CIO61OW%omp}b;sD1$f6~wT&tb<5T znnE#g;&Z|8r}RTjVKk92__+;DKg$$)64#u+^smwHF@+WG2V-oj-xanqmo|iLH@(?y z-)y37r*1b4*lzZ@+nJro{W>!k#ro+znxweMIw+2+ ze)mBC$_#pvD_uuT_1yL?SZ_~4KU1O4kVem8`g9UHI>(N=ZZT|m;Md0PAY1bzl4R!0 zmB9m=P6pZe9FbPPTd1E-;)B=wrr(3;^+%A6ek%!gcnwNeU;S>?s_dmRvO9eWj%{k@ z8CH$BJ!4d-Z|$*dB>%{&JcpUZy^q@T%?wyftezLPe80Yz0qq^j>{SncJJPZ@GxCqb zyVva}K2*_X_hd#ekE_w)ZPI@v_;`u)6B@?Ax9FYfro(osO)oWKk9n7-Ph`U3Uf$9UCfpt};`HhK6yJ)DE&JQ{gygceuhbH45y5i({9n)&{S{wBF5Q^-qOz1P0qS# zUM}8ti#Vpdk^YP1B6Fj->z3(b<(-x(wOwya@AfOJwo*N8+20mvS$_AteeIWam$0cb zE^<<1)7CQvuJj6P+;|Z$M4x5}-@uFd{%q(7U+CYaLB3wahFnwkam}Vv9rW!S7@)w_h~>T-%yOM~4T6`iJ*j z-M-e3?FT(+Z>_tg_k;M{wW@1g=0vcaGh27m%^9X7$A@s|w;px(6sM$S@8B-jc~lhGkTRq=#A@-CqaKkxDMNKT ztd_q&>N)rZV_5A2t9E*VS6!SiH4}_&UF{&gbvi+~}_ucV^^0u1(i|B4FISGozkm+5B>w z2&}nuX3WRSHiy0vK@A)xFpa}pXb)|x_E8qO7HaY0;?rAAFYjqVCcB{zb<{2?b-hhV_1z*j@s7^?ANXf( zWdU&Q*w(7OFGs(fq2K=`VO#Bumt#Jj)*t-q*tSWZUj76u7IvE^Zl7%TYAl(y@G$@Q z_NM4p686l6M?DfdXXL*sv^}%%c*OC}*|59F*(CpDd_>6nwzI{aarvjScZcA+ajC!d z#+kAF&_(BFm4Nkii_R&V3`?KOO9#AMbOF2#Z70&p;@k=@&8iAp16^dPBL%vzd;Ebv@4TtE8E~I9r}|jv-QKzS0gwIX)ST1a z{j=Sy{#lBu_R6NZw8<_HT z6KArAGz#6^dvxzSvBenn6uT?;Orx)hEhn+33hDJ^Qu1ML-Qu@Xy@sqb&pmmVzwd2h z(5#hA2XQ`TxIJ{6#8}MqSWgU6c#e7^d*e;}|cpVk~%PL~@Y4-S|MNS{~Bn|rO(wsVau?xY#tD8T!G3=3$vnV+M z_nk=xZuZYlCdG!#pTE>y``08ou<(5D;2>b@Hv@s!07{W2!=ue5_GuUM;%7aM8yD_NCZ_&v~n zJ}2`_&8fOo)?3ym1kSiLt6aCb&f)d?q`~Hw=g!!<+Uc8Dve2im+JWZ{5>qeFr**IK zOpvAKnAf-M*x3;<(R)ad&##Lv?_3*kz#FI+4`232>$-s-o)2pfWUr)nAl`pt<{aar zOaPM8H)iQiUs>C)?!$(RmW|o#Qm<|-_^>hW+{O`Ir>}0U<$<4wio9d}M(kLCLukft z>@~xx@Ga$|eMjDUajolc_*Ts_-_clM`o8s>M!%Wy+kT@^Tzom^)6LvN-+9{`c(2AX zM&=!H;&)EZ@dNxb*N^x6t8;FPU*C}AsvWIcHcRUQvCSD9VOV^}ueATm8y6-=>|EvO zFH5Vq`Rl5PT^mRH1fq*K*raP}SU3I_Q z{T5Jt#COcUyBPn@((eae+iEUYfcI;254@DBCfxZl=Hv0)gMW6YCcd8V)7K}thrT>k z)qTUbf3@j`{I~Tm<{r)dV>gIVPv-3(YZ`gI$FfO1RWv|io_qZ;*b~$gy7@j!yXT10 z_n_uDzXu$&=cvb^;2Fc~Hb3AQ_8bH1-kB1IBD)IZNYSPc$#;j|C4cZCgS%* zUu{o{`S0dVA64w;Y2%)t9Sgc}U-jNIW4?zh zJmU8x80|ejcCwZHBE zW7oDi)~m4=6RsZ(*xfnDjRlH5N8UJ7Qe}YmUX{l6zj=9i#I8+>*A>QROh3M^oJ9<6tv z$K5W7f+B77-%_BT74H3r#b0INv9%X^ym$eBJfsZL%Ts?ezO(1=u=3bH1-}aX%h+gq z6WL(7o5`P=%D)-zv2z>Ecet`V9?_Zzu-@bp}(IVCXcRowwU!!^KI8J)JJw`f2yrBQvjn}_Pg*N*3 zWJu~2L!h}4@D(%uK2wj@Go;7ylm7$w|8S^?F|KnDjenTtargr1QGWpgUas#Q0tazc zx$x&-pz(K{h92jiGdvDo(#NDjH~x-`Y|H@2MN^>iU=t zr8NDBVUXK3Is;bQn|F^6G=Aet%k{rkz=57ArBbn2oPd8~apu31`25h4z`(-Tuzyv? z7VG2Wa1#vcdLxG+Calu5^z8iV^xBk~VcD5od^Oa&*Zr$&a*7eiFk_M_P8W+a#>a`p z@nUhQSS%OgwgfRQ<0f1VGftZ#j>Y8)ef! zL$b)&VjTD{)N{o4#tLIwQgxLiH@w`~l$=o;7#Nxzt>3l)`qw37M+FA@7X2GiY?iT$ z_`e|amHW__KSd zwX87lU$DjbMlvRe@!ua`ig-juBxWlvWsc7=*7XhQquvif;m%^QgOTpy*jj0BcvYcN zt}8MQ5R0`&qLk^q^e}Mf2#jlBM6K_?)|#GZ>=4&S_5VmoY~Q${#-{w-R9TT?M2I9e zF-VddUD*dR#Yn3_ye@r08}u`a8*iK-PQOqOgX=J2Lu-ws3^EELh7kLIVMSUW_`Iz0 zypZCW!q5@p(=irt#$|@Y|BJK_`>-8bD2 z(%^ii5lJk1#^eX}`*LC`ot>7ST7bE z6-%6u*vE#9KC<_5_J1bCBr*2L&ox#Xf3bZ4`bdzTZKTtGiFlB)y{t%?T2)*VUNb~l zP+pvzT8k^ieee?!hv!s8=M7Vg2rEt+QCSosuPUr7SO13sSbXq`@!X|9W=-lts1KJs zqhuu{q@|Bn)eJ39uO3<}##W*tbXa_8SX_Bd+K3TZNkg(r(}vcT2E~;d+r%|POI6i4 z)Ebgro)C=31;;6dYV-4k*2a}5gy8zL^z!_g!1U}KT#=H7SJ+qaqg;`eA5vCUq)05s znAYI-;Gtp_URM|K#~HC+yBKDZVcGZ%GXD3{{{_`$ BUt<6O delta 14972 zcmbt*2UJtb7U)dK!4pUhNgx42OMp!1r_WC zu~+okd+!Ci*Q;Ljs@Hn&pK#y%@BQ`vT7UiZ&sv?7f(->5Q9J>D+^>X6pT;wm^`rw3Wh$uHuU&( zqAz|i3V?*5=rQSHB|RoaoDO0iEs=~JPHG0G){ zn`|1P2l`Gc~~XTzPqAwtCJ=U+;ONsZ94;a)1ypyq`}m} zIb|KYI~qOZ<#9KT*kAM0EOgVY&cd@xB4>Rbn}^c**0j5SA_d>hX?xPS#UUo3_rWyp znGAU=68@*?zUx}e{|nX zef>@7QhnS3c8s)4D`(`0Y?v`pZ2|8*i^Ei?3#Fb17{f_zg-TQj8*v|9nIrwoWD^>itoztwUfaJx0!<`uPKArH(i%XJp^~%8 z2qx*L(U#9;1p<}iAzh)ewSenGezvUuRX#thFrjJ`s(@oaBlQP`lAFvJd66byG2nZ; z@z{$mp*Vrajtk3KjzHHr$;Y0p(aZHxc{L#>6;hRSJ*pSj!2q;e-~YsT73{>$%QMx?F$SmW;2^irkW# z2^NX5p~f?a{>%!UqEPSwX&t>uJyZIpEyd-a4#$DawM=-5om8NeS8-#}JI5SYfD)Ws zI3rn-Xm;j%mMxm4aJ&HI+ z%Jm8nmm6e`=dP0KIf-t~BqPyz3+fhnxLo59bAe(#mt{{^YkX=M!+=Kc7pFeNK2@WZ zt91&s-~}=lIl=*5eMM#vLKNa0j%}sdIWA1jJ?~?cE?4Uny6TApn>uX?)MCOu9ZP?) zR4o+~%=8kuy4kaB1>_`u;}XwFg-XhOhF&>`z+*`0qG8Xnii@RdHJx`E!|0ka{yntP zC64x$kDj|6ff}^VRYZ2%5JDh#UX3oh_Jy_RhwDj}j~ydMq9&~9N;#i}E{O-x{`d|K|G(Jf2Yq;#h!mc0uUY=x1by$jB4U74r8C2JAfrN|)+q5R2?tlB=1a@u zYPpJt49>#RBiEN0Er?1-!A@ZnRx+ic5Z(03NU~1M!s;)TRm+rEh;*IZsHWFI2|2b#m!8P z=4a5k?d(8WlLWY$^@WV!sZr5n{d{&j+qJ>!6e%%l5;CSFduquHGfDeGZo22>%my~u zwh*$(qps4^Y&Kvxw+l0(Xs4aKql7}vF&mSG(Ni+5(0-pViwRu}ZO zg(bXHdYr`5M^r|S4`9s`{mPOtgC)^H#0!`kvOqMI zK|YntK#3$Ez<>b_CqPX0D0IfpYuGNxq{l`$IAbVr5jh~%b~yfR0I?BK^q2sJ8<`Li zAYH`E198;@Av3iBPh*>odli8shkOTf5W?%heSNCyn0T^aUKxmWz<(86P>O%w*j2<@ zc5HyZB%X0q>IozvHG%Bul~=xr}Irx;=>^o1@Vj*FpOp1F6Xs_+-5s^ zu!LvM49J!EXLHF^NrY!#5+krP4lX75jHR6uQ2ziI)<|&`h!8J64Ozq6GEixN5Dr1J z14Q_}B_IIKL_GmR>_2@1sct1CcJWR}LLclV42K6);~0fR2Um_#0>#hfW>4fRt>gkPr+1J1oCdzLdE~y#V$xspW2T)9>#64g0=^WWfRrS-1C37^Q+uv8 z;}=r^!a&cdHd&u}jsquw_ng>MZ0ESy_7DSaa!qdWSJ3d6`;gYy1s~|$R(-QKjX2Uo z)V28FS^(;>MH_iw0L)gmF#5Gcv`v&#i5GhGkvKl7-60 z*NoP6#lU(q@mQ<%nIL8PmC1dZH)L~60Py_^&aEqV z0dpN9C((_==Y!~(_DS1aJ+Hh=8N&s2$Ybb+5sW(dVBEH60wbv7+~Q!&rFYvp&Myr& zvP-!3!g5@GZKM#$83WR;m6ma%T>u^BwSqI+0+PtFr1 zvX7%b1gsgnbl@BTsJpgd zSQl$}I9Q{8^DX4{t?k8Ex2V2{LN!`6B#isxA<6skl%B%7lHR+)|FyO2(U4QD+S8+K z3jPTKq}__Xwroa#Et?krRGh&2b@Y;IH~_AqSE#9hOzs%cqo6`Bm1)$*E&iDU6PGkB zcB9bNf{tDPFL5D9PFtyUda1UQJIR_Xl$Ho&OsgWf3RiKx+05c4B^Ubw%wN&H)s)-^XqdG|Lbu7TF%DR6{@xZ#cCD8Db%p_&@vVX-P{B@SL z6wrvS+gh*^ZRAP~j#Fy2a5Y;dSL!v~e2OlUQ@^o@*f=eaaphJd9w?bj-QY5@FQyY` zTj5|uU8GfJ+m2=(AS?2W@6s-(9 z{(TD`i`&7*(`n&e#wEhsGn?Xai3Ly~DJRu>IrlroVV=IhG{$_?QJ&-rD5Bmm$YQCM zJDUTF%sf3Lo}{8cA!tV|siSF~fH31eKmk(AeusHvsl1dL$rW#Amnv{X%9n9~k_xZ^ z3dXObQmUnXwH0k9v20}Qhfnx_*a8h9plj4r2AU)duk~b7q4tD7RFRr8J)8#501Y*d zBfm`7XsLEa+$^A}&x{*NO{EmuxJy`cjV?|F^~^FU4t)A?rB3uRDfg@Z$oU&>$wG}z z{D_-m%|FPpDyx?2bW-s`(QYgRZ66qBppbGCaNEpCom4FuAu_SiNws>7&QrsGYmP%V zwL}S|Zz6y$={@02edfTGZ~l9R-y-5>XQRHT;M${hMIVnF_xi_k_Maw+k zN>nOyh*t`@x0yr&snM4(v@8n8v)o#yErkWFK+ARK@GSR!$C(1Ej)IenirYvAPJ?hb zznSGzMCui4YBJlF!T>MGV*8&pm%G!YDrzJj$Q$k8SWw7!;X`w3tDX2FgVhE&^RXmS zAyx$Cc#&a5l*4CyVlaV@TZK{!MGkkJ7@Oe?5{Js%1~!XH;yi@&Ba*JyLJR%`G^;R* zAHw6=Q6nw5ZI(Q45`)yri-;V4F?v+!Lblp84`on-*@!9k&ly6|u~8YuER`44@PD%* zm5R#HBx|FR%$RFcR8UbS*K${LQpG$@z&-|-ULzH3u{X*z&n3>0)N532mHY-rEdE6@ zsY)>0j>n>xDY*WqNglz>bcFA*VR+xTm9j%OQFfd+H667lj(*%;iPi zwHJ7TjRJO|TwN*UjxZ?4uXRsWaB? zM~vn`#pm;&8C$N#=^y@lwylMy3Bd+>X^vo}SdowQvD%qlqj6r(Vp+@>1cPznLsP}0 zNSt_~Sk|fm3<@O{=R+5?2EXq&mH0thVf(DqH*%@`!0%&2c7I^JrglTrg=4>{Cf zBrWl>`ygV~dqET``hDz4?Oe#8e)?rD<%Wm6XlAdb=#Dqakv3hO5tz^K1E^EQzTIH=#_G+*`M&j z;iS&7!)fWb#XDU~mTQ*aBI7RzXe0LkEsz|O@ zlnRn9SzJmXV(2M>JzZ5qwW18QGwrJ{s!;p6pL6A!x)RaSJ?r~1JgKW3?)Fe$Hh5Mp ze#7Gj4gn!UNNo7|KIp94jWIEhbI3q2xbiQX>$zY#^*b8D)hya@$qr0WHwOvO&-U zIhDsUlRdZpJ3t8;S3MJNNzgX&=1>|8)q@mJr)8X&vF{4xIf6hc5&Dm9{Npoz<}rP?D|7Tg{*Y(ihN zH>vP3!;JNnqM=z6ydplN5)A=>M88i^S$d|>D+(Qd4xzf3f-XK?RzaOWnu%g8K+O|pJJE&^eL)## zZ(|B~Zy20Qi~({=I#4jxk}Omd^c{erCRy7Y9?0zpvMQC9l}Yv7zX$Ne3B*lMMjb<% zNfPLQIwu|C{+%W|w!WIKsp1AuB0I>${!4u=-_k6FV5;h&wRlN=u`S-cWYiqAp%y0+ z6VY$A657vL?`yOB#nB(y@(hT%9lyT2g{&OkpJT;LicoGgVL)G#^O(kY&- zRu}UUsc&pYe-ZF$Psmb*6nxM@y#GK`&%CEgOcR@@aN(Cz>b$l9X$df(~?H<~e*swRF}QxW21s_EgAzUA*}|R)@mV zpW67K*tZe=nB&aeF#^aOUq=uWwJaQ%QiG81+(9q|splqJ4$Tui=SK%&ad_>`EUHje z3T~jYbH#88dOtUeH(0^ox68%;pcpGerJ{Wz_HN&x$azKZFl)uoagFa zQqCGBl2Li?tnGqv{#I2LQuSB`-+m-@A&gD|d3-n17A3E75wm1Ro)9yD;F8Yl8M zFC4}BTm#Jo&Hb2qIrf;hM({Tw`(`oBN72m%a3N}Mc7Y6Zx;YOYk-4^HVI8h+$%ayN zvBe>HVKtX>`~w_h3f1Q z8s1#M}Rv#d0V@Cl-4_E&8x{C@ezpOG2$yXg~?~0}H!s?Ii*SCbrmL)M);a zQ1}3yTq4Gz@dm%uU6xCqLGyFQ z&n?Y(+K9#wh*jl)}6kvv@5>T8(Pg>Nmy`?FnCU&TA{+n z9$$Unc8E0pS%i z?yv@4M=uUnQUwQLe+q;%e&y zgq7&bg>1O4OL%cGgiT0!X$9(r;H_%un1_)BbvaLhsboN*b`ks3o@2)pE&V?*e1eO{J(*)M(V+ zr187D_gfB`iE6nf%7#5gt?8TQd+7}av*;|1x|FRrP^ZS@s(O3RYM_; zPt{shH2%>_VH&iK#b<*W92Xe#oH~UD=VJ<(JUbg~9;A3E)Fa8=$#4uhes?vrM2dT( zXmRtqPTyMw=|ID1>MDM4(F{IEVZUbd`Sa(au%ADrOW5kdo6oClW zK3#j>u7$oNyzqE<)T|PbPY1Dc9skDTyfL$s99ndgv0GHW(p-Jn=fLsZz*;06F?|-A z^Uj)}A2Y8GK9i zHJbO{&lMvfq-RlQ%Om^~o?o(GI$5WuF20Y5N_fe3SUp)krS6KfAA0;gf)GVjds}n~ zKd7N2&AwrBS&4Yd)8_7`M^W}OCznqbZ!c`Q)bu2Mu<|t8^oNq+O2@dg4*ASLqL0IE zqq|euJVTCm+_PHNG*o{k?U84snEqwqN*Y2R*O_u@>4V2+bV)u@kcb8gX9S|G&tifB z74hfMq|aT1NO-qoDGL2F*P0${KO?BzBkg!+xOJZ=h4ynSX`$4~U%T4>R6|14{r3+i zWb-wFVP;&@wpRXARPt3Ji0-y)h$&B`&WrkGO?!RG;b;tQol-Yo&9tuHzFI?5Px>;~ zg$oh+-Pzm!%Nk7QN!)a^waLC3y_do_aF z!Anbqs-?S5+bbI%w3%lHZ(J^A zLx>I0&Fci&Yc^yp?z>yNAw3(l{A_jbqWf=}`fQsc|Jcl2ZfQZrrkV0iU;YU*XggS@ zLPP(`HT9x;gSeg2ZX>BKo4Nr1B7+-R=@`)C4lOI zQFZv%j2j@<0e%l{OdYcohJrpXfn$$JUEQpymkk0Mv^Tx;DnsEl$1s2f#rBv5%#c+% z*Jj_zh#8xdy51+Gi^WH}A;`6=Md_7WMowKj8?p4u!!x$6T=wS{$(~fTr$G1zOqh{&K{iqYi z!)?Q!l#H0uRUSs2d=~CtO{=t@_nU!5huKVP+8O($=2#UkoR2W5=`hH2A3N&TzRL}3 z=`e@O-u8OY$Sz&wMe0u6ezx#Uhl9a_fPD#J_x*$Y4Fd`2CTgskJnbEK#nJpK=GI3M z2d4FT@4VvJ(kiR1k1?gky!Ul9G!k$Cz3Jv36AZ@*s3NvLWgI$U2s4EeV%Ue=(Z3lc zn!*U8vF@e&Ps4sw=uRX*_$I40yfB5Ot}O?wNfTKsb6I`xHq$%ZcGFFCt<=5x0o(d~ z>vkgPgGaHg8Vr?vpxD&AI=$Vwb5>ixfT^eaZCeJ&_b?Y5_K-LdW5Ng9o=%J@voT=% zvfZQQz*>^GdR5l4nOU8E^Nw$v&g)v0b8qH|POqBdTS@*et8%@oWedDp47(YykPvHv zn@$*nX3)<5)+gl?)v-ByGs51+Ke%N#@ri~$_ee%Kb@G2FP)@`QS$Xi>lbi^*glBu~ z7t3@^c;S7-RPfTqpbxY_hH zyT^5&3fW4X>L*T1^(#@zYIeqBteA>{ij3 z`oK%3ucDkh=yO`R`i9I)uW}@t?^gVx=6`G`xb(V3vh!}`)z*8P_gC*`eY@YCUuCIz zGG}tr?hi!|`mO8pvsD;8W#%PLa`fPJjL0^RVEPn*A481={2g8}jAcUy_|h<)4LwYo z!edRM1%`_p7;1RUhP(gk?DVB!3kTZ$SC7AHpVN46Y4~o$zmIKgjGH<>BN`iJLoQit zeD)6FFC*~vw*RdfS9HO5+mrAwZ~jiEVAGgi`jbL73s5s>|l1f6#1> zuuu3;&tS^zO>9r6p9oxZnOQu*L~waNK9U1Zw1^A!bM@zf<9l43z@?J|zg)Jc{b3@6oKsO` zCVR3yUBt*Z6%7DvvjI%S^cY7PH2*k^;mlcZD%K;DGiwCh#r84@LXR$(TlLgM$e58B zAKlcn=&7qm(v0MsqfIS)o{Ifv%t$GUMoVrzbqhZ|Bdzi%TJhznd;dpCLnhD`wvzH% zk62GLFk5T2#x>4!urzt-vJY14V&nP_ZA;GHq~&cYjPuHWlspWS;ZM2OsIO+ZN1av`y&({t37zbt+5<#|{)V{X~h zm}QS`UWA`YnyW1uYX8LEJp$xXI?S5q;V&XC&6un2h*|zB_eH;3r{`Ag`epgssy?;g zAskY5EXWbeUpwG=ghkDj)hj-2TO0Yd+G4_Emz7^HtsVGzuf?Pft5^O6b%TDszlcxS zg^)EpiU_<^&t51be5OlST71R|>iS4LqPa`hjUZiQK9Y>Fy>e-4_%)HmL^4*yy*xcJ z%h_@{8Rtm@AZv#+f9I(mMQJt3I@o3oM|}lQS9HClp=E;y7-*lEx0`? zwX|U9(t97>K(}X_c8TTkSA}c)Kk^)cp@EM(+y{O-J*1YF)k+WXh~}M1ubmd1waRLz zM|{Yc3{YjY##y{RDPu!s%RZ})!1nd2!QFVygNtP*cl zWNgg4v5&uNd;4Zp`NsSQwC>&AyjtJ#IkQGQ3%t4aQnPObG$Pr(@78tSaR<#uy>GgC z;AOVo`1|Igzh1d{=*xA#+MniQpyjP@GRJ?i15?Tvdh4jo4gYD8%mNO&b<86tVAe>c z%=YT76X7=kK-FuR(0uW!`1tKji(eOd3|@RD2dn9}O>*Dyw&x1mx)xt%f{@y-+vm$# zf|kFTT^xxI;wG8yXl1BMV!f7Jo;x)dxTY!w%kW)>OTlX+S!2QUCD%IQcWxNY0>ge0 zfbAVSH!{nV&IOy5Mg8sWTKr#W4GOVFK<@YR_?cZ@S$V( z!S|arlfK*a(A@VN;cO{W{gU59$MW}!164j_=)K1_H^cGT%jZoV@zfQ^RVj0|&0Y7N z`5Pk6tLEyK|8eg{ly$$$bLQ&XgYN&DZs>P?^W2Kfy5+r}om(oljCXil;J*L%%F z_B*`QuHAqC{g!cuzB{~Ya6j;fv$g6(f5#6^YY#jN*jjyIyyHi}j{G%sUd{E|t_PpC z86w}P=8eDq$Adq+tp~oJGjGDPpod>C83umZJa6I~-NWxa)`PyDpEv1K*XS=#!v=wS z7PVimKK$#;%|UoI2*#@BNJQ*{iJ9CdPTD zEtr|T<1w#uQJjx@!K{&V+`s3zUqis`0(%$Rvn3~jRt3x%JEGRb?(WNY+%%_b_G9P{-DkyA?Zx!k`D{lrL^}QcKS@tz7NgYX19A6C!Ni^ z^Py$WxprTpwAa3FG93K)%&*=yMM|MX$Ag~-ELfZ(_eG1(>z@a;*`_Me(30!)x{$3i z&MU|2mfm~a5q6kyp=_pZ*;DVe5f^7%&~MN!f2~~GAHGYgIx%#`A8U#u-!SUNKMq>? z?VkIf@4sHG#U=-^)V>Oo9X`EGkO(ptR9;){M0m!E|EYE+x)YP~GQpycYdlidC&O)-ExWF@`!y<3 zej`Dyvi^x8i4gl*{?De-^p5AJCL^_ zqxn_V`n>Foqj(#KUw@Ue_fGa!TF=HYtc|%RlW%M{VvnD5H90#vvNz*{_5Azaa`v3a z-lA*w`lktiik-iWe7|Ivu~>88YxMV5HxJW7w>3C;OU+Af{o)+jIg{uvu)Ujmav*>E z0-VUh&*`+5?ae!1*UB+M=ZbQ=mOfJ!M}8lEX==`n)nb(*b$s5nj+~tvap&B-c{dO7 zcXc+uQ7ZED?>^w~-h2Ixy83SZ!@u}@HZNCcYR&6<%*O3GW(1r*;)$d6-qYD{wTthL z!1}!R;y=^%&RM6{xA!0UD(B|Do5$6aJNJ)#TUmQ^|3gAkb=-KB_1{n3`zCAfEadlU zSoh%LhH(d9tG14RX#VianQ@0cZr(ca_gN2ryc&1-$D6JAeo)=twD4}4qdy==j4^St z0c6^?2J3S@rv1MhVb9$*#XaSbS-uUhK2bI`B5uZ{evi1DhqJg4&GYVkj{%S|iR#YK+IG-8BR$iH*7qjKlwiK^Y7<6#TL9`~F?Xl-_(4}be0{!uTtR>PJ=7|O!s zEs^{~zHY11-Od=^C&DZ?uDUY^@>gZJooRz^)AP_Q4^P9SB?q~};ROrHQy2!@E-AI1J zQZsxmVe4%JwKiuBTT&x}YLIzhTkA|Ei2mG0arLjWB3;s0s#}?5-<=vt4VAgQBaAV`7W(D^3!NzrrQ> zdz>UmB1z7O!R-=bInG!fVl3b)JWH~1!Xe}EpqOyu__4-Uys`WbCPUMM{QQi?jB(k< z%0%PqAM`K`+|~H9l^ENibp?USis8o2(KX?Iei8nDMF!;}=wlk^m+t4MHVkQj!dheh z1Z7}uP)>z3H?ziAlqAOD?tV#rc%`@$Evf3Q9d3O0PSRVHBp83Bxp_r-37MrBUzL%1 zxGF}Ho)zKeXGA|PzL$K_|H0olMk3MRzvxPtDqdInpNV6WjA$jLhy81Tsl7zUh;W1TXjBr089s%vg>!HYLO> zhO3j6g(_u9VS=)HH= z&2ZQN19}%T7Oyg*_+Mm?{ugfl#im}|{vn-_0}1i|SQ^F|*P=-GGjI&hha6@kcUY{S zakY*%y<(%5sUiY;SCkZsC-58Y=VzF0fX=lAs(5`~FSr>J`=K=uG24tW5an zW$S-Qq*0-a9Qb!rma$VW!(-!&RQfMvNi((#&rPl_2$EIE6d{4bgEFgSy}DwAA03^o zOis_K!6$-=naTonT3JD0ZE)y+C}0$xaYoGXuW{CBoe^L!F7Za&5FH&eHg$07*x@y) zS+a34W8*^7YKnu0NHhU4%AD*>g@16&SXpqIL}P3lhx-jq&Cpb*jZLab%Ss)bmQgmg zAR)d+HcnHOR;;PUN!GwrLoI^*q>va@ng%0Yf)Q5Aa9dhd#$Y^QFWWP6l80sm$U^gS vOZ@YOh15ugMN|w?1t<#>;!B6;W|kOnG!g{k8E3e&1ZI)6EbMpSe>nXgyd^}d diff --git a/data-raw/antimicrobials.rds b/data-raw/antimicrobials.rds index d1fe47b1a09404d34012e72641ae7938a014252b..df1ef553596d1635163d21e298c7f68d8e4d1572 100644 GIT binary patch literal 43436 zcmV(jK=!}=H+ooF0004LBHlIv03iVu0001VFXf}-s<5eUT>vZsd>Q$l_#!w{t0WW~ z`4%D=@FG&D0g{n6nqR2BgC5ilVKPfZ<^D9_$shyN*6kJ%rH^ksPHyG=`*Ka~FNE&O|C`evYZw%=auEb~Q(rsFXz4 zA;F}X6i+kM74v5;{#ReL>uE-+65xM~Yd*@0M`r-o@pBeMw(7-{1s38E9R4Rx)^*0a z{b)qf;6`NXxg4wdIEbiBkKkS#eqOGy+S9*48PT)0#&f4i`qdIQRZNCGxx9EP3h}O* z?s={{SZr*4@gcyLYROZ`5uNdW^$nxj8Y& zXpJ2n5oVLgd(;)&Pf4DzDL7ko7Ni^3rKn$mL_u{*~MEw|Oyd0g4B@ir5<(YzGq(ZwPs#-M4k`Ko$aKVGa8l zpE;xuRJVhRD1sT;5g6c0rmBMSQJZ^0~eoBoM$bECq%Pf7lKj)k8RfL1jv%| zeL&ZBjdj1te4QUKJU|8#V{5?z;I#Ql81whhB{j5R_3;1E6Tb-)&Vx zY86)x`kn+MJJd9aYJ_kRTVi+aSLvYtPn|_^i~TU-7Az zW4{ANt=(CZmM_i@(0Rp)tW?6=y(&RG-7B=LH@n#Cp!-a^Lu^eqm0Bf^5H@ezc($7f zmA{s?hgg@c%1}=9F)^27aI)rx?kU_h&b(xU)rbJx#RS?nVf!cPIxbWA5ZY594dQ!h z818$dcC>Ljt$#?DvMHUh_^;z(RZH{Gn7S6%!gT%M?V)jH=}T4GX0o_2Mi4Ss!PBq% z`!QuU93DijZ6 z^U}_64r;TzGe*oy`~%txthx2(VP63o7CnOaxjgL`ozc{yOxhv=U4(L9GJL)YO1%+a zP0Z1e$w^S!1iW~4x_BeoQbED7xJm1U&HP2(gPk8%VBX|TyXyF2nDbsBvo(XcWzTuj z$Q-l1;iMPy>nJg9(qE~$#Kv-;;ceYF{?8m`p`Lx&0u>fLaiJp)NuAE)8 z={`%qMcrG?S5+nlM%O|Tw3{y_51%4NBuE3ByDd6HO#yKRf93rBNEz+OieA7%t+b&5r#&XCHA5Kf7^4 zJ%}Oe@TziBJb7_88S>PZ8bKuYhzbb4stn5lN$-S8jf<1cr|;|-502!@(63d+q}Tv9 zCVgbe^caIhVBfwxHtuKlM@(wA#am-8fh&3qfOs!-v)S?>HMspJn&?-jwn7`gt*}0U z8MP#(I?oS0zO_7)Ryi+7mWbn#x>g7N^?s~*{o+pBk6#vp;;e1pTQW@f2T{-y66P6E zzI&hLR^QIzKKS>rcan%HdK!KDx6BWjgmaM6KlrQ<$w&{hgcGuCw}=QRCi=*SlJtT? zh6NbWtH_0BewE2Z4tREx|9f-v(3Bor5LEuw9*O381$0y4p)X`^L|B(zv@t^89IS)y z>Pq@`_)e<(_qm=!6&gkkTTSSTE{x@yy}!Zs+;93AyUZXElwQ`DGulXseZn#L%gICsMU+4)7|k*+C%$#jJ7IIfB4#1uII37iK`XF~s{ zpv!?ne4uT^2Ltu(wbM+@&@HGVflzXr{Saa=6412Cj;@5|91>*e{Z|cb^X^j9vCI_! zqmP@Y-mv5c^0=q&E`+k6KsMjx+5bJVRp6}1)pl4HTE|HqZz3hFh@MW;Oixe_z9U5> zY3yiRU8FH&85(&zzEfrrjdqlRMM0o`W##;FgNh(z(+HJ4vDROVWAjQlG(ISLyAXYa zP2=om*`?+6Fa7_ZmcV7g&iWbXMj@ z+Zx2qNRy`}hH(FZLVx7z{h6z%_{bLFgo9wH#rBLP`G5_U;im5by1nccMd z&E5KU1VHV+5Qc_u_DX3FA+jSVyyU@buza_jY7%7fz^SUu_zan2pWUG<#}M>dFJ$SM zH;u>Sk8NUFTHdjeRz`8W&lfA75{2TW1p?v72BPYo-I^k)i_k_z_)3b4PAWDFg0jmB zw`W|P!-Kt+Sj0qQEf$0~z0-0-+>okP&ax5{!*(W+SDqYINfmx8Aak`=T`S&28A~Vi z`bRHJ)%MFBIU6Zt6c0PB-MCdMKDm%P`<@=2AR|!;WmD8J2NLh35jeuvAWYnn34gsF z4U8b?9;~@?uey>OOc*O%9rRh?#6o~g$p1wr5_$qd^8dW1D`FD%$^1z!*glMnbIufes3-ZX4@ z1reJ+FL-fMBk`WepUS!T!oW#3_zWCxWrygb^vJK!jh)_-vum%*cbuqG5@>>z2o|l` zly`akSkQsjm;vlMgTQSvXrQ77?diWzYBo=udad;E=GPxS@+@G*nS`BWMN$IeYs3rh z(E=09g_!`$sa&*~FnoKUWj5I5T+K+s@T7Fb9u5|&Ka{PuihzheO3Nj!29w&9Z3NX) z#@u;dTIR-fbDJNju=TlCgA5lQX-=vLk&O;ND}lKea+8cxl$ZM~&3=<&UTA+1;^|Hz z=Fo(er3@3oYZ#7^RYL|ccKy?tlM-~tv?{L?&EPQu2l70=-to>^tX1-gE_eq9^>0{k zP(`5SHK+s(sWVcN0$fLnmeFF0-6et~h{Z2}g7k9Ta3ICIP{+3(816o?qR&m|k^DRp z@x0HQxErzN1jUkCzHt#yK+{?iqCEg>pu* zs8ys2C?nPVQ?;2EjS^!}kz0q-WPrKxO07QvjGd8hCWpnW`0W!cm8>}oT=uA-P2*NF z0o97fjXabouXiQRWeM)ZawgpQ#jVKG z5Hf`b7B6Nwe;==lTju<0<5G<-5*c>kEdPiCR*#e!egJP9tE+lx)A-}Z1cgu`RPY8ri<|xVS&Jm)a_A^ekq#Iz9RK52T zRWE~=d1jA+Q7Z7nYACmXjG-ODSC7J+Cn;RRjyTXXw{BcZ4G5AQ3-3m*T^=3mW^I6J zYD(VkfA@>7GAvt|&2|cTH$Cfreq@^yUz##m-Vcsgu(A9}g{AqfrNUz9Sl8o^N|8>< zhkVThlAZXNfSJl z;fRf(HSYG$&>u3~-4If8S9JtC=B`=x&e}gDm5lnY_A32w%^<)a(`>80skJ+hWu-W{>kH;#0`%)I!*=;UZ$ zY~wd>LI_|H*k15?#UG(VdBk8{=`PIsb3L3exn-JWrxe5kwG&fKVxQMlF8Tg3(Jk|l zNRns+lPkQrK#Dj|F>DfT2+vv|k`(;@^?R$u!c3B{=(%IUl;}6{(a{YyYW=V9 z-#&vrMj(b$5~m0g;0rZ9XbYem7ML@`!B1t?Ly8Qe+Qo&oyG__G(oAUJ{GH^CjP+mr zbk(}eENDZBt9QJ-)PQMM5@}TX&{@1}D~2pR2(~^kA`sLF->Ued(p)nWKrPx)m*>NX zZX89afomWuQ?RdI0^sgLA+DK-rx^}}EkDJZT<}U`M4~3qY1_OIYoO9jLK!S+gMHO4 zf9sA6<9C0MW7eTDWsr=Gp=+WU_i*PGT!KS%fl)WTw-E|=gq_A&q zCr1$gKjeHVIv!QXE(OSFgPEN|Z)kc(u$rAbZ64gqRo8hWXjPqjR8O;%b6k}Ck;)-! zncjYfRhsu6x5+&*5wM?znEHHt2Ew{hbmXYaN68&`>BN{2&X(j3mp#M~%)2wL&l5TZzs3@9SrP^{1NliS5ifPUkQ=BYp>lg}8w) zmL`9No`&sm3~QYcZx@#Uxt4sX%j%5&dF6k+0|xV`eZ+F^t0aYXL*~XJ$sSVfmaJR$ zwHC}y&GwY%YCW!cEMbi=1Hn6@{=5Mb2fO~V=_m`aH5*Ue_Ghri*xlLPF!HI5c^xXh zklv)Kkx*AQE4yI&B*7^m%o3FEf&)m^`z%R ztgnCmm(&Gr$zbjstVY*pUWs_H-G)^*v4OKWzE*agmSptGZMHvBMos2@!2V-;-QLve zN)*vIS|pg}YAe9~c|tcQu?p?6MfSqEfVukwf_x$(o<=F`yolfs@?5^zFM_*uZ|_73 zx@8X*m=@oLMMJ;dtB)sRR{2N`jJflK?4>cFiWQoI{KeFUX0_)aN|dKZlnCE>(R}vk zoO5aN1qTnkFF}9j!;?>UqSef4qL8%4qk)dCL)Shibh03C`J1b(GJ~7(`Jln4j!L@E z&QJ45-T@Y8k2Q{ymv>SKs}ZOLq@;&?)bzq(LxE6zf|HA6$18Ad-r)rX54c26rn{fm#P)PWQ; z&zqQ$5mQ85`D*UUPocyV@V7C*&I&)N5 zZJ(H;J;J8dKP9_dGDz9!%nU-UwYNtVm=Wkd;x^dg;(E5@$vsNQ2viVdvNUA?IMGl|EDxXaC4m&auCO9mkXO@}M+@RK=Zwu76md$irTCQ<(w z)~5ppf934(VUhOE{Vtm(YufmYTBu!1Z}%1IB4#NV7`yf6ajmQnF+9zISr%U zu923Vyf6q}ko&t>3!*hcne-x~z}g}$vv_ne4Gc{e3IUWv?Y`<+RDcc)(|;6ZV|GvZ zs0VA5><|oHWDA6PL}8U^iTRl!*dhCm1cCEHeq}jOuvgn!wm{tC@kiOZBa`&+&7@$l z?kQDfvW*lg*9B3gx`y?=Il&oaH%52pKv&W`Xnue7(*%11>-F1r9Qph~clJjO2ku<- z6gKJa_x)VyI^)JWN^;+7G4q|Tn$>JS0tmC4s`<&ItlhGNdJejj2r3^9TO!idm~H`uKsdsV-8cj$6TyG zeJ*bIqFth*#=;UV-(Ham96C*HraFs#htI(V)3v$J(mUE1_|$5W`u>t_A@QA7l7N>x z3L$nShT((L&%DMd-}vs1bFP3}?kga&Z;qx~1Jpn5HEh1)ti^YX@TpI^V75BR6lx`i ztUi@b=kc`P>+_@$#r5Umb+VWZv@o$4L4w=w_Wa8iX?(5-PMdOO4{TIB&@Fu@Mr4*? zKs{#;ts(vyz>T!5C80R`=Tk2Rf=-$Xn+3nI%t__)55O8x5gFbgUrcSFA zXHJz->7fJ$gC7cwk!XG4b zg7rH(f(9<}of$w@>Gj2p%^bZIPhDAJE6xGN$Fgn26LyW~eBO+j>XASiOS10u7D}qV zM42r7Sim>alM^))&X(}~g?_Gmee4%}WQTa{B+b?AhdPfXzn1pPq^ZetX4il>Kp|YV zIW6qWqp1OF@-se^u}p}PW7Y?a+Gihp+c}Ijyus{Z(2~_3JBvzB%>ay%CxjI^6R~xo zo7DrdY>S%}1)q2DV3}bhm-@P{<0*#Yv z9pvn0(ke^Ko0@e!u^=Qny7e!AZeo=IU5$>{N7i^cd9_gL@O&dpXPTKgjgR8^$uUtB zM_{2FP(qYy7cz`MbwD1zg^P>YWggrSo@e2NNIN_^4!reMPKjpoyWJ7NWOrPH^Ilxb zqWDZ;5Kw_wM|T{$R|nh+Y~%n&v*IYr>AjWl0WB&oDJsc$%8RBAabA{U#rm3_!gv&E z6?9Ql>06o)sjX?Ei{>R;NK(kN5tbwneVFd9S?hM9A4k&vzu1gD&)1RBWckQ1)R*7o z(kcDlKO^8D=Z`hihrM|PzA|3kLkHXeOYetgWd4_Sqb&rdb9=CyXpjow7O2W${h#K= zGHa=y>+bSvmL9>=z8q@7F*^s`%W1zMW;T%=1Vw;MznVrk4P*S*yz0Z%(sM2HkC^$u zZY(p;Zno=b1PJc1q*cnzqdk(=z)8tg(Y3}+&9KZAZ^ur9D0Iw$WITc%pN=mMDA(XsLD{Y6eG8^p!6;g;(m=T^Z zm@=y3{{_#c?Nt!)0H*bLMlwv9zDBH?&h5DB7Uv(eTMiawk+8|>JA1SF*TztY^i-9A zDlN1=qiM0t8fi}rhK zLw?z%i8e8VLTs^7<1Vn=yXl0XNpRuvg#rK@u(WJWXbZ?s#sJyoqUe-hR>Y4K7*OQ8 z1-WPb3X4q&mRb!)46#)tKyEC}$ai{4$^(j}bm^$(t$pLBL)~DG6;Ec4rogoGVas6U z1dZlkTsj<}@0GhNhUqObW1s2jl{GP8sc}H~@|Ee7e563$)AMe2L9a^hV72n{$6H|j z=c2HUhwzxSP?$1CgD8DL_Q3EAD_V6LCulKc1lNIc95p$IQF_FT2<43yTpZ_KiBozR ziQ44W8I6_rte|aAYzJtTga6oM2lIZ|a0IFs?bT-$-mwkO%Ms%GBu-M4iIbA~jVwBw zAFy*Yh5#l8eIf!HyyXje_s>I-@BJ5k~r!ze~Lt$$?PXF$$snXzDg* zOY}|RIaB^Kk;IppL|M1!LUf-)7+||2Wq5hPeymHZaanr%WK6h^BHFd5a-h@w=2H2A zbwOsLzlo^*6kuE8C;nqkSx2J&zW+e(JQD@4Fesk2m3V+rq#z>`usce$&w{{S#wcS2 zp9YoYx7ig=c6X+Pn5gPqZvf0;@(wbH3*lm62R-Vx3ri|P{-SNlJSi|PgovtF$ znImju2uf2D%8WckX9A=kO(nN+5#IhZPP6}_k-KGF_!(D82AhcJw1__}&0!Ne5|vD9Gh??5P8RqqI%}s? z^r?+JIrT643Qy`Ygu_nx1|u8$^Dw7dtv!J#XP$D#CsBZci=+FP)mX)SKKB z29CNbGpRZJ?Vgf&~($|XfMkkJ`Ul3qeVR#K6I+=*II$Z>bEDrXXbCR)R23jzTM3O}gX1Rr z<3ROW{U4+*J5@sSShoQdn+g}l{8hDDff;hU6B?j;)9wvn!*Z|ey@}#$U%V877e$^38tg3uH&fGw>22$YRnh>bvz zMFTic-3rx9pu*C51ATj-)UOwQZ^(LYE@mBHci?#zxT3O8a;c%ve(Mjc;0{d|7I^v` zVr$-LIPC5c*~f4*(`Jhp1HV~qjpwk&*v%qyo}+T_nijfEKi*yU4EZYHf5ym#L?Qii zvy@a|Vk#&kK!l-N$Z;_v3#6{Pt~Dq>VhUXebz>cjRy67k>ol5SO>7?$e#6!6oU2+r zuLboLC<9yJ2|Luu8LaWDn&-N6&jYV50|gzc9(JR6dnMDI^-uvYjzg^Trn4^R-y6jm zfC&!X3Nv>AO*>DX=mjR))o7?l$ur1charfckvRVhXR5&E}bYRagT)FrW4;7O$7-^8HZtQPM{h-vV>}# z-DfOpEw|O)A~p$ZWX(jvp3>oSsoh zt+c_WVKKSIOmxH6Y1Fog9s}GKCj82}cd;!R1%g_dmrE6JzAPW^9=T=<@75D~G8!~2 zwp@Z|R2Ra^+m;b6?53z>9@e^u+siOBwk*vjfSDGBZI$+caJKPBK}mbl8so(h3mT_e za;{&eMU3%PJ|*FrYr0^W)Z?86ZW{-}RHvbW4UY@<*b(nXiSMI}*O{AYE?jb?O%%LZ zbg|8d8vyb69l3t^21gd8>u0*3tVl!!l|?7tdOEs7TxXXKT<)xofD4`^57nABWES#~ zj}B|pBG9hrnZCD*(>ZAXF`8m;fjywezo;?WD0p{VK+Twu)@^+|5PJ08^h9`Mkh>Hv zX9DpX3Ql=*!0VoUa@roxWthe_BYG>H0en#7n$Pa%96P86$w`gLz~qTc zI+Bd(cBO(QaI1}#6MiC#Wra=-NsFi8caU_OU%Ks70K>pxyLhqJcFp5GYgLF_Xp*f) z&wfvyN@p$Pqgk)#Z#SdCtisUC-h@&ny2&_t8tuM(r;eSNNfgbF`!ayqX8D z+^Wi-qA0{ByL=m|ub|P#p~gOI2u0)UqJlql@&4uqjqrXLOm5b^^+Kh8`?|1!Cc@2C zvt&}sF&000f>f;C9x26mL@mM3hQ}DiaBpMRp0#_UzPkVwSH7v&r_`lcQ%d}=7XT~|7uTou%NcwIGb^c_1Dz2-Nt)$|nPrNj-CSZG!+m-nzh9W1U) zn*q8B#c?t`>?!sD(u`lws2P+`Y1b5!fV(vIhw17p_f2dz|56lRf@t(L47DrJgUh4n zQlUbRsU5W(ZOS3rkhogy>>s3QSu%Mm7Z>XBlp9D2_uuZlq1NDBa;mz<(lVK*+DzuI zx;z)d{{~GCVTNI^dh4m#B|xz8ZgQt)EYXpi*ExQ0B=aeoVtqx4+W5BC#(x=icW7mN z^S91M$PSmA(D@t2g(ynlpdWiM^1FW1c$pp;4anD;+rmhSX zYRTFI_A?q{$_W@2M@1;krtb5+AO9Hg4Q_O)7VJ*CoTz}$?ummftyE@IUWV41+*&=j z9&+iD<{qq+^mzN3G4;m*=FOdWmT6+PllYEDw6ZVea}$kqc2e>_v)6mhePo#g4T7et z&aYSGJ&#uh$2~uHbDYjkbaYM zz1Ffr%uQ9Wk!RUzb(`yuLygd7f>KrWph^{7kdX&?+1M2-K?i4p^a2J4X)q2+L-_=( zQ2*XD?k}5!(QUhnOr@`WC%pXd>$E?O)>Szt+tQeX7OClHj^bH0Jl7GtJIhh?XAh$k z&DWkiy76_i!23t^G18lkToE{a5bo4ephSKs(GDp7pACW=H4xlqr9`v(r6O_M?D8N9&sPI^t94Ldcs%&PdCHSOj>^Eg1<(ym2v6L>P@e7?pS0 z_4gG6_Kzi*TJ_qb8b-R1>0&w$ON{y;BX0PCTn|4eA>EAL#7suk z*A$|@$_Y;AZDDC8o=UaBDW^3z#kbAK8ueb*ko?a67)ly-b`U3(5Q>T^jd=mI4X{g@ z`4jg46G=3`gfsN8Kdou1BV9E5M=icV_-oOE5+De|xohzDdMGUkj5<6Rjo&pmYSeuI zsIWZg?2C0mb>mq!VFwUlU){iafY$1;c(DT3)??2QU(1LF+U3|9D@oICvL~)K|Qdk`9 zEbG~UWjp;Q=RsMu8n4(5kMl6W@3`mqR&)aGyKe2A_;GT{5y3x)tTS?d;UEF{JF|IC zg9o~aXfx0wg~L~|Y{L%ZV~KSG3B9%%^W-{gBQ>6Os!j~1cTnc8HfNK(7lR%8w>CKJ zy95cIJC!X3JL*Bu_HNRt{oL8&RVzXiz&X!5p%1|n3P4i6f>fFS0_Ul*nQ3KXPXZ)@ zWvuH;&FIokL-$h&#A7121TGm3I? zfn@?Bl@^r;Ii|5!br8!KknyR;+i(c8Za7z(!QABD;YGFz&!l7jEj5kSY!2u zz)>K=e&P-3MokvSWh;QYTc9#ErhoUSomfM$o4G2bOI?UQc9Sg+4nopA9^9H4?)U;{ z;@Udq?qtLSde=}N`Jo5oCO6Lu7==x4n^GLIAs&$p@{k8eBe#!b{OYn62U#G&J7PyW z?Qec!R^N*kB`Nld1u*wK%sD7)nV}bJhJ4~|*y6}q(?7>i2Wy>5s{uj&Q9=#t6tR*N z9n`0uz1(Kk($+>6-s(sqY-e+Ejr}kGS$8yc@^$#1`EYQUTzTvxIbbcMZ_%7Vsu}{U zgglKl(Q`N4o|Vf3i&{TNuN7&Y|lxWfud!eAy;PFoA$h3NPWkNFuq4~KQb%vdg z{w*c1%US-ZiC(MqF|Gzi>aKy$+F@X;*e+8aRH8)O@l`7lf((M?*ePvTIvfZ1E z&RU&AciIsv>g?_sp5fxaBil#j^4YUqX#8zy7h(+TEuQakNVy&Te6}dytchOD8(%G( z(_Zyn<~U?Yxg?zQH6lOo#!l9&&dVEri6}XxoHl5E;(E?hNl?TLw}LEP!CGpLfGSMI zU&jKYi(rmyQb5Ld?dC4?sph1W%rGRN^Izts~k3%-%>1D=l9u?ia|uGxv^md>y{9jJ3c~M1L`;fpC*WIj(itN2rAD3zWb{0YoG` zE-Yb#BV2$pxKh%NLN?)D5X`siSB@aA2>%JJ_1-kqXqvbtJ&9yK4OUNsu-hV$p_hj% zP8qI?C}Y=sYC?wFT4WD*r(GBAf1~Y!4Cx7|6w@DJ?e!bx4oa@{WZ2DXE*x2_GnAd* zj8aHnkM_&Rl`^_NeoRR(`=rKer*@E(4Gai&MZKSdxN590hYNN*Exf5F*(HxXBQAtu zTz_G**5ga+)tg@6!~7qeuKO-kOAyD}II%4ocF@P(B~_AZ!~}vAbyWu|!X1AS07W;| z1VW_KY;$yNDR_c)yP#eGXI<=mnpd59+IOR%{n!XachuL}H|$J8UD6q>b4V2el)z>( zkc9@d2%CR}ffFL*IQ*HBr&RrPKgGqmUzj2Wkn5|6O>?pgQF}Ri6(SUB2^;@>9XrUr zc0!paF=ZyUF&%5oSna!rE-(N(7{|@w`j&K}Uxpa%Fi0nA>mr2`btzbmJ129mS6MLK zRO)r&0CCevXap^(Cg)|LXv8dYCa)cRJaB*-@$nE3lcwE~LRjl6uQA>o1cIGLTl>Aq zy>z(_mCvwQ2HA~f3V-n|c14B&M{M&gj2?}ear@)Jgt?}a&UcRAx;l1ezRf1pQJ0YBs0gC9Xn)*D);d)j&v=ex zE&z0^y(qAAQ_m;kuKh>md^L|;VweV)26iTjOROo>SY$;@8mv)7V)1B;?Bt*x2Y<~u zdosyr%dTd9R(iXBQY^ng1_;^X3kbK=F|{Br8>d0hr}yC1NGvzEg6kg?74?Xvm)U9i z+_fIKeXAA^(<^4O{+-1jBOfAh>BNTIL6)?TjRDGy>&oU&6j<;<%d?5|MJOVXHXA;% z8`Pi(p*ufD?2q+Yp zuj{ZoANe-x=7YpKg*J)I+(Ts))d3x6mf`E^ruc*iY#L$elsU5Ik5JkRHyKc_RQu56 zzv`CbpFNMEiw`$*U#te_U#zES`y!(R1ZUx=C-m15Hh2X`7w*aXq4*`VZn11L6~%0# zrAwI@40kv5(Rzr~vqy9Rr+133eA>S;fXqWy0F2>l)q4#&TiVW1+s@zE)coB3{g=fK zPgzg6!Ms?(4^SjzK&M{)pBdO@tcya6;ry$N_qR)%e*XQnT-l`4e1=yj8(iz@pBNahZkTrR`Y+~8rXQ+M* z2pUNaCLiNKZt)>YCDJnfnPm2vGlOv>kmfC^lIgq4EU4Y4Ji8QGZKe+x%$zlB9GUa< zB~sm-6-HQ$<&0S^l%P#HM(S_%M<<;59~1-I zb+MmeAuK;}f1+5MI7i(~n9DeulKyVkDB&R4-x0${#SSNYJmK4oW=jWq|9w^jZQwT?Sw(+{k@#J19 zu?gI-=BJlDiOFmy{-rtI`l%tpP7TVaQXQXS($f>cUC%sIi$P*bC}1HJYAR`y+^R{J zEV#mx11B;#2XbxTo`-dYnv-t-X&>$H$Wjw~B;XWXRgJK6f`hR*gFul9$6m0nTwE)T zc_2$fY@S(4c6wBm43Ubra)?9X98n&)`ns?L68nGCcrrcW+Wc?+KEokVu`vS_`SsOQ zQP^i)i_wDRU|cc&BMgen*X1h$&M|ExF|&G&E;bz`&Uo1v7w=YJxE9 zEV2iKoa+{IvGPBjFzfjKa91L1aKF0U< zy~m-ETLlY<`#FII0PY)Neo=E6J-**6k`$~g!&GXcla*eZ;kf?C-aoPizW8Zl9tfw^ zEk+6Ym@qvD^V1Qly=;vn2vV6Zp;P= zI-}Chz}=26rUU1~BnwzuXhw7R?6#BQPHg-Fah~mQp}>Og^+Sw3v%_E|`D`6H)t9+F z`U6fGjB!fMdk(1qQM-*D{)tN!3xgChcvs^{f>xjKo#S%>>2K8=o^R%WwWk0UaTnSLQY|dG@L8E$k{vlYS<~29 zT!_SZE=XT-Yx5xXpmWSkqzv(Um18a8{i z?A+gt2F%W@xFly4D2fpB0%a3zCXv#w3@G%wDG6HK0n->wP)R2bbtb^70+F10RmJ@( z{#zUHck_sNR11u!z$k(bfx4d$h#nP>buuAwVni$xxM8Fe5g%!Z#3x}>m`BE57i~XB zzz8mJQc^+(^;bq5M*gNy^}!+CxY+fDkO9A-rZydmaAuBL0MVwR516bMf|gzVD%+V3 zbYLAUrq@oku{Ikl#VuQ!aLj=u(1d|Kikub7uL|ul66nfmU_#(}=Mqo(P2u1hgWE5$)x#HnIcmAT7#BB#q*jHXPS3J4xeH!W}Ua@g90Hem`>&W zBCE@uGLh*i(?XMovvvR_=-HuC8rA6hrA+`%p`R#{u;r1uqy>%Bv=c|}@{QN{9-|f8 zL)Q%lgj>G+ZfqfuX_itCOIiBqu^?T>#7%t1hfNUhh)6562${qluEH6m zks!12HW?I+f3VMOf$HS%#JXJ_3CCVM*0@!E_8CTsx4CcMBm5i>2#o>bDC0TVmP+sd zOz`Ur`ViLQFck=N?X4aP*{XTJIyrk7UXT}(CLkZ^jd}&NO%Aj&qy(s7CxQ3pW$j)n zi189BI0x#me~obk+;S$#Eas!8_%+V`$ZGnlx>W zC<#14NpE@~3Cemn*L>NJwQ_T_zD&+XF8b|GJQ?X;H)ZCT-MFiyn_H9_J zV~4%hdIjtFPAyMS!#gaLwZugAH_FD&i;=P#5D|~&1f<42jbYe7%9KLSl?<{)bb+)z z^GP?$DR%~BdQ4L=+?1wy<(uEQ%ps6kkf4Gu#S^3 z{*zRS%G)&Ng$L)B{RvoYx8{~lJRnUGwN_iINVZTw|iHQZ8ccB8VA}#&>dhc!C#E9Q4#zd}Ee7B;GC#FJ8!DB>nkK@4)G=kJ>b9AA@(fSF_Kx z8o5I7xHJ9T42SGZ$N4dNDxjQMxUE<2O zJnqm*R!2xsZ@2&WJB;cP0dNOe<@jw+o&^V%W(nMBC~8EDj+E=Kn|v*>sp1W;V*X|67nf60`oN!Y1ECS0``UE5 zrz13DFAZZoS4Mp*>fLtnq~o{HXj2Xg$rGWH{jSyHo6f35%J-StVH^n7eYd3NuA(Nt zf~#Nu1VP$`ii=Po*#b(CB8<-H+blSGx6H*Wn;!9yY586ae;Xya<#!9TPqcO^1li;^ zIBqxu_)STw_B;$Id}=XF5G$QP2&smz%F2u6pSq-lJdW37DmB;}@52n4<0-0k1EpqS ztdlFRBxH|VRsAwJj|exXPQ!}uT;i)@1RuPq<>VyFyx6))tEq$&cP2`o#SgzC_J$}& z{&owu6DwGoHiS`UZq?inF7BAbdBic=aHc*UaNgR6LgkJ=y|}jRdSc3&4X`1;4!Gp^ z|0)Mh_VEDRIFyzYG%pe9!Si46-h-K0X!XTi@8E;rPFc`c>X~3~Mw0H#2XQD+z!$%P zQI_Mp7ha9zQW2NRklZ7WEs)VV>*8$aMxy1$W$367K*H2Bx$0GFyE<62T{&CK<=sqZ zEm-7*ge3`{Eks=+@su zx=FgHs!uJ4=?Fq4xN9{A^axRAV|=zLv}TJQ;r!E3EX%KY9wH44Pd$v&n$5tP`ST(i zuj`VqhB(7&!c5xnGkEInUG|jrq3DRgtm}tvWaW&DQc}UHN)L|=sf4+P5SXsKA|t0# z;tZv5+T%}V)*P^SfcB^cvW`il76oicQ4Lm5WLOE}Sgl~&Kpa=TRL)XzWFnX~YWW{Y zj6mwSFxDf_sAe3wArH5ffgxzLHc6!_7E7`+ZF@2daloP!S3kxdL~WEZ$MWzBVt~;4 znV3711Qpofu>(WbWu6roiZ(eV`F+&%86l)NCMHp?{R%{LM<8%y?L+(1G1*z_YD=x~ z9+d%nvx6rqS?y2TPgrhUWuEA@|GziTuP z>zF;7@&GD)P=JVSja3!M0e__aYu%b>pzw^8yOf|PA%m-i0Jbw8iyW1s{$*HN)_7AJ zrwv?p_FSlX#c{~xSdY*us=RUd3#*XZ_(>JDI)J(>G_VT{aJk_3Lz(qNTl-Dx(tWY6 zVw*^znU$l|RtE%0twv{_+;j$CAgQ#f4YKOwsfI34{3#YU730jw(I{7P?T{NvF;I2` zQG|o3*G+`{Xx=C(4-tOXC*56Z$07du9n!mWZ>K_q(fcZhEEYM56N}4P)emJRUeFyQ zQrcZ?HNzt&vJ5>lhW1=n+2$EgUt$i)@n2I$nO!yEGhxnS_Sp^;ssa-_y96TLFrV7J z7=+sMOonB12vj-KCBjw*Te+6UZcto0=W{}L82<42flib0C$SqDZ--MTRR1PlSGW;A zmj0q$RTUs#wP1o_@=C=Am*T*QD_6lB2u&jh4}nzD!1CgCfbl)k?=4$fQ>~psxyRAT zV|RO?YQ}RNy9{X}3C@wgK;QGDVwn1TM>&GCm62S%=B=L4IIX)Se&%bl_Xav zdGRU=fZLf;GBnaze*SaLr z%{6`^q&=$qK{ay7{y7~q^~;<^SeH{7oxgJSO_>gVsO{ce?hD3kT~5u}qqs-JD}v?- z5Jjgcl$=b5@%K4G!qP_Dr(r8}|FBiIjlua@CdvFs6L8Z-5LNGM#g7hQ%J^=tM@a4d zN)utu_~?icusF}c0PrD0*B@9C-IQ~J-%>_jb;0gBMa~r$X#P~rd0wxB2Xbp^F&OL| zvqx*??8#^lC4>AMkXWvmYER8@03|@$zt2?^`o7}_L#w4k`R6AXpN1lvM6s?~JKg25twch|2Mz{HX2r_pZc%FD z^l#PiJR}dZw?y2Q1aLaoYdOeLHNQw|yl0v2!#6`)yhfq@?Toq&BN9^$broelEr?7q zyjDx05H=29E}y(O{)dxB@Q5Uw1Ot4bA2&!5F8m3AeEQ4>b>`m3t|`hE6DQy_6p##h zs!zT(3w3W%N!R|qAG(Cq^TdMtQ!}D5n>V)K3 z0BTP(+V_@U)AazD>kbgc&$S#0MY=OgP@Lk2OJSqN^n7CkdUtNPCW~`1@z$a`)~&YT zblfAoiU(oNKyJ4-@{IFsBJ-vR4Kz`~sOxw0AdtUUakf4MQYlZK42)NSK2Lz)v~O*K zCLwVU)V&hrk#AS%A;ZYZ?OF|$Qg|-u^pPp^!WkGVG)=7_mIm?ecLc#)e`DRu^{21Q z)8i~zZOB5Sw39C4zJ7*9zATB-(o4f(vgJ{mj1UXx@qk>%;bjb$%oQ^#f4ls}>XoU( z3k@Sj1)^k{4|nYv!6@a>VT10h#EezRb)t5G$|!21QY?ka1|7FQDkxX8P#s;avLETk zH6fEbe@{lSH)z#UstYk&b9|xGgjss2OA*OLvwStnsX4TPnY%9MuZ`F&w)i3s@@PZw z80S5K@tIxK8=wyqj4#vf&Jubvg4DwQ#eQs2f}?Sg#O8J{nm<)JjzGn1@znwF-(3B> zFq2@OXG45N?5n9X@4{9Qi>E?ON<=|P5@cB1R8Tu@5#YeqvSsQ$-_H(|{`Mv9o zXsYGA_=~du@Vwx#+@e+TeAEb+Qvol@BN27V%O}kk_CJD<-ebF1!doUN$t6hKLX3*Z zNNL+9M7Fjz`dcxmXOm)VfCeB}p+!H-bK4RXHTayRTtr+A*DEqTj$MQK$Q!?{DXYeW z@t+nLnz07i4(DSU9(t|p8`r|=-A>hRGt2oM3BY?Rgv>>zkvmoq-Xh$e1HC7?fJB-2 zp^5JLii(NYfjt3$=|H1mNq5VVGhb_rx*W>SY;!4!^0x?SC6%!7Su2Z=9utZn4JVz}I#~wC2F=oB;R}&mg>Xo&qctj5w;jou6 zwQ2A`c%?mfsoFK^d~tqtQp1^?3U!CP!-Kbo1`ZVHbMaoMm-CN0`EK`Fzcde>SR{(p zXBCUAW?b4ooJ{SjrdlN2-fm7JXeu#+I)PC!A?Ca}Cj@ zsgNjQ1((!{D%R4BR=xw z`w!Qz3w z{PD(Oz?%2bHOdW^RpFJa9iWyh)c4nQC4?xc$H=noU*l&wg3=!^mNh0$Wmwgxg5{dXahZhHH`0s=Q zK0M6QEa2&~(h*ukqIWVy2x^-!&iB>Sqz$U0P;!a)yM8pfk4o?Edg|B4O*iNfVb@f((OqrorY4FT}K} znl$e_bPQqJS@;{5RN;N26hLM0p|pZ3VHWbf@aqD;!b<(=Jb6{O_EotRm7*yOuI${U zZ9N829d!A7i~y$+#;OXNPKlf(5^MbtSmCdp>-_MQnI?V#U1lFLC{!zzrGx$_53R}w51l|&UbAA+g z`*85jYK2+(6uQ@>`lHgVU4(zS{XZsN~ko5u>*Q58zG6@M6U(gBU?7m`Q82j9xUB}{aGcdylmH|iFlQ?v78bD9Dh8U#`^0>LvYvBH z${raNe{u z7|G2^R8+>b+eiHn2JOd!i~Xe_q-!&9LF4TM1eOyuusbC?qa}R@t!ygiA*e?(u)`(E zNo}k7qG%mTY{N2vbNr(C4s6 zli6}}s`+e~^`|iZm6IDIP3UKe4S8tyh+|N*vMTC+YUY94ojAK^2(e-~CqPvK#V2^z zYDKA#o!u#7PorwtN28A0add%R{bWP4mk6crF6`K&GI`@h`>0j!m9i9zxnvQnnsgH9 z1L8)vW~e;Kj}Jl1%SOiQ`&qc)-eh07V=FqMqbvDP+q119Mei6GQ{GJ;zev=rN_T7- z)oXV`f0vMrCJ%(!scH=I^?~RCrjZGk-4bq$!tfzp?DA)!IF*U>z3WgCrxJA878iP>D(UFpUxSTH@%vK#p-MzDEh&mFQ8@F7ag z^9gH!K-nGH&oz+Oz^$cQPwPi)7eRIN7oXC96k}kU0~J|Gid*kL-laO@o~tZ|KmcEQ z_#H?2RJgE7ojDje*Nr)>VW}IJ{a+UB>6YCPU|nx^=ypmTl4x#VG};e%mD*o!V_G-= zhxe54do&j}eV;X@m@vkv^eWKoM;>qNHa26yrSQ$%`2822K z3!5lLqhs8fmacxU3Th>F=W7rz#a{{_Xb(9kCWuUs=jwt-w`?mMDW{#Bzx=1*VJosI zPdVP9l-NrY!PWVweSNsHw!t93V8arkZ|~ZGJMQed6$fQvgT3xC+lfP1;Y$%+SFLGTch?#v=Q6`$kD{ zx1E`#3TLDSn|R_Q0THQ@eCF&CV+xhwmo9hC<9UVvWyg}sAQISy2d)@@@Jn7&!t76Q z|L>i3W1-QSyjJKi$!}()`Fm`wHp*?p7nRKGy3S>n|11Cvb@l>mE}BgWe{zWc8kD+J zng2viCGC2d2alA$5B~=OT`e#0CGEFM=^94J6DUef5c=OobE%D{jWlZ)JH-kdpWkqc zhEFZ#iGC{D*Ed4Uy5!51s#+?oLxk{|S$_y*vd@l@@EojW2ASjk$$xCUn=JrcE~|Xc z9mP!C4%c+B4XNjO5YZZnjA9vR`-4dt$_Qere}p-ptfugWaO&%6Je!3b_y#P6Gh(!y zhf8g5EAma+)!s=+cW8dPhWAg1IOD9-=&3ypbVORd5LCEIiF{_=Vy>s=7%+;5oYczE z9M3u2xOUS*C<;jYwUXk573(~?&F>y*MsFO}QslgRTJ|VKqmV5e1t=x(6M7R}l{8<> z>bJ7FBW_FzypzwoKecZw#qR#jf?WEHxR|{eo5xn`EHE&CxByz+YT&67M`cl7>)noU zoIzQqJ7N(fY=Z0^qY#tcf%QYsB`kz>;PSJ%rt=E` zu?eF0uGAwbN>WAwT64w88V5${Qt$z$JgdGoyzgeHj)nZK-i|62d zSCK2}f%rkp3)uqWwK1WZDRBgCz9S{`1RAC*_R{Q6Tm1pe&h`mmPvFfah>+%|eY16# zBCM$CQvvvo$`fL|?t&-tv&WoAQQ*NH)GO39jR?MdDnlbk#Dtt7FE+b(mY0E2g z=!(Dm*a*Y;7iD8Kbg%nJD7=GMPWk&5Z!m{;8fADpLunz-17K*Mv!$bf$9P&9 z7rI3nr&%E{E(5Qrvu&9l>}ddGVQw~Aw*^-bJ+5EM07XI7*yWv2L6G@7`Wmfzg;Ms*TuT_=RMstZ38pLy4%CX6TVTBA|BjV(vu_-vW2SM8)6cd5q58CQKL zk;ELY7+(leiz}EVU6L35ZIT3#hhy&&1mi|W8kumLqT^PgYBVZ9lrI`fMfL$y8NYgy zZLBrWlu^D8c0obGZ@R(VEEIfoV~Z1%TH<=N)^O+i%Oi>3QT=joQ%%emWxE!!tA-fp{joMJx4Iu-(*w@v{ zgOX#>bO1Vt>Dt9!xZ^FnFVJ~83TAGD1BMx^n?CV63J<$K*$5d*pou7V&UZwF!wPk` z^O=M0ub5nkT~MPN=o)g@G)l%USUy zDLraPBMD=mG9d*52O~`54e>%kC@ibWWl{Y)a4KNO6kzpu;0{kI7`4p)u!AmV&F_#U ziUoR$)~bEAh?MTo+9(-r6!#;viXE}~)o{V8m*r;nFtydiTnqs>EHK5ic!Vq?B6P?m4|TY*~rxcdOj#cl1m7^tkO$i_^uD}jYsyI!1lh2Y}a<1*z1!y zINud#N4K!N-!rTpPE`x)@7exZe?6VZk@)E+!#m^RaoDvkc54dPW@DZ>3+(Pl_ofh^ zoC)vVee_PpLyt4oq=$j{UBbEP1!*rI2e?DoJrk8m2G)I|@W+K&hTdX(kA)}tX#Hr4 zLemLjqt&(qLWzcTLP?`X9Za3>eh}U1z*zmN-Nso3iUXVbYA@lAk#cV8g5XxG=6AhB zBI)z~m-QlgN__V&J-hbrl-n5e<&B`2ECn?Mb=FHaIzlD@`o1*n zIN&&g7>t18-Lm5F;#y+7Iw=|%TccE0S806`MQMH_Z<}+fv4cQ(NiWS$4rovs{UCGJ zN2TD+NtTZ{X>xt=mC~66Ml0OTrC&V=fJxwd`4Bzsads`3?A(v+ec8SeCJm}#!NkR| zg0@;dTuG)+v}QemqHgFy+V{-c8e!o_H*rWD&0?2tVQeya$_;oIpMRdWG+LOgv}Sb2 zO`o{hmW2%1irv)?z}0*y3Y&fCh;L!Hl!E`%o-jV@oiav@kMhhxlX}x1{tT%!Hs+=i zQx*#ov5HmRhH_AdLaVo-<`6MwxN{*Y`|w^NVHE3W$(ehZ5mh}2OnJ>qP?-^Xrf`BkyM381}D`wZCWuQ4M5{!X1wr0Uh4)5m~__*F9135nJ#k zd><1pcjo=eWyv(w8sv&-!Ggk<4@*C(EReDcJIL4_6y_w^PQK zAfwoFK6U&A)q-#<#e{{7S!b0yg;+R58HeK->YHW^QFyLXN$f3#J!$_zb72dzI;(hx zU(ykgtv5KtTQsA&%!wiK&!W5IQ7JRNoj}B2Eutm(YC&3;_M@cT{c;-PO~G?l9w4<~ zhf`!P9@WZ{c+CbMfI7-*uN20fHsTbgx@3z=Pgk+a&NKu=9yos0Q+}rcA7$Yp|Is8$ z@}CTdP?m*o8=gLirbVOtYb&r3S^CYB-Y1y)XEFf1(;e`mTDb*y^5GQWR609U6^dwV zE#59CClR3uS+Nd3UqBDpuFnFLv)Z)4M5pd8aC8B-4F=wp3+?7DS6&r35^t65*z5zE z%|lSPd^r}8X&D0=S<5b=M9noT<6^zDvB(1%RVVvG6C?1XcMhjHWWRbqLT^VqnCAs8!o0HRm{oNQYonb56^CB|Zl>mk`m*NdqbX0v#G({0!c4uSosc}=QYk^j z?7}RcOsTdZ>52j>SSF0JsXvC*1&i|BO0R07t?UF>h}4QMANJilTf})}&g8edXL28J zR6u4LKc5L6Ca{Ld`1b*k?lHRoomZADFu%_|vbq~lPg>B;+R@!`d`OtAGWASS-dKwO zx+2N7;}svO`ET{m-`iR^)IbXET&Hd5j|v48I=|<8&JAw9v4eCYAk?YsZLR zltuIl1mK%G(dSTk;@YHN59?{9S`7F~<0bdL@Y_{%O{@Ezr)CQL{V((u_o?!a_~P(;bGasQ_u# zg-J?B4WAXbxHmzHPu{v&Dj3#mddc%HamWClSNpx=k#&VnA-2II`tcbNBmpY_KdbT4 z-0y0)|1fSkau$(tBY9ZtL$~1;tYecllFFg{+)4c^w+FJ-@y#2%>eVN@ zSk{|?ljQ3pgg4YP;>pe2_0lFdNejGZ<2ZuI0zj#4ip)^XM_ zMm$0>s~T(%NjjP3NzL`w_Ok$a>`Ig4u#_dH{JCdtkxPJ~Pno}>M-fJwTD(n(z`*tk z@_nc7W!{FeA-`nO(3_fmw>Np=IsL&!K&F}*=~wyRvXUOwb=qL%A^<}{P@dA-muo;y zLYEWyN-bG7H{`?~n9#i$TahH^ibbe=h>tHhL>JRf7U!<8o z`EO%V#g>O9rYU*f>)AiCl=}u5xs?2Ii)@6U3Yk@Ml?_M=IFytKt>0&hyu9mo8hU}h z5fn6@+d-2FqU5asSxt;s)YPqLfVbu^;U(jMUJFXFpk*BL>ZXQ_rrf;ymmOm;D6;Wf z4z!2jY-Q9mx|`l5_-#OM zeLN9`mXhLoWb))`8Vov>1Qy3)JEJw0n!7KQ;gQ51M2vD~z1bTySq)qLPsgwFSlU5x z9zw7+l3iv2hESqrEkx?Hk%u}VYmd4EC)lSQDaCEw`i>EcC%GqW?F?jV#8uTQhXs&IL^FlU`gkh#*{=)n zlQ_p<9e5R@Q(3|m+vOTUX19!RKng8U!Fx#O!{Szq+S3vwVe+!usoG-?%;Sz0w zGY4(*Ny>j3`e`;y=X~|3tUkWDCmfsVj|5r$E?Y62mpWV-cJm6_%7lw}xJON#@aA@! zZ>2aTh+)oZ4cirCvGoiBk#;Dbk44l$J=%gpOKCrf&@<8aMHp8H$QY*ICIYozkN+8U zVvEJeiJ>U(c%4Q4%CpV|pfG5ZQu~5z{{Q33tEkv2>mpmOe}nAr>u@$w22iEx&^3tQ z^}yr*eyy_Pp%|2vs~uuYkaZbP7w>!L;3**V7#e3GI@valF?a0GX5Gh~lHV-j&Rr02 zHBY-cE+>w~mPcyvKrL?NPPv3b0!Ul+{!rJ)mdEMcQ%?UuK$LisI-A}dn=2Lut47c*iuM^=wh=9cMLvC|8@J^DgM;%9WSOE79SXnHxole=sS&A?6<Ne$T1~;@h}_93jS(OFo9NnxwT64@+!E6 zBYW?KDq5y}Jq))|qx$;@MfVq6llPCvhRpNKfA4F+K29G*e*mu^#bt zWY!j-_Hdb;X0zX_Ule}`jQ0J#I(vzR&$%zH4|c;FOn0|UWN8Jb78#suB$5--d7u;=CO8#GPm=+K{ywK~G0R>Ki zZK#ou(mPLe`3v~lIE*;mjH^)4@e=};K&UvB^$g8R7FoWEbpxIgh~E;YU*2u2G|=sm zvBgGJ&rcMU!nmJ{l@_3}e6I!xb`}uO`jcu=k%p^2ZdqtgTc{D^iwR=QENcX@bRFAN6Y@{p+nxR;qab= zf}|uJRg)jBH<>hr-Y1$hDAc@vUG{4pP+|tku_@al1b#PUJ$r;0_;KH!Sy^JvZLJHn z5Qo_I!GeVyG~a>bRJ!=*n`S-HRa0Zj0qqr52PI@+6UGx$W80Ft0vc;{;>H~iglE3v zX3v^$k<|;OiR@51hF&+<9s`L{pOuZ=zoO+@uzeYt6 z8Cb|7(zFL5jpy%HxIQ8?>UM?betZ7oL}UJ%01U6rk71$wDfA+3v*QgtQkx?bP zpGH(}5B%sTRKcGXMOuWxb1OYMvu!Z@tNl`4U)s@>l9L}8X@8l!p-UzUV#EhpN_izj zq@S2us&t1wyr~<0(SG7ttYjFx?we^>NIdmk;zY$ptfe3Bqi5I+v`FCfOxS{NQ9$46 zt5x+<&^$z z*=jlqh|_~6+4O<(sdU@>tfs#DIU`Ogg%yWctl7DEXdJ!^zpwu`tYoO`-j)5L!yxp3bB83ZMgwBqVx%q)E)*j;Y+O^@Ayw85==sl-*vC@Q>~0; zcy_a030B)z%oK)uDFQkm)(!IY9HW#V;%iVLGLMJ5r|~IeM7pF^ay`Wvb_Z+UuS#G-=gPU1RRP0p(e)}R<_9>IA@AeWviFRaX~ z-+axb(oE%cfWPu52+k=C6r6O~xW^f!a(AVgbFO}E#Vc(r^gBh!Cd%)~WAkpUM7P?n ztemb8EPC^^x;KM(h>PTw8apkQ2TDn=zZi=@6!n4*meanr0c!K$Q@7l9ue>9uT%E~4 z;(EKUXhspA6Qki#-#ex7FO(wXmD`H3E5w!_uzNUTqZ6Od z-KCrOq$|LMJ7W%*zdztFv!3?K;`9QPTIlGZuYZWO!y%}gxQ>-?;Hjuku~}f5QFkWD z+`XGrNBZb54oRfy-%CMsrc^LvxzZH9v#XP#YKG>VYakzE3iG-{;-!>sCKD=A;lSPG zbcpo%@HfXB)rt0vxSvfd>20Uod!1hK6Iwqd%>Hw*rYpE1ys*fuAvH=oPHyLlGQUr1 z(9GO-HU0#?UK5G4AxUQ7T}@ICRFIE!lzJ90&3neZ45xz)~=scEcr6` zbbHp|;3ss_qFKNhn_D{7{j!*|NfjIZUeWWX@>{_wswtO(pK4=8dysGsz zGC}LiT6L$rA@S4prCZ^-5U%wk7zRQAakN=yA9>T!PNer8>tfCsud5aN_k4uPVuje| zVAAd7{YfB?&M*!d2!duptYX80TA<)mckpn2%Fb-@KD0oi#lE`>Qi-9x4dO+8s4qZm zU`CEKk~v=ob!S~{CDz_+etoCum7e0c{7UJ*9+Uji1ZbvkJ)c7)Z+r@Px#M+wCN)y9 zDDh8+iY1>r^hK?0mos

    dL30u_S6IOE5~yh8eiN4B0FBs-@PNK=9dDDtg71gdtk z_Hj5e>TtvtfxT*VVoZBe$F!4Zu{8D&wUAiXZmF*3a%d@!48ZXb& z8Cr7085{$Xatac(o-%op^!~H!h>O3w14uiMklJD=T}MgU7h58iMC_ zH%9?o+}*IFpvyhgNj;Rxh;j(pi~0164|YLJh}waS%LFO3C-0=l%ID-*um&P(N0wSw z27v5uZ8gTh#{DYX1NxicIn(C^-sYr~s@EeK*^)LGc;tm!wA)8dD^-62uz&R&MDBJ^bQ!Zr+S_381=|1~%UAI+XQ3lqo1zn=w)<5i_ z%QV#tNGNkBxMUaRpEJxFybRx%5)6%q>iSw0D3480#rHWPu{1#46$aD^wklWRk?BB2 zAu)_YRw{SgJvr%TV2*q-yd_HTAs@0&Wa6ZRdLq#$1!vhO*CCvpn8w(FV&`@`#A&l^ z9eX1Pz7b5NX*xqe6xWm~#`$lrEdekWgBWk^Z&YEN>q_0dk!E_LHr-e04izSV7=cxC z?kUVK@-3IAp9b(gVOFTlPr%H1`FB`7;XB7eAng_o-8XkBdhiWz=*5?zTq{Z|4HO`& zp4F=XY=8}3L~SLw6J}}|0sT1tA?#BLQN{Ap(zrTWak1gJ9T#PfHDU8Q;08FX&lFMm z3ZDp`voN}Pcm(l;mloT0@agS}8kyfutE}6=ZqDH(y8cZsq%|3_vR6Z*_M0#QFy>OV{LL=OrN^f8zqUjznZvWLKC2an4+j3c&0;&L} zIzXQ+&1z^YcU^SY>7ARB2=aA{g_9fUv&}1<`kswrQV5;$BAT; zHIdL;TSJ{7DUrnk2|JNf*;*h5Pscr|jqWDm7NKNu{Fue30*^Z1s2mUCFpiweERp6@e}V?KW#KuF7c3hF0zn1Zz1}w;OrDcxj2e&cKwk~M zfwq9(Hhh|ryc!Q&K~na5i1nMW$`JW!-~iq4Gml)Il6OiK^b{?Yw|pJgk=&qq%=;`{ zkbS#B7O$BSFtkj=AmYszqC_(kN>rDHhYT)phomzcT@pz+@R}rDOe66?D!RYhZREr6 zRi7q1_j?#KNn=l@6B9%LyC^rPESQ8a6X*Xy==?~O$3svwOk0zda$ET$69kYY^9}?$ zTt`!ClF;DYxi#tzGtdGDVG)!#o_~6s5Oght!fd`t!-$3*ecQ|DJ49%M_`u5GrQ z6uZF$B2YL_4!L{c>A}U`2W(o)sEw7mT`xa?bd*l#r<*ku4*nf0at8Yn{_glTQcZjd zg{r7aWk2L>BO*_*`K{G~8|Z?Lu(h4czToqJi4E5q{;I-*YMvZs~{o__G*Juiz*LvxMb+<(GnHINsd()e_4oe`{fto<;NDX zTk;n(ROQxDqGjDr4z1&D1D4R5F01h+6VrFn5!KheLj1ykB41W}}`n1f`Ycy`C{UkdWw+F_<%P;uY z@+Xx1=2X9|*x~&YNf(E-ZY*)x=zO;hEL#rk1Y`<;ZNaw!pvHz4Qy^|<2L<=>!RH)( zjumdHgVxMB?<2Nwg zBUJKhkF*k$?RJ2DO{RD)wn2jc;(<()#YMS4Xhpynw~VzT)8b7bi{QP9j5wr`fl(qy zWbV(4gF&KoAf74GJs3zut3^SvTDU^(^4AY)wvVvvFC=xYws$168%6lmE5MDa)It#cqO?Asl- zBev^fD2HK%iG}?93oP_c0oI0F#jD$M?HA2O6<))Ez@#%fdNq_m)CGUQkngsCv8OuQeY(aK9tr3I9$i+E4 z*i|*y7O9jRlUJ(TV)RGU`l}zr5TPF18^xDgFp=CO#PGLU7;TU9vB>(5qXU}~!d~9a zhM~K*ye`Sqk4-tF1E9%5Zpxa*U}2#kEwK8iufItC_`Wth?2ITjn!=IVf5fzaWXZ7H zWEw>k;Nj;5=YZSFq;oljdW!&^h|{c*%ZO^zFtr)Cn-N2r$4nZ4&i8uRv_=(x@AV5Y z+{+&2L2Ql<)A63ZzRxnYC~QBCeG4Ac*l8^vGy5ibdaPA*hfcFG$1!;?sy>P|3}|W% zu~H@!3Hitzd$il4|1AL9qxBSf0(H7gwWU3k{_o@xDEx_xT`c1>6VEIQf-D*3xYx!l z4d=oyr96KqO;{QQ!T>oPY`as z{E;yNU&F=0*Zkk0kjlaJ9Bm1!UCcAylj`!WCe$HA1CcMwOr-gini4JJSCPq8;SQs{ zL0BOMWz;src`WVnp)>6DDpdICXF^%-k|jFYyTrq9$<-|xJi*pGB*%mppv-Y}`&`6{ZUcoVQ_K*fS2Pr^si zlpVXF4WZ-+wL)#S>EcdQ1ZrSdzaNn*s(xK$AiYr)5nv8DA7-$>JVB``g=T8mD&wrb zzOhmrRsAFm>AAB&aFAR?=jIem`@=GFC!OUhh-MupNo`7B zPnp`W7J!*0KA(9a%8DA3g>QZ$-157pTz2Jn7|5A2p6x}2UJ)|cT^C8S`-I!{m^k4~ z@_VCZRy|H5{?d^VB?;T>nn0K<_uNWpDOwOGfAwZB zW91@T5%{QoVPlb#1YuR%)C#%p4m&{C8zvWiHfac$jf+RUZ5XRw(2pQr{d%{y5t$mQ zt~ad|s(#jjfV;>2= zc_A!`*N+DLeMm)Jkv=DkG#O~oTZMrW5)pt6re8WF7W1?Ltb(GwPqU%vBPO5P_vJd; z)?+YaxEO3v@A&GbpD$UufTW{gRrUR!>= zMG$SIo`pbAW@|cve6o<|`TMGJxS^Qd`ulTGwIU80dti?>Lt&d`$6eCQ^v^js+-n&M zvJ$@MON|n^X_0=KQ*Yxfz@6yAa-}_)xT6_&M4B$>LFt1iH=!k?aG&sl6`kmYudZQ< z1xH?S#kp-squdE%dwP)n2^oJ4VHSl}xIuJ`q9_OatknDB`(hGLmH-I8BB3coZ%WL< zaknL`fyb^rlWbPy`n^t7XqapcjBBhFs*Q@%7@XR2!g1r~v-3LDXOv`np=O2fUV4-U zqKi#|#D*3R9^Z!g-Vl$i%o~P73=0@)heO7cZ&pG&;Uny&9pDI?^OTjDca*`a-I-wO zZ?}_$^S+Ml^4%1gjv}&t7ysxU+H4*(!9ptoP|33byzL0Y2G%=&FPDEN``p+F3fG2g zc@jKZn~l>{mJwpL++jf42FFzU&ul_IK-Q;R!UT6IeU*~0PP~AV%)*Lc; zIIqlF7Djqs{qCY!T0+KA{xqu+kw_f-Lp4UnqK-6nEW4d(ZyyrBnJYF$h}ffY3K7fY zJ5{Qz2m8`KiL7I3emfEAtdFeHi;ORxHE6JegTWhHObP57fk2pl#!0f$y&sseBg%tOrxmJfb#My`NI zH`td0?hY>GPnV1~f_>d%8sQ%4^~6_MSYZ)GoZ}W`4vNskljtbNReefP!Ww&2T}AHi zr(0Xv^im=VA6tpm{jG)G)^g0JAQbf4hkWq^iqw_RQ1?0Vh z@=N4gStdM-7z;~^nX--nwYwif4iifE5{dJxTb7#+AE#(P8W)VJrsR8XCbwa2(HF6c zw2w`ggYor*w3bI);ls%U$XRgw3rDcX>`Oe(k`c2KtHMs1JvD?5H!}Y_#LZ^@faj`b zC9BeEbHGp){;a5ke-5dWy<(h&N*eJ$I0UT}rXtlvFJ`;%w3eJ-3O>kIeNJrKL^I~f zrTD+#eCMY?{=rn205ET3jL#ocd$ic{mLiQb)CFxnrU0E&UDjZ?_Z{)|YDRxrV*USn z-MM{U_chRf)^r}mB#-o-@J?xlsMmnbS^{(lyy;L&l1dYyn${a8~* zg^p0+#9A3gSgN7TFG&C95~UF-cYJJ;`v~ycn05<@bCoRLctAHq2I{HCLmCn8;i?ZH zJj|+0BQMbQ#7PAnRvCWWMCNu2CUI~54eAZ2)Bh1~3M^fd(Zg>dBXtK z%8D>`$+g<+7u^vgTu5`z`H5qN0a+7S0X%GL{P=5o_~ zLIl&Hoy(AD4)QB6U3%TvUdOgGt{HHSDR9z@v#u5 zgJfPnm;}fp5(){>Ua8!Ag<`( z7Gj6YY3z@PDTm%i5o=0eftC>vPKlm(An-gHLMGTR$=#Kkk=3|py7^A#`OTXdI`!>Y z8$7=y9E(Q5B~do3Q_lJu^vz9{iX$cfs%wD&-=IHo0O^618<00#GM8M)iAZasbwFXZ zYE`PD;cttE2A#F8NboE{HIu#yNgc??W;vj9dt#ZL{P+Bc>6;kWoMDdacX}w?=4Blk z8S6bT1%AbsXC{`}>WPJ)T}`xjO$0w?z$3<-&y5`T?UD#L(S zSV@XwSsL&&CYPYi^kPqD3!M4CUNH8VLNc?4RgT@s&>cUv6m=OH5lN&#$~+y{cQGf4%{AP;9TzaK zT8sZLm!`0g{5?8iG?yDBx6W|b0o~lQMoO3Uc~|X zP)+!uniu%{OVQnir8gXJmN_*6GIRMsFSr!_`AXBJ>hxqhS8_j&1}0i5<@f8W&;Ibg z|A>_II_jo3`4h?4@(Sj%!1Ij)<7m)f>S_hgMS9uSxF*3EhZt z(WU!B(pUYKAPHi0WtFme{Q{`58E7C9T8!~ldYWgJdXlhw`y5`c9`~Q}Hl4*zu%G6$ z!We^r50NxvIhvS~O?ee<=jlQy(1U>zBB#cTVUC4h-Fv(XIFrj%cTV7Tm(sw5OdqmZ z{q*%WubFhVIAa0w&8Uh!2x55g5W#2>5hsH1S+(;t$BuL&{rRD=9VE!l329m zE+&#wCNHJ|3^4fQ1LJ-K3L!Xi;4?_~!_blJd5N*f&@jRep--%D6Fpks@QXaG8;8vG zjPkF1!f3dNZsFuLA62ApnZZVx6np0$ z`km1);MN{=HZ5`xa8vRYJfL;!G@=E{q#>W&MxqgQN72ouDtw^XBi?2a!N&Dz#B!AXew7*pI`+w!hIS z8VA=b=BO1-YXu3y#L;K(VxJD{8`Yk4#Uz5SN_jK57bNL)cpHReX9-BGhNi{xh&RGY z5h%x5O`C)dC2jw-69`DeNF&hCJ1VG9gIw)*LR$VRM-<@S7Fk1!UF$kqtuftD<#Mi^ z!of+rPZ=<1!ut62+Xn=+l1D4kN0*!ys}40F^)BmQ4iEIKl4ONQRn?$BTjQU4<4%`K zN`ce_U**uTB$ryfH__^s)zyIHa3LGFC(WIOt4`FsHnp5WJXZM-Ovvw0PuEf)^%a}f zLa8NtVeS~92o=!Jms;Xa_a|BgWNxdSUfQ$#DB8ize6%m1<8%g0(2zd)ruzpn7dAP^ z8DsQdIJ}$H?JfQy%P#FNk*!Y1K?^0!+jx>4{?8V+%tw47E`;)-Y&fDMROwp86THyB zVQfILP<-ZgHz|6KQRDfhwY>ik=d5wdA1Ox)kSTP&yTeHfAfS{o-Y#x<5oY$m8ty-x z{+Du=QU`?CZNOEmAV_$aiKWgF)0?YLFCgVlcGCg*vc4);0zfs|RS?T}2{h zjo(C4-QFD{^xNvLGJhSj8j_634PP9Dso;pEmRQHDnl{ar_JZbUMf;|?qG%Ttn?`gl zj0Y8Y`w=vAPDtL2hA6P4 zJ&VM7JUPUG`4SH&os;`!KWNsXi4r@@z!p6`?G&S9nCr;!9S7GzK3zrYvD4_=lgMLDFZ$`L!uXpmST zaop|`V^XR=SnIVb1pTuxTb|O?nlw=Nq*V8d*AX;u*j>v)o_2bc?wc8>l-divFt5K! z21tMVm8opn&)(Ym*1KnqrS^%_Y5C+-3D%L@jX&+iSSnja#erS<-N;3^z0*D|Tb`c7 z3(?SLBuN=S#$&=-Q{=3v{%R2jJdazc`kKFgu&Y^WHaXh)CFDRWK=3|<^Q-xsl1HR8 zZUL$>O~{R;-TJqc0^ra)EZ>l7ubQWgC{v`&OelaQ0Zcy4(!$Sl>QLinDhM-!4 z*Nt)sNirr;zL9F2yPRKW2QA|9wW7KX=0W_TY{wXqzR}% z_1~P0V@!l@@lt5k$ht#^QLe&r!ZULai{*#Q^{#(9!&VDwsHjTxt$PS0-3)Vo$M214vRX#R#`@aejF;xA(ZI{? z{eLMkQ%Pl*n8FWlG%h=x4WjT#3Y>{0tIdtQ-$*0+&n2PzgwN(U>}N-LMZ!xYo9sMj z6{qeO@r*0egu;W^8X8p*iwzm*MOOjn09SYmhcZG>4M7yhZ4kaXJQ~!F2tL72HB#UG ztVFOOIt{-3x}T(*?!*+5!F#v?+lXhZ&N(XKNOiz=qHr36bsa5Z09}Tn&c=GtzFTtN z1q^9Zaa|Fxxotun=#ojkKc(~l`Wh6=0%RHD=yP#>o-@@q=@udty@;En3=JcR`f`4R zYPut5KCjelbrTn2#$deZ{MxNB?VS@z#Kx0!(eDK7Im!C&geMZ9XZ%S*Dc-K2u96jg zUw)2#J1+7Nq=fRTq&cvDT(0S?VDmrqB9tT^vke=b*;VlT0csyz9HzOe*Ji)0b3I%(;Y7QG~#z0qC zAa){rGS7!xWljKbs%D&V-uMW@Xh( z8m2dGvb^fNUKu{bv!i0ruSyFm>?ts_bLq605ucr|w#E>y1vkqtS^H)gm`Bq5b)EMg zhir3`aBdN&ib>4rn#}?E#j!7w2$EVwPc%SKz1!sYeLUMU+`;t}vRrL^M5R8}ZC0jg zP$E=c4>UX)UH_+x!U4fQGPN4hz_c3lf?D|G5O5{BZk1<-zd-6o`73Sp5de2Gz_>n% zHM!?(H$^al(!a5Yr}qWM=ucjgGiZr$hyowm1zH2667Qkopfg18_t<0+Qu z!bbU@_M6D$Bqw7*@}CQ&DK0hF_ITTG_uR{r1oL3}SF2ZHhOQt5JT^>JuUv^=rGQ(K z%+wZbqip+MGO^2j;?=XAQ`hcRcZH3#b`Kl0K3Kp)jFe%z0H{#~KYyVX6ZLz%qZ;Ay zXhUzrt2e;60%FAcX;uWI?c~;;V0fE3i$bX!vmI6zm8+YF z$(#)rO$;aoNjrW!ttz5-NkQ|=YRnc#QwXFG-Vq7|w+aqTz##>r^F0O6S6Bvwj!b`` za#;y`KXQW_@;$ zZ6Z7OYSS5+vz7ni3UXb&*C*-dJ%G47QD-mQFzzhRw_Zz)b>3t+7qO;F3eTefZ`@Zc z!kDu6CdC(N41dhew%}WblFzVL5gS6}IF#iwApj;7G2yrWt})f0(ab1~f|XR-gD1He4S*hV)-_{vgICg4YR=e6>M@sx8_3L z^R#642S*K+9MjPrpX^^;fV_)sbq(4Y>vrcKTTZrbf}^$CiO-EROMxAOmSp< zBEBuer|U=%t>O{*`<&!>o5I^hq3QqUa7*V=2*H24t%VJTi`cql)p%rG;~bIxm(%(L z&V?&9@eX!UAO$hZSuj%!p7@n1#=C9C^GtQa6|%NG$*$NJqZlz{+8q^zCKys@KZc#i zM4Gjoxt4&NBrkUWEr*(<{8rKX%rP^iucGIph2=#c_`)AXtSshE)u@X@UsYf)uF?-Z zzwPV5J_KUdb=co50uc1}%o(A3X@nk4=pSr_t5_>_+*H7ZF!C=kkEjas3Y8{Cytw41=5{~?QO}gMs1%> z*E9N%1_V$@HtpWW#H6>33lyqVU`2VLNrZ>V7%%_*yr4yTipOcqSuY=B9vTBRz(L8l zcVm-K$y(7x*IGZUN-R%h>j%TJUz2J~3fML4kfqIZriW7WR4Wg87;A`VR@jmGexg)J znbISJzrZ=|qp^kCT)abtWx{L1o#y~Bf4ytvAixxTywa-iJnI9CHj*15-*;;bYhG{* zd9ZrIh-D~yr6TBWW`|Yy#uN2Q6Vw638avp$_FydEzvLZgeAXRgfERQczTtP+04t<6Y(vW(SK)HCYYWH;*> z7*o-);O0~UlQCPzBv|$;)sR84?@W<*S{py zzFqb8$Mvf(^FE^{LiJMK#XN{y<1`df6o6h=ad&gNI3Bv8fA5sAZQFhFI&H{aB*$z8 zB8T$>HQ&RCg02i=-PN#<+v6(Fnh;#k|n2m5c}~ z<+jjiqGfa;JTr0Pxvwo5h-}w>rYZi=NYAr=-)WUuSi>Mxu6?G48MPlXWj|a`2RWHp zEtYcJ@gBdy*j;eIU}y(%k2l~zv{`HHvG_z)$+)iSXTK_33AN;Xe9+_i+}NkidEMoG zmRmuQMCm9#(g80WS&f=U>FSD<7iUn{Tx*NnON^Ds1lb<9gvJiE@LKtpriotwLW~~p z;{I$wB+i!7{bgTSL@rP#qelU<@YFo}njR2z&Vjg9oY*(GMxdgXAH%gkyG3)p;=!sN zt$Xoo+N9f9=L)!3K3TQA2QIYh|DvB#oDDE410R5*-fu1vW(WPdcguTI=!4_M*-77b z0#U0EUw#n^4JNYgJ2oh#sByT5Si(tke30TIH$IoAk#82v?D(|Ab5%!(6w zZsU2xTBc6c44bXy*tibrA4FdUB$h>QbObOxmmoiBk>QSV)4!s+xpK-|59!A@LG-n#al=I@TKfG#QKhg%jR3{CZhLA$^aP|fT;G-W0{%J$Q6PIM4W0b2c zp0q@woJCJrm?8ok;CCGevvS%ez3~r>Ma(pOTcZGGnVf_%DVg#vkf{QVCm;*#2+ zW?r9?K52$KSFD$J-$ggNp+h~_f3I)Bxl7%oiIHUp#VtL$p(-O-Lw|7iAiYVcvR}<< z2k3B5QbX|&FfhW9o7Zlg=@!Lk7O8hec$N?k?}#9r%dSUYnPK0`)H^MHGd4|dJ23zk zNum?><>ef+?l}wwa_VFs*8z>AY#;KsegF=yybzR7doVnfr>7z#V__b$qbB?B)9TJV+ zHK4n8!gNeBNK$v$5nPuyB+#Wnx;Piea@_I4^%D55_&f%^wuUzo-7G!qaBLa;MNiub zZ)D8|vyxCpQ&$-&>R34w>aE+^KjXkvV$K#8BJ*4JD?ykKsMe2=`=O;XZSQiMdMYES zMO{$;GO52~Ef;i73?$AKQdLGVQ0Q9Nm=C$)fNu~he z;cYYx?V4>GzX9hw?tr20Y1dq*WZV#@z^QVEY5%p3Tqjhn13Pkz!#JUsZL|^i-1h`6 zqHRCES)<&Z;nd4Y*acRR>ne@R!n39e4IP!{=$JB2p4vB)oSgzw_=;}d6yD4Zt4X|_ zyFvE=J)1k2GV(pYJ3wlXrtqs+L1kV@m<7?f$QfbLNFO@{g$U;a%729};vQcFoll3% zlO9x7#bs^HG9wu@CJpN?bQ0p{@RJtJgKq9Wc?;D~+$O0&kG|D4Jt-cpGBe#QbK$0S z^4>Gmwa;cVA&n+-Z!oVIc9+3xfF+MtEbwy7KjB>d;0553yvd8C_MF-~y=kN6a%q5W z*Dm9%Afy_-Hc<)2HQJ55icK4W*YAsxHKs#a$t-kQ**ZP{Tkxxw`=rZ7H^f--s>3kz zwzT+Il4yPuwgxmix_i^iR#m%XxM9e~@KPsyxQO2~=^BUdFlAdSpSL*i&g@67_Yc+C z_%qEz@lXxO&ISvT&Z^B#CY)nfbwwWCE8HRxHn*f?-@!p$PB=MyuF(2YaO&CbWYqF? zZNrv9;k#7TVX2rvwv{4VHrgL>}x04c#8P(Bo(MfBH<{^l|1Qvd0;9 z%f0U7=IYxEcVJJuqcD|?o!mQ~c?M)YCp00pY@=U&90%N|(r z#0U>94Gx#nRAkQN-|BMBSB+K1J`~zX4OZr&r*@A)hZmaq=&8`HHZNM2{t%Ba z;DO-aOlcEwN#(?$OM7m{fSL%F0iWr8uSxh|_tGHPqZtSpG3a!aJp#<}(papbk?D*G zU1z75HFX!{!=f!`M(6DT5|qS__%d4ipPYziC?kfJWKoS53bnxVTbiPLiy63yIDsqm z;E0_{&uM7ZN_h|_8k#H7o;at(0nGbo=kV4Y$u;h%yr&;Nv^s>YZ(%Co6oMhQNk)9b zpA1%LnpT2H9pQFA`?=6)sBB6ZHfjkHG3cpe0YHwEXqqmTsjJjB5Z*4=pJU>UxBuL^ zKs=1J4heg`!sZobZKWzqz~^ZRn5k~gTI##eSR!A9PVjSPXx z`o_!LlKs;Bc4kBf!Pemtg7bWg-08#7!pE?ACt1ftebOO~3!-bAOgn`;_>{7we*iB- z#%{Afbrg*El+QQ?3~HsNQ4{&15w+RyI;9vJ5^@i=kceSzN^_IubEzcX?1db_C({Wi zgFtY|c29+S`D<27`L`Mt>jQ~3U|Z^q4%DrP=Cd=6(t)vSw-T)!G5(AKup$u2Lp!j3 z4|0SNe!>9$dx%SpCChE(#NB>!oVCAnFYl~qBCm;?L#%yzK64`CMMpJ|7F$7I1+ciY zl(4+o4F;z7 zRG5w!L_}W3XKhPrG3GWwV{A~?3_-=5aas@k01Aq7D?05E41A$(wG?_H|_4$Zw6Zc$jBdKH$wQDdcYR~jn}jYg*jwZ*#y6Z zoq2|r=uAa2*aW4xQR~M8`dU*R6qo$jQA1r;V4J1;9?;x-LqVM1p(M20faeQkuMXVa zLwYOKb-fkHAOYisnoesnz_ODCx?By{){LW++?qj2-R-PMocGAPux~`h>hYhtTut>* zZ{I76cCC4&cGulC^`zY< zsZk4Y#^9LHET=CsnQ`GoceI3o$s0nr9kPx|FcovS)<#620=3iUR$uJYqlCfTTiae+ zNMuCUh+@m!i%<{;xgOfT0tJp=HSRPGjT_j3ePhmrs&xuuHOJtbo{J$0jP_+IHsjA` zeks`?romT&uw_1Y96+p2YYCD9tFO%G-?@~Ld}8<@X|!-dwtJOTIKkb$heLyf_=TmD znNSJU%lHA|@^czSTwJoYyDP_}x(){54TCe}V`R$0lH*@lf_a_8jgr`AH1iNLWmcwn z{FtKGHE-+q8Z7D9GD4=LVe12!?YfWk>@do-{Uq2ITc2BJM3eqcW}LjmdM*8X!43|* zzt%^=oc@WaQwl;h&Z#8hLk!EBTX0bQ{gCz4w%nNrB7M2JO*em#95QAOS>;~m=lS91 z7s&{wM_{}ljc@$jRVcc$Zp>ebd&N%fr0Qk~1Fj(!jb)3hp~53rI9`1wTH50BqO5JI z(ISE9ce~lkJ?fqL2{BNqkz|ktdLz%teHQ=K;w6mfJ)#3uJ~TexNws66Qi7%Dy>=FC z&e2d_5=jK+x$Uv7*vPS5VfElr5%#JEKn7gMh2~9*QeED`B`3g?RE*J&bG%X9M=zbu z^}SDt9iP_9aCSg-tDp!9V0X+GhltVmH1jsH_ZYV{SqMm!fV@JXNO}_^GQeVT=C8~7 z0K-B=_93~l7BrV(2e2(p=c8eAhr#`RNzQjS<<0y|d=jb^w~%TfBz^u}N7K@EECX`s z#!ROmBl20}%vSz`<~qS2|K5>99f}3w6=`wLfMd{e(#0p1p3@25w0IQ(vr@qy)2AD| z@m$*juRVz|xw{LQ)?Je@$9Rt?{D$V40?pk}9hHZd>Iv!#a#nb$kk$ISC{(u~`cMko zQ6IRRS$xKK(4nZ{;5S(2To!*X@Q{FjM9Fv*_)+~l{yq)mG0yW)+3wg|{j?=s7UT}C zw*X9_z#|hLfJ2U=J@;S5s0zUXo~uK9=QEypOgIKww`=;~BP>BnCeKV>KR4~>I;V*q z1Vvfd&BvxGZy(FxDy*d~@=MDQ)In0aAt0VLZ-nzpA!Y-|i8 zXmZKdA#h^*6DUJqI{k{Fv$fK9;hy;kfBzJvq+WV9Vi}5FxG-fXh#!(K=*%FusMS`L z%jLgXZv8=D)IDSG^iCm30Ye(M`DKE4PHUc%4!HchBg7mI^HzWcpQbM8P*FF1uB+JJ zu{M+9$oI?-vZB`34HSogGVN*5>t92QqNs8Bt_A{Sw|zM|X7|vF+Eloo;SVVvR?^84 zNi|rB=`6uLYzKun@X8mgtXJ~&h23AMS9bT*`F$u#V^H9~s^ia* zyRVmWhLZ_4IyzG|2d}iNNXfLLE63+-{v-_00*0^Mn08X5(rq~J^Z0k%kosZp>3>wR`{G1H?NCG`kYj_WI zrCwV9^Hkj#;6J7uC+VlD@ZgFr@tx8zb74{KyeN5Xx>!{fV>}_G)Fm!=;u?E--ymF* zjNLb?Kb?Xbs45auGDL?F)~0|`?^@xh3D8j&-{)SWQmp^z__mwCL^guE4BH8CM@F!} za{dH$o+_4}l&!_LgaYmKf3`Rt{~CzPp|HB0*PQ~0l@FHwOa4ks&YUvyS4ueZd0myy zz5YM^Xu0jr9ayaQPZcK6B7!b&6 zU=f$ajeB~@Q$=;nGO3vpp93Vq@>@Ln>jg;*y*En{`??Rp<6={vwhC$z?l1BE&SzHN zNf>S*^O1M3!p)}Bl^@JwYf^CaJcCH{YwqlAa#0x@w?0d`Ih!KJ3$IfI3vYTWzAHAwcN_Q%z>>l>ZlN6l_$t(_siAa z{79CuxcWCy>ThCFS!n3Ce9R(E`xElCOxXcZ{mL$`)l1EsC`Zhd!0g(9(QhT*WXEmx zqiw(KrAwv-dM~sqJBT@XkbT$e#zc)_3V~QKwna?^o|PLe6tH)6y*rYhNlOdxB)ao+6Yri=~JsjUuIbU4znBVe)T?1O&C`-11~a$hi_H~!HK2g

    `tPKh0C ztoTb|?QvQ5HtKW+7ySS&l#m3BK*Nnt*cP=(h(k`*A?>w~_K;<`cDyxjZ#usP+9pI$ zYwTfSdnY=e!456^&Uj{44C12PK`Y1MT&4BQta&f$hYM)ece zf6ewog<7Bs`8tnV_;RBK zR%BM;FH|9V0-49m!#a%2KIM+e3QMnHc9AK*4v|x*4puj@SBd=LQ=)E*Au#G3vFFv? z!R?hfVGYK68ptGRn1c&V`1jtu*E?Xk197u%KHG4!j@KAZ$K z9?jzlgj07%z5V~ngNj&jW9?&Be?$EfO&%*8YBFPpR6rf^kV$CIp~vQXbKbxD)r-Vv zsa-21lWKf%dVcz@>Yh%iaR+EGov6Xm3M2|shyhDv?aN*DM1Hx*Lq%yv$H@DR0zgtx z^%K4VvgR~&0?;GWfh*CaqAFGaY+DUc4P!T1iP~JN-Hdl^xD0nz(H9zC_W;kj0`S^P z1W%!JNgH09{^vfB(G7u<;$%8TUVF_EeJ~uP69jbWZo9fr!&}^UR@r-C!6+Q;&bMID zeqX^%mlUkawu2g?cwhDS;U6h*mgwW3hzQ?^6aG`HBD}Az;Y2W=>OrOo_8Ej4oqd}K zpjN4mvX0%$KY>VE99~2&>=^8p5{U&C9DTp(<6|b>?7?9}zE8OwWpK~1(K{C-7q6Bq zx+8tdi(uwGj6so{CWI?2ug?RSrqfD0kN;SU6v^EHX}=%q^5;Q!##_iP2!8@$Dm^Bw zQ>*d-zZJmagWgmgV)~gm>w`O0uE~_*;^f7EnFy<5d5=gT+Mqs3j@G}5&I_K zACK$)t9K4I`3pnY9E(p%kvyOBM@C!?CZ}t)i#pExDg8;6iyaiuxZ+}J? zq<(Jo$pfwg%b}hlYoXZs*c-}@d0nRmU1YU5K;xU%K}8Aw7iSC;5c zm*buBa>~|HxwGB_!H)&NTsH6AR#r?qLibp%mVa1A5LL-`ngN^J4|5Eqxn#^7yMoik zClEc!E&9C24P8=0no+iWA+74hke4{MgajoYR5!bDhofcDRGrUbi#J&N;>7Or$^Quj zt6Z^`#9$doqHn9&Gw*fytK||nP(>fC=szK2E2lM0D+GUFle#}$BFAD14A13+i}a4S z#YpY(74e0A8JKY~*Ks(ip+oXmf*l;mzFpqoD3e3dV7=-2f3CyNfxb2z5tdwQ6J^dB z5J_kZ;vPfnuF^{1>+wK@1j?TKeEJ10hrrn(Tr;7gbB2?E71FWna0`2TAJ?hZcrE&` z>9iLs!tC4oQSh!b7F9v;tZ6$Uo#YOd5_Qe#kIjyVjW`Sv#!+^fdf?_*=vm);k^or4 z9#)*LKwi`zJ}7}g=~C3}oa&(H@ww)Q0X(@u76^GIfaKw*pC^66 zSY^c?#mdLa4`8dFw)@$?H3Omzk67)VmM+AoQJzBn%(rh5oDs0G2}0p{^=`;ckdk#9 zb@unBO$-{4FdYq{ma7jD@FB05LNSS+S)?RBG)H;G?e*`*HD(@dcyOx@#FA4~i-|d{ zQyk=`zozxHWplQJHJK(Y^tcRb2q{mXK782}yvZsd>Q$l_#!w{t0WW~ z`4%D=@FG&D0g{n6nqR2BgC5ilVKPfZ<^D9_$shyN*6kJ%rH=4}3u@%bgs?88Z}N3pjIkQ$f0^+_N77s_DccQ9@s_NNBKkkbvzaJvQt>1H9b<6U0Q`x!654Xcxe|amNR&~) zQXXGYq(PFw77K#FeM*rxxkpD^bL=qG+R2u<42~dEpcr~1b(Dx7z>6}lUGKx0DiqrH z>a8LRG8jcp=`+J8+v!|RRPa|=(oILpTiTQpdy}rg-s4HPVI5_h!nu>S z1%@C=Y(Yym;Ej@M6`>qIyi}Ij>c@mz_1u)*NgTYyL!u-7H7B=hm^zzXSB&1h;7Lw9(z$P&-zFXlP5q-E*wgCLd zx1SNo@9u{Y9`}n43IIh?+m!E$9EXc-j$ATR9dAxE6FQQx9YKUc(peRXB(4DQ+PQuC4T)1#zdto` zu8{>gi#Wu&&+WlWcGj6O&&-cU0OhD#hfVWc`qXnRB@`q{k;PEmIr{S3S5QI;mSR&|w6A7Wai&j>gO=zitncrSyiMqns8?SNVWC9Nu-%cn9 zQ*7T3b7W@ zORM*WR2E-o%XJ#o%%*sgkXy=n2%kr@)?J@|1kW3)drttJ90{oXiVWg^v>njY5}FN+ zOqv2<(1i`A-iCKD(}}Xe^eQo}=Y1}R%PXNFN@PH!ewEr}0<3OK{@t5FZyHgE7$Rrq z`zz5f<0eZ0+ZKB7B?L(4)ro-c-Xj98GI|qd3&=5{Gb#b+hh;Y-H`Hf%oSM(HW@>Yl zK|J4Vvyc@1+uMC@nQS3KYqBdR8@J@qS-C6no98-2$C|PEOKpsD0N^C`KT*l(J60)n zUi7a<5CNK>(=&N1U$1UsU=A_RLKQ~dc#x8FQ?wKexdQ@k0z1=^)3tDIK^s!ntNF&^ z6*av@66*#i*bzVlK(X@0$#UsnjV4>+A>if|-8&8t79io5@|cq^9Dw(kzqUmnq^n4U zqQ%^Fg*hc5^_}Yq$|gZas&_*0;JWqzR^7g+GogVq#b-Vir76T~N;-guf#RwP6rFQ7 zu=y`(fVS|*+SRTTpAB&poX0Sd$80aXvT;lXMa!Vf4M>9wr36FFS7h}~AH?v#E0%kY zbCnY|TZ>O3q4(P#HRRy%NC(SGOI^tT30xZTog2LiGnx7*#g*cAMR>3j6JLWZrb(G@ z0t935;1uHsI6dcmfI%iZCSpYUL-c@(@vO5^74yH9uk`Pq5|tot`-e0X`MFU-*WW%D z+_Va!3&URJQKOF`EU0%`TliKWL}1<4TB^WBH^T||E#p1T^Pl^(4epzC&@S`E{onqR zI1;3CF1lC~eEQJYH?E(Ri5bUlAX3UjQD|0W>TIDQle+Z6sZB_6t$=dA1{yzB)@c$% z3h9RZY`Sh3P;h~oio@>m4fCtKiCYNgIO>u5d-GD~@%6258Ay+zL7FvA>ita^`LY^P;fi{D~tu_R+ zU$j2<;^G5uer=eoEv+%>W9hU98j%dL9dY-sjx!3cLM8Jox=q!&;vK zB^cAtuROznlW(|`SF_$O|Nhqcnj=Br1EQgx!=bS%@_c&Z9_Rd@@$Ob_>El=6gbnf_ z^d?K;?=+Tx-wvWTKMK5p5CE3RI5o+qnA=b26FC;ri2;C^i>QNw-_p27suEN88Xxu7+1w>dkaVB=zuF;H@WIp$@lQ+CI{6jmlJ_tSTqQP9esvzXyf z=a#ozR`laf0J<7lSa{)#n@}f2ZvfPuIKOy!Ad1lnM^=!k0Au_52PO!*UMaZMX9?5= zZlngajNxX1^q`3vpvI&E_Y3RONVP1F4uSFNcTiwo^59komuJrhPID(1@A{5v<&0$#?e|QLRy35TCI*lmP_KYt7=RMm zzvTzVC`$w(Th@q={=p2#}D_0soi&z zk7&gD-|iSc8P>(jgyc-@WbuoMuw(+6af~dn|4}zOwZxy&+yR;Tg7ab0>jrWGR1%C$ z+GXE19PCI~;SLL=I-v#Kgve1x$VY6gBOLU5V-WB}W$cvxqDf~W5era`W?Qy$wi!sg zaJODl%mwcV;l^icNj4)VIr7@)1PW=ho#+TU$Rzvt-HGrs!%lX+J6o&&ET#34Wu$_r52XkfDJMOQ5VOM5x2m>s)c z@`|#jqOnplUj66$Lom*UY0Is|=!A2bMBC)ZDIjWR#Pl)9V znEs73MeqEDwq}$IB#-~AQZY`@?0Wb-T6KwShEgU%Mo9VU5CA5{#`MOJVuuwaKRw@6 zoXWfU+L09~Xnam!p-J;^6gpP$kUA0jO4-gDa|wN!m_tIB8%aDgT|wxA2SP1=tW_i_ z7OYvSmL)9)WcH|n9y+`~I zM8NDNs&gh-P^x=7{hK|mf!5wurP&0Cc!L?3$d+RQ{uPibN@XZ3y3?}=4f$cgv{wk; zvg_L!LiO*?h(%aC(iLw$!f3%Bb-?Ilf(M?%9DgNDxXtQ9(t%Z;)H6S(SZR$Ku+P!6 zMq*XPdX8Y^&fzOdFiS{bJ3h~|hcSrg?-xyR+Z&8r3?kLN-Iy!Yqt2jU zHwQ_e#)5%Jd)EB7?iDn*Xn8269wo}ZE0Phs2=!mti~bPi<~OPH6Ifpyg-qaDF{X;U zRGn+M(F9O-bKu5jkNezmxS7BAp9L;7R}Q+89(I**fn2lgYim0q!1qmtQ0q3>oN8k) zPOoz$Y+7Y!|BvtH{7ssSD1k6#I}8;pKE#2GL6~dOORCyg$+?&{cH5z**$4`;scq4- zhFL_M`&aqpV5(PIk+uz3bvT|7k@`6V+e}yZ>L9fZJ(b3l>OR>HW#Uv65WT;{3zG!_ z8XpxC&?~ylkxKIUq&`?X;x4*2sT(RqaXiNjHev*yN+5<9dM}bY_=kmdo$)_DQSum* zd{99vIn~&pmwAfnX0_QFZqW{2@G@|x58$upENp2DzL*kj-S-a(V0%UaxoKWFwL7P- zW7%Xl0G&N&u!@M`L+QSZge=EcRC$~tlvzqn4B17tQH#D=AQW5)VrhN-?gP54i}(-b&!psUp_H6tB$d+ROZxh zsgu*+=Snn_&|cos#tlFMCTn*MRi;y}&AuE1+IBG?h6aE7|KoYWNUxD%8%uC}{A=f4 zZf3>|^4IhdGElfIYm7DzTPA3|+R3Q!j#vab9OcS0WkbZIQsOazuSr&*Mg;;@C|um@ zWZ2RIJI<|_HJT*S6O=*f?k;rNm(TgsOaRO%7y-5J@)u(pt*()b`eN~D6qzr}5=j(~ zN=sG$5m#8hRZY;N*l^%-2afkc3MB$gT5!+w&l5hM5Qc?>$I z{OwVnxk!}REv{y8iT;!?a9h!AhWP*e;{K&EHkJVJXJw=KGg6bw^UNIiUO!sLv3INd zL=K`_2osswq$Q(V(ah2m4yXN(?x9=p6$QK1E7~S4S_n4|YKFa!Q34kiqq-NnCmq1? z@Mvz>H*s{e=#iZ*@W>KuJu*fQ*8cDn6}jn+>k}<}%&)uPDT^4J*DW08Z}h@KcvE;_ zNmUEszU{OyXaAfrXWzEFKJJ-s77Z#LC5?EQL?T-d?x{DES<_03bHovyWat(B&xw4` znGHzI_6l@Za(AmZn)%k4ckAtB1SjV<`KO#?xO&~ymLAS)*PQB}>jJ$=M9{kd72XFp8-^ zWxc7LC1uTp4y$U)XvUnwx)D>;yNxmZ(9BJa0b9aXMmS8iz+7IpFSDb~ z-GmUX^Pb`T+V$LyOS(Nzk(i@LLKfT8LjHmS@5E7_#2>2#d2urU_){{8$Zrf3ZMS<6 zq_AA)O8hv2b@a%wC#2$PqG(l(aL5D{6hhO$ zU*ocFY27>j<6l`pbGwiLC)9QzM=D#zwoxXdd~DM!@RRj!tqu2J*hk5%T5>D(!>qlD^ekQG;))4LZ({+FY{ymy_vgTu zIDVuyjwgqmD2tQqF@`r#HDyU-odn3()-Vv+X(<}CF`^;xY=H<8n&$oTikw++l=#jU zbhBf@AA7lIyTH_~l!0H;4SC?ytJunA;bAszi_6E$uiT9^9NDle_x2FLv-RS}`^Zo^ zG1R6vqucyoD2;20doNeebMu;I`CMy7{LP3B*=xk@?P{J{N(wZ*Ov`DdpBl4wS#FMC z0<3zCD5}11^-~P5lM3k!pfL{Ol}fI^d^t;3!_=W}9!b&To1W-DKZE7fbKU+$$d~9NH?#z9MYSyRF)z}5MbR90 z*wz9AeT9p$>uM4eGrN(aJk?*nM=itUn&pq3}C4J8mN@+8iB-QL80j@S4 z0!xZkhPW(@4jsax@*g4vsue5dPcpQB2iGt|;7S79rbYYmbLnZsc-tv0*#KK|@gO3l z5zhECCsQlOl8(bi zdL>?DJjk@7JOVhrg|(Y3H+~+1vu@8|kFoR=tZ}v;yrh8Fv(4wro8;uNQOu1Y0|P7V zof=p#>g7<8kBBT5AEMf(+Fder#__o8y#5#I8dBP=o~Px&mBZJB7GYf3Q|>X|gk;u7 zOeXMKaED8;NZBQ^1U>t3bhor*7>36d83o<1-FH;NtwxG012Z}^qhm2F zaYLc^8Wkyqdk+B7Y6cKNM5UVCid%;_b<^_6kD08du?i(MYaq>^^xhFKv}9?jQXerH2Tk8=9x<|L@{v|m)zj=Nc>f4Kc~AWnQ42bC#VkZt zw-CdsB5n9;@T`ap5)7ghjh4Q>Y{K>^R_`S_Phfb}2RtD(;g!DKVGB9C!yjmfIg-DR z&V-1&!=nla4K;c8!QTjavh-RQoFr4O7w}5Zx zg|lKMY*mMtiT)uncd%$=+y^S`djKB4cj*8;ir){;=j@CdXw^S9uBwPelqObc^Tzm~ zW;CtohPv+%&)N+)Zl^fl17+MefS=XI9^{gP=poc_Rh5b9Y3<^$^c|B+*C>Kn*axA#n4{$J`_|ULyU#~ z-h)ewfxi|{LRd&i7`duwzi|DFxM3$V$R)(BJ~SmP7q(xGfb&A>h!FGm82H5MGYg7f zR@K~hl?diE&Du(TD`rfUgW5${eVGm;mXby?M4cWOrMI=0)hWcp2WLs3{g=aCk+%M? z@0AtzaGf!OoVmv9M>ei_V~^Lv?Ufp)CkZaWYR1&Y{N!e4bUpVSv2*`jPAgv!j!R(e zGqFYpSH)R`Ezg&Dq0}?0!f?CPZ8guc{!Aq|UXr3eHh)e#4O(gUg|&5qIrpofT`hSp`QpL`RdeXpJoAHPqTA z>Hl$?|MT5q^-mSBeyRT+Il0qT=Lf)QcGaAILEgU%zkKOIvMpB+s8J%SvAc3(k%Ubc~Bxl49tya zi~KfHm{>x*PT~0!G}g}#Q|ckj8+R}kH9kV>#8AZJVz<%$g;$tn-P$*Sqs|IY5Z0kX z0d4_I$4C(ZRvTh$M2PK7_tkQiLJ(;V1n;qZVv@3fPenMTB&kHt;*qRbbMN)Z)0Xo7 zMxlw)P}%OZ^ZU(qq}u5i6rAC`$LvPjUNMY?ou_uf$m7A#g2UcVn}NKO)w-v^xJS%@ zQT=r&&7@)>)NlaIe_Ohj|9e?^s)FtM zQ&N@3awW%j_1CnQPnAGPg_xW&qu&iSrsRf~lQeZ%#SZFh71=*4I|G8kIxg)geoDHU zN}l;Lm;RF|sL7|821Pc_MzxW4Twh=@m(Ury4{14GJV!wE$MtEUr%r6yhtEreA!Y^j z|M0BMQki287MmOmg)7ziZWiWd`Y+6;<-uLPQ#gm>?%s&zn@}F;+G&XY z2Aw#MX_?X1g4aQXh|103{cHxAQSK|5@@`R^Yp;o8#Ux%DXk%;fal1c&r^#!c1;|*K zgo}d$9wxPVckncpcuAzetIfe-GgyquU+~E5nxir)&`mBdhiXbcRaqBHI3_ z{7TyVRJvsT>Q`fXyPetlr6W4@*^ABHuE3{!>3==`Yi;4$7HF540J_@GLv7A+~A0SA_`LlDx{< z#=ttXOW8TtP6EK)DN?+oxWh?vyjV>h+O|e;jJmWL!IRYbAn}xPzj1k`uYD*R6^L9Z zbUR?fv^BQl#}k&6f5_thxDSc9CZwzc=a16ndQauRyxe8buyXS_3@H`+zE-Be?rUKv3)CD&{FYPpR?$>>D4c&8@P1DmxpxoqV48>-$|&SeJ7i49Rglj~#t^ zusj=;m7g^nQvyMI@{xTJuo!AghzGP=DGeF^P2ZO6)=XpYj0)X9OA-Z`LQUKG7)TVx z#CwRh;zWo~+v&^>&wm>Q-0QtSNYCg_^th6hcX=uCfii^xpa0CLDQzNx+rL9l1`HF` zNQ_QtZT<4Egzrq~`D1g9kM+;zz%&kq^MIh&D=oD!Y83%4zreQZT4Sl<>fIXc=%GBS zbim*qwr~az+VA~$(61>?S%VNzY}Oc!-Qv}4#UZ?(ZZ2qLuZ$2~_Uy^2v`8u6fhxF9 zzPghhSmyD}McdM2yTfwH`J(>r1ja0F3UJK5Vns%L&wcP+__>8aH)cHMK~t!)gHptvlLb z56p(oa|z$lrsv;tYQfHh1Ks~c?y!*5Nqx(nJm>kUW3f>$ z)b4r(h%c*{ptjoa3#k}AMn^b-GU#~iIDA{yzhxrU*ja;>Fie^xU!6a925V%0XYZ)& zT4|VChunJ)8C6m$u#8*o>V68&!faRVexdO#yL@j+xIrNkYp3R$J(g2xxz6cl1gsRX zC;>_N`ilGcj=S{7pHFWW!|3)FKXTo3YUAa-|3Ux@|FGW*m_2b}(V)@%4p#>6<>UJN&FI$M1aHjWqq_+AlBV47`<9<)`=50j ze|~sne<(fISqGwhK1Ji14P2`IP|B=)^}Ab~V~FN$7pMd^jhkfmE8XpMb+vjZ-!N5i z0CVNWZGnY2C43XDDuJOn63s(4nscG>mF?&~{Wy>&gBXaf87m60cfm<_Z_Rh)nd3Kn z3O}Ae%u05b?gug0^;>Gwry-dG{y%B=U4HCO{uzc%p2tsFe29ULDXQ;IvE>Un;_5gM zlqBq6AKe;Yyq)&mhGKh`6k%G`xd+uP)^qK_0dSq!$zgV?G3N3btn1e!#5!9qdChYX zUE(NMIU#7tV>pLnwgD&lIYLL{V>-BB?K z6CqS>`La4;2qL&ai`t-!$0+>9xlEnfE^`c>DP%;gp!Tf5Z8VD!K^CRM(J%b!l` z{tFY-AO*eQmRa%s)j^VFKHP5BeX=^7c%7kz`)zaOpxy=@2K}elbk7=@W-RWpwFMt*8YM=uwIb&5GxTX(i|BIhs9fbDy!_Xg+7!2T1EAa&{~EJT03dbZCLT+{4@98VqQ6ezf#9q$_iEUy|c zy77K{-mL=4N;p2}u!C=1?-8Bj!wC6Z?fWXrM6BGkH)TF>H92-UEa-}8qVbb)cE`7e z%88B#*i-rqEON5J`& zclt2(I&bj1wIiA@e;>PI28H$|5=Pup=|6OG_n)5=Z*fK?1nd0_?CMU0%68ZH&VMko z4yzP<6lh`WRy;m;%N?02oL1IP1vQ!8WW{o8aySuvPHeh(d*s@lvR>YS)tfg|6uE9% zpdHav?;5x&g^+n3WmQdYVIg&^NCJB+Q>CD`;*3aZ?JNa=;1+$rW)kPV1xZhTy_rNT zM_~$kIiD$;sQCp#{z31Gwz9@5R_!V&8a7?lvfghbYAe0a6z z0&rpMB`!ZnRw`Wp?L2{P+IWGXqpAkgo_v)e--aW$>@sA6rk(LCO#VRduKJFIy>gKs za8k^ovbdQ(#!^EeU&P|MUhtY~y`BW+#Z@?1;CkRh0FwVd4M5fpa1{y&-rhH){DbZ;9-`K-DXeqa35 zS;__yI5q-}2t6wi?Oi*`{{J^VbaLd4gE1Z+RPA<6LY}?@j!8}bCd2k$0CVOUo_a*b z@6F|{Ej_Iv5F-qwb{(TdveQqAXwJiM{zjYck9O5JHH`f+0k^ZKwm=>oFQf}``>VM( z$6&A+I#{&d$9$MkY_0)D?B9U0Snx9+(M=2x{VFjMSQ*$Zboq=kXV5U3J*9CA3vbm& zI5a-geJQPSgm(Xs;ijVv?E*h$)w4LJEHvtTEiOTjmg6gwm$>Xusk9bT`;)R=Ty}&*J|+4H#6xsLuCEYw2jXoby-QnS>AR<_rv<2C4c0C+&SU zQtX+Bh0iMJ`|$OR^@BnmMLnu=ez9x6_g%@E2Ibmk_bd0LWu7NY2uW)V2JJZH z2hU1O{$W=Ek#kVSmLoq>jAo;DFNDacsK1QypNfWxo1;)@SNcHp6wq(qCq7kD}zten-EbHIYsA zC&m_;9^S}RX^d^QBluM?i^#rQhm^?)yEQUVn8W_`Vb~%#cR}Hy{|>e4W7I^S@Br+W z2i+k&_%v*UhD}vTVD;dw6rhi$H2*-Gu1b?58xhcKZS)eoTtg{$Mn+hD4rvsB0IfrB zVqBJEQc04RTxk7wgp$T}GN}kcQvT^4&>pmV#6!JpnYF6*&y#Mq40%n^+zh?uf;;c$ zk8c?OV#`cKMNZ?{xCp+To?k~!$4N zr=-H@+X{%X+&+-+2B4tV*g!i~JXvk^tJD7=EdZ?K%S}A0;k5y6dGI2RfDpN>_cpHL z)i;3ar;DnMBzB-|?bu(yx0`3LEZ(FXRArENv#J67tnhzdg zNm=$liddIuFbt4*11s4gqT4v(buSnwUUv($V*<^$ugKHg(^*VR~&11hn76HPlm@X(FcMomR6ZBOZ%p z0J5x$tgC;-j#ZWUAWve0Oz+W|nwdJl!ItDCbwCJFeypbJl=-Gk`YJ-XP3oaIDVwDL zc2BUEKL4JRok#@3m4A0t%hNlX@+;skEuSG|94R{jXrfbb6ljP^G&?{7*C9iP-Pv0U z2FVBq_G-l6&zP)%7v`9ZEd0de6yqzV!U*EKoMBYUM;h|KL();>fVq|+HG&Zeg~lJJ-}6+JJ!WrfSE=Y}pZuZlRG@Pc4N z@1CJEYL7P;C$8#;n-O=>J0ed1a)29Yc;w>Qm?GKQkrAE3U&ANmbGJr(LC|f=3B5ts zb1<2IgbrBeMc%EnGMuZ%^}3hV@TSm=1TDL!vn+78K(f|d*VYep+E?b zt%>o_wLJ+NJk*GIfV>-uC$~YmT@NaFHRVJe2@kI~IW@e;Av5?^%NAblYF7R{{*q5$KAa)$XeVKgue)gDE`eaHdI3SHbFl5T{P&exC z>$(-<@uL`h{?8o}5HHoW&CogXl~(;1X5Ypa+>&fteiN2nU*rPIFmX0*wB?;pCwN*k zbN>b(Bu&a40PPNa~OPULjj4~bI>@`O${z!u4Cxj{V|TP1d#V^ zplWO!wqw=oy~`^=_}l=x_fPYiAM}my)z8bh4)xlsG+BbP1v)ps?f{u=@|G^9nOYC? zC;i^9Jg4O1x!-3)H@7yF?RsUrfL|dGufNPEA<8@OKD2PEq<;5Vs0bpYdVP(ui%xd; z6NRr_ z5kEyDY?)Vy(oTc-z1db8YLOQ*>OHk(W%aSLm!vXnT7cMa=PAl#BcwCFN`T+q!d}(J zkvDQY0Tm}%8X{HA#QP(M@C-QxAzuq>K#z^QD#m$_Pu#aTeW5`cvSu7O3_9phE?+|f zU;0P0C1a7rU5ctc*eb!GQY%(%NzsfT*SOWB$p*>ybYGsv*f_~7$!8W#TyIwr4PYI# zZV-DU&{(gRv?X>_ukLKFZn(~z9*&ie+JTK35~#Ad@tk>!H% zv)gSpqKhah$2`K~(PrrYqN;L~@yjxQM{xlx(eq3Ji$SJQ)M4#Hvm{ee+e_IUeqz|5 zFYEyeQKO3s2NS2$`&Ndj4CyZ-@IF5o1KTu_6CDAC-0zlwJo_(DryX1cGR5X+T#1}8)% zVZr-kN!qdIlP6XiaJvSioX~V8^7}CS{r6#dbY6-7z~YNZ?ZauQ<|y)h`yk%WhtQp zfx_f$eF$v9E1cra$oC{elz4ndw|9FL=GR68)FhjM-{J~_c97yl{-7)|mgPKh<>PaTP z)H1izv~9QhCuEzz8B7hU88r4-jL>1uW0 zZ1>5ax9VnHD$O~>vG92o1KllCFudsyi?&vqJ1L_IFf#nwvZesb?Q{6P{z%1Qz9&HP zQ+~d978o}z@OayY2C#csKg^U5R$nKlNEQ_^K2g@Z3kpsa`^@y=1&2WTBKW++-mwdtkxozn@0%V=ctm8BG6){Z}IU~&7 z`~T{}SwRWj>BON^pnS|wAUdU0-=rwwM1PdY+g>v;xPUXtla|_H8)Ln}TTu(~y_Q!J z*v0hQuD`1yyxN64-Kg9d%=40ao_-6Fu4 z*=aj)L(8d6g+#Byd?i^B>Pvdf$5_{a+mxN{ecC3`0gEx>ek3#_pXMcv*5A38(k~ut z#~7Z2OxV?AcNqqxH&}@|3u)&6XdteI1(#2odG02P1aZse+vG~lc?;~^o@ylY?2e}C#$tA`EPBN--V~v$#P16 zHouQ_rI2dyyy^H+gtD5N+BJgL%Cc>x{Hyi`=(4BE3Ha)hGF4~GidG4eds7OQy1onOOBHx0lVW+kP|Xl2$fqZXpnvZO-q6>O2GR=({tAh zGw}%Dq=-&WbC#;7_j}jBlWhc!juo8g19od6dR3<_EkA1%W&c3}+7JK7l0khRqjnoA z`*I{ety zi)AJSKid$rc}7;5wvZDjTD}-23Ti~-?^)4Ds{U1Kzue-Nz>zau0Cfb<`mmQx zF13{gm6V1G_6a&{Z2r(0R2U@MqPt95&wCCF{DhYvDzSz_zD!7-ZN!;ntI9r&^bVlp8D&=`DGF z@vCgb>2m>&EOEQ=W=jHG1VxGW?QJ+TB7R42+1WOaJ+9>!LRnbeODW^nyurmaBw5v= zWI^mqbTXe^F@qQe+L3iD#ML@g6dobeYwT_s7{$}cf@;~ePO;tK_zGLO264Km`d|eV z#y8+)aGlHtZ9m4O+f#5(02CU8Ed=Y%Y!eeDpFq3iHka1rBv)YTUHs%gcqv5J`yB5vz_3<$tx+H z*mj!>S?foFClWZpo5;tv2#us%xN#JrQYn0>@a|OY6a$TwV{3z4&338{aa?$0?g@=x(Z^Eer17U3}~NsEK^?BnW4sj;_(ES z^GFn&vnY#OGz*8al94@avWZ))mZNG72y-kQ}(0Vsn6*7U6NL81KI1s1~sXj%m0Y&rw^g3X& zCK+^wFjxZbe4v-i`vA2Qy`f#&ZaJ>1nt57I(`GgKNKueP{eS5KyRkU82uqx?lZk^ge)WfuX8qf&ZBMO*}ps_F!M^DE<1W1B^9KH^Xw zT($cB7T1qhCjxS2pB42VC*d_nDP@Tdf!;n)hp0nJ`Egy=V?t05?0d(!iU#A~#opoc zL+sNCLoWoVjG>TOgW@XrH3;A8w6eGw7m8Bt^?Y*0R~jmrKrhN1F=@Rnk^ekD^s{!) zN{a_ZgxO#egi*R=>Yv-~3(BxadV+DaDPFoM;o5O}PGs^Fz^8;rPMg zf`{R^86f;9pF4wDY8Xo${tk?#lw4ZVnnooNRXW`|`d{0vU6bA@i(z{{gN?muFP4bN zINP>>A^&~*OJctQB>~x9=Tt9z+RR(sGvwqFKd!dMsLpu<@nDSfA|h;;V2St|Ts{yT zQ;JTyr&?LzQttI>Q?l!y~8n2{XIu0#<%|D@7?HF^Y z*^Ss*6*HY+fFM?uC!|%^7N5mizt34Vhn2b!115_@MG@(PSK=W@NqlMBS-(jPqTl&z z=C$4=wE(OnqY8j8&68ZIPdDK^+eMCK)acv9!$TMp1W{VC`-=t@-WKiS4h6XL^kYY7;$3F9-pM{-t;g!pFSEnby zw{00}rznT#{MkgDna^=zSD`s1!JmAD$%G(7sOOZMF(mjD9XM-kABc)jL-h>hJz((T z2IKx9Q5E_ev({vA20P~iVtr{RUa-HIp=^If*UTjgNu*M;^d$8{ODc3k@d!3$tXlxf za|vW6h5#3T#PqXS3q{hDQ3BWdp$x-_nSn#cm+)n#av~ox-9=(9IUO%uKGA~9oIPEt z4ze%cTgz8_CK%?oSy)%Dml&FC9*h1$tAHi~x2o!Cg)-R{i{su|wK*$_f#5WQKoKid-Fvd%my@6ul z7CbHy8iQ|Rx1uYNGElBzQh*wu4g6X_@iTE_lit^D`S2@F;^DkkKIzqWL2z2~$Grjj z7;w^4hG-HJ{X)&1SRYP&iJk~I+?t>c@hcFY`S=GRt|!sPP}x`Da8Gs?7Iqz z!vmM;D=hBd2P;7ffAq51=4G(tSc07mOgJQl}N$UjPs!Nz2&B9hrlh8&#nku$%xBSPrXnh$cH$%wr~JBMQ+q@RcD zvS9ky-`YIF8@?18T`Lkt!Hw4OCN9S@F34T=pLznRf@x-Ki*S+5Q+RC z!4f(cMF9!WNn8Xa>S&rBJ>w<%40a+arR4sEqaqk2UdYFkOWdx~alVjt!G|cx- zY+$yw>WKp~%1mRTui~l-s5kf5j4e7!PYoojO6HMmF_+O2VyZu~PW8B}&m5KwUelc+ z8Y!`1E3_M(1SR~EJ-56SDrmH3(6SHBEZ21j63+baQrS)b`h>n!s!MxZkjy7hH|A~( zK?eAnjDh&c7I6OaXLkgn5U2Bb18A`-_~p^qQGEa{K+?a8nKr9-NfW-g0{%>X`TFOR zFf%@*?dg!SdNju1y4Iy|&{p$Nnzq(N)9mH6a@j*&mCkNZYC(Uy$a@kEk>cT^0t?X@yTDv_?RD>r52W%xtj!x|t2{IzTy$3UbpR`T*Cy5a zc4T8UpbFeD?|p^w?v?WCbhkWNB!`zFF<%%PL)szUvM{?E(LzLFz+219P--qitHo_a zIz^So{~S8}`E8~lih&IQpTk`SJg`;N!8z5PdC#^~wNbK+QIsiqWbsZFf8{{TG;%ta zIOdV>!=Dx&H3#SF}A}o*LV;RduoIlR)zBd-U;EW7dOzQcbwb-%s zyq}eTHh8MEhi7tdYL}jt-zBjV8qEFc!hyVLxvy8}&)d5Z-koH+q6o{Do@q?+eUk19 zI$LsgWv{Z+7dm~4Aiu}V^07gpE>BL=%?5EX23Aa{_dJo~SI$`W`RU56wQ!vyD z(d!nxZy*=SXYjadkly08L{3#tr0x~%B3r{hY|3an&#lgUFOhj5>jGbe$SS0~SttQS z)$$sws*SU8GwPox5Z@|28LD!w9+{MxSpq@PC~eKLG1Y&0B-%twkipUang1g)4ls}N za41g7RWX?#Bo`ZoZk6D&jNY5FEve9FZTzoO142Cil~CpDRoI6}mf3txR%!EPwTOL9 zS7=o4>6TsLw+I(HvqtZb>>2RzXCJmjW`I8Eof5cM-1yMvhhvZO51I|wO5e?jciaZr4ilgAI#OvXq{RX)J-H%X9o7y(0QfPi4wo1~3`5MhL@45ZnrRjZ&tiqqG;k-!XJ8Q~cMdis;M zuN?dCc9ew+;LTtXAsDjk)k58JGQnM3jxG*vcLlw<3KApP(nJq>&5LEHJ_?B&!kPE~ zK*k_Z^*Kh+PJWq6E=X~?5H85dmKan(|?~&)*J?n>0Ki5$Ob7| zXLSkS5{scGe|~Gq@X69lo5&>55)9p0-($?}-`rjtyFko;?cYcw>NKE^flfWW}q)p4b#(^cqRWn*LDM<1(mGk0lGo zYt{1>fI2xy{MNlPtZ)Y^K0}6a+}Tjh!~|3WT{;iuz&9DBT|D5XhCd$WeR-)cf77J}7+AoKwjtz9`&- z6R3_oWo-ZD-MyXYt&Na@{s$)Kn|YKqXSV|1DDRh`Aq;JCoRxsr`jNagBeeg{#!Cz2 zhc{Mc`mkNhSp27r=-oCfj-$;UE$(Hiur6R@qjH>ck-}S6+2jB!xb+>~30p!}UOJ>N7dQKUc}+3FDsX zb+ZxNhSt_o$VqV)zYqm;C2<1%3UsNhx2_3 zapr-VuY((dAuOP1=3!WxRe9C3qALxp0u#&zDFw(}wqvsmzt2GtS1luP#z`!sqxeTx zRDqQ=AW+BTlG0T3dJOG=9?kUfvjNmrPo;YHsgTRD0luflme!a*;n5)X(lR?Ytn@26 zSu+rv%9VHW%AQ5>6n(iJZnRm`R7BMeGG&t6Gl6J9T73i3C=I@+D9hEeH|coDX><=Vgo#?_{T!j?>+HjP-4)DKE#HB(HM?t5X{1fLE|>E$c|HYp5NUZavL#}#E&kznQ)n$Y6X)*rf{k|WOc zVT(4I9I90(rB{D31lGf?EIbD_oXPuB8u2Vb@*=XnqV0Jescg)|G(01#19D!jn^ z2K)5Qk%TC5P=XUWq2FLzAQ1j?{jeTjM&~*(*+oW>L$PaIG4Q~yuQO5NS%%@((Tf_0 zUvlWybB@{7yAA2xx$z+itfGY9+=B#xD5{Dj#W!NzZ|1-=XjfH@9gl`9hoLT5l5KOjYa;P+}0 zcy@prIvA~dE|zvb!OJ7UOdFql=-!lungJHxs|wV#8FzyPsa+3ko7L2NA6K_oRpsb8 zWM>OC=;wekw4WNIgyZ!CRynl!Zy`gZA=({IV~^n31JE%=R#~v2R9~WFT|6e3V1tGG}g)ugoVtEb3MO&_>Xc8 zs;Rn(;#f6iaEt!E(jBk2Bk7uPNF(X4B~)^gqOi~JiI9mTj`aXB1rS{r#2x40Wwc>o zUpe4z9ywTXhM`*6li`=t2QAvsywPG0z1 znAlq6I6e&96aht^n`70KJ(ynMWT07xHsnLz7zwVtEcNalMKG>(=LZs{QD6>dR(4ES z8CQ~zA~uCMFb47A3g?-3^4cYyN5@2IlH|}Tbmi7f>P-~h_#s_Y>CFl<1ouRJ<#mEH zQjTM4DLrQSh3FtmsFrU;nUHxK-wLpdQzo&tP0wGKEhlG`8TEUkVU_EVhlSaf(<)Vt{QxyMoe6Yw#_w!uY6U5ZRKc>puniESBQBEm!0T zb~P5sQ_saCRv^{g&!h<@rnEs80<7=#9*W6Ye`UdB!IfsYpuXO5r$X4(ptYdyn{8&L zc8t7ZxDukE#9Z`;r_vsDhUiFSb$<8!ie2fM?B%yI%-;L@@amTaUG zvV7W3tU};Uh&xmu!xZTKz@ZJe!X4rXhpC5nOWK?tKip9pitK|O?bn87 zI@?hNkOZBoW|dRC(l>BUxQLS5S7h@l<&?C(x?bEcnXr-6%MftTXF_O209t!j@s~y- zYu*grlz#3+(hq2pmQ`nz!>yBzaRiutREef^#`!xoX|}C$SVVeqV{njc zRxgf1`H^_Nyt?61#TM4)vAT6SL@kX?vpwJyZTn7`S@W6fI-(G0*#bEiXdI2sP=22C zWQ??U-mC<%C^zfVZ~`ftMwU-w9tm+g;q5yJ-f`xJNc9!`f)vKw^zm1Bpj&g`L|c$+ z3YbC{$P?#gBHc((tM7+^s{}$mvN!Pqme$$9tl6I2Vm146=cWEZyI}T|pHJ8wdl#TL zC}BHX+){$=!^Cj!lhF5H{IQtV9OYaVn*LAqbL}S!fJ6wIT;M;?J5I4zlmTW*L|k3@ zFu=#4L+(;42_#C;llQi}J@Pg%;VAprJf_X_-Vj>mlCk+_ zs>YwhO)8`nL77#%4G`^sb^Ve6H!ec5ax4VS9?TI`U!($WeH*H8n)U+4EPOc^`LVkP z#=G>}3@@vntyfkv!!P>ocYrTr%%+&$r6cH0Lm`m-M-T$T9-d1;qTExp7>YKV>rrot zy1O-0yVTZldKcjklmd#tyK0| zW@{6n(7&QI9Ggpe>l0cU^;cyVAaA9bWPO6tF8!~2a3>bi%AMqC9&3Ys@b+(7ks~kJb12V~sCUP*P$ebwd*c(DEwBO)uEF2F#H$zB z9X%$fkZl)uUWVW`ct88Ie~kS2=o|r8!v_6nAQYa&Cy)W`4Y_AcARz6**#Xz?usVLP86*Fr zmCOh6J)MLNNsCk+{h+aUg5tAT(i>^|j-uAP8mJ9pa%`?ymdRM6iJ&e;jD2rG)dRudIcFv%37OhM|Qm1Gcqx<2*+2 z!ao?D-2bnx<}xc2N~aD3+r#mu80NkKAFh?WSDkzL4LNIS34UEgI^Rh)_0=$^Y|?pF zFWA6omrm3$2yLccE*Dquy~}=SrAWsKt}~qo-FEotu%?Z#OuLSD)OV*2$kqETDa%7H zU4R!PRd;cIkJ%K>?Zi@XAoP61lGd7G)TYRR9aJ~@ke$@VTu;zmya)s0I$WJZm7!8UFtld#I>s{KngS`YwIm!iWMFEuB;9tRH3G7?bn0iax8J}*tz zj!8cJp|kHyoPVm}AL}Dj4g^~ysIC)jenf_Veu|z&$I!KE^k9BAWo}%2FTybbIpASX zDWa*`uUO$BY4Dr~XZa~yOnTei@#mZ{*q$$XWpo^YocM{`W%(+y;@H4O4|QNl5BGF0$6boHAeaLmGgXsa_R08Dec~c%o^9o{}8BwA647 znOp_ottB;dDQaVwi?v*rAc3Pr0si~FItga>Af}`lUNRK;OSU^&(%}lkfvv228P-m< z9xXjIJ^TypcTo_h`s@6K&)+9*-w|V8arBF*GT?jgzM~kfcp-D+RU_NgYI0E8rhacB zG!Fr^@!Wu>jm{7@21P+84!|+u4n`Q^zU27CE}EL?;7ho-y6Z;1;`m2$|g2xgGpf2GDzx`Q6J^!P$Ga zDobRGx*<*<>8uQ%dNaEQ9aKPU!L!I4Z2h$2lgV#V0rnFb8GyqIuv^QLc zcb_Q3YpoO`OwK+XSV&7?Jk-lry4v2E=t1K;lwv0Rsy+>In(y!oYt}=9jI?4Fkn&vi z_|TTg@y|B#T+B=b$m%gs(jlbq4#>1?H5LP!yShp3L@SQ^YG1nT(7ympO6--+NrUcy zIpZD&l;gG&(qIr<6;bz*7MP-&yLb_+S`*n4U7f;)d-x`>z)xpH$k4;wlJl?e%f%2f zO-9>@4anSF-EEgbQ&w0llN@b^v|buaD?KAdc&9n|W@rN~sYhCjQqGjoCF}n2BQQK9 z)fCe3o&jcUK1K@Hdm%0Yta$D#H}-zmUBtTP$3&tk-8pe9YPrWMlT#U_!w4Ju;pvC6Depnn z^jBqWMS)6gzkVpvG>timy$B8|g|9!RH}kkf0;(Nnm!8&QjiCVeu)Hjb(nRV!~j z{=EV@RlCB()Mof77o9(SdVFaCXt#LnE*(GAYWldW(lFRg4+->S0!7Yf-UE_6n1z$>Ja zAf;XReGX6=1cu%`lzh(JV=dx-FS4vbLFml^ukH~V>MnR;U7S?KE13f-sg1}{oX)L zjy_agJzbVpcrdOZN3Z*aNEFrZLs)fTdfd>@+_UUZLcHI2=4;=fJ@Ev$xV8n zP_rzyvH9xz&NJu7rY9qh0&^X6dYPyg9Kae+cM>;hI636!~*-aGWoO zqL`@NHa!kjDkbHhOAM=w#D|^`EOp6vC_}Qb#qzgbxh~l58!8C&ks`tbwo_G~9)vLc zp(x}Vz8mmS1jo&lkO4WOq$2eh&7=WZDThDNj8GwaL}nJ9LAmFucVkiP z%yndHy&t<}{iN}!Zc2bUynOtRB`T*;hyVQb2aa3vYR%h5*O+6c3}D11H0u5t6HB9# zLwzbv@65bEj2Z={_!t~k$>jIK;Gn?iL9d+t9JE3h}Nf$N-c zcA5X&<+bsd(*l2_*TR7>i_0R>H)_fCnshP_X_s$s-3L3d&-0|G$W~gpX4ADL+0NUQ zX8~1oVKgJ*MuwmDd1^w)D+>HMXfgLkzOCvT;MBoEe5!3g%h7B`j?@ZlJ6kc;1JTnd z!8DGgJNc%C6iOHTQ!bf({u-M@&l$2{|45anGo>lySZpYytr5inF$dr!feM}VMt{5j3?uxNz{ zHw1VL=paQSw=n2CQ5QBw`DA|}L5HC`^XIP3KcJotZ@f1!JlA_jJe{13N{4mb3Aj!g zMY07qs-_U;!Kn`(M=kIi_E>)J!J)h`;oUYKVAW9)mCxHZgO^pYhZV;39m@RvE160n zAc}#uF{y>LuF|Zb>+$$|Np0N>dCIjlu4GC{IB|kDo@CFm+Gp^sQ#I^RzLRT?@$gjf zi(G3nyp%dt}j>1X7(SCH-aQnEIl-~H-g^Hu__7qJNlf@do$%J2YOiKt49WG2zqj4{uo5g zG_f4vqj2n`GV`3z%Q)^PkdC8Ri@O!1Bo4(0%5HmaKhYowR1{axzaKC5VkN{lnS(vh zLsV$*3vkr+unHWhd}hP{P(cjq%?MYYqTV-(Ws_K*T@UF8d+oQ0Squ*n!LN+ppWM8Z$_NdsxkM^@gfQaEI;@)6p%rRyWt3}rWm4WL4GFM? zb0V>T7F%sNdcSiX-FUtpAJt374M1vC?lJ~vk~4pNYy{+2x{Vvrun;5yMF&hqC1Qp0 zJ@au{;U44I*pkw|zd@4kdgG2DPtIW!|JzyADRYP%j5b_I3sGlZ~8m%|g9R zJp=8Qo`ZMwMGx&Svu9TRnX^5pNy`n8Su!fa^hFPg8RBzeW<261ex85b*Xe8@*SHhH zw%~vCJ&&f)((7nUOF;jc;oOJ0IQ=|xEhZ5vltuRrF_<5-S`fd3rwj{$22JvgNUlCC z{Fc|{J|JH^x)&Gi76Xb*)~?{jWacU9KbGLX*F{@6aLt zTg2cmp0w`+zt%tLlCS)|%!~a-Y`X4Y$(BpO25HF+1@o-8S($-Q`(1;!Y)>-4%woI3 z1>oMB|k3A-Q&lcSS=2woFWRFrO|1>+i@3 zMf??$GTC`82rR~!)vA2q#e$>72c@&6-au=Ee}kw;`&c0`aMat*4j&7xcTMGC!LA;QVPOj@Vre`?W7uJ38WvcL0ky^jJ(h!OS*Npi z$p`bvy$$a9XLakCg29dnT9fvMFmH-d6JQt#!WC?E_66ZpL7BLv9cWwjE^#HH zhXRCuN#UvdtVfQ1ofIj3>JqXFT0cL#Jeuys8L|x;jO_EQEAoX_@jz{G2zTNu_#wcc zB1)9eJ`KvuF-?jm2lc`xY9(w0Gu5&ggRPe?Oj+5H)JTwK?I}iyKdQZa7O?jVWI2UA zC2gj0gkkX>4BodGRp3e9WSnA|0|K?khs&jfx;L_IgMwS(&P1@rniP=F4|C(uksNM7 zznpT-!~3s11c_H%68*LC&>)Qjd6E`4XOq~=K)FR|arbT>1vV7Ii?i9axE^G;SBWWS z_1kI5YJS-jAbWyWKad!;`DmSS@*;0=7%qA8GFWytJk8k=Ac&X&Ak=;V7ti)6j8hInamUDU>pOUSZFet3f@FWeZ2Z9Q{K9+EPBS#aFclvZNBUv!)Ymsdy` z<+hVT34dTsfE(&AUEO2$w$!<(x~qr#czxKc4ks_5gTznRtBVFXcZHaGckM=^Z4j1M z!h=I|k`Z!SQ2j;-3f+Gj(2Oqpn&9fI$Izw*$C$ED``@y63=9N&IJU_-JI)0@T3?l^ z@=E(^oS1h`W#F7K2_O-x#h{QaOHMrQyn2hS|FtR-0193z@2mD`;=-kH%U9GFnXFBo zLLhP(zph1^T0XwapnlT^!-p?2s!x_me(lM`DQ8vh{en9U&bQOR0onUz7e=lrPg-7e zP1G=NLT%D=pRTBVxilK)B!|a-$vJuE`t@hznhk}w_C@V!QndmZoGwpiSCJ87KM?z_FJ>oZzLSDnEb-xF+zjwsgr6T-BP zHa;y)xTAE3-@JApzlS!-S$OeC>K%P} zMxRI8h{%dC+lcUU-++_y2VNBzfD^n~H4=}cn9ssl7L|FCTWGe-fYI8XA=@p^noM1= z3)gtCK~_STdeaCc9I{cSV16VvYlGo2tc6jD36?#r^pkQ%9qEr-Q==??%wG2JWZPhF zO15~NRwXJG74)?qV+LU=1{g%0%aZ3V4Avw&?Mia+Y``CcSwFJRKvs*`gWYoIIAnkE zl1d`s)dGh6|XU!||t0m7MP(v4bUzL#A_sC-{A8E0)laZBmm?eoQwtQ64XY3KS zzD3i$JSF{4F%xq6X-0yUYEN|oCaqRjoojjo-BM4QkORWJes5p%m_(O8h%qhUvbF|Y zl&RTf-ArfWG{D+w8YzmwG9quM`Vdc>uozj??@w@N?VKpcn8%+2sr@(R@bYEmdyNWg zwE>s|ySX)GK>+=CF)xzVFQEQ{|k*e(gDZPWt`%ne~Iaw}M4v13u3 z-R)k$(P}4YqcRMPzQRmyWF%cDxv|cb`#8Mr*wtoN4YAzC{Yqiu5(v^D5D4Xy$_${} zc|HJViB}_bcpQR`Yio;3mpO3psZgKp(!msEb#P^vF03jj$aDmvOboX0XjbJaC&+36 z#LNHNY{s?jByUJ%xHE4`mf>Jrtf5<8gMA2dwCFJO=#V8Z`vTfy$R)U?T4Oo#bE8e% z2jh$gBkPrT99oc6AE?p?OEs>aHxbJTs6NZiE1cRYL2Td7Lwo()r=B7zH*QZ!;5bqV zbnIGTBzGCFR6_@_M36kgGM6)VVjB5~1|*j=zjAR^1p&u3*sfkCV0@-*XVEi0-WIm_RZM#px(@*tbZ_k?ttE}Pf(EKgmvLEW4 zyO%)pnb#bp^)+<{Vwt5?_O)z^-6*Lf-gIHxPG^W{0a7$ckKIn07>VJ@Q6_c zzY8ifnG)mpZ1g0en=Ae@(|B}=q-Svi=NB3oeL8DZ9iqnvpH#!+_!>_CbgGmbx=Q?b zN{5y==O4mN@d2x1DgK~HXv5N0ha(#SH3|8`eC%h)Lu8-MdeF)454UDzJpuJDFb`o4 zzJ7ew<(+p78GW@S8N=~#P}L(>vZbc~k%w4=)!Edwu}LKxXYn6#Pk=l;Hjj>5!Hpvz~D53MFHfJOD*t?*<9xue z4fT=~2MmHDs-|5TFTgohHt%%teH_jcBxFK*Y<7Q(URx;PmJi;az3o7cWrFp<2;Z3H z+*$P369ITR6>nEV>g!;E`uQO|Ehka9o*!&JXL-3ti^mSS3OWvARGF+`P4R9d6}%k9 zWKL3Rd2az$j-vJM6g_~~^><*KRJLZqyDQ_eG_=QHAS7}&8VYvsD9}JJ1)$)VyFCryGQDRQf1N4 zCFgB{E`_5Z9vm=W^BYzS3$GZpAG~I>$!6=9XKwbY=)ybzyP)#02fOgW_+tdITXvNl z6ZD3~biCk8A))3duhI3FQXEhGcW8Pb=rVzC(D94dpZw1o@kjdrN+=>ko_m|;AwnDr z&2EAVtFaTfz>hQjXkkpdLZDcFE~`a(53zPAlygsY3Uhlv+m^Edn7_J#kL^y`JtPK! z#vJzdETTw!l2IPh^s3>A^AYP|7da~p4RtYg%ej8;%Y%Rdw_rTMX0~ZndRrL zE>`}TA>;t zF>;2;*Z|Eg=4^UmZ1v+P!+#K$e0HNP8VKz=D0ONOCGoCdY7U1H>zLM-d&cGKcDCNbKZL1k%*tl?K3V(&ElUe>*5XSzf?_c_%sv_W5T9#)$S^Qe&A}D5T zEHX|bo$>S^Vuu7AlNOeUJYvQbx-fAg{lA0pb7?tlktDnUfI}`g4U&HY4FCp({b2$l z(iyd3tO4`XBV8~#6X7?vDqOubO!=SUsZmQqCQ-m?qIehGr(u{?yAY`vgZ`oj;ule# z&E}h?E~TgwcT0mg&V(GbaRlKW*Wio{wMRofo{N#6Vc#mdE6Oxa(j1|Y-8l_{K-OYm zma(o+b+eed8kXTD?_U%KqHX5dQWJebCfYi76ftmP$IV09{Q^?Y<4IF64;8U2ig9ABe>yMxi=i{S04xE6|*XTL9F-QBu`?Q zr(U>t6GgyvH^s}V9P-4LVChhJ18r`><6r(^do7_V~ZTjJ&&@NMAWrj&g3* z*Cs5_^^7rz>o-ac>CeAD12zv8#=bP{juF7D7j^Avif|yi4glyn*Q!-BKCcB-iiRU! zuC@6FL_~m@x%i3)`?Cg=GwG>59*mh)p(wT1?%H|X!1Q38W3h3_rLLGX0~7b&9~|dT z%%IrdK29ZET;Thf)psj*MY-?u;4*p0Zzej$e%&g<{|JaJ$!LyC#*?-vE*kR<_B?c| zw*_p?7H_aHzKH${>NyeA=q2WcYx6Y2yCYamwz74{ce{nIBs8SHs5?*FbnlFzR~bT} zBOGR;n5x<(RkZovdnVYokrrQolAz#f$?E4L*^!uxnLZv$q9aR2)aMD_wq4o3C#lrr zd{E1Q1qC2q%w(&^E96yHdkJ&?sqon?h;YNCR6hv`kj$0w*x_^b2a2)dExlu3Q6Sd7 zz#$0l2HssOD3r7hyVjs76x7`HWM;J69{TMuQ?~GIM}WWt8E;9NTAW z)ua_)?;*ar1mzW&{^lY%$*H2@pLA0qJB44B(f4wHy91@lL>CaekIc7>b(6beQUK)J z&K5K$PAm&zN)LhLv@SCSli@XU6W6?XEW?b7Iara<(y}l@q0|`RU$zLb9NOW-chqRG zF6>(eBKr{{0Z4RDCLafI1apt{ns7Gk&5N$_RZwEP>q6D*%WXrS@#L<^R$FWzz8&EubJIYX1Q0ve#8hdusv~x+>mdK7k!M48%aC?PYjTS zg{amaXeaoKovtD0Nrz@zO{N3Ev4)J?XXDH{e=132cmNSOQ1AzC(G8~o$wF*`nMT(v zo}O#k1o)Enc+jxF+g#}}xE0}(HwwtFO%_q&VvMIU_y7Nm-gb>|YXv+@Co0~LnL@e_ z{I!3LEtYH8zk{u|#wA_7c6pc7m-d^|0)9o5UlSYm5P-97I|^mm|2ZKFRG;?bjv)d# zCC!|j?GU53NSfyhy|2akqB+RKt{?D`KokO>6>zCorRJ4Q@`!S*z?T0 zcRD?79E1jDNuLa8k@_Pa=+N9^ev=S5i*-S6{^J0dm3Lt&N7`a;*p=6c&;y9kG(e+j~F%HXH6d~*o?nHnw z=D5svGd!~xYN|l4sR;83!Qr;kghypyOITkD^LjQ>4U_Z+GuB|NfU29waCX(feWd+0 z7)FpJp%LGP!a6K}ioc0_L6w3WYFd)r|{?(0swD-=6G%k7Xm+egc< z(jeqEQ&qAF8F`&D^8$RC%MN3eb?8X`w%C!F%fjlL&~|ncKFl;a9E}g*)4VEeBZ3Tf+KwT`RwGF1Q=e#BsuBE zOSLs-dX4-v@J_`Mi@ALK?J4g0sPSst8K6|LD+=B z8+KuPZbm&E-jq@#JS}r2zQi>{}$p80x}>%T>RCg#M*baDD%w?U3`PUT-m?Y zVNvuvJ7~YYsXNR&ojV%&N_D2-ms2mZus>^|uraKtYngpg_Z|^pDmI3pLt;?Q{BFhk z69>TpYZz}p!6=YV>mT^sn))&`WmPP%W4CYbmgnZuucuJO%<=H2!UaIHiX=tc#x~_@A^{*)fJDcc924_~0#z=pxp374y&I#G|WL$s>+(&oPo>jZ)!)zs|*I4LTSU30& zGiRZIcfM#QYL^)+e{#E}J$vBmA99v{LpQt7kU@bSz$gVxkOT+Y8(EXKn8TC}BOfzq z-3=yfUW;Kfb!NS?$C6yiQiaGQ<^sJWd%FlvV;BZP%z#KUB&2SH z#2W37l4G~AdhLra7r?H)fRQEpH*8ZW&10NPMcz!0&n~I{f0oj=YOHOF&l^i)8YrkH zh;u8D?pn!t817Yxf?$3I*`qr5%+eRD`j&IjjH&GdEJ-+P)lf}An!SB-w}5yiwo0)y zxeDl=T1=GZ7Q!j2Z9?9)i=s{Gkx?33qhKWTTcyB8si#=l>k{e0!t=4 zTyI5o8tIcM=79oM%4@x>|NTB4u~ZEudAq=I(+nF7Fx2p;>(UjLOS;wE`5?V5|VvdFiJiqaIB*0IY4*j@l`6rfNnA9yJ0( z!>ed}WyBZqc*TM+pJ~vk9|qMSR9H8pGH93Uz2aC92K<~RBQ7L_i)bH#WS$-#{oRkQ zbxm8?Z$3prUU2i3&!?IU^@ZbyEe5S|N@8YFdH`!By`#=~2uSm>Km9`);Oo7Xv0Uyf zL`M$`99Hr`8o;Ii#UffXjJxMmYpcS@z5F;2+6~gg9Mp! zKOR~;fwn5TpdK|URU8?YyX{l)$X5pC`7UebO7Xq%0i-Eg)}>-c{e@E{f!B<3wZl6t z9L@h$`xY!U3WBtSR{2NcV=hG&tNE#m)4$fdh9Zxy^r_m+w4t!`;GkF+;e}OQWXI8| z`vB)9ytoS)tp^)10hQI;RN)2Z+92ViaH$!|ImZbpx+Y3So1N)v%})g0#ljHJsZH+| za=SnWiMcLz=@bQZUWJ;gn@aoi;&+^Mcs0l4VMxI-z#&7NU?)FCp%h0)fEDIdCAwA? zn;1Lag3cw062kTwInQN0RgA&& zf8H4(=({5%+^4M@0Z$`(^(Ln*fIWBIIDV-SmzEnE3tO)XtYaj*kCZCVh2dQn8mWLI z35ifMtAkPzPaw53cATJZvYg2fB;5AozEn#@VM5SG#?j;@!~r(<(GX#`LziHJXJgDI zht@1@sgAfJ)bye-r*SS4>aKPOB|r8wzY4S1hL1CCoR|mVYSWk4{0Q$MVp_d+4>Qxq z14TKMW2a==2?I!&4p`c=;j@VVmi;BczOPhKmkJb^ z)Ks6ID!F{q_B;tY{<+4OPy2S&Dr5xu^lA?Dqeq6PWLuDu2L#(($51XA)~kgV{B5fb zvfX$qnoP01C@l_h{wJ-0uZGo30*%I^K)YdgN<5SUA!$5Z4)7gI1(H1j#VW6mrmRE)T&mzSFH zi_NM;s*r!XoGKagJDpz$sw@g@a?^zg$;zFJ$W3zDws}K^UdQkJ`>=ZEu z7lsY0Uy4I08`!bvga&P$D>E2|QLd7nCdlam)zdv*alr+B&pw7QF6B>mO^|bXqMWD*<-D+=0 zh8MK`(Y^TR>2m07b7{k2WK4)57`Q`P@S8*_3$4C`JA7O4Wtd=Ia5EE)dv(faXz-$W zX}rW6M*5zNS~z2G<1{-LtYHt;42+#48HZ7Dobkp>`yyU-jJ&0XWO7weP@~dF%Co6X zrB}ws?lAWdnMQ)drJ|G$L$ced41=gSFoZ%!p?1;}rMxV2KBLjBLa_sL?EMyU{Rce= zPPWF*qfJte$%Q2f7sLjrnLL}cJ)mhVRiw;&?0EjkhRjTr|BP-=MoLH~E*;q#ryaB7 z%D+INHW!Y^t%sM+**x zSx|w#BKGYR3@lFZnPsv}LV_`0x*7j9FELUWB-^*eEni_zcJCZhAkx~j`AAwrgzecP zRz_cc{*wS(1U9K!`d;3t%t%>>jS@(1Ou>U_lXqCs_}xI@Ky)jvdSHwtl0nx&?9cCG zQCpmewB-kf4X7b1R+D(>b=kjxU!7+nE;bSA0@Sj4OERvmRP%WgM!l5KZx{vMN5g?n zAc@*-8ec151Lwc7FXHZDvYxvPUN)3DM%a;YF(f%S@}}kcanbgJ(riz%He3c<5t%3? zY*xc5HdiPd5mpdzmI`J6Eglw1j7QQ)iVT_HZh_OE_=2N6u78{GQsNR__a{XPg9=P! zhcg}BkGkYKChBs_#ns-YiNRTWnlA6L>ArMyUKTM`o=@=X(j0bIKD8eW$hnl`&2)6w zwL?&89>A$Oeg{133Q$m@(-&11c{r2J>0!NoyFh8pM_?l%YtL1AMV#1C_IR951bpM@ z&(3`TC(zDXHFD{~dvqRQ&E*FljXni``7Y=1q#x_DS-VmR^`mR#d9z$2z_k<&U5qrDt3n&r7|9;j(%tN4a+r77nF9nvwWKIuRY&s%A$UVbAkz{iBivzf`IAVwq5UIFfncIC z1XfAf!tNhl7{1_RQT--$b2K1&1oxr6oud=v&+)G!OfutLXp00-7hPtVUEfOz%?4bOG=-=7#kk+ zDz%Tzs0 zx|o-y_yoJ?Rcq~M*u%!+D@4o6<-ztZnbHfFx3xt3Y`yn>%Rgudpv@Vx5#~Nf*9Stp zeC>lYZ8u#B3IZpTzxRQZiYFzosGRc@r3~q1Fj5I&dk}jmX_w<_VH2fGZJ^wdla)CZ zF{ivBLD6T#GwIeSCEiJQonAofW#f)=5XZ5;AmF?MHmVsi6KjE?I1?_^G)jeDg{roz z#^eTvAODPbS!oiHEe8hAot`VO45dV|VZ(JmCyCkmawwVFGF~u%&}WwuKfkZ4fRDu! zYk(E{1!3h&cSn8gtgKTRe7bzk$D| zhmT35p7D(bN+g)tr7^(?>xEO5G*{tIT@C73;NyzWAA+wQ{BnD&F~S+uoE|oU`b;c; z0(}x7b?tV6*U`&eLs6MCk{LKsHdP(a_C+Kp8Okyi`>F$ z4w0qGXWEn&jWY;Q)d)J=jFBsoMuuC#VRS~Jn}JOzBgbMUfS$px8Qnrq6N7`eS{5B= zOHQBAYm-mz3+T+fvFmwdp(P?!87l6wR@T2SktIS``#+OeKPV7FBGf09&^?C-el%qC8VX zzvsRN=;847OIBH7y_NzT{Jz12fcOzOuO=NM!X`x{ zDLsQ8R!-KB??U)1RUgOcMF~_ar)UPcc?i5X(MJh5Kj=(m`1GJha_);Et>cQe7yVx( zH(g-LKUbhZO@LYqa9ngeC@#D97C?YVQ;@sWu@X3z{U6q378rF2#W7mGkl_`OjJX$< zLy$(e3HkS5O3&zW%RI`NNOTDfLiR53!GCb;9&cd(J7nH8 z0P|5_(=~q(`S2VWmB>wz7b8V&_mmPxPTzhkkz>|@pmS3TOeF7mUI4Z(Tb2aqAM{Cn zJAFBN7Y=R2byy)r$S{LJ6_@8rb6vUsXmv~lN{Vx7S}%RQRv=(EgJCXSw(fIh;muT6 zEihdl2y8BH^D-JkiC5BA=kw_e9_cWh$q`5zcU?ZO9|Nh6kxJmg?Q+hwpk(ZgXh|1e zdzgmi)qt7%wMbbGcK=sf%ptyR zO1u?QgV}rB6Mdl=wK#EKT-G}UQ%y_KJ>ujt5tAG$iKBosd9nWDz?jx7RuTPa!T0OL zPE0ZrSxN55wc$scM>DJq=k}CHbt!ElX;b<<0Nf+JA5^~=cF8LcX%cHP9PUU`MAb$P zR?pkfkjpeX)N|sf&*XRm&p+-(uOKgJTc$zx3FkJzRZ8x40w8va^*sOlfaeOEPy{uv z{WH+JSF(;IMpHVo_g{d_h6)Fi0Gcg&7f-_JLw)`i>CaQSgU~MWh;FeK(OKi^nV@%e z8Sa>uy%N}EDlfBX(L2UvL6CM77LLn&(V3k-389R&`Oz9%uFLkM_~v4hX|}X=vn${r z^BG{As4&diOtm|-<~~Kc=)o_@gE7|1Wk&YHsB!J<7VsHkow4|khNb={s@I>cd}4az zqf+eh6`1ezYJNMq{a{nF0JX?wtd|(c&syj5#}pcpC=ZgX#{+@u3ismqG^QQh1uxNZ z5EaUUJmt1g5lTSusMnhD_D=q*x z7(Keg93{{(zzl;*9cfibMCX{jmT%_fY&iAdc@V}CdC;RYaUga7Xi(eV<6J)i-d;D4 z%*lKNT74Rn>sl0Sfz(ieC+&aNH$a`82DHkggKya&?XGbGSi>zlBfmlY3M>=0%cL9vV2k5srV_UP-S$>5XvT|K4uu4kOGud*dU6h+3)RPs!1iW>hY*OMZmFTeYy7l7VP zL@Wc0!)lm?Lp6CCI7!ceyL5(z{wL)0ElBLUJ`8L z;bYfaox}_7{@cmu6GqT^7X+J#P>|;yF1#o4%`Pt3g>`TXXoHv{$-*@m!x;Gwx6Iec zW>QGPk(zlufbr2HMTx05Ut^x3Edy%LC@3Z&qpa}iSIEiLczs0Gsk{K?(4vx$^>Tw& zSZL<5KooQ+t)#MSmNa0zJ@EThkz;2SonUREi>L3S?=z3#S{RuXi0)T(cNWq9oXYIS z=mNVrgwz1K=Nns_Ag_^J8r*e`#4Bys;MA>QJ0kFulMdm-vZu-T`W;0Q+>*JCYOP1d zu=mOivj%M<6ZzGO+D2oNN4nXXm1nRa(1GKJGz^D|hrWJ>eB9mK7|kLvWsa>8IA2zi z5Moo3Aqh}Rm-dE+OjellxH3&1S;I!u-l$I$aL=q6llXF`_tL*08@OL6t{eXUxlI)6 z7TBG-@wej%uiVPNs<^zF#^!nAyiOt{y+Fzyf@l+}Fw<>X>$Qe)jK9>}{6sVf2EdwW zGDAfd@DBHk#bH3sOKm;qq07Iuo9NNkD^kIl!(}5;-eW1E;BQFawAlq`d7Kf!Ik=fb zf0T4jemE7ni@LutoX210V zs3r0#Zxm*6_h?Dg9zmEsEmijf{E{s?Kx=gg2aCb%s>DOO&wT!-096)rm(JuQ^mnbv z)nD+U2NR=mss?H9B!x4{hC_2eF6$yZn*Vpc-L3g1CB|L0rIWQ$ zBY2tnd{JJ|UaA&(E5(TlU9#uyKr@K##29kg2<5k0urzy0F|x}qtb}l}Pti-G_6n}f zmSDwnBW4c(T4jL~)y@qc1%%tIXSM&m?pHegaPoClMX8(N5^z{JEbGjlGiLFt0P?vm zFhY`uG9y~M4tKnD$-jQR+^DiEB1mqiYqWmavhxK$HpAuPS59>U8S}(E_|;zaijr({ zFhYnGKK<21Bu9A~w;DbPHBOroL1bQiBE^gr$dDC#WDpo^N5?TUbc6?%!d`U(fNxzs zbuCKv!+M8R)@Jg@KgiF5QAMIU0)lP7KrJG~i?JzYT^ZkOa>!;aDb?QGlPeHrfVvom zzOEQb9zs4T@YiHb%P-C|MYGA`U93xgv%|SMo4&9XE!mvK0>n;0ov?k0cI!>(=U;NN z^BqslKA1L|a5CjDxvKTDMYJcjg|pZak)S+mI5+jHxe2v*m>zlQmTLp~!*|z%&<&tY zNLlI>XdlTU>~{eWfPew91Fd*U;zk4H=hHlKu(%#2syGSSPMqt;FZK!HX9;M!pA@YE zDET?gyTX}VwFE}zlg^KI>_t|rqzFQw<7;%$z3!|wnfUrWt-dI~WgI`8C!f@6Ya-@b zA5OCid^(2us>vW3{qL7>Z1v>Ne*{#d(XT>T z_?S_RqEt?2vDWnu5gjsh)h#}Ce=}hBoN{E|6ZchmE^MZfpl+SCgM^XZ;q4#o{`?D@>4JUs~mt6nhypJHfK%7?1Owo1$d@pgbKcrXA#bJECCob8p#CXs&hWB3i*a}ebL z^mG?#dwo;NI@T#*6q?Rc*nf9_ug9&bRM#8s^&aLEoP*-5VqL)3kJv3)M{+kJhPS%>DgCU%twE9 zaUfU-A{K)ecFwK%p=`Ur&|rI`VOeXO9<^cUPz59Wfp!@njS$2j{gvO&J3k&xSW-e5 zcRwV!LTSY<= zK-y;IYXZ~j7Ek$fQAI!Nx1H8!L7HV^)%vd$WF;^b^d;+}f?o@3gRK9JggBO$OUM$2 z5&@`KnH_~ncnBGU#>b|@t}u(0(ch*;%d=;$G+g^sck471!nvL^7KfjHWUW^Mma4TD z6|Na#Tu5F(O|*+W_?ZzdxY*2#DI7wC-)*<~-+?G`NISc9F()1}o1X!>E6DCJ-5PKXtL3x);)tm(_M;hNjw5}9-haT|5Le+g z&g=8xmEf~MPTV#v>gCS20WVZxogFbzj2!?h#+7S>xSOr(=1!(rymi0eS0kN_>Kj)D`y*J=54WZI zMW~2p`mkO8Zf~XNHp~pM&Y5(aby5L8B2t5L>no|!#n~_od=+QJpDE>sI1pfifpZJB?YbIKePsQ8RgWXo=!_RaCTsf-sG(IiWX1Ng&}xaBE#o6&c%%`{@4p zml@(Rf1+mR76P1X^W=?H)4H*0AFf?2bmEG<^B{wyem*QPg)?-vP(cOXH)dq2fQn6a zyUZY(+k0(7$^UBHX}Q*=`mfFE#IIDmRK0>okF?iVEX_h$RS zb111QGZ)zL?_AXUVezZLgRwGCIqNCx!3U#=nU;S)qPO9x7dV0~w+(f6K2ZM<n|E$!*Efa1*WyHeQM$kESvC~ zw$KpKbNb!O0yO*1EbFMmyNVI${8fvgrE2>>sjCO?QPZ{4NDi4{$F6fw9=QN%FbL^o zC@lpJZkR^K_YooXM<%qC@pJtUvbl=-e_ zT15~_mpv8I*J=*+(f|-?;EupjscB8QTCRHC#7{vYa}Og_JgdWOJi7?l8ayLJ?f{(* z=joDYtEw;w9Kr?ReYVu>R?$*8++bScQ>#<1#w4Fxg;9+yzoT#1q;}oUEVb?$1dZCX zmkeJRMiZ6vm0S4Mq`JfYlQ@tHQ&uczF+lUCo3)S&YQoVlDZD8@8l+Mb!yrrXwBk(h zX0)srG;Crpq_FtI8)e}w@y?de5hUCL6euxhzJfN5dDVkDo_7Q5 z=Bx-mFMdKea#I!MR7)lB!k7+bH?sh-CWxEbPp1e8317H&*CLbULb4&j^k^6rvXc?c z>!q`bVtxM)si*6W)~tZU&wxvWt{HmjJ7HB>(^s^Ruq?bg5pER5laFVs-%BZF%2s-| zHCH;v=GStouKQ1wwNe&C@*0TdOgRjn*9QS5wrbQcT!WU*-=%5Ll|7saJYEt4AvkC5 zO=%Wowp~z+uD92@r=q_nmTiPZj$4R(r}Zy=d&v7m2j>U9ps;Rp>1!nAd3I;HKa1FT z@(}6_#RdUiR*S#86y1!DA-Yl}wp_{>3```K+mj-eGKk3+VNmE7}l?6H1-Zm?8C!?-%D5)KXs>+N+lyQ}5aDVmDGEk1YqeDs{9pLFv_c1cdDA6yCqe>cH7Aw7t zMV)4uT=zBV@@!V=3mS#Io$(>4@pBzt?<4MZ=d*BoNjI;#UG|du%_H)Y)$fa%6Pr>{ zH}KIOs!q*XA{MRi`zAm@db1!Gwkr1@fG3gT>&So+Aa44__G-BGi5YYw8HnnY;cRa zM!LcfOm$tK=v)-~0=C;~O6N>h&5jT%8)(<%^3ue(G}%P_hTfo8d@+@f>E3KlT}PV@ zlJ8*;Z_c-*20Eo-i3cUx0yi%uHE^ZzK)x+V^+nO#APZG4u*6Y(MwxrQnjwivD(A$# zLDEv_P>}tnu#DX2-oI1xJvdIv#{DZ@Ex3dGMR=@Ex?50w=SKKdT=g}ypWpc`&qAEXGmNresePOJIGLA5k@r)xokyfdo$F)wUM2O1oK86xwVCu_mZ z72@N_Ev41bkBwb5}tQyKq*c5(N+^R!{)fCKKJho!d$-3?TKQdS{a1W4v9_B_?bzu zCRXwJ`7BBFg;DsRb4)rIzkFS+#)X(_m;Gdu1+D;Z7S80)rx8G)$H0s=H-{HSs}A~v z({rxrFskZvs;^1#3^`@d7)D+;jdaMKkns};k(jSZWr5*4QYwDJ+&Q1mnI2n3Rfngt zLdS$%Ew4OqyP`qIQ;}P|wI4IT7YGYR20x>@Sc5$PjWTmq!`bua0q$xv+t`iXC_kHZ z5OnY)YeX<*fUgF)r?_%5;fa8%lRMOWY7dY=_#Y3X^d1(EC4G=__hX$(RIi3@L(=Wy zrSA(PD5H}FN7iTpm@s7yRKwX8B17eR9nmS`5Z&wLjrLKR03Qa^7Tbk8hs7Bt#9>y% z3~*HC5L02UfIwKq{&JqWMB+9?X{>1rxw4C1v!|^z1w0>VMIyPBYzKxq%HaIdpY%#p z9k&xxdc9z;bVvOm|BK(Nok2uglNh}sW5%Mn&I@5VGxoY^zccouy@M0P3U=+xIs zb8fG%>!8NBRRvdB*y09*Wny*k5(1tZZAFshrzub9{%X!}{LC@-GMV1W5a>gO8m%Ov zjpq7?`3tp(o`{OKdM*REjWD> z<80pY`T{s#C9Trr91ieCL0}8mgtY9)rtAv+OfJ91B!J}8Mrkb&kyj+b|9AFbCH%C* zJ0<+suwFxlg_~HVQgF2Z;hH7BdVP#FLfaRgB4paosU0(AO&;>P?2%2TU$=eAv_GCN z)Y#_3IU>ccIfmKFC`8sOI2F8$1^4}>x)e!y4ac5O8{Bi7WXL7LKmuaT9luUTk*Hb`#fzVde70TMzgdSjSy64PX0)p5m`TUoiq|sQ;s1(YGxSaF zWbFNXP;w)Swj;d&lqBTU{!t9C2cW5E9R#Pn$_@p~wRW!yJBV-5*(C))dj~)4;J_e) z8cn+fy!vuJ`_f65xS+VK_tk;Ccr<0qm4`=b-3XgB;*J+E34TbaIyLde*HQ;62ZfBS zBY)07cR>@YLL%;FXptD<@+r&#a6r0}sRFfhDpq@V%xQmw>nrY2W3}chKZ}-3qT;bsS`h31WM|?osFl)7b2s}grToi0i(setJ zAlz#T)P%8RC$Fc_MSkh-XMpiQnc{mN_(Eg>4d?ms~(}&kP-#~h>3#>x~^Z>6w*gBj-+LcJ; z6iE@=e^4gcQ=X@Ig;*D%Dm z;eXhsK5bSZ2?!qKG0uSjA|W#;1hm73nI8B==P0`XyYavlpft|F_ ztqRqaGom$Q;4X&%J=@|)$1x1vrBo73&)N8LXEu&slg-$59qX1%+0oS?4q6{@JLIP+ zZtzI!y%O#U$@03rAhAJp`Q|_khtOuO9KlfQ-B#9z`^>nF=tGJ&fGYA$g{2~^6aHq)$ diff --git a/data-raw/antimicrobials.sav b/data-raw/antimicrobials.sav index 79976627e97aee40ba0f4cf67d07961f3333ea73..78a06448955a888d2cc590c96eb0daa68f19dee5 100644 GIT binary patch delta 1254 zcmX@}P;ARnu?YdPFBlo1Akx9mK*2Y$NWsX|(A>(v#LC!WVxi5%29}L$-OU(ZZ2oG- zpD*E-Q<`6tUs#%%m!FfLms%WbVCd*-V4*O1qovYjyJhBVQa-*4AOJMfVQ*20qf<_5 zer{!QW}bq=^!qZbvK&4JhAz$qhF~3&|LtYx*HB8zNmbHO08#l$nwuYPHe#GE*T87s zT)Jj^=^DoOTmtB}ZZFx+Xuu|lF6?Ds800v)@R0EKGkY07Fk)&uv!9WJ3A?uGj2eu> z+y5M7RN&hFvy`i?Zq24@U?+vmiy zEMUPD_DNxR!HXkVL-O$UydoApc1)c;l`Ii!G5ib85Yq)WG8=E#QD?0%!%z?aEKnRL pE3Q!A{veh$g%1+db+)Wr+Z%FNWw0c|HRY@eBr&aznaElo4*>DY-Xs73 delta 897 zcmdn;RP4+{u?YdP&lwq@Akx9WQo%Q|NWsX|(7?*X(8|zcVxi5%29}L$-OU)EZ~kh= zpFcfk8>0Y6uz{hYtAT~W(N= zXut;2CcJ(AenwWN=~t4NgqeaIrwgh8h0Yvg{J;nn+J62pqbU~;vi@yitVxX9i_SA@ zseV$;E5TaX{qB(Qpr2^SN9Cg=n*&Cmy1I{8D1_IBn*rk{+M z-sEX!`T)_lU7(HW4mViCwng{goS#ZSgyKfPmQo~DT6r|AI#%!b1EL=!*FsK0%^ zEwe5!rkmb)F>7#ujc0W+G;nmAthhpJdvGvwCfH7~?Uxdm5Ak3aXR!T3F7p&&kUrt< z<&DgHnJ`UuX<UVG`bc=OptDTd+D< zT$)4t&CYU-5yL?mlO2|^Z2!Z_vIFcWk?kjBS=Km1%}!*Q!-8Ux1=ysxG?sl}Uy5uu zC}A;Shp4WoW(ipfVLs4cU1J8;xP4AM>jXXwTlKf6=dsFiV|sE*CF=r7h#?-6S##t8 DX=BFVL<)y$O&_Q5eU_j!3S=JyDfr5Yi)-iy(|2v2;13UWXkN6~T z2B4B)nhmL?`|p0?$ib!+-5iJa_(ra$hoqjtU+vdRP809<8yiWtnU=rx>~(Q;a(PH7 zLC2$FJ(Y5s=7}?N`=JXVts+C<&U^AabR4Bx9IkdEA-|J8kvi5Ft*M&h1{7dxc)_dXb#Ugp=_2(s+SD~3{i*rH1JY#cwJ9i-Akz!wC@JQ1YV0dXUYIk!@>J8EOmgyL zBsV3oqj>Q*?T0*9^S~m%UNd}-%eK8?-V@48LBoierf*S#f`Ax+fq?w~%v$#jf%zZ1 zVnV@!{cB)im@BA%2N=i=|FQHq3M%(#E5%>)Jcm;fxpM<{qWU*i7 ze7Jt<0bA_S)`9K7F1?Mzbn8#6hS8=gW1ac*a{tkni+5kO!{u;ln~}$?Q_)Lyjhgp} z{42tHbewrl9hzIY`J3wDrYKUyLzDQCZzw>(c5>r6Hp_Lq_sld}&##R_^@aIPP4+Ij zvM9@yC$+-M+3#IWbs00&GO7SP*DjE4{I_Ni1 zTM^F3?bakA3x`%`?(lMLo^n@oB+S+<59VKWUaHH)`rhcIMYLNz37V5%&%ozPw@+XT zwO{JhiB4wK=PCX79e`~h>HDacyKv%%!XEJAvu(0#byE%KTM;quQZw#hAZZX*HGBB}q2lyqLreNoGn{J^Xo}j8{qc`TFVh`mqDp1PFR1om@jdH!me! z)dB4+DOLHKSUx*wR6n0P{eQbJV|@O_*fdSoR{B6w`>3o$;+6@X)DAA!09u9v8PPuh zcSyM<_w$;gvvaM+RJM!jEZ|Y_LIt#R0kgRMmwPiF0htQv6hV}wb!)Gb)R}jqLKd)`3zqZa&q<1 zFBdMUzLwJ@i9LBG9}jg?#LuI>0O{M4BY^|=pP9C*SCONGQP0=s5LxbwBk#5euXs+r z?bA_?*_tSjxu;nl8!S}s z$JmX<*afDRW4M-MIG)+Rw?#JyS_=FQ>4DX%ahB8%0>{H@dT#RxjtGjbX$x@@Slqmot|~n zI$l$LqvM$KT6UR@P;EaUO2mT9e!IJBe_$Wcx{X=0`u=m>KB5?s-WN}7c-TGS>HGq` zF7O3CwehbTnf1-%TK%}n`=01`K=7fr+rT2S?cUo(cm%v$yccFHa9|iF(lqiwtFjto zSoh=;l}qpqmAkhu<1+&JGe{uFEkG}bM37zPia7d*3w|7F9Q&2xAg^?uo}#1?4YUQAT{lZ`@>8#jk$W`N%n(cPVJE#}@x^Oagq#oZ>OrVNkQ+EX z98WVoDOjZug)`bB$tzjz+$Wi1PD(O=3&XvUwe?HEVbbJxwL)>V(KiU1}k&;4g)(xtx-WU5@pEG68m<-g4N*5|j3vcGOn;lDN zXgEw7#!ih&v>;KL57P+s(g`!Ib-dP@ zUu^EnRVS+Nm$|*-gUB|xrUQo+M&$#-QD>rTf8In@LFEzhL8$5`abCnywC7#+&V%Ar0_VYI2`j+MXs^=3O2j1&gcxiZxmCMb7G1S9uHept>6G(;H!^rgDAfkh{JWIdMEfXePuL^-;;dlX#j}}i(!r2ro!>S;3LRWFlyim~Q86vh zCq5dd6lj=J*aN!v9ni32QX2l`iUqObd=vpIM2MLJ$ynz)72$;7$$08bHI_!LM>|R1 zvKSSU5-;W3)P6g1^R{yHHhA-vbS`N6%t*_kJ89KUJpfHxCBe^m$FGhWTr@UVhUT}2 zLt(nq)c%^Y&vc1Uq>u%JCkANtciJBOes$64y;y}xrFb~mCd9U@S-rh^L{FE1?c^nOE8*Nz9tprf3!9J&Rl26SUp(WZ z3N#dL!=%h4d~{B5)Tx`Ug8Usxu{Jx+6){1pg~#@XQIf@B^*GOaZs@%rA>)rb3-Pkq zQ6Hi>*itl-4=1v#kP46P2 z&FlQ=agy=nkV-?{cUEomR_eipBVmJf1GsGm3Du>xTiC^X^sNxk88%#sousO(k)@}V zwW*%98Q$`O{YPyIrCfC&N>xZm90L&qQ}+JJU2>gDd(^duvyshTA(oW1l|qpgS=PM! z%t^*xH4asZPKat8=@X6?zV2SLWgM=7L<@TYOa+}W(9NEeIzK2(k*5Ql)N6V66`1ts zaZCv+l`e^`^xB}eSJ0^M#)-n&(XNL75a+7>rf+A+KHz8-ZEpel^IFMlA= zfQRwQFrY^kah81Y4bPp@XDrKD^7Jm6ROuvnm@g2bH2#Cc*dQ?>6)O4U0UEJi-aaLe z1jF?wp50HH20xPyFNB$zkUNUxKp@wsrCav=ogsR(OKnXW-z40MYSUwBXkmONeooTJ zW)GF@$nFIae?!SNh4b}^>w%Dc8imjdwyfyuS-xq^M++b zT=7IjR|IWI$rJ$*v$5EzD$6?YlF{>8Zx!RINE4tPupF7&LxYwO569~69>~}fM|KS^ zFf(WGu41ul8cj{HSx=XBi=zcDZodpi!w63-Tnz7pHG>%(ZJw=w30&-oz(A_P0Xec+ zO=hiE^M#)?BV+r^SVnN^@ZB@5;)fo<^%0pNR$s8>N}blDYB+mNC^i{WC7Iq}Q%!Ki zM`a8QnnsH1r}dFjH@!|%BoLN}V}mQ9+qAmM#;MxFnIH^y3!zK7zjckEw(Ow-NDy{g zkITjRoK0O@I~(cCU8EX2D`JZjr`504{0_5N-!_)f@RJ>^G)MW;!s*$crLek6=j`W4ah5!cAh3BoeOA8b@;2&KsMN$iX>1o@ zO<>>7#VGmSjQeln_9-zmq7|o&9q_BfpgO>Cd0Q?6kQ5~p8dCdAJ@iyrbHZJk2?&H8ez(J(xa{4Hgh-$f0<1oX_m{~pPy zUvnZoFmeZaeFx}NB!yiM-1fWGxQLJEx(&~OAK4UShRa~IZiG7ZTrmMXVEc&mOikiB zJu-PQJeh?eFcbHm8+M2u7nLf6AE1xSE>oxzonApN9DA2!gc95+K)338!;C<+{`_ST zdgM|IPyxI+RN!MOo>GTv%fl9PS*fN^C16#%jzfI`IrT(q!a+SSItF3q2n%A~ zv~7x%T90-R`T1G5?1~0*I)8%_rf+mDw>#!~y^f7Hj963IB1jDOrc`WNsq(`;R=qs3 zgO5@5Ve++~R=Mrer2QoBve@RA zGu&4|B`YFN<|*-vt6RYIrsZz)gc|={MHu9IT6$95ZsFm3+!Fui2RX26qa^o|1`(#Q z{xUbr?=r}jSo|jd#ok7->Ctl?CT8C3DOZK}KHpZDW+u)(fTCd&yFsqQ$y~Tv7=~@C z4>C)Hw)f_3CcPZ9r;*O;HDsybwAh-vndkvu`*_hs%BYHFvT8mVQ8rb1%y0&l_vSZ7 zM;3;L_U9v@zI>@f76LbyLuGn5>^!~oPl4oU_y%sFl-&Z-%q`8>p+>v`F&^+pgJY`B zK4+XUV4S&Edl5!AX3LAl@B{f>khX&)Ka8-|h@FzAW+)(eqPD?QCh(TuYZ7clD@)Ha zK9i&xadd@GKuJhc>7lIv|9{ro&{p3#HSmamoc+vA#PjgiG|YRN>&&FMS5J6L4X$8Q z2_Ht4hfbCs)xrdJ!6qFhZx~O)THn@IYUu}@-aHc_qpf|&+c8xTcNPTyZ`QNRn?4TV zG6iV`XhNm_E_oG3R%%)gUY7kD`x!v}gJV`eA@Mf+x99_&q!kh_q8*O-vU`l=6`fA2 zrFpgt_UT|uQv}*Ej%8-B)#~zdm_3oi@mCrp$rVCS$c1bH8jjd6*W7=O+JCNKUtIQE z4CEk)Xn(tnPnt}ib;TMK;QIaTW-g0+O>5L*np1W0ul?Vra(2h`o1K=WL-aHl>x*eQ z63_2-DD8LgVyJ*Ib1~dO~nn}Bk7WueEArXRz#5bjgXD`JmLWmmN3>@d1`mBh9 z&I6mp<#6UTQV$+^(oSs{HO`eOFj2IP%XVBgzqjq49`J)VxWo*Og{IkgCJy))9um17 zJ@8NS8m~@U9Rwu#`|Xzf4+K&Co7VbtZ#w>spgH(AofKPOEp&kLF|KPm>a&Q%fX$V| z?RPck(#^YpDfT&~bS2tj`kRXY$GD*`j+kpQ<(LMq5C2_UW_);)TTXC%V~@?b{4{$WkK8~Zyc zmbI}J->H`zYSJ*CRmKGDnoRaHS%=T@O0fD5C`kVpnK9tKg!Y4olE31!0n)mPE+mH_Gd}WCf(xM zV(`@IL3U`r0()wJ0dBgJa5S8nF%A|qKhHJC7Jt63n{h7LB^{g>Lb}%Tbg6oih%Qag zNO?7~$lf1$z!rI?jlNU%VDpjnk)<4fgU)&r{ek%&)Xluo_sUCmTvxqC=&4tY+82P9 zn*2m!R!zgWWVFYSY&DQ+U6F37B@vdhabE_S_;x2!1squb#=#E+;A6JNU5$k3)!s8L z;j%SX^>u}~nsO~1o&sj29J)$gRt1Ve6S`YhHge5=^^MMOFLBiL9$j`q-u?4>2u|VT z&vis{jVvBHzlJY`x1J?IS$~iKCdHy`uqddaqA7c~152tZ!EqRBzQ_MzkH)D56E?Xb z0>i>^mD~W*cUoZGAC*iBW_`|a$v%!_t%+sna{t~iBZu*?u)|fl9UG%jW5{$WVMYy2E0(MDnATPnKV>DHp;| zk^E-sarjTF_)k0nzW3ijBW(aRAQbGZcU~p0NZ;<>6KbbNj`V!cUD#=0Te+(?`!UZlJ3{9T{5;#X6(5DxH8 z2Y99nd0yBw7tZprizes8(k;$lQ-Z_-sfs<_ck7h@c%`(+uWmBy4$MflFfQ&ak`L>g@?Qd!7o{ln7o3=0K?~R|K_$+RCeMxddD2(Lp#EJ&Mm~5Z--Xt&M>5CnPbKuSv{~+&&q9r?LE#?2z$W)ikOkj&B5&GP4Vp`u zN&5F;j#9g;t^Z9|(>SCKtJhE|esCJXv(u19E zh;Ip`$5;F9j9imE>uP8Dbqkio%mVKzz9XrwN_Vf~XRt}9RVMiqTl+dvG8Qer=V&+Z z+Y*F4QyF47@h0t=gNcXlxfI6~VazWL`>liz4^CpwtqC*49ovRzKW~$S@BJI`SyVVc zK`Um~{eik6VaE$bM(lngy$<<1!b}m+&4KQNoAj6o-{JDQY{>1pFW@*N_V$grdZr<| ze^wpcLoI<-a&!J8g~(&Of8^xn?Q5B_ua&K)`OegM;mz~nolmEs7~w580W=pZ1a7Qz z`aB}kx_`=gr5H1I5B$0Jj>qSglY|FqBBSfH_^Ue*z~u{c~Ke<)irDNy2d^LwLJZbTKD#*c}1ncZz7cVqW*N|qXk$ufWQ zrWvI$zQPGFdq0~xD>+4y2YQP0dVASwK_)NzTgTrYNiJC~OS6-Hq2P|EDqVFcTyI23 zMa|xNQx!{JmvAGtEOHj6&H{lZB>l@3dyM;J8eQOz;)kr;<|Kd8UUvN#dQG(OU*m8k zUiIk}9(sCz^+EIc0kNtJV>atS45!lcUOq~|_~c5vr?ag52^wdH%60!*dLl8aYx%a$ zMYw{&Tbg_LVoQr6E-%m;tIZwN#`tC^4O1y|r)%Iif9-Y!--39zFWOjbiLn$(S`=e9 z!vL0k%5P{b{wB1%V#X^^q&=cGWWvvqeSWztjNX3U;7E5x;J{5Yjfaj&Y-8-I(n(E9~i7Y(5TOLKyBd9-}z(XAy%3UR`$E{MR04MW_ zU=b>X`_Co}Kx`9ZttLwUk{q%6c4NlDFUbB+nnFClF@g#tTA=ZKlpq|?^k^1-I!K6D zS9EEh*00k0{=%AE_6V&Ef(@rKcl*1C_2v-1gPyZ-;*ts7&dzHZLAQzd}K0lNS#b6S44Lv^=W8LVe6i#6JuHLL`>N+ z(jMjhvm|WZuN85yXsohN{JAVPAi#a=e`YQ@3 zbvbx%u&n$VskKTwnEPKg-lM%cl>?0pjzs?QB+>P*Ok}hLnFY9c=}{W}8!k*35>au# zNTC5cv9cz?oz`?+-yQL<>$y8P4qqm@{jc3H<;=Qhau=0Ptz$0I~>P=D4km zwJ&{Cd;JT6V>s`7X156zoFi9$dVY+q_0|LP&&q@s%H0cGlQ;;RAv>!F)gZ@5ph6Jl z``!MGS2Zus)RpV`kU*vd_LjXz{%18_Rx~8jD2_{=0U&Y%Tf<>HX z>_5A_*2q0OAn~}3CSfXI1!3qE?}v=X^_oNfjQ2VR97Uh; zSwynVXBp@WFzRi;;G-GKQs%a@S3^KY2tLEq!zlh@9J#?E5KK@?1?}Vh4~8=2C%m+@@MUJ^OYJoT73qw zxQ{Ndqmmg#UQNW&ReMRCGYesRRnPQ)R+ z3uK3}VBkms!DHOFR-{PEHH%-i_QZLF$JL?sLP+2pALWQYP$gj&BLcV3yG$gu^?%+{ z95kb6nv{zS))cDD!R0wcHylM8(HahEKIh{bm2+B#*$G9!odCu6tf<&rKla+O0!zh# z@T(G!Ai+Hb-~mAumh4eokfL0<{wXE7Wd!BojX)7n!iN*x)XT^B^P=SC??M^2`#!2j zSLN2QDp7bJM}^88T4q{LjImVAlKJ@1`7w}{&o^Q@sXt1s^b0#20M!E4Kp+6p2 zYk`M4s#O^cFNuCB+o80WzYS{=gX|Xtq?0c#2*JF5NFE6UZ(a+y;O5IT`t5-R#`n3@ zlvZn}Rxo4d;h~Zudi~si^R5ayrY-K8%au*0j;~C_(g98r7rUn9#F3FX> zkYyIS4q10iGB|Sh{!A>tDzCTS;`15sQDvVe*fX8r+Z>6Jy>Q&uqKxLqYuTspZ-C3JD;oU6~JeCOQfJ{arTq~;ZbB?2p>XUCgqGe zuz^7gaeBPy$ri8yGi`svKw-f)uo~UQQNbuVZO44%bCXYjkY{UmhocDIQNsdFH`l;c zrp<}vicuSvd5jY}UB2J5>;xainvl*G(V~9w!YnL6xlFN?gHi4=^y=6j;0#WF0|)D0 z%n*_4(|K;P)*boqWG1MCPUbIlm-oWgaAap4zXbUzVQPbasMsh5jrRUU zmUly(L0N|v#F41^MVN;N@eUyd%j3V3i`FJ8PJ5!_KrEZRqgb_pEzy9m88xFc=0_F` zZlyN&!a6K(HJFCpGRP`nB}I@qyUr$chGC`1qVXEyW7ViJrZo z7Ye!aJ|LUpxOPxYLbq!3-hF}tCCM{ z?(|l;9BzV86E{};_!go!s!u5sJ`2l*mH@IoA~ts;W12WJPXt#!sN%MCns|akll&)A zjh&7-Y>4scpMASGn0cbjN`O5uk++N)6E4smrMu<`yPwu%0nVXRRg>h@bmhm7`eHQ} zvD_oBT6c&ho-UKkke>=PKP&*j^JJLz-@H1V_iBJw3AX$(J= z5u+&}^^URgt;dS5CzvdGc8jOEyrSEkqH!)G^Gs`%93Lu18z(dAlJA#++F9}|Qdm5! zFuFA&L;@Fe9?6S@I>Zsa@n5cBSUAfJc+I;T9n@|DQK+gzuYnW#oExN%%Afds86!s* zCt(IF19FdBUT01tA{s^3p(^Su8&z-=i6cc*vHyZCOFPMsClr2AJykW)S9gKZH{&N- z?^Pu8!810jv*6Tr`-dLLHs%TrRdvI+O2>o$?eEWs$q&Pn@yvGb!mFT()?zYr1Za{s z0h4QWn&S?cdHX4QV}!O_+p zL=lmCjUXkQ81m96JuKxgQQ{Epa#yALDfH`-yc z#3YiU6O`u$0XiUNs`D>C*!Q^p9kHI9H>R{RF@KwNR4>!KrkamRuGM!|4%W{oQ>tZk z-=QzXl=hV^d^s%5#(@;9ZuPTxF+WUQBq>HyCQV$hDL2{OAHW48#+K#P^pk+|y@8So z{&L(Y21R3yL_JGSG=BX{M?PJWy^pH1_JS8?ls5Best2C__e_EYk#a z)R;84lM=%KCnLZt4wOHXS0z`)HhQP7TGKk?puY6?G-r=f(h}jL2(Qx1=M>A zkR}u%Zs14Yze}5p@y4Lh5EVh%Wf(*mjwKgmzAp|N(4K&0t?Soi)>fZ#FCZk0U*{-BhQWb_LBjew+XqwR0OjEk~)=ZvrTG33#J4 z=H#lT(8@ptu)06q*}a{%dAvRYO53wJEr*TP zaSs20ASwE90Nshmpm}WfNP>beyRgnV!i%{`K~Ly}K~Gru11u50ory5;r$DvnB2V&+VEu*?3H zCgJ~A7s^^3OWEFg+M4(e6KY1RtN+n3w7?oLa4!X-d9kVLBrWge3Uf<4h8OLtU((=l zPtJN+Upw1=se7HauG1d0tN4ZIWp{l(o(19MO$`E+aY|)k=BaHUS_L$Ld2M!64s9!QuB!!US z|I-}6mIZG-z#EHEN4^HAUvY6TPc0P0RpR|#w$`n@t&u{VF{F&iKl&B3SqSDbbkFNI z6aRZFDq5dmWnM*$x~r*R-!w&Wph|4N1XEfef;dKo3%f_&eqJ4svV(C#pyfN{z+wH1 zX;_CK5{}$pmm&BESz9}=!(n3G$n>qmy|b{_5!A%$n1z<_u2R9Md(saJYyaLaL36n& zw~dDEG6sx{QRU^s-wMKfmw+ZhqxfWqopyDIc2$g+((wR&uuvm}5$VVTuz) zJ8N#8DoVi(7Gs1PsJIED>7u3@5gzBKx#ILyRoZy?8hQBQPO@4=dX-a|I%LHxYU;+z zi_jRxiSBZ;F*0g(mfuOUVOTL$%@6aCOVLOtsi%zT3pS52aD{$MrKNBnc@+!EG?bgx zK>Sxyi8{mq9R%`%px5P$0`AKTGl+}$GPq^2X;~RHb?h09c1pS@4d8o|-aFO5w^$ga zhk^`XLj3*5tdSrCC1K;mz&lx0TAAkm>RC~Te>f##4oGQWt|fj_OXP3yMuW1-iP3qX zfoFh=#k3ll*7fuLj36U7KTOwk;I0wYXy5^MNt5GN|8JM>Yh=gS;x#B?wYY+Pa0W5O zmFOL)5OtVM&^ zO|+e_Sh9k>_+8fXrCH6OGhI{kZlWnhw@1FEjTU(?UbwJO{0>s}lC z*Q^3k&M@f!D9tkpI=;;nw_>ICkOdV1qDZZ%A-fLk}W3u9A{yX_Hkf>@ij{1y6jF-$yF^#rI z&_)q6IQrwm+%)1s5!e=pLy(VYl@jDgs!JbVU{|FbIGrwT_G^GC~A_dOLMAD7L6BtNw5be&gzw_WWh^fW( zlVCCvSu@OKx4aK(5H zPC`L|b>LkB2g}EnjF&IDIwxfV!gB?hs;kGP(1ri0kOX7T@a#|SH?@4%$F&JF8(rcE53Abb;=#O*k1HtvxQ{N~_ z&1&SN#vUwQ&WAbAXMZ!V6p^+6RIW{PcTI{F1mivB-vnCjXW~VPO#2|=;K4V0MTg z3;hT~K0xUi*xlRr5BZxk_hAj|bJY0FdAT^>{H)naYN<0;5*Mau?tcz2lm9uulvR9} zPua&zq_x?$2X`vs?M$!zds5-Lnb>;XIm)Z!rU>2~F<}a_HGl2Mg|W(N+pf6iPPw3Y zT5wpu@J~4GCdxuZEHBcn%2s92!Atd34mtrtl+1qGe#p`0)PC)8DSL;Mng0ltooA@4 zORtCs|Mnl89Q$v>y(;{{jbdnAXt$3xlH~k3xC;oL}ONWM}qFiK_J=uh0p$h~SIILk1E+!?0?Jxw<}S zDz3Vt2+$oz6bx}G@W>@6W%Cv|w}qzci&->k5@_9&nw)*HzwdL+KvUjMQ2J-0cFf#V z?2-<9Z59a^-uX*}sZe)d$;6v<#2iTqiSp)`gh}}!0 zcRP1gXo<#uESyb-sL_$?o@%LFTrs#hj@A_}8P-E0C@<8)<2ddx0n+Dl>SUq-{|4`6 z+kEbIK>;w3#L5egl6g}Yf+Pcx>q}gnf~T3KS6ijSmn(BxJ6#H06hDsq|2-g)`RYC` zenOuS+NCV zWnh?GIc@f=5LShaV4Sp|^|H_JrnlxFF}kuuU!{R&*cOe}j$FE?{yinbip;Sm12q&T zS2gr~CVtigY^w%mqgU89F}fp+GO)Z6;ETnBNe|)q z>xXh4c}=_0lZHd76Lq`Nw5}QdnoOKMik7FnpR#L-6U$odV@Y(h6_bDQ|2AO)liq*W z=?@V!%PePqT~KI9HBfmdWI6;UrnIGeCf-*F^wAnT8kXYO1A>)}nE0#kCV5x`S; zKosM7!9}r@lEwVj2si@mQT`VW?o+=mN>S)(c1557%1iN?HGeOr)+1X52>? zra(Uy4&V5}hV0Nr3fFhxvhWh7Oi1`vcWv zJ)yfpcj zgMF;NxOkgV4ZKdNzFsn(a`c?OY+Tg+ny6`$8tZxv4{b)PlLM0FhxwWuPhA(@wkLR@ z(RDBV=NxmUaQGim>D_Om*bJjOH3mLXDby27t2f5YRO59u>1Iakc3f@Pu|o5lvf214 zPsQAx(`gl9YK>rvjbQAJU`_F!+d+`;pzyW&^D(%*KzK-;aIy=VJ zPA3m;^t<6?gglrW9Ukwb2{ICgHN?uRuF@x! zv?|>ifWB5E^XhXLA-?LRm$5FKoasVPB0VQ0oX8&2=DUBr?KbuG-?|5%K4cZF;n=~EdmE^$UqIrAVjrTn& zRtI(x7D}+-a6utBs#U0;`YH`*{0!pUBCKOZ0#0(d_c~Rg@SwJ6O!~lHcroVh^8|NqCBKp$krcrGkJxHrJA+rL;-1yQVsLz9O3KsXIHbBc% zi?)h$)&w}!GVfhw7hS<`sb{s``^qwz;77k$+5C3PGkt276OAeEexX6u-3d1qP}I`$ z#@RRvH%>FMoBy%j1x33xKm(klax@N~0}Z(e<)+7(zoiXKTuZw~+nnL8E~O5^B^US_ zW`_&;Hg&v@sBW#OZVjq#xhguzsncOsU zaz(hTYcJo5AKS*&JlDy|I7t%vl(a4^Emm7*>loDN%d#U7|5{_Z)Y!dG4qx8%0&Oze zS+BGx?38^}v*5EFaHcNp2mJiq5J~o(Qun^-l{E=68LImQMpb)M4kGBtm+(FMx z1m|jQh_PiOoKX$jP}Pw@kM*5vp7svAj>XhUCngoPLX8;XKuO;pbC+tNk4hLy_Cdzu zo>v#;wY8gTgxuc_=YplhvEP450d3+vEz{>Hw3Kh6bQ^s{+niHHDwA@hQfNgj(=U}) zy|Y);*&AwXEq@p0<%0S>+lRBJqQEoy!9&82zZU{Z;F@&60;X_bJ%T`~gDUhIsqe@? z3d8AJl+SR%li}i9_Mt_Ss3t7zhLv6w=Uz<@aEQopwQnwUTy-w*mMvoez%4eORc0LD z^Y4$o_~UE6nXFFmxY|_K_5~@3YT=;TRPLJ{U8f#8#YTqcgL%*DSW_eKx#f3p^?=lq z@nvcFI&i%XY0+PGjxX3cPdEJ_mZ3gS&LysOB+?-n3?<)ZMl0V4o{97jZzA#ZmKc-` z`s5)4bHhEbsI|1+iz$9#0*$ENBDey2#bnU7;TvqO^SRvl8%=&l@{UUdvSZQF^gq9D z-uD$iY8u5wibj~>(9-mi750|T;+5atrH~X?Z&&n&G=(3#moaQrbeG^#G3RfTw&D%7 zvBjz^@v9nuYXl=2W7G+#GJ7?6Ey4AK`OibEv(?YAVhOAtr z=VoGR-d-J%&ey(PiqWn|=|=DH6g-+ zy|H(bKt_P;9=Q|-G5tb7{UN#l0_FJEdvYMWk7U5(O5C8Iq^0Dp+&!Ozf?ya`%XAWH zy!GhH|HH#IClFseE6wcv3_s1(?uAV@dmPH+xE}~Q+^4)jew0SB$!4q-w!f0_+`qZ{ zh#R6{jw|}3&I0Lh{GLWNj1C{-`Pe^_V!aVEEM}@8hEFIsCJQ~7aLSh}p>ypo%rbbX zpr!4urJt*@zvBr?sTE$P|6ypB|%}R7%Pg(WAj;bRbVc z1R{{?SDq8J+KSnezp$9Uv?bmfxU+J#{vIH8KYlV-D687899%Y7Hsk}_pdqO1wQZ4(d z`}ww9OntyPNM#8{)j&ucBUG5AFy^p=tj<7{(N6;s-rjei3_e1582??J{S!xD_33FX zAw45BY+TnFjTeog(SyBayeLsgg;N8DgvctTVJ+QJHQ>KR?18`~Qq2!{(tWlg!4u=)1;vK@5qs78L1(6jSa znL}LtK#Vf-Fs(V7b@O@xoZZv3SpnFU?`0N@+u_t3wc*@6?Ibf+E*(gzqf!yF* zojJsiK$h2@MM+yG7nzi32JEBd#kD<_8KUI{x25ueL&VEUdZsQiPEVd-3yjp2o2nB? z&O&Uxvz{t23#41l-g~Yodut}IM1Lj|e0hY5%l?LP1GQB+WElQAr$yuL>qQ#0{wRJv z!fcQ}z-&jfmpK$P#|#Y;b5oW_^8X%aiK3zVzo0s28y&8)(BK;dC@ zg=H)~RxfUjl(*ilX&{%hvmgg-gF*hN3)R(clwr%CulrFEJ}z48W=AkFg87~Agc2@0 z0PsplB1}L04R#4!oOdy1`n?8P`+}U|cM}(KT!I3-p;uu^`VSF__+kcTJJ*gf`8=lK z+3+N8+s(mnJM;K;HO6IJr#-M{_R8nH!S1;fR_&p>sSs4cNZV+R#vZ zf8W4lt!_i4vewvHwC_KxTdS6}yoaSnmgkQVS^X$ke7z+djPLGLkIb{hIr>47Jnz&v zzG(!+vIN&XA2{4LMgx1IH72Dr69J)}Gj(LL)73a?>emiFY}YlGOZ8Q=5(4GLg)8PT zra{OE1*;u^g+b2OOgfd2K|;n5LV+2opaa{^T^>ke2SMP)EPIWLGp1~lzG-Kg@xGV# z`%yiDhUPY_?66=v{|mbnVKsZ6X_njQOePD6b(dc^HZ^3blxIPjfo^4{)5jRc`2&a8 z9*q3CI{BKl?t!GE8EXV_ze0cwcMm$cWiInWaNuce-K~nU>>S_1D^7r-^{Cu9*?C!j zJQPoy6nogn5VtAJW=*n@z~bF=xZNQ=WzgmqjvijuGv(Vw!%M$U{nP$$<}Kg>4{E8KR`EEPa4(&?k$-*SF1dYQj6{QLy%eN zQST>r%NN+8KAd?E-PE+T-94v^fvUfj0A?`qSu3b&tz>r$MoaO)PLdrF{Xnk?t(+!`0xwuNlVUw&h^@v?BOU}bw!b|U zwGGIcTN77L;skq#|Y?DBC zTiogfEyH&+S0=xMuGrmnGT9PS)jmFj^G7>Wgxwz@X7Eop&RqWN^VIfROwbr&X;>4y zpq;OPwrXR2Wm{s7g9T3)m|pYbm-m*YwD%Xzdi_n9q*u<8HQai2C0kY}H{4OKET1#C zWTw1J&5)^A*^T*yCJoby)g;^K7E9f6fm9lsZ)en5!t4(!P0;U{OgvW3%Fivk^GzQ{Fhp)C~ zYQTY&ZT-W&^>my9>jd*Q^r8@>hA_+?~Q%? zsG+#~pWWHpWur$1dvL|K(Vv9#@qKR_Qk(LmxeU_}g~~)VJ?Y%{D$y9r^UmZST|myc za;@$m8)0-}%efzil>xE6df)~#nW@p=W}U;Rp(R4W(Iup`baxY*=N;02BDR!Z&V7E6 zzH;1l3Jt&G3aTXhYv6!rvIB}?;tM+M_1etCDT$mNeWqnf_Yt@Iq&OHH%mKY+FR`iz7fYy8KOa!Dume^y{pkPK(G`5$(OoiD((ug^|9)%saK2wVUpsbk`1sTit*l z+T&3a>PnerE3N14W$*G!|(yQQj!cF&4Dv{(PB<+S(B5F6+m#F+IA z(%CSNIKLT$);zF&)%JeBFq81f#4e*-=)N(X+t@IXw+1ejU2I$%`CZiI*D>Fy)(5Lz zw-eXZd7bawXdM?ayzLK#cK2L^^_9=YqN$S4VNV?Eq=VH}J?R7q_ajWzTvn%TW4vg)Wjbo3gAy~Th<1suVhj!QVcSH!?9ldHs zb7~>c2*6k}!wD(PCgZ%F@M-oJ$!60WY<{wNaNjNvS8M<{#NeXlI&$E{VO^l3PxA;Nl~R9l78B*>AH92ga3`^H@pb%r9h+27{duJRq1>Ekm2Yt zNHCKacjWl}Dx(zWUkedr5$a+IiuB(*CT@nC+yPd`@wcnkQF&iYw|M98?zgp;a~IAx zc`M3}V_C%erl`g?)faqY<^$wRLD9}CD9xn`)ucmU=-P44x}oaho=;yD2!3LIHPQO6 zZvftr;}!hero;k{P!nW#6rz%te5Y;qM>&bCTR*QAY=R3K+bc1?!{ujg`NN@M*Q?M% z-61e&xo*-U9|h^CuimygqoQ~2khaG47_P5M+!9>3zAo zs~^-bt&*Q_iOJ(38$XscseM>r;!pBk|3F$~lOK#?Vipn7z6!*YO2JEoak|Kr%&m<% zBtu}Npshm63iQGzz%st_pv%E6dCGcmW6R@6RzS+*tVNuULb&=6O8RTQu=w#*0c>^; zAt*)}ag2UBH#D9jZo(%7?%J21?qO-F=+ER>1l;<1iO!+VEV}3ZE~xWrbb?=$gRbxI zRasWb+7j>{labylai_jpvEI70ClML=&g@9H_D)V-=f?BO>maE_6E~;HSns#V&R!9W zX$SB&NLR#oQp!xV4?_zKE$Gka11Xl1JSA!;Aq{&?aoUE0SzHCyidbISSkMna{t!0^ z2*V7tc2PMs-?%N|!J!8*`MId<_u9;)#ekg6!+H8V{;a^TH)vufB# zBIzHWKp%>tE&VY_<;*KRJk$18dI$6tFY`=DBWjp4aZn#_w0RdC+Z9eh0(-4dkn$y1 zByE;&+!Y+-;vQT8P;CWbW^LBecD^bIVkoJtl7FgL_!ck<;uoVS|G7emy>zYF z9jM=K?-y9ARw%`8{3CY}PXjxwBkt{6Ud!Fngx^E)BZR1>WPXsf8b+hBFTnC~=3)zK zT3@xM1*?A;tHrQB;M^j?)-Xm}um}BH`>=4sUoN|R`-^B0!a9B*U>_`^G-{&R@22AJ z1&gGGH~6=TKIZhLW}r7plsK9ntL3L4l=YZvm+bT3=4az;>ko~$6%W^5p-W~1?2WGD znMEOJsL=cwxV>M!=$CZbY|`l3=eBrh`4uhJh6W0C?ay1{tGQ;t3YG~2Yx&VTX#PsN z>mi_K#uCfphuer#9Lf}V8(;*LhI z>QsXUcf^C^F6gFIG(RS4s8CFnI<(g~KP>|jYz6)TlMa|SG zpJ)zoPANVnjtcFRqTD{!cO_y2$bYuuzF(j0T3Z#gO0$pO0H}BXoqn`iPdbT;)0VVz z8&>zGF$Mak(KTv->9GW6^%2ZC`dOzzu5SRA4+g9cRAWIfp$~~@&p#AB>I)E|E5ilFXJgMq4Uiwm%&EEC@g4}GdmZ*$XI<~@WF3(svY`1=_(ou2r;*bKXJS|3 z?QkR!4<*-xL;YidJtC zeFCPza&Ooky_V4!j*2CEWnykKE}$wOvrITx{vwj~;n3_GG?@B@&C`rx7i4vyVAh4$ z_a{=%`pR{YZ9k$XOByAb^*V(Yn>eitVK6$OhB6b1WcWfCO5)B1>hK657n)?mvh0sY z>>HB+vPWJtSLAGs!UXs-!aJs415rA9DJLxtz2`t^P@IDjSvz*zveVus@UrPGQ64ce zPW@Yv9x=W6_rw9mpS@G(a8J=A-trwWWcr4&!JH?O*(pB^WaqH2s)`Ap26R`H=eyKe z#8YLM^E+2(`=7+a|70*uQSPWA)l9F`H!KBf z#JIQVx(sx=*YPyD+%QjJ#1|LZv$hC65EhaDjpVf# ze_n#D?DJKH>R4>Qf-g`r#Aq=t7tPXu_uo0l8Wt6}cD6-(^oz0rx&YLeWGv5LgS8c8 zoMS17;>WIi>6xzm>Ivqd{6g)%VfiIOF(_V{A{tZW70f&QlJpADFjK-*;Y^nAE726O zOgIITQ2s7YINyy7oit+MM~=BClz}*;5=wz};J6{>$ugEWNPiM``Ix4$ zVTXNo3iSP^Xd2TN;RC6*+$eJ~Qe*YF5Ld$rk);nu?D+*>5?gt=ZDxpNR2h1@%mbRq zmMOz5Np5rB@uNNLZ0RuJE1W?zEaQEo`pZ+kWy`NK#(?htx?z>Jh!IEk1R^8mm7l3j z%8nk`5sOkO)Yi-ly%a5>adVF5`{W@-T+NdO8brRxr#(chyCEo>=&aP?R1cb!Z z@|2c8J)V3(CwwiJ{|JJ)Mx>p8ny?Xsc5G@74kdN!#a5U#p^M}OG|lrPI4Lmu^{lNT zk03-Akob$>Bpi(3-IbZPdWumLZ=}$XL{L8NolJ7#Ww)Y_%`%?1?xa_30g*&463~1E zTR$nQYT&4hy$rDm)#S_BYxPg1SE!WQAjzQWKGYP*F^X-m;efbwHwwi~hwi;jcWJtw zP(%lbi&+t1&)w@&f9_g5&yy;98Y_FEDtnkVQ@Rd^(f=-WrQ~4XeVNX0gDZ-gKd2ix zg@e(e053nXf0vzdQ~FH_m&Zy3y|-VwZ9~R>rj+1#ru3bBmRwje0%|)?U@3(qGNv1z z$$cNFN}}+x{?JYFnxr~|v|nU|vv5o%5GuJRP+x4F$7!U;Rbq%H<{z%AdF?eqrXR$-%^P88!P5M+?Kzd;x~NMAm~#bZfXpnAGbD@Vk+Yy`lKC@@qxs`!%H}u^Vh_f1O6+bNhSU-&^b2&N)!Gs&zToOqg=pgqIQ(2UK0Zr>Qix#V6X1%DQMnj=^tko(CBQ`XRhLUBUJ88rC= zlH3Yt@S26urz~2`$lB0xwOn#pYMQyY=uV*geX*vUpxN;{LP!xkRZ5|BE+&?`B!Ptx z-a;YOLrqABK$t>1)2?#%^LPj5pDBEWRChVan$KSzy^HfXtH)65R!HS7)lAiiQ7(Bo z_7#6!%)4b*pp2wNxa`AeXG>8SaAXt%To|i&;v(rAaIYdd^j0ikc z?M|W%s)n&9)4$5@e?f;&GQwNoz^IwWGv)|^e2-VS%9rWJ3#{~);=vHT8Q5}E8xO8! zM;_Fc2jvR)?j6bx365*)zur$`F>50H*@b_tGX=Gp1ku#9TH2LMm65m^XF7@k{Rb|z z4Xs27);1v`>7ZP@CQ$A)fgLL%y8daeYgy#Ma~N;kx9zYb(k5&A03%*)=VT*K3!ybZ zA2XG_qK=n9f=t(gWUtI0Sh@}ux943J;lpbp*YSlV#x7GeZU&6aWvZUV<7b1a3nz1^ z-I^aa7%*^S<*uzC6}fIE9eQrS?II#U1IcR6yB%i(2};iU^x-fJd%JYDxFH&q4OUFX zmuo0R!BLao!NrDj!yp*ifByZV`tM!U)zu!OY74b3wg%T)LkttmnW|X#)pc%K51ITE zkn#!2DRr}=Urs>LX{*`8^PJOy4SpZnR?~unz8_=}a{qEA?TZi37 z0CwFwx2hTE{9HSL4$B1C-%K(~RFG|6vJJp3J)6NR(0_5Z*w!g?e#1j^x4=vNQ!EqZ!#=E*aHfWzC6_MoK$o7b zG@_kT`P(=rNI7B2_m%llxMfA}L(>Xe(OUuMj;XQk%cAI#ma_{$xKVb6XiT4J^WB1_ ztPWJ6gC%dV8Lb;qaw(uahc5p>|7Tz%CR`i;*8%cwL>q}i%!;n?KJhIE$q|ik`hldy z93i~*ABtRA$3P;!KC$d3QW~e3;>w1nAC(KNLcbL-pv1d0S-ue-r3Q9Hhw0U`AYof@ zB(L2zQ0fd^M)cPMXA#H<)Fdlm_I>4tmk~5*gWmR;m-a>Az2VOKgg5oo8{{F?!VmNE z0q<8n)yx*4tHgWH-D0a6b{iHw0n1M+qU&lo(f7Thhi$vDiW$Lhr{ma#r(aWahBWoJF*3xv!J ziCs{9D&Lq>FHs@(B3rX#+&3BZnm5${~EKg1OJa0^MZPLRU^5Bt` zb6%@=GU?%I+p%Zmy-ZwQr=J_zEc|Zr+M$z4$^1JHjKW#-;OENHP-Ijkpvx`&x7l!P z63CeuNjJ&AUF}yUHbO7)7PBENLF;D)hBEXUTsnetA8#VXkd_l-5i{+z?|Y=`CH!-& zb}w{07UeB#*+I?7={~s6kKPKTux%6OM&qW`$e|GMls?1-TNd!f-RW+-7S=#xR-4qgW`js zS(Itny}y&Pg)ri@v?rlGBhxK$5ddHx#n3NQNN$p8r^8C{9s6Y@rjs;mID{#gI3u=R zf`itS(@|%znku8k)xu-!mrP)AiMk+5s++svOVj@0X#gQ=|Thw`BL3@Emn)kX8Fo~jqHTl?9_qfwAgb*`N<$Q zCTZ{NB7?TyZ*4yUZ9nY~E~7go4vC(l!V)mQ8EJ}oPHheagHUdbx4D?jd%m(e+*!Mc zJjP0^=EJ@uaoa_`Eq#Wy2q1fplprYxPaONUNxq|Qx|LS9F43uC%A;RHDRH{u@0jY$ z-eXh%j*w^DBb+uBcdtKR>y%5g>*I~T&C=hz|| z0ynZKROA6TW0OI}OJ5_cY8%P5ttu_r#Nk1GVh;`ef9=%*i2bR~H(_rmt6ixIy8K>G zCC>;Zm2r>Z#3(rL4{Pbv`TYLn0y*=@5I@Y61cT?Izjn!UOw)vMb39QZ{ZN!xX+)DwG%r->k}%pO7h z_Gedwwyi}fB8O$EB(FjFhlD+dA19__Gr3MoO_LX{q( zh~m~VORuZf;2X7S&(VEu#nVzejY}?H?J3n{wa?|!5}@8`Qhq{hcfmy47>use@C9g$ z4BpSFb-|_IX9g+ZVXyqFbiCU>>@kk)sGiN-$1D zM|7&*0^$ttazzu_hncs+#Gmarz+NagDHj)D-;WX$exbD=FHiUvt1;fd`n>i_boob3 z5ru0%Ryd_rB0*l9!g8tl?Wf)LG;qoD;AvpNRtWCLQ{@uGqPK@L-cWu2t<&h8b-&Uv z)gz(gBfs*+#0L2ul;ubO>KO_O0tWn!wQCq8O{;RfD zr2vPZ-b&W(-ioP-?#JQh6)bh=fUG~39rMQ8*eu^x)XpEZT;!9?KoJqby$)V!-5n|j z02j*za#a%X$4RI>>B>)RZk>m{*%o(2%-|Z8=(!k!(Slv;gAP1O4>qpbk+qvad&Pnr zVMW4HFiHsB8V}-Vi>dzWGk0R0#9^u(FWRbC zkX-vJW~2xiZKVNxIU5Y3Y(A+>Tu z`f|pN*x{8Q8a~=P3$A~h#>(a!&m%P^-04!16VLB@U!Uu~>h%ceKf57%=W2r#fZq8d z$GEX%0FyZB;B;w>rl!4L2sVoa;gHyIhvxc$8(H0VJp=vF-QE=cH7sXiR0g%iy^oR>=2Kt@)nt9E_Lv~YsqA3H$qJs-^svL=fFEBD zcQM4*Rt;vc>c=^`N6>rU_&>g~x~}R-xx55_O8rkL(u%%6E9^bf@|wHAbg#A;txhkN zzLP`UiPSen(2hb6Sht<+lg>+TACduxVT`X#Vc-hhG0DhEbF2ZiAk8Klx>dNfAVC~B zB@Sr*_Pmwsv7t6tvYblZ!ZIg3@Z(FHl9IX=$!PNIvwD~6R3^qEJ6p17xzJe@LfHXj zHv@gRve+N!nvQef3tw2{ z4%vZ^MFd*n$c#Am^M{({O^Za4;ciq%0;U2l&krH%ErfOieaA8+anFZDwe9{D0Yxe* z3`>SzNd$WPI|7bjSYwN6SZD8Dzi?f);0e>CQ5ejtkyY#PoaHW%cT7V(1tuxWX=hd{ z*>9$g&l&Ra-9iMDI;hwf-Wx>Ab=gGHrR;mB*Yff{8$XEZQemHGe3Yw2 zaX{p_15G2)XTPObB1J~)1YZdBd5izj&quDitg)hYfVxGdx;RVtn}pBLn~Cku`7-#k zi1f$8uCYUt?2P*{i-Ggoh=xrcY5%xf0}^Jf7@2| z>M_<2C)ZY<_inyRL-6CO9_x|ZioYAPqxovD2V8=LSpq6KrCBHrke3D}n9;5i)u$H6 z4Z=Q-7`k3Dr^{WRl@n~$zZ=-PT~#-_z@#wp6J6Hz*a;{MkZxNv{SpjMP>w!Wc+lH0 z$3KM~grj&5am&<C*l5`PiBhUXDz#kc4)*O(py`7HQOSzS1j4iVKg$__wVdXa4ct zDVNPwHGdh8vHrL*PVatm_Bej-T%XVAr2S0|6&-rft+UG!%} zB#rG#O+%P!qYYkZ%UcTrFxAwV`LA($=4`0?rV+|5-&M|J`h0z(=VS7ht*SGTd=~;C zbp-z9W;0`A&+$1?d}R~eDqWBr`i)w%V6_Sv);sf7EIl;iWz>Y0UCMto)}()f?RdmM zV|y2`*MuVkM6En%PK|ID--Jz;dXe817nu;ZrQq#M!D7jQ$GnV8`lPlnhk;?JzxYXk zHL-_-Vc7O8Fb+L{{vEYy?Kp!`iyIf2g)KM z)^z+*X`C!+#i0+5ucHH+;ey25907E_s;Y|mGPHRFU>^Av)!{(K3rzWTKFQB>rlo+B;3t~=6rhF zv8#Pb3$aSe14bK?1^frnybHeAf~sy?K$65m*2Ka&{~$s;m51@hwoaBvC1ZbcUE--?c!CgKIIBV%XUP&wyArCiy^;FXYdnW!5dMHH3<4&6`QBBC zfSDD!{UvFnzZ)gyZmBcjE%74I5nJ_(^FfK*c> z@v}M$&VLl6byTdoSqwQuSi2`^plBj?IT62z<1sK3mIq#Hq`qDtTq*Bub~q00dITw{ zcxkPltKc>^E2f|8#@=FUSDuh0&cFqt6}{;dmavp-F$FD4_{C^#;4#9*Jy)4^;SDsA z+?O?p{A7%SP?_xU7c1s^G5s9r+Cg3B)B4u>U`G+Ua;y>}`9qW>O%n<3%o%Kq*vZ6S zWShDpMf)f@ifm64$yr7(fXpx5HFTB6KIbpFp2uD-0%t^TlgmGn4pK|^P?u{KoJpc-CKuayy&#XPe_%&B>9GO4}mbF!Qe!ibNa|SJXY81b^|X zN9vN&-0G-Paxx_k6b;5-3Dd8s5JCDYz?5I{mDXmtvH6#T{z3$M1yDOkjPN2-mG&`K zhAUw$Ee#DU*DwdLf_Mwruw{q=P@p9GV#E)Y5Fa2~=rS zqw)XOG@3J!viid~Y9*U&k~11#BmNK9qjK(tm>yh$eT{vVhMGEz488lUiRrY_^Ia5Z zgUTGbcw#=8HjYuXg^TWn3tVl^S$+Aj3IGYHU+^!UD4C+1bonsvL6TD5VyR-Jj|U7K z-1vHvwM~f|l6;G7uTgb8DG42 z805@>Xn!QhLAYZp55_Rrn9orU$6tNGFE$t#H85I^Dd>NvBIU;XUVo%*gJ%t-Qm`5#=x@L%HmIV)gxQKX6-NW%uphasD*H zSrMn>)jVK^k|pQ*ZK}zx(gP+<^B}cf)sh`i-r8*YWIT#>#fg|Y{mWNPCmTF}LhNWY zaU8;&Y`WjKUX{4i1%9hxFkyI?$Zm)yW#W(T(&C4Hl~22Ri$-oSjju2VuXb^5e>b~A z5@#F@4R-r_hJxl4C7UWgC0+6FqU!l8W|kUdF3JF<%OvVXvcyv4Tp4RPQ%h0Wm28N5 zLtiifxsb1|R?<3aZPZ_hQznM&kJtYpb}rs8ZY5nwM_i6y%5%ZPqDskRey7wg8XZB&7BF092jHqA`~s;%_- z?<#?IpX=J&gx`5#pfXJLu4!0aU(yyL9!y+;%#fx+8J#Ch6PuNt;LaB?aA^vck#}9e zJ@Q8N7;*3%H?8SoY8JWDQA)2mT$*GAcY6%H+`sKlBTvi=u1 zefQc>5z|i1ptz?llF4L>a)s7ED12$40MjB*{3Cgf&T`%RR+v*_eFw5k`|&YcSTA~* zDkwZ3$=xSlO|%Nm84G>1ctVeQnKrG5wA#{Y_0LG3@?H+L<5-ymE!5Ymd7_h(1u-CD zZYsbw9GlfL@Mj6R$$WL7h-?)qT1u16$?&Z(hpm7C-1-EC(`W9$)xLIqG)niF^Dm-8 zIcLw{Dxwm^s%{4+LTL(aFy8qrc1c%COYWr>lmcWV`+jUc3(3D}c_w?_#>n|oH?1r0 zXymM~X{A&GqFT#bN?MIR-sed#(=uaiRxU#p#NA7ee=^lIq8BOzUB z&l6y;ito1PIqqtNwevOe@Hi{ikv-}+kFyozgq7;8*c31$)Mg6`&TFaw$yL2nn7ql_ z)2NTgf^(_LF$JdYjMCLyDOTH62{emu^JRwM7ISuRH*OD}Au9G0cqbc$+jOu-B^|gL zeV0eE+vV5~BJ{{yRxygLy#j`CV)z=fPv-(wiEM1bOB-cKgb@t^+D@f?)axEUP zPpgItzb|+^L32KjpPnB#5{im`CZQdko>~n!y_n?q7h5C`!52!AOXRGDoOzZ+0}dbT zI1ccmKO8Cvi0jzKv>^of*7Na8R9_pPp+=T6>t%OKkNo!pV|cfp_N(x zUo>++{Npp^g|Xq;rp?_NO`Phy>X%v)>4=Hj+hAjXMF#6%DcW zCLyD9_Ld-n>ADvD05!38sJrLEEC2bd8Ge5btNb?v)Yf&HaoA^0qhEl;g6(GQ_l^C; zm7gIru?Z4xhx+cFlWNbHe{AQj`tBr;*(CJQBm=&{Ok3$Oopk&%NzTho_!&R|WG`-T z(;+OiziuNxrD^vd&ugh!)k!#kX1QO>UhlnetVjP8=^mF^yTpT30SK(?l59mUP~;BC z3~Q4!|EUQ-Xu$)l*ZD{A-fRXR+4$GU54b~@I;@zTc?*P#)?R}P!v)-rk941lxG^+Z z@fiPW;ZQ2ql9|<*bZ>ty7H=3>k{3b2Q)`BV(*S&c84i}WlZD2V6F>f($Yk7%9EiLet{09OtN{4yHbusMDYS3-C@Ww`aee*X5?cLW>VkU%8gN+V=j^kyzbAC1GX8igC&j;%cbVFLq0{b@^ zUwAwec~kucgf7Q7Qijwy?#@_pvTk3V{YwON^JO)8X_|8|u!$~s7etF}d^Z(8fak}~ z%A7xAFl%@(`0*FcIgvT+v@MHEPh8Uhb~y-l+_lDA`GhfAeAHca|y_jeihr5?Oo&i?~@@s8|@)i))nLr2XC+JVHq zG)F4~L4g92^S;GaJx#4nbSgzde!tmzb^Z6nSH8dTt7R4=k@U4B3d_xol&16NF2I@z z>T59iQwcX*{#A>Y1na4w=>G{{HUTY$1Zb$@l(3)JBLkELj6M`)L4;W+#wEk!-d~fU zzSpYeqy~I(-RMxs!7taiAWq0yYj!mGO(YpkssFD(r>Mjz!J-W>sWCkOJ~!Y{^b@9H z*sxt6XkVz$>MQK*k$p$st(~vq;ew*tWss|d-1(hA6e|hbpCvCZGu75=vt_PpOb|a< zS3;LKhIE?Lz`k!hd@REZU%|Xjq%3Q&)z(rziX@sNI$Wp1$&a-L*=~Iptl(CBwKptL@uq*OrI0$W zYXI|fg}_6b!tJ^9(ayfY0a9 zR9ULkykzzr?RE3RGkdcuZ`f+1T* z&)vL)gJy=EapSIO5Mqm~y^wnHP`+Yls^hyEa+`mD>Ahc2Y*w{~Bfa0It9GW&UaRPFg)iaGW-<8!{&34ZmpPZKkL)7r)1r0Sah?hU* z7y99;!)LzG9~^7KDf2~R6(eki#0l{tNb);b;vsM;Jz$01*Sy-dTY4^i<=k}9lcLNH>B9RXG=^6OCE z^w70JDTi`L;#gZaf3JM~s4O~i8Ruu%FfrIBoaXS}mnduU#XTP=kueN4KRSC&4r>$E z3w`R?8Bo1A6wWjrQ(kv2^aL;6ZPOmjP9osayFzP@BWi3r#xD`^>>n-Py8B7^@Y*j^ zQJ#jB=HZ9}WtD#{bBKL*z<>H>6bo3n@hg_p#gPn1S&Z%aiD%KNj4^Q%@mfi7akNha zZ&e@n`kBL<8VMpFbTpUs2}NI#06BHLdaB+hUbOLlIR~FCA{9t%aP*p;ifoUfcm;oZ(8rmuic{4>#As?SfPB1iKcqTNBhdHrPt zz)GEn3IjI#rgi%{K7--hYQG=|ni*Nqw2nBT) zd+5hsdaklpvL+-zPVez-{k)$S2Q zzJ0GGIfb<3<0+rMaB%3xLg08pM>r9#P+ynO<8FxhCmi9M!4u2nR%;NmBBXG_RX85N zh>M`tSbAc7oH*DI?%ieFHaKyhP)^@&*&c}DiF8qBlS`tx5KR-yCO}ko-n}J#8Y5iE z@QD6F+vm<6C;MG!IT3Ohms}_yB#ZS*hXZ>UtMDe(Lmb2>kCX@v6%wGQ=QTa`13@XO zp96n%*WGf39N1EyJ7R(ju{bzjtdj+}um+u5q)X#d9u_K;mfAl` zQf+$Y@((tWJww8?3qTm*ZOvoUW8#$GV|x}AVU*1H%{+_8ucj0eE}aMbRRoRmnRXC* zo6(~qOq3%xe>q9d3epG0652mNhvna4xz8DGqd#2Wpbe#Xen_Ef2Rofc?LGCm>1>*3 z+I&-rl(lD?6A!y%R6n>osst4T1=^XdtnEc@Iq|54@QZM`1 z2@ZB?Z+Fm)>fxSvs6~0jHz<}VXxef*U*#j=Kef?gCvkfmibp&OifV?tyzsSA2_=y`f95slyCTb$lx2ki&@~m;G=1@fwd*D6n4v`hi z967JGXe5cQ+-G39Ms6zDnVyq?j>NtGZS;0fv5>Uao`N>?>!8@3R3Vs>ey|{JS0r!* zpBAjK5#hbuu@j7qjna`ikBs4TazxcoDjOS~f)+)YQ=B^sq{&K!kV;8fz_JV}jKv~g zoP;gsUmZj6OHz`~_qR<`lYFz8gInLA8B*jIGUCrBTFAc7Uv0Kl@){rU`S(0Wg8Q<4 z-tFQx1!c%j0C&0~q+!bgcPb0}|5{TpeIA@>$>-zAEcn434r^dV_uOx1ps0;_5TX?! z?lQn#^;bHwX4zz-4x=OaQltI^QKE{`Ba?Sr{>75PZnR5t7??9u8~^>E-Nt^(;^a_o z$4V;0$Dd;xuqqEilbiEL;3!SLk6)2Ko)lgpV>ljU9%JTexuLnG%EFQHSK#D*sW}O0 z%{)MLWeFnZsbn)Ka4xMzY+2l&&X%}u2taR3`_HTaqQ_TQ30brky zbhnyu_T(Hvy>#W)10odX9<4$%%|*{T7R{d}j~CO;565sqN>e!-YJ{(JO1~Td+e2JP z6w4PcLyBL0A39Qruz`gbg#Ac9;_v?7rdQPuemyg`WSRHf8)#AMTq4r&rAHpdz1rbS z7$3_ZJM<_`Bgdu^ky?lFdM97CouN10-0Ro|obnOq9IkBfOu;PGcEhb`NyZG@`BTIU z!@u11bJQ?GKnhLm3dPtqdr*P^X)PC$UU$Aq??$HS%;>BYOvK`q0XM#ATsuR)r=Qs; zpJiN6d8Yozc3E$zp1MvN#x0FQ!ju}TLEw!4kQ!tce0RJLuha`luZ(3gb5 zrsD75RKA**-(+6kM?CVVt1jYx_ zBSu?D)K5>(m{C}A%LRsRUWA47nPOe4^~kIQFb4e0b>89|53!7dx=Y zVj+Q=VRUs4;v3-!vhl>5_#GmaLRYF2_h4=pKHZT-tUiHoxV){dy!yd#9F6s{7f zb0q`l&YagF1~y_Z>8TVc<_S6RgxE{1iN7D7;JCfAQ})=x9N1n}3@CXMX5vY~yAy8W zt$|>V1A`bcT)tgm7_FSm)&{vR;upsq?poM{x#{kKpX^-PZtBwdQyM(pk=r@ni476? z0W5^AGft-r+SB1^4f?z2=_xZEA}`Db8Wy&(fISkQ6Z<#&l_*bnyNy6oALzi=9Jz4(rJ6{_0~ zaeroKkpB)G{dA5=RIB#rrFw-}PcyOn)bFYWOd0H~8SIQ1?08FCS@1VVEYhDUY=99G zkJ`4&vfY8@Bvg4sIqRWMP1s~o^se8DmM04aQPo++Fyrxmyd2Evu%-i6`=RxXd5@fm zk641AE#3THrQPo{8l6|ipiSxV1!8V2-oOyM^m2P$ziUe+dIicd+4>@ktgqVTW*9WOIAVRH|OlV zto~N+zYBMU^$$9V8vdfY z0sxz3IwtTJQ>wrH(?L=dGT9+XaDN%`#y-rLmiM)RZW;bKgk=7zuZ7KP+R{ zQR~K>O54FtarO*uwaMbbSv_ZSNLFNxhF_glcxKE9P54}*EN~zYwJkc(}nhTkq#&o=wJC#Y>`oG zTzDdbemv(3)lK&Qu=SQfadZvWE>5t)-8HzoySo#DI}A>67~I`mg1fs0cXxtYAh|VXrwQ@-3z9_9b7TMZs@qza*-IKl`*$O2b7qG==0#o<5(9PPJ z)TJj8fKnAbu0!K~*d0z=1$N%IeG*mtfp=)EZRx2B9>GW&j z3&lI_-BDbmoVf-1{4j6_t(=V!h?rP_4E)q<4+s1?4VPQMI~ZD`B?tLiKHh;YTsV0h z;Gv#+Td#V2k`Uo7`8X^t{j-XJC8;$HNbSD!0QBay{cK4?hog_1k{Nq;5JV=QfA66p zN!q!hpY10;oxz!k_A}!}kFr950L3{B;Xhdiw(iiFE~?|4@pGqaR+AP-I0HNsOONgR z8Zz8jBA;rTRtb^vt)p+-Ijo9z{0K!Z7_|bL(;m`)a$T62(BBka%e5=eqQYrK>uG%a z#q8-CrlAQ5$OsRS85z(E3K4_hByf_Q&bln(+Li;TwY`UK*2w1768H(tv6$2^Tn~@6 zW}4Y3u1&(^SaH$uV^T@?RG86CuPt^Tz<$4OlG~qm!n3~d5akqJpytf^5Eq>HLLJ} zc6< zu`>(?-&@IC;9!4%-Y`t~-0k*N{2X_rSoFm*NbpWVx=U1vIh4^+Uo2bqhRG7RsWoHC zqgpUjBO*%EzP%PeL4vVgt{$k`cVn%9Dd+6^xov9QX^xKGH7sNb{BFQ7EPg%<$jsN) z0(|w%Q#&kcm~A(;I>tIUzO*(B)PltC#QQWO^}^IBTAjmz9sq_5eqw|*_Cm*PT6oVT z4xJ9e=RWREz3uBjvltw#&e1?$!`r-R%QGlW4366T(qAqZ9BDB>Vg4QYBYoDbQCl

    )JyQ;>w^3{%vu2I7%$I*OkLlvnj~pmG$Lkdr zhO%}{w!GYTmoLVa8VM5bJ66PCXTkR7MbqYhqF^RFFZcg<@$zLiaZyutR#r7aW4FB& z?*d-+{j<(^M5L3Z`7{tV&9XNjt>t4ORv~o1LFUzr}R&PO&Q>a<~&H+Nom-h%q%fI zJRHR;5vU!sLM}F``Q>s7TD)HSZ|-7U=AVQN_#eDl?qh?yJR1@tW+9}ZP=OT9rqM~* zE-s00$Wif28`|N@>5yAGWK})?IRnQh*Jvt`-VdHvGpcz0T>r+^{}dll6rin0m|#u! zieYbdi(xrCR(j2`$GcIum@VmcIxylFi`*;iNGN?kmNGF!x|3LlJ76YAI`X$Qo(OBo z#+CW0P&+GJBudrgY_~DvrDU~tiW;b$RWg{Q>|j;7f~*~BGf@{)>Jo-!Z#hgAXW#Xp zQoiZ1P&EOg0lL&3N;`(G{+amgi<|Mtj`IdhMZ#ItTN6Q5;eVy$xw0(i@YnLTXJDWk zn1V<_=y~Ar$X;kG9jz=#xk2ZJbN6JN!#DugFODMt?H>gO;-Y4^cmsCyyYZS3N*Ar8 zsl$|;OR>1syTm+rqT?CQ5)|y(9s1vyBZn)t9{y!XWOO0EVD$!2{|Ra6WMbhpcu?e) z7OU4vFXul8ceie6O~F|IA!+sph`3cS4(d07W=Y;~!!va(v$~7QKHE7ak+kyxV&8C4vI19Y;5Kghh8S_#+#ZaaG z<4Y^cKqWDJZ@jhb`5BnpkcORk2e8}_f)+zB4n1BP7IOEU0VL0R=p zACh0KhlFVwMN0CKc#%rPN`UBGD_l4$ZfvK8uLov#*J!~hPtAtNpkMh&-bl9FHkObE zV)&0^?}ms+=%dVn5YX{BQ&MSX#r@#)_)ev}lNMb%($r@dZzGXXfC6{pwg{b4f>vH)AQG2=9#ine>E~9P z{DBK&aH%u*)6I|)*f)=D(t}HaI45p4dRI#}5hPox(j6DAm;WD)X~h~WC4^;MGYYB* zQqI3lQhrc%{BJ~T`H*Hqa1R`kH0ZcQPLhK(YMR!>TkjwBCzF7xqjN|o4Z>}zcxhOJ z4W-m5R6@LVe%%E}zp7*L1jdakqaA0152cFNK5G!4Z36(b#iCIJ$6U|^#oLHKqP@Ka6#BL+f!jd+$ z-%Bkc(5kq>?#N*L0X~OERcRT#`eijvGspNvV#~ha;1^09Us$j!EE?@q~kaP+5D3Iv;*Bxl9Khd z+mHz76s3>MBWXUOVy}$eMfC4zo^&`Ylz@$WcR1Q%o-{18+RMsq{kL1%_GQ5DFo0cY zy%ZwFe9G1aq~I#;N#B&0#?_PvITm-+A$Vx~Bn)T$YOiF2ts%KRGom(P>{U9d%nTKT z2T1%Rn!VNC=`wv{X%)DrL)JOM7IAq?{rY( z}642kYf%SBQ1TjUviN)VB4dto}XzCSv)sHv3VK()z8foLJ za+NmtkW0M;svRBF1r+&4N*z7Vj7f}qZD`n~N!KI|)PD-D7uVEKJ^dP3Xh1z7PCNYEPks*um)g0bmC|rk!LjGcwFBUO zVX3=soNeaJR(yjM1D!palNZU&B3eplXLo2gtCTIWdhNv0ADp~^bOg{*nE;V#nRKcR z!BfaDy6nJHfON(;eG?3R`HTq03Ju1KmY@!Tp=nWUFK!y+LsWYeE$5hwgvcpdhYR*2}8-ZtH_FF=(OvT zC*68D@twR&0C#8a_76~W@aN4#)FaBO#@wnpT276g?9V9Gp>HiqJMpRexq)41OkkIC z&orK0eF$G=H{V3ofz+4-;eAFoRtk+N zCV`o7$Aq8dj}H7?F|m?8CtmDlZ;upb!PSU4J5lg_3oNM+&N;}e1?8{Gr_I$P_h3MQ z^H!)n|08}fj=vr^L8`&%!xHR8ivIU|V)~S>*fmK^SG=2S4#E9CI)UCT;)q6O;Ueaw z_zOAy8u9APyCv`1G^bsGXQ9&?!LTVOrQb*~6v}E67+EIT=l+5F+&|#r^uXz$^T;GL zKO7t5t471W8X#N&XbF2)@=4WJuwRF;sC>D<|MV+qjVMFL?UMdQFBH1uL1*IkY%t@H zGx7}b4}*QdUrDyly~~7Ivbd{<2?sz!O`k_p>SGoqE>djtcHNUpZVj!B)UN9v*xZJ| z50_eZ4F37V^2r4>^6#2(H!HJHyQHGajGZl3iBb)7`h&=WCNN_4itPYtsp?KT&8n!7 z%Zt9CAlR7^7!w#{yGRC4`b&Ow(U1HjOQ{-?!B7aol%26zXM93+_ynrO#rlwf)QRex zi%3=Ti)&72bzDo5q8aJrvP+VJYg?Ki0riwk&XMj`eG zYtKcsI#6jlhN3L4d^5n6s|kBfK%!9J>`{z*@Nph9D@mCkIH9sxVIA^vMbNqYIbLwO znpPLqmd{(@^e-L?@Yh(!C`-x>k!v$fwuc7re+mJT-K4;V7W($m zb=^7K_AyNk&kyB=cC?Pl@iH$=X;@Qp@D7q#J>2eVaubBY!@hVHQTAznVT=aV zCXX>D)SB0XVhG1&3M8@!AzT&qF`VcNe)W(mfglr;Hx6^=0x$GMSQ!rt>3KJofCphl6afh*uMkh`f6*j86x7 zhBbmP?KeJ%-}b)dME<%AigLt-A(PN`ln067esDxj*xCK`_f;CO-g~Wn7$ID}^>UAR z3++SMgLxxL8R#@ho8o6KY=#uG=3|!Enoa))GxUGlHug5?4tU%3Us9Mj8TEeoY1X4{ zz0q68jx&6_U4}W1$S{*;B_t@dlUQ;b5<_q{6+s7Dj%d;oPGF&H%ti& z^0BwMLL^#W@Yr3l_(eTq#m_{~^+_y5_s{R?qd;jL4Hp%1knvhZLTdnb;h%X4*Ad8$ zefCkLU%=(Tl`(Sv7R&-5*0m>UL6|39RUky^X7aH|@=}rc(=fs!chY|UL|q8!79==tc7GOzeoY~K&YF|9W~vaRQz)eM*o5}@ zoulX*mL^)QkjV(CP&Q-qlzrpAve$NxD~OCbjMykGw5|JAGz)V4np4tK_$6BEjlTsJ z=!oj&C<+cit_1@hCEzj#SwSE{0_dj>pV*u+wr76Uc`JDT7mMl3r0PD2#hOre1c?~FxJlqDwFc}$BHt-N&Tk=pCG>btfm zea@7zO}c)2Qd}W}gR{##cm!YhG zryXeEK-&fRONvg=qW(VF^Bzzo7ttY!LgC9HT06%76u=@}5uloBvqku~o+!R^I}gM( zO3&~ic;CJBba$Un8vKCdOZ3_n3S~bE!zSHeJwjX(=z~1&G(%n|P)j?CbyCzLY{76p z$_JKsd&*c$3w!)fg8$wz%{4Mt7=wLH1r4|50`&lT`q|e4;i>iO1q@ZE{@E#_V!-mX z_N{+nC;wgAv0u&D{Az|Il@fU`|0wv2_ak__=#7}m+Of$#;a2Rdl?6&0R1^gfJYoPw z2m(K%7^)-&A3@+FjuIl|V07AI<6|jTTv&ncUUC$)DSg{d*7J_3ooZ4}39#+gOnLVk zx(7XwYu~d!pB_z+k3{oni_jzI0w0lGF<4y^tlKNKsgg2Mv*w~$&kt2E7C!@)FMhvF zsbf|q=lDb4>lDT*nyu0YV3gj$JuV*5@eC{pV^ukE4E*y*F(~VB)uLdZsaYz-uC;t_ zqqL1`eK7_%xv7|xY7$s*Hf6+Rg#tD!llxRb+s#_dwTE>Kl^*;8l|1XM(I@!OOHH#* z2MPiuYp+5BoFB+_43-{1gl~ceskzLXU=uMqk5617SL%pBl$)rQYkHPjmI-{chP!X5 z<d3 z^#$=?sRf?ul*C zoCzidrH*75X^;>`T`CLQr0TB}*xxsyoTIng{}B^^V>3U=!H)aNP9?K=TF93viGYb> z2ZCUH33lJW6iK@yuERxyS&*2&P#3!M$}ofBoTf9|AiIRd}Xfw4?Ubd|J>iwiiUscfwe2 zd0N(wLNTo$n?Zsp2Kp8h`3Eot#$tEq_~p4PSuPZuUkQQOp4CcQSS!ibW^|cuig%>U0Si?yQwT$?myiL;zLR-?mLpRC>Ok0*%rKw5jb*J zL?^$_Z@9=aK5yLrzho{t`(7=g7fR6WrS5K-j&@Yku=}@Whvv~th{1-YqA1N8!sHd@ zy@3$Cuk$KU@55T^N#B?EN>V5cRk1s|9{tGpNDzJXcXK>qcNcCNRLS~P{sEyuwaH8INxKRA}n~$!!o7Nz+;4rZ$Zr+&1Jk%|##t*RGl16L|00pP32zXk=Qw! zAu7hX^0N*r?VyIrKQN#>E@GUP(fd?|cnb=1HP=Y~z$%3X%W%*{cvP_NYyxoI^~XVH z>-z&~34U^C-Bt@_c_Ln@f*T~2^)20V5IWzcb{-@izqQECb$|T|S80nFZdz~TS+nQ| zOQvAQk9QOe`Uj3eua~1+rSY-)RX|qCg%^KY}gXUopA?0y{Be z`hD-IHh;o0vjGu?X^UJo5{Xu3oWN{PsWO0bSe}YDS$9q~t|fNH<3a3bFBFp&Rg z%`U`E{q3GGle}Fh=%0|Fq9WW>&ov&!cd!-P82GHfPoH~2Cjl9fHBP0DM^oudalB5O zRiNF(eG>hFZ4rbbkB8WMD~NHKv$<>b=w8EvWEyWHI`O9ilHc<-Om+NVfhuqd6JMA# zRb%5{`#UFWWr2$Rw@($IEqC8_G1qV84|ztZzrb}`#zY-XkKJh0!a|})$Pv&nsW1qP z@+ZY$YD5fbdUhx{M1oORxsH*zrA$;tG>Hrx2rl~XE!c#TwlfGgRAiXYED8hxUk22~ zQnNY_&~@$SvMhzKjiw?Gz8@VkNK7R3_OX*&ZHsm!w5$|y8n9iyTP4XwzJ5ys zUTl*LL>5%)t4)TeC#l$S@7>}iV#PlU_gfP+Ppf_!e2zbjx#aNV@7rNy*Z`w|@@S(7 zr?D?aoUmPwuN#)Ho!$VQ$% zGR?b%^SZp~bV|0`9@hP1^T*nsf8jvz4k9#4yN=CK7>~59W6iem?UbB1;I^kVQ!9eaY!)qbsRCj6@Ow4XgdHW%-w((CKQm;Ei! z^IA=@K@=&B@JxGCyS8*m|Ly7Du~!vO;gx#?zK&F7#9GFS{koZ)M zv^cNASvj#!h^V^j;=OvrI@bJfolIYSo>--lc>ywR>X4e;@A&THQc?3uY|H2=E%G|JJmvrnYhx>#Uss$szjiC#G-+@f6IHps$M;nQuiO?SG362>d| zr&ROq9Xz=5PfGI(k@6XCgxqU}p^eP-%>5_WF!&y~Xb}tLOo|obgN^Cn=13N6Vfy@+ z0ZxyC6|=o>OW7ux78Y`|*99-s`XhOMPZ}3DddBb|MOI~?m z{Rzib+MC*6deSfs@F@=`hD?5~-z;~NA_Q~kA_S_sD4`2j1EkqR1EdEWK)@ezyx5lt=h67+$U1G@j6V-WEAgDAomN?hO1rq$VKl$ls zA-;n0OE+0^7*gD_Eja$~Op-zzY{?n8$&|>g=+l55>5|8tRNpQrZyKiVK_@+52M(!( z*fW8?*3YVTl-Uh#v;Hd2MUhEb`2(!9lyY|^@0e`I|t|UZ2b|}m_7>Rf)XlRv(B%L|F zPS5a@lBQ|%SAy0agjRsKbaNg>2~*tk+O15nO_KXPF&D9Zr@N?0oF=Jk?sL+KGOo*h zQh%ljkk*DLH00YQedLK0uo3__YB@0#X%@eR(W;sWf&C)NPa$rJ1|dyLglRmsM}1$A zgreP=oG=Ue0d^Fc25g8Xch7rFt{?lxm3v3Naw@S?;BWjPvSnWxA3wK0X#p!{8oAZ_ zxCAVUT{H)$gCr_{_|t4M)+&f!C6|(7XO#8rQ`|B6e=?*$02n`1HJc7&?LFU{f`hhc z0FT(_SmZaw_U4-lBb}aAgw1m{pfoN4@*72D4wipLtM?5 zP{qzG5zP>!V*Id$JH;R05kIBmMc2`at!s^*pVmtNz*g4J^qs12xC**C$+Mp!j(U57 zoB7+HTeda-RNefqLh&2j7Y)+a7?bb)8CgIGj`B$i#8pPVybR+>f)b*JGA_RxJx{E( zWA756ASPe|hyS04E8AP?o%PuA$QZOpTv7st16-bze)H2|_X+EXe)P_7mGi>N=?G0{ zxAi+W&XJ=)eqj9H>Mzn;9rPndx^7o~r%4+=$1YB~{H$vwTejIh{_7ANf2a-vz2UU< zw(`U{(h+n}GsQyN#hZM#K-SgJmm1vwR{$^7TsR_?o+BTx)x;vIXJqi+TajI}V8)|_ zG$hb$-Yb5vY{oe_rEv^FQgw=q>W0cgL-~}(I4U`|;*OImqS$|=Fti{kYjN?C8Cg(9 z6X6wCb;vQ&Pt{P?mevD;Qt`P#&qmOvrBx?R?Koy`xG^zk(d>OYPv)JTf_f3J^M6ZA~Kn z!*7i4i&iDLNTZVd$X$r*ALyTFg0EFAK&RNcgWb#4xSr)ZOH5Yr<8Y$2%QHhWxLPa@ zt9e{g^`=aEERQzCIF@Py!LTf4`i@WfA^SE!WCp1vbIczb|IkQ&o4&n zBR`4ce)7ytoSj3*Oa#fqkVay`GgKIo^ydX2BC-#(j>%Fg;Rc`i(5lyKz(J=B(of?4 z?I%>BRfjZm)k(c&9VydHdNNt2xNX!)@FEH=6-k9$S|Ai)>6W0}3an#1;jiVY@qkf?1S>Wd7cib|Tx+N|xubV^G(jynHkizX>DSg{kkh65O&a>zu}^6`0qKFp2hMyqkwW{ZLz;{DA6#-_1;IEG=UC~lgk#Uok} z{f6u^Q*(GGaG-y)-NR+53T!B_2s5iuxiGAPN!amRkKDcCY=GG`aw?`vmceVN-Y8>N z7%)unq+(MM%rA&!*zPK&os*lp{R`&zZb;SQfQBGBw;1l;R$=f$pv zhYLl@hS))zsU3>mvbAmd?|gOu3UtupLM);n!lH*Y188Qn6;_S(b{BhVQ8osMm8PO|?C)L?_$3FTAp-&5j}Zvgo(9N^ zJO*p81^?3rllSj7-u2X0TZ%eNApUG4OiOh5EM_sjW{Mz0T8BPuD>7K-iPE zvAIaHJ6rXXsxZoBB!0eFV{Yzu(AJYk%)Gb2M|jIr9euDp{@sf$XEHq;A%e4gf9b4Q zOy8d>jJTGKt)p!U4WPI4{}`0^=+j76;68Xm0ClV<;)-^ zm@hSkDyzAkgnXp_>C#c6qPUgk@+!kA4q4MPlB{^x+Ls6a-{bT} z#1VS;`;`%z43JYDJk~HIK=GlrQaVR*Ho=3VJkJ#ijM@Hp_?Xqv`!Smgv z<0E+v(9iY*{-E}s$KvLO{jht@n};00d%%9;Z=R$-H?F~o@Y|DV?1gc`8IZOxbVQ|T zzV5J~**<=kDo z{sk+eFLMd?{bI;0)Qp$1`qMJ{d8f6|Vcxr;G`4<|SIm}@psMw0N+Znei1C7Lu7TZ} zOOvUaa{_h{MkBD0ccIzZpiyKCLQ2)kntb%A15uK03T*KGQJ9Vu(MP6I+qI&dOj#gX zkQU}bpba#kRBd%2^fMGf8iOnQ+&`st_VK#m+?!9S1u#R9oJLa*9@HO=b z!Uq`53s1#B0@Jdyya2sDfuyK?iTX`w=0NPhrq0ZZ)js4mIS1l%j3>r?mpbw!kqQ?) zei-amAhRCz80%I=LbG6Thc|fWe%68kvhE;es3)jKaEBz5FZRhbc`?f=+0em}1sQue zu`ONdFog+FKaPRK>S(YZ&(ee~(TG6CHW_p~i+)Ui9h~hxH1wE_VLVRXj}1BVy_V!b z2sd8M6y38PBiC81_6z>bG{4bx15;YrJWMnKK09Nv*d7p};t2Rdn_FWUa-4TrlJ?Ec zW*YS0UWv29T<<SZ^^@}7m?TOHzpkk2%?R%W3opH#;~5%XSt?;^0kl>6Pc8izC^_ z3vJBe1u6z>Dbn^&iTPQdGqBH}&4l;{h# z)1M@T@N}GixV$Lbr5TNUdo|c5dY(5MAqcdM0PictAt|PVsg3^KlpVlw`l&}!acVxq zi8%Af)m40 z_Ly1AXD&gFex9v<O}=#7i5KmPP#z{@Ws|CTup^UL0nr|cQp?1uGr zQjs+PI9GiX;q9)1$YlA%O&^(JnyHbqy=bp@GF)Z46c1`INW+ZnAA;ukPn)e6Dgr;p zcCCb1G;@@mR#AW=X5HU(CG<_<;6CTooyt3S8afmH0d@i&yzOwaY1je?yiZ#B=S$}8 zbP(q`fq_*@;~fK1kEx9f7394{hsf4$-k+L(l>ax`gVjbh{!G`9-LToV4BI;2qHFUP z?n@9%1P)QC!^h*R#Psmku)jkh>gxph_~du`&4Izbfx)ObXk9BJ>_{$07A-H>jiTTK ze!&dbzMvvC^GItMqV*eadp8eWvVBOwY1rmq62{X?vK{){v}L||iHi4>#?(_99D`K(ACo3nR8!SAH+n%F6^tI6h64^^Z?Wt6Z(;E(Jq}$ni|)`n#|P`c zM0`Jo&rS%E-)!Q5r^ocwX$6lvAc;4;3RIs62H^U5m!$<_XVb+DaDQ;NL~nn7g|g*~ zv8IXCJ@cQXS4$A}(BmRu8K1{yC%EZ6{1xyU=_arW#Xb*nw=SQ@?yj@}bfjxq!9RGO z*t3=K$r`qpMK>yA7G)V{dihUCQf0VN?f(PuN=q?`g;1cX%P8LK1qSUSB@yuhz~8Sv zYsyb88UhY!?oVOAGJN}Sw@aMT$A6As?qp!N*WEkhGmnYed3-pQGx>eBA)U^Pb7iyP z7wCQyxUz}gd#^vj^ddTKN@$lWPKHbTED9M3POY2f;B|4=+GSCz(cOwtol~P9JML98 ze9(2=%KwsLrgwT15%db1bhZzbxeP7Z+}PNnO$$$r4^4Birj%#6wGpY*$8eM%JuHSF zyG|b`kO_UAM8vmq1ulN#Sh^W&Ke5EA3KESbAxPi982~e-xyQu+3|#P#Dl!?QXR_GV zmRSTUbRE~ytha9DDTQsc|FfDM_T;2qY!E5SL6W@#DwlKN%ih5#mk;;lf|#$_;fg{? zv&uUi3Uw#u`!~IZ+^r`jp3QBH?Wv+pRt?psVG2CwjntbRJE{#ZK2&n{xbQ_me^yaM zr$bOYIfG_0qftB|gJw)bx~4sq%yJ@niQu^DtjzgR^xxHgo2^HspCoWO>#`=U1F7>Z z#NfJ)sq?uuyjL1XK{-fIH^9UGoJntYS!X3}YrjhmdMdXvuEQ$|%iTf!-B{d+BG*{_ z1ZcX0T_XU#hU|=D0qRB$ecixWj(R(kHn|p!n(^%a!`Rx#2S}o=q%hpM;bAEiM zqt!S*`{oOKkl*kVeUNL}^5Z2YQEC)rJwLqbnu&dUGpsDaPs`3Y{RZx;GEOuNd>gJFSBZdkti zykm2a-)bY0JN`mn9dIdO$}k~Q;jj0S?3C=2f?)gu79yW&%kIW((*d&Y-`{_*1+4pI z_PZKP5FuIth7ex>GXXF~$oyDa%_AmJcYc>Dhnq{DI4Xd8$# zmRMERcB5_-O*YhNRgkf$tlBzCO5Xwm#*2tH2U1ho0yr{GZQ(Jk-DC6RNPSHC`KYJn z{=h%pDsU8r%+V%|Zh1UA(CJm!GKB(> zrkx#pgrIiX4|_daywhjAxILlQuF)EF1rjdRmo=f4%jIlV3kwbjjUG(dl@Lb~_!}#E zNhHNL@ildRXe-*dwAl2Jz`4NY-W+JW@0KH}F?YJDir~&8+c%}!A~-ZA$b6O&r<31! znnyQ)^831xFf~sZBz;@nJPxmcjyn+~KWHSuO@k0sQHpxR(}r-S@sWnmZdBrT#q#l? z%zxN}z+_(N{azL9@%GnAtUl8}nDlv#AS`9jS}vUI3#am0i~roai}G47;D1NmNJ;m$ zdF<<{Sk>&;J7CTCI=6SZ6Hb&We@W1c_|atR7xXVl6uGIW5U2ZsU~pdc?4#VB#ww1O z^ay6vEUq9$r#g%~=s`X$?lk=Vn0eY53L0$dvgZmN4@gt@Ggq`_ByS%r51{Jt=soGo z%PRGWnu|!~A6HOBWcM3imfOBJcXYH{{B(O)L9@N#pe&aevwb?@LWhNCjhCNuy%>_5 z7;r(&^M{h4@)H;I=+z|z5;>e1*8C;H-XO1AR&hC4Qb}VFKWFsh(&1lnh;q81Apj6L zakn0d4Ck;;AEW{8>?xfP@7cozW=c#C-*@-;bu#*Pp5PQLf{}M*5Gx@H~Zeyo28I#O=m{HBtiH z=g&9%Tg3qE$UHOr`@%PIkdvdtp&?i4^}UD!X8yR(dsu1t&?TW1uW!*a?Zw~bDMAo4 z<`BO*XB6M2XB4}r&+p%p?!aaiTFDv|T4ex+5+SY55uFj+M^iNY{g$Dd?RBkF4{x= zK|T&3A**|lYe7{k>|*xW84kQ*RH*8_AO!s``Ta-Z@?!))Tg(o5O5`-um$$a5=vX6+QETHk3!RrK(Vo5qbiu(_SQ2g}Xnc6|Oa^aN|cr;))6id+8BjgMXb$U7M%0ym`fkKEW zfx>2e{_tW_MrC?a|B5uU|7!>LAdM&*avB|gG5x}0aO~Sb8HR)T{uKfCX&PT+Gl{jX zlBP?C7ZVi4Zlz2x64OS}k{WBFvLw-|OTWP;$udZCEzQn0>S_vhQUadGXr*dbMZWr5 z=_gbme?cjFFQ#J!qL@&>4qqJYusl`JoiZ4_H-=xpwkP&M_wTOPc}+)@yn(p!5E$+waviOrexN| zS<i7atI?oZJQ6!UI|pJmS4vU9DbIK{#8Ex1HwdNQ_G8UAeeov8!N;<^8{& z?7o22AF8he^(~5GX{{xJ+e_bmRW;3bd5uc_K8vj}cSJ^E*ZloDmY;wcDl3`gW;ft* zlpsV7?vIz)Um|nDl5a_dU>{}KIeRvMh1&^Y!7JaeGFGS?9e!f+Mg5qB!XpP*Mseq{ zWB}L`kcT^yoX=^x|97_eBn)0rA61YOL+|$V{4el+V8=B`NNYhpJls?RZxsZ;cz6iluOA?gI0Mfu;&sboo5eA~9 zx35C+eZyT;cc>#0jr@=^zOz9zBz7J4p3cgbY==3+$8eWyTk-;M72N*w@jqLnnRZFK zEIA9Yb>j5JMU})4LEF-S9KI>0WCZ7PxRdI(p=&l74fV_0m8i-WH`vo|4cJ20yU_yd zrEOq>e$e*Ii)r;?P?XetJ&ry-b3Seg$BGe>_td73cV}WqyacEX{riV%QL?CHI`G+FpaD3)uu+^5di~TVe&Vk zzr@LIU>wL45NZu?8GRb)n`0|&>fA9cRiZkuET+=w-vO2?o$WStX#mEAz?#TS6ZfvI zjh|mHcd^jfK*yPLT4Jdmx^3^8IBGw1FZNp+3B25%Zy1GhCNrBH$Il95FMZ$~%%H={ zoO9q9Cu+C*5D_4nI}1VWx;yNsGb;;M24*LZ z1!}`cr}DU-@1H}T6M0zf(O+)Qbkgg|d)PFm@O3qyFX-^x_{`6pX?+3xBG93M5v$!T zWVMgk;yc|PO@U-HYriPM272F8s6uOQW7H?(-ii%RO)YkDNFfe!ez8Bw#{AjsHjH}N z$DjS}R?=_yU>5NJVONFJ+LYp~h?(VFo_3Z+OaDbVPI&#oU_-v7fo<4vADRA(m9;{& zB7>?X$jw>rk##caixfK>akv`H>Tz2JZo>9O3nlOmn8z-HVI5uqA{CJf5&HPitSr^Ch_h(Py@isjk&S5aPCkRQJ?ay-i%f55DM{{I^r)KyT zJ3Z(42Q^k^W{evrCIr9{2Ei1K`Ce9E9}jdmNdDbH3JnXsD?)-Zicl2Y=3axRT;*$r z;#_HD9sQU^H~tK2O@hP|CGvan>Djk;8K}n9Eo?B0dpLe(1XgNX+6m)%JDZkfeen;H zsFwkLZZ!wS`~YV-O4y{bk{N7_9WoX>OG^4Y)wq$}9yk^8mo1Ok-lf>$AC}5G{PkbM zK-lMS#_GCCr*OMX4^USvmVagH`P{3{1p?&7zgI0pZO8t; zwr_GFyyDu(|LREEOBe0>Bl~|*^^U=TL|wOV%$eA>?M!SZ6Whteo){h5wkEc1+n(6A zH8;=q;(oX4bgi!b)zx+CRPVhPO5+AZJ0#_v&R`8dmD$@<(D)*JaBRcxP_E$++%WL2 zWf6}1(|5bk=g8>2G8n*8Z$sgse4(Lo+2A44Wed#9Fml5nbWlyRG4hwKk)#6H{krM_ zp~$X!Aq==Ax$&o&2C%BRdy+@6f&@q*w8#t%82D`rG@q9<38RDXm^G&qQQVkw2hU0$ z@8+rUGcEOX8O?XN^xv+f8U!85FG}KejdQQznScM%DB*X&iSpLIs%LSyhU~f|OM88o)nqe*E(LF6!u|6|C7$srVCg`&g zIwE3(u1`t0SG)NuXOgz5bYaiSJKWTfy8U&__Vx{R^$zTtW^Rk5)T2|tZXXC*b2MqF5V^p7mmZhWMzGj+dEW;IyJ_fVS#zn=P&Md^~6dJlhh5p9ezUn7TI@ zUm;bD(#}PCkKHLyJS9;;my{}h`2p>t3zog~gH=z;U96`WBWOf%8?Xb1>s-cDQLNcf zB|{kbIB)w(C-NIOF{FBg;#3$h+#c#bBYBC}YBK;cD6VMkf0LL0D58b<93n0& z#Ot+Im_k(*W}Ja#pSc10MDb%mN5HFWW}iez_7S{jeEK=OsFL~iM=Pd$*|6^FXPUb0 zvdIT}XHLE!KW#Q%0QyAgPb%3s+8XS})pfo#rE*J1|d88=-s@ zt4?rigfXI*AGg^fyPOUK)Le*C(pMkn3eVE<_Vj}b=4Zlx)slgy2yLY1CeE>ZWDP>} zdR*1SEg`WuyNYV1%mqPjFa7kf-JPF1`XwvZ%ty1>P6S!$#ZaqTd+vr#d#m_bQr@VdBTew%-<%ivwU=fFSqR*Qu}9(e&kkQnqdP}PeK?W0t=j?q|6%xbSf z_NwG+AqxhXxkW)-sb`kjB^Iww=V3N8TZPW`nWsMEQTo~}WOPrioZ;BWNOiin$(i?Q?*;bC_ zIvNL$n`J%ykKJ+@TE6_wHwJN=Nv)QxR+b+~uSbAjhIR)@_h`Ahq-HGmvN_#sA}(A0 z=3`J_;*7i?x{UII`av4F3XWT|IhRC{{!IOZp|hxui;)E>jP4ZaZ!r$S)o1z&7K)ug z1zWpjF6MFB#9#}K^=DLA1F|_oDH(N#RpmxFmUrbmg`V(Hx)e07=bLB zJJxM%FZV;h1j<>RBKXJ&pZVp1GB+GwWwUJMt`Zvz?Eq{ejxL}m|)~Mb;po8~39rbPK zhr;+?1GflawAq;mkY457jKg}pyGTUc29b3`^%qHEb%5&<0mX~r4$sw7IN;AYov?a> z-dRE#ss?L_XrVxRRA79rz?gqDBNm{MKl>H$3@WRJQq(MU-M5MwSvC<$Pvmy7ip=Zk zGIRaNZtm`4`Ku|+f-OR3oG)ylz7+m)h|@D z$8aAuBrXA5nv+GAJaxb!Hc|ptmTrZYIPP-#(mWu{g(13ch42uiV6<1;hYH|a&_n4$ zqa>p)*%(-E5Br-JdH!zm7oEjTfjlQ~T@RCX?APA-2&;X);SY29XwV;T|(-pJfMTO8yF#yDH|h_ITPCE zL%C1OeMGR&v%KwZWk1T^l76q9!;~6CLP>V~cIV0&K&>GSVX=KZnLE1ZdXRdcbBptt z0vkp4mNP1{w{_sd?N_5skV-I?iYE*;RN5R;M)O$yxzap$i2vQ|8{3EZzC`K$VkUiz zepwA|q8DC52r%I8X4cngN0IsViv{;smM)i-*kKgjXn09JO)(Q{b%r*&2zslFmg$)^ zQ+ouJWbw_loRS&dTozS@N))ZfEavIpMYlU%SGPhws!p`pwv?!qR>1>}b6Fqiv zGD1AUX>^U!j-cORX|WR)cIDF5eltmKHm~*a)VWsa0Fa+cfJ}WtEDCI`&+z(ty4BLc zNW+)RkU;pn{+=CI833+;idw~uSI{hVIAGP4pJDvX4@)koAcYn0mC02<)gaTC2|q?H zUW3U>_{+DqEKZd2pDZfj-865S23cbpepq(`FKdi7OSVKZmvWah!Ro%4yGg(=WQ2_&dhk_aAb>P+Da7(dy>-zfufYyx8fOwZI+AR( zgRKS@x`*N`T@xYHiLBQg+b~#>jU+M-Sm^MITVaJS11Rw+adkMO9rn1t!Z!<7RaGuHPhSf) zejCI0Ink+&@^qPiU(K|SwdoUT8r4A1h_pi&!)oCUC*hU|>h%vfINb5TYK z`|#Sy#4C+n&xA4}%AFl}{NuMi;*$W@T1d*A&NvOjNLV*tak2kjmBfnth+q2WBpC4b z$#i1Lqhe7ljmxQk;`4?`&HV?Xjn$Z8D|N_0QGMG!shws0z<=2&2})BhoCld-st-Zhm(Y@}UQ!6C2_1{l0#!TN%HE5c z2XvPpBZVnKu7h_!<^O_F!U%vk;%DTrRlW$8A62&`YFyAB^Zk6!?z->(I-%{9Dpz_a zxLpfM!ock>UODttr!_6vhb4=-^%H+31~SL7AW`|^5K#(32VH`cIpfx*F(T>vZa|l< zr{&c25i-lWuWXT$J-o9ub&MKQnfoAiCQ(FqblJZ~u523zyAr_=HyWs<7i25k&fW59 z!QYv$Q3rcT3#b=Kua98~(|9L_k!c`Fb~T!N zQSD_Lzf-H0igl};SNVR@IbOuSiQrVq2)VLm;EAP>KY=0>qUIC1w>$yy=e*+Ti+gDlFU@1Ccx!mOl~P)nV(4(WR>4|o zOe&85ewS5AV@u*FYRKmI$I0&@1#l-qG6h1LWa%2KWq0KnfYk6PY@FpBa^TIlC&~Ef z0Dw$MU6(r2_;s?xlKB>IASaIy_?B;-z`*6=wx}DL_e|{^>>bzX)G6C!=^C0`x-+u{G8itDu}jsGt~|?`aB_%(fgiQDbg! zWJROLE5MYDm$fkRY)|gd3UAWma3&P(?^qMGq&RNtjrn<=SYM4T_@67Wm{KFp@h_%v zB!Cb-v4QNrf@gU60Mij+@<~N5%0=L zW>>LITcPz3_)Y!AqQG&1b8=I7%v?1NHzeP;_zp|o!YZm{C0%-ba#P#N)yWvBJ8J@2 z$(hzni6hH7b*?O%v>?!5XajeDfoa?6xGhpJ?3=xI|tUJ3pmr(vjtghLCxN(y+9 z+7>1l_9=0ae;IAPb&9f>Krf@A@FYF7{D8}`9ec2Lf-YtGch(uNofPvc2gh=*%KYnjzZK=hh^nqxjx$|lMw!!&42M{gA))wmq5j^;jJ-W~ zG0u>F+tbp-hcV%wBR_q?SRKVk2L4os4&igM!WU0S>cqh~#$gZ30Rl4hy>S5)AwJ%u zcZ^=&L8^&HIRsxJH_Rq=Sdn43qQnSP4lE^ z!dQw6XLq;s|1v=i07z%h-ctVAf+M-{g?pJYBE)BYX*52BgkVjIi+8k(tbbLDpV3N< zJJY2h%>TlZ&2V6{8R~7ohMxabZ@4z$Z^4S9`LSVRmjoN_EfsDVr*mcHxQfXLg2=)Q zMi4vx(SS_pKzrA&YJ$e;BoFO5s_2-CVj~fxGs+b*7wJSb2{eFT`wATObg3u!oTAz` z3jU=lYF)$+itLMTw-mQ1*!*pV`d`A%{=P~{X%cw;a>|DN28OP2PmOs<*>BWaY#TOdVmTs7wc1h0-?)3?6gOa^Ksd(icEHbX@(-3%x{-^4 zIjD(HT{tSCNU}s}4w)dwR3B0lbtjBm;EsP8SfnxmGtdSGe=#NL`}$OUSxB_wQf1N? z=;o=tx!#5ulp?sbI+0k6opQ^zr<5H}+O%N{^9SsBsyqIuw5bO1E#+S*s?e^?P zf+w&tOxO(ty-bP=ns76J>nG&qzzvCJh5s=nS@Yz&%QhJVT12g-f3)G2IdUH4=Uaax z*fY@e0KfKi+s%Vy&w<~TkbRB;&}79i-3q{F%JzHaVZH_+iLy0%HztaA+Y%JDP1a#d ziStSdc;#`q_su8_R1ap{P`|ija}HZ(zUk{ySe;8kc)1iv#*dq0wyqHPjp__ zoR!gvU8z)&FmE~cgg&?;-1w02&xp(=8uy`^@=GZrabil?;OO)SZ;_%khgD;reys ziRjp#PC)g34Z{+d!|5j^eY9BkomcdK7M4cZf66{ift}W#U2c@^k0VCgY-Ix-ypUPn zBe3+Ns=GxSRnB%1zdP+5RZ4u94%>RW=@We*S$Ro(gZ+Lt$2>HFM8Umg^^6a>>YloOkD$pk zEdvi$oCC@$1%!*0qK|&v_!|G;Wxx>;f)SAbayo2hi?QtUr?)4}G7zI{)tS3*t$>oE z1UL=9Yznq(A$IeC2>iJ3CDrgampZG2>~L8EZ-ET0CF+E0YS+LdQrbt?DVLW6m9wQ+7F?dQ!j(2>j0zHg zT$^wAsn9mJXG$uAh+I|?G@~h|>;OqE15OF3w00oNcN3&C)VV)lrMa-jo2*SN0>q1< zoyB&=mK*CpdQ79tg1!F!D`~1&GM|nL@-%OwUwBssB+jC7XguCAx{@y`mOxz_ zZP`nS7UR0SiaB#vIGrb5Tw}F_FevQh9!VpZdEaT}0E5=1)^EHk`C}(Xm50A{dQzJC zTe56@6>2%>q{PxltTyRz%`42}tkm|nn}b8>a06Go)-S*GBQB_~{NQ*h5F6c0_b|2} zsGH`J2O|*`?8yUvH$ZVz&0<>u03yi{e^EBWB<~Q#&r@j2)mKU7w3^-Mp2r-1_kkUH zk4|(~8q2NdI6dDoW7UrV&CP^At!gHxz1ws|0>dLZVO&BayAWZa8Dz+uQu(X?fi~@l|?>U4U^Wwv`2m$s?R=YQvq^rArXnlJ}3dwQLi#hyl59@mhJWh2# z3m8r>CV%hnWb*^C;@02BOryeLnj7QIG2N)_EKMGrYZIVVQcO7kOi?rXR0peEFq097O zoyt;xVm3$tSVx0#JGr`Lyk-Cj(( z*;U!`O)j^;G_|XeJ!iLhDM1dokBRy@OHr}j(iPnfYvAPy|JKKEam$xn9^{iN!tw*p z@jWK7dtdkMEU7eNcVZo4F{#b^?R)|mTAB{RFV@RbV1*c<#+NFP_KRLdNHCltu-FaK z$*{Hb3Z#J3ps%TF8fR@X``p6LUZJO^%tT%Cx8%k^&82;*vCbm$Y5jR|BS6!WZCB;vTT|7ZRvk<9Yjv%B z!9qq4u(7`xyUbU%wK}%#;v1c`1~-bvyZ(zrX+eNH%nV_}*iRYyH1LC7HI4w0XL0lf zF0fO-I=Z(cm>2O^U7Hm9^~>mpz)IL2536dbi_x66zapktor{wa?H}6;OSjG{uy};S zW%$}SC?5fXpOCNlf>|M=s$`o!z|}XPh#_ns`3@3miS>%w3aM(Vsb6$ z>^o`;CQTZtT4!d`gvDS_U}LF|k+BUav#=p$_b*nKKRilMF4@_=JK3GfYt z)%Q?X`!1o(UBzrPX=+^}U+U@a<9KU_K@GE2PcPqhy-S2d!tGh+%*wm&)i--E>W2XX zjKQYAd+s87PpKC>M4tE(=Q1C1ZhURe=AU|hl=26dIi+_&zJwY%`D~C}bc;`?>O!DD zPRzVW;;k3O%_6AGcN=KYDwKMV%LJJEmcEr~^UCp!?B#dil){xin_oan_PlZm+rq;r9gFR)xJ7;n}Bi7m#qdd*aclypq6>OCl$3A*Ki zQ!DS7HIUfA{B9kW!!cOQy%c$^(&R1l*Ccff9Hq|k5L-@6z<5>p6!%`mvYxGEEx_`p zz%gZ@0y*x=!F=~|)o>XO+9~Cgp{td^PVKKi{0uc(g(|B49Y*NJluQ^;6F}h|9F6VY zC2l5v#M^sO#n?JMlxZMV;v{N7rU}DQTq{Y&{9BM+TK5Y z`<`|D=#j!_=dy(72sDYkT|*X`?I;YuZCBDi^S8bNm&@ zZ-#L)%@J`AZdDXt1VsM(T;)?t(kwu1+ZRGAMYg=f-8XML%C6|WqqJiBp}B$4@(1yU zQyo+_i)L|#YCL$;hm0OxM5`)Aq~|0hzA&Z_Q%o8+xMU8i@4XqW;A=8y0pZ+V`QyXG z86tFWcu8OZY;FY2*4C#BmTdLm4`#Q(-EPqC>A>V-wHcgLJdi%TI4?&u3d(++tNsg; zoDE7^L;5H`s>w+i$IDo$#PWmrzJbPXo}iWK`I4vioyZm4T4wQsdIa`Iyy301L=>)h5h120vE2wCd9rXg#abKs$;md8(5lG!pxCbh z(7apg<9An!x2Lb8{P8p>t=1HNyoqTSQ9J?X_+=3fDd;5ss}<)@LK^f=CJ5)!f#sHg zQ1724Rh6cNp$?=QqC%Pgu-A-56cQFjRJ}Va6uw(7yP<{&u*Ow4a>SKCjpuSfr)?UU>{AoR+_bv+ggV}fhaiIXgyI1=MO**NnamF9D0rGA zK-gGOKZ>T!#;IP-oVukh_JUM~w=$=s*ydSVN?f7m_rq8C-FKeO&%L5pN^%)Jpv3z3 z>piTzEgq<)+;_EbQ=cO}iiH9gsPO^b`X4#0<#*imKO6$N8Q;k1X7mS z{tj)L1l$IC&RnJ#XYYDOGsml-bLAf>`BGL{I2 z0OL<#ZoR8(j}iP^I3hhaiNjr?bsc@77CXloR+lkl(KhKlBeMCQ=6T)J0NO&dIyrRe zt~@>&4K)$9nfV!#NoLd?sle!uA#JANhBaSE-Bltw7sOMXBW(dror`Pd>v?w>7_-h} zr=^Hb>oc*fI=y>|3QXgtz$L{ZmbmZ2%rDrif6kb#5|6Z*URRG*Ts%3StIb*^Q9u@aFCv{2~b7E$Bjkkfh4G+V>r1PyN{+#p(elxSxH+9PQugpcqf|y+ZAWJW!`OQ zG9fa9vc9qjY}}F-t9DH~^Nx&3O}p119fE*UjsU?JRNVjQuMOnpv8;o5DIu`w&Kg9< zZdC*^KiM<_n(_iVJ)S#iU50{Kde)K1X#m$-sQv!*si#G=ixCO{-LwvRl?TbiM)w*d zV?#FSg+ZscWKB@(v^ZAz><6XP!wILo2y+gOXBPFvHWg4yU%8g7c<%*Y;#rYYzQlu{kOS5efiCmi&%K*O6m z)og9hbo7`RwDy=0VIa?>$qF9$AK`{Uep1mKZ8`@mv!aknebATSaceC%Brv^W1J^yf z*S?!X%A6rqe=>+Bp?<0KwqT=cwV-P6-A$JG8>rBV)!dz>DaI9K7bd|KWhlpi|9jF) zXGNU0LtNX_w{fWHefU8d5R`T587bk(J7`jlKdr$b}0j!q)xFo$j zV{Gft9RKJ?TX(?^9*07;%r;EP045H2S=1A{#uB)HX}Ur-I4@t>UdSLhwo8sEG{9zz z+)Z}++y6!-hL~Gsy(5wO;L8~K?ZkB3Yr>23&Vk;0L)@GaxUScS%?z1|tjzQ`l)5G| z6>Kf^#Od(xZp0iLnt`Ra!;a-w5FPH;5rZ9fnprE%dF0g6zXxSjM`N2KF32 z5{=KOYEkuF{d^UsN>zgOh`Y!)-@Yyip-LCg&L0dPjSdKYiP#mQ!9CMe<)^cSJ5gwD z@mmCW#9kR1yKwgNE)&s~0Rkk^Uyvi1q;2AcZ+<*C(tP;=ioBzgrMj%Ej2qun|E-(% z24Pavy>2l5(Lj?L#bEJzE5sbUf1{cHq4dM>5Q|T#i+vSUKRKVgJpKwZT&Zf3{pRUZ zU+r~Dv)m$7Cd&fRogfLX@S1bBnLv{ot@2G2b7 zF_bSmcNjKS+&(_1v~_RA%u({MJt$D;nd*8~R2t>HmCP#S%9+asj>`d`>_rOKP2fUaMk1)2l`+(i1XJ7T;>~fT*`>TX!l6i3pKtME#^HT1ckNRz zEA#avLeH;CvJES}geV@p2 zu>MjzSYB0>gNpu@>2ViF_a#Ol0zz;?1%1ZH)UzS5R`k@#{xR$Ic`u)rd5jODVGOl# zph`~3p0Dv8irH$RzG<*&F%-Q{$~FnU+!_NRHLb8|=Pcl%j623R3%_0F6YuFBy`afP zeyIS*QKm#V*ju|sjf>?F~ z_2mJe+w)fs6ULH_5tc*2ItT*ZIn~8oJigkpb6V5K7c8t@d?aUpRD(ap^zy zq@O$zypQ`#W*Hcq*Q9nZb8ZbTEk%J^hJPROFp`0mQV}>ugNO!YFeqD2=HJ(14qURK zo8+&u%Tf7_+b>ew$p73_W*5^a(gT$`2>0Y~Ze?7GomA{dSNnc9(k zqjUWu?%n?+?tKK=Fk?fNMfl3HaPX5|+`boe!-sk=`j~cteA^XGw^27N6RKTWLbw;O zE2L9IIJA>fq<2EEB;?fRrMh@T9|BKKcz;g$d^g~4$@cRGkHD6vp%C|PwbP!`zKCfQ zUY#g&G6<2uK@L;CJGXC|VzqwiIQ!D^+M_pwfM3Y!f`2=88lI=8l)*f{w|VmH44l{gy3X~`X>Ip zv;aV)cI4lR3_mYRO!iaLYTKayI(CcU^eB;Zm^QM*@sKy~ay+@@d!v2hHuixv`0yd& z3*6VTy|x{FOxo1Pxn##2*9UwZnuTxZsrA+$FwEQ^fI-dZbH2X8o50od8XAE(PG$6JpLhLD-`#<3S{7B zaWlqh1s+>ytxjTaId)YT(IMDQg#P`@tm^RkloJ|U8+!Bw7mL6WdD#XiL@84Ve-*Yi zzRkDoL{DSl%A>L`GlDVyMcHbYL#qeY2EBvH+ZNBiuHieCJ`A)hMT2og>HTOTnYi+} zCQ5Ke*v>(jis~a@P#@JMJYGUeCYR>p@@5o75q89MYsK{oW3hd@r8woEl2l@WpkzLA zN+;`noonzsDc}@`_>{9<@eg*YEQ{w8HM8-f8#9xA-x^b7%7yvAAWnyD24L{UmHgNG zTp9A|DDH}{whsK0#3=rHcV65el1iZq8g;y zGq{>9K6|RtnFp*FqLFH2idyI~B+=iEqeUnp@a8J|{rJORow@bc2y9G8=DiX1J<8(? zY=&zZ-!}&gvSU6Pr4wBo_qdRR-Uu&Qw3FURGz$M70dmW91OE}2qMvP&qI4ZMCFps8 zX$98YQ26EV`MmI+B-1{4Jg~XYQ9_c|pua3}=N#U)fviX3Ba>0F8MyON5dYyM{XZN_ zYSCCDJ&KlJ1azZr55pVrBI5>3cwrugk4E2;dJWLT^q6M8g^)hFx+Q|4<&n^Fj#OQN zZUNe$}&&{uQsjeB(ob+L>z)0rvTP_AcR{Ogq zon-vb*-O^j->4$Dd263<=7V!LR>+oSUsQ^boPDAJ!^CYbxl2h@G9^)f+r{fneRZRYnxM_7ongstO}F;z$Cl zS=R?qi8R-=xFp%WwW#ovcpx6q;1=4?BdXDBeZg#@DLH0Y=|m{IPDP9UIucl^z3 zi*88TKhqP@rT0bw88<%$}hEemV}7Z?fa4 zqm#-j&G@;bP8Onm=sNO$UUfpA=!Y1K+$i~7t;-qBkVgq(?(Xh`>Wn}tTw{kL6bi8! z5%Pb5&}Y?%f>&$Ns}zyCYRj1Oq5_G$nL*mmz=DfDPa{)R3N+1A_s^M#R0?&vapWw} z#R~u&%%G02_XWE(JO5;0xH|B~JJsRLa;UO=UJidGioIzhoD4*pq6qZAByIF46ATp=sPCsVCf@h&mf9f)KBQq4W;BNN9hAushhd+IaCgIwYjPv?E3og=c%( zhdM6rvl#h~o^&^p<2c02dx+UDpUgYMz}*|GPDrV`xY-9QqX5`!f$wI0{>aeq;&^me zaxq#gttZ@^=l?IOFd4E)%)~b;0%&!YDXza!5{QHbftIT(x%F(oBu>7+e(6AqW;nS# z{-OB1OU~z2NzO->a!=!0y+z6g_YjZy#AL0$*^a4$P!j=g^)T#$w1#NSm(G?EO=Rif49zk&K*TZH&@O;UhzNo2s^V1 z^7=sdY$(&7o4P}lgGha6Ei}w#`j2v^flb#Y37tdyx_E&Q6{cO2FCRN4cB+)1=lF>n zd0hdJz5F}n9zuw%m68v#2anajxuT_Zfn z1sgd8r=Sc&&v?fnwTt7Ge|XoqI4eqaNTz*l;6~BhzKsk`k#l)n{KjE{4)g{9g`Te0 zee3VC4<(#`zf8OG>o=W!l)lEliA?m8n>k08gn$E#;Q(>qzAuri+1w8*xfx!BSk!G# zr0PKu|F=Kbv?TB%k&-J{sKgjn`g;Qk10cyorRW(R5JHi9kV26|$fC{0D)+8Lp|iB4 zp=5jpznY^n&THvyZ%v~^f?Bn&Kv0Ct^ zg7St9oES}5apv1GPnWCtwPK(NbGY)D@jA0~J61X=fdM~O zZ@ytYcyxDyGI)o`!lS5eB+(jm{Z!%i_*|vbr`vwbUO19<3*=mOzANHu=#e})o$R9j zDmIg-ybGy&2XxztVHb^6#~FXp(?H}&y94xlUsJ3W*9T299Z= zG2~}?U9Us?B}oxTqmHd9VQ^pIJ6@Um?7x!Y=4Yjh^NNwfTtA6avf;k+K$KDu(6g!e z%+wwvYcT8fI=Dp?U%;G#{S`>3IC*!y`v07C?d+rO+R>TH*XVXtUe^S5Q1hX*eF7Vr zVuS7WRjZ3p-^>m4u6E-d*CM&_*mmt_Li>eC5unMpe35)GSdYNquOcOVZ$oe&W6<6) z;8PjFy9#IJ@7cAK(~d@c%+gh{Y2!oXyO6WIi`jSz%H8X`6(gAO?C)%qt$ElOFCJyK z6TMZN$%&Cn|CHrF)Q|X(kG2&-eg`Uyerli}ma}f{YK+B*NyF{pC6P`ka_{ymg@SAU zSv4rH=}{B%|3mnhk}w-Im5n?YCK)eujGvw@%k8G2nrOgUTAVRET4k16K8MI0a*#G< z2)itLSi^hA(gI~Kw}X?dI5$CFOd@SymU=bT`;MHdkPO&_C{&8+ z9#I$n_Y3_B^H_Mph-&&B>N4q;E6Xm{Usr8o0WyHnJYBGB(Cbcvr*yw)iL+wa?NhTN z{OmJH&@`g^rweEqmZZ6B1}FL1b$juBn2i?jA3 zOGkiZ$EMwVJp)Mm-_v#)s6fCy^luw5C8o-IkEouMv8(avR1JI-X*}sNS83{B%3wvR zVKQei7tOCRY%AKa1+{@LHrs-{HME5>&#Jvt4IU#6cMD@fCJox!WphfTDE469Sloo{ zzFD2V&2^MEb*vscthKeJgoUnkcI8!FfbLP3-4nj@2d6EAklUZ5Bm=_V7?d;Gs4HwE z#>mihPx=cEuZ>54&I%ZXDdwHy9@8be7C(*6uSu!GQP&m0R!4kFnGz_|^{6XCPLxzg zKhdcCp%WmuoNz+VEvE6kvgUO$MT2I76WTlA1g2=bWHHDg^&WW2Xq1=+5>59fLrZe7glY;vx9ixFp~0o zk?hZjE`rKxGWw7b_STbD3+Zure^zazOxL>Yj)Y>~OVrEn0No{dB?x~jGs`MAA}rHC zs0!T38ru&+?TiRa9_)y;B?$j|3ZzVSzf@Z}L4F-qFGkDu*`&UzuYSw+IRb>4D-l;a zc<(BH=&B2JUmXupL0*r#YY$&umYY~69AMxon9z@;0I4OYY{X*$+mj&`o<`8&f47aE z30<9f*(<{j==d!6mLeB!nlhl48P_JpRWWsS&^(E`yVgR?&awI48driDXDyhpx*w{J zUR|14ud0^n@rU*hWic?bxTG0tpnSt2`IBRP%k!;NTS};v=1TQWZgnJN1%qmUKF^1d z(AlX)9T9qts^S|FWf}%nKLoYS6RlU^AyjtjdNK;70-6b|(ScvQ-t zBfjXLu9e2VGqF*)pV*Cr^zsZgdX)@b2$4rJ*rnr5e}xm95@3zdOLj!TZ8UHjY+`XC zpe?^ntF<=K*5n&hUJmzZDWHwyHAd@HaL_6<0ZZkxr@4+^V+Thyr{jF+8fYBL{f?b0 z0Ozv!B1r_aMIQ+CtMI(TwDFvc-bDRI-hU}PI3<+vEe_$ACEKa;N*O0^xp0S515Nu# zCCf8dh2b#&#K-0yxlV=(@0z}P5Q{%N*pfok%{x6j2*1<6dN6M!uAUQFjAhA-XY8&rm{>= zr?}nr4^a|oTQVdKh^r^7<#xP^c2DQdZXTlH|M5alc>lj@qW_4AY*t-i=ZMa5^L|P- zurN*qFU7JoqVzi`dmLdxM-x%Mhi~F_d)Q7Z_Xfov={&ptNF7wkN~`E)x&l{4aN$B zFhf@1wzy%E+=eSGEhq(H3!KfpNk5^~4Ku%AtXdegu*R(1hpWS?6A$&NX1>_oq2IU$ zmJ@~X&ljZ>gaF(8l6J@baMdf{FB7~UBov(r{|N@^#<7Z`=hejd7kgIOH|hA-AIwD_ zAjZU;bnKBX;(?CA5J_~9u)qoyhMFA9`o*#DkdTRo*%tTRfy|+0$BdCO3ZCgR4*a1g ziSv3^?_pMPtDW#nc;-U9Ngrtm3CkI43Bi&e70E>1kOxrkOcv5*zY?MS*+AX|C!}rU zFoMETzU|J=?MLgsZj_B(F%OEhdITWLt>3YECb_3aP0SMprmZIC9Zk<$=U?CNriSiI zZt$eG({clfIpBAdTCGRSQii|v9HGqoS-Ivb4pLKAJKVYdp3^l=Oc~9woJM$x4|J|- z;+SoMJOjliNt}bJi<<9V<@Ii4Bg3m{S4-nV)6EnSId*d5E*G}3s&?1ieWOJt(| zAn*_6RQVIN#d4cJPPSTAdDEZnoA+&hE30*mPVPV@(>%3uKVl7;;pku?-1^|GOby&w zo9!b1#a_4d7efmKu7kDLt`TF_8Jc!29ddKp3#&B`C+8$?#U3%J}LjDtDJ*=J9bq6yD`FD4EKbpgvEgeY%d zfkPn-RRe=cF|B0{_zyu$wP40XhLw5qkas56zXaqDl^}nab{^HNzy?#v^u$V zv6yzT?0*y}@RM}mO_)1+I_#VT7FfjnIGwRCvHQzImhV+Q{Set_r%L2E&E zyyi*>e&AD{Y8tr6=1*_IC@LH~%`!0)$-&PIv0u<*cLQAVyi%Zi|!ocQ`e zm)+r^^D5g2Ud!(-Kun$x?C@%Ozr%>FfUwGrCbyTxz6g&`R+aHg44X<1PuXm|w=(V% zA{Jru{sVB>@DaUtRytVE9q4wXDuwD3bug|2XWFs^*#!{%xrgrZ&CFR4&Jr{OtBwyz z#=yR163-Yb>w6bI!}~k@ty>WmF-B>7-=4ZeDzAagJ9;tvVW0D7RBGfax=3!25kg>( z`TCBOT|^)EJ#yH7oBxVjz@k_rb3c@6u0Kz!;tr5MoYMn;q$4z-jd-T?o*hC=l69~O zAO4aqD*a8LnqW$0zRSNG#`D2(dbZ%j6^NpLXQM!#jtLZ37#_a%r;@@0!;H#ZI`h!J zv{%9*$lI!k^<8+(i zy9EA!g=G})juia&C@GLTM1M-<%5%xN9pXfB5eX8{xXvQ#A9HDRBVrk$t>&mV_vWa~ zQKFBa&A&@8Wy0SGKuWZbLGz3eJR-S|nGgFU2XwH)sO@%O|7zOn%kDaDt@n}|1&s!3 zqWubBBV%j4MczC~)&Z%KDZHvYWfc~3?C``?3ob~el_PdiJ~?r0kgsv3k?YS2eg87#cq6cAF8Y|$Dwk) z@ket(nC}_3%1%)R=jDA02IXe0BgmUt{YVKjd1kBj5tRACA-y*aT;Vs&%O}ilEZ_gd z48A$e0`6R53>o0!S_9oF6#P9+GvvHhC04EF%gyepY`4Yf?QSz(Gmvf?PW3FDJ4}|B zQvaaKQ!`j_fP+VX*%ti+wQL5=dy!%Md@joy+Lf%L0gGA?!*U}4WjFcPm3y~@Edd`dw*HQ z=jBoaG-!JMfm6p6sW!jOuJn#Z=2lkEdQupXwubNvyX=H1jIxKoT zp!)LQ#)@jeYXX!zJe)LfI0d2b*&zJ<3eqJ2aP<=a7PL>BT)oVPUjTPRb<=lB#2bsZ z)`te!?H)HZo-^RFF!tEyZG4iw44(XY&0MtKiHV->uR0xLE_-s+G0Ok&@@-())3@kZ z1l~(YTO2w)MSH2io?190&UnAp<6W(UGkzg@+#5Y z+I^;}kwfI-j?dr}YH-L1)SE4U4{9~QACtkA+t8}2jtz4RH2)2L>3PZ9JIij=X~yBV zObItAk8fxQT&ld#Gy!qEOIfJQkDDZWdyK=ylT9b0`n1pipO9L;+maR^uj7TJHr3;P z!*~c`S0lF#m!l*!b*wgK=F85_wL_>?tm&G3nzZJ8nxViW z{j;K18FSdMS{l%beSAuwgr_`Vq=sh4OyP_+We9~5LGwcIW(rCwOV3FSKo!zWQ^dILXtIBC|xRUSc2Ey zh^z`LLo~5sB{@8)qk_TXChS|h%FgPX`YddujiX8#$HX9oT0@nxRxT%jHDqO{_gMw) z)D&!efC?EeEmOcq_os^8p5jH6HdOGrY=hbdyG6quVKwC=G1#n}X3MUUEyhxGS-fJ~ z$Cwz*qHS((u@B7k_CTdg3jF6hp>}xg{HT@H7kXm=w>1v)^`(33Gf;_Tw5!I67!u2R zmGYMnH>&IWd96fCOB3q~-^~1Wk@0$Levq`NSDCHjXk7_CJWqd*2b8#US25VvVsZfW zHu&sB>1w@v`&77ytE79W$TyG2^l_=r6;8Zu z!;NmWo?|}(T8vQj`SyIbuWZQV7{1M=tqO$)RgHqU#^GWFn?#m*-H^31C)CC$hYv-eKEK?5qOE@dp1Hu{KH_F}iP; zgV02Op~f*~*umPjbtZ!Q{<-`#=TjQr$O=^!e6?tbT$LN`Sjg2q$y}>gz%65iZI_5i z*!DB>7WIoVTz*(8ZaBOcjN5AJqn4Oe$)MaT>m^zje<;r-r|%grH_pDv#=24|4RG9E0saO zX-0ARRa33%KAn)bGBL~dVa2!^_JbCR!JLF&Kc(VVLB-AEx&Fv(rLn&X=j`!3>A$+(*i>t)i7uFjd|PfHv1!(_2 zEuMJ9gnlK8XXsoi-20oi2u~(Rv6Z39!xPCsZSGcLHH+0Bks&C+^AQitKW7(>|1BbC zxI;3!nHq)ZJ*LX^Uk&G6L}%#Pi=FXb*+{>63C|gm8 zx0wt57XK#iyJYuXHS7*?Xa3-4;U|gGgO(g_kKA6_2bahhp>i&Ye&h@rK6fMiT&8!f zl2=cbM`7*{$A1M$--Yog-z`uM+z+4M%&^XIISMu9eP^PMFkCYOnmwO_yx5?}!cyGF ziYojF?$XsC^QbFX&!Tw8Eo&JGpFCb!{ba{{0HzUFH`q;sZyk*1Rhc3$J8DN@>amU` zZbE^M{Q?J=%5Fo8*R3PFp`|%(vy=ti#2Lc0?DbJX;}~b(I)h^Nq6T$K9IleZkXLo*CN1h0T$A!k{0x z(tI^8?aF~~3}^K*cgE58_m-w)m51nV-r_nHVszC*&pt>&dnOa@$@6c(CKe{FStSr-}W0x`#guygts%nm;Ifs?JBn0IE54n zqi3Gu6r{*@`XU3uDIle2R|eO1f{2ycc5!tlDvhDC5==eT_}7;aZQtL`rfL+HWk7?SH;K=OLtziq|(N^mwF=H z(6YY*HWE#1YDunE$t4yY4#3(7S7nDtIvZ(Ab0c^7;ci;?2RB$kI=YY)%HrDtNXIzO zb(_>occsU5?lVsz&W4wPB!-jPlx35KL>hh3IY($0+D=z&(M2<}*Fu{S;d9BEPs2cI z(<^NJ90cvTnfuc?HL`h>Kgx>h`^B|X-Hik}CaO$@61PVZT>Z=gUlpBU7&FJP)O+k= zniVNu8=E}FB@E)R@Y$)as0f?08kc5>bEut-2ck5b2*=Y6Y~xuw z`mp}qF>EjpTrtPv$d2D`O!Vcx%FOcP(6rDYsm~dH2t%49|HlJpdO|o&5XxM85482o ztw?y{jDEn#egXF~C*)gTf;s@1ikzObkAS}a;-!|3&SRs_3r=)3^&Tu77@j7~tu8zW z?TiuV*_HqFI--aRwK!FY;uBI1rrm4en0IlEQqw;_=zm2mz hK>N=^`F}G8*5LHY8pvw^}2Vh}g`42(wJ~#jX delta 70230 zcmY&;b9Cj+5^XR^CZ5>I#P-B?GO_K6ZRf=1oY=N)+qP|+FW5Q2QUGg0gx4I zj1!8TLBfcXdtKguVXF0+SB}upZe(dFyy1DqarohGV-w!5Ge3;TP9I4ppMezTb08|- zPCI?-p1hIW2UP%38X1I)*Oe=xY%AGpcXbv4fkE;_VqaIdmSBqEmyhYu0p9P4j>4IO zvx^FQeblhT^wHnoLmseZ0O1Rb4#4CEQ{?&~AB^hBzha}>2-3|sm&FeieM>WVXbDpI zHt)B9MH&wW1*@9d&XM=1gV0@IR%5&(YWT_Ft;^G1ms_Afpc@8W0@F?D(&c9tf0Mbz z539QstKnFl@$H91n_mX@NqXaP@2-1j33T#W-k+4e&naWaG=r7)S{tGt z{!8F1w2NcG%H(SV1HEr7n&&r~N}Y0&P~SDLq?jo{K|u7uKtTRKv(~%qiKVCKeos%7iQh3Z-GsWNj&c)rF>=GE#^4p0cSUfI ziaqbHO>-+de^WKw7)hdVXtV$vLqY^}ZY4IHWBs}Ydd^JW`XRMTSC^G~)mwY3tKiJn zT~|tN7Sekk8gu09r66?}Jt`Bz*0`VoJxEA|Hz%ov&}L?_T$di!Ex}7^}Eyo3Ei4Zz}Ki)l~G` z$_yz-)<9bC$x+YcJ?fSLf!d-HD3Tj^>uxoVijwimQMk^$!UapT#gZZ^D;||kCm!dqVp&4nL#kuN6CVd>R-icmx z?_HEyvHa|O8A2B|kKaf^xm7@8E2KyTVGT%KE zg{r|?@}Dn_s$V7_;p6&7E1twEo>*7+Qf@MvZd{z4mdvO;52*f(D*zPV!n2<~vt3+M zG<3`B0}2*MH7%<77l60%1v_jNJ0DHu4TF&t6D}19Qb_xs>gA3Eha+l-RkYaasTIu{ z{lvE!I709jw2fNnHB=4cx(_^8wu3`ChJU){nwpxY+OGV6Mj__>^cub<;Na|@TrOBr zc`c(!5PR}SJRa;KZvZZ#JOeI66C(iq_n+z3DnAB{b_d>`oWW$G)XI*h z0sMD!Z_i^{yZ}X5Z??{>k+-Lnx2Lbc7cz%=1qOLRAIAZo%7eVV04pb)q}ysgF&`~ z!NzW>1sJXc7!K#A5A8t>!up>Qy;}k0YMi7DJ)j5?t8eQaJtBgGYFg)=ERSyRqbzCE zk*m=$o8F#HwqAG^fWX@Z0;7&n=Jk$UDMz~A;<1r-hEqt)ht*Ks+PVUUdHS-x-!@S}A+>_b{0kT5lk+iJi`hl9t zGabj&d;g;>q#C;k@sE_?)aPp}c84aBb=&Zz^N)DzCXqQXdcLUKy+3UtZ_bat%K~0u zQkr|M$gIyE)++}k-uAiS1R1s+ts9Go)_ZRk?id(?Kri$dKsyi#a~yNLQA;0@#H0Ar z;mCDkvU(SK?3wTNN)}VtmHcVhp>0YUr7grzTzgRR?@*w{_DgkiF+nKEMfg;>eT4bV<6(P&Ib9#IV59m%h$+KQWJ zs*KLJMiU=Pv+(w`^7j04g4D6SwYuH4xcxN(&I#%Lpt0yS;Q8TT+~HcG;02^(*{Jes z4BPVLPa=z&@edv!>#%?XC&h=mU9UDrb-!xVUZq#P3jl5Wz4Z;c z0lC!k-ntXKt9ZfsmY%~L>$jY|V9T_XNXPZO-d%5S*T^W-Af5s#+wTz5l04VHE*T*G zeQtsWiMAmM99^vYuBM%)ylqE~_Up7OIoP3N#Uqg_;ya>D zXK$T|MwBJk9ms{=a=N@G=zw#wGac-BQ-ZA*&n7wv2ZQFdKHL01=wLD-9n)NX7SRISfYI0` zfDL|WfAArCZ`1x!CA8~vhVN~&*_YCoFI8PMA<6ar8(f1~kH+crJhcTQs-w4(7f!px z2YY`vX)oJqxH}uTJFB@njap;Wy`^9ykK7_v^PjTzS)eI`!2(F-T}Le2I6=iL>QlDR0b zDE##>esAffmMGKb)TQ6bTyJ;o*R!Czu@7xMf+#7Uc6OKd5l3m} zJY%Ka7b*W;EGXS!$?W*r-@ntZ{Bd(rCBHcNtN1qcbXFEO&jwk;4mXR_`&z&756TPSr4IR>rTE$#K=hZ_~($AThf_spbm)PNL|al@zE+tXxMe0r zAy?HE$1&FHzKZCW!#XE|$Igy=%NF;W7_wPnta>eBS0+iK)ErN_5rSyoOSmF}jT%gdnV#cz0N zJ9*p}7a&Th*Z{%A@$?$C!>68^j@-F1spMn7`Rl$T-@<$;LSVq?_@2zUvS0$i68x3CS zLLU2#{9Y;s{T*gg`h1VUsqV6QpFBqlRze}Bt^8VNib{3)3nDG-?ZW*qsLFh;Nebal!5D{OAKVVM+0<-P1ga^Iie_2FnTaKw|>S z^?p}5`vv@Ex8Ke$NY}4iKCpuk=+rfhx8^BU-*W?M67T>#vW>W~H5ziWy?ugeAx%xO zv(B458S&@Yx$ztX*utc83sseFU8UvF|PuKPepA|MefpX-I{_1k|JVW{id)yhyv zZe4Z;Z3GiUxboKE<`a#|Q>D;U?A{M$sp{pDKWa}2P*Ik!IxNv#j+Q_w$!`cG*Uzr` zD>ZAJTt@*e6P$I`GjugGHq|mVWsVaQ%a*9g+{&1y&e>?G2keQUKq%RjQ}@iQvIj>a zNSIzwR6L{ny~ZZCc6NeG=b0EgTr-~N8W4&(?&#FrLE6jf6swB`7hi4ZFm(>->Gjq2 zM$0Uj$SZ3L1#OH?r*podoC@yVhkZ%>&#y6Xl1^adkrp{yai>{Wh$iHkV+#}7^BmVbe}jSb^tlr!(5=0I2P??KKh0vZCj$u0gnpMtd<>F6hV8wAXTs= zsj)rrQ9X$cG>8G4P959J$j#fz&D+q;d-OwTX%r0q2M1%Gt3n@YfpqU3g?l?nw>fp# zTR|XrVBbhC$!{5HIyZ%TB9n63Ckqo14M5=?o@=5qG$LH3|=J*LsLSop<`Scic=weht% zDd(szRvL@fZ_@Bs(#u~?r1h^8g*8{T9qGGu`yGGI{f-jON?4-ct+zRp;6Wz^80(ix z#~ajqo9iZ>yGiJ`0r>4d=O>+U_*&^KIKfKUYV#88>HDn`oJbca_chjCeQj^$=565S zE#Y0;8#CCHC5-Z9%P{N-qlBtJG@o=@NYO74_)%P+hys%m#=UvlGo3c5;2{hpjB8?F z-?5|6I_d)7x)O9t)-u%-ksXLd?jfp&lTeT6+g4QLmMJ13|4N+I^}-wi0rfBZqB*3) zhv4@i(cIh|lGA2VYMwDf_&bsi?-ld7G&Ls7<~Wp9#BRr2tK00c?)N)XPg4FuT3XA^ z6uqM}CUm6)juT@67zZ&wHPo_*MsGD4F{qGvlt|Rd_GD=f=<~Apz8kQyvmEW2@nDR5 zjjvYJqM0;FAal#@c{N{Y?VAe0VoJMq-dZn#+yp~GAtv2YE7|X;ZOW*QZqXdwMsSA$ z;NNolFP>YR7}@#fgAWs4nK7M)PG_udnnB!96zH#9^jn4j_}>-sZI-Nl?_rRlHFgh< z>uTW@dCy`9ZOX}7$<*g{4zf@!|98nQLuTr zXB(bywV$g5j3;PUbUrF^bNX*|d1_mxRS;0j?jcSvYn@w&z0(+bEP`1U%6JNMTa=g$ z2NXJt(WFJuo;TBt!4}=467rK%+{Z=7d>^NH4`~Yvk$d7jht#J&+C?EiTlKP^jwLG! z_pM;ps=aC%eE0@C=rxTk4a0nM8(YZsly|wfudi+es68wh+q}Fb&8mo7oUn5)gh+6Z z?vb_a?4B0ose$MzGLolFIpm5KVt72Hs)X>rp&trhu zK^2{*+^y-$kep4p#kEEYSg!Qbsd(?)QWHp9tOb*dS}@eY9{t^letSRS{iu%c07%Vu zYc=!5qn)fo+jJ$iG)c(k(ZnuvziSIn$xR@MEBj7VWsz# zhwiwxYKy>Kw+gw}4<%XrEtXj=0rQN}K54XmN2Xyxy1qP5Snl#=-siXXOU@#n(dkg2 zK{o>Iy11)RFa5GR))_p`+TymZ5P*vr@AURQ^Ekh0Q|bLYYgXvDp0?HH6m#FU(J`K7 znwtKd%O;q+MuskR5QhlxO+AKOGlg5OZ_kD3M~4Ex^w5y(Q&BbiE=m40k_fve!~MJy zKR6jWBc=Op5g|3d5+ov#kGy^%iT8taZ;_a+7y8Yc;wk$&o1ra%oBO%AJ0LUp=eLFq zE2(j2^2WD_%7nwjk3VaU_QRJ6E;|3li5G`hS=~F!zMQDWmBhp4Mjys7G%tMsIPx!bK*VqSTRGkjJ#JJ9qfCDLQG@ zAjvS!3UBs&mQ9_Fs8Q91L@x7BB5IGa<0}EY|y8k(*)P<{o8eGh8*Eg&J4_!rc5D zT{l4%yx+H;zXS`ljjxk^0oo~TZUMTzG|TNBdzK#}YKIb&60at5E^9npK}Wq3b=eV( zI`|ErbS`yHcgJu1D`+Mw=fzwA94w6YCeJdDhdt%qh>b6}wl~`{sL-v?jXkLjX-xm{HF~ zPU$Qw*H%0_Mh&041m91hD(I{~DmbVj9hytK{{Ty(Z5AIsQteh3<@>F@@LgB>BzE7r zIUeZq2nBsee{n3TYzYBe>#Ha1>^zyxMY-V)Zh^bE0X9m;g0cBXxJh*A-kPBSQ^;V4 zd-f3@XE<0#xbOHr8$tRz;IFy~A8e0_oA>FY$kQAC_N_Yq$!&SUFsTAc!NrkqBDU+= z$n+t|^V=NzXd`cB-HVas`m^iZv$%Fm9{O`s+UHb&)Ms0(!^;KMpX-nG2Zmt-pKy`W zXEHA5j5zc#S(_i6nkF?z>Gp-y#4a7*J#^xeTsC{rVJ6(y!v}FIe9y>Rs-T^)Bq>#BVK1)m# ze1YZRaMNk_cUBq+pcNmIlUtkD&HTATEpg_y&00gB`r{pB5FC!S647!Rs#h~iw%P)5H(=PHZN49u@c2JET2mhNJ`|Z}R3#o~RAnN(<&Vz^r@{tpXJFxD9jA3*ygkkc1}zK**Sj%+v3@)W&>+T3wL zjBlcNZ?8CgkOscxA0A3zL88$KZLF?XlaDkwaHN}La7QmS>_WS>5-LB08Il3cQFYNf z$XAa`u}4WLwWe4VLas~`J^FW1!I)Ymo)Pl)$6%Kq`#+bu(tn))er%+=qx!yP=Q#`T zhkMyR{g7JhV*>^&UYsghRu+&n8I0i$Pd+O9&(!}-^x+S{QUnl9A!%|RB?uhU`pZQ1 zUn#?D@=nZ^yC%x$?rup`FA&YsF`59m6{XT1$7=+X9F`LOnxo4fvKoUhs@*go%vB&sUs-Us z*6Nhr55-gnl+WyXH$)|+b4+2DLb!>)oWGPy<;(YN7m6H%WEm5_2SGmV95+HVbgeWD zt;`Bp)Vl6x53h9Cp?itJ-*zQA#s~pJ&hhht5u0mAE{@+IQ}f6y(pmw#4T2(x@p}{{~t_uYY9zdL7{>pAiubl^W7v>7e;gQ z-1#^!4N;5%UdsZcO_Nz(hUuB4yxF(a8#1{EFtr#MHe{d0_m`)Fo z<9%qD1R)iz$WT@hy2U$I(Qjytcn6_p`U2u|fG|;)PszbC9>m$WbqTYkTh~w=ydEyrcE{SgLfAcwu z!u9^4MuYGVVabgwtM>b|z`yr<7bI^;-j{%)6j|ws_%Q|vk|B~C4wp1y;?WPk2TrZ+ zD?<#x5_kP}Un;swu|FtZt!)%!=ZFBp3}DctJc$N;!m5OIyOpE*4`(PWW6-yLsDkHx z{)4;+O%$DOww%bu5a0+j6Y{i^HvY{%8cX2jgg6)vf~U1?N_29)UGO=I+A0}pkeM;e zEO5GJ=9nqc@b$=TQ+@?sKobO<{?*_#+CYDYYh>0P{}qp3_zN8@*+=W5Y4HH=^4OTl zO1=2PuNZEkp{>j1_6wC~6&8?iUJpr|EqtMXH~~^9HTidBahVBfx>d*2vZ%3ja_g+I z)LhHrlip^tt#!1q^KDb30wW0e!CwbR|4S(7*0NdMKsU^N^UX6jhOwBZU9;m!TcaS; zGIFTHY1ye|)}&Mb-)Oqo62f?D5P?O?i_#=?dU?zIoO>r-y1}L{w;$jK{S}q|o6^_d z`4lQST82<^vi2!)u%cd1`kJ}k73mLk^AYf!1_$@W3Qpn`t6b$>0ppa*@o+x+stNfq z2czM^J)e$=Yl)r?adBwSlfjv4QaISz4Ms_8u4dFLwmabzU;I-~SA20+=KbzTH4j!< z%(sk4BQf)|X5_@W|1|$4hK|2$0f|3PH>l;B6LHXTcF}`Xu8*Z$^-xaCjcuA>79kk? zd7vVO3s7ry#=l|N@Cz^?H`Y`@2ynrGJM>gdJ4y$-G2#INaX3?dPxT7=U7#V)N&9+` zy^d8u2?!yizdnfo1Wg5|?D`xtP(4|nwq#fILNejz56X;v%~)m${Cc<2h*{Zp%?GA6 zDpY07ZOwbBtI=8+8_zldb8A}LXE!}LSohn_V-krgFC@BT<=uW=b@e08fGIjk1XDsx z1VlKG9fJe(gKEL_gV5y`zLHQcoG6Ypf}JGT_-*D3Vq(WTba~s6AL$9gqLrQch}%K9 zknZp5I9G&mKPp1}w@^EcB)0XaZ^;juP&16m0tc!K?!i!l4sk8Eu?97UqUvuXxCYb+ zdPzIr?>CD-31chs#Rr~&w+3(}MDMhg@5l`$>%TtGF%$hD4GMxP+^dL| z(PKTAN{{X<)j7IqYezNltMh*XOA4Ij!(a&AJf`^)NLDrD zE{p(Lrpvf#y$#Yj&dKu|!xm5YPpgYV87}JW_6sMfUk+E9$z9fe-s z&jKm3q0qbsq2{e(SeL>6Lcx*3FZP%8*c&xW{1G-2kNI_09zuQ9j$BZhR`jJbk%&fYyeN(vP)zB5w>xH(#96q~ZXAU!GrVL!ilAVWziGk_Z_i ze6Y7Qg3H8K=jxjT?y1U=RI1M7!%HVPrmW!AzVr67Pd=3^)%4WP^!UEsp*^avD|y7E za=dy{^Ko*p#oJ^TO*&qzV4S#sda#v;#tW6_u$YJmFlI6k-62Q)iRrqSHS@u#Muq?c zCfp;gvjNI7GQuKnG2l##p0s!rCoNP<SRqi~*4gM1AaXMbSKFGw{1KTh*#Cv-Zze`ne7KmKSqnnjUm0!x4W z0zk!yB^``%jiFY>5P~x}`1BiZeknrml%I}slQm0-hbJ=u?R3&ZRGpp+UrmK}B73nD zaBk9OJH3XiYjrZ8C3a9#C#asMG!%Z%0caoP3W1D3FVoy~2!q}_&~?D3&GyT7l=_n7 zg8ymTXyKU`z7N~FVV)iIwzPbvhkbC}u1i7C;q4deW?R2M0H$>q2m4Hn^w z?@QPT3uWz!RWIRIhkE2Wd*Bp$yH?OxYRU3V)PV}SDS7puMyGA&YWXHwKr)NXfFSn% zdQ_vW7|s#>I%}+7C>=M3YUTXt#XMd=I7&b+vsUDU93pw@RtuV&K@W8rR+!R{WfXe z^PYC#D`mJVWL^0~;*{VC@U#z=;*>N6D_YkRF_~5ii@=t2FON7%!l4MrW;&(=*3Hd!YO$_I@!eUwRkb4voYmK{1Dis)J<0nQ=eboRX(v|TxgVpP#H z-}@O-x!j(my7$tY%|!g!P-N<1Ca~$aDt&Uehsu zSXB4HfhCM=ZYJmmcpSMY26m2a%I_*=Kf-!qN1XInByo$7I6_lJ{q9&8Mj|9ysZQ!k ziBwvT!xx^&0ScV7LewLx>n4{{Ao?zmnI;p@w2cqvd8^mx&eS|f1<(Kqa-f><0+jVc!;I7#lHAg3q z!T`;c*F5@CJ_~`=doOAc!ykG2@7i}W4*L>>SY4bwfI+N8@DZ?(@2}b$#g|Yl3Vf%i zD%Uiaw7g?o*i<%Y?fh1F&^b**iZgoI^i^AobVa-43m5+Oar6^+#r0yn!gcR%G3Sb=jct-g@Q+=zo|`w8v~zS9YndU}JljOgIqi>r zhV=V&z)Z!z+Qq6Vojd;hkz1eOVrE^*-`IecoH^LpEmZDsI1tXWVwiG!2h{Yyd7|B4 zh05^}6VMs8eIHHqC&@E_1avCgNL5`DIIdlmOhy;x9>!pSQ^&9IB1di)xNoMtNX zrcjQ)8F6cHiw;Gr28hO5qqPQIky-#QlQ4QP+!s+lTMZz1rm8EC(8n3jj{vnIl#Vby zkw;_}E8F$6(K!4a8}K+o;tZ7kc|pMnp8z>|wX%(zY1Gs=u$_a^oQ7g<9NKQ&RF!r8 zn~#^Q)h=X3e5`PxX1dI0Lf&%wWT|IZFVtw0ae34|F3H&VB)xmU|3aK2c%%W5 z%?&hnG&bR&tg72@@L#qjbDWUKy_{Q!6#jCI=1#O9j+aaON}Ta)tFWqa^+;A%aeFqa znawr_n)khIkt%uu0G)Y*r;c}W;C&!G`aaOs0i=HSqY1>$R9_RDUcR=PyPi`qT93QG8O`>p1U*ZZpic(ES8a^M+HU;Sf2%j zbuYVP$03AkBqiiikHp$w`R^T|ohZl*I|hVpjQdd}l!AR1U{{n^P~7x7yxJ@`q(lfg z>p~DUO9z~!XyHe<&bM9;=&n=)DNo`h)JF=dF|a({x{d_{X6^?@XIlRouLeqdcAJB0 zkEm%ZoUN73q@GGW(U=xXc-d>^>>*ZLiW|t0=o~I`5NDfDuK-0!~oUu0Kx~T z+lAuq>CllF!{!-PfxG{#pJbqFe zOE&@L%@_N9jZ$DNrS7%L?7A_A%40o37%yhO2?5Fi$mGMODNH|=Z5P(}A`_w~{N(zx(R0&a-jYZBAuZPjE7+v|Zh z2rZs@MARbY$9dFK9}`sW^q#Hpnyc~JBQ1=o*%=ymAQLe21fb7F*<+S7p>mzaV0rvUEVmUkw5JC9y=16Z6{{ z7%-m@v;&nTQU2fcnaZr?axlUQdd`IZ&fDUN0%egEqw_EXPXiZ=ZrL%ey=$W}_H*ty zMr+)i>oF+~oCJ{JR7ul4uis4k6YTD*WyV=|)hVDgIRm}02hhb8W1HfFDzIwB-N%Tw z8N+e#Hc4l!Dej23qqw_CA-i()So<^o7PAN1r6weejqn~vG5{S?;;Z{~?0)N;frfm? zB+>{i&t#o2Zx$teB`=)fEHfyE!&8_xu~RCLu4M&wTFLq6aDiV&xO&OOYuL!Wrr+J! zRr)cp)kk!u*$~vOEccLs(wDZlcYPlW)`oXAB9`7l(2Nr6psv87P9~{6n@5ISGx*P; zkAvBM2a`!|V)`9IKI!eoQ4|M3a zqAlf%Vkx3)>E5jE!sA-kUYW6tDn;7W%vl^~dl{Rh;XiZKjF^7)?HjH6axNtT8TwwZ z!e19*{brc*bdu@GK+;1;yewK1^X>yo6Vn$!770DTF3Yf|;5VVCuy}OGdMsZbAX068 ze=3lb=b*EdjsOmx6?BcBS!eju^;D(*5BkIOEGLc>4MoZq*fU{?NWvNG&ymBSX#8aP z$7kY2r7*_~1S=dd^Q;XV^)v3iYxaO*Wp*4NE?4oixJz&wFoO3$3cV+<+N41kNCF~$ z;4n{TpcqI_e6J=25;pXKR1fnOz6YFqEC_3BSA==PBs9Kor)_t%PcLyjx$OjDO_M+_dSi1lB%eniBAGNcd|Th@DLdt zb+*+{nuHhQN#EUkBmr}(8HTvi3=seJx40o&#kxZk0ZZECDlBQbKN}9~yI~4Q| z=q2;|BRLS%_xcyRcjHgM*Ylb%W|`eevRdwxn*7*JuYEnx_t9riEZAL9T(qv)A5a3{ zUgLj#aM;iEnGOT*lJt9aoOJ6{P(tnbu)0$0Mm{0Cs+gYT#U~6h6Oztn?*OYnhm}H7 zlR8;RSJk3FEZ1i=gn{4O7koSBN4Pk!!*gD7f3c&R6K1CdwiN${yM6zgYpv7^Tfe4< zcULWwfIb*RlH6L>TzTZAmVg65XP>)y`^zmlo7Xzm}v%NTt5b6 zp?p%m4FX2#sXDNA5d%3EM}Rkxe}zb$LcZwibl#vE3i{@oc6c>esK`RH6lUh-WANX_ zKFJ9Ki^Qb23h%Hx;`=mjRds_(tYV#AGLr7-V{Dz46-$UbE9Or*mnIpGT5NJUdLX>f+t}KP|B(U>^69)A8nYW zE*$NdsVcor+n!qvOaG+Js`(l^hpk=G*mnfl#y!~CDI+}0CnMba>nDz00Y+8FlQM;s z#CI-m5EtkQ_$)L0Q0nnA+iA^qF*lFH=07mcObon`1pJ;ffFD$tJ{`+TXzKfl>&Jh9 zEDidj4T^f{ngC+!S5@DMV#eju=b4$J|8YFW3Te%i-h4{f%lGVfjshw$E8GxM)Kd}` zz5KSnmxYccXsLFSG47(VG0qv%lgC#;(uXh}a7hbjJm^)A7jRr?1@S9<$I9EfxdA?L zcwT{h6T22I)*>&;jLpr ztz5$|%RO)f!7eyTB3HVL4IT`aFC3R~=9vV72~z_C$*0ZjIx}rnjr%Rfn&<5O_y2{yW3AiXIx!bTbdC327uwqTgJ3(rkLcv_ zM&{IOpOhC9{aUw&;Nt#|shc;Z^oTy0e=+30#l8mE=g?>}?pe4+!(vKUpO0)7GD*_k z7%vs<^V3q`D5Krz0;f_$>E?e;xw#8Og_Q})*mz8;bP|><5TYpw${T&t;X;t*rE9uT z*?wsdZK@G1(T^r!^cG1357zG_G z4&P9#$j~X>Y$ddBH?pB(716uicf+0k1pcN&iH>tpKnYkw9s7o#VWby0;G2K1mzsgX z|HYEc^`u2(6jA&lv}JIfv3pskF?-e)x))8jyneafd$sGzuC*BI^1zVY+!IA<~{}&l>hk%!K$hH zBG}RYB@KYh8ooXFvnB9GN*vc~o6or#!?lZ6pe@Y`qd;Rc$F4jz53Kd5!ZTO;k-~fE zgu%6$n|Ja6aM`ZrQ1<`jVarj%(L0zngrU20mS(XJM}{d?Z}}K_RAZD^ZSucb<^s5R z(WC5wmMrni_kqs#$ zSg-JqaPHVGw8r|ko>sPbRgJyhGmdhg7lQlJeXKCzCnu`}#NB9fiXi#$fI*p9VD zA}i`XbMI6(uL3Y|8&%o*>visG!`Oc0vT9Lj2~n|XzU&*;KBazepZ}xM8*#L%Md9>V**0y(jVkRreDHt$UF+1p8R9w2Hxt%>U>*Jn+i&$ zl)ihn>?d!s6)idzV_gA+s zq_V%QS#|8d9?-Q8MdRJNV<4x3VWC&SE4XZQco~<8;#HYo*lj3W6o>u5;}sHo_my?vF^M2jrgZr$ip{YaH%!FdeVtHl`T<84{W=2}vf3D<<=WykGZ}{&j~g z-*Iph%*ElWeu{8zwjl_f%X}EiA)9hqyahS}~vXE8Ro>ai-a zGfRaD$qlP3Izo(k^&@OD%7>(=vBO`FOl9WhII<$t48gm`SC%nSwIzZCqS@scBxOxC z-33=?P*z06OmXlWa!K5+f9VxxQI@yvCPz)t7fgmUo@!9b{B#aqDrQ$G+aP@r+6+F`z<=+YHgY*5+rD912bJD|A%&FmPg)X-*6_0i0>T z&HcbkPB)9KBAJb%mojb)?%iKHlCWk__M#4EyHmjr7dxOmCYA) zjR%v1t&9c~DUlLk@rB3z(04&rLjWDtbFB8+JM26aQ_Y!}l-~+AWQ+wxdw8pbnd zM)a|6k~ci_R##ga7_Rq`NQ;ev@n3GEQb$OoASA^>?0Fl?l$f=C`<9If>jwAq)AGGW zx!S17k&5By90w&a<&2uowr1?EEF2`f8U4N^xfL>R)@@zSptxn@xOV<00MKRS+F+ve zvO-VijWxM;+?LE$Ukxxf{9LxpXY--v*-)=sc;HtVFf>3N$bDX7&We8(Qa=_l0Wi&{ z)+RrU;d|UOVO^%tdAONZ#tyr-&2I3VF=t8Er{YciX@&;66Rw|(T*e~a%>SGmy5_+N zI$35=itd(ccf+L8Ttg|s1cZ-<3(LOT>r$Y~v&5PJ`f@y_kFx2k|Gybwm7plOG}ZvRTc}HO~c~dxm)@c1_7$ zg?omJ9Df*D(|8hLyya-y_ruLO%O6iXBgN$FJ#Uh+%?m3)CUYFp?YJIvxL0X|>?oXk zll6~O=>AIFbKmCbBTkUK9*!tztr^0>_&tqEC@(Iz{TMhF;d>oKX!KNmw2UARfi}6j zH~;Ig9H$L&so}O;Ho0=W9SeVNHNTtP_j#763I3;SIUOvyTbx-XY+7ItXhBG9ki=Qg z%nmXN?jA4TY}GC%*uI)D()R9P>$g7~U(69jj6|eAz$eO`2J@M`_DS6Fmy-Yj*3*XR zUGT%Sji&pAf3!REwftmIv^%S3oY$^>I?u@zI$Y-gG3Vz}DIwG0BZ*;a5ulmMk9w;Lm~xvKE~ zh}Q)O=6dXp3(@l6m>)08Nz$_l@Et9I!n1+r3RE4!Ur9tmKmytqYV&)@^%H{E=R;^w zU^P?x;8V>f4JO^>IaY5VC+f0eHynS>NYbPga}JsDTf=v?WDr|X+TNG+Vm(hqC zG8k0cMdIK1Sqt0f;6jM6h6O4UK8KZTCf2ATLUIe?#YR=#(Q3mTh@xn!_rXYL!vX%a zmgoq-BwEAKDnj4)I|RM|Dl^LED?A20U(cGy@ZIIbU2`LC&i7;Un4^0rw7L%o#O25Y+5C9M0wpAbY#T8M1Dw#J2be|&RK4OCYeS;hz~xP87=&a8fi29FBc6qY&j zSUR;aQdxJqC<|87NrCFN_4Nb9EDO;eHA?pc)xqG*lq^}2cwpSxsx&km=0@clD%P10 z7zG@ma}a@gfE3%lW4`0TZrNv_1$l<02v$+ke6L=n5r>mg?FLH&oUAK`Oe|X>ix4-5 zU!D7(X{#6)7*(vm-~ zYFQE{wVh-&(U(34^&H;|iMTG95-dDvrws~(z>+-TMSI=b<^* zb-|ifWfZF0gOoXW)5=*qPu|AO4+;_9@Ls(5ih{f=p{IKm*=vb?L`a@E@6a&5X}D$v zu0xx1Yg+>i`i9Pg99K)^gKo~uk<3;}bEo-b69*mo8bF~`XK8)5PfrjS6#^DCct1C4 z46O{m>(BWbEkYKKZ&X1)e?)0&f9nyd4X0)VfrAL2e;*KMiqj@@)4?+9fI-pwUUt*> zZROV&&(mZv2%_tKFsUCyHGyjwM)A*ZOu*utw>1A182~gmFSB4LVo{sbulKk%<2|pWwgFtpc&P-6I;LJcYVTRMT6 z>*B8FpY!?+-)#YrXMem0NXLaDK*yEaM{a{r9RWDl744ACNNrbYz7Zac>b5cvio?Zezg|+VT@Q6h=*`J`o7hh3xPF6~A zcbfW#@A0n9vHz0-Qr)o1oDs1U-IGCq-Vs1aBjv-SLf=I?4olR6GRn_LsRPXxqJ`Cl zF!Eh%As}EEnQ*)L8y-o34$Tw`cAj0&HhAX0DlmQSr?B*u!h1nhH2} z$+wIwi*p8H_;t$Kf^4ZkX$Iac8Heruf0+8ppgN*uYuw%4-66pb?(P-{uHm4;?cg3f zxVt+CC%C)2LvVM?$9?asTkpr7s_vSq*)`KM)7^WmwZD23q0BD+)!bj723|*x`>nIY|pJIu=Xns-8F?D5Qv~hPy7*HaS=Db7~afdW#8X-I){@V z`juST=cBw~x=qyjwgm#QLw~f$*-)fCSS-ljvD_z{QmD_)XUlqn(b7kAx zl8sm+lkI~$#B`TBI>%C{8}=Dn;)O{16k3E|SX3TfF@(##+uVn}h9^X;hR5o=j+kGR- zWat*v=?&}`B-WX4lUKH&$nPt4{q^snzRGSRSLHw055fw3>c&Ue*0dP*FJNxhD9cWQ z@f4R5Flr}-PaD4b83BpSbGvk6EFL?xpUH0H@|o?Q)!?5=*s{~RBz97Gm*s)0C(~+T zE6!4+`}-LoL~PdY8qmjJl*WAeU;&6}_g6S)4$<6Yfr|Ek>5om2AO`fk-m0nCOR4mX z5K>Safjymm@1xd6<3iL9^UsdT_L>DlRlgcIv%1T4)w5U5=;z`eWgn+k%W9qw{%4#u zV)g4taTCcyLc}`w1vand_^OuYY)=i@^Pmu%QZ7Wd4iH;*Xy+ z#bKm#LMsXh#z1?Ii=0jHLstG-&b9xj@D<!IOw#VGWWD!6^ERJleJ%?tet2-f__mq4#2z&=F2)%&6@#Sdw+X(LgsDK@dT|Hmg4a~@714h4dW`++2=I1lGMMK7JC-hS^PX3B>_w6 z7m{`yAr_c`&I}h8N6GD|`aJ2gRb!i;ZZ+4JcMTD&k+U7CjACxA>&p-L3f^vCSHZ5Xt`k~) zEqAQF&4j!^_q+UIsFs`d&GpbI9N&Bxd0Sffg*Bc3MnnaS&g}6dmQ@)v%MtlWc-lIK zxkcPN#ReaHKDKlZwY)IDoT^vp!7s?a$7xeu%18*L^A_5v;rQs|z&?bKNp0UVd{oN> z*aDD1`auQB7^7sV(o>|jWs;W4#eSf5fGewPj`v(hJtsUGI!i)(#8K1j~I|mT?2ha?t3ywfoTZ$q>NKnJiACp*Hi^3}&+@r_Uw9mlPx#sS-J-_ZGCSL00hLiQAF1Lz9jc%G!_S5{v zQgIp<3fXZ9Mrgi46HUMH&|WLAy?f?Vy|BdO)_3~5o|d&hQ^H?qsRgsC|L4jdf19cucO`QQi^8xv_Y)M8;cpi~Rv>Xo>MkSSrY< zr;9}-E!V{XO?|&?fo3fj_-ygdCnWGWS?I-pF4n1U?Crqf{w5(= zx222OJgR(Gt+>&>NU?}ZK08+LnbZ8E=Arn-uIZ(YE76sIA%+UyV3q_y>1Pj91F>KtN)hL-G<&vi;QzEX9-&tw`3xo%weB8i$gS> z#!Is=+>0d_?aY!Yd+iggOf2gb5(7EoDG{zwBf~g5@RiaEO;w@{pMGD8|3>Y6S!R!a z3sF*1n#YJe>^e?CJ{Y}?#6+BeND7A_cUnZTk5U4&Fr~y`6ijS}+$W&Y6 zVjuejgG=c}mt&Ht*1e?Hz13#oD5>v^D*9 zEnkc)UA&Ov_e}RE&}M)z&83M5^ebx}^A`Z;P_PY{9CUQiho+1-bq zuJdww0&8@*%HFM}O)V9QCiui|QhofJet8T8-bcX2bwrJK&=VR^|MuP6qp^@cfjPzk zl~c9LfMc{1d-JS=xGNnXdIs4Gdqyk;<%P3-iUaEPGPH0-yA-1eC};CHVN?UCovJvK z1OV$Os%SAv`7p`{+L+Gtcv#2+I?%zeHuFr%3qAL4Ap!eX)BqmXFGy%V=41Z1?o%^ zA%pgQy>_sa{v#U&LY7p+uQ)ABh5XxeH9ESuMd zQ9!fn$7dsS;!d{33dV^G9WKj2SOJX7tU6|g2(|i@%v1=+Bi@`hux_Mp$2uUmAjw4s zT^YMz{a+24di=!T%V_dyqZpw+9Qml0IY6#;k|#Ys0StNHX-SeglAylqYNX{SA!&%g zGhn`)_$P^WcB|}kOW8!iGb>&j!_w2Z(8slygkPv9;&c)cbVkEKpD+3^$aZ#33;se% z@~V(EQ1Tbb-V7!n7PAgvWf|n@88_w#U?osAMux*ybl>miK@+6842*kwg_ssT#say0 z*Pi*+SNwJKY#eUT&NVz^)x-TkqP3%~jx8m5Ing~5#6JEY0hm-V( zveOuA@mK#j)>A$Sff2(gE{JOfaIe#whrZkR#Jn@gNUoB2%pP|CR5Lpr!yk;=3Qq2D z{xgc%#q+OPq3aOK&7aQ*52lEJ4Apr0g_ZeK_(zmiB669B)F1hipgqviw}X3Wi}otx zN8H<;klq`lqUNj_Y1b7?RmfHfB#wCYn*_B9^=R(M7O#Qk?3Jjd;6c+fPvy+z-InK@ z;ZcuHYUY|L203lBUoaQ!kK|EAxi<_Ar+df9H~6T5h%%|#j}#E zy>YAYVeNveKSL}&- zf0)YE!Fzn66fhHo87Ko#RWB|=d6X(M6=g7hT;ypX2yrz^0SWrnbnF>laaSh1&WKwk zFhvwc@s$C@eEU7?I3?+eTH8J&YaaY3k#Di(QjqlCRm(5#vyZJ_$kcx02;9o6i;@3X zGWcq)BYN@ej#=gu*9OIZat;L%m`)j>^d;Drk_}h*S+I8_L!rB<0%DvXUY5^6hGWSr z5^g-T*!fpD;5W!Lclqm$aT%wy2^u^RP2N~6*SjeOn2F|C7UHvmGo{B$Jecs+Wy@<4 z4KWjTd)ZIV_{FfBwaNMA|)x|{eklaMHHqE6NNCkxIh z333R}koXSpb3mA*>xn*nL$43x>Q_Fay%Sa27${^%1?m{dgZ5ikVgNW($sv@ zZ%(l7T{hG7Z(Om|T-sWvnqTu7$$laaC?w~{tO)h(2F$FMYu9D5HQ?)LRd9;DS$-0@ z2q+lJHVHluva%;}^U17Iwc|)Bw)<{n(O1 zG>Lh*ApJReYh0r3S7bCq-}~49pMMVR_IB?!Ma!l-2)5Io7+K6Uo(X!V!e`Spvsx6v zf0=J4{nC^=G|!X!d4=~KV6F%W#5-k_!oR#BMTrA7x@+mSozLeDRch1M_X3>Idmseh zHd5YU!JmH>W*V8tA9Ukrl$u4fi+5QDSwgULuWkq#Q3ut{P-K>J&F1EHj<%ENLEvkB zN~*=?o?gf<&fj-61e5w{RIaMUF_Ob+ibmwVAm4+#J~(2n5Iz2Ojc6aKLiEF{*jh@V1kvh5Gy%!yq;In?dVeYF!<#pnmlM%G-u4-{40-zw{*l>mB5PGOMLC zMizsBwr4Yj5@_Cqe`Z|Oy-zKECEk2LRtov{FhnbDD>--H5nQaA?p{_{$ab-+xWKXo zR8ca7-fi!I-?8+5)~SPKxffd*Zk`|gp^KhnwXovkQPImDUFK48kSkR>YTw|j2FQaI zbR*sEd<81W09Goj@2EtW>@5mGl)TaGCw{|1mhP~>y~h=Na&utp1gP_rtY{jKql0;} zFx{>^*u1J>`SYR-ZHtuXf0Tqmu6id>aNJD1l< zDuo?gh*b0E!q{y2B1Fvm#2+L%0eWkcB-Vn#m2SOTcU>Lg zMQ7XI*~Br0nE?K{^gSd{1$j;-c}+PW0h`KFvc9^0y#;p0&&OCYbB9=qxvQ&wCB>(+ z=Z>bVI02de~t`IGDu_@Irr5PwI6tC-#1y zJB{qM0AjwpX7ztf>$wpGI{`wCbnjjx zXsxI?kXFnSc_(s=D%1)DN%Rs_GM?QirvZDPDloc&p6e*&Cqcy~_KjFmAhH`{_+Jyv z36uDxG3dAOKs`d!z7d0y0WJmT3TY>E1Ku0%NN|dch!p?m^sjHL9Jf$*ICDhMk|K1b1JWO;uE{^H@18# zJ5-JQcL;W9LgI#VRBpdRL&E6kb|?|(0OWRW+sY{ab`u~th+yCRv(kwbyhV891$lXY z6A|ReI7tDb-=m3JpRATzxKK2i#1|(9VH@H#dVam>!pH%HfpvG=!I?t&I}8nJdrW?; zpq>6s32Y5zGpeusO)pM8lKseu&8#9uB~2b!NrRZ*#Bz>hYVzP7ID=AGzA}qvScbej zrRNs!bS!HFoltH<*JBu&{3PU=wg~Pf@?Y`MG&#hzeYeFgL#P#T8xLR2j{Iqp?Itc@ zdv&~aw@>3i0ZEudh2VFkA8T8MbC0~0pxfx*cX_QuF3KOflmGo9 zNW)RW;NW5`7dAGZ9j+Y0L)FBmLc{oXcY68lB0A|%oG2zWvE=vpg8{?r(S#TBo2}5} zELlPf}7ue%Mr7pW@#1V`d-cy8fc{;CQd31aFzVF_^j_6O1xu1wQ_+C%(4lu zKzDCa7_AVUA#j^7c%g zfY^{1C+{SpN+cg;E`MQAl!zYpUadjt8D{9>RM-B2*|H&-=+UwN6S_HB z(NA413e*KNQx z;Yr0}`_BP6G4yn?IjKZJLRNQ&rP}dg*at)CgQ>SwHSaH$NGSjiECDoM`F)@e7>`h5 z2l2d?VL!4%LvHSyXmy*zC!k zBH9Sd`OPrz@LDy2PLPkj5u-!Y_)M#I4VCvuqEyVH%1$VVXu>Hk#kmaqG^Q#t-_xmr zD&w1|xdyVaQR)jKLJ8FDxiYJwu>U`5w8gi(G!tjU68VEaF6N38b7Q;&frEt~_?^O{ zxc|Q0)LbzBJMlWcsn~kGzt>`4DQ`o}^hTC1Hwnh6N;YCOGvK#Q-+&cu9RuT#NIif~ zZ+xEkuOO&FHMXP1bMaKUQIT$j!i|A@Tr#9g`JE#m#5N`cb*tEQN z;0t|#jYGBzO)UemE@+fiL7bOD!VOn%U%|P*<;N@Fw81mSZsz_14iQt^^WMd07>t#! z$A`XRpTZ5xG&$XB8WxMh#wKQd`yFG&2cO}=8FU>ugOQGJ9n2b28X>M?x*V-`BG;6v zt1Atfgs_U`lYGI(j-*f*BgPUTBq!1}9hl8;9n{V$Y8_OMPq!Vf=iXUp;9e@m$SV2t z7~rCq{wTjzcem5(m^ajK+Ok~{(pm+wv%$fRU0ZzIs57o~wD7iQw>?%+3kR4pFKjxl zBr5D3N+}Was#7Y91kxtPG^gECMIDW-kAwcRh%h7-FAgc?RM;Eoab&24Kr$n~?SUu0 zjfE)gjhKlf>$^j5T@(Hjf+cIPPI%fgT=(u@#^xw*La7S@qPq`@Sp=@-wdkAtwI~oS z^)A)MJcw)*r zWZDQ!?+Y$%+T<#Wk5R{!(c^A{&a2SGB|*M%6s8m>&WV|}wgH9705Z{# zqZ*fkaC56(IM5z%8GqN~s_2SG3Zz7!sD=+W$ysL+O2z;w$zuPH*D{rX7GjGWK6E!i zYd@G{>j)m<^bcjJb#Ax@|Qigw1P4SKFn1OL;r_A` zI-^IC=hS-20{=#vPg*s4y`+nstf9j@)x;JuY22lxoJwRfAd;JfWJx$6PED4u+{vP( z6xyc_g8&H7=)|7ysSXvLwT`(JV20o=)_9;=H#A8=#wk>v;(i+?_`3 z#3qPsIgicj=~{S6f2v#%=VloO0fl%tfmCQ=o8(Dhpr*1IFosG>*OXORcQ;^GbiAiF zN95%E&NKqzb#qxcwq#+De@+FE4H=mZoE%q=w;b={GDExnIUP)=h{QXD^#WFlS+&7O zZV2gsNOQkV%|k}E1f}mDneaKi<5-l7!Bu*a8=%$mv8iEg9Tsw*voU{J4m#v;BX4-o z?G2wWS)x=jX=nMp5G#^VEC!tW8gBQ&Y?|>82~00ZP)x~aEF+AxKGU!D+!Ez`d+`-7 zD6bE)Kj+WU0el^+Caj86CmZ^U@h>3hD(6WUl1>O`dxYILSWul(g}<*^SFzE9z5DW! zgvP+!o@_su537zfMiTgw9dm76p}%26p&xp|KUKm+WQ)sNEP~?I^ejH7#3B+v@Q2G( z5*SY4)Ms!%p}3XxvKB$a%aDT-;oa++Ap6+vtRomRC^sRk-O zy7%ge7#cOoA!v;!P_K&=M_qo&lRO)vfnUozp()2$5SH2|aRHs68QaaS^}`ysSss4G z+GAWpAlyzKzE0`b-&uA3AU=j z0^a+$tei$+s`p^83**7baq2td59*FfyjbUzEfGZ7sUe!`YeGFV6~apI7_X4OgMQUy zX;|U@sJ0ihPlew+H_EdzBCaJ{^S^)4k8N=yD<_+ZLBT-hxJ~W575?|4HE-P5b|vzy{e^JG|p-VAP$5|KuR&n3k7PG@o`w zV@`}u)pfsHh!}DZsES7cnfg#^t~1s^c89ShyDFpy>%FPw>4IIfa`Qk%sq6cJfAfyX zpT$*dgZev{j)+S zL^TeG$h}}vSg(w1UC4n_0Zt-VL=mKuA0_Vk4-qvyzS>#GAWRXkXMe06+4bJBF56m5 z$2snH_HOZyV+vgP&T? z#hh^j1|y(0bAu6jONFa6BIp|6E3FY{SeNsSH2a2yEo4WkT~1SU=JNU=Jx}v>M1=@9 z?JY)UKZcxeu0Nv3yo~)rU%#syOkB(CoC1_;mKsbP2!*39cwoWrm0U=Nxz7-SZ%}ap zt0LA?ixYfEqQ#jU9vviA4rMf5AByuP^nU0eu3%Uqz!OlL{i-)TF(MYMMSiW~@HVEc zg{g0XpUGN|3USOpKbfrW(wU?ISNC!T>G)9|8k$EQcuu+@szAixmNNDiOKS?vJDBuw zl4?sB#9ZjBRseRjoe6r)NT2;4@D1Wu2WVMSNomFBr$?crp`DIa%nLA8XV&h31=7KN z7E|4m*u4EUQqi}ce6HBVY=urq0$r1z7BhI9%*}W$46EylK|HeEOb3>XQ6d?erSQY0_iWIq0T(UT*6Rc0bVncH_Bz8y){otWFltzsY8~`ff48E zT@ete|KiEj^O4vp;81Iy#yt$fY*XAMkuv#wA#8iz^yB!|7PSMWmP2*T0*6z_^%zYX zM7HA1rPKU~!+e%}%vR2`Hti4wRqpB9q-w~nUt;Es zvfb+PfIfiahw|buxo=D*GdXZm>O3n!Sef)GY#`{rt+~7rw=%NGtMwhM{UZ$bt1RcT zk&K>IjZrb+o$+fL{vhRbYSWMGCLw(ikh=k8`O+uTFOOKrUk^*MKr)vIsj#ae=~|1z zDBvSAI7HL877P~E;0&g z1J*L*mV&U`$-3C(g66;UHIInOQJLTpe@x4SDADYa2CHGjnwtWeV$3%8vWtha38yJN z3+O}o_vLm%1@E)g5}_2X%$oGNN5d#_9%PRfumeQ&sCZkC9>JwM9M;HXpt$9E0;~+8 zzNAmM{jDf5C8CGh;*gwt(%)ykn+^|im(e-fiyh)wPuZ!V9^z*{j;m|>nAo77x16W^ zkbdu2Aq2~i+MNo?C@eHy&=Wk`{)NH1YuspxH zJR)-o+vhNo@TDI2b$eZ4L60xQ3t;uY$^9E z>w10sc}ZGG^Wh~w!$w)^sWT^!kPwG0M;qfV+05sh;inl04J{Q^IDLy7*)9;uzwHS8 zn(lOAHz0pN`>+J&%l{nLya_Xo34AiPq#oOz>XF4PPiR9Q(tUz;1*NR8bG}Y*uCX7l z4X=NRhYQu*km`uIc4N?>4VZzG5Q!t$~m3!jAu`iE-6l3U9 zL!fM$$EGw3_TsdIG$!kRrGzUFXVg-T^h{@7|C``k7`M ze~Xr6ilrTPfZn<21){>GrE)*3&MaA2*J+P-1?6;b#`Ifd_ilkuJEO=muf~e85|=ei z6OPFkm+4GV*2@biay-{moL@}Z&)TajbihzcU?^TNRCA)=8{!_S%Xcj8F9%_UOSE;z zZC5xs&f7V_DaV|&3#)9lpjJ8_rR4tNkp#shbGc&MdKw-j(Er%WU-hsu=oGm06KM&p z>uEB3yHk)myKM4JnS)38GWk?kDwv_^aQ}GLb6MBb{*IETq!JKFqNZ*D{_@Vu1m-!WmRrL+IWQq(ba z(eMo5KZJ0Gr)Z3HQ#>O@#Iw%KCIrYU_A;`7e4dMArQ;ZGf1*nn5=mPgkEmvLEQsEW z`ojQ)>;;XHrQ(*wF=^%`FcsNeHXc_0i*nQNVvirg8u{M)dj=LtVSL;rw==;R3D&5Z zz0n|9UMiF#5?h4qm3;5`_eufek;)c{fqzlAqyEXamI?JwB341@+VWskoj%Czu{Nj$ zo^lZFI)F)M5z@Lxi;GUHOo^Jd$)>Q7$LOYPBIPY<3)JfgjhZ-b#;*dZl>3d_LOw`c zZD#Y^(=K&o*(*7Xm76c>Ppc!gP@kR=kA=jKr!s6s^p(|9b=#KL34?;B;*;A2ir99I zHU=6~P|9zuoS+|E4PpB8XIh}VuqKUI{j)jGZXTH_(m)mLyuBuKo_xR`{U$TMCJ6N!d>~~)Jx70!;>wWQ zCPV+YmmiOWG@Bke-D?Uu+yX~NTwZ9v0i#O`*3d^?W(VUgbo{c@w|8$@LLvMY9=1C> z13pqu^R@I(6q?u;-&!A0r{36pHPij3l{zs~+N$cve5iaek7mL6`gH)*mEE^mYTOr9&P@!+!CB;GsPtesyxuaxSb218U4 zwSuExeyf&_-1ltFE@HlW2qXNRfJe#8@C>$p-aW!&10{R4)G=@LML=-dKpRv_#bLEv z>}E|Twt1L@$FqD#*LuL>z55<@WaDpJO!DpNV2}KzjP^%Ka=bjL3Ub#}UC$S~FHMqG zY2T>&=5O>ozBavW7bhbsrS2oJHMLWvDqkef<5w%BS|r1NBfci@+>;0UX|q+p4mPgm z2d2m`aDxQC2WpYr252RK2JMsYV_7Ovs)2q<J<;RYls{|V?1_r6j`ef$MbNqC3BEAV5e|2w3i`D>>h49$KlzZxu~_u zcK)tEper?qjfDW`X*fENvO* zlIy=G;GebMmNu-}apEp;)?B-Q2%icz*YJ1na*WwGv`?GqmCY&Thi1wO2F1iytf0B9 z(p7`&Ke~bw&F0Dl`cwbu$H{EXVGdMBiW|voY209?c~o=$2zKo3Ni~oEo1yZ;$+)w~ zfmZ-|d<~7oLs(3C-03On)qocO2DBqABN@~?_|yxQ1UsHN*qK;=Hh}&FDA2A#MyT61U4$tHL#!iktYb&OPv)=<9 zle<3#9m?3X5CGDaYKOUd9=HnB%$lJM{AyY7hJ@a_K|contjR-X1Cm*A*s9~-JV;uR zr>Bogl=1j$l){fwOsoV)71lRf5=`G+nWL5N!$e05@Me(rf@%o-(9PQ~(uNahn9d7mB!~aCD=(>vCy89Wc z87j)@g(F#T97gM2I@24Q;rqtR?h6Hbuw)(nFO8JTrH-EL4s)=Y z2-c41=qW{Qep@wR$FvP~@r}!r)N=`?olEX9G@O+$JxmdcNO6Y?If4gi3Py76cPGd( zhOgV?)vUq4T14b^UlrumB*XLj@;idZ5xz+SpSlvZVjOqHv@MRlPnwBoUB>9YD`GDv zFLi@E;J}P@wMv{MThcZJ1uDrjgR&U`PK2oNiD(u7uF<7S3tZ$3mT*lwqU-n3YLVHK zFO6Tpvnm2R8T6!vDKsGQ+@<&oFK5=LJ+r^x;`B`Vcx!4&Lbix+kT~RK`Pn@=@xvI>=vf1mhM;+E0+n3hO zI5KIQv}WQ6wM<2FYaRZ|j+U;Sf3%E{J)lxweeT&KZQ}SGW4s6gg-%ZZ#G8RmeLNII z(XwbBA6`8q<+Q=1#eO)2$GX*hvq5v|n2>uFlcL=oR3Lf;7S#Ja_If)wsx?cB^e)0w zV5q(K`G5JytXlJSaG$v5zxgE2a34py0Lw3e?HtQtb{@oqPmsdG56}`>jijW z$oH7jLEM;6UgnVdMPAZTcF}li1gzPU)-2!91;LA(bFFwMy^!-!s)x9Ii_lhY)QCSmwj0r##8gy-0P4VTIJVw5$2RV?l^brm%2Wb9 z&iu|Hs|yNq-{ZpfFtPidA4!8tT|sPf4uXo@pxnf)b}_5J?A5EP+vh_32-DD~*hS0Q zqsAS^C6q-(zs=VcZk-Yr&^}%ZH}w4+^dxu<5vTx z0uhQHXTYfn_-e_nd>59zCMQknzUo$HTb26MOMZ^3I2pi&7j65Z+<2-EjdzP;URbJ4EPBATW==zr~MiyiA1s>pnDFAUvf}@V&_yz ztYUfe#-Dhv=iwB7Ne6ySJD$>iJ}jul4^)@7oX-e7*kH}03)-bsF^wQm0sZ<}GSt7^ zwo={OrckOdiadswI*_Hk_*az>8!1p1@x7q?$q@gbxV@pq?am8jmkOC@MS%H7ns*#x zwItUUh|mjx>|wa)o%eSN&~hpAN;O+M`TiPLtfvGa*Ukq%KLt%Q>(GOh7W!-c3h1u| zn3YF4t7gWNzEwe|)pGCb=acKQNSOA$vY?3v-e0)S%I(}SFv7Ia%j>q0382yc3#SBW z3Y{9gijD&J2+VP}E~}?PGaJ<^JJVhl4vjJz!3cMNgUQbtZQ58BKI~)?yg6y|tTf|G zS!~@JRfc}&5BS~7h-ktp63JnJ3Zj8bj-+xaIV-UbG)xR!mMA$?K9a`iz*9c+_n@^d z&pVr$LBq!4>T{VR5Spi{jgmgSr$NP<>bUZT9>AC~qi`|f@6A-cocb@u*|er)$F`wqEu^Css@_iwM2R99>LEJPHxFU9L>~K7<^NQsn#7 zV`i>c)FvkJz$1=F9^Q^X{Cm`$ertB{f=hk^VR#sB$MB^VY2&|=IOg2Mn;9oUKb3jC z1AeO%%BMgO{q=2eBm{%YpgefAAROA5Al7DqKXoY+KwW_Ot0T179o)eICf@Q_j9_Lt z&tF(DHQNtdYnx)^8XXRppNNrB^a6Yy$isuVZj(fb)J=J&e6>7*AazfBJ6AwwTsqDn;IBB2{^1aopZD9OR zwSuYrM|&`q_h*a2J}*}H6CEALB1~F;{%2d^6kW6`;{kK>2=>;JDg(>kN(0K+C|neU z%)M8%#TqMyadev#SDF~GgPH^dK)dYdc*@NIMc}v)h1qZ=bluL^OMP_L6zu57pzMs> z=~-tuimwG@E9W@s`gduQ&dQ^O@)jx|`?{$YwqF-s9HsF#+FgpTJ+L)8*;((cuGF^h z`VR=9-F3VTlUV<@Xigcl5vce1GCh|32pb#WJ)@^RG~6QaGN~g^?X2#Y7yE8uKg#kC zL~p5HDBNYv1DaEFdmtSHsxe$I3%P!9u)F5J0$6C&b50Kycx>;Y9r{j%hz&1SuDqr~ zm%L|ygXI1VD-C8BUh3D*rPM?@0jP z?j83}xOuad?A9xG6MPpW?mUd}e0|7>?!j{aIaLh!?3DB?3XeL7u|#Ft?P4e$Ft8Pc z+r>?ZMs)8PFOL0tE+-e1kD!3!tRwa;nCY7p+)TqMTlPwP;2Ih4R5V>1qXBn<6uGj} zS_gOhJHiUEdN2^Kn(25Rm$hQeNeZnd`+3ah!GwZ!*A}LGW9ARhLJ%85Xv1$00r8SW zJS&0sMzv3}t&4A+6QJm0j1q+-M(Nw$f0SI{<61=-}oldlP)w=Qx zifb9SEVi zChttzP$l(B7stgbpZcQSQz6Q+vKe4!UJT=MUZt&2(-|sMGFlFCu2QJy-@|Q-F~KcW zt*CuZJs9eYL_Esa7{B1~v{j`;hv6gZ!Y=E$?tzn=YD)G}s0dNUE|KBg6>Y}=NDI|9 z><0-04W0TT%i*Z#q=I0wcq4;(nh@175octfyoi`kSCSgx6M}=?u1rx9QOab*h1l_M zh&CitFcA^%YuOq{WZqZ5ia$O?IB7=pl;WM0epHe#^w!JmFfxUD{(GJy$A8&jH5BZy z>aFR8`-4RM##G!_V=C~*1iY%K?fH)n^ywUZuoz20ks#u?hnPk}6M1zjXkNza`nBgn zJhb2$F@v2Et@l|f-H_S}`|b??ma4I{dX_V?gJoOcJ$-Tz82{nPE$U@W)wxdbKy2ap$`Jdd(=bGjYdmdhK8&s!vEr;UIjahFn%+glX z#LCewD8A_7{OV&hEsp09u(&*0=sSK?rs%U*c-}a`I6@`{nbHHpv#fm+W9RJ#0N&bQKE;8?yb#nt$0GII?q3cB(zP4+ zzY0tt&LhG}aY1vjNCz$eGJYTK=~bOWn`f4mY>pi-4p!{y#}Lfyh>=h2E<~#yK=S0g zF&qo*21LX%1NnOn=ml zKG$83fC3@Z6F|0Qe=iFT*LNfD@dQ-)HnC3I#bmFTA(yQ5djMka9d`s0;tBZ*%(S8K z#w6tizKFd4ypOCh^vtM=W7UT38X5tg{EB1Nww8xdfSAB@=I&;B&xU^!;y|kRlDHs9 zREsCqD?KFR(hPKVsaVaI09zFXWDmY{jE)*yE5>XuUcp5pCgf@0-(CMXQ*RjlRq7JvvyDSh(@h+S&ju00ujngv z9jQx^q&pWDm!E=XZ=DWu?=iWdzG!9ixFnJ`pmGq0>I$*d`$`+$$FW#s5A$w8_9yNy z*9;%&xV|?_4F%~%FxERu8%ER;);r*xvvQ}KCvU2;FiV;I-eKRwD>ut)XG*&$^e&*& zpZRHxtqm0EerQPnw)GJRBtb9EY9t;f5Pw;+RLe>U`$`eitm?rDivezd)j2ZYE3}C6UtCri#>A}r0SVU;0>W7$HIiiO zZALIFGVf!mC6FG!9S385h_Vk^aeqrKCFq(TLxhBVkiO4&Qc#1uIK9>^&@Cv(KK91Y}9MyYu>nDRY z(~$H@nakp@rv2i?@X)S3LEOU^@Ol<)^BexI$Tu9c0Dg2&73^H^IFKv9MP0?ig7je5 z0d6FY!mk*kE?$RP#)GCAf{YTaePR-Zr_!^aGA<&wnLY$j#v2S=uZV900CIGjIJi=Q zq&5#;sT>L_DR(Nz^X< zbhi~bP7xn@FF+yHmGI1$li)Rw^wrA=?4Uuj%Lqp479_gf!a_@2PiA2hpC<6=iIwgm zF2#Np9&;zZ_p#ET|2)a((Ju|!M?arMamx2Yzhx>Xku&8BC|Hn-XtyjNddZ{oVJe?# zA6{BfAU?J6FMmq)Q#iQ9WBH?-1pG@W-F?|o&bN<2JW+X#B?A8F+uuCBlM%>(Q+73nA>`=C?)B(fhw(klFT}cA znuoz87FExY)h<;IwbIR_%_l4`EH*#7Cb4~a*S-%q^;>q_*fRi($Z3AYeZMs?=G(%- zD6m5kDms&YCCdt4c;WSvj^GvOcUdsw?v3T>{nHVQs3{b)0`>*D#&AJcJ$n*jrT3z2 z%09zvj`!B;RkTa`Yoz%Ezm}Jc|A~^fcu4)*|Ge+;y!CK30j^FMT?6a`1_bFjofRiMEW9hSKJPo@|~ITtLze z#pUHO`Ac&u4_x*un}0TM!%kyYd;9jE;{-Xg>hd13c&nO zv}a-7as??D5P?5E< zBG!D+G*gmtw7-=ddG-qWXX)s=>MR{_JRBmlD(8dI_FZxAogH6V0nh9@2^N1nc4v}K!N-Xr9VfmB5?7bv?OkQ?fzg53;SF01c=t5w4A)zH0TLR@}_{V`W7 z+GJ<6#OYc_8SItV-O-_wL}x>vzS?t`K~Td^1_`i)G}IL&D88S7(t*Do{FZ4{eU(0y zAd{m&_(VHSq)<1$*D_ujtfVD*S#GC3)@I4=_}ss#zeyHbBCAoxKh|4bAiLcneQn!5 zJQr*r)g&_bQ4HRmydyYnTv4B$*P1HLw&BI74(5+3l~_}KOU6h7LB}$qfQBN_yf`WlsK9ZuT|&9ue%ms{2-YUwpMO+td;6ZNZiHi$`329X_q%49{b${S+@~jA$IJU>m z+y1J!!Em6pc8K%VjVIj888^Q;Z*8hJz9KPC9Qkuu&))dmJ)t+$0{Y@-a#GP9Gl>4J z+~NH4sGE_XU=f#y75{^dx}z1Xpg38wD#1 zSCt(b|3DNC#y1KNLqqlQA!vv!$!M(Di;cAOUrsm0805T*dc|D;)rT&VvN!DvOR{^% zctSu?lR5@EUram*^)J3ntSBT^xR_#S8_~NEf zEjHdk7i>l?2h`qohZI?@ZgqpY2$l@X{wJ;$^Z;C&#*Tliod4@IezpK=0HyO%zeBo8l%EGRKyhMK(N{byaY-US?M=@ssc#&gT%{<7`#gAcORHo* zK3~VwR;H^$@NLPrCIA$Am@-6V zsZSAOC-@8BnW)CX&H#%CYD2s*Qute@ivxeX9TRB#CED#7 zFxJ8xvauX4$^psMxksvlm+Y#^X}lZ;*f+hVwm3zPoz`7&x9g?GtM=YnT2k#aEH`&% zIM)RF%H78Ld)qZY?zzFa0|_^(ZB%yK0#Q>sxvQaIxrCXRtH|IPO$$JXMy*hC-ZG0B zEG$|eb8hli%_G8W0Rp+EOf78YISdDp+zxau2&845?Q<)t$NBHxFWWX^@+~*)$%O}= zFpTJvZP!uyo&7ZvGxEjF+{E*f6dFCHaZUu$+uMX+k#+798IRKUj>!uv`nJ313%9Z zB}RVR=i3rr?1%PR&sX@ObRp9moXx1GG4MlM*?ylR*?(e7u{Hqr2px2}0ozUna8vK> z5aKuLqWR9=u`vbxBZ$3?wFUoGc|~X zXwJ5c>0?y5drjNpKV=}!(pEA{W+1Wt5F;uP=UL!_9yOvO{n7)c!C`5G@)eMEKmfSo z{TxYt6r#vc0&Q2_MY89hG<>|4_8z{JFQs0g6$fn2;)Xf1Z#%ZM zR>UQ4h)QO&_;*9n!pgWbcamC}VQHk;k_~~?=zD7;`vFpb!VI@@B@gcPBPZYoH|noz zd|w=1fv0LG@|Le5au$2i3!E|-A6nckiu6l*0=W+IyNF;WbPaL2ky)nkuD|eA($W(MuaYn}W z-O_{E@92@nSF)~M$6QAahsy@_>>!r2@2}&5Vy#7biOyBm;w~aq$CODF&g!rv7cLRj zs$@R_|08ZK4;ZkFQ46p0HC??Z55pp2hY@|_mW4MVLt4Y&&b^G0+AGreB6aWn??@T~ zn+VTxVp*;G@$B z9L^A9(jS&6z0$(4-YL>}txW`!m|lN|bBI->z!Pxd$3=)rR7sPC<4IbN%A)C%1W9)r zLCD4Z$#bw!FYHP^qZ)RdcOv%d?NnIZ>X^K>q$zQYCCJf(fBa^7gNTcLpr*`pV7%r ztGV@LN}WjzU~|B8 zSXuHT4}pvRT|LR{4o6{$!I==l?LTt?Psfsp{PqWtsBdl>>|Qf)?U3Co3CxTsb)V0@ zm4h~(7yrFH9->|vmC(v<*kA>F23D85&mGm-CvF)`6Df(vMaxm`?Em_mu&-QL&vi-h zjBcdc*ZV_|jiX!;_@|sQ$BUq|s?}wtXSANJt!ZrARM5H^p)xdX5W62S0Pk@Hl-TLf z(eyE__`}KW+7r zKM2GMJgf|unS53U8i$&hz2&?R1-{WY!p)w=UO|bAcce-B_-bUOAt|vLlbt>0#T;r} zPH)1q8g zLnf4H%b;C(dM^(|z_tI5wlhpE-a#Et`jfiII?BrQ*GSN(D9hf>h%p!5WY9-G@Hu|1 z?HhtIhfU=;T`6wA%+c9R06P(rJQJC@Wdo0{hv?UwhH|~)McC);fJiAqt z0Uh=`{>t{(2>6#M%QJ5p+?OcmGp|0d2Pw5q!8X9A!hdiM;3utWbPtKrxgz{qatA~x z4ZmagWnTo}yCnMGXniA)SIcqB!AeLU$rPaSwN14@W@Xrs&9<+W&ot_GMN$1-F` zIp=Jrs&iLPkWq>M1M0F8jiHXchu6>Jkyt&mMS+u3c7aA@QaytPHG3Npz0)Hwm@};< zLrl@E+6A1EhUJmLb z_%;`}(@zNx+EFUVLS)LyQHVk;N=bDb3to${-Mx!WBDHgTZ9?8C$2UQMNV%wwC}OO+ z5b;`0-F=PVZI`EEw`QxeMZU8|0iv|5RH@XYajEPCpe#F>cdEcfWJJHhvAi*_E%thLkv&v$H&|~m6QF@av0kj_?%*kKl6ykTxD4U*ViT8_LQ z(YekOMDvol^@}=>@kghsaKz||5cx&52cq3$<5=UA44FL4c!nWoXhNW;^{aZxZS{I9H&Yj zbBt>^*%e~Z%1F8s0kzbwxE(<(=j!oc?7E6Whlk!jH9+Lt8ut0^P51}a@o4lpQE$5t zV2U4QMsCnv6uVL?{d@X6RE;}h>w%}4DBT!Aw)RU7gJ(Twr9Uo(6*fKV|KR%$V7c=k$raw*2qNsMu%U9AyN<qe2VK z@sl7yrN3jJ+MEs4#B}gSj1h2gB`U20Byv?hw}@ z{|1^Yeu?{5onW?No7jcXf=QvB63J9MLG;?(C_=5mNTb=DQ4R$v2Whth9)btg5>Nlp zuiX@1G&2a#b#nl1WEAHO*CdIs>F?7$w<`GW_&n;}0KYHcDp(K<7{>|FavWiF_y)$Azl@x!ry zq|%kf4uehC@WU8RPU!?f*I8^-X}x9F;n8UQ1gIJ7Y4v<%hx`uB$aQ}6C{ z>1)yNX{nGIXYG7DR|DD36$?O*RHaSAq2HKAOpmK(>(`}cF&*`6)veivvhmK`T7e39 z2%mLK#C$|G)dgm(@a(qWrp`BsEUdd9yVevNno@P+lCma+G~tVC(_`sU*Y@q3|MD&@4|FxgxmrFn{ME#+9#YJyu8ZAF;oc1`e5IIs z{7!M)`nM^7Exh2<@NRSEzyp@~$7&w0B zWhG^Vk0SAlJ|I_NlP_?lTsFgI@jINSVU~}$fgUKD`as#G*xDF^luw&e`^Em>vGO%BvFoWkCs=@nJ=;=@7*hwYleYH3 z-zuQi^R_%`tOGm2MPtSfzB=FaTDbivD|j;f^!`xSrtbqta+o^gUHEE*F)0hYL#|-2 zrGu;SbQGtI#=8*zYx#J13nl^oON}?_@9r?Kcl`HD$SAk~846j8k5OX1Cmv~e6Pd>p z!RYcI*Z#1e&OGdcOn4o!j-OIUOX0q2g47`xf_A}rvq+jfkf-jOCY|rYcOCBz|6NRc z!;^ZOjjhX$`)L$0fvI>JU;i~d*puapAMDEOa~E7q=&J7{D+LOB4MmY9i41!K)=m;J z;peCbz>gx3!zXHh9KSU486Bn$`$XtW6sVwoA%Gsv4R$jR){<8}@A0UIfKBQnV+CR3 zaq{;6HPUJnWpzofpUw&U_>kWJ*O#}`2woEgP{C!T7(uVr-|Pjy&BG?@nEcJ)2Afew zE^sYal241#-&>75ULtHHdR#50Hk&da|3we-Nlg&e9rWV;x;Yd3+J zm9;XiVxI(bJ30Y$8%pEjsSiVtE#)%C(E2~jo`2Ju$(Wx4s=?Llc58J600^xlS!sct zv85QY<7j0pZbr{8O<4)!r%t)Z*diIr^t*-}A{p0N=Lnb?@fms;TknI)54)!X;XFnu zHEVGLLBM1zuxzz@J)v-*GR6iyp&0bUSE*XnWyxY{G~)5G{c2e%O)MoQ^$UlScHr+% zd+5f3G0X20WGuXQqmDgE0IQv(Hi)Ggt2KGIY~{G5%d}ggP~FR>`f4ZmeG1{J0+!;3 z&`Gn-*F&OUn^7+EM4G5Yh!$i2o|r%8eqx)&V(P#_g!iDUG7u$opdLE6J(%sjZfEJR ze9Hm-&|mL>>U%C)ezmD^!3a{0+mS)!A0l+qEg{JrWS^MCSEEvf+AOud>OBKdFOi7CvpH9SaS3Te2XHS>dr>FtSwrkTtSJuB?_?Yhl*cl7Ks3yJ$y}wd3I#D!dcrT7 z1b7+JdD@*mm8qYY3lM@ok`jb-X=jQA<8|uT0Qc~UsXp_?q@dh66rhk+P+NlO{W#Ww z2sTm65T{ev!iy z@YY{oN2d~9(Dm0!-C>H*pPqQQT-6$<6@RspvdV*K874h6D&whGsv zHyjzGv|FP@hMbhDOAP@l1x~-+=KvfWxIeT0jqguqnP9Ee>k5UtlQuT!8U?zOR-=2! zemHdu9q|0NO2K@oX|$dc^ni5zYnrzYPcYy!8#%Mq;*& zB~r@DqsT;Adz*dvdcU1AUs`QvC))qunxG3phoEetpqC+ZpD2Mcp{4i+puZ5vZZ@Rv z;3{`}4Ih4+8Gh9l7N^83`rTD`fUltWIHu==>=SS+v=Q?L{iBL6SN>NOuVTHFgI&-4 zk1D>@T~TH;h8IvZ-WX|RbKmNvj5p#h;<8sj{s+{Pr^UD2;HCs+*<}zsX4puX^>5dy zw^#Ng@Rn%;zRD5O<2hNY)&qJD{c8$|xo)&)9;pL$f3+qfk<-0lmM^;|&bI-!CzxFD zrclE`=MtxN>_He~s;Ce)@#e zW@lhA{Wlrbv`5OFKKl|>XW_^It8Cg@T=SF_6lXKTU*Je)F~63JHXiK#JN_>G_zPT| z09U(&1&gwk7y(8~D3gpw{n@4S=ta&E>1rM6M|`voXrkCay+}G3aoQ zdN6OEFg}+UbKJF89{e9M8pjcdWDzK!fXk@XXlO~WEXH0oe|GRE)gnacM!`~)A(h5o zs}m_huEt+`rEr+C#YB6Sdv##vE@GZ77q2AP`+6Ehng?Zmni@lrR&ws<{%4*9Xv;bg%Zt4bpx?u#A{B`@=c>bt`xB9LEz#U*d% z4}DmCpuUC5g-`(w+%yv%)x+r7;ohdJ6LVMKbI+0`M|gQNS|-ttf-;_lw{X_5+_=9m zhB2$tFY`fvi|c1zlwe&mgy+AeInl&P6tG?88E3hULQ$n3VFhYwiaoNr*n@y2fio>W zbu9xGusO27Pjuwqm};WeTvz}YY_j>-S%y!HW~E=`bZ3xUA7N=3P@nC=U-~0%m-Z+! zbL3bew*QKOj6p1UP~tYI)Z=kMX=O=#-SKyUy<55Vi|UcyXa?)a2iZ8`WpB4s-zh1h zr-qV1%*r4gFRk((3CV6S_Bi26Kbt>X+Qvb6-mY&D5^)+Db674?X()xNVBai#|R`J~m zhOpIbyIXc1CDpu~hNCNM)@_zA0xTXThC_>2PtIofY!Wtu`da}&LNHC=BxyuNM$JGH zQB!^1cOpSTrf$L)8s5i8zO$HYL6XFB~q7U zZ+v89Oi7jU+IRz+OVo+ zMXAJ5WjL}RhzFTGKDj)DD^wA(jfMjakRZF*7{Ir$DakCTATwDdF{QvKAm&Nphurw*fVy|K0Vn>N&gPSME{`nK&j(|FAcaMm ztYhnri+mp0%aM4_HdcUk_x|K?5)=N-51&+nMcX3jEvx*K|FjvC@B>YW{Xc2q*<`%x zo5LJ)s1xd5xuwp7mE1_g=4x9(WMR7}ey(;hDjrb@h8KW;p?qhDs-&4cA8OrVQ~aqz zalE5FI|q&~U+`Bvr&!rdp%GuQPOsL}P}n;xJ$Dwk2Y`XE>{zWnJL*8)$_mNyA_^Rm zvro|pn=8slSdEFF!^~V6fQX9Uza0~K61@j>^nh#c<~Hxq`_1U%k$@f)CMdJKVlzo7 z1td)4zZ7hnDL2j(ka-pEDwr$$X|p9Vnw=OSn9A!JP)IeLomkvdVSdflRSgMO{-B7lc?@)=51GCPwN>Q88%P+wITNMWskEgc0o0!Y{e@*v*TEjX2*Adao^`__5* zAAZ}vc(s2F1fRGi2L%;`llWWr?-nrkJ>T*Jx(RBLL+QBAM~|0O^U5{;JLWoj{u-h};ulSj>DXkeuGZ?d zh&ELNSLXy~3aa|Ng}Dvqk4(7R7Xk#${WdBP<9uC zl6`>pQZzxSITBbGojwB=A9X8HV5)8q0``!u2=Px))H+W@l-_-Tz&Ar`EDgdSq=OX^ zl%)t7M_+FtJ7&4lwA`CxDxV&@n z&M`TI_5KYocapxuR1`5JrFctKp1)-~EEmTvMqoi+P6(xy+(hT7IU?7N1^;$KY-{CQ z6VaKyTXOrE{nIe2FuPgxxKlDWxk8;$3TOqU7vT(8pHGYuX9Q0b&fg=ajmOD5yFzrP zZxfUois4Pz7a?n#F2H<=rRcwSd|St@@?m?pb3$fs@w0X*kX#>m$CS)%?6+DB7*`eg z(VM@rDc^OnJn;Gdos zxZ1jqpMv<#0VFr=G)Vnmz2N7mdM+KYd`fNO#?4>FFeJht^@6PTYfgIQT7!)Q!xEI= z_L1P0A45X8K_q;B3Gz*=*RK7_6$3IV(M81*rs)!#qULa7^1>N* zkRioJKe6>tFu~855|M6QG7KL6aE;Kn1qVV9N+>d5bt z$(v%X{y@boF|DFY!VDgknNd_GZI1;SI0}KfMO!Bb1D=Ux)$1;w@bV zwLuqJkGmLrjy-W@dS)P%?(rTxHTZR?WmGlZ<) zjcesQ6@G#(_}k%!!@O5p{{87OdCETSd06$xH3@(T6xfWS>9Vao;xjUT|h`6UT! z%;htfiuqp2&*Td2uIHh-*%KHW36p>FXQYe}hs6;(fQhdki^03O@!)?q$1k|7vo<|) zIJ)V$l@aF~p9?jDw`K(QruZmiLRS0XIebZ2;x1zb!FLG;LCctdtv|ML&&xy3wUHOQ zCzh<3*G-*|fd8HCNqwa4s$IpxOtQjTS(2=|Rd2E^G!89AI>=vOJao?UaUp389WTfD*MUd5cgOH?6 zZTnL&G9#Zifn=W4Ff{QWB~-lMZDLzyN*y#o8R|pEJeZRHD)4Pzg=6QA*W+jZ*#f*I z{>e8}4&Pjl`1Up1U_ZQBHN{gy!NJtq^gmA-Md=?`qC_@tY#nXGB6NcXEW9#xypCaI zM0k~c4$LES7(J^SekUxrDm_gvz!wMvVHfQ9nCT9UbO4iH)<&UyPD^%kK@kttVz zdQ{VY&iNJ-8gTq@m&v?7jfYxuGqE0B5*MoX`mFls;)RruIWR>}d|&I|g+xDC3Iaz$NP>F`{1~~Eio|#!F*@s$sVqBTOg>*c znD&q7bZ<|Iw+jN~QB%*l2Ed5QI3klzwK-C#EBM6KA*h2`W4Glj=@_h<#&4RAlV`j) z!Z2upi|yAOAo_{v2~pu6ahb2FKe2_4A z@{$ISA|DfY{ZI9>7aCkFE^GOs_S*R}{ff=yQDxrpXo&!(Ydure~}`%%OX+qztlGC(E$c=pSrw+L7xu%A;@%kfRq&Z7xX?F|~pr zQFX8F+i1&6O-E;E0EA-0c`hl0oYm`Xj(COe(&`Zv8jzWx5z^ckcILoo% zwivXmmEp5zaLiy^e09vpJ^9ohO{*tZpaQa*NsI$*8gc`@xBBUg4Z+;1E+OsA0HfN z)%}h3yJ7r0`lkxh}BBiZoer z14l!%?w;fd8QI#7@2vX4H+U4hpMvkNdcWZxy@}Fx%i10_8IN@i8-x`8qwscsK9~@} zl5sOT+8DVzuu^~vM@>p21$9NCV-mR_wC-_cg{30bxXa5$*gNGVg$R0)Q_yG~2#R|s zJBQ>Iy##6_qt+Jm(x!f`ePbz zyL-6ri^pTw!PihgxzhE0ShW~@toExeP$FcTDV&*WYukcx((>`;y^6h>nQy*#leUjI zgOkY$H4IO?S>;e&N#s`y*mdd@%o0RbsPQ;=T&rs3Uy%K^Q7E!-&binC|Ge@il{>dA zzu(>lLhqrGtUs}BNax&`7-&%6^hvY^N-cRN(EGz#NQIkD&U&4Vx4=D49PAV2UMo)X zyrzw>5U|YzT;!H+r&+p8b;1wHPD2(C>-b%2+|wQS_$#BQTkyt zc;LtLNLGv!hg}{tlV9xsRH;q{$H$XlEqZ%?-&94-&%j)C4_EUZy>L=2J&g7$32qMM zfvTDeQgBKX?J@Wx-iLnmSM-qW3FK%ICP``!9t`EFiy->K(Lx{KuL+Ce6B<8mGJJo3eNizO=nJh%ZqFhSep$Lj3H zUS>n17(sVyMvyEw{nl8(;F-R~^+Q2mk@igAXC1}+xI*ecx8(({V**;(PtOAQ0C36T z3ABZ{j@l#8s>@qP>JbQ>ECgyOexc+I=llRFOfs;d*oLyEiwFhr<}3orRChI{?@Bw^mJ~aNDe!4rtFb zu=4yo-o}r%irU=R?^yyUy*7vdf2lUtiOTKfl&YTIu8xhUgGp|@^|fdL&C*_Ucelju z7JannBnEFgQA(MVmimIlsMS<3j#$u3jK*B$KJbc5= zSEh{bCKS(C5M)#vPEUn-r~}>BkEZr{wuZdABHxOr=t540M*EC2s4c%A0N@KS*h+N9 zf)DyY3*kOGkKEkxPHJArZllLJ!#{sy0TDFO>pko~sCCk-k?Q<$t;(v_jvfqOGPu#_ zK%43^Qb&L5Ang4FK453(KXCG;r=hu^@eUIh73m#mfBZ>a;_|c`Z#(X$yLZzww8!FM zpjXeDHETe|#p5Fk7QFxQ3W!`;4U&jK3LpaY%)$Vo8tl@~zq(~66WThUa$qWgqeNvX zQIZOlSQ)wi_Yyc?)Hr`%Tq7Z++P&!lC7AG%fh!NtZt;N>wo$81;K`$ zjO3(PGg4ccX4m9;^%;LZBklhOx}X56BwNF_UbyKaDwZQOKzK6@JE+h;94Vm}2SZ}Q z?oKSy8iVJOb$beUvCoAPG8qeG3p@MMPVLFGlvB;08x5X)I5;>i+Im-$U+ub;g!`wf zgR;={@l*H$J^7TuT#7bRYr*i1JH+h`&-QVcMvBx{kT;Ra)b02BVXjkO&>|GJ23g#S zzl~2X6dFtWyoDQNU@r+)sHHiEdnS3!mEH$|)D$D6;vNA2<&{6>(+0Nh{@kD5D0p55 zuXmH1gBz)1xo<1q+tdErX$^!GEz@LS6+zHEF3#HS1euwr1nITjREU?DZd%qZpji&U zXC(N56#Mf3%{A8K4>QsaX=Bg^oPHj=4Zi8y?UTpWL@ML7nBz2P9om2o-hC|(zu%j{ z2X{W~$&3M5I1XwXA6pV2YWIkKA-t-iSFL!A*-WJ_n)ks_mkM><6w<9{LTBN0V89-` zhmb3p%8O=o-@wx0PbGx%(TCsWe+MN zc7;>~vYS!VSad5?)lJ#+S6uQD%=9vdZ?af z0epXEBfRSE--Iti4@B4Hb2{`qikJW|Z}`mAjG<$U)cYZ+CQ8EMswBV#S_TVHDS;*h zt|i=3#Xy9^GTTG$J6 z-i-wiMKg^GXTebMl5ox&AzjiIvOprBf+4{ zt0pr`yr~Bgd5iq}fj460qY56q{%kubDfDbGKe2Srqq`Y)N56BOyB+O>WVQMcAla|N zF6!P7Hg*fIf2jEA%l}rMw4`cfz1U=BTN4~EFYrULVXkrI1FZIFEOBv8GSx5IIhvh} ztdRt$pf{$mO`+oC-&=&iK|EQpwe0dwrZG-Uq|osEkuZhYSqy@T{{-TF60~-GFM8^` zkbLI~%H_Fj>HA4#zMhKx7__4fuEyq&gkV+gX_|h}{{`^4YFlTEstE6r7<}g-6Id98 z>5&{zr|NT}10-KuR$ZnZbAOSCHnmEHn#b8|dcVd)`JfmQrWRamayk!4NudK{iOCs) zi0vmQpOklGbd5=UU4GF?vBZyPK4F{%I{$`1ya%HsDD=0;6gyPyc zq%7OYXn-V+)tM^%dT}^y;(=xl;MzyLwdD|y;n}SM0C>q`T@KbMsrWmrA1`axenF%K zIP*s^}v2JS0|?Z<^+*HKSfNn4D!w51i>TCz$@9L=a~9! zf^SNSMlS^W5Lm?LP`btDe&a@vK`^e8eAv@m#JR1BUc|Nf0vBEHcWTjGH|LVIKPCkm z>Dqxx0E*qC3$>bmBTrvW~MqvU2^{TJ$f{(gPwqe@V^Zj zs94!cw4=1whTBHvUkNXH8hYEI{n)XD@tdwAfE1tj(y@MPpKj3z>ifkTGZ6M>S&xlM zpgrhAfWt(?N(tfWJQq*LOT)8}_95J4N`8;5Np8L=c`3!9;Ms z&u;`Q)J&(v$|^8uL>TcUHyhT{%FLaF9LAK>rfv&`(}rR9;q8DM30=|_sC662o`IW% z<0T;a#aIhn2Ja`%AvN2Cx@}7RHoeJhD}do|cbEXSNDj`8QU(BaBndnVIzI*)wwyk# zR#fe{fdJ_M#$^akZ~El-%{D;4Cy2PSjLQ-pVeoO%gB8CH7YYqW_Jc-w;Oj{{C;!iD zs5nwYsb4?S7=u;>=+sYml&Lp%ofGeNk`N4%&thnZhbe5WO%%#VOI7!JM@kH{SwIe( z94?cvbv52po@JOTt4^CqgmD;u0}=yMYSS^$X)%8`t(k&#CDF=yv~YxPru;nAc36vY z*iP0?1ul7_LD_7#J2?;-4>TYDH49dztS@u6803RVbD55@;{#h3z8lOh6&b4nB1avMj4 zh)K7|MUcgI8)r4#7v!T22xsC3lskP}#Q@qPq_({Dae8nq;{Zf+=|HrXJ?r z02*6i55IwUfv7XCK(I<^WY~|LrmCM(T&>6cHcmlNaP4NAt}pf&-)86S~_;9>dQ$YE11-9!R} zchlE0WccMEo8d)cBh#2ZWiT>b?1w=#4u0M6;Bh?F>y6;25w~6OqTIVCl?-$9t9urP)<{ucc zt0#w$_J{Y!_>@}cJUS^`WoJq{UCV^Z ziM@ezFm%k*nY^8t*h=M$bn!|UX&F&{9sNQ2rXl5<(9=|d?bLYQAOS=WBpn?7#f2zu zOOUtCCuHA4-!pHfksrje<|_Qt`gfZ2umd3sj1UU(qVRqkIu=%3DXR~nnTF3-p6E%s zQJ0tDM(AL9PpJNSCY#gLemAHLO7*1-brERT{`OhN6SDS|OY`wZd&}Stsl%e%Df)x2 znaeH!$&mbp3g-h2jmc)_O9xDhNxl0<>u%E+-E$XENZpTwdG4u}oIXDoN@~cG+qln@ z02w2eX>ytz`M92Kgk}*9^Be}aI6Z5oG>lbL8<^#3;KKp*o?RwlOey+fF4Gw9+jbTm%Hdg-ZsqljO=tYw z0^?b9w1uX2*@4##x5!Nn|e*F8*xq zx{6ZLVwCZ>_#-FUnfrY0?tpAi*A=qU9H5lbcX!NBfBJ*?yB^6=b{~nq zzzH~VB*_9(vH>CcE$WF4y5i!yAz!2chh;-|410`92tYx?X zi!1P5o0++ILziofjdsvf^OiqnQ#HquFZxiy^QaushNcLbtk0!2qixHmW&B-=**12W z3)r2n=#dhZYIv}rR!-F}(eLsH*8a0rMSb@vkr1KPkyI$tv+a^I4uM)cFaHl!-vFFh z5TzR@6HaW~wr$(?B>BUM|JcUFwl%SBYhv4W^0K>c_wB1X=YF@k>UPz=)wiqroc_)S zeyLp^WlxxUYO|>RCCsdD_%Gk1MtwG$L?4LV%&0$pvAKrFX{`m@<|Qs@udiphyx3*1 zJ*{P$uu+6lL#r0qq|_!Q*BH4V*PRW5!Gzu5CC%J$T(aZF#W+~K-(xZAKe_KGP)Yr% zTLwSV*E~w%M;#kx1R`Ywa#}Bx?=Kb*VhxHT*2BIuWJUZs0wt1GB7L8PK=SQ#K&4Y} z?XJ)eG=O>tMm#1_78{Hhlf4o#y^?N%(XFJ(L4sswtLz_q@RBEqn^*g+m^G*{)7e@&ZoF(14G`CMpfj?26b9!h?v&pBz$sPk8F`caQ&J+6BftjuPBSqnX z_#RF_4Z59;+&*GJp@1HYcqt$I@u7wfu+pkC+4wUJp8OH(X!KWZiVjAvOct} z3(Zb#XD9o`N9(m)tx%YHz(CpRUi1%!S^LTPN1Gl~k(H{^oAb&!FlX{$_mAf+kUTlF z;{`=Awslo$CxAl0q_JY3(n;i#T11~DBhOnuB~hu%K2aB4jK&##ADgx`PL-m^=jeXd z+&&1SD_m3|rqvH4o5$K7TOZZd-xi1}$#{h{+$Hj(+;(FtS~h0Jz_NHrhU81Ms#&h3 z2jd`<&(u6d$lj6JpnpROpV1Z}tT9{;lVNvDQN`dH`~CEAcPt>ISDWK9kPr3tXhHeR zyYJkjQ#q`=Op{^#Yy~T+7G}oj$dIic?pFeFVned3VtF~Qfe(qrnsl_u4z?$UJUK@^ zn|GmwPCG9-0;na|z}dVbkI(NFgx6;rnvFYfDmd}nQIid5QM884eY#FOD3pUf3HJ}z z@!4u%r(pJ%HybP+RPjtHVfV+S#kb5+a2{pII&KueVLnF7B!R!g?{-!ybCdBZJktkN zGBe;Vu5e;=`ZK78?8mZ-Ty)b^w7R)tcMGJWtyh5^w*P}Nkhy(U`~lx(;(7Iz=0zG| zVfaa0Q=1P@<{b|GhrsSTC+QS${(6CE+>4D-%AO7PIEpTpH9xnQa7&;~RZAj|djot4 z8(wsD7J`}1U3tzo(`V>bYq7u`bich;rF$!Xr%{@<0}|4hw$0>-p(fGCJj z4SS&N%7_rTpHHzg9TY_ao3IezkC%)hVdqb$s39Urnl+*O)wsRm8YXDECoo#6-tATV zWa50`L0j}x`ZW$u^2H)iO&d_jzcMc*wrv@w{NE)=02wsq!zR9TC^TyQxcyAhb05gxgkCl{r-wXGQ69$)*8;3~`Mb`^X1S3qzkOOABCC z&-r;>)kAa7gvOelqOQ8iJVqYSwQ8(<3il`QmS>CT9WhIT$1?dP!6v3UcDaMrZy~rS zL+`6hj}|w;l$q1q**P$tKwbEUX+~DH+C%({FZ7fK}zKDNY2Wf9J+T4)JU~Pcgu+ikFCV_|ZYh7`_$^W9x4Cd3OS3Hh_(y({v zvZawG(x+-4*7A@D^49%D{?8RGNk;6icMJ{e`0HKD<{Vu#*YPN+J~Dj!cjWeoj`6j% zU*Nn_>R=Bxy4#k38h*xmw3s2jU`GCCZT^`#IlHP+H+ekF|P@PC5`nZ`eF$O`@34G_*rPL$)kfJ@zdKbR2xdAtvZVuUDAg8S2u<58J zw>{3r?UlhCcO1vA&}taCH7R0Yv;{A%BnAX-eB24+0!=m`D*HOhUiOS~AE9SPDml|>9WaT~UbK{+VWAXR*z`isE9^vQ#5ExpaG!qG)lDbXdNMoeM zo*LFNDVDNRl(E7_2(`ZE_uCRv62nce%;n^shHJ}xTV@Usu?*0YfgpK5YH-r7%k8N{ z$X@j*2tSfdW&GWFDCA?}4>Hj4_7{ztdFvc1@BZ>A{I)#qzxm~JtT>;1qG8;n-{B?| zK`m^_H?}mO%yFsb27SV}=fTjn-A$q6N}^@`mXDt@Q=_9Mg$TB&R8B3#{2tzW6|)a&_l{-1AE9&dp+sM zWOE-Y_{L02KP|~XY6vY53rBl(eW^GW3{X1ID9NagHwHM{f#GX;QRnY=Ylk$y6w9*n z{uvz6j#=!DkFWw7jCrgSVnBH|+f*Ff9rZPI@2?@zuMe+lsh*f}8bTpAX$dgci-YZ> z6EImN&Z_o%aRn0!UdOsnQ-((XAO9mjj`S3Gm=#yEpXn9%zothApFSgu2)xAHtLd!` z_+n#fY%>3T&Oi#y4Rq5#&NsHthC^%#=RgXiXkg0Q0Ysm@hmq$`Qzsa7l#*3~F_x{G zSJSPr)ZYu&%ro}|8iYk`%a^}A-c?%l^Y%@p2~du9vY3y$u$?b6ZhqwgS)2T(QU}Nx z!|>O*%p<6N%;jm~$s=|7WSIVw>-?jUax3_6! z;h2XTY{&>ZY5MhSn#7EHanTZG{AR?VpF+3I>F|Ib&`y5RXX>%&4!ost9zF@cnTrDlN%_NLmtP6vd zq^d$X*sU?K9TBlMM9pRoLBe~H-1U$)G)44_<_7tL_wz_9YL=xBt-uN-sXZT*Z{woQ)HF&@3?rik^?+#?(WFZRI<3P9-9y#0e2IJ@8%kY@FH-XsqFc1 z2j%I|IP?5!wx-rIGp*q1?@>+=*m>EwqYMS>`x5af&o-rDyFW=jo|62M0QTKKjvh1Q zLbXOE#U>F62$-Y}$3{q_eN8|$ydn`t4uC^9JleI8(x{{@MH7=h?{AhFB;AQ-`j zed7mMfC$5Thm;r*>Ca?Gp8)4-i5W9A_dxbkia(2c(q$vr6Et#9^CvUwqy8uiAWnUd zLJGyuLKK9K`goYLrmgj3L<0AbFFZB=<`1^#a1_fy>J`Env$q~-R~FfkOO?~#{p8Lp77_LEwjW0M0L(i*gF)b!i7VM1;gG}>#G@(p0D;+` zCg~x0*U*>xY^{}>Jpx<_dj97;w5=j6sOoZDYRo%IgJwMCsdAF&sEGgF5F`pjPh2TA zG0BVg5$y5t7_N20Rt~eu1#K8VaJ$%~HGjDi?p}8+Ex{0?e#O7jnFu&G>C1~8b#aOJ z?mI)#Ki8QFVt-|S2p%3|$dAFHCHKs!s-TceX4liWY*Yl6^zKll9jRvka?Seu6Gne2 zvD68T2Eprjp19e`lNEp$P-6fy-sB{M-G65}RGgV;ThjN|GP<~szX7j1pDcr}JZ@KG zs>ym&g4-!ZIj%#pUhB*}0sn&F5HkS1#;Az;a$GLVY0(T67;ULaKgS)m)_+Rn&*J|T zz%i4~4@Zv{Xl;8*aru+^Gm8RS7`?lL(y3el&oKg));NDrAxuFu0VEsfCaF&11@gz& zGM~avW7{A!29gD7)Iy~aq*!Pf5CwO5Yylc6EjLBOsg+-=ftt>S7k>Ez+Z<@!~TJrb%Fk=wxTmzQRfo zYkrs85fpfff;c8?@uot7A(RqVCLIp)7(QBx4Gofu)Cft|YNLP7>1ixFxp%6R5HJeI zPm#zRJIdN;&gEejEB&geRgO8 z_HO^Drkku_s(XGNz}%l9x>7m~)yNYld1)&jl15W+0T&>kcl}v@D${b^&!EBv0JRa1 zmIP_3899T}vbpmvQ(HJyR~cFi+3;pgwY(D&4wyRNPuX)Aol$MdG`Lu>Yr#8 zL>1=`v(LmrE{_DX3zX;u)Suxo@nM643g*1nGx15cq6;2qyr29ecnOO36y+{*+ry(p zovLHmA!-c@+#ivYL~yKR?@uMsvJMM$%!pb5J5xc?e;cd{myI4L_gmYghMpTRn#4+G z8Oe@HiuW{CfinI%g2W+iLs=#VmOZ*Ti6~~{uCI`nb)F35T*9r!aHAJ2Lne}1ZDmHh zr#;~VjwFGLc@13MY|TG^oXb_)q@28f_Ota@*?txR32)s?Mezd@^u_vF1txh zQi1=~Z*9VRUx6c9Hd>vi9!!0~eDZYzo#*9oQfp`+w?iwRrwuwyvUR8hXqQXKVtweV zbEvp0v#AuuEmn{znjF2WuWdVOGC`lOLOSB?0K%wiLTWnixwZ4WWs z+DKjqMV2f;yAbCiA}ELAWV=>4QS_@b{sprm;5ZQoWtxxVIF`zEdv^{(`O|G$5+yN6 z^Ef*Qw3Bd0SF;U2)#|D9_fRebD&?1Rj%#Agn?|d8@ndDr;MLYiD2W>#BAh%oT@v0; z%cz>eV6hBs>^#@js97B)idxe=8L60~6j}NOHge-B!}T5Jxwu|LtB8+rU^D2yb{z5c zIZSAvsDh+Q&u8v7c>Vl56TK=&gJ!`)a^V42T;Y7)N>ZSODq^}kw-v`h?urWsTZYce zFPZ$Z?)It*mEJl=X=TQQGaqq=w_Qj-VHyb#aHrNBj$JZ)bKm9|zg>%|6A(sj87S3! z>#`Xd>Ladnrj_FzA6l$Qie>r?ndvSDryi{^nlP;_Sg@@iOJGi z@+cX%p>5=BEvpb$+C9n`zHsA%JM2FYhQfUk)a^rGPR;Hj5~N+d#+U%+8wbti7YXv% z>1c2BfloU`nz75xZ-v4-H(I6m>?YgFEk~VkMVraXoxhu)=1cspZcOU%O5Qom<(Jt& zJ3Q}9r)$UIroa^rMl{A1yx?4rm@{_-W(_W@7%;gxxZx+MVH8C&ikoDAO4m69#yO6T z)kTU^ z3<}bIPrrBBCWGIKsC5jFHr)9}?t?*r^EZCo16>cR-*?@-+YUVVf3w%`Gv9!H{~3n) zk0{Jy;rG^O0fQhb0pwP214i4%uX6_OL%5VUeYH!EM%0iKNp-_Q8>WObJD;#iDU;9m zm~wY{ck(&WJ53BtXq$8Ju}KTVP92qx7vG;kQtyy!i8M@b15?Rb_jT1Z>!{>6mHJQ2 zRn7yEH@8gI?Q4%PrWHI?AiN}1b`Sa>N(Tj1&ogrbXTf+!Fm?&qkgOT29D>EUhl=M8 zkr<6U(x&^g)TKv!*H{M@XtbbG?oCqO(KKAdG2?KI!zWnkv;61G;hHOAo0i(kvO@N| z%$&3QPn+X*yc4;mw-UFjw{c@i~RFdgazzlNd582?~L6voK z7qC;@xx8Cn&F~*3rM)m!KCR_Vg;R-_T$EXq@&^S+IX-~?WqnE&f+HMn@=*MGijN@q zuKk3&knBV9g8u#T_y!AWPFsK|UJc=xFik4qlijX&z0 zybHk!()$)&DJDZ~Ku8z#kNXPVY^`P6pgZrFyZ4h!$)N%ICs+S??wzWxaKGv& z*AQ6rnN_{z=jPz08Y2oxh#4lM%g4Ia!(3%yLsa*b=W4jSYGdW#204!&fb^k5@`L2D zTItO?-KF#YvT2K(9ur3tp^xXu$z2>^Vs8)7(IyC^YsHnhZ?*7=y!7<;u_?fzh1lH_ zBIx73msHF1T)LtPvZHAUyafU#9Sv%&ij({OoC8=ffoi|WhT)O&ETrN*iDqMTSB$xV z8=6*M9&^y8c9by>i)WZI$O9cuLc62W6eArc4_ z)ue{&ac_q`mRr0J!UR!O-vSq>?J&~!X0dKy=@%6KL1{XR)<|PFvwojjBgN;iCV>vp zQh7ZQXZJ?9h<1QO-&zMil5cL!{(8N#+E5lAjN0m1X4zQa$who=i@LbGL^`z7I+&== z#lf^a)mA?@*5_}j2(i*7l+i!U0TBbng$7SDo_$=pSIpvGH{Rx~rL?bovga(^LcW*V z!e_K7g~aHSR{pw=?St^PfT8QhI^{lh3QVTh>M=Jg`@Ehm$Ie+e+K^#}kC1DqMy*}}iT?B9Z)U$7bk{H`CCYe3~!GH-Y&{G&e-+gG&dv`c+V$K?u2KTqi0Of*PdxQP`5WQ)$ z(A*~p3h5E4{+`%HQZZx|-|+{FvrT zR0+7>M3X)QnD+AP66)>H3pgTsOQbgx=#70^`oDHe9|_crGgeg)H|4@cNQEcWVK)sq zFnfy@6;PW8K=w~!O=&ANnSJ=MTzyJB=W6wJJGqfcFh|bQOy5o`jcZ6a7gpAKPQ*<% zonMz^+pae=<9%F8&SN!-XIXJRGL_wqtKb!iU+d$yxD`u(7Zs8#!}EjB@n6SX10F`V z?v-kZ`ib{)8DyqHw%%d%0e0hTYpt3!3=1uIbh-^9!06wTk{HaR^d<{_(s(6S9`OU= zm|X~x=9?orOH!(#u_>44^rwFs-D@kwC+dq8R4&=+JwMYqPzbl@y%=3;tY^=vtjWrB z|4ElH+RWaIN8=zPeOh?*?Vr2b{~gk=tiNqr0qy=B%%S^-J99i)0~A<94x4mnLXq3n zIZD{@2*em4Y^r+LXvf1K~dZl)$w)A$QK@`&VuOfY~|@K$aBZS3(o- zMj_s!>aMsziCMdFjIU(})p9sTFXDbt_41;sYH03yv1%rKAJyrKq4D3_(`qywj}hyZ z#j_2)$g9~{Rdn*MYO|rnOXolKw0T~9lVEgw1lClZmvoI^sx@@XHV&2B-Sf_mn<(O! zpJs3>p2oUuc(PRLW?jrW_V>b|9n`^l9rzeDtEVB`mK#V87>P$8R+S<*=S!?d;7nq` znc99to$RS?8wg>~XCo&(vheIEp$h`#qa~5l=Q@jrYMP4`8c#g3MAi9xPO^S&_xl`O z0snVYdgo$b*KUsNXtyDw5tS4-ERTZ@+w|17C&Y@0(?fuevY_5yZB&0tRVHBn;hEb5 zAKRZ~UXL@DfmW_fvPtLSCYq5&Z`t(+6x4=hE65LBpBNj^uT8&HkR#jyYJx@SJf%5E zu+-D_+KF7dKeV_PHaQzaz|Bw`wn7+6Qs<^qS)e)lFJ>=z(|Ct9{%p<#*H~?Q#PVgw zfv$zEpk>pD*o`e(H5oLnLkU?tAu;p?RWyB2MA^m8Pjw|fg+uI|Ff!fF*%cDlbgm00 zgo=GY&?!<>EqmZ8hN3FcX^T~LmRhj-J1ab7jo4LEtu+meOg*z65J?i{;rh&bw!0N- zPqe}a4+(On|NEM3KWCv!3Q{^B#qOg(lO^Sph~0ZY!5O^E1*qNrh_N20FO_E2U}Du`=Mz{L$tu#&I)$phQ!dcW#ck@k=>9}j!9 zb<1Fu;96rS-^OvNosH7Km&G}*YVxP#&f?`4xZoDc^&P+GpLRvQuBK~Qer6@?m(724 zjLs&Wi5tM@@6xyhG=OF*uGiGNVoqtBKd|dL_M}pXEmLFQnG4E+1fKGEKKWR}=$FO-=YMj| zb3;ZJB7a(|mblzN^}W7Cvl17t@-O%hu%xYhb_cg)J2{zSJqsTpDDYdWwOgk*3TI zV?mA%Ptu_?!B^9!7E>T|NAN@+D^PL1M$FDa4!n688G(ppSXx4_1sHKzayy5IM;Ss1 z`hq~u**8{39joe?4ZRP~;yAK04?X@3hy=VD5F`upB_)v!;UBUGdViVS>~#XS($G$I zfbjfPG~0hA8QP!*>t5#R>1s3=ZHgjlWs^>OYM}cH-JvLi2GA1~P4a9IKN!BX*WBwT z(B)>5UoXn06m0p=0q1s$=Lk0t4NAP)-8aAoQMLj+ug%FoKrP5b!{r_KnLtj%Wkw&f zA_mAf&op7(6e$J>Mb8wBv={a^`^D#7^!>XdDZdH5J3lG^7qB8eTW~|l;Xe`qy#HS! z;D>{*gol82?4u$l>=hhJ@Y5idDsIs9Qw zp7~{nnE94TT{NAh^7>zpfcis~CuW!vqsv_FL{_I1^D?-mxg5_u@-;#C85YI#KF2{- z+6~hC23*2%Zmu)p5aM;O$0)|0zy8a!=?`0(wx?NwoO7q6X^dIydED{=fw|SQW?9I? zU(ksnXC9naAcV&6Fd5L(5GYR?)YD=fn^f57oQv_jCw42%ENv4PB)SK7*%5(H$KNBe z&OJjDa^)aaQ=@dtrhjSHh%!;PhuX9*Z0W4r|Nf0w{nN(ED8?sMF_!E1X^|Wd)|OJY zY_AE)d{Lwud_LVEbk7YZmeU|a1|7vGIP|{iJ~*T74vZeANA?**R|rbZ7?8$1DB3}mc4tOZPZfwjbCYcC ztm(AHmrQMZ?%bV&Spxr@gY9q+QwI6)ap}2`#nUVzn+j z-)^C7(ss%#)BwuZ7j#}!e+W_tyTee#9rVF3`QyO7v;U0Pd4$%_eFr}|7~0X<8FHr! zI3+aw&qfjXfF?RJUPjb7=#ytziPxYJZwCGME0Hn{s5GyrZfNe*3K#EfV!3HY@MWro ztC6to0!-vaVB65k(ll?i+cVGeO$T{UgTX!bnK-cNA>Top@s)HbGTuuhgG#kbuAnzc zAr)IcTC3oBy4mPHakdPvt>pGhn<1ePcqo5h_NrD41>qYqJP}GjE+9Iz{m1p-ahq|%y48q{yTXQ5*pPX$ zgW}PCW4fNOFYk7GLHsQ0K7Lh$Y5Pbrc86j)&NUKfJqu_)#z2Y&1~|UL>IRVwpdU3v zirbCgo0oZ6m@d)hM|F=!qlRvF%&ciR6>hWjALR1L#D6#d#+s^d4a|~aJjHToUa8^H zs*=gDF*UPnw-!+DIE2Iw)WLPL0V~i_;?jzNS^zIaR0V0konq|5-*VXo4(JMt93) z0N1T?gtXoiW+;M=8uNQ`SL^+($x5COM9u}1&(0Me2Y+HH3Et-+7fbZ^neM^2ER%^f zilA&W{WP3Wc3wq&@CilNzMSvMyiw{O9@z0z>`CS)$CP+2N`&lDCA2fH@^8)P2+ zhg0`^4%Xk6G@+NGS$%#biy5!?62DEZ0xeCpbMQNUxC0$(%jg%*nhd(Vj&|hW!KVh8 zw*L!K?M$$=C_+H-pRO9NTAK+_pBbg`y{1c(cNl&j<-AEfWz^n;DMJ$0?Q|Fv3MMSj zK^ih`=rQM#KKEiI=rh)Py6PU^!Dh1I1clBZbeFnui|A)eDf@J4=Dnq#x9Ou%aA7Ib z7k?9$+ozD`IXbVZPGS%5N`5mH`VWz>| zJhssX%G$uh;q6mvz<-2X+hF>;EN3sfD`2h((zzbPz-3a>g4vP>b0S6rOAE@mH>@}F z>ah-yC$bf=4TTz|GjU;m7mo(ldq;m5a08?Y3il%E&NkP(rcs6oJW+-j1x1e0fc0!? zS_+GNZyUtgjI=f1j^qh5skldHiajfDUoY5TdNrWE>Iav4np}j`x&&|Rf;(bBI^FL`9mQ@R(ije2Vnr_M%^vN*`$^VjEqrYTkjIIg=U zKUN1)==)$y(|k2*^WDy5(?d&tb6ReOyyxRRlraekz<(Qz;iq0t znhInlwK~&U5>2gK85qxe0WY)240Hf)ssvO)h}u|pC>nQ;gM_%-qRe;?75&ELpWd@H z)$dOO!;osPC>{fI^)k(m2P`p?>>07QxquWmt$spqW_R4Uu8BmK^D>uhonAdfWFWT* zx&6+;C%+=sb=YXD$!MnRfi_a*aZ_9_iI_b(zWrP(m0e380Ypd46pzQ29IRJ!k;L^l ztNG9+Ol84dHU?w-@LEiP-Ew}VvKgO8ptT+5{nXEjda__<`W_1(K<>rYd7oJ~Tr)_A z`V?8a`hQqwS#GL>sQrkqkESJ6H08s_ODWw+gv9gBxnf@-5CWlbw=*Wg0x z`DuH@%39f7?x=U1m^AT+OV+6qaknhG@B}m%X}10P-@p*P$0>lP*>_#uPt?o@!CviX z=V4$#1IO1IatH7OLCnsF86bla_k`(}9n2ThF+XPLw?{VL zkVNwX*^*mf=nID9{(in)a6TdCPL3o{VTG*0Ql_G`ar$AF%#l+o;ew=yaqcG^Cy)X; zmZ$szw~h%`9v^e3G_W%lgzTUtYt_qQ*h_tCX=?ijYn{$Ydy{lDWw*V4R*ZGli-<9T zEM5xGa)MyDxY`k?uzh!Q7@{}P5*LXr*@Yu0;V=#G*Zi>_+dw37rJP1}rLyw_i87GV zTMq4{cM^gkU_fxtGu7avWI!X7Q2yYWEkF5Pb<_JV)&u455T6%+ z61&@zZLWk8LJYB*A5+42yR&|h8CvBlPMXq-e8<^uxfq040e9aC0s64nDOM-0je$7t z(&8@xi8_~eouJi~Yk$&PO75^XCLE_fvc#6HXj4sku=L|aafmUG{rup68$-iPrX%-+ zGl|j(!h-A?xhqStuXm5Fc7PMdR>YY2^!xb*!Sj>R6rB7=As_!Q_RfEaT3iorEi&hQ zaNakmwyHq%ILH*iEf0?f$k;e8r!h2F$FD1W0UWl23&>%6ewNE1e;oX~nKTsldZPeZ z-Cgh)c3Zo>lvia{{L@Uxjs%wFt$osNudb|akqK6*$d)O6J_hE}?C^abF>65n!HtXT zB!mV;70MFN-0k+`3(U+gN=1u@aOhOF?yo2LA-#tnQ_t@1jTW*A&=I@;t3Nvj3kD@UGt%>(f~L>X@sc z-cs(m7zUA(X?>X2;jw#h(!=Lm@Tx(U6CDUd?q zlK=I5YXWO%4GX02pnZyvd9aG`iiFgWj#%PM~CM36_@<^jK| z9YnLsbo;Z-&vwKJrB9>?5_@KE9-7h+Zd$6u_qe3DCp5e`1(P;eE}QFbJbrf)^l=!5 zlx;xWpp;p>;1mq9h&!YCxwIl*aJRIGU6;;Z5C1P=V`$(P<4$)~;(;}Zwod^biC_8) zNSgXo6-xv<(?ZqKa%ufyL2WzQu)q{H8CU8znIz{}MFK&k;fKT00&&J3C?n(zX&eih z-^mX8WRz%}9!jc;yFBvlwOFZwAF&2X-WUp~aH_{A$zvf>GYVsLLi6YGKtqp^a0tQ6 zwt^zjkRvb)i4-l?@Qhw6p)sP`u$2=lVI;_!3-$XTA{`Z%mXcho4om9^H|P29>R!m@ z?F3r@`-x-DwT96R2DZ`OuA%+roRQ8kxi1z12x7XPfyI**qX^we@0|xVmj2wvtgG1d zE;+w@6*)gq$~}v7%@!%Y(?$1>#9AOKo)INij{?9C{{`11Y88T(4wjOj zIvHhI4jA9_mG8)^ZVdW6Agb1Jrzs6HZ^xGLdftCGkRl}|SH4Qp2(JE&yt;<`_JQ|# zzT8HNcUqAR+30pUDa501B$D%SX3V8=R^uO5Z;lF3j_BOtAKE1&af>1`HCW#pK?1!GQ_K)Y#uS;Qoj*{}B#V4P?c; zXP>OjJ5k?spFUx@EW6tz=pcd5G9o?|EX7i+@Rx6`^cko4fpcrk>FIPG^q0(&{f>Go zciO44T@z&2y0~rU!Fl1IoCPXooj5(g=~18o;9u@{X5LBYXMw6YX3~Ha7If+l03Xbf z6Y=(^RW+<}UT6Tsy8tp+-3?33hZZ7;b-GShnMAGV4b8titYO3r2IbwW9>hUf(@-*g zBa3FYjPtrlhkEmnVYvtKiFYQ#VTL1(v~4=(3ky}4LLJPyg30kyQrA}Zi> zm|BsklxQX`b+J|)7#W&`gK1twzyK()31hjAc*h z^4kRh;DpyqC$6ZxNelTdIRAF`Zd%~Q33U1Co0HZ@+R<8l$~l<_DnX;+@F;(oO;;m! zLM#7+;&P5(zLcOs#>d}DndDuq)D~#0-_S&B&HFCC2CSc;q1`~#a1!Z?;E_M*X_B6B zhQP$*q2Y2-oAFTi$#je9{$LEYQwY0BQII&)Cl49!@=27Gg~J)V=bj3$p2f^>sj(=P zidnzc!7Zx%0_Ge7rT}?_&cIazVBVn3^cH!K4jzMQ8gC*eXo%xXW)xZL<^@)idSEKB zwU=w;!M829yBB`2Lx%dnB7&mhfzfb5Bzc3Yyjl-r!q63}#?9;_ac(oRU1Lb6GJs}I4fh|P0(}|0B;UYz^FJpleSr2LT<_c=GV_Mk{rx+}@;#@)$D;O|{(Grf}wt zoj~7MfAT*0K?*z}g^9#Q0EaN*pQ+sC#+k>1O)Akr6Oq*JNsR)%>&CnA>f)XqB_M|4R8foNlqR|e zs%psSLrd9PPdt{B{$!C^))H}dn~lDZD|)O`uG?y(NdZy5zV;=C3mp)DFkSn(ejqPZ z5m@m$znDCkaL>mGIk`b3G?2#4U%-rn+QwdqJ8%{!tf7n8r(_QL@6#cYSvnGNM}l*& z?FvC*T*Xs>8E)h~7B+E7nI}mBjU0s%`?nRiR|QZ_cvqYQ{0lQr+G)AB^haMV$4fpK9$cmt8 zr@0@8M#d_fCm$MMV1btk*bz}%Pn35H?RAkQr%D;@wC|#}dHA`87u-U=aJ5)qkNEVu zBZL#247y)f4JpAWEVK3jOPJT?Z^_UU91+l2MGGWPT1s~ZH@U?r@JTHdJ*D8oA6go= z?V6igLIG*k(a(^9bC#VDaKI@`un$pOveBrJ!(yfrNFP)A@~|#fA5Ne|PlB#{wfg5e z3oY(R=OXYXZ(P5jxz<&fxaRivRR?ndwT&p))4ig*z&9IlId3d>xL$zT^?U|n_$Y)E z=?W;NFR$LLh4HMcd#8F~=t*Z;KF2ZK?E+r5W$VcSsHLt5)+jszMUT@&!BN6B7jx5{;QOH(^>)+*>~uvRgLlX+6Gi@ zEZr4OW9so2;B;BPOLa+2xvO-e5=ps((Vv~1m6F7M?o-D)B4fJ^)+Q+0!%F-c^_$Gv z!C69T$3zVU<^H`IOIfNz&X94iv}@CDK*-Iry2~J-xhk^qNC+}eZeZqw?Jn*qjv7>>+O5?GYgY4n0;syTM?^BXufDhh>uOhRw6907ns~5W|W8O;; z_%mu50-wVq4bWF>4j`9CEpxCBq%A|J?xVujsh=MJSQ6BoB-fynio`&cbKPwm(%xRd zs0pL^6w5P8BlY^k0XJt}&zWklq^DV*{M2rg{6rc2VezlTWj+ac??UIbAu&;5lMECu>24zLZh)N9!O0G#KRVdg{q!-fLO~+OCH2y=04P5?kb}$ zNC~{t?qJb$N||?r`(%c?N2?F?|5H>O5RJ->Cz%RIq+~{90ouq@(A%;|S zc|$zBl$kVKIO_4H)x7kOQ^Cqg$?Q$rho6GCz~(0!Y}vlQ`YXlSsP5KQ-ko!uaNG%kuK=^|oGtm7alL2lgCAo|_hfq{mDS zW4n3(Y`{7%6u+jbc4s?Ex{KTjGV;&m?GZU^)sT-4lT6>gje%vP$4z3YAuFD=iM3?| z0uDI{g%hJ=cPT(~UGExa&yCC{Ey{r~-kcmYUIR#ebHPQZ{Qc zLJqpkDILp7n)gbPlTw)#R@t5MCDVVvBaMC}A^#coMrCM=T=mAL>si83u zI*q}^bhP;HwHQU7QX!#NCI~mD;4ya0bDC(n^P)*N8u7h{7b~vnhy~cV9~Q2rX`HR41c_IBu+f+_igjN z-nYm%2Sym8$tjp{c3*ug6`8u`Hu~_~ZV23N2PR5ldhiiebWo5sP}?;8GmP7d&@T1sRgW8^tSAOI6 z+qvOq5!L4==I*aaofluwY&pC%DU`59o>&>P*k6H2QJ2hWP&k{~xcw%ag& z7nenW>YMO>C!0Ib;2bTWc`&#}8q|wUnuj!!R&^`M>XF{+bym-zI& z8U!y1Qy4(bSwha=`CfS^F|3mvC59#Kid)MXP*)8gQmwl9dtxhAL#Rqo<3+@G~GTMN!?Vey}p4NiK)APm}zK_xM|5^+bYJ}B<{ha zk}qLX?qXc9{pF!y=&$UQ{*@kZ)IS{s4$2;Z6?6bCpI9S8dfZs z8fJB0hg5Gaqi#6o{RFbT5CQXr=Lj$z=#56kuw58{P9LY*P3E4QSZ4qKmTW^D=x@6 zgp$G&(h}MOq6a>-N?Nb^c~M4vZ6PxH0bm zmlSI?MjH>OedtK2}=l%emrbn02;!My=js|BU|k_Fw@Xpe{DQK!-eZiUkZC3B6#66EKcMxpzCGCb?_zO-`-S&s z?BJWpEYO2Xkl_qmLUW)SQ(w-{&R)iSY-ZU+v&x}?rDjp_;&K=Ht`}|FxIM%CH)>4Y z2LHjG5qd*)R7lH*A&+LnC-8?Wmw%T{iaNu|Qdb}^iUv*;VlHg*i7>=j1lKe3?)Gr0 zq8wA0JLY6RVS(~HGg!y0WEPsi-avmML;8pqmIHqnc`>k;_SKTSl)7_t+W}Z~; zM|x;I&9>3OYeK)vjhSa+3|c9X^7*kcvw`HMja@_aDwb)mlsSZV%BNg_U<>b;sEq83p<{^h_-T`~;_tEmmiLo0aOlVck)!&xt_8gRp7;*e|kg+A~^64OHGcVLJWh zjc?#S`l5j6aNa((u~RdLW)I~s(Zh@3NOl>4%?|nxI*@^Qo|Tc>$5u8<+fk*fS21i7uc)blwa=?r><0^~WIrZWUed8F>N<=x_^V!IlAHl% zW$Y^aFq1~3EwFALx3B4uhNTv5EYOTniNA-YLF_zp_d3qQ#wj9^e$bBC+ZpVpc^d(Z#& z&+Lcw?Xldr&t%-3a~88}*;=XCaj-Y6X%9R}! zuelH1u*1=+nX?XMDyE9c_dl_QG0PTT zW5;YxJ*odL@8O#<)SqO3GuvK0NC#j;*(%l%a-)+ohUpCAmu1Y;qbwUpnh!QUEn!Kb z?nKI>kYdEtqhkV#qxPvwglHHeeP{1@#3!}0FAno8+ek(sl0@boSG^FP90}f>hx=Kb z$%RdYb{~s)@$W9@FTBq(diiPNv~P<8Fwz=s1apteUFma9m-pdxckS#sDTKa#rLPl@ ze$yasRP>T{3vOS8I1CFs#H)3Ep7-z>1Z}VEv6{6m5Spi#6{;apyMwYta6b;)abe17 z9Y@%SdmGxhMa!MH`CR(V;9O;(Pg`JlLd(E0jGCb3wVFQtVe1j~*@_S4q^a2@MyEdp zaNc7JX?bM1P%Y#K!l|OlLY@Ga?1g9Rs)53O7UzG%$o7ebe0Amp5FI2%BLP5`MiobY z3#ipyB~|b=c4#`?c!TCs&q6L8`3d%=R2Lo?zLBb;D?jKSKD{U*s*z44ke#GNpH{r=u8}c zWo>o#J=!|ehs3@fil<7&vG}kxAk%b=@5FDHQl6;=wG17X5P*yN^Ix^DLi9lcx_;TX zlV-$jtoP4X?D*8+Bg7AfO|PJzG{cFrb@ZujcjP+aBip?4w^j9-ASRfA0Q8s~tebrbxH5H6qkuk+(m*KMagF_6!YSXzf znwus52O~OG=3^sEKLQx6H}Tv}f*r#alVPPkpu6JEk<5N-5C6zYL1>!Nvl?<9dzR8p z5jhthTVvU3j}yDGx!q{uk`%1o(CP*$=tMpXJ*Wod!<-F?%Ot2DXolgR;&fSl2D^^& z-w53MF%B9^Rd$yxjNLW}HD>%uBLEPI%C3M8ZMr7;8oQ^mVf zG_2A&h79Z(eC zv4cW2F$3LvvAuLw#crMj`IVncLccgA)lOkWux%Mq5@+9PL$kCBk;rG?L!`u~F7&g- zVaQdaZAc0U*)0v-AffxSJO1M`2aB8MHHx-0$L80QCEt{7kW@FEw`|>?3BmnLm9aHp z_Is;g2W8S6_|K>A992tMVga;Xc++l-WY>Dv48!|2R+X;E*M>@$zP$YGTV$kzDUDN1 zj}7^4Uy#BS1NW;UiMu>J(`+nzb755MThDJ&dcOMU`Y!X3PQl<0*DK-&>5}1NyEJgX zQ=Pl_Ts{`fC5pJWW=Q3o3Gi^ay0=OJeFoV!^)!4#M_Lo`&-q%0Qj#=2%I~Bt(=cKf z{Q^V8olBVY8piKjrCXh8KYUUqK#uV>Rd{QQH7E4YU!rT;M|S^8pLJ9ox@?U0z2JG$ zL9yfC%&AU+m)Hg5gTDnL-qYLNV12;l-*wV%y*01R!4u2o#v{VRQ3aafl~XM@HbnNabo zWA&W&`dq74A5TSfU3UYnEn(}Z4S7jfe^5=qi>FWI*%lX$?nz5?tlKn@+2r`fXZyw@ z)p{D|o8iCwn{7#)rI`HG?6v_~o$Z@rBtrCf6dPRoWRTF-|44I8aSDL?x8TS@iUg^j5dDX=kKl zla_R9`5$qp??>5XTJWXm3=)QBUcQZmftBt1I$W<%I*sQs3mV_gp4NvU^zEJ_*`|*N zuox7R%u%e|mPanAAw(qD_61IKJiH^#Uy(Qe%;U*u=AuGSU-|PybB^zALNirbme9jG zC`;74u*-Dc@)`IZqqSM7(q-`;dxz2q!{{#w=>)#RiryIq==$@fg6u++7b#k-wI?GL zer#;k0`UJF`)oWc9u_&#N@1a5wq)>`1B17Ub8Zw%NDmORs+;yqf!vv6ICk|`ipqLd z&%z=~ZNU3nDaI^>J8h0yFTBwe?AW?h*hTW?7al7GCdFUVT?X@Jjr!TrnMoqJo$C>x zFbPiMr7m#yOSw5uePM&fSOkPq)4tRARpto);_WD2i=t$QkfP*%o#7^1!WHBV7e@}f zj;RyICPXU7T^tWqZs};ZN9aFurRxS2gLJA{h_F5n*74Tb{tE^bpXUm6&;xY|xr1vz zy~|s-=^j`WW`BJ<^)+~uOBMkM$5k79Nk#=aG`iUfil=WESf60SKZ~lR6DXn$`PsEH zy#*aR^V3#BI~a*@a(&2@%i~^!5&qZd7?^5FOmhFr46|zc+Zvof>f9PsW6NDM++F#? zx?@6{YyGMj%2g*swv4PjiCXcx?zoH+ z|98m?+n}4f@Wq0(1#gI_hMx-tt$qH@X)j*#FpB>eQ6ZA5e3s0xyGRY)bzeGCKK^3K zoOGWZR&}`3+-N<+r4V5`^m%><@lbd4p5sj9D&q7oH%NO?j6!#fj4B^&IdsQg6@G0> zEpvY&rCzcblUB!kZiIyb9IwSuN+i}Q#d{Q)GChihC>uMnKll zHkTqw?fgu#!-%59o#(EJmOvZ-juy+)6PVHO5Agdx^pIP9@Z`)|@R_)K z?d8Sg$X`w8!6mt33z0SLk1=zDm~&8CYS>OgYd4#s3vPA=cPs8-Fk6D~j5w$Ft}?*K zkC;w$E79VX5H7E;gjw#uh81nPSlP4Rl$Y&5oc;uW_TfA*)1_ zrkG!o3V|E9G8jdY%Z#DzFd>EAxXV-Z4d5`hrapOM0M!X-u@c@2CO z^3y{coe-p9!QOP=@B8iT^!>OBDpll3(Ws0sw&j0_W~Dga7~l diff --git a/data-raw/gpt_training_text_v2.1.1.9191.txt b/data-raw/gpt_training_text_v2.1.1.9192.txt similarity index 91% rename from data-raw/gpt_training_text_v2.1.1.9191.txt rename to data-raw/gpt_training_text_v2.1.1.9192.txt index 710ec980e..6a941fc54 100644 --- a/data-raw/gpt_training_text_v2.1.1.9191.txt +++ b/data-raw/gpt_training_text_v2.1.1.9192.txt @@ -1,6 +1,6 @@ This knowledge base contains all context you must know about the AMR package for R. You are a GPT trained to be an assistant for the AMR package in R. You are an incredible R specialist, especially trained in this package and in the tidyverse. -First and foremost, you are trained on version 2.1.1.9191. Remember this whenever someone asks which AMR package version you’re at. +First and foremost, you are trained on version 2.1.1.9192. Remember this whenever someone asks which AMR package version you’re at. Below are the contents of the file, the file, and all the files (documentation) in the package. Every file content is split using 100 hypens. ---------------------------------------------------------------------------------------------------- @@ -732,7 +732,7 @@ THE PART HEREAFTER CONTAINS CONTENTS FROM FILE 'man/AMR-deprecated.Rd': \alias{ab_selector} \title{Deprecated Functions} \format{ -An object of class \code{tbl_df} (inherits from \code{tbl}, \code{data.frame}) with 487 rows and 14 columns. +An object of class \code{tbl_df} (inherits from \code{tbl}, \code{data.frame}) with 488 rows and 14 columns. } \usage{ ab_class(...) @@ -2287,8 +2287,8 @@ The \code{\link[=not_intrinsic_resistant]{not_intrinsic_resistant()}} function c \item \code{\link[=cephalosporins_3rd]{cephalosporins_3rd()}} can select: \cr cefcapene (CCP), cefcapene pivoxil (CCX), cefdinir (CDR), cefditoren (DIT), cefditoren pivoxil (DIX), cefetamet (CAT), cefetamet pivoxil (CPI), cefixime (CFM), cefmenoxime (CMX), cefodizime (DIZ), cefoperazone (CFP), cefoperazone/sulbactam (CSL), cefotaxime (CTX), cefotaxime/clavulanic acid (CTC), cefotaxime/sulbactam (CTS), cefotiam hexetil (CHE), cefovecin (FOV), cefpimizole (CFZ), cefpiramide (CPM), cefpodoxime (CPD), cefpodoxime proxetil (CPX), cefpodoxime/clavulanic acid (CDC), cefsulodin (CFS), ceftazidime (CAZ), ceftazidime/avibactam (CZA), ceftazidime/clavulanic acid (CCV), cefteram (CEM), cefteram pivoxil (CPL), ceftibuten (CTB), ceftiofur (TIO), ceftizoxime (CZX), ceftizoxime alapivoxil (CZP), ceftriaxone (CRO), ceftriaxone/beta-lactamase inhibitor (CEB), and latamoxef (LTM) \item \code{\link[=cephalosporins_4th]{cephalosporins_4th()}} can select: \cr cefepime (FEP), cefepime/amikacin (CFA), cefepime/clavulanic acid (CPC), cefepime/nacubactam (FNC), cefepime/tazobactam (FPT), cefepime/zidebactam (FPZ), cefetecol (CCL), cefoselis (CSE), cefozopran (ZOP), cefpirome (CPO), and cefquinome (CEQ) \item \code{\link[=cephalosporins_5th]{cephalosporins_5th()}} can select: \cr ceftaroline (CPT), ceftaroline/avibactam (CPA), ceftobiprole (BPR), ceftobiprole medocaril (CFM1), and ceftolozane/tazobactam (CZT) -\item \code{\link[=fluoroquinolones]{fluoroquinolones()}} can select: \cr besifloxacin (BES), ciprofloxacin (CIP), clinafloxacin (CLX), danofloxacin (DAN), delafloxacin (DFX), difloxacin (DIF), enoxacin (ENX), enrofloxacin (ENR), finafloxacin (FIN), fleroxacin (FLE), garenoxacin (GRN), gatifloxacin (GAT), gemifloxacin (GEM), grepafloxacin (GRX), lascufloxacin (LSC), levofloxacin (LVX), levonadifloxacin (LND), lomefloxacin (LOM), marbofloxacin (MAR), metioxate (MXT), miloxacin (MIL), moxifloxacin (MFX), nadifloxacin (NAD), nifuroquine (NIF), norfloxacin (NOR), ofloxacin (OFX), orbifloxacin (ORB), pazufloxacin (PAZ), pefloxacin (PEF), pradofloxacin (PRA), premafloxacin (PRX), prulifloxacin (PRU), rufloxacin (RFL), sarafloxacin (SAR), sitafloxacin (SIT), sparfloxacin (SPX), temafloxacin (TMX), tilbroquinol (TBQ), tioxacin (TXC), tosufloxacin (TFX), and trovafloxacin (TVA) -\item \code{\link[=glycopeptides]{glycopeptides()}} can select: \cr avoparcin (AVO), dalbavancin (DAL), norvancomycin (NVA), oritavancin (ORI), ramoplanin (RAM), teicoplanin (TEC), teicoplanin-macromethod (TCM), telavancin (TLV), vancomycin (VAN), and vancomycin-macromethod (VAM) +\item \code{\link[=fluoroquinolones]{fluoroquinolones()}} can select: \cr besifloxacin (BES), ciprofloxacin (CIP), ciprofloxacin/metronidazole (CIM), ciprofloxacin/ornidazole (CIO), ciprofloxacin/tinidazole (CIT), clinafloxacin (CLX), danofloxacin (DAN), delafloxacin (DFX), difloxacin (DIF), enoxacin (ENX), enrofloxacin (ENR), finafloxacin (FIN), fleroxacin (FLE), garenoxacin (GRN), gatifloxacin (GAT), gemifloxacin (GEM), grepafloxacin (GRX), lascufloxacin (LSC), levofloxacin (LVX), levonadifloxacin (LND), lomefloxacin (LOM), marbofloxacin (MAR), metioxate (MXT), miloxacin (MIL), moxifloxacin (MFX), nadifloxacin (NAD), nemonoxacin (NEM), nifuroquine (NIF), nitroxoline (NTR), norfloxacin (NOR), ofloxacin (OFX), orbifloxacin (ORB), pazufloxacin (PAZ), pefloxacin (PEF), pradofloxacin (PRA), premafloxacin (PRX), prulifloxacin (PRU), rufloxacin (RFL), sarafloxacin (SAR), sitafloxacin (SIT), sparfloxacin (SPX), temafloxacin (TMX), tilbroquinol (TBQ), tioxacin (TXC), tosufloxacin (TFX), and trovafloxacin (TVA) +\item \code{\link[=glycopeptides]{glycopeptides()}} can select: \cr avoparcin (AVO), bleomycin (BLM), dalbavancin (DAL), norvancomycin (NVA), oritavancin (ORI), ramoplanin (RAM), teicoplanin (TEC), teicoplanin-macromethod (TCM), telavancin (TLV), vancomycin (VAN), and vancomycin-macromethod (VAM) \item \code{\link[=isoxazolylpenicillins]{isoxazolylpenicillins()}} can select: \cr cloxacillin (CLO), dicloxacillin (DIC), flucloxacillin (FLC), meticillin (MET), and oxacillin (OXA) \item \code{\link[=lincosamides]{lincosamides()}} can select: \cr clindamycin (CLI), lincomycin (LIN), and pirlimycin (PRL) \item \code{\link[=lipoglycopeptides]{lipoglycopeptides()}} can select: \cr dalbavancin (DAL), oritavancin (ORI), and telavancin (TLV) @@ -2498,9 +2498,9 @@ THE PART HEREAFTER CONTAINS CONTENTS FROM FILE 'man/antimicrobials.Rd': \name{antimicrobials} \alias{antimicrobials} \alias{antivirals} -\title{Data Sets with 607 Antimicrobial Drugs} +\title{Data Sets with 608 Antimicrobial Drugs} \format{ -\subsection{For the \link{antimicrobials} data set: a \link[tibble:tibble]{tibble} with 487 observations and 14 variables:}{ +\subsection{For the \link{antimicrobials} data set: a \link[tibble:tibble]{tibble} with 488 observations and 14 variables:}{ \itemize{ \item \code{ab}\cr antimcrobial ID as used in this package (such as \code{AMC}), using the official EARS-Net (European Antimicrobial Resistance Surveillance Network) codes where available. \emph{\strong{This is a unique identifier.}} \item \code{cid}\cr Compound ID as found in PubChem. \emph{\strong{This is a unique identifier.}} @@ -4508,9 +4508,9 @@ These 34 antimicrobial groups are allowed in the rules (case-insensitive) and ca \item cephalosporins_4th\cr(cefepime, cefepime/amikacin, cefepime/clavulanic acid, cefepime/nacubactam, cefepime/tazobactam, cefepime/zidebactam, cefetecol, cefoselis, cefozopran, cefpirome, and cefquinome) \item cephalosporins_5th\cr(ceftaroline, ceftaroline/avibactam, ceftobiprole, ceftobiprole medocaril, and ceftolozane/tazobactam) \item cephalosporins_except_caz\cr(cefacetrile, cefaclor, cefadroxil, cefalexin, cefaloridine, cefalotin, cefamandole, cefapirin, cefatrizine, cefazedone, cefazolin, cefcapene, cefcapene pivoxil, cefdinir, cefditoren, cefditoren pivoxil, cefepime, cefepime/amikacin, cefepime/clavulanic acid, cefepime/nacubactam, cefepime/tazobactam, cefepime/zidebactam, cefetamet, cefetamet pivoxil, cefetecol, cefetrizole, cefiderocol, cefixime, cefmenoxime, cefmetazole, cefodizime, cefonicid, cefoperazone, cefoperazone/sulbactam, ceforanide, cefoselis, cefotaxime, cefotaxime/clavulanic acid, cefotaxime/sulbactam, cefotetan, cefotiam, cefotiam hexetil, cefovecin, cefoxitin, cefoxitin screening, cefozopran, cefpimizole, cefpiramide, cefpirome, cefpodoxime, cefpodoxime proxetil, cefpodoxime/clavulanic acid, cefprozil, cefquinome, cefroxadine, cefsulodin, cefsumide, ceftaroline, ceftaroline/avibactam, ceftazidime/avibactam, ceftazidime/clavulanic acid, cefteram, cefteram pivoxil, ceftezole, ceftibuten, ceftiofur, ceftizoxime, ceftizoxime alapivoxil, ceftobiprole, ceftobiprole medocaril, ceftolozane/tazobactam, ceftriaxone, ceftriaxone/beta-lactamase inhibitor, cefuroxime, cefuroxime axetil, cephradine, latamoxef, and loracarbef) -\item fluoroquinolones\cr(besifloxacin, ciprofloxacin, clinafloxacin, danofloxacin, delafloxacin, difloxacin, enoxacin, enrofloxacin, finafloxacin, fleroxacin, garenoxacin, gatifloxacin, gemifloxacin, grepafloxacin, lascufloxacin, levofloxacin, levonadifloxacin, lomefloxacin, marbofloxacin, metioxate, miloxacin, moxifloxacin, nadifloxacin, nifuroquine, norfloxacin, ofloxacin, orbifloxacin, pazufloxacin, pefloxacin, pradofloxacin, premafloxacin, prulifloxacin, rufloxacin, sarafloxacin, sitafloxacin, sparfloxacin, temafloxacin, tilbroquinol, tioxacin, tosufloxacin, and trovafloxacin) -\item glycopeptides\cr(avoparcin, dalbavancin, norvancomycin, oritavancin, ramoplanin, teicoplanin, teicoplanin-macromethod, telavancin, vancomycin, and vancomycin-macromethod) -\item glycopeptides_except_lipo\cr(avoparcin, norvancomycin, ramoplanin, teicoplanin, teicoplanin-macromethod, vancomycin, and vancomycin-macromethod) +\item fluoroquinolones\cr(besifloxacin, ciprofloxacin, ciprofloxacin/metronidazole, ciprofloxacin/ornidazole, ciprofloxacin/tinidazole, clinafloxacin, danofloxacin, delafloxacin, difloxacin, enoxacin, enrofloxacin, finafloxacin, fleroxacin, garenoxacin, gatifloxacin, gemifloxacin, grepafloxacin, lascufloxacin, levofloxacin, levonadifloxacin, lomefloxacin, marbofloxacin, metioxate, miloxacin, moxifloxacin, nadifloxacin, nemonoxacin, nifuroquine, nitroxoline, norfloxacin, ofloxacin, orbifloxacin, pazufloxacin, pefloxacin, pradofloxacin, premafloxacin, prulifloxacin, rufloxacin, sarafloxacin, sitafloxacin, sparfloxacin, temafloxacin, tilbroquinol, tioxacin, tosufloxacin, and trovafloxacin) +\item glycopeptides\cr(avoparcin, bleomycin, dalbavancin, norvancomycin, oritavancin, ramoplanin, teicoplanin, teicoplanin-macromethod, telavancin, vancomycin, and vancomycin-macromethod) +\item glycopeptides_except_lipo\cr(avoparcin, bleomycin, norvancomycin, ramoplanin, teicoplanin, teicoplanin-macromethod, vancomycin, and vancomycin-macromethod) \item isoxazolylpenicillins\cr(cloxacillin, dicloxacillin, flucloxacillin, meticillin, and oxacillin) \item lincosamides\cr(clindamycin, lincomycin, and pirlimycin) \item lipoglycopeptides\cr(dalbavancin, oritavancin, and telavancin) @@ -4702,7 +4702,7 @@ To define antimicrobials column names, leave as it is to determine it automatica The following antimicrobials are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://atcddd.fhi.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) +Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), bleomycin (\code{BLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=L01DC01&showdescription=no}{L01DC01}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), ciprofloxacin/metronidazole (\code{CIM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA10&showdescription=no}{J01RA10}), ciprofloxacin/ornidazole (\code{CIO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA12&showdescription=no}{J01RA12}), ciprofloxacin/tinidazole (\code{CIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA11&showdescription=no}{J01RA11}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), nemonoxacin (\code{NEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB08&showdescription=no}{J01MB08}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), nitroxoline (\code{NTR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX07&showdescription=no}{J01XX07}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) } \section{Reference Data Publicly Available}{ @@ -6386,7 +6386,7 @@ To define antimicrobials column names, leave as it is to determine it automatica The following antimicrobials are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://atcddd.fhi.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) +Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), bleomycin (\code{BLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=L01DC01&showdescription=no}{L01DC01}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), ciprofloxacin/metronidazole (\code{CIM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA10&showdescription=no}{J01RA10}), ciprofloxacin/ornidazole (\code{CIO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA12&showdescription=no}{J01RA12}), ciprofloxacin/tinidazole (\code{CIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA11&showdescription=no}{J01RA11}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), nemonoxacin (\code{NEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB08&showdescription=no}{J01MB08}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), nitroxoline (\code{NTR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX07&showdescription=no}{J01XX07}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) } \section{Interpretation of SIR}{ diff --git a/data/antimicrobials.rda b/data/antimicrobials.rda index 1f44d06ceeef06b2dec88cf24bb8cb26db856317..55e39d5a85759c9162511e0117cdb17f892cf17d 100644 GIT binary patch literal 43456 zcmV(jK=!}=H+ooF0004LBHlIv03iV!0000G&sfaks@JK5T>vQ&2UJ%gRpOV>D zs)9rkVDrO9@CKe(@YECUelWOVArpCN)-b(j#!$c1X{{im2F3-PJgMSu$(5;CeP6m6 zT>4h7aS~!Mq3_ZVg{ekFTvKMYR&(qB5i936Fry^lh>*0p_batRm$N}S!8YxWyd`QL z4Y(PMAqQV;(WO*j1dvL*n$7Gb zR@wtY2(P?l;8-IKb8 za+1(WJg@0`0}Mgo5pLtYj||Qp&V{^puqXJHIA$O+?14A$s@U;4PHE>;?H96P@K~<5 ze6c@Xoha!*ihfISM)87ph^s!P)$_Jdzp7g9n!UJNXI}A7 z?@@OfIlpPTL|F;X`0t3Ofx6+-Y$VOJQ_=*t9>+tr20OtKmBY+#%BOTCgYYXca1kXE z>hODqtCu&0O*TThgZ0~(!Rpi3<6r@(0jdM7)&*v?5y?8XP^pyd-|%T)+D>$lH4>v~ywmKA zSgLS*jP&uGaT|BpJv-r>m3On@NoDLSQQP?iQd%tY2g; zDP_(wo-BsLJR41eo=*^g5+w;_UANWA=5Qvdv!6DV8Bzm$`$@*dkn?DO#zzH?2_5lv zX9*1bJU?6cn6>`XBS8qZ7`zsKU}iCm+E9z<@zIsWl3vjqK(vGh91V+li8dLNi(Xr( zJ_V|v%|xm_iHsLQt-W9k<>gbLe!vUd*!(ynlf;=%Oc*Zn;EGI>V@N;^ZWRv|(&zvR z?c%u4M>R@!#>ec)sg#zl*gDWBv=FE8uibs7y)-LWFJ1(QkQ#qfC z)Rv-ws8eqnT%s(3NjslV)M-jCH51*BIFzW|b)pZC59|uJMvZ|?o`e5&osclezb@a9 zs>QO6Pg{DU-a$`&)m;Apw9w(>Y-#m3G-x89S7YkEQkiLT^pqpaawkW|v@@ZQ*H5|+ zBmWRZdePbD-#ti4Wb)72KAqkKumfSrLK@RuGyTF4TLaIHVkTeArcMJO_dzeL&?v{X zv(aSA*U|zthy=Zh=UACniVNLG&R=!+asK~Glyg<6K>-AJF;I-uaHI-UN6V$!_f z<&4&U`GP9=hmM5yQP%Z$O%EiLot&-B9M?PalZIo<@>7OZpdO8bHqeHI>FA39QX=M= zf*>#xukr{NC7gYc%m>p7lb&2mxFt>r->#*rQ~LU(L(EHxMB~{Jh_wh+v`(2VNcd!C zmaKTOlPqMEwR&&t0b~BiMxjQ^iiZA_EgY7X4Vpoyfw_mzev`#SVOTc(ZzlyGjA&p+ zqh&n!0NLS=!$}9(#c>f&$W&n2XGR$ub@<@_ZA;DmnwWzqP}fdB!jicL2k(0#{~E=S zIWEbiAO33xSg4Kg%G>mD8+I^vZL4_(uQyN7t(45IX+a(opREt%9*9uH8X&Clr~4N$ zd%;>!m&CeWaMS~AkI&%BOc{kuARVKXIhn}E!z z@5H3P12x?1%$$!972LsV3UQeTrh8D%hi%uG_shJB%79d?GZS=vQNPk2o9> zQz(L!fdB(fpVo`ve-h%}rAfGMp*R>Huv{O2ofkK;gF=5mL*Sj=s%mMJlR=2-9oAI7 zgaB-HAxhXEi7;-V6ynE#;#lByWL=iWXDtT>n;+BAVjVwS`%CZq5-Q#>Qoov$e%z=8 z9T)8+i31}~62iven&A(Y_gh`{%n)5Xa7w8hO#ok6Vr|V>lXIC*58*!7F&u6@T|P+; z7>`y#5C^@S!o#Oxf>1Nb(u2$izPx?jV3*P%CWRS^kpYsYM5RE+*4q2dCYnvwYoSXNF-Sesp{ojG;~*Xc3*x%dcuq43~)_;;d|^ ztoGC4IctM~+^tjdM8R^jXd`yf+C}~k2|af5Hh_4)v$G?1nD0S5Jys0Oz7uPxv%L6* zVA(t7-!<2gxVqr`!7Z)5vO`w&vCOLw(3(+XEhSqi`MHhajQ=bnfhyIW_bSmHUe)~Z zlV7|X*mpJXGRo{CCatPI;IQY+C#o7wz;FAo*ki5K4tg=cL3QPifw(aE^exaIi3;(< zxos?5PV+H9akWdU)FoJno&rn&GWd+!uuYNo?+-|?5Q`%tXR40`o%#J|d`bQN!B__T zH(krz>8@{8=*g6C>Q8E8+JU{k*^GgAhG|x8^EmT;%bcTgPlIgP(Pu)QmUl zmaVYM0arKiZ^b8=mfTT_r?jz|(ULD1h zP%dUV|34D)7*aRWr#)7&!Ce4`p;jt>fyaZPSU!@O?0Cb@LzPoplxy*MaY55i;O6Es zCj0?;Bsc6^>c;78StC><*!4XDGpC}0vNU>J~N_D!p#OZ8Gq1I;X ztsOdA!ZUIYfxkN$DCmP)Wbhz8N5EL2q00lD^q8@fP>(n7&vbIL8ejf2DXO^k1iZ$T zTy84lA~p#6&;$aBARx$d1xFTUlZ7*kV zkC6ViYVTys$3^TE@72+#$;V!T9|UH&Rl7sgDH**4284Tp;8JIqUqE?3A(zU@(N5Am z`bWMk;}$sg&nZV%B~E<>jSDY@)nTJTbD3%U!RCS*)OaYb$gE|WjoJKSZA0Xs8N@$U zk*MvN_^=WMaNU9l&LNM1YDQ>x{$6&OA}7cEL!HoQd9NszJUP-^Cy6p+B{6Fx=vt&8 zFoTReKkvoQ)uJGbINeA&>U&T$Kr5xm&E306Hu#DFuEhP})h)oB!l-iqQ+lgi5Yvm*6Y1b#I80A@7YU&EP~YWOh2J|8%x&*D z90Hr&qX8w<2=2_+n=xg$a6;6=LCPOHxZAlFs8hxmS1V*aIoz192bPrH4&~EkRvlL3 zV?jzs&c*@54g#6r#=jwhie3PUWUUD$IpZyJr{son0+kPMt874$s}gYPhNWcHY3ADj#u#|M(l)CsEA>e#LeiHR33T!$Z@hLd<5XAy1!TR zY;hh>6Kf~O{;V?k51~*=M>|_LO&_LZgud-E$g?1#Nv)b$Bqs$HhkYz!<; zw{7NqEAK4)iG+cgJzo25aQs^IR`Hatr5xUe)lfx1qf($9 znJ3=ajg@}J>~$sq)iyhEjFg3^L=)@%L5}6kYe>L01FM5vY;@euE2rx@oeb+HbBZ2{ znWEYd1kz&JPHjO_2Na^Ki>23@E2S`}pUk08jc~Ilk}R~hl6wDLvbQIn;ru>WGS&~~ z=m6;VkeqWc0+XAQa{3ru2ltWz@9cL4nh@e^?t_$_+iWy>in4tg6khhfnx)Hz8oq)n zi07cADadcIOgfgPar8q-ewCn|&@IWi$MF^I144Cj)*8MM*G=K1=O_fwrhK3)ZFY)J z${wcZVcK@i0oD3mh&0%$QMKX{DAcGHbQwyg7cg)!lp^{RP!Bm^c znr(T{>lUyQc1+A_r_L#j^vcP5FUs+$&W%YeLkr1m zEbsTMt0~n~lXh0OnVC+&jFF22f78?gf)_kF$9HM7?P^9EOTE2Rld@;tX>eD+`!i&54l6JS_^aXCUj4 zoec?79wJdReQ_MgM@%&nudtkB1EOsGpE)?{UfGPe({c>(3uW2~4y}HAdsH%&`5ERQ z_ZS;+UHY%!E|wWOQ1@OgZsi(!!E7KOjw)KxZdw|AeL?#9pH%#uR-TD07W0gwTr&?f zWhT=+-5D8TnqW1qhgUrcFg)C3hRtyu=cwgZ2Q4LHX-DDA@KFVMc@t3zzKyaldEp9kZADnij+< z`j?P+sNG)cv&4B^<1dL(b<-mk5bBt@&P#WHo6$ol*eYjn_f7jazyQb^0+06b$gGnQ zDW}huGn(@MilW~*?BWd*;2=^X%Kt^!=biUS1AtN98QF*H!BM(^?cZqO1G?FANP*2b zS_Q63u_d5KN$_7{U#On<-&6N)y+{LS2^1+&*T60t z>NbTNh~P*%_`gPv+8FW;65)B##Y}vgvZ*g%P~ItrO?WXUECS78O^)5;hEbD+bD{Jp zn+1eib*Anh<}<>E)kGgnABdwqHo96eS?Sk4Wct->u#%qd+@sbS?zwlUsgC~kXQa{9 zQM-{Ii1O=D`k0UPDdi9<*6P94Fo2U&+mQ+6#d6P|K;D%wgI#Vtv?!cQT)zLped*Ax zs3^a!yQD`Uu~FU}obI|UENR*}qfLr2m&haLJ1B;98HTinv(T*vo%R;JZG7Bw3YF;e zpJ{1Y+1siV`4-ASt0EI(Q^>*UgE0+*p^&HeS3mM1M0)5RVF^VRfvKET!{rY7PG!?69Ee&_gR$g^_pd3#u`c@{`7tsbmLn5oX%yK&8Au?6QqmYpW7^> z^Z)xxxHD9y{eNK@4+|!=E+`D;s6~a-$r&t?Y>UFU$=(fB6X8c+c99Q_joCud^ftN4 zsiqZCXH(7KbVx1QsbE(z%(C;e%Ba*`E6Rp6xFe%_+P`OVP1j+CD5#G6V_M$+JeC;+ z>V4LD=dp_(#uP&N&E2Ta>m*SJ=N3W&$B`FIjN|@?m=>Uw{>8@*Zg3Rd6F0+u)P6V$LSNIZW;PQ+q0aJ>%|Q=*p0k|Nv2jC?v_s7 zS}qxjce!m1O?sPp9hu_~#PVu!<;KJ-71bQ%QHaPW)OtDxu@_3$E4(TE80FGdTv7`h zf^($OA<^4ATcs7ej?R}9WLxk$#fiR)lZ6mrgMwY|jAGN^fI}1DUT)5P)9^bPJPd}W zFM$Y=+A;O)y*?ecv1zDQX$>*R>g9Vkcb}JzXrMEwD1b`iIpiRfvN1vP>OGxI;RL9u zd&e;X7D1`t=A~PA^$8Z?w0_Tk>@B7B zkui^q#0K5FviGqd4Q-MBjr13>ekh!UP&Q*an=pB>Y|_%U8aI@#8K-EY90ZbCKa1OnXsYJi!Vh zgGoUElb37%lLCts_I}qp@-;VPDFD;Zn>SH}=gp z3z7srKIcyBDYoCPu1>0!BDNb_9MMRarPD6V7Pf+(Em+~e%gi=ab7cJ8z^g}B;qgwb zk1JymSkXUO>R}V(+L;dHuRmGdaHLno_X>QO>~t~QnIO*`>mJ+|IRO(a=IU8x#5l&z zqb865cIk#MDb!~>vFjdX&)Mw+$tmzRSn33ypZ+mNsleMpBl#*Le=O~oYtl(K90OH1NAl7SY z0jyT(47{R~JT_CB!!E0i?&2!~wJ!hC9T~tVbu&j-`OkOjj1>;dA)bwG=XZ_NlPvrK zij;xg@oFnU6oL4Bm(JGL1*#7Vf_J$5>Yz_#iWMGv=p%CRK!~4Y?UIw=WwLWuyZ4Y| zD^2^-H|`j=`aT(9nmY%N*)B>7`WQ2J?o1-#i;;Z55!CN8Dy^Myw*Z0MivO`Vzo#kP zj-fk3#noTpJf0g({WtB$OjR=t?qX?P&IyQYCc>8k5X^aixK^Np$?GD23Y!-@~6117r#<3amRF@428KReLjCNwKO5Xu0b-- z6%tP)B1Lc)7V57Mu7R}Vm^t`1A9Ew|P#g}1cd}ojdMfz?XtryzUI zyQ!JUOejGkJ4mzNR%^*Jth-JUUxzIAG|{Vj$qr3)nj5@5e@~<`++2#DHEYj1_Y&LTdXV@!V845?3C7amRp!YKpxKcK1*BQm1%3CV>ZXfY#da>i1q$iLUB4*w+Fd$ zm?0QK5QpBO#lz(gp5pE!J@;wE{*fvE@!UkGVU>cRh0?suu2Om@D^E^7aMxHpQXn0* z&e8QlDi&D7`K)42&7QQ&X;T2k5MFjK?P0j_FvElkI0nM!>Ie5q^z0qG-Z15qI&XVyHP#YEgA zoiQX7V4r;Nxf=lsp2v|S-SeJq5@O)jd-Cfc>$CrmrUyy7WLi&xaI|m3a`!(;n{5#0 zUk%VfdIm3}whwkQ)GmbbTTOUb4uIVUpH2=wbC5i70V6L`wo;wR$G16;Lz6|kQ@4Oj zwPjun==@~~K-JNOJUPXNru|-&VPGx6kRO@IFk1feWmdIAn>y60B#4nAejs&X|8-IM zMM0nSm8c^Mx=-0`3;k1VSkJeHF@?=iX@h_zQEPKvsE|_S)2#_D)~V8cOw(&^*oXvWu-_I$|GupHUuNS1~943 zk1wx#{fFjn5xXQ@3p3pL-b*tOus6S0PG=xPV1KOw_wf>cuB*6 zW!Y}hl1HBDuW_{G&AkbJr9Dt|ZiR?+GCjeplag^It$EkA0^lY5P4p8OfY@+U1t02G zq8wh4S4o4OMY{L?!3&H(C-2~1mknIee$xYKfgXp_DMS#T8HHFpBBWW1ph7>o?dUFR z8>GF4&zr=C9=*C4)#A6@w{JJXB6$h>lbUdVBGjy^NrUZmimV;tmN?D-ocyDj6YanQ z>%j+vRXnH`y{@U$UxjQ=<=a|hfx|vjsHp_Ti8S9natj^XNr*;}jz?*vCrv^5;DXYx zcBr!|bW5Kzj02)03ViWQhG6hBC%FEi3>Gvv(DI$H6h&>CYR_ zdqMlPfk*=fxv(~%Z^gj|Vs-dE!zi$xe>j29zX4tnbol#T5Bb-^zk^p{c~4qk!3?9U zP$+MX0cU}-fYSxNqVgA$$kF6x+D}RE}B(qlm?Z(v<^cWZsal_Az?gs4bH@qs|!4ngjEn&DfJ9=9V>C zZ~NjrTn|uXeRi+u*5GSKiDDzS9mHYqrRpOjR{`uVxJ9SjxS<{#f_5oS7Pnz(vi;>u zpVHitWQs|3)uF|WQ|Rmy9eK7ui*3)K<+O$Qk!|2P;fEgS2_-iJNxCPt(HMP&{*)AR zi;TKju942Q>^t`M)=&_`Kc*PzAP}@^KKR$<(|CnwVBT;eae5Y-kQm6EvaRB}hWNPM z1HfuQMe56^Vw-i9{lSP*PI~2{TOEjYadGAT-}L_V{{Bocxb|Fy!>!Q)fR#gBdoi{0 zvJL60X!2adl?Dupa0dOQ8?JC;HCR%hX>{*8vvtRv=XE?B zk@~Pw2wYjQczDx-0xziC^D_4P378%tVTB16VJx8D>9t<_R3k0|>LXK^AZrE#i(<&a zW6iUHUn4|I|8bINQw}>Gs}sxQc7W2a%e+5_S=M9~2s<$D6j+Ji;AIbH*B(T)ro6d<^@jo+^%c^^Jubf+rk65kNB$R2RI13P|yNTSD@mI$T(+1E&JrGogZO zPzKFIQ*rk^=qc>D!q>(Rv4pWbki}AET2) zGd1QY=yWxgCXAZwxg0TvC8{!+Pf>?O^b9vBFQC~xsORsW1EQtmfM&=&df|J-#!+;O zE0<(qN1^oRKrO73;T(twlZkbnA?}YoI^#7ja-|vfVyJTC4hhX2rPHdL9W|(eIod3` zL8F;gj;fkwe&G&_+1pHHSCX-W{8`O0&lD3^hH1~Us3I=1y5$y%u zpIh~!NU`lyi@fGr)=EqfhP<_#Wk0=L{3+bV(QOypGrLvOz1~o#n=KbKL)%5w1CZoQdkjoe+YIz;E5~1~*OzKgYzuPcc;W zgIupp;kjaHqj6xAWzwL;ngQeZ)O?8ex&UpnMYO`(*xJmVQ_Z{9QQXKaQ@GsCaL^qm z!5Sc0$E~u$xnV)s2W#qUFctJJFz_xV6s^ zKrZD=f^lq8%nMy&D0;kmPx;7QXwr@d==3}AK%Te^{~u&LN~rV&HXVX&YP*{e+6<95 zqfV>p)yUcYn(*c|EwSP-xOT{v)_7ekeGJHdO}X_7P2}>z06zKuz)x_n8c2YcYWGiC zYCT`0bz>q#PQ4%wCo_ipFuS~u6YR$G>a`M^$?$lb>4?AKa?|tR9D4KGUd@YWq7%~+ zjl-{Xh*G4^Q?$Wlgk|@nWw?lsYVeiUVF0!3tp4S zuccZy(oo!a%h*^iDkHiuTC$}KLBp74w=GTenZ>{n{F1WY>5}|eti6)$eH0;ldj~#} zijhoCQW?>4Rf(_$v-eVTnPJCb+_ZDhzPA3LCIDi*=P6%o@twssEPh)tK|^7`ko)ll zBEAJUjlcGuRC(Qp*XeO|!K3TWpHLXSrCO@CUuR=d%(mpIdNCzElqmAPZH2K3%bKU} zoVQ-v?jofrpXD^|FI`k*3nt?n-X6v+AS&GqbbI3u>7Nmt5A+VvELcKen{9gK>O(E< zKFjjYznT}y_PA~FoQ3jtP%or<6>5+Q6iHDU&k7J8Z4JM67j%En{v5994~;4)ui@y4s_ZaD*=}*ms|z=>Gr3kXBint%&?D9* zspE2TRi=c8gz>{L z+uVHlEtH2;N*;#wM?z50POoT5)R3`quULG%p#<3Z>ryh!Wy#}Tujb>PLntXBZC;!& zHFF>uVQ;2;TD%X-@_>sesxC6UFP0=r&$2ux67t_8S--(bTDLZ%RD+hqE;=&VW}J+O43 zv!jtuka+aboSY9a{e9yDQohs$)j_^jz~o})(mpnD_~N=%hwYQmBQb-O>*-<#ZVRUa z;iG05kgvp9_n#g4^A%#&F1t@RP_MyZ>Dcnkg>Q#T+-Ww6$dXzzwsI|<5Yl>j2S>Ph zBq3z9wG+18ZoDr!xvgI9<=BMrJ^7Suskrm2GVxF)Em1(4bMO@+;bGHT2!9A)^|6|W zzFqw8?C-`)VZsT6Oc60&IiLTQb-!@2OdB}74E16d%Q7A{{U>t!PrS5p-5Sv=*rjVF zcYuPL8*z5qO<_h(am`4t!Yiu6f9NKDFTQJRSsh+GcYds(zEbrb8U9VAC~DPzLN$k_ z2ii38j$x58w2F9n-~mV}_|K71_KmCqH6OV^V4N9!T@rmND4JxRqkTn!Yav#Y)ve8= zN=nTxZ*y=rSFN?V*!hNwFxEpghr#37mq)O0G-VZUZr325ZHx6@JDn@4?|*doeqd zi_jq&!4hG^2&E|RC6!F>Z71j+#cC#7{j!P#J`-QW-=h<#)H(SW^eU$>Z89XHRLct# zuuCt9=k<;rKijq6+PnuG#&EWOhs+veN0|}l65Ot)5mh6V?Rwu-X_5`R70^SYf*=8m zT@Q%0q#XbB?0Ei8j*rhz3?6!UG~o+s-x?o=W)ue=kQ4A8G9tNzPwl>{!Svl=OH`XD zc3>ip4UA>8MPph>_F#ulw_hSy%hb7jlbS3RD?E<{lL&4LxMU=CUc3rz4pErJP@%>h zE%v|3RGDN-~z>Uo46iX4edAAj4o@ zHK~(G6A;A>rYL80Afp!j!%sOAm8zRw%2G|f$*8S`Dbkt3=x4Ib93@=RZv#T=R5lxy z3JRENT^Wq&!u~yxH=RMEI;>SK*B$?KUH30zJirHu<_mj5nWvR797+DKHm= zI&xz8o-Nc)=eWz7VnyKIp%%lh)wVpk;{;9O$vhSYCaECP12JYp9&n;3reg&DK&j~^ z4C1C&*LXFJ(^HM>jdy%X|D1lwlkA|KV_u3i#shnirx}lF3P?CRXe%x3eE`_NOVKHSmxvkdbtF(GLJ+ztHCk)9@i}A~;M#$t}_6l4^pW!nLGANck zsOpb!GA%>BY#zHyXywM!V1}oyU5-b;BeqENzsl2yD6S57GGM+^llIZ2RXF+iKQX|D z&|ImCv^A;V!wUbyTDqQHa9oyLuS@%ul_6P1W|9vU2%$d=tsjj80iGxl`48lsVlbWF z3EAv|1efSSg}P7%mt)*U2S^oIXz0l^d-@t0{u^$Goy5lX7m*Q~EoUYU7-*FW6FyI% zw)fu(>{?+;q-85oTEamOdNhct)K;UL*nuMONb*K=*z5*F45|`fnyIGT-U^gDm)FtT z*Zp(7NS@-qww%J5u_%x0k>)OSDH1$N)w75l3K{@?;iI-U{c`jUm-mDc(GQ4P zDlX=(cOmj*c=y~kqw<66;5$WXk&Y)oUN?cKd)ZWYu1+M!KRQpo$*R0EZC1`spuhLD zwh7YPP1JYK8XVx`y+aOs@Y`xg>(d8N-`;IN9m=3~O1R;NF^o24-(g%b)udXkzk4Rr`ST(M6yM;{j!t1ohT)?h(*_@AW5#Ww7HAi2>l3%n+{%pZmy1YA zhP(Y{4`COF4}5{9WY$FEgOCa%D@qn~0UB}l^$w&kJq+GxPY=8~e4$RE%5^Miid-&s zRI!2#>bzuP)=t~~@FvJ4wzxJ#@MfN+B_5*&bA&Hdi$)QE^0;(cMXZZ%eQz#cjY zbWh)}$DiI+%yyolt4AJRxooQR2eMN(~mR+?DjpQN{;njoJJw>jF?~Md8EE7 z#U*;?Cd;tfX9?Bf?Zz`d#uFj+dzlepodd(-*a1{1nIMjGL+8_cuuiOz>Hckrf+FUg z%Clv`!R`^c*YVr-wCjFiP9>&GQd7==yh5>yaNfdmjR{V*#^*p?K>PV>OkAiMD^v7q zzTdxe??ows4-$#RZY%cK{3>8X0+ zzM{p}&0oxz0PjEQC>z9PV0YGn)>X5t)q{owdq6U|}#)rv@ z#%Vh9y8R@mQ({j_d#9epfd?-&w@dGMXT878ImD45E?MM{(!pb|O0?-uq(g1(YFV<= zbdL~0%f^2L?n7A%_?CLrlE4~htsS~CP9YK|isaG=2t{xNJ)uA?L8jV^!U~dm@2h(u z!|s=@Qb7jKYzW{!5&Ka|H%ErwB5iX@;I}tWIY+UNFW{Ih`?G!e1#AWfb2$7=0HDHcd?=5p<5-{|(PJ~>dBhs85hXjsb3H7yul!z2W z$x)ik3IA76*I5}e_BJ3~sS@u6G>%TOx|Z}<*kZYpQtTw=NY+I+ad0#Lg~;wVNTi4G z(U+B(eA6R89QnLS1=GSv+g#)t4^&G2?11>aJWoO-v|jwG0R5W`YZVy)p!aUp~t^;28&3F0_m2({1~Wz88HEq zjF^960_7eT#+}`n3TdnrvZ)R#hV|kvU?2s4V$mzK52HZE!Sb1AR?nZ5AYRYniVZ~v zkya}r5)k9+ygDFvNZQN$B7I95*TYd6Tb*^ZprJS(T+-UJk;CvpTb`>n(W^!2iMR`$ z;C@xZ;JYw@&*G{Y3sb8yv|0@t;VR~_)G&H6=0==lOy8f<67P$IPxqULipWB1cYze; zZ^OG`aFE)a>Al6uq#{<35vS^)k#qs7I17V|8>|Q21{=ckUQOHAk=xu$J|VT#{+%2Q zUaja1(Y3<(##SPWGUSgEfgCL)z3Wvu!j zx4Efqn3DBg{@>CC=C8HI1qS0iYcK)aSh@YXi43V5rX1O1s%B;lUN5_-NuukwmO3;T zk`_GPuQtnXv6m+B619v65<7ee{m%t3N5;5b%=IEuftQLR!EvQormmr~49?h5!nNjH z^S#w^aWXfG8WcGPcRi>aWmw&+xd4O?LR$$2CEDsxyRrWS;ZR&ql7k{CZT_P2lG-ih zX!8wN?PII!W4Wvz5=5x)`Y#}VXeJ6q5eHNV2pUhG7l=;;$f1h06r_F6U|@K$D3}?R zdWpt>U!s;gEvdH;ZLcKMKqycmim+PaBE;Mym(>;CzU&A2?zuzGZ}54p)C99Kr3`1m zC(nt@yfPZXMv;lT{kw{l{bQm=efB_90p3#AP~32}O>%zs%3=*o(7Zo-^^b@ib&qaW zN4u;Ip^_Z{J`&lN<8WATJeB}QdXWeig8n$)j*FtPzkOXKno~+tfB5k?y_iKxTZC<50>c zWYefQox`14IXZZ*ap|`SAuB=zSl)omVxQCFGq;hKZpdt>$_NEiVQdSeu2G&wl zULrYv)b_-{%!MLu0!1z|R56o8anop4xiN$ci-qUjy#p_w`kUgu?s(#u_~FM60ovTv(LQ&@iNrg{|A(IcD@Sm}PFNV%Q+vv#km})Mw?ZEH zmw$LJ-^M;W6-RnV^IH?ATWu0 z$YSY=w|q5H{TaeqR@J`k(je_H&q>P7Yq0v@_$kw!YVOn4lSXLU|MPN!vh~&oC2I%2 zK_EyR7@tPv<%blD33M)uraKB9Vaq&f_F3`zOMIK7XuV^3-n?j`^K^5uNl|clz=)ig zHLTTg@PIo;ZWQVY5nn536+HL!3R%|oLcQ7A; z(%Nm*$r$8Wb;E1UrlWQASS-{+VhfL6Q);?cgbfH|#3c+B){r)t2a%QiOZrFLQ(n@9 zmh1AyetVRQ#bvKCi+lCXrEkmE%j+IFbm-T-W9V}66F+(`NiD~OLS==r%RY*FDyy=Z zmUo|>%JpIRrPXP^5!0ZLWX008Qv8%(2s(-on|e{WS+>k89Qp<~8)x)>hfT@tFM>rr;v3iiydtajGJPHgCgiFeSz11uAc9D^?4pQ;3$|>rQ`-wOl@Sp=6!2b*#D zW>NJ*A)5<}o8C+e8WLRhhBr*@ppMK8jwbag4xU~PZ`STQrqlBGYY zSJA!e1ULMKqAfKcuO_nI?xZ(x(%ATNBsE9Hb`>99NH7=p92X3UPFn10SpOD>N%CM%Ik{=Td+_{W&7`n zxK-|bHLA^^1#5~4L6L2|mZP80M4+fvcb~@RA75veCV2*7q$BZlILN~Ub5}li!e~ZX zDBBR?3{$xB+)c3d`=Vu^_5fJr<98DUwGWXd&4lwtI6MT6TwR2}GIyG+;f1Qk%8U+s zBdHJB7$W;~s$UCtqG#QwER}vDEytCBE;Ju>&Pnhi0P{C203x&W9$XiA`vUg~147=8 zTVv@wmhqYA$_3(6{XS^5dmSpqu%5R4D4+fZV1+@luaCCLSl2CmyOsL3kBoRBY9RE?NmF3(x)HGN)=)&Q% zazZ7ZNydL|xvEGTPr?{Kx`S?%_P~gAAW=h(y0p8#y-z%Igh;4LSnImKD&U zW~VoS;F4$kNGxznmY2@HFQ33B~;IwIu39re(;fbUHZ9H7}ZI0VPT4(Uv=cu^HF!Y zvKaA~Ib$7roH}TI|9)|ple1#kUqLdEI{ryXg{iR9mqAmEs>1m5?9DgeB?KucZm}+I z`s&nQF9GF_ayO!dh`3O348R~?>A}(mzSKU)Rw%i2&4fv?WYX@fs{+AXF()7ff!`7A zN4vGGhsvA~em479<(eG)pEm@Fk$xD1&Wn1{{g~A{#7h3f%kL@kZ4EI7mkE508y_ZT z*B!iE;*FyW73wwDBWBp~DZdwwd%kG;t~EjsCK-A$FSt9I#9&gaV7 zko6eGkLYcL<$@5Ma84Fpauq#M^s=hWA|hHOoC)u=D{LobQuhpi8s#x2M!7H^T`Dst zrsKVWPhqF7x7T%n{}Q49#4@T3%sW8wn7~_aN`C|F;N;6(tPKOs%JgLWY_~H&4aa|b z%YIwi7bTEdF!bX;<)_ttpLQnJa=iqkKl^2=3wsG^h-D|f?pE;?xMMDZwE`j#e3 zs=QUA%`&wSMLI5)rFs{k)}FG+Wor@u0fl$POEXrV3FS3y|Lx$@%;68 z&)dc$nm^D^RE39(QAM#-B^AAtx}f__NRT&_A!_6BN8*O>4yR31?XLcdfZ@gQf59hR zpKiM+iIl}zE5&2V2M$61Naea~>3`OwEFl_lh*=S_Y%M{T7AstrVLMJM3$0?xWwsiH z`uqU;!75fVIQXl+aag+tE0Tkb(+YoxP;rWX>v1NN_ltN6xHNPHF_~Qaphc$cNwNkG zFhbj4GP^wT2rVl(Tkc!+a`o>vX!NQy~B)+TfLmJlzWZ zU$NZ`QElG_LA8n+7-VQ=Bhm!<^TI+BRdsnWR}Ira0KDk}>VUNA>|ss__? zv#VM8G^&2pI{1Nl?&RDdL?>5CO};Z_C#wb{1l6N9ZQYqsvi7&Q$E4<6T6JuLvLjH) zlW{*QB*a}&o{)@kIwd0hE2#kJoi(N;<(ha8g{S(KT>LS8j2Yk!&hAbkPvol;6(aDs z)H%+R0(oqoOv8U86TswrYAyj>%|~nIE>BI|+Tp+4*>`nJEA(_61?~E46CYm_-?-H0 z=IprDm1$1%fp5mb>UDd!^Ky3()6q0nB?!|bur0tAlX=>08_OP8FulxAj(a|#BGL=L zjoBo27M&}Dcu*qME^Lrxhhy^NG^C1e6fGoTzd*3xVTNdopGShUFZO2?(}DUghlc~G zVlX{|05`I)U}qt%IKj|R@aLuRT~p6aY7kmCXh!P&oXZ<~$-}c9=uvB{vTAS`F82W3!<89 z$T@Vm3;Rb+?$}k7ScKfx6hI2%HmPfVt8JM1-zqD^6tJUvoX~lR2jkCu<-};*>`UKy zTD_ceXYx(&&q>H$j8cA}xumCM`7BrrI@oJ(bui`UU#IT=8g2|%rtE26U|evU3z``0lGH^!YRZv;%z}Zc)YKCJ54dPbnur^1nsUnf^b@vBzu>agQ!P7* z{cBeGvK5d3(n{@32H9&k1nl{Z3L5>JNIa)CH|@9cas4r6le4vEfK`@<^5AEyW%ASb z)pFTZD>tfiEWi_Ci8)2dG8zEY3=m3?3T5HRcsX;*GtklujnM6>T!Rugw!PCt%BY+; z*SyQR=^ytvobXz77^~$gt#-=xNBi@DIKnWwh)gedb&+m;elh`dVfGY>^j7>**BGJz z$n=M(x^RjhmFjS@6EV=-J*oS0053q$zpwSgRUM(=NE!a3JZPi2VA^t&K(bH#mCg8PraK(30ET_U(;^Y|aH8%<9~x7GFF8=P=A zgghz?9b(ox$6X*z_PN6liXVkVcID*MP5fbBvCk8)FLgnKZA9#kjr?kgZz<~J`E4PL zhUSQDP+9#n&wEs`wx9`B6`qmY6X#>;gfB-Bxeg5L72b^ypE#FsUWS)U`zm(LyLD~~ z$*v44rdezs2@FIR3vWimck9L^5y9OzTK`>K?oNDZxz6UH*3G(mYvOW_GqY?_&l*Ik zQ7jICCvoLeq&}ozgGqZh!kC+Vll!_XR&Bd5;|Y&jOS$AUvL}O_0%J!S22NvSNndA$ zO<0~R?};y1Y3-Cpq~cvz70eUkQhEIZWlhv=$_s+5{ooo>=!p`H4Co>7wL)<-9W6m{ zY7^|Y3r+_9JKplPS}JLtgS~vKCHkV=ppU~Oq5?G76Y0hW{}j-5hAq>R?-{L^WcF5P za6Ip)%r)yjJNBW)elf)?OMJ@_=Q@U(_=y#TQ&vHY+a{yN=7B{nJ!;Wo$$?hPX}ei0 zD>_E?f>0ky#n|@^95&HIIcI#=%@oqdXus9ozK}3XWa&wuhFCL@r3oZ1|4A`#A=!G< z8_Ih1ckK5`Dz)!tP-E3#1Mv1_y4_Jv!hje+ zR_F1cGR`zq0~`_T%PImp3z(@doP%o@KG9G@!>bLm)NYcp8{J6~NXcgd!5r6 z20S#o_(`KJDbIpl6!WyF*TvS*o3ZOAMs?fNta;IaG zZV|}#*!~Xv`5p~|6MO3Nb)o7DH7@lKG}$RIJXlGovPqo;y28I()2!Ek?C3ZlBrF+O zoku5rMo|H0LT`Xxx+9Y~o0>2nEtbD!>B>Ntqct}NLgf~39Io_JaU?oe(at?gZUJs= zY00!6MI}I8A@e^%hkz$D^zRSuCC>D}jJ%enFbPJN%$NOzT1LXEjoT1JY@6!Tn_32N zthfGI`MnXoO#>2YrF*L=tbeHHYTms64xs ztJ9izP9DgK`TcI5(le=zxClXX2*j=HPL08Ys<(%fY$_@k*>>dA(o{033gd8dE_ksxh(SI_CNxyLwCX}gjG)?r&mXZq zfgWshfe!EaJM0YAl2l-bOc)hw$Kg}Q>QT|u`KhU)HXp}^R!xt9)Yr04CsOsUeahMW zq9&C@^`Av#9BY79TT%ct2W;!VykcpV?Y$<|5D6kCvt`{TCYuH(g74;CC$#GeVLo7F zknrfotz#AjSBif$2YQEE!%(PRz1BmHdj$F>8wZFxrFXSmfqvi!0m-o9GMt)*DlVuZ zM+3{#vRtPjNQPH7+ZgUVze9Z})q9iVgT+_MySxJ^b%vhXx+89bJOT6HKWieXfN$;Q z_=&CZ3h7FEaitkbMsd`K-5^f9CGdFkeEu=yKJs5K65rEGcI3z)9gID$=v zmaX^#qEjnl5Z)oioI!V_U@Pf@+NZ1Zs{?(F=iAa<@UEy|r5(dN#FUYv!bXx}0+2C_dbz(B-(nV^V}|E+C$(v|;uJFW~kl^Nfn z^(&$~pqv1s02L!Ss8i~Yy}Wqa!aPKV+o0rK*n+9{3s!=5EST(RPM}2u*T(73W?v6Q zW<<6FH<0V@4YW~_Fr=bfbB zI91(NAVEH9l?TgBtpks1h9`Xw4o0z0iM)=oVDhsv*mklDO(}Q6&4V zy%(F9ns96vIhMkx{;r4dP)Dcb%8OI|EVSAKjjG?(BI1^3ZRPaB4JQ*=pG%DBy+pM&R|M0nL-a=Pxi=B1x-vfK5vUhzp=k;} zMkMA_k>x!xQc>R(jKVqkLVEzIbruPblBYbA9+(6-Y_$dXvrIpfZGbSBS-{P?6=^#j zOH*m`uQ+KIY!FlnE_q`bI!DhrP!8=uM|qr%EM1h`p9N~1Z#mVdvCkbn7*>g!p$Wu4 zFBHOZ`<95984Fs^Fcvhf=&L6fo;Ykv&FXKetj%c1TiC9#j|PgCi3soI8u0 zHJk|ZKzubOU4o+5R$w9NO+7yiE}k6lnZAF*&Zglqa>WAFk65s?Awyto7R(2?vt8=4 zMbLyNbc{6tnwSK+jm49Zx>BqHFy0!-^{o-3YQV0Y)vTBSGiZ7vj_@X{be$N+BW#8y zBZ)mB_7gu~gMpE3=}QSS;DEw)D2Rrmn6W4fjV)LUJOCXERC0iU4XvYAHKho7Cy`BJ z@4m%`TL_W*Sd+BYUnq{mDR}O^afSy>NFp|w!<<6*S)eh@*?rGn)0hM0>B|-BojZVW#3QH|l!7c)Qp%a*qGPT(x1%aKQQGb;fAWvF9Nv*SY~hCc z(5ul?R-a4RcbB@@#ZA`%V>pcRyUVXhH2M+DU@Lk=&PcQJti(CZi(1vK=}Fddq$GMY z!|kllCEO&X4znxo9pm6DcmZ)Hb$Tv->iX`P#Zgezq62oEX-g!a^?e8B2FZpLZ86@2 zp>^!Tv1-Hg{jiR<{dTynQOG7d0rXvF6m0bc=R|(M+ncx<1LVqOuC2deSjBEj@noUJ zca6DJp98F4Q=Uzc56k9^-jvMwDd(Ad3qGZiI@E^Z1!-{_zLz$c`DPjY9zOyc`}iPl zO%+yUW-D7d?aAgVmI_%Uk?Ye}+C%zx!P30+&4W%|wdlS7n|u}(YF8Mr@L(EwpQoz- zu!$Jq`=R$jj0HjARt)9^Y8~horM!B)AI+O9HiWh@FFb5LDq5NfM9ER1O0-)b^G+}< z_RvKhYmjosmq@;fDH@Pb5;mLmGTCvx*Ajy5(hX00S?rb}?A1)P*RjNV4~zPrYva_) zeeG_DhapLyX*h^jmlz7_xP3h1B*M6%3g%$9w|gS+@~6|u^=jJFxNd6{+!rv~TwLRS zj-#_y2lgO~l{VA^sC0{j?U%>p_;NLdwMnR^pl5sf#WOSi)I+bac&F|%&7yYXMM-ZS zAH#i=qk$bm5nc28n9xz2z$|_C*Jf8=bFXrGc9Z%>h(vnVE5h+&FJ$LsROr&v}b`Zh2louW)nb^k0W;F{9f;jRGz zW8WNyFiz(C7-`@EqO(>e|urE7L%A-MXpU~hlJEVN`f=u@~Z4}wGH=|E&3QU!F^?N6!E6mq)OBZW< zt%9q3lOIF|X?Oy)fYrg61=Qqne`3rt7o%awtsb~Q%00X1JBWV5NuPypH*?wOYXKHX zth&M7qB#?cuiOFlzBY9E*pxP$7tin`r1$STl}TQ9L>iCGv5P4n?hrW)lDR1_3=%eH zB=)=$_^nS$SvoCh3cY?jcPge3h|!lB!T4NH5DS^z51vpvWoTQX(t0>-lerawM%{GnO2cWaD!R}SQ0TXg%% zQQ8_5&hHB%)hfmASR{Cn+B%;uq&vXIpUT4(3RPi{#k9=GzMb6V!%j_=pKhc<1*TgL zo|@sA8BB9UjRz85p%#(MR%7)5f;-krCpA?j$0s)5%TVJ#pf{M%&!M5_oFQ=tN`2Um zBV&?%A$%R7LG7aiHmAlED7G*_b!^*)3z)m7xA3vL8}|+)`M4V4~bHJUHAUH z;lNX|1D4?}**K6X$m}f82c&3cB*iVTjKie?8;3|UkB~Y(DimQH6Rj*ATl(Qc!*OYb z>W@}8(6Ka1|6Yh!&Tjph3!v}i3SkXYbhK$uSu~=K2L3*uum4!6!$jf~Uj)~i3YFjS zyXLNr8>naAH5h>Q!5Uco!=%G=ORJ(*rk+cuPftysZ*OMk^vRWoYU5OY&n9oQ7@p+` zwl!Ne34Q7c2`UU4zOoE%(=g8LG`UJMYEi=slV?f8V#G}#C2x7!mJ8!@W;a3lR2W{V z+Xr!maOFWtf(XE3Lk%V_s?#4b;Yv2CZ=kmao>}7s!GW>O?okZai<^6y-21<(apJFF zSxNG^YMkd2KXZ=9{OwRpzi7RwD7g^K#&q%Qb}57jK+r3V3Z-44C0=m97Isw7x`iL&f~4Rqj@_$3c&A|$-~Vgo?Pu+4 z%@P_>)7FjWe;|Th-+;^R_}A&v>$izM55kL7=yO#7Z*(D(5-dJZ+5q#!QweP+Wj@eU z&|n^XsCT&jjY$J;c(TA49x6Y#d=!o*JDo@VeiYAR!yR*qO!a zC-Pu21`E%0RnzLbv8whmaoosZgCU~48B+43fe_Gbr*B>?79+{vjhT7l*!zNDWGBB{ z`+e!P}Z1L+$#cgIIV)HIi>9>jE*9s%Zd}ptth}Io@x%|n|zm1H4ITh0b zaoLH(#Dh^H11#Kfz;rqZDHkGIz|Osc5*T$Cw$G*tVzWM|U^<`ccPx!{O7iq*Vp$)` zJ6+3t5@R3hbU%Kttips~tN>~?rM&+ksm8ZX9qD?aUn5E(fFDC{$RiggU7xusZ{!Dl zYgj>Ug?&Rpr8=B_OlJw3LTsU8@{n?`I8yS*iBy?v*;I~%C|F^&=FS;1nlsCo`d0XM z0lGGwLpQPs$mX2O;*rvEACQIYm(=?@81W^4#IX=#5S^FGLuD>_^^Sh;S_6pp&Q|qi zd&Zh&o3$=Gh)QU<51#f)4ZOegaW~h1*rddm!P)||VIuQ`!8sz<^1SlBAwwH1ehdoT+v$ZB zp9YF8fQj~<*gtZM*k-V{J3;S{_Ni9`b4w*Nn{|!EG43;9zFI+Z*{e5_G$H2WnTHG# zs|q8BU|sSnsJ3xAAtbJrPNUFPqhR;QzQ2KCw`z$h_KR|*tEtC`hBFGxJp6nHVUJZ{ zpGgMqPSJU>3z3y{e21+=+*LAKLTMW=$C52mJ03qdglHtrO{(G_N}S7)OXOR3E{^cl zX&BLFAb%oWaNNG#hMxsn6ny@7Qe_jGh{T-n7@|%wiAtI$LIP6 z9S2No^utSoEkX)=itw1bc~wSf3Th*+{1$QUr&Mju^d~yLeVUZ<7JUhYin#cF?7kuc zJimm1l;@Xo0NI}Ba-hsqHNiXH3q>aloy8$eIGk(wa+Q~=-q-Rz{GQXF{JBd0m4B-& z#zkh3i{M{ zlhqdmZL;pzSGrn(cNWY?k(tk9Odr0RqA@IKR%Hat!vqbUf5wyR@=ApKx}2`{IV)C` zbsf8$6)W6kXV7IkqtL9Pz^KVQ4y=!PnY(T;eV<8=MYcb7Q#?h;vzihm4`kjvzi)Sg+bW>O`P%qGqI@j*Pqg{k-|kWzNC+hb~#Xwt^rTwJdU)~k9> z0YWhUjVB*OAn%elZa1_9+&(`GFLqfqt+8>yE{_177Dr}$jSLI15c{Hx#8C%C^_-rD zMWOb$Ro+bm*t5B-KvYJq2L0ml2tIiUN%T@54npQYF001e@uQ2;8m7LZ6R&YC>8MT^ z4G3;}iorg$Z93fHAG~o6=;JUsyJZ~$!tY05rd8%-l>VQ{O^JTzTB8K{?qmNq|Ek)a zK*Y97HlMo|uE*6RFbAU_!?%q)*g^>$b*=M}3?qRP;Sn*h7^YJgMAlu@FD;Z$#%u=6 zVvkS!fjJJcF>^U#TCU|3!Y}w8DgXoy75B{SbKRAc%3Hl6z*F7nN3bmPTj#^~3y2f_ zpz9@TqdX4)i`V5VG~hg;3~>{?6u>h}F7HyM_{XPgvN*{2gMjx(yXSY(yY zcHaua*DZ(gWMjn`y@ufOWdzNg{z*JvN%wPDN)F>FK;!+RdbUc#!*LKm)0DNyxb?^= zS7E70Biu>K#=H*?0#un7#M@Z>aK)y|0)WTo$W$&Tf8|c+HIJj{S6P%fJ_F($Tqqti zkdT7xtD=-N&)A~F#K8@gg4)ye^!?E4+ryLpP(5Y@hj9O9UtEw-LDPqR1%Yb8R+D?$ z0PYA%8$;xMzHa4EDec=KA3@8rFN{@-W+`5Yo3bC@39!jx!?k+(H51Oyfno4Hg>6g( z8!KWcgY-LHzG25k(l8Pf&|Lxs(wFSYMbzD3UEE&Rlo&Czi3_2Nn!7gqdaO(JJif-+ z9^&Ra0T3M)>VdhyKJI!-!D;H|`hgpOZ-3OzjBzscee;JYzIZ;xYE|0w<-UYJ35UIu zMkRC#xz{RlzB>X?-2xhEEBNJ2Ognp($IgceB_FG|_r!!m1y!qcXQI3!r2Swq&9}8; z7!twJ%IRVe_>?f6{jLRAr}KG3rzIR-L>V@oMn+``H@CZGmsc7I00(uC5}i0s?mkZUOdwh*a(Vrp0Z`3vW;L6PU(=O92&dj zT#RCAMIU8-Dv`*_o$2c=~tgFsS8hA=EwQ)AWx1el?uT+pX{136rt&JEAYz@{h$r8YK1VEF(ro#Dy+Q!+ZJ z_%erR)IVH-b%G+UXeYB^B5rrJ`e|fvq`9j~p4~C?$8)QlnlA<-8KXh0(zX9n?fTJ% z{HO7*-VfPhfiD~CUTQ|4(GT6X{5e&o&_i1Sj7;?`r4!@bUEd}G{Q`KOP0Xif!Yn|NNQH3NzN`u6@mP-fr_9X!i2r}fQB?U#lW6~;zVwFO z`bb4s+8H+A#R8dY7|LH8CS_64FKAstP+1=fIESh(CYaDdCiG3c|Xw4=sz&C2q zFxsY5uQGga>QwTH>#}0luP4IeN>S5+D#^R{h+t#tUtfM+3=5tL6hv+nXM~LXRO}18 z$aX${4vxESNr6keVOzZ%X#TfX-Vs(9k$T4u==myeQOO$5qg={|dZqD|NiK5%djsAi zWH13nVA>tVF@udtTYQLqCuyPs7ncqoHM`@-PZg$HU|xx%dDSckRPHOe;#w~-RRWHb z*2LBKdXNSCYbKWn_r90KWcN>bwFil6U#*686G_K!^~Z3u+vjo^LnCn*%BZ1k=eLiR z_Sy&!40jmI?tHKGXSAlwzDFDr?#3&(pOf7AGp16Isb^Np9_EuK*8{Kxi})NL>X;Dw zpen2|)NHY@rfW6d**TTZHZuCO_Mr*h){g&D5O};Y$QG7{V=HHQ%@`#pkn3rqoAO2i zcdUddN7a{tx=<<5aXu5tDx$Y;t zPuqyA^A^1sbf;Pyf2Ge?Fn-JMt9b)~Xu809k-=~zxmIMs$xdiqwTZOH$RB632%B4) z+>aL7>V)g-Pa1`}*%(#ckHL^cO{>3}KHe$C2qaRHrFPvH+mFObGf@oYt)V8xwd2jA zsw+vgo&P1&fPNgJ9uqp>r2*J4X?7zzY|J!(Y|Uu$GDuSsPCsE?a=tMVY(F2x43pdi zY87fcFCQ&J!WBgbDsq(ljpy>u?z$SSKy(9XVv@}7w&)I!g`|7dgmCS{;I^F&S;7Zh zifvq~7efrghthiwJn@CI7NaTLtvv_^$V~N~+ir5wI`kYvEEGyzPIQDQ`$Tq-F_;FI zoS1wp3x4!Gg3>5h)d#GaGvOLvuZMXj%rDb+a~;uRQHI;0R8f1*cEmFru(|ov)C-TP z1d4;j>>0Da$ayvfA3F>C$hHMY0!=G@@Gg$Dw)hqePh5TLQXr7m^uvk>{(ud$_lS}d zpWc)!UIHSx$E|f5Bp{0%;7b>2)0q_jSf^>)lDL_FQIhaX-F8}XRk$yVuZxyJZ*mi<)HJV8NrQ`>98^(}(Z9cC zYs}P&X%l02xZcP0{eOq*G)lgNTEVC*7qMvNvqy-hJU?UKOPADM5U15aF>H>OSHlgJ z=k@8`MsaLk#xtxgfl*s9juduIUjAIP3Sd-n|5^mAN-=@{pD?s7cy^)*G1`6HixE&zT4%pM*>j_~c`Q-s4LttnSbwd&JQy|VGqp&2|E09%VFt3u7#mKSjA@@?KG z?&g?muUmGAOM!Wq3~Rd)>*^?Q`EtVGuS#`jQTsbSq1upVg+b<$8*^eb&P70q;}ZFr zV%ntrPX8VoA4K6}wQ&TGVSU#@l^oK+$CFqGpfoHDdMb;eMNpMuy!Yir;~#Zskb8a! zsQlAUM*=yi*?LD+H;>Wgb_uy6NFPZF5-NSt56UWX$n^a}xARqKP@6^d`QtC0zwp;( z(`A5(B!FF7H$zptsmv8ovMXvX_L9KZbTQrZ>>B>gZC2AJMYK{~6C&3F{sDwfQ|Ad0 z)3!I)*isHHoDB{K_mNHv&BJMcz!+8cg4L0b8T=5qLN9gMB8D@rH6J(|7xmQF(81~A z^j^hKww!5B$g|w%g^eOEc4CSI6?qv9^!6;7fR=aKHW;1&B8e@nOW3Gw-tp-aIvA`( z{)XFJgqMT0ueuc35GiHhE~xnmj!Qc&mZBm@9dZn1AfYiMd)Os<`M%n9KwVQi-Ur>_ zLa|oV83@HVN3T6+PC8!H?y>>MV7a{nxuH7lPZ~?qPLOuN(ibM7QjSzS5U13+U{btt zPH(YdSBq$~hr>wi)9!lkir@rT)9@3%?$}l#nB!m^Ylp%>kS5SC*T}(ZDsC(B&i>@O9)~+gNdp@&#>#J2a zK)bgdy$Eld_us_o+0nx`wWr>Keh74vm{)NY<4F_pKa6=6tCndO!QJ9G6g(1=tK>$a z^Mns^2ZQ@jpo-FE}M{J3J}W0{Sz3{22LmYb5xOptfq$Jo7BnO056Eg_)&-=M2aURBLp8HaQM`vI% zA#yq->9hnB5N;Tk9ulU%Rp{NxUB2-w^w+%%d;jQ4L~RJP{OWvVf|jPAZJ>!%EzSN2 zhFx}5wMLe5`6;_2cQki$)=06yacoOVpVr|;PcZXPHgp+#=9BWHl+=hCcpQ;exv=(u zeI ziO3@Gbt!vxc>%Rbba=7fatGmzBtfU=9dq!;9J_mWo%87%4Hlr=C6@8z@c=QS3~I?c zFLeuGB-_{G?@74z95hJn?EiAKK(0_har&9)GN9t?@jA&1^rAS)Hp)i^Dbs`nglnnM z^AolPL5B16;Cf5%2KE&?mu&;c7GlrhS<%|Ym5X+-Isp#5_5`A!UXU0)TFh>8bKPHL z-IsX7bJ4L#LMjW| ziD@#bijn$$>JZ!C$0QTQK#(5*7k)yDlZPEuY$I4f|Ic=+g0;E0WcP@36@n;AhH?JS zgwr1W(o3f@#H24&)qJhEbJ)}%K62@GKh{x7Q?xQ_PWspSAf{q$bF>?r3K9rQJ_?9B zjd}95Mf8s3!StOy`DdCGVH)(9$1EtdScdlPnM64?l45Uf`p03FF4(^aS(xKJog+<% zem%MDIBg>GC2+qrBi{}UwFC$K-vCEKo!sqzgsQ#BBfSHp1aO^94xNC-|}1K-kofon;{MUtHIhqCSU*;~{u zKHo}EnTUyR+=+5^#S=h!P1UN)Qs=uL0*V>gN@=H#X6nbWfU+3@Ln4a#9@x!n@*qwc zv@7ri&vG_qpV%=gkHxnj7~wA=NSCEW z=b5BFr03NxNiuI*8rQj~`w8$l)3cx_ws8W3^DfHarx#V1UG9VYIc1S_?1bhM9}}3& zfG~(x+8QPFB^h2>dYn&^xtu(B%EP|~XPZlO(W89!W)v20>==bT0Klh))-z9VI#k@Elk@p+Ghj?I z)eqm%k|}E`SdncftMU>@QQs-gSHcJ=?5jaJ!uEn|@G{qI6IxC?I5~GE!uwet>a3{v zpg6@y5%V4^j7-r{CBVX*;>oxO(;5QGKN6OD=%PD6bO)&983ES@6+m$gsLHLPB#mUQQ*T|zr16Nr!t!y0ClAwQG zg()krP-u#bNyg`{x9nv29=wpP4C$cTvGGlS{b1gszydNcqM_7OQta~a8ONTf2 zM%=*qnOxKXIUZT}42Ak6T+cR;t6SSCsHi=Y&~Z~B3cX&qL3|-yBySAn$X|vvm66+7 z9`eGKYHLC`rjzDkQjo`q0MW@=j!t4NxZ=ogD+Yy2RXhCxn!l9zxg@fQ?U1UlfX+Gv zK=Ls)3k~V^+=Grx^ni_a{_16vCd@CPTs8&z0}S=A=d?m~HL|VyxM=A6S-lK-Y1Zl0 zqU>7d{runht6RjFWNPL|fLAFIf$Cxg<>aCnxtCY#M(-BEKc7KoCMn#ooPe4n1E%z_ zbi)mJwGYHFs2uCb{X=IVLB2Ib}^yEFbGSP)i6vCB6^n+Yu9D6NrfP*RPZFc<$GXqT#&k;{K4k-nWR(y^8C_w+sphsA(PlYS8MTK5W>xsqcx$WLu zZaF@7JiBnRsxH4i3Q*uWL7ILG9P|)ZYnvQ-T7aJXPw-)sSRW zT69UNLD2H2496aaQb$3);T0Mh?b0wTTRDO5!aIHIlsj>}NT7UbYEv;c%4C>=UOzzf3Zt$-_8)5oJ%Io~-RlYS`U^j28S%$--O;C}0rc!y%)lkpZ zADpV~NRm=~Pz1bAjpT4zji$Y<<=~+20D8r)lD;eB6KBqpz zKAaWt;ouT6BTyThG-jMHY0^GhE$z5Zpzv06>hSz`mAJ8pvFCF{?<9qX(^srZ_zY_=Xf4u?xW(%|})2iBqi*Fk)O?blo z#o0CQG8pvp-E>uoV0cjN=7a!HkD7hL{s7JM1;E2H6l^JJzt z+5a!#JSLCm01p#53}5ztGOJO{{zYe5Nq#*7iLPQ6K~3+q)1I#Z^)`oQ6Ul(BfP2K9 zzYG3;T&3IxL_tTjx%j5dttVY5sVWM1@=fJCM+^B{Z3ko}f2{0wOR^m+P4&7^rn(6L zg-y5v;36oPrUj+L^ej7T{ki~41!*YCu#mBTod*fqXF^9p&ejd=I9z;frnK!t&0pDQ z(Yg-te`>D#$|M$88bx{)cG}Om;*c@wTfFILz+}8vZ+KuTf8_hMt`>b`P__Ll5K@c{ zz&#V8Z6J zHTLs(3GrQ7XaNb9x`7UV?vbR($KvS3Fe|L*)A=6k1g}pL zB9rl_gTEXaC+}YKgGOKW(Tu)YIO3vtoTxF>G7-*KRiCPUE-K zyFxztV>l9fj7ttCSj(th)OC~@^``5#*S4c*zTb>mX}}8a0Ma0gAU*iNmp(t6-UPR2KYJL3l&?Y(uOUt&z3>~Q`)fUtOc|Qlo4H=T> z;IfgNmq1F>_@ zs^%}rVEZ9i@!Jh)igg*ApRxcQ!3p`p>Us##5*>w%p16FCG|Q0f#@kMdm%6Cr_Q;zA zYtClTs*ENN&Xn)gc#JqroLV$-cikzONhrHJ$07_~hKT|r^FnG6>18Wbk%H3r?*%-B z?KWO#hU8i|IFt<9{5EMzapo}gkv$GH)Vl3}?=TSKkGul{QKrU$vAHOPC-x^hky!*4 zYHC_z;i?<6Q7qiDraqi*Q%|RmXebLT(i40@3>*={?+|`iZ7qHT8_Ia(?iICjkZbbn z*A#(S6&p42tJ~8k@}g9>B32ne`MtdB1$A7T|KytBay;q_3pC)FSoHaCo`-F-_3(Wj z1{2+0SGiSNz+Ji0cU<%0Dqfbf2h4dKUhdqU>Ts>T=OB7u$ z4qb58uAtCeEpE#i@?g&mPxr(@mpkV4hw(Qq!91axz_~BAOEM*^_@8ld8g3N~aRErw z)1wo_9pCWDdUi*>^{9x7M~tdJcTx{#+gb=5eY@3}zxYq>H|v(p4mdKZFb8JA_Pq36>8DC7(; zdSFIpdx@OU^0QY#n@Kx~%_~AGFB3=lN6~`k!^Gs#G;PS9G}j-kZrbD!+-#?tTOM*P z_zBg~vzU)XKs781s>1_fV-F3pHj8rGZJ!( zTg(K1*yj(cvc5qSF=9jOBBCz%HI7z?_oR+J)@tm_1Q%~%nCs3a*Q>>mYeBZDF??XQ zS_97#Y0;u3ZmlJ=fY>cO+e1aUv&VxwDt3K{`xeimC`j|I*cwWKH@lJq-ew!zP>Jtz zZ%J#iNJY}+BadUS(XMmfHh8%8ADPf)Y1byp!9lm;)IpqM zaFCgMW#HIBgFq!FD3hP%?!L#hJkf2+2L3EVM-}6+8zRwfXdDALO62qI7LLQ0!8rZ$Fe zlVD!5frHh15%ohnk7pm z{UVWUKIR2+1%TcGXfF{ZLHp7R6@j?a;^vJwy&#*7;-sqc{rZ3~T7*;bvp$eg z(buiFTp;Lt9KmgvmXI|>f2dNERIsfnVRX(C@LdfZ-u`cpdEZlA2O*R=HpU=`uBKmV z#xZ0!3_VPSj({V2+Vo(MO!Api(xmqPLUT{%o!5x*$Qs#xcy*LJ<()X)m6q|602pg)UjLrQc=QLTiYJnZ)~Q`Kj<303jZ5@ z=_^k@S|xj}y7={AtudGwlGhj#DaW&oFIO03B@t;qR*CcF<6azf$B~W@qq{gQfjsq* z-jO8X(YLRmRZM1gb z+Xf+Qb(zz2#ft|18N(@13SMQ|aV?mjc z9bdusMz5PINRU)#2&ER%Xy0a%uth}%g5nUQksO42)Id1bCCHnDf%q}}aY;8J<<-p3o|dwo4!!4le;Hbu z1gZyu!J6L7WB>bGtnwgZfF?U|?^gxA zUKm@#5Lb=FG^8UzQTfR;mCyjt>iqx5x_SvUt+Nw6oAy!xmUD!(ti%KzYFyn04lKHC zxXofGy=T2NiV;Pbw;8@B(ZKL zQl!Z#IF+nEA!4J8b83t{IhR4g2mX&Y>vD|n_!Sw&8>9w7<=?C^4+?M@OV+%0pKnkK z@?b^*iGGuJfZ&L_sqM4KvFS;j&G6YyKqOv$d{_oItV z0u+4JAIGUm%QcwrnPnHb|LY2#6kqE;8@4RX0VT%^mx&$rP&`7O43cFmEI=R0DM6Gl z&41do_=nvq=QWm*SO$bh+iRf;XMZrI_o3y%Y+p`HjTC^f^;+F_UGxK&aaEJ$g9l*9 z=53A?hD4aT_96&OaJ?v=@=3J6_#W>D=nbetjkwhLaLLx8Co=MaJDQwp@z|5TY~~bw zyQ*YyuYfv6Gwk{1;>vOl4X(BN1*{r8uf0Ok_aZRzn^P@9p)MIS{0|;{ewdrTF=-Gz zwN%@UB1E;OwM8jOgP)!$%$2TFTUHVsbOy9r>D!oAg;in!5XHY9A-W7q^F2OESG1=D zfbR8@Bc`KcTl^O#erL&;R0Y4oqo|+cJ`bB2Ynm`Iuhg01IY7U>?Z$$@h9jVCg7r#l ze-Z6mV2O}XW=pf>VQ5j?yD0Gt#{ZWg-?sc5@bp6$SiVmd;dV$*F?;x1gx(9I>VWif zZ+C+u?e=i3vSpJS*R(5&sVg+(I=N2HEKUf`lQQCdnC8}~t*-6S zC4%#Wf8K#l0N1Ua8AVgUd|M-=o1qY#MjLv~pFK>9^c5{TS_uguHLBMN&4)14+$62D zY_AXD+X+ge7=IqSd!?F}SB+Xl2nimSXuYS6Kl64(YM*mp`E(nwbza#}eNM`qw{}#R zYPrW>F#F+GJA>A|zJaMRVXhutS!$sq@ZEF;v#e_=z4Sl{m+xx-R-SnmBlL+C5`ZT zG({j>+3FCJ!h2^Zfp=-xhExgXEzK3ECwaH60Hp;TIpIp_Ik5)+b$bzG)J|nMsDrs9 zQ9C#%p1Wx*^#o*l-_u`1oz@j6KBRTB7uxp-6Vpr}ay*x)#XW2#a5-2~2uP^{N(wk8 z1qu#&{VV=bJvtIGtXWwJfB=rxPTV>ItyAynNkOJLFiHhKdqZX%CE2BP#ha2@f zTz6LZ4XlGbJ9TJ*!MXif!PQSE6MkHi-2fP1QVYk3is$j=%7MKJ9ldgb1-*P6gNrf6 z$VQJ%G0;)A$r|D~IPY6d5 z-ZZNxrJEow@o%d7#G`he=w~-U{rIdpGdl6>aP_voznXbywy!p{4H!+!|t6lP9a0t7mNGolz zqQ^#metW<*d8lJOeAMxxgZhDMO}P9a%9^|Zxw%uFCCd>4Dx~02@ibcnQ^)?V?A`aZ zZW-NGaft?grh#ZH z>LpLP4coMo9r4Nw+ImfkdVGv7$6{LwTkM{jYq#b8wzTU>Y?EaXs$yXhK9&oo^6x#m z4#l(SW%DQka z#ArV`E)G4Ls*##{32>}iH?=4ngP8d^#om*ZhPg623G_Bz#`(7qFlg~MlTV#Rea6%g z-MT4iiFwms1=}>fRn`T-O80%! zhE+>yfZd&dN7;q`3rYu1_xNf+_K$A5<9tABOSx$6?c`-{Km(MRwaUJw?>8IoD~zVa z;nR1i%H%>)NCKZK7jLq;(IwXM%FTa5J2fCkR^NyQmhCaTl!c~Ehzp`Y9|R@qvE}vl zo`*5mj!NQL)-Rmpr1WF@=0pZUA-F-W!`TkN6|g@4NH7eFTN1yRkzI$%!jF0|pE4-v zJ90+wM^1~^JKG}d9QU=)DV~*^bbLjo`Qma!{}00bfHVw7XS~ZTuYgO(QBUZ2k@*8? z=ugMT>)twQ3X9J+Tav@a_TKdo~D~^f@JOMCnNsQP+K5aEik5~_$0TBNqC3iDGaZbx?_wATVCzps7C#hcwlDG(rW(^n3h zTeZ8Tv7B)dd(;Lf04O)v7Xkz$MKIwq-NYzpecK3hVcKk@G`9S5u2v}Z2eOw&VGZp4(uq8}RPaCAO9zHCqjcV|_xhDDOl zoh_Z72WiSb6>jl0n@`4GQyIC6#BwcIhlB+d6|v6je~?AQEQL4F8|;znDoYG}XZby< z$fS$Cr~fgPgxjHUO?bGTaCtI;Dsb3ZH=W&vu1GFdUcV~5;kJnW&OXq+#Z(f{QXF4yLV$8mIEt}OI9F+e`?sqk zZS21=6|iE|VWc~j|K>K$fvONljIP{RFcf7jT2A$mTKuoy-kcajJkyB-bQZsCT384Q zUe<*g508HH&W(0RZnDsv@DNl?{5$nV$UvTXU9JC+5w?df57A64SLnHRuwrWgJ5(Wm zwr4{!Mugyw94@-UgWNv*NW!FEssm4GpROXG|6rklk7wEZ8&VN?a_C6EsA=2)ut}y= zXw_ms^xjLDr{j5l_kV*(26j;usS%W(kDg}SXS)g4Z}v@&*1yFzWu&-Gvd%oqvWftm zt#melHPzL9$L}E|1kNr1p*#c>ZL+D>1kwNxjjC}M2l>T;<9kk!$;`n)D5>*<{DPZ>7V?>0e`8qM40;CsB_p1G5uXYyX2f)oldp0Yhsj} zqNRVTiBLq>E(j!HCH7OE9$2_(7&6|Vl>$v`D1^u?=E_y;3--JQ5fR;F{>515I5|;{ zOMMT6vL21sP6=~_`cldbnllIwN_F32xXbyG5J23Frkq4{|37+&0R=k@$;<`&COu}Y$8-pVcj}zPSt3}I4qpHB<5qgFciZ)=N#%6x zzI-zegT85l5~`k8w*}Ruj5&jfKMOvKi(<;4lfwYZs<8!0_2CZG_}dyg@rO*ovv--i zIM+anCJ=eqT;~%CK_PMSO@}7frlO}e;vjD12v0k^n{H7+4Efn(91 zP-J^*BuXfz4W--&k=9VJEQTS^zN6beQSw z1d;P%CQ4m@4L%ohs0ZNGB^tUnht{w+G$=!E_-UAZuwTndepMkm%_f5QBYikbe!>IH zY5=fiysfbHT1O=#w#$P}j&`_4 z?+dzuF5fieo&?58df4?MD$VyR^17%Ym8Z$~3}%b!nQ*UI^vVf~0`*SzkRqB@&Zxe7 z|Mds&G;elyR(Hw1Fya-`W1eGKdpVrqSq!0a$lsXfI%K3HN8J)e5kElmCxT$7Yf65F zjx_*msI?yDf~c;B9v;#E>>`Y}KmNH)%%35J4Ty4v&QaO`{nTGv6lu2MV;m${@9e7E zsiD~*I3qwK=&>fkw7%+)JV-MIx#~?rn|CtmK@fzb;jF26ssEwcQn_7v(@Rv5?Bjw%Ui>nEn~i$@ z0Xl(ZpY_ok6Mxtd%@eVhtMac~>}bQAYqz;hvjNvqM%cWmF7vXI9?^rz1J-o*aE5JE zL_SDE{yCUAPCk`GN@h8h@*;y~hL52xF>T0CZ%2?l?88;F(q)^@7w>pds zxXV}no?O%pCgZC!0l;3d1kNK;pn77#p;Z*jgo*yBcN#$8fOrqfQGvdZg3}uhi_wmC zc5!dv;KN z!zP+FgbvPK3*x&7HGKC{j<>&{{FZn*HJHFsTNACvcpX+#Cdp^^FlYoaSc_!M*1kbP z_R0WOo}Xg2waZhnD3A7vy%Ku50tA?RCV_2!c*;C2BfofSKf9mOD*Hy{KZuql#|9hI z?>xeqGS@tdoL>clytZS*A?qb1e^B`v8|lqwys@wVWkn?QGe&CF1tH+18o#BB??A_e zxgid|u4LC01h?Bzb9?&VNmw|J;lP^kAMHsJ7Z{t=UvT-x5kVVv-DHg)0o4Rl2}fp; zLeAB-EDU_NW{VhMzjDbiOdXCj3+gG641lZH{n44mORw)w*X>1&ZDSK#OlaMV%GzB_|PEM&+9 z5-p_Q@$k!9*UxcNuVZn!{1H=y;1|chOBOj_;X|2g-@H*8>@v~Z!Bpi>ADIDsE;aFa z;=a*4oVwwA3k)|qRSq%@Z>LzRLiP0sk+aegB!oSie*wp3#Ar!6zxB`$8NDYLYILJU zKMGk3w!~3~TK;|9^qx20SEt7cw`RA~C!7fjip0DVg3-odPm|Y*8&@!@4z* zDq}_t!T;rHtwmCzXccnqXi7fW)m z`b@QVX0fHqNhnF-?=vw^hJGIozJjsx8;l0^2h>sP<826p%sLx>(gE(1BEjo~b*=7* zp{s#H*%%BzLD@*JmOX9Lzgo%39^I(8XoAg|Er73K&jestx74gl;*GH465?YWx#24y zVAnGa?YMg=Q~#busZN;##SA6zcwhvHXTr!?{X^YgeYE-f8c*ScR+6(PRQOA!sWBL? z_fZJP0<>3kww=zG5TlIb$u(g3#+&R$Hggz<@}zEgQ~L2!Xz&^dLJ{NK;sTS0#H`*j zIYCn1OZ(%yaJoFRfduqy!ZuyM{B9f=k(tt`Y+_S-29}3(c)f0+FQKYvfi+1V@==ga zbgr`L>tyvtSjLh3%xMVKnqcS#HF)W*=Auj;z7zC%7AG%2qkj$urT#>pqqmR5oigNh zFs^Eq%$m?9J5{#sGdidy&^w&68sMp<#=5Y|8-~LS^%5gJob_*}NU`YE?SyD6nYaZL zA4h#q|N0~YYyJ;FU90lNaw;9eI<)Ky2`mLL?zvf=c&eKEhygJCVJJe{@HRX-IkG0q zo=H5hskQ!3=QRP2s75V4xe5LYG__UdQ-<4&m6Q|W1Dk0k>~egjE6J(JKALy^*?0t z_riKgU`$9*jgm20-UNNaSRU*>=uFG?(BY<{oeMnLqjdlswsj(4*J424 zHOJ~q9u_cS{y5YRh{a9KJ3Y@M__Fb9T_{$FlEs7!jAmCg!HDo7K6Xe1wc(QEvEEkn!bDa z6q=~H^V!XZJ>%Pmpn6dY5SMqwj>4N=5;0S9*7G1{bAX$v)l{2;*%1KmsFTZg`QhvE zKNR4<Z3V0ajn-QjmPYikRT+i_iazh9DK5gmE{_l9O z5&@N2G&H@?H2PF%R1Cj9ZEOo!(5U9%SV8Pm_KAEfiO-3T^h(Pa|__YpEd$uvk z(?(K{b1qdeJ?(+feuXU&Bfy3AOT?vTuUYDs#>W?!N^#(*`rt2C1IJ?JW|EBf9w1k1 zr+}u2#ei=X;ge0IP1x+kgl*13X99kRG~dm*a2dfmWkhh2L%RgR1$Jv@e94J0_x3*j%D^Z_dxH;|IU7WNf9FAh zZCgPaEus~{q{-bhU?D7vt)K%_26JZn53i+*1SNr4BDCBmd;}kGD0^ZI;Rig9<8Dw* z?u%ap;GkwLm>#FXhQ~??eKX=Idfx9j+y#R#G!cVvaW^g%G~*JI#eiH;IA=YPzLDi% zYtnS`GaqY;3nnhCrAuDyQ>O)qIXOP$KIMTK!6%9*EsmsPv}2veJ~c5AbFj_y4fJU; zz&MF<{}xlZLyUK~J8#Lvs1L9OS3uLgPv{rSw*sJY#(a#*;V)-g2F7CeI%ZrlQy={N z&-j`V&Cnm2XW^x45f%JfFRl8D9_kR$U?$kN3bzO+Hz8{+ zoM)wpvteopNA#gc-}Uef@?FjPAo4aphDW>_{m_c2pu@s-m^76VIve{vh`BZc2sz$JpmfkrgoWqSo{%?GU zlm#+=;di0ghzlbDqQNOqC%9&;an3(s6SZ9WW#Mo0y@Dp*dEb~>Dt`|o!n`M$I|Ji= zCaBdtk1S`UzxCpzy;lEaD9@!;p_&Z-8uA9jrFp{<^V>flEv_HOSKai(GFYEdMuKw} zx@8PFD!nl}08X-&hx{_9v)-tBidPd;G1jo(wy0cWbmh|2u`{IkCbXxwo89BT*>3yc!P8v1b{E94uz| z1{&&Di_{?eHpY__|F;&dT)y-=FXD5M!mXR0u!X(jv7HMIQq?vR&g+#lmS1lG`9j$# z{w!$#RGPm6^e?}!`b*9uKX@F+3n=(fav7H*^io+frp@yJgXK=NUfhRjUQxr}8Z#Rl zRdjU-TIb*f=QsK9+c(bvrl&aRyS{t_?DiyK`YHQDuDxDv z9b)SdntYC_-z}&-u^{wNH=u>7$DlO4Myks34a>J)_&e#{b*1yce%Ozl@!Hr-eKEz( z2D|2xjiUZdN)T@mLeQd81|FP-j(3AEF<1zCKX%DU*yk7x!^e4TJ5zZScG=^Fb8BGF zv=cKfjlG!5KT$N$%#$~~;hOk9aK{@C$e1!VX$2{6sBzG_?4t>0fSUqHZ9H7-6UU|L zgAB42E4%}6c|@+@Zy-Y>9)wv!@e4h0aLIDBoGh-lJ`qX6I7F`Bh(~DRkCp=gXH9h! zvMbwvHWtUda;R!4A)E#y4u9U7prUw3yWMrp5)ZCq#g}58w0s(a`4yBo$`l`xLy@Ex zf87P#FCQ@KOPs6+u6hsgm76E#xvL)mm8zcI-mQ^ZqqR`;4jJm1sEU3sQ=KzY(!CkE zCVMuB#3~^8JL?*yr_=1`_M2Ocm_dgSL*)h*n@aqRVO`^h<=wet~Bh|H^E=_Y4 zFiYcI!UK3>z9Az9JzSPQ%Jks*Q>N7|wJI$kjM#xo1eIUt&$v;K`-D435lpGX+XwfU zz3Ml^6A(_ps+n_@_B&c(V*FM<1GCj7XdUlDj3YZ1f9E4T;Nc~>-V+124uYuLeW(G- z83^xHR(wELD@i*DO_c3%X!|;}9`a_Myqe<@A2h~~ zy5&oG?9RCoVk#SFl)k?E-|T%kM#N)yqX}aRuIJ^YSm!?wV0ycGbE1A!o4P;Dcyf z1x^^xVxwjdjGr{vQ=#fDDRW5+oT4y8eMu3IaA!Uk#rR&y?JFA+P&QmHgG@$q_+b*? z0c>@qX=%~$Xur*2Mch~DB%#kS3${w6o+P$vC(~mrdj$I*>;-kN8oMUG86ZMiw66CP zJ*0MC0-Xj=+y+tP4$QhNcdScOtrxQ|+&X{0@(8hNaQr`j8d&=@-FHz_DX=de$qgSO zGIJXJ$GNk^~R5; zi1DRT7Vm}^Vc4#Oz^A`jDQ8L^thYL}{$#iw8_+D%y4G&C=rLvK(6&t@3^QecHr_cA z(_B>Zj$i{=_Sh?~h^l#P$y7!Tf6E$WMF!n46LJKro^e=OPY3Jb_VXS|9(k;V-%Nu*Jw>cppXwlToLgYAlWqPLC!e0VNVNfQY2SfIDZ<**-(UU{KY?3b}qb^CPTRS8xdcRqy* zAfW|8Aac!W&(rDW_a+Zep3 z^0H;>UpYibP0U?QF<={&JG#vswoRd28XREA*n~v*xT4)VkJ$!af8gyPj8LOSKgM~X*mzW4d-zFvuN^f@3jn{YgQa#hyMumEy8;hA3rXAqWUbF5)y^m15?6jrC$+xHto9gD#i$l zTDlBf$>xFpXWFNoztEH2D&xC1gn&62{_1)J(gN8$EfD1{dPLC&snp)@gU#B}d?e*W z)N?kvH-r)d>k@f>3K`+zw0Xm#!r;rA)}^1N=#P|w_#0j^mhZakP5A{-SaighW2O~# zHT;KOmIh`zl4$HDY~;i?YFHs$`T8}@n(xN#+`>5H*VDfn4Kdb8@%yemUKcP z>e|*5EN!vYa!%2+lpEeudbVB8X;&JACM=Em*0)wh2U?&e3{OM<>~2zYq_I^OOqjKq z(G&!V?chgNi5{+k7qc~Aw*iDaudI~Eq37PYv24T(;ogj3=pYBIDm$4k&mVr{zQhA| z#4FPfa=SwyCQNpScp2h^eAvjgYPw!CDv+DPC5WV#JcwW^6(~BKYM3!8UE2sd1nJPZ zVH_+=-XZORZWoH^E>r$tPm0+du>=k{EuzPVfpkYrj>^CxbsPl5B}@$z{S@VsTb(){ zVR`_3Tu>_jdZaTfs3h--Ktq1=Tdcd_*w!W>O)0(jAbQ4U1tYWKS$z}5S5WhvAUfkP zH&y)@NY^X{?_if`LZxJ#{!>e-JkxwUAaMoXTY17Kg)kPVwu$F*N`H`PpqX&9S5s5q zGwe*d_=?X~&pg^kL%FN4wtxpz)7Etk9EjN#S_VEIoA?d4Om7-~eW3L-$BO2SwH)WY z$z)HySoN=BW{>Jqx21r{{NX?t;tXKq5ia!*fSGL9;wX~Rf=m$yAQbH4N-u40ZDS1O zjaLztRZscII;L~ur}3pymo-8pbno<7h@^XE z3W4rR@SWV}w&_|VsN)J`8;WL&6Y@sI-7o{9ih@FJ2(Y|44{50>0K^cpLm0knBdY$w zUfjO@8hp1UvBWN{RvNp;~QD5;DCao-+ zP@R}-fdgQ$0sYr&A+00<70tJHWAZp94WAc3=?U-2vXh6tu&!&M$F$g^XOHs0QGVdv zSn;8pZl4L0rqe6_{`H@fsAMpBb^_Y-h~+WmyP zclrix=a_h-c{_`U0ojxd6)u5GQ)UjaT6Q*+TgA4^pt@R?3Zoh7RL8^gRBvh<>HnG%yMjmgEJ!5&#k+-uZ=}F4YQPHcLBm8 zk+;PzWe>cB0OO|bO5&FJs=KgEVHbaM2g%)5m!w#)Hs+-x-iW?+f;WCM)%^ssIk_>~1u&_^H6jiTK>JT5B=h$8a4zh{E!}M6gk=)Goij zvsqskNL9##$A!|dRkU4E8?lQ>>~+4I4_MrAV!9)qZaSU?JVqEsSnou(u2EMprY!iw z;4v(#jce`~{5_IaQ=ZMTA9Mqg(cHqOM1$SPks1nyz6DBd`?7<_BcU>&f5(?peFt5z zmYFGcX^Mf7h_+9PyxNn)LUNO?T=R<;4(()76mn&T9C_{n=?2`s<|#g>ULW07+ZS<< z7hl{Sme=y3mpb_x9g+kWArUkBRcHVJ0EQ0IF8~3X(*oGl4vL4xNIozPivj=u00045 ET6h$I0RR91 literal 43488 zcmV(pK=8l)H+ooF0004LBHlIv03iV!0000G&sfaksPw6!T>vQ&2UJ%gRpOV>D zs)9rkVDrO9@CKe(@YECUelWOVArpCN)-b(j#!$c1X{{im2F3-P7czl-4F8y}t(@C* zUV2upaS~!Mq3_ZVg{ekFTvKMYR&(qB5i936Fry^lh>*0p_batRm$N}S!8YxWyd`QL z4Y(PMAqQV;(WO*j1duv2E{6nE z%Wi^p>sp>p+E?z#HqaD~$&SwCJ1TVXjL;xU+PzJ%t*{O4laYSfUNw#5UQ{xpHTp)> zA4_nN;BPN}fF01VJFQUr@(s=MBy1+xA zb`6g)nHJsQ%5|Be`GXr_-F7^EV5z_3rj2Z81dp3M9l2=C#{sqy$X*v`j#N_&?ypTi zH_%R$!C18j%!Vpk?nRlca2w()`HVrWD=pH@b*)B-dAKC=Kh3)Q&njeu~P#+ znfs=i-h@po!{P(y-)7@8a2Yw<6O<=mWJnH9nBYHe$3MT6N@aRM64ff>mL<0AOgs!h z3bNZ(OUtU4;dA$oNIJ_Q2A987tbj#}+a{SK;W>vxpvs#`oajxDhw-&@Hq?_cefcWr zA^lKR%OA@-B_3E|)q|_X3$E?_RWCIW|DYF+6f9?lDdKvcx%}OGwR*uB#w(u0z^}Jz z<^^VRwKbQoqY>ZwEe%>0q`G<5SIbG}qwC)ra4D6ShjP(mN zWlco4;-Ug?T?Zz!{T8102K)2H|EdfA64CW?&yfXH$hq)#g-s+Do!Y@6ga!uwu7qR$DZrk@?sysc;Dlcq1bZtxTm0x7RG+FkU8Pz-_J+5-Y0#XH%O zRn12W(8$71Z@hsxTU)F=z6j;zWLTzvv95}>d44oGD1x_PHr zg|!8o5>&*0%4xp%RO6E?9bYefQnt;*HT5Uf`?hh3Bn&6bYm$WM;~BQI7zTFYTT4(n zh1j$JM>z|t&k4a_@oK1#bdcKuF_cJj51wG<}+_(;vy9%J`p?<%LR*2Oe<;Fm} zN>GC0aE|?3TvHqPCqK#c;qWJNnaQ0eP+4>e3|@MBfLs5>%bT6nQ*xXHjfb61ht8?$ zx&Qm!cI#6&`mGP3{)JA-^@zzGeRfej46n3Mn}civTI!=bde&@wab7r_jNts@8X1V{ zNfUa-xb97;E|LSu+kH9M zAhXdg_}Dlj{<)<~FuPXk>f?wIKgwEeOWh&t93LZg+c=2C?-KVP$apLlxvtP^(Q;SkfMGEAa+ zW4AAeU@U6Ze4KBJE3dY>?m|725vS$(uy~BU$=YgLUs?eb)jQGvuKURc8>$mxyB-0A zlmI$&)uJZ65GUl2=0j=`_#b;@ZdP4*3s;Ot`|Y4D`cM!cQWV8Blue7b1ceW(HvWZ< zVl(uC-s&QmZ`mrrju8V_<3-$mMYA4HhMEHKC8R;!K_u;a0HH2QW46izj5(-iAi?$y zLBY>$wM&o>b#YurqXMCSN>ggbFR~qFfnvKzaBbH-{?7%jgWo!yu|gj$7o?y1mzLW1 zS&K&R!A!1TO@o7RcLS`1t6O&#Z>@Gu!PE?Mvg|_8VKv|P6Z_Ei*{>)%zTHIGem~PR z|NAE0Q9So+u||4(@Xgwq@iDXbwmt@@K=x2KSu+=Cf}?&QGfQ zj;Kfofe;?4eLE7t-FKRll$ikR7Bh*NwH53i8MxR9c{ZZiO~KPL9d?o7E9%FB&?@M0 zo)=Gg*yOCNNd)b9_%LZY(*voDxGdmr6?39w;QS~;LYLX|$)yi)Q?lV{r^?&;QxfAj z%>N(Fc$B_E&PrAC$`hlM^8R(WKNgZT9*A{=!%8yy7hQCYfq`oWlUzFO1r`U3Ljpd7 z+fX!8>nKip*OyJ+3Fc-WI52MVlV<5S7PC=PDKFBVsZ^tY`au_c3>SS;N38PJyXB+S zib&h?qeb@C)zA5d(YHCII>g&H+@$@~gsOSiDbU*L|uUb|CL5R&jahke7o6p=rO;3Sl~X!eK& zA{40U3Dl@K$^*MqsCPtgg~x++sGmlQVs(HX%FKY&SJqX|S1{U3`LDytEIpg5L2uri zI3}1r=SShX*37CgT^Su+V+`dAcO%D)9#`5~LwFcWT)kK$6SjAb6KIlIe|^JrVH?7@ z9l16ApTR`sj#uVof_5Hq{o?~e&||f^X@vk7v&L5}JC+W9K9E;FCA`}?e|#DV^ZbGC z>hbjpuOf#pi5OY1c%`IP!d?04ovzGuBW!t5e8^;l0(5>%^qTy;xwT?F{K#l$3Zf(x zBO%3LdoS50)9u&6rBh%lz$aIl6=h;ae7R}DsY zR@NXFbP4@UxS1#;j~HM%fQ4ITNG$#Yq$5_$ulT(e2&+ccz+y9WiIt_5*X}s!8C}Tz zZwDJ^6TJT=x7}#e7Q#u2SGh5)xKmRxJ?*D4rX*mBH?!zMJQ#fNT(c?(p+#RS7n#9! zvB+`%46y}-Z5D$JEyl1e>&$OlJ<30fBI--01SCFn<^nUkp8Ns=jllDo63kA zz-TZ14AW|W4OcD`(nt#79G-~1V#7iSu2=-2xw2zDLZKUbA9$yv{jZ51*YhHm`A{;x z6TqlP2b9Q8<>v`q$jDR^+9~2wPeE^J0n~`7^g>T!y&uX%cWvR#=^N?wZ7N-LBy;kW z+u~kFn`r4Y0C1X2x>Cb>9b&PD0@4|Z25(g*PpjAZa{%Q;?gyV$T40}N&%M*KHYze4 zhAsQ@dlW1l9Tkm6bS}uyz<{$pRO17hNM=Xb(=`C+t0nQi+29DD zObsqPm2n=sW6CA&whQ*qvx+~7^jTV>UKuVtMNLk-oqo-5Nl5utFaMY`;{-)GWSAI@ zl5jaTN(PYX$?5WK(x*<}*TraT7|UDv!+86c^(ks+4&|@I-0EYSP|6Smwj3B2oBV)v zz2EJHdC_;QWA7l-GdmGOC-@vxG07NApY9{B^~Kf!bO50jvgW}2w+mjye_d7!_ncrq z(j!8S6`gHfCJlch0(M8Lx*uwdVx#1?%s}W&I7h*wg%cf^FK*8uLg_6z*n(XZMz70= zX9QR2MKfwTl&?pm`D+$i;&9tz%Ir^py@cW9CkHMqyoCT=lgIIyhQcB0T+f;XI=l5d zy-rP)0a1F7xDr(CclKrtv}&y0De2JX!g3S=5*AIrDIB@d`hChRHvR3$4zYJXtDOxv zPaY2F8-Tt*upCcns-3gNinq+R5>t`l1C!`>%MQ#1P5xSY(P z#O%8p>87n^4{_X@5d`_aU?S5_?oQ?WuT0POnJ#A23Y5ehcux})*$T8y0lS1{KLy2 zGg#Azt!)QP+C!)4Y&kLdc9`An7|>NZ-Vgr~$Zg7e-+ z`=o;V`_xyZ%m+!m2VcUoJPcWsXl3%RgP}Wu+uJ*=F9>)!xKva2PHa30=-AS)Zm_wk z4O%Zj!l$D*su;Tdu-9a7x4%m>d! zweU9pkxlQKfcY(8F9Z#3(S(dNe=V!hxgdkEtmu%dP}DfHwKL(d6O9%!SmWN;gLA@q7gkD7a`UiJyK_j7bd90FzzzM*Iiw zj5(+B^xTs%e1M4p6 z;f%n?(BeoE(k6ZMK*NMIflZtoaWH;O4oorWODaUx6zrG2G_(IN`^%^rLwL)*CPL>J@)hgsE`i3h$tvqR&ox zsa%=yrJIFSH(1GzV+n-#C4JUXW$Jp*~(j zez``WOG|QZNm5kv4iT5UHmOfaVdOpXs1r^k?A(P2y>*&O2(3=j6clOcuYYG>yyD+9 zs;&gP37*}qvYl2Hw2!nKk=v<>@8#W06GN}sfq(L(h+#?a-A7XK4E%CI>*}Y2XO_#? z=FI9`_PF^ZdJqZxEJbWqV7pIAcB!ohrhNr+rnQdEz;neBsL({6`3Vbe!CCyG4vcEMo^V(8;zm=&;^O9#JRP6z1 zi`NbtHE(62k3E3{qv8Z4(=v_vIMkVD(Jp9zhkM3EjTTAkLG4g=&@}cKdUC1@a`wnz z7DBJM@lOq^7P34MaV=)M6eEm&qRTXSKYK|KCWpxtaA~-r&s3mxqDzKBG!+^%IS1#3;ka}pv8&%Fnoyu^ zAD|}OQ;*O+T=FTwQ~hGf)&zCb@taU5(f+)E{hD3@y+=N& zs3!(+5zgr3W9zKC8;ZJs6GRWKZ?!%7tX^4Dyn;y?bu~FM&m&YO3lZ@EGDw4&wYc+O z+k8jgWol2Dc?#ulJTZcL@H7vdOB;5>$io%U((e2U!4HQ4SS4tir^aip1gAhNoxrr} zJ$91PNr;R|(*MxoZVHI>thJY6jET8*djapLy64DOP^OE>eAS?!Y>1AP8qjB1SkL%z zCj0~#u-LC!q3QgK^#UJndbWeEx=0(1;F{IV;b2<)>4EicCK7#?x$OJwiLG0yx*LUj zo3TNV5T_+Mgo@!<=<*O02Gm<+{{tn7R(*C`LI$h!mEE{X;&u8*pxbnwKC44j$|ZI# zNGy*v9wK`8L+Lcir-%PiPcZH5Impt`9&qM&1An<#RNtG|X;e!+0lCjh?z7byXX*}g z%q}Ai)wC9*`zAlP$9O&sek9B8ZSA{u=h0k;gDacZ`ob|jf z;8PY|_i`2JUybozcnnzN!4h{KKfSN_qWG0-gr!@bHpkRT*q)RAYb=TZ2mxhjpHD|k zM^iw(`3VCs!Vdl)b)^FNt2kT?mxPZxavh(#FECN-^=_3A*En~hBP;V^y8-`r%?M8V z+QicuXll#vRJxZow6+YZERZ7hyB}kZsgoXG8;!|xC}1M7;bxjAG7m?2)BVIPLRWQ8 z+S$Z7>V&F$rEo0Jru9X*+Pp&sG#N=5lH_d?KkS1+<#+|ttb~#U{$eVtoX94>k@E%V zP^dpUu(dR%UvSpm{6DH5-<}tNW7NH*gfoUss#HQ1(#nC5?f5}l-j%KCUNNEm z92$#BUeyn*M6ijTCdCl*MMs4}p55^R$=-VbxmG0&w8{UY0ymK1kzhfm2Ew~euQ{`p zBt-*~gPMMTWrC$Za-IutZJwZEBGRx3#0B*S_gF)ukj5`#j@@LzTLTxW+Rr2VYVLtI zQjD=()~{dH)~Kpt`1k(CC|^3j!TxqWSg_GMq5RDc9pE$G{^&epjM+z>%>E5p>Sp-- zj5+`YR@(1E(6@eZE&;H4sHW4+k#ZT1t6=aC?p)syhgF43f{T0wvKa5~yia14M6Hm7 zsf+wr0Z-GQ9JKw30?Dur4$CRX*l*nnecPY$s<@Lsg=Xo#Obb7&C7dvP6e_g$B67I& z4_~N}11L2<)4HYz7WEKgi>J~4+lzJ10Dlvesd))+99^bR2DTSg4f*i6sJ}||M2$yr z-9`4**QaA(1>01)OO`A-9q_G_$mOMizYCcR6P`s45LjRHz=X+|1VeKiPv-!i)OF{j z#AH?xyDe6_%4(VrbUUVKrRB6LqXs3o+ke6dfZW|hpROsTT$BT9NB7^Q=oe_6_XPg0 zW%!5>1|4(tb`>r{oW0oL5?L+=N60+)yZzdES z`CLav7T)~+z}4u|hGjyTrZf?@+Uce#`s$73h_QpAeg_fXabGI=(h-TgHXsV4sdWVb zX&VV;3iQI{m##B3YB`)NZD28Vk|xa8?U=0fqZw|R@d7ieEgX}2IU3iJ=RMHr4$*}| zfTW1YY|`HbZiG;V#YHI!)(i%dKqtGX|0-3z_5A0IVV6&2X*o(xCu#a@>G}q(fV2-! z=Jt# zngc~FO!q7uI*G~!SkC|BaAcirH;Ng&ENi>2gR34G;otz zf*1OtZ1S!HnBvMO$g5N1)p~2<&%rPo0olt>9wY-J+i&A>eXJhkb6-TMlvE~OsT&yB z2EX-%)Y}{HeVe=EnI1Athv0qpi*Apa$;1Y!jr+rEpjz6+1`f$!@ptnvf5QxB=c})2 zAi{a26l4@vTB>&-zM?ZjG(Atb0Yb&fbF5G?#IhFr>Ia&L%z|-Rrv0Sn`-vX{q=Agn zG?PzyS6;7qKi_+b8lv$4Q=T?G{itzTDpT=lGlE9k=iC<7_5io6mv-2u76^v;g_IH$ z+wZhKJh`N$%>^St&()c~lUj+?fJ$jxtv(2$>PjBE=uqrz?D$6%=$jb~Kv<$~nT2^$ zs&8k(A|hDMQVSiehXmA!G*LHvI*QTasz6IgmxTf>$PKGXa7cKa)rd2cdDaSNB$5^W zjcUPhlr=V=*^Mqz9m7j3%UP>R3C;*(4Tc2;hv6=jC8IB?@WA)PJc6+AM8oq%(ntyRQ=gB?kI7dQA9CoMFsl9T*f+1uzfH0nsD z)5yxYp|c55FUjiK>00x)g%`!y*J_wEw`uETR$07)cg_M}I@*etjp;v= zU4HX&J_iZICFJl}8m|vnDp*lhE+c22`O}8B^XkN#spbDV=smJ#)cemcizFzRyBLrH zcEB^lA8H@RNuAg(o=6t*EM~)U0Snm?r6=cOi$EIyZv;4leVr{P*u#D4#-+Eht&~My z_8{nE!@)G8A174M(l1}sa(P&#M1<|zTP5-8gWVmM25IX5Keg;@{x6vgk12}FO~u`3sIa*lZ^ zRd<34g;5;FxqBBOhz8Ku)`1YXI6hgeV6oI{L4P&nHjT9~YJ z^ZI^|3>ntQIlIRRYoFQh<%wY2)`H+g7%cxk;6b(94s=0+cp1IdX=|Uj1VT??k>Yoq z*M!b1Q26C`7gWY6JU7PE<`R}aP-xtGV6F`kEZM(F&-F)J<%ZB7;0ygxCxkkz?X)!M zqsl5#5SmxVyRn`D>V0}yp*l8`2>6#?5WxW2)5E=5*zc+-H-obHYGhebQ*P|<3m2~U zqaRiZN-_ps^zKfQn7*La`NRoY?|;FYG+NEeggYt%4eRx1$=7%B5~)~svfWU3iMMtU zs#OBi%_GTq-}@TPTuEx30A{r;w0ktS$yIr8N>1+mu@pI1@5nQh+bos?RdozQSkUHD z7~rLOQ>TmwPi+F8n}6=5+sG&gg{#~kcR!F`=ZZSIT)Jd+dvTVQtf1XU1J4apVUpgM zxX7UBU+%S6fDGLGe0%1j^+e&!$p;3}x?=2b4Gk~eL5?1rVUCQZrWiezGG%FytYv&Z zW6sCgM-puZBmn-cUnaL`mOc99%o+qWAK3HkpsoJiSZ?&a#h@8z&|pN!E&k&O3WQZC zZ9Z7$GS&SEW%uz91Bo4f-p!|4UitdK#B*qObnzXBHrr80FJE>E5w5I^TA#vVOrM(X zzQ;*>l#Tbd0tI5esag{JfCNa5PLqBmWhw647ip{0A0o(`o}25r?A$q6o4Gzqxp&1Z zRDE%+L^{h;k)7-{Pz*NQxJYrGXkVY)QeEoR*ZmQ>G_Nle>Q>+?m!bn!0#v8r{o3bP&1BEza7l$7f)ImQisBsRR`f|mGP$p)ZwH*)` z_C&>Hq_@?y?9K3oefI;Os*$sv6)x|nj1prm301U9biXpQ3wQ8bAJY{u8$?thV44mP z>D7y;>$o|T*iznb0;XMK#-&AtjJ4h?B2Ofo>^8s~jyWZwc2Xvx*qwZWUG=Jhy1aNR zQ_tpHa6M=CAAAWis3Uy3Ul`XR0|AvO$*u7@X9oH49&Tw3(jP+u-IUa=f#hMa@o|wJ z65bx8^NL3|EEwBJ_>1ddP_u0REd1wBr<%YJ^sGvm@37#PM$y>3@}Sx|=U6U-3H#Z( zSnNavC4eqVa# zCTG6Wk1e&|T{PY752&07)A^Rh?OyZ`8vjDwmiJK#=OS-bfe=N(~u+gl4DCJLV&(Ty0_Qn$E`;Zwei0r5x|zJWx|fY*UKhj$ZP-C)*07shb(g zT=lGXrG2t~Y0frVA*){W_$Zuw?bhdQQjeoVq;EyN2hK#^z#I9hE<+!JAlmLpB@q$8 ze3nN?8ln1Sb}>Lcw;tVLdK;ug&0N%W#_@&WkwBvPUACc+ZlBQh%>F480o~q(=vJV) z@m+3y;{w||U*2Ee@Xd(8aZEt76bBeV10NNg{hcv6_m)Py^4)}Yex^wDZaozpno|Zw zHD2AyLHcSp+6JW+SRjYwLKiGUzwrPt;A>(>7P4MU8`Mz$%@P_&J;Nm*L#KTFC3qy= z42~(wywCON+;!(G<2aGN2!1BXJF5%uj3MtwHB3IIO96AN6_Y^4$5dYjz=VxWjTC0o z&{H~JeHi3vd)QMH*v@lg)_wf*z$PHI%#R>~Y%feb%|O&kDT!x!2AH-lVZM1C9gcw^ zp&*ikXQ=TizbuNmmJo9F6lt9uMO$0vKdYr%62e@LE%!l|?p*Ary2FpRk61b+LpZQ_^ z86~Bi)3UT5gBq@z1f=Ra$T}a0rd`E3U0;}>N+)eDzfcM6Fwd2$KwW0}!q8gi?)of% zng?4{o{TE;c$MjOjBo#CGO<5O?``k(rN!mfLL{>=?9Q$u4+0VQF}^?IlRj80dv@EtIt=D#}Ks+T#$tAB))2rEwn5T(X$F1NkjZ?!Ku;m-B_ z;;n!A#YjBZCYOi`&Xh@tf!GFSI@CmDW03j~Ejr|InM`;NM;8ya&%o(A<1Y7PBK7HL z*x;>EnUqBnNxuL&nRXnz^p7dHyCZn`m;BYLaaf~M%ol;RH9<)Mnt(Dv#mw%oSAwTZ zzyg=8G=&`{<8D`-gpHQercg%sXxfR^j}%3tIXzI{^#B4dUMZ7;bD8HjT|NZq zmIzWRYd3mD7G;ubmD2!L&q^$mYmJ5ntn1ZRpwhbw%1Fm` zgQT}@L>K4N@9YW)@5pTO?2y?7uWk*R=N zTlXcwBqOnAEUPihUXFjE7hftil0GMO;i~SUgC~I|;X~^%DFq5dwBEVf!lEbW#{`nl z{8_x5*~B_WJr)jCG>2T%dWIzn9Wz2vJLH~JaZpy@D!}=M`qqO{4+V4{5A+$tNAQhX zViK7NZ7LnWT}x9<)|dsMwEhU*vVF%LjL}b2Mcn_*NEZXE6G8&XsLU41Sv>``9BHU< z4wP4$pudf+96=6O53s#yJ!1YM!=_^}j2G7WpC^;QY=ZJG?#bgE4*Eh`60y_A*f75p<>k&7yIX5=K(U(~>0F zzTt)wc@=Q6wV~F_GHR1F!F_MR+ns1iBr(6K3ntjN4hbdagm`d;1bV|g`xcPTeMimP z5m~HTzmdNyjzl_#l>;l`rt`{2C;XpcTfxrrYUi@l6 z%(}W_lL36$?&vA65$c_z<~Y(33cO{8;tZZIf*TIUzxul&%x%?s$!}-ZL>6I;V?0g; zt4IxGOq44uh?k`oW#$8dhn9DH+jcLUd}^8OJI1|E3LHC#spw#6+H`EncO;LACrzZo z%Qb^L$s8bk+ZT4l!`pgKraI-k4(c5@_YhkmZBLf$s&Aw>yRm_-s z##!kg(c+PWm4Lx-;t&m5jTIUcd$S>f7@=WJ2SS?P^k}LXj2~fnlG!$K(#p4GGDJ}s<78qwwt6MWA_%Dp`Rqhbf-emwWZn5Q#*=?rn5Y2U0oZc^1- z1N;M6?Zgdh#59#4)B?NJEr{lmN%Xh@(qZjuh+N%3k=x#X@gX_Uf;&c%^`E3jf`FFK zOyK3c{J*^&1~XVIjvAkYl~O6aDw3s?^H*F;VfXl!L|Gt72$U97WtEdx9#JUxX$~;? zXuq0mc~#Lu|L-9TX41U$BsVu43IuNWTdK3cGTnJF~JF zoy--hGp|enHOCVZjJIVt<<7zS9+xv5t|*BuYFCPI;JJMV)hG@@?8RXz)FqNP;{?bZ z(kX@28fxQ6*3u~+SBwtqe&*wWf=}Gc#a{k|(0qM9>S&OW_~p(B6k@(SehX}tC{1jt z{_c*9&?V8v@*^8?In#pu=fC6@ zcE0ptnYIlkU#i$)iMk5pEgzer`zeOpJf3+QXcsA9&fw6>yg#oP$N2Z%e zrTI-UL`X^M^%M`H4H08a4;y*6Qhrlkp?UiyVo7G?7os-BTJVn0a6ePm)2dS;Ep1lY zTk~n?b4S;lT1jQ!U+HIL;_#v2jTe>=S)E6Cg-n)Xfr)h{@5q$mOWLf`3k_EX1CEVt z`u0ZCdfT0&ZEvT;nDHqY2;kF>sT><1hp#Om>FaGTz|cB3GD{*Pgy*}EkuHCFXJF)JZx=$f7mFcW z`H(;k9Y<)_UOTBu<{58|WGX(p4+}PVt5wolH-Pj&BN#*2IzUPAm5crmqZM;f?ae;Z}{=hli+NJtl1jke^CHIQ5z{5K>{k$eMzkqQA z>!AjXqM;@8)D7$^uChq!!I$rKAW(S34F;wOJ4TkdhY`<9k~jB`h!In(sE)uBMgZf7 zI1Hr&#_CQK9sY$$y~#(eChZ=R0*^{afO6HcZOBtT#}EofMTQA1~DypYX)_^Ht3xkB~>O6yO+Q@ya3|qlj0W^W+-4n^AUv6@+Xd}gI~ znf%5AxVLi$J)}V^s!Qo4wuqK|s)%>#RZMteKBVr|qP+t9u?qny9tsIQ1U-uk0%?}s zHU8%am zq~;FTmFt}<`v*3EC9sHUvFeU24lg4_B&p+PBf`QJcN`;?Cx!|MStz*xWAn7?McAqA zpnWd8#MYUaqq*kr8I{$dFIHWn_fLG(Z0%GJI$n;p9%#F2D0eK&7?RTjg;jS+wd$u1 zrPfUvUR$3C*MQ)+DJ?TbDTLaZX_*+Ka#^G6k4WtBX4^V+Sci|vcJZDhYkwoJ$lCQg zQJA2#ttj~7)2@5Xr8sM5NL+H}82_>x!!vh1PJUhxJDAHHNZ?&s{+*3a72|P9SvsE; z(>ZN+!h%g|OkaG0x6VEgQ5Y{3Ld)A#Du{(V~3<3EHTPIXDx#KX829mRjB8Q8Lpi`zvS%CP|!yvy`XE=z^~h z2EIKCqeP`!AfIZeqK>zz`x&253F1L16$m#}i&4y`I_8bh(eQ53f8bIIQ=ts7YLS{E z{F+_MmcIfB18+8=+bIt8UTF9ZY+gnEr+m;76S1uaHmTzuKKDlQ^M(XzbP79>ULeWs zHr-_i7psN8Z|lA1KTPR{@LT>!kiIuVNVbLZ;7JSCX_XfrwH9^wF zO_SD5^b@f`Ov>75fu_8W1nxLzSYOCh!gg$w$N!q(-~af(2+_A)o#4?Rj`}aQCymq^ zRuIfBvP&u{;Nd;HC*c%E=VK>s-Z+VGmnTRm zey4R8DhtCD@)X|;XQqRfb-rSC^Daq6D^C5i`n;L;r0EJFZ7W}-?}$tRrZAi|cRUnU zT6PQH&LjPVAV3Me5BNcA#Arn>jlto9sJR|0B_)3}(*_xL@C>a^~5 z0ZPf4Z1>K#S&%LVJ-_Ryrs|d~#6~3!WiRS(jP?C=j_c%HWShlZY?~e}vCZ6fEhun^ zonl)U?gKtGC)@1icrJ(o8CqOj<&~&Seoaj_2f?Jc=F}cyoQ|$-*+4RPf|~60I$GW$ zh?$grctpaSDFc#czSD_Vq_(!R8pJFAqIb$+vyL`_3Kx)z)>?aWhFg8gZvC|t_8g5#oHO!iWwJO8(Agl1C!;%}QBM}}N*_0bK zHj^$*lE#-*ZA`^qN^n{dwq{ABTnOnaf$ieszJDn3{FBQ`t7ilMa?Ou!|In;&6ZyN;L;lcRf zqu#xK)3%5|&~%3_oK0h>u^iJD>;?;@VQW2E57d^lBCDHPrUFzs02?r}yZ@DP6yZ+{ z(Q`$~MVP#0X?5`loa|6LEGgQrEFo3^$|Sj<@ApGgXHc-GO<;LERN!a=MMIF?#i@(aAz@?{Ugw$@ zd05Z^j=p`O_VnqycKZtdh`L@iW!Z$tSm(!$BkjcYC?}>l4VHm`ZNa5v9v(dVmzBkcZjD0JPi7HXFWN`WCxT1*1j=;JSay~z2l3{@VY#}|h%!Jfj z(*B`_avhDUvPA%gKC+Z&Q%7YR%IT?clHHeOF!-QH5lzlOsST4{)$Qv5|Kp}T!w|1Vs}Emb2-g#tFf;bPxaD#; z(u9%N+agxr-`fxha;Q`>i65Xfl_dFVz+Lu(oTw!tedxZb3WgDXr2m6P4&kzY?0D|= zoqXPo$6nX3q_-Zu9^0s^JSjA(A|U$FgE#&)Jrb-00+~)sgSy2R-L~z#GtJrBF7N>o zQn|os9x}6%wDJDU$(D*7vyrC#e0jK6J|sW~2DeoiRuRfhg;!b`cwBK#B5smAZdVva zYZt}UBqI)P;I%0OwZ&;5ty(7ipRKf2Wob#M@{8qjO{Lj4wT=gT)dkZy^%hYdFOZc8 zodc&vR9?OIw|pI{f!9kMQi7SnzCPKSrq=sO>VHw>gm|(seF-)NX5Hmk+rM8Z?Fcom z?tJ@)ASqDK^+(!>RQ|(D^a)s}Sqe5nQwY}qH4SQyrBqog<%WHF3YY=BpK7XToF!7n83+yxra=leIUj_#3^#f2@pp1Zbq)^0e znj^f~lhb~ZCg|^3`uHPVK;JlFNs>nS`y}?@+xc`vY6$e)rS_g)#^CxsVHVg5f*TaI zKCQ|j5M0m;*~U;Nu*&3vu_vGVaiA+`%`1>3JZ++uL`=U2S zvrRw_%RRwZHYn_idJqPLP+w5@p{mwgYy9-eTkV}=OzFFdzzEIV{d2*pQ|_y%u4!xQ zlG=si`6HuhKzyQ#Au$-r+9OJB6?bYdc$ivVhh{+lYCf`!nLtp0{ElVK@8N_?JPvUV zTmUh>80QPtzDrP&q#W=eO2meKwf4ky2)8|M4UR{+0?>^O6IJxC3Y+K@pOG0FmKD9F ztvS+6NicSF4VzdzoLjoPF`DA?L z0;$ecmHr`SenEsDAP2*(dX+FF*~o+;$l6g#BYQlV+r#HZugFCTlIvMb%M=fGHq zUK0p2s+n{x+F0N1_P?(Ej(Q$-GiU@VYK;VVjcdZ*z6D_tVT`z?p=)dUlRQ;2veCAQ z!9+WiEwr!mw3xx{w)oI@4T>qMH}kf)Ke^AK&!WK(j&=Cna6;Mx^N&}bj9#cEACMRV z=~8Odf^=%+YToMuxjqXDD3Sq#>wvxj+Fl{cK@=XL3xh)Z+{+V6C)a*KU17uc-sCi_ zh2EXbq@q%nq?ds7-c+7lh5jTzQAMT(njCT;9=1HfrI58^p>e3I*;u67&Y^*%28`56 zXKNb)1k!t#ie!zkxQMF%T6ZFJD+_`oK2^ETiB^Ph?by~iJvschD?X) zr-*bR1iyn7^vyA#Cb7rA%zOUjzr$ebod1-is&EJ7JDKQhBEJ(VJ7gik8P}f1o{ifl z?+I_${J!)~i5%mW4W1hKl4L0su7*^QfjCAP%lx6{a^g7JkmTY?id`VX(6Y>su+&vy z0y$Kp&r}(Ra;-eOH-TuJ)VP_tM+Y2=&GY$GAY`xWCm#%)A0H-1?r-m=upgLxOhi+T zM1UhOnNS=$EKsHJMdf*V)2pvD7lUL$$%5wV7e=>#OD;s=sTtzYO=#Dnwe_@>3RT){ zdr;itDS#bKC(y4+4oJVr0mhFshW>TX#%z97_8rG8KDxobT4*?TKskhomUJ#3SYa(# z@_Z7+2IZ{a@j>}(&8;bTmoVr;ff`}f*l4nYE~VD*jf}VJoFSOPZy_ zf=iwZnegYj$2S5?t(U*uGRmC#MUOPX#-5q;Y@P{!%pR{I<>#6SZ@<`5Mm4>+U0T%3c#&oq; zXiNzV+fx`BIMZ);&|l^NHjMOdP1ABh02L*;-M(HI|Kl>kpv@@&AWV`c5_0>8nW(Ef z(|-qwWw;jqKKxik7qqYV#X_}vww>lhIB*xYn#LbS90)rNrr7uMh(IbnK7fVH9OYPR zx-~fI;#+`hXVy5_u+;ua2^SV!RM6~FgX5dtW9X4aX3#pW*lXEyBq&p^e>(yCvheXY z@F)o346o#5U^EMC*3MM80&Z?V2<=`I(CUY@nqs9jv%o4=-g+5CVQsGNmMrmh_3wVm z6bt>_d6?OoCye9Rd8Y6Gfb3qvVqM46CM^ItK*qn=ctkNECLjzVPS{W$Il=QnQnxY{ zOcD&LS>mM|mU~?V`7uQ#yj%M-(fa}1e^U*O3v8Y@v*c7^|5R{de8ojwGLgwK&qOiL zGj*?nGf_zehcF=Qp``=yv+=*@r$_Bl(}kDN`tUn|_6!O5T(-Vjdu7K=bLWsb-IbGX zWN0a@JESh|Xm<2A*RjaKrLF;X58%&85y&~fw{FF%XZh1nMPIr_SHE>(Cr!8}yAdJC zFz-BS)}&Va&d-Wht@4{F_&x56Hz$ZVRnI52$~x~TxvQ+={?@Hq7UFpr@s#b|&Zx3) zOQYNDO`O!_Z4Lm6SNp`>hzWels;wsR_kQ@k_JvuQSSXcZfjT@22qo2v!c~2A#f2jC>hm`tW8{Orb2GyiBHcF{O5wjRg^771||$C=;$onq+FoSEF`&c|MZY&oB1+9fe~7I-&!T zyiQO?*$Q(y$%AY9!j5t_U+w+3v!pMt^KV1I&C>%KslXGSKKu|KDp}27lWgi99u>hH zi2V#%0SFI$iS3OHIxA!NQ7>qc;ndLLAPbIMC@uL<|54z!=s7h4dYtEVvYnFW8=H>J zu?eIiI+YpDGDo;a>Etxxw(6UhD{M-K)wiaFnAzEIBdsq!zHFgw%mu6m7vPD>ASn{0 zXeTKO|6qd-%Po;6NOL9`svRNbe|?A<4^nBnr!ww`mi#TfFM8%+uN{;s5g;_j_$Z_> zq#M~p4o#*fQ*wEOafQkqj;6_nEt#@$W16adfvK~Fvx?lmYF>%d3u`)>GKdacB)p7v zJpae`h2Y@He9*}(+-4awSfO{ANF(}Z2=ZvQ1EnZhOE8jHzDC6<{=9ag+=dX20yY*x+T8q*{n*Xv~wA&nLDf0_C8-CB*C))VJOMz$E2?g{o z`n?-dhJrU;`H}`G`zH~L<{l|&lwG2=#lvHWDzaY9|oo?rNFVU}il z)e;A(7X<;|pif%&$4I}C0L36<_}blt0=Wp^Fly|YrLoHeHsLja58|*R9y93!%~hRn zkdboO*oGG($y(oUrhCm83rIeyXnnFnGh~r1Y&3n9_E!7YuRGm;rZU9Y5)d#PB3d_5 z02!lu`e>k|WP-+=kUJ@39OTrGyqX4AO5Zewwe~&NWza5<(0%b?8e|SefTew-bKEO{aC59~J zc<;`?vT^O!k3KK2^0^MlPTD4&?)!GyP=eo2iwyTL2lCp;Ah;j12AAwhsn4Pwf1J{n zSgE^0GRfoinPLlBzU#$vEfo6^F&2$i3p>z^;$r7L!W>=f*@ts()GCtR4&D?L_b-@uYYaAqI2-_CozC(SG@@rMw2QJ0@4 z!;HFXk{mzO=@W^Fu0B6BS=!utv9x=Np~5Ano|+2BQZ|=ll&_TifFZCxV9Qb>p;k7= zNlfQ&UG34I;u|<4{yLKGp3#f&MCPDwWC7NWinKuubCc_YZY9*=O=X2Z`8ZT-0d2T1 zF=kI<`zmXH*Gr*bF*=heaS17hNK{;Z4r8zF8Gm8R@Cu8&FQ_^=pMTt+CWpT%f?^C& z=-SUVAU1ZYd(P>=b{SjG%Ew9gL2c8fe;zZQf-DeKOM7yH>6^+aFxw?WU`zS0UBg=0 zvJvdC=AU@AjN#u01j?GmICOQ0bW(ABrM34}Ky|b=8j))?QW)3Tej6^b4sfy82VufK zSkIN>lfs_ZVT&VusnZZU2Lrkswt>_g%>p11*)58W*5D_)yby>6*T7&oU<-(pZ|p#W z8jGPLA&>D9LAiV3M~vfO0te0Jk^=kga02Flr2^KU%2Hbr^vjWoYIW4OVMnnvA0t28 z#lSUA>kUD;J1$#*0fjY^YKSF$q;o+YhA4X&KC*KLx2hl{@o=LSxaqiv7WsInTZmc} z^o|Q5oc%_nm9?=Opf9Q4yV`6V1*O@#GHyUA2L^Q+!4d_<_@5(=eL|f;-W*JNjddsX z_L%E08e?M+kgj3G;q7!IALxgNyaAV4ednFcg;M)c%r-6=V&;wERs?(6kFF>%S(wX6 zB{7X+Dm|!ljmdm_e|igpRUS{tx*x?9!k(5}$#%O$^LdHgcvHkk1fK2!q@ zzS3P@{9SGo;$njIGoOMy+^P}4AEQ2I-6+)%Ic*KKG8BvLk-1qi=e>NfN&Hkdl>m6- zuEE^Iz;D!(i4r$(y>KQ@8e1t^Aa&@_!m44?H5%Li^dvvR0U=Kx#^ZOj`P$;$ZWdy+j(8MPv+z zOA%ly8b!475){;gmQ zCo`U5u~eA98lgv-ergA!xf<34&G{IO+{oy&2_szDl$~xxq&)*2`Yf4VyRJT+PAhZC z4y@%ExkCUwDXe^BK#j4Z;NtJS=tf75G9E)9D?tr%==qj$Cp9Qzb5hfL2Z zQ00}=$Zp>0XUEc!34;W0(ze(ay}bkO2_>X<^T|{Wm!J;StNCV%_yp*MWfw-aZW?ML zUm6Ve^AQvBEuk*Ofiu8xp~Z%UYII6pdfii8CuiKQi!E*7ySRteGymkq{-2~=poQ<#I0kC`JHskA!u17=BmkEq^eo0)%;r}fHQs@QPS0iTz}(+P6Z>Bs&?QayuC2y7A`6pW1*6JSe86X)3+ERjH$-f(0rNaweN=8w`u7oXh*qQw5cUpv*&41E+{PT7se{PZ z*Rsv3jSRnCay!Q|HP;M1y@*I_2=7(}B(EweN$7tkbVH1dTU4qVxkq=h_$8qPtvCgL z@Zw*N7na!O@JeRbK&H|~!dVSb50%SI}8tq!T-@T!!8u)Q>5;qFcu>e65W@&Zptc z0vDcVON6*MUuGa|Q71U)hSQF;LVj_%Y`hRRNUElajQw%4bDNnJp;-M$G83pMw_aJu zr&n2Z%)Vcg%fGmuQiqhD)OT~QP+NdR?k#g3q+JY5FiD_g9#Za zsL4d0G@x)dxg2pKc(74^86e=dB?e5++?KHRqc#-DeQlQ?JTgUZ#$En2H%J-bBG+XG zP({4;xJ$&qm){pXA?Gn+EE{epAPA!;rtc{Xv9vKZZKHd2lf}_zrgsB4%JwA>w{Dom zEdfc@wSnQYOMkwOML?m`HkUmoRGpPL0?;&$_0@3BO`2fApvH!#`*_^oBjjHPVDV$7 zTvTrBx+k(^?^^nulnG%u?w^Uv1|D50EVJVz!X?uSkZv+66F4$1dvF2?LisbR*Ctii z)(t?8#$cRLSMz892(f4$w-k+N>59-NB)zNp1*gINomjwlY6cGA6 z?S*#fwDYeU(`SWp7bb`0MQ`DQyx!p3UHC|aYOy(6`sU@5-)%xYZ=-4^KPd+SJY6Y{ zb6uk*^)Hd}41sp`L=xT^f;qovc>h-e{-YbQeWMkLvop4mLhC(tZZ1~mqjmoB{6ZD_ zU_&bhmLO7z0Yn$BjkuVLe-AI2!o-^!fAU>H_cbnt&3)+M({52a8R<>29yd4q+3bD7FQj#G$J77j{$fsoOt zFfkl{Q#hzcYqBLsuoSv5O3H*780_7a3 zqZk|)0NCwJxOgu6t^lCMQsy6v;&i~;Cwo#E2J8p}|4BOH6BTsC^?|N!@NCTQ3cCtf zPn3(HYV3)oxc-s>4*IU*w$q{KN&fn^ z4W_J6QWk8&BN+!$tO~L!yRM%VcAIiQo7!vA?M9i=z5yq*c>Us^=;EtdlBIkLZ&&{1-g&6j3l&x7B-XllsQ;uy#Hm(^U|~MfPxl~~Rq!mege#k>C3wAP zChIdK_2q&6fX^?k-uS9gu*oKB#AKm$2Z!j*)YGc?)QvcIZ-~D~h^E7+zJIDl`T)#f z>8NS>GwGZdyHAOeGdQ5=7jh|T+SV#p9`949PE_q{sh^tu$cV9L(kl(;AAk;9nDMoA zrf433*-&U1nxAgQ@qL1p0LwNKQa6Oceyql#CN}(5&j1$E`Jjuu*mRl}=2m3KbuJs; z?}rBjErbO2>k9OP%K?^a7QZv4-h<3rQ6j?pEK*4Y9xg2OV;OKFeK(QKuwI=8T$d<( z4#dH8MLDt8ycdq3Yd8SKGS!LYBnV$Fia1Hvr0lx4E|pS4rW{X;YC+ow$NagQ(cPPi zsC`N>vz`>S{}@9}y*Od&^zB$|**`Ne(j)flktQ|BE;7bAt(XgGvX*a7)D*%h&M?~v z$yOYLH5KUlC?9;?fZEjx4cV{;agA=h}r7eYm-1q0M=jJ|#KaBn?EU3UJ zl^V5*IU6nq2$$GfSD0xeqIJ@m&a1OpGYIL&YtI5s={6EuBiT72;JR`VA4NIZRR*sC zph?!3kl1pgh`Le+5?|VKxip(jB&i@NZ(br6kmcf&czpJy3AwT$TtePAxJXgecSQiT*%K>}*_-*>autCA9N zL%S}2V|~B=0Vw4MXyH=fO=|D;<9o)%U^N(_!_b%9} z9gY9hwo4=Em2%p9gt&8tg+wcYa0Wwgs33NSPd*Nu_4L`QEatC;%Re?_rsrr$?ZoYhp`Fz%<;mLmTB0ZOFE2 z@ylABnU!m85d`)vt7mB~mQU}zDEQ`OA9vMGNe{5Mpm8V02`wEm;3w~=s0R4# zTO$Wrc@KF}(Lbs0;vvG^rpB7xTpf~-Kd%%V;optLG7tO{SVbFf){t_wo~lbdT90Kh zkn=4JbuzA2H=dFq&Mna>tA87|)LMj*iC+p15u}VdcY3u8=23g~{%CkB&X` zb^votgbcS?W!W4r@L~jdMBmd78;%%ZR39Ct!Zr{KURe@%luk(;)X36~h=SSIFdk&= z81X!G>-jKJYFScxIH}O~Hn;C-{5~T(nh|_YQ`oqQK&SIJhXogy0A+7!rIR_x6T#o? z!nEbz@1nb!8jwY8)&RiL#1G(Q=>0Y%5_`pcI)Meu!*G}Ff_#{@pxT9FEk8Dw7?!Bl zpze9FE9KSGgj0B^FN-G3m}pJem+~{!JJa$#q~Z`+xhu6WQTLl`F~zNxeriEpDf=7= z@MWXm*@j)wSOfmcj55H zCAYL7x~X&1A#%Vi2i_J>#rAP%Es zPaEJtg)cP4f;*tlWj342ORWodf>~^Y5@o9aa?3@QxE~D%b{pd* zd2#O=I(Vis(*SnCNo<*Hn5QxrA&Pwb=MyxYs-Mzsg*&h;_H(M4ZnqL7qnve^oapph zL3ZlprM~Is&J1p8em!IDMEyrM+lD9_cMZDM9>3j6l?D^8LVP` zAlF!E)My=|9dthmdx3@dMPkL;Sf#o^e#{;^Pipm;@d*IOO(|^d-x`5}2+%L7`KiJ} zjb_V%KX8X^lgwuA!nr?YHLr=K@o~7J$|x?c#1H04HtGTyzkhkwC8D$%$ScQO)y0>Z znG2X^yb_)1j3{dA7$d8NWH@N~vDxQ!PiJs6nr(DZbOG~m#Ypu}YEoe#D2z(#Y6)A=<<)AI6Sh zwYI`(*Zv8rXV;5%8H*)VTm6UP4q06=dWvlj3%j^d)P612*er0KFA3-Pzpb>N7Nlts z`!fqBgTg~Ve#Uh)c!+uTr{7ZsdyezB9!KQ>cHUJ^|qAp(CN=A1}aSReGRdc@#NDr+)-Vb zaEKyOR0LQ}b(#Lvka@KaEqQ^MZAXisXJ z&NdjjGV{g+7VW?~-7DxQ$)g{N^xZs1LO%}e#s&JUNTrXqI3cg4*>>~W>rjzN^BvFi zzDfYlDM@?Z|3`(TdmfX_mXp|5M`^@xD6g28dVV<*IPGl z(6%4!fZ71Thcqh%XPNR2fcJmsE>AD@Nl`l2M~=T;Hq4+v%$8a1(ra`~=;gG8%wUoc zip_R><;XA`#)HXS+m3aXK8A}%9TvxMJ+ZO9EN9hoVc*g#q2!hJM9;Ag?gJmBUzpS4 z6csSm(;wER)Vou&a?d7;#VEbmOub2$gNk0$&lGoclcU7jMU(&QUsrOgPcnWk3iwB4Lkg|E~;iu8^@MXm$z5)-#H37BRAVdfUkaa zqN#3{P&IGILI&*|I4eAcUnkWD?o9OJEs_t=Nfk126AnY2VJ@w~awCtA{I*I9BX!k6-PXaq#QS}aK$l<{8(6p{gY~VAWsPp1%VlCP3 z$#BVTaP?<%*p}2Rwoe|~1df}b(?kJMRH-&}XOpYQ{I@=YVHGV&K1{K_x{!$w{TrOZ z-IyJ|fQ&K7F>FUI$W<+%kgV4(6w=0$Q^|(+SP5%et908`L;ltqZYgp;5?EX7U_=OP z`s9;|91v)K)|&IDr?B zZ)F4%d-eYL(lyLR5ghts1zwc(ZPl$mX}`xFL1saL@nP;g{9@sugODan83fH*ADsfS z=#l`SdsLsJSk2o(xaQ5RRG=DdTDS=8d)VM{ImVG&cK=xmp#};%5h;Gn1((K^r`Frj z$6T3~JY~;JZa?-@SH~Py#U7%cO)WR0!*snBLFYSaXJNTSvpj?Y6}AztNoqj=feUu{ z=x~JwIINlr#b9#x$)tRrrKAk!?t9)9Wyj1z9ihrwt#Mw0$iWtcHqZgP-KD~0*y}l{ z%5XSFPXjZkCF=NxODti zY#+^;P1{2WPL=x@M+_>+^$1&Amtsop?Z;&%@?XkW$txfuD@g$_;~&&|9KMlhGX!=; z$ZQxOTSm}_USY%E@9}Z8tbD-k@5h=>TdWP9*>b)#UqVP*(mF7HRBEnHX6cvwIJ8~m z0fCv2pHpyOmu&R>cX7+iqmdNbT@u$+!1N2>R;f9>WI@CEJ7-{cK_oxrCkk{)^EDA101!KL5^^0!W5<7@%{Gdkq*=I$&WgVOa6=qKbV33dwMPnSjf_ zxlo}G6lo||FMVGiUh!w2YjsGg9Z7-KRXh!(s+1|AjtEg4MW$<5BLiCq>Yt0JnNAJdI zgq>eKQe9PXu^iGcLR|)}{6$jV?VypS z-ahw?*~IEen^wUJ6PE>oU zWg;12JDf`lR#2esgT+p;#FAM*K8bvJsw6^lrtiy>*%3lV)=Kl=$q|dlGHq z)6$8ism&h9G`O>pccbc~-`%6t_kmzDz&aDnzOZWJgItK}-$mQr83`M4VUvdTvwUO- z@SV0Se$S5mmL2B0D#Y#U#H7qRIN?$lH&{GoKk|%9S%xUjnbvIAlsy~h`FS`N$(JK) zDNkcBk)VJ?^&^+-qgk3*tisfiC8_#~vak+`Q&y-1-~IXHl83`w>Pcq;72@E!U0(DL zS_Vs;4W;_WJr3QO5)B88K@H@pkT?9p&SKy+%6`1A$*O$ne^WZb-xGjev>v&zeojhf zaG?t%Ke{D^w>vJDB*-opFp0La3r@)5HZOTd(xL@iBAg;7VV6T_$RU8NjJ=$ZQI*u= zLsjV=A>()hFJo~bIMiFkK#f$haBX%HZu>qOYa{T_0;iQUm9f@O@`-;?;!g#ZufTLU z`j`kG;99s=&f9v^K0e;ftTL9f{4a;&j-o5@yz(RiAA=vE=MnsJ1)g=f!y;N)sY^d~ zO-HUK5ygIa>NvsGa2=sJhVu~Zry8z^GDFmTfC}$$mS;rjBxj1!v=}x}FQF&WzP8ck zjIYuYeqdu#W%9>Ea_I2E2K<&w?_SA+#~E82qshf(PeupbM@H(D!I}VdpuQ}99u~yT zEDSlI{52}#tM205MB^aIL>(?U1gJZtBk=t7UjTtqRXUT-2>@nQD%oUh6ow(YsT=KT z7qSSTI=m>%7A{EKj@pAB=Q+hI63eRJ;To2hoCj}?F%e|_R(triJ`fFC0DuMIsn&&c;w zN4^xX7b=@V^Io46)eX{rEv0H>L~F$Kn0jQk{4^DwNT2QLK1=)5f;DwKLG1Vb^aF2 zww;ULOp@feNN?}@H{JJ}2ES{)Mb9EO%orrUC^D6LeA9x!V8SgOWs}cw_#Tn`czORh z8$q-Td-Krbb6DUxcj`--`?(uK@q4X1NNXh_nbH8kL5ykgks!Uqx-V_sBi>d$?Z8d9 zXY_hrVL3l4H^YS(o>92>5Jps7!HRZe678mg2YO9{bL1#aK>8~vuTlpwuPEENtsRC%AS#uHFg1cK-Cq7`w zW=s+EL56s0o@?DAWVg(Pvjn@WlmQ4xM!U@S7y<$?1c}cLEE&4^nJxHaT(<0rr-0?9 zIT_1C0cZxke#|pG8H#zEpwl`#xCZ(;hjYU5fs=a zB1-cjnT=7;>yo7tnH6+&mxr_%-)@1sxpUfxfDEkU10h4VIC~{kGy?kkmBfs(vP9>% z_>z+p!0w;U1{+EPO^SA4>#1M#3=$u(W($trHG){V=gcilTOW^__ zos}%3>P{+^j%gP&Z%tK%KTjtUfchF^NUR!0ANrz1s;$BNQid$gmd~<*m%8Gc`Aor$ zP!cCBW>*a#v-fQC0-`PBOtJm-2srUxI}WggmkpIL_Z^X1)<0k~8CDNY!u)jL+sLAa z;p}+VF#dIh4F;gP*Crlk4|qqI=4j-y9fJk7s>AC_ZJIFc0|mSkTEmz#78icGs1om_lnKyGsSD$)KiIc)IAVPc>wdln2tl6{TpXvz;2}rP2>$y=_ zwTbaCWaPBVkmZcX2gjq>+T4(}ea?cS*u}dbYBRP7+Pk@U5h^G%FYl#|U$y8I|7GKU z*oaV*hP_6Gmn$pU(|E|ah9Rfc?&_671g|pET=7hZ#x5+;EY(6hPV=*`rd$_}>&@T; z;Zy<-UM{9O8OpnW^Y@zT($DdoKr#Sag1H}+7~ zT2pQAh^s%m3#7$qW?dGt5^dg{H^1B^>3D z+M$E2oGaY?f-8`F9z|=`Anv%# zyD*qKjNMRLY1&f9)vMVyp7>6)JTLd9*5TB}RsW15{fXT(y+IaA?o}ucSCUCNNXx~d_pns$A>~qhz(cx?sOK1~IMSSX(F`+ z1bJLepYH^fpeE&!M=w9Y%N`|36D%VUC!0M)LQ6nMyweHTmPECaX44f$wWFepiaqq) zjIBods4j>yZp4vM&c`YD9lgWBkFi`=JB~~qao3vNtbDV%_8SLMXa?9H=4|BZx(Uyv zeUdIzD0ZZlde5(_STB2Zm=MOVKslNJp4v!89Jh3t8R1u6Zv-}T_KGiz&olqaWja@@ zpC5!1vQvcP0b|45@uN>fn((DkbAB$Bs+aE39p5iHxqmv-i5()HDI`d`OZKBgrA#7f zCwM6}4d5Y{t_mGsz=sa?W*c6X5R>b6(2}lS?i>nFZFskl{~Xv~no=*nm7QFTL343z zPoW_@lKbbOGZQfk3S;$p-{A(Bnl!xOpT)eQm;uMyy zah61fBlI>0Z~1%>c$;}fy8-dDdt6fvQtxTb>OxfMB*H#SlZ;@01z+$GoNcl#NROn0}s-@h3(<&vWNh}ZZNP-f6sZVO;DyQHFpw%&UM1hp`6^R z#kb;Ybmtha1lYp+s~$u=bkA`2AZ2=N(^>hxS+$L^ES%Qdl2`6c^fM&cA#QhG*|~a( zA?y<09IMjBG1_;?QHIZ#&p2FeGTV;N?4bgYf=Tj?bp3D{v1Jr7sp`Mm--8*s}C8c-T5k}}n;;9>x8w-=uX2VSznOAT4e@X5ap7j=U zut6Vlr;D+e(iYX-gr}b++EnBQH9X(2zlnOzSi*vs>`^V>*In%hpLMCMG&rP>geICJ z?GMUnEEIpos{1)H_&DcPMWtFHOI~iA*^oNrU=U$UVkc=91y90gM$tk#ExbvhK0u8f zH^fkp%u&Cp0{$@-mzC|(qp{}+6R~@?l^1ITP*79!5)~zS2YpiJ*ks>tByA>6qo!>tUv9$?s z)6rWO^{0XeCqen-V6)UB-cS}s6;i|<+A3sE7hMV`>PoXbhWylz?aNIqk_LtWO{Br~ zIutXpDUu0tc+E%z;j7&W~Q$r|4nOR$gcp@=>>_xlkV^5~)dNG>u()i<- zVaCaEyr*eg7=;k~0D3b$GPk3k$lv6-Lx$v|y?g?+jI4ArveQbZ!jCe} z?D%M5k{4nf3(-Z5bX}Sp)#%0@HV5U}zl!>=LZTV4o`f2l`;_tZ;E}3~$A&UR+TSa^ zC&v7gN}Q>}ama^bAw2Omq%y5u|8MM$9*4eq)^sCBgzE7ggJak-Ghb&O>LPieqjx$K z%qDT=n3a2{gUs#r;AkX7bhmy4lZri+%8!F~iNa2OnkFDz*4D6vvXIN<@olckwh1rkywW(VJfs3By`x=>W>y@8|^4vBMv zVEq(s%AB|QcnoeP@v&dVb|n7n?36JTN$&~lo3kCn9hty68X;%(xKG^oJRZ2x6Otx8 zQ%&4#h1-h=-Y)&2jWDCicq0XbuNVlwSXx(bk#39Otvip7KYav%we;Q~BwH z#X8@@=0um@@juFvt)4Me{e6buVx5bO4)gN9M1F^W5wnGtIsflNT2x&4EZegI6tCv+}#IX-8j&aawO{XZ7Srb|!?^xMzBGJtIhUwbSJ=+XK9_ zL~aUjLc1ixU0{acI8E3In-^s7Kz%-3iS#rT?u?q{_=-5*@#4I$lW z=5YC9bY}*$T>vRNy4a?dZY&?S0Pq(%zO);P7{S^FgF39qb!bFxZ6I;KhHb^IfxpnMu}*abTn5 zgLG>%&4miT&W}Yz@eyfOg^^*HY6Gf3*{GufTpIn%)K~P{nqa>7YBNjr5b5?{kYdF% zs>@v{+y|8Y;v2*kwUroweBsAXv2}T4$}ABu$Sf)s9uHtH=MW92+3nY-81itB{}Ls_ zxjIZ6T+vMm`dwM?DcK3)mw@&3z6#6~l8f;`Q)+}|n{U1*T`^-E_NPM!#LA&R@vhH> zmGa+d49kJ%R_D%3x~oU#U3pL0swBtEkGD1UonzuSSrD!u9_BGd{2tv-=DN=+if^>F z7L};v1gtRrduX)_NO9}FA6IBOiBPT+SY1wrc%NYHux?mh)$|PB>T9tWM18%=LarDm z??5sO_)3MQsCtw3UKuk`a4;#YdU(Q9MF!AWv8o(!=bT(Iy$vIxzAqnCS^w}ei46tIvj^T!#*nV4v7xBs~Ld@Bbs z2lgkw@{XNafArrv*5?}8%J7qqEAiDZuUA=BOD&t1{C1kZrK0Yj%$FJ}&RIs!5gDu| z`l8N{HTdf^pbI1JG6ty>@(3@_QD#LWkdk;=#4{0YTKy&|JhY9$A`0xO-h^recl4jq zfn-L{iKzrEi71Q^t=O_!kG(lB z7^rA*6M=`RJh9qhAJptFKMGm1qF`B|E(nc8PwcCLzMKSqN8w`T@sk&wG+JxqfOjM5 zG+`5Lxts@y=r)isy1=k%+|c#R|5Pu6nw9&JOta1Q*AW|;h0&dFVmujVxU(KbQ7v53aMFldkDZ0Y8de(8zy1fL5K0Lq6}P=fys{yMwB<-(BmtUOAG_upl=On2@1pl6S4}PqZ@nu z^S^!Wt}?SG8-MIEqLzF-_ckBuol#`yL1#vElm~tHsLUx9Vp<>6?dFj)>qt1cE?SIq ztFy8Y(!5spE{b|0fTI`6t)gSC7zJoNR$(SWk4+Hk(-vN)7Vr_ec!oM1kxyXQ>w)V``@|JhfIlArQb`Y@!d zH%R;?Ehcvf4)>f92DXMIwvw``5oQug3@-F_`uo9T(sDCNzA@iz~Y%0CZd9Jcg6{myBXp%(|gDrh1Jfphu03&hV&YT4(?DNXV{yAe^ytf(g~ z%=%3cE{D%zMG50BDOG!Z#nGKq338(fZ&Tb9KWf~cUx-S?ktg|o+BEH88NZLzdrvja zlIp?&3q`%<&%Q?%CYLOW8CbUCWPJ7AKN^n&PdCrDzaL*ZF>+Th%B^1IMAjp2)w9UB z!d<49iqq**XM!qVlhSvoMDOu*LajTwMVDnV*-n-HN=wOOJqC(D;R7Lkh$yh5IJ1!S zMG6GtIkV&jevx@fuR@v$Pa`hF*7~aA7B~8et>p(4o4Muh@eqRwzvj?e51Po%$eueM zn0XQWNkD6h3XEOI%7^d*KBeeb39aLA9UC61qZVnZjYNO794lY2E)-qY_@kRG%2H4m{wt5 zAyZ>~=fRJB*7eZ1GDh&X?ER9}UX{YEQ~D|e?t>kjjsso%gpAg4yKbu+HKjUq3Krwe zC6rh7*Kp@yC0r|c5*k6;_VdoH$C8E^7S@k3T@(}llN!9~4HJ8xsaJ(^mXm>ZBho(u zle63c0V`@{Hv%9t>ax7$=r=|`o2o~INS0L#bM7v|D1WuIC|nw?Q@xXt7EC#-%+;nL zZ6cQHCkZm~M5TFIu=9N|VQ*6_Ds#cNRvH+pZh1fa*S+C|jO!YRzY`dbYdh6k=$>*< zL@`wZhxmA@+mG*xIBm?>1*s#);&>GAHy}C{Md4BRL3iiN00t^#FyaE6iyV4kv`WBFGp2kRYtywQ zxv+c+#rNCp!|CN|w#lSQ7L~An-ykhd4w}H_DCnDaIBM|4&T}fd0%khFmT#V5ZZSp9 zo@{v$VNpEO0ys)QgfMg>zF&NIYhIJlU?EDcE(wGKXOXbYGqnnmQav(9jZNTi**~r* z4!1%E*_`F`F<>+Piw|vM=AXm@ZKy=L_!=CRt(-T#*_AZqz`1?H4Ij2!6Etccr&0Ztn1O+-M_aFE zZJgt$d&DECab!tCvSfN)5tLI2)jNpIVtejD{-bd)3_@Cn1VGVQJz?J&pqIg@YNq>iX)a}Iz~WkjpJ+}ncu;sR z*Jpjq4F*a1?^WE+x*G(8WwKz(;Ah_8Ga83it;hP?se?NI0^=!}Jd|{}IZ4K+U{ISs zKhVW)cjN?_-35_nj=_#5N597|x>$s+Vsc~dH%~E_e9t!za>{jUk_`)+T`d*}a^H#r zcFGFk@Lab7pyW6vrv4b%o1ga2iIpQRwNEjMmv2xXQ1hxW7#%I1nS%x~zb@+iBV!GZ z>2Z_LP&md~@~Z3ogH)QSrxH7Q^K>G(?SeQd-Te0t?-fs>$~=`?xx@pDXjWC|SUT(F ziOeC2=Gq@s$^S;@<{o%x>AZN`z~R}tl0ei21Ha!Lrt97&FcyyU~pN|Bf!RjSJqxJCgW+kBG%VFoaOf<8or05cvgca^lK&UUm>!JqG%aXEY zm#IZ4w3o`{sqkPtt9njodbQ{p3lWbPtUBp}NWT#pMjZp5P)X4Rye5<%bje~iEk&a8 zYO&^88+|VGPpIltS}C$T%;}OW&`N*@t;U)Dyx0U^Xhg^+!(5rlVZX-dEm3Y@(7Q)^ zl*A#DqjMgNxJnOac3d})yBTCWT`=>6NDG}s3rQ6ADxlEqhp~KOS6iRA|9mFlt72#i zGC4P!Ul|dfFe`!>8VyD^)38x@K z4xbL^`cBn+ei>84AakuxaY<_w*x(I;&4{Xt061b*3Hva=%+Hb1!7LIt1tu9t!_OBm zF3Lfy!wTA@FVtNa{A|Amh;EJT&TEF4XVan$G;V|3{_zfFYqj_wqu`lb0i>!Yf5f1L z0?tXgi&ea+n)agP%Z!P%lDQ#80?cCrc|Y}2-6;L)M~?D8JS`iNG&Gf5U007oT+J7i zo<2^8@xe*S<8S^Gc{r6cfepNCZC=Vtbct%_K$2K96b!DVeWRVP0A%klG9uGd{#Ypg zZ%zAf)d07#A8P)4m~f_ww;5@T(WBTfD<^;X&9i)@i{GtvB28N6)q#)gmz%_Z0Os91 z8SA+CfylIN*tsb9NrZGkN6C=HPJpv74rXva&;LHe%f(>LfC+e<5Xtq>15z^hS6N%K zV6wj{0b8`=uyf})&IRil^f|`hr9q#v5l&9<_EmbRP&l}XJuJ?7qB+PtPq??j))LKi zqseQY-NL1t5!+8FD(v#5iP;QOm!UOgd)K8Z`_ zsk~ng*%tu<&edXV1MMIKoo?(^y1`?Ep91NWVju=gbZjN7w~WZk$$eIc4xp*+M*9HX zXE~4gg@KoNw!lsGkT>15fT>6M$+T2Ru^%H%yKU2(J=F)ZU>k=aRxFW21_RfR$D_XxaB)hpH zLlZ{H1r`A~QHLO*XlcYCf8ibGO?>bBIn#u?w`(51dMYNBt93*j0hlRg*5n<3FuCYp zN=t%b$zBGQmZ{BB;&Eixr_DLTU;(du{_A%Bj$P^JN$L^nAA21$k0 z&RhhQ3l(rb=nTll6&9wZ)_=|MHKTzo`)$Ueq)#Sayh3B|;r%k(C24k?6I=X2T7c(=!DdUUuZ2P|$*Ou*aGj$YuUA8NhnXGpm{xnB;h@!D>L(l8N zbfpQc6*vYIt(AFX+A`l+xMxfaBjXTufhI}`$&=u-1ENk3NM1??%OK)0=w`65;Qj$b z*#%_PO!6mok(rU0EV6(p%TCg&gKTLZZN9t{PDiX$Fa&TR`xA+-NjvxsYYFu^?WLR$i!p*D1$Yr@{pYHAz2~VL7P0)U;5kx$e4coPR;L$ZcQ(=ddT3`34boblM={dc zh8N(=*hwV^D?PLXlx56?Lec})Mr;gQg!sTkab-}1X`B}BHKNb{t8IT0+2`>I@ zRB)b0T|@Wo1q4^3yFO{$)JeyRj&B%q9DYyckZfO5W`;oFu}ZIamR>DJBcCOhfTCg= z3xN=GAmz&|w{Iv+kssSpP=UAxMApCf67`j*ywV=N_79zD$9jj4l;&Ujb>jbs!6X2a zKknJX+!#acnMS5QU=%K>@_w^ez@*a6#ni3t>A6yyhS5>e1w2(B7=d$o@-iFKPfvFMZvCWAL&uoW zKIPMl4sH#s#4mOauV+kv4W^pcmr7oRdIAO$LdD{cEp6VS@fyZ>8|!J+_636#&K2&! zhi@z3MId-J0E7yBK~beZQgHq@YS_!};B>?K>1IUVHD745tOQ*XWw!#}{t97dSzoEq z*S=dy7-Zg}YC1-QHi-n+dS30;rPF$mJWg?iOiaG_bT6vrSXlyWat!0$xd?8i5k2_V z1ZnFQ$l6+q+N1Qj9jN>#z~G$p0ZEXlQ_bIGEwEZL94f$y_T~D1%Wl@%WM^4V#TBa5 z4==_AFC51(WV=r#HIpnBO2khAwweE08l2;N=UNt7`Hk{_&otbFaNYb11n}Gr@b#MT%-) zO{6(c8j)(U3RFkCkfW{X{tljppCmUDUjVnRomTbia-+muHTTUhv#_&d7ZY2dv^+mv zxWqeP!Oq17*6x}wr4oitGC-7tHM%#z|9?a)uZ-5gfFMlXc8O*RA<3OVvJzuvVYS;0 zyYRyaw!gfBD;U8cAgeSgSxscz?~HEU&K<|nUSek7PzVuvf`TqU9<+M(W-bgJrai;s z%XAKUWRepWSfc+MmCsI?HaXKiWM)R|0p5`g7IRQG*5p=^(*!zK#0Jf4>%SQc+YkSN zVn7L1I`0;oJ+quoMZ|(D50n+zquINi61Cme`SD$1BJ~t_YfEy=q`+h?#p_j5CdvcyyLh5~%fG$?DTb&U z@F498U}8C`D0}<=e5uSJ8|_zUkXs#5nmwbHm=M6|Sjlz4FW#zSvwSecwkm#IDYQa( zm!q2KDC=+Vr13Lb?HZs<>qfN$N1Eb7pQtbJaW=W3C(qsxS|ZRqrvh!!4AS_>kY z8L7(hi8ja}=vzOjL6m!gSAzovoUD8xDT_GY<-e-kM!SZMvJ&Lp(5up)tZB&Q$pvi< zJtr6gh4H2p-BzGLI>G5&pRKB_p4tl-mv$NcY^7cnWv1w|h7v-SuSir$gg_SzoZ!6F zy14>aS`e3@y^6rshYv#`)KaQ46Csa^K3a;UXFBUFS1xhx#aqjVYk+?6x#TIL^DLQN z+}7kC7e_0PdceKF`k`^9FFI7xrkt417EHkTg?z;`B}*I=cb7?tBeo`(EU-xP&Xfm?0x*b`R* zmMsJ5K*DrZ$=I@X)s3gW7Jl9e|4?9t=69^7|{>r8iG)? z1Ew{MB*}xVgI0VI*+_?66$OG@$ek(Rx0?e+Eup!IP$Gs@y{He&jqU* zZw}8>7-7r!m}Mb?Wd#Nb*tC}GOLUt9QKzjib{9}GdQr_w2Ojob+Kkjvcxc7L9mkQt zEc3loiQ7KNw3O0?r14MEvw}E|K`sL!ecR+G+J!5{1dhDz5t*!Z87#4dRrabFuVgR7 zu?>bsSj9E#+&sR~rP4^@PDHZAKm%cq`q9h#m#p8HK&Jfl7E;ZJ=Y;{{R#>|yMOMUs zr7^2zczwiOo*E2m`3kKh*?LL+3ot8tO#&g;CszOUi!R8g2@Cs zQy$3KI#kKtz3B-ssxTw9re}1Rht~6rti`r|+e=MlL0TT{%;MBdun~CkORDmS(J;j@ z^#)BLSDf&$$O8e_QIbb~+{A}h*)Cd=mBkVn}gt^fQUnwqF&6&+N9Lw6lp|DeA4cwbOD=deVgRUlA6NV@ExZ4wcW_WNg(& zjZKJN5~`a|px*o9-nr`rM@NV2{kcv7{0S+jki_Af0 z$i_TK+HZhCYR!B^7yaJh39xS@^;i&ff|~gBoo58J;-){xlvl{2Q<^JNUVx@2P6h%Z zCcthM8zs4k4o*&4D9^99Zf8|2DlF2?_XMSE3YwSPf>twRNwpQpZIxiA_8hA;j=z`^ z=%j5VdRkR1Nqmx#pGiI?{}g~G-cs+Hj5lgqi+~a*>of@?hB^%c``jrJ)OvRoR#6=b z3<3bYCv<#?ZZtu=uX;^7U(8cIhN9fI{;i@9TFlR}#p7(}D9%di^fM3LX_~EKlPL#7 zO5b%r%v4>9L^=_Yd0xp%s$c)$1-F0U0ArjZeHnG)@jdEQ;Od35joRMO9eZ?wLyZZ& z9KOhmv>7F9vTO-UsQqu0Z14FhR2sQqF^dzs-2`N(gb^U{Zettb3riYAl>ThIc7A-@ zuRB2RWf3R}wOoyC>VS88E*=X<^x8%)_5wEz9i@0${dDpT5$eoVt_PIgO*>o!UyUTc@AK%kg0xDBlVtp#4C- zcrmldAtc&JZG2Io#gx2%R(GjAx^DI!pQ#)Y8k$0Ec}CO$dIu%r!9#YWB6@wTrRynQ z9_4|6dneKyTk*Pg0m07Qzd%xH&gzW%npH@LKtG+nQ})N|jj~a$3uw|N1nTr{beHMF&*-j32E2oVl1`7derYU^F*UF?6`m zB8x|_LE73)l<5CXQk%yAEJ#ujc6Esvb*gVzg%FCkT9vgbM(!;|+_v^7W+<45Uai`| z4^Bsj)6-K)W!tS=cFpenza{zr>DQiz^%{|BtQYLM0m5|p-sN%EeFl_At(yhZkvp4! zX^nIWe{dxmMn7@k7!Y!s2Cn;Web$#VD*}vRn2(Kx!XE*fP|v=H(LvET6XEo+Y5vPV z{axwH4^M2!aY-`$1Sz}X`5H(hufamo2j9sWQt+iFXD6R5;SL?7qKDkIulIk0`QTD> zZhm2>T$habCXC;h-i_+`mDts7Dy^NA78J{SPL1C}Bv|2XFQkG?)*%Ygy6rkjYVm1oUOI?MrQd&(?L5zV3Z^_9c<3S`C3h0Pd>``M z7W|HqW+j71_HWaUDy4(*8>b+!2Tv+Yb_LRL&kOO z-91~&H!8BH^3{d=IDH_xp3arKAg{^IP&2L|zW-(pT2JD{@l)fE# zWp1iCpW8+t>qk^^5QyLO9{!p(2D2+C-m+8KkxcBd>kUUb^!fpfNDB&lAdlG5DIynE z48hS10}sh6wNGm;)y;jXLgOGe$4J^)010p!$#5-3Ee`O!wYoRtmUKysXNdahsOo%( zOtkR+Dw9x!I6dfTg)uY*u5$YAp7C!SRdRi$x8J-TpYeS9$RHnr@G#64J>TvZtpaMo z%N`W#X1L0%VHd#;%AC?}EULKE9Hb_scM&4mwHu?hs=yp4>!QgH!up2H2R+emXe62Q zd2Bb$c1{gpw#kB$${7KI!G$ZI)BI!3G!^EJa%w4Qf)4U^aWZn({8#h5#rjTaI@AX* zW{6^$reQ4XK1)ZfzA1}1j{cbCTDeyDVZ8+Y<19tWA&mL(`u0GwJ&1WOHz|!sMP-A= z3u6%Ch+DtoWuSYuat73Db%RwCr6JSn+S}>3q`e9^EXCHT?mIuF_gYkb71Xv_ne7O> z1bMqC;pvI9Y`Uesj(iHbsMqBlmEBzu8$6}l!e(!#A@&|ac+nr0$03*5OJKt1?IeMc z<$TVOlILw#i2A}@h!B5_0%j! z-ZU??b>tv*7g*N%QR$9lS`gPSwYTFvZi;pIRU~cJBkrghDw6#f`LAXa6b1^0);fU$ zbeD7Em_m!K_bRJq5-l8sgg*L^3|uyqgo+L!NAEqWlKEAUl=+7{3s4sUdD}T3V0Ja% zs;rZhKKij}-Acc+9Bq2! z2@W?^u@5jN132#;b;`XKZUX`0AE(|DD3o)42*T@tX>D5NDhPd6j4kpr-&sf=UHQ1I zn|+HwKjoOI$41blg>!9(^ayLIrF|+femQd(YNr1qM4XQj=j#FCiH2@Px58-&1lWf~ z;r!JE_l1_lUKmNsm@QM5p)4u&nWKe!6v}w`L9LR;9i7gK;-a9hXQIW2Qq$rjh zC6FiVNJQzR_S@m3a>bI4T==C67N?kQ`1e{vSRe>{1V+0+hJ&r{cNZERpO%`S0m~9WQ#i7^&Dn8H<>o`8%Tod5X4o*>wT#X zw1$55sZUsqwekEz8<7_yZOs@ACx5Tc?hVtce3`ajN{;qmvFd;Ioo-bSeT9ywxnRt6 z5~P8H0e_sJKigUZ%TH}Zl!vZp85HFpE9e+EL7rusKwz6WNQE^UZAJrxmIPsb_Ulo! z80W~IfE6z23w&v`n7$1oXxaa0(RzuzfO@Q&H*vocQNL6dJTcrEP{l@q>jG7uGFPJ@ zkAmWDCJGs{+|+!`+yX&qVeHH$ilFN9KX)M(Hof}W;O(9S$V{@KX_biM%xsV6dIJ%s z|8tIfg)`Zc%zjD%q=&&!ck7j;p}=#I62oYDV{ms1oxJ7oBxYy9qxk+xmAx~1Z0r(r6`yP6N4a8*=yh#ANk(0Z())S3<5Zzu zp!L|l)64QKWYKCWdj2CmXQ*+{LXagVBiE(5f|Nc!!@$YNTgMHljgirFSMLIpys@h zX4UyT>7{{oUO;%C$MPEQs{CvO{(Gq6Vj-xZW1wX7XbaO7>1zsG zc1KI`b?<@oVwb0js;v`2RWVZjLXx6Chuip4ne4W`ePOl@Tmlz(7_FRmMY8g0(4T?|F88w!{@~|s~6q!epv0IYw-nzFYmHAD7F&tAo zEErrc88Rb+Q;gXRw&OYAd4;M){Ze~#@UFpREu1rryP3?QWNCj$J~mtt4@d-+L@0Ty z=GxYRJ<^XnaU%4y~L$ui9Sf3ee9(4X{Y4#iTIKAEFrbuoT+ga?QcfU&e1XzNU>l_dtH_2)bAJl0})( zL;WO072AjDQ}4{jq}jA0HZY9l2C@8D_y%q$(UDVIrSFaP#JaRS6d+aWKIyZQ$>DMp z66QnTK1J34Rdd1GzD4=~<1c-^netTr)EWCgMJm`otc z?gP|2MhjbVBs^ZW0LF>Nzf0 zlT`$0ctPgGUHU_!A~)A;zrolaSgUrFU|R2s5tWMq^%E{fEzTc=sM?GpOU4%`<k4Cen06&FKu{X=%6WV28#a8F`kpX$KUEUOLO3;r%$ztM zc*@e(VXM3lpDYnT^rkbU(I%p(?&jG4TM5!SXo^;&D}az}nMMz|s9IdTvmOeB@l7UQ z?4+$oX?fYjc<)V2CSJ1s`fmd*97k8KjQw#iy3>n#05UYubWw}Cl$pt_%8_amy4rh@ zN5AaT!DwnwfRnfvBG3U@*-FnB);X}Dkhj3WWlI1jY`H~ZZ|2?@RtyNGnfhBG%0<%h z;j~4AH$XWMeWvby9YfJ(CmmVp^p`Ku`E>d7m6l@*gFGlpxTi{)#6U;WHF$F2y4~Se zaP-aDG5}~TyOP;q7)C7GGYWfMy{`F;!;fXCO48Aa)DcCHyj2+j!-fyvbSBwm}vtPMA?v{=~-}EF7VQDgP}1&5s`|lJ(Ry_T4R`+l*vG+0a1XJS@rHwm zO6Q>KRmFOOXpBLn+smyUJ%5^J1H?hWL17bsjA*|Su3@tCxH=4NH6JdDCXN=&T$wyp8Ah)od z^qwU?Zokr{5yUQ61q)CSkt;$FD!;b$Ju}nw#avFK1KLAWlk7z}MQ0TW`Q7u|Ze%{Y zvwOM&4h3C^W&qCaO^Ye({pjeyPgsD%7IAC4isp%+4-K-Hu&TB{%ojkbY69n7F-m3> zlGiIQFrnHzbU?&pO}5f;bgVj6cr2{xrRqJG`H98~xkEAkgj)(5N%6UZeR3Na2MycP zwX~K-$rjeEuKYa2v~D6?v#s0)$nlXfhThlA4(Cmj^&-w0#_tjtIB`7a<*ZJ#OCqJl z)!J!WP%J4<<5R^i=RaqJ9}2ryJP+L4Y|3xnCZurXw4;|}M}HZuVyzO1W(kI7UT$qa zqyB4#x!nlY$gmMojIb%L@uctx3x=ED$c>{}CL~!AoU!zp>kx9y7F+x3jvv?G2j@Pb zW{aEK{jK+D>ylD3PQfU0xY>>Lb|>ryNUqbai3uhQN>pgjXFY}wA6&tQf$s&l1hiho zba|8(*;dTp<@ekU|1c7vh94VLZj?MbNp7TL?b)w}G6F{JXkqv{V>nDb8;RW%H341` zsD)VF!bKEgzjf7BBXX4m@tDvL(Y&2-?Ue$~NZQB-hFjzcAJYTFbqw zXm*V6YQ+M;k=NLxV;0%;3y2$Bspe9H%RN!dBK_r~&P?-lR={?-H(p`D+ zay0(lIn4{45I*)UkzX*D4I{f3Hg#~R-h8_`(L>usWlP7JZY?E;tA_l^ zoyy)x-caAyAYqeH8@cbfvQ3n0j*f=N8=|-+c^-359^SL_5F-%O&aHP#-n48{lWZt* z;(xkXv$oCN)(<~29?ai*_FqrbUP^2EY2sF&?uqOg*Lf>cbN>06necd!cS6L{g9gQ z5z+MD=Kw1KX)k1W9t~maEe{b2;T1Bug~$8W3V0{CTBt%w(6Q@=i~w*|XdXGzr^u_b zK)9&F*N&sQ9=MmfZ>Ph(lvY}cC@~BG*mtY|Y3Cf@|HC^S_I3XE-3+a2G<0MhDWDzf zs81nOz_qICxV14^nhI@wV&-R&DQm=c{NL?kqF!0%T+gDk&u0X$Sk)4+(>5bM!?G}^ zl*gwCJjClHtj?*)3|k6|uL;%A$S*qIKTnQX{;5T8cs}8N;0y{a^+*|`O7_>l$>os@?ZpFG?_6k2u?rbb7Ke{K)!q~ zik!l(E3-AT-N+YU#nOtyx`G4C?nbT3M_uccd3H!Wx|N|C zyQ}cmQw$XURahsc&R`>|z=yMkW3f4Zl>i`{ec#-|XBTf4Az_o(1~~B>4D?Lf2l&3F ztUyZyJ#5#6=!dx&?aZGBlL+hLH$y~!xH4`wyPTRtTqY7a~cF7pOjxkKRh$z zt}=18)wJ~U0!>ajd*W8v)TeS=v_S8eyU6rFSbV*zU?24Gbutg-l_csz3=z-TKjK_O zOCQl8nBBgG@#aEH9`GzAAa+hQRE-t>Q==PKXWo6KPY04L2H~nH6 z2R*K6!G9LbE@B)u>P~l}m*u6|r1hm?toy&vF4)~h{e39!Rs?iA>NZr>cTIUjz zK8uk=K0mPHf!bR^e`g|NqsPo=tQn{ZN8vGt-Wz&1w#c+?>^_FNE{RD3RlLE zlDF1jyynlx9FF-H@VJTa$l>&RG_QFEXZUTwRL%NixOjN~dN0c0O}lR4L$!=8zma!o z5VNlS&cto=APA-}a5mlFC|7rm>8sgRj-<29T}^x1cP@k83e^9%PcyJZ{?Upl0Dsva zi6dRJfS{0FAtxzy`*Ca8!isEdKx-$w7)O7xI?tcvrtw|(zN}F^FZ!J^FBv@b#nssW=yRi z_W-T8S`gsys(Ndwta_A%%gWXeX&d|()|XW%{taa!E7d!L6+A2P&(q}e9(^z2zD(9; z4qq??7TpO3fnABS3-nk$8uxR=vvN)x!x1u4IO}2OA@&_Q{H6~hl(31{4x6Oh7yVF_ z>1$Qh#?lz`eD-DKf%{SwN7p(+_j0p(y{N8i@9ZB<{wmQ~b634x7YgQ^hbZcP5!8E)FT}uJ79+<=$17+IMnrrg0 zOEYB`9}a=;+)FuBFaC(z$N~k-hN{xe(^(D74S$yP@yT6J^^OFyr93hK-Ck0G$TB+yDW&(*pI;4gfP)Rz5Hdivj=u00045T4N0^f&c&j diff --git a/man/AMR-deprecated.Rd b/man/AMR-deprecated.Rd index b5ba9f605..2e385810e 100644 --- a/man/AMR-deprecated.Rd +++ b/man/AMR-deprecated.Rd @@ -8,7 +8,7 @@ \alias{ab_selector} \title{Deprecated Functions} \format{ -An object of class \code{tbl_df} (inherits from \code{tbl}, \code{data.frame}) with 487 rows and 14 columns. +An object of class \code{tbl_df} (inherits from \code{tbl}, \code{data.frame}) with 488 rows and 14 columns. } \usage{ ab_class(...) diff --git a/man/antimicrobial_selectors.Rd b/man/antimicrobial_selectors.Rd index d3f033134..5a7e68fc0 100644 --- a/man/antimicrobial_selectors.Rd +++ b/man/antimicrobial_selectors.Rd @@ -182,8 +182,8 @@ The \code{\link[=not_intrinsic_resistant]{not_intrinsic_resistant()}} function c \item \code{\link[=cephalosporins_3rd]{cephalosporins_3rd()}} can select: \cr cefcapene (CCP), cefcapene pivoxil (CCX), cefdinir (CDR), cefditoren (DIT), cefditoren pivoxil (DIX), cefetamet (CAT), cefetamet pivoxil (CPI), cefixime (CFM), cefmenoxime (CMX), cefodizime (DIZ), cefoperazone (CFP), cefoperazone/sulbactam (CSL), cefotaxime (CTX), cefotaxime/clavulanic acid (CTC), cefotaxime/sulbactam (CTS), cefotiam hexetil (CHE), cefovecin (FOV), cefpimizole (CFZ), cefpiramide (CPM), cefpodoxime (CPD), cefpodoxime proxetil (CPX), cefpodoxime/clavulanic acid (CDC), cefsulodin (CFS), ceftazidime (CAZ), ceftazidime/avibactam (CZA), ceftazidime/clavulanic acid (CCV), cefteram (CEM), cefteram pivoxil (CPL), ceftibuten (CTB), ceftiofur (TIO), ceftizoxime (CZX), ceftizoxime alapivoxil (CZP), ceftriaxone (CRO), ceftriaxone/beta-lactamase inhibitor (CEB), and latamoxef (LTM) \item \code{\link[=cephalosporins_4th]{cephalosporins_4th()}} can select: \cr cefepime (FEP), cefepime/amikacin (CFA), cefepime/clavulanic acid (CPC), cefepime/nacubactam (FNC), cefepime/tazobactam (FPT), cefepime/zidebactam (FPZ), cefetecol (CCL), cefoselis (CSE), cefozopran (ZOP), cefpirome (CPO), and cefquinome (CEQ) \item \code{\link[=cephalosporins_5th]{cephalosporins_5th()}} can select: \cr ceftaroline (CPT), ceftaroline/avibactam (CPA), ceftobiprole (BPR), ceftobiprole medocaril (CFM1), and ceftolozane/tazobactam (CZT) -\item \code{\link[=fluoroquinolones]{fluoroquinolones()}} can select: \cr besifloxacin (BES), ciprofloxacin (CIP), clinafloxacin (CLX), danofloxacin (DAN), delafloxacin (DFX), difloxacin (DIF), enoxacin (ENX), enrofloxacin (ENR), finafloxacin (FIN), fleroxacin (FLE), garenoxacin (GRN), gatifloxacin (GAT), gemifloxacin (GEM), grepafloxacin (GRX), lascufloxacin (LSC), levofloxacin (LVX), levonadifloxacin (LND), lomefloxacin (LOM), marbofloxacin (MAR), metioxate (MXT), miloxacin (MIL), moxifloxacin (MFX), nadifloxacin (NAD), nifuroquine (NIF), norfloxacin (NOR), ofloxacin (OFX), orbifloxacin (ORB), pazufloxacin (PAZ), pefloxacin (PEF), pradofloxacin (PRA), premafloxacin (PRX), prulifloxacin (PRU), rufloxacin (RFL), sarafloxacin (SAR), sitafloxacin (SIT), sparfloxacin (SPX), temafloxacin (TMX), tilbroquinol (TBQ), tioxacin (TXC), tosufloxacin (TFX), and trovafloxacin (TVA) -\item \code{\link[=glycopeptides]{glycopeptides()}} can select: \cr avoparcin (AVO), dalbavancin (DAL), norvancomycin (NVA), oritavancin (ORI), ramoplanin (RAM), teicoplanin (TEC), teicoplanin-macromethod (TCM), telavancin (TLV), vancomycin (VAN), and vancomycin-macromethod (VAM) +\item \code{\link[=fluoroquinolones]{fluoroquinolones()}} can select: \cr besifloxacin (BES), ciprofloxacin (CIP), ciprofloxacin/metronidazole (CIM), ciprofloxacin/ornidazole (CIO), ciprofloxacin/tinidazole (CIT), clinafloxacin (CLX), danofloxacin (DAN), delafloxacin (DFX), difloxacin (DIF), enoxacin (ENX), enrofloxacin (ENR), finafloxacin (FIN), fleroxacin (FLE), garenoxacin (GRN), gatifloxacin (GAT), gemifloxacin (GEM), grepafloxacin (GRX), lascufloxacin (LSC), levofloxacin (LVX), levonadifloxacin (LND), lomefloxacin (LOM), marbofloxacin (MAR), metioxate (MXT), miloxacin (MIL), moxifloxacin (MFX), nadifloxacin (NAD), nemonoxacin (NEM), nifuroquine (NIF), nitroxoline (NTR), norfloxacin (NOR), ofloxacin (OFX), orbifloxacin (ORB), pazufloxacin (PAZ), pefloxacin (PEF), pradofloxacin (PRA), premafloxacin (PRX), prulifloxacin (PRU), rufloxacin (RFL), sarafloxacin (SAR), sitafloxacin (SIT), sparfloxacin (SPX), temafloxacin (TMX), tilbroquinol (TBQ), tioxacin (TXC), tosufloxacin (TFX), and trovafloxacin (TVA) +\item \code{\link[=glycopeptides]{glycopeptides()}} can select: \cr avoparcin (AVO), bleomycin (BLM), dalbavancin (DAL), norvancomycin (NVA), oritavancin (ORI), ramoplanin (RAM), teicoplanin (TEC), teicoplanin-macromethod (TCM), telavancin (TLV), vancomycin (VAN), and vancomycin-macromethod (VAM) \item \code{\link[=isoxazolylpenicillins]{isoxazolylpenicillins()}} can select: \cr cloxacillin (CLO), dicloxacillin (DIC), flucloxacillin (FLC), meticillin (MET), and oxacillin (OXA) \item \code{\link[=lincosamides]{lincosamides()}} can select: \cr clindamycin (CLI), lincomycin (LIN), and pirlimycin (PRL) \item \code{\link[=lipoglycopeptides]{lipoglycopeptides()}} can select: \cr dalbavancin (DAL), oritavancin (ORI), and telavancin (TLV) diff --git a/man/antimicrobials.Rd b/man/antimicrobials.Rd index 9de86e7f9..3d1fe1096 100644 --- a/man/antimicrobials.Rd +++ b/man/antimicrobials.Rd @@ -4,9 +4,9 @@ \name{antimicrobials} \alias{antimicrobials} \alias{antivirals} -\title{Data Sets with 607 Antimicrobial Drugs} +\title{Data Sets with 608 Antimicrobial Drugs} \format{ -\subsection{For the \link{antimicrobials} data set: a \link[tibble:tibble]{tibble} with 487 observations and 14 variables:}{ +\subsection{For the \link{antimicrobials} data set: a \link[tibble:tibble]{tibble} with 488 observations and 14 variables:}{ \itemize{ \item \code{ab}\cr antimcrobial ID as used in this package (such as \code{AMC}), using the official EARS-Net (European Antimicrobial Resistance Surveillance Network) codes where available. \emph{\strong{This is a unique identifier.}} \item \code{cid}\cr Compound ID as found in PubChem. \emph{\strong{This is a unique identifier.}} diff --git a/man/custom_eucast_rules.Rd b/man/custom_eucast_rules.Rd index 47e1dc18a..cd9174d1a 100644 --- a/man/custom_eucast_rules.Rd +++ b/man/custom_eucast_rules.Rd @@ -102,9 +102,9 @@ These 34 antimicrobial groups are allowed in the rules (case-insensitive) and ca \item cephalosporins_4th\cr(cefepime, cefepime/amikacin, cefepime/clavulanic acid, cefepime/nacubactam, cefepime/tazobactam, cefepime/zidebactam, cefetecol, cefoselis, cefozopran, cefpirome, and cefquinome) \item cephalosporins_5th\cr(ceftaroline, ceftaroline/avibactam, ceftobiprole, ceftobiprole medocaril, and ceftolozane/tazobactam) \item cephalosporins_except_caz\cr(cefacetrile, cefaclor, cefadroxil, cefalexin, cefaloridine, cefalotin, cefamandole, cefapirin, cefatrizine, cefazedone, cefazolin, cefcapene, cefcapene pivoxil, cefdinir, cefditoren, cefditoren pivoxil, cefepime, cefepime/amikacin, cefepime/clavulanic acid, cefepime/nacubactam, cefepime/tazobactam, cefepime/zidebactam, cefetamet, cefetamet pivoxil, cefetecol, cefetrizole, cefiderocol, cefixime, cefmenoxime, cefmetazole, cefodizime, cefonicid, cefoperazone, cefoperazone/sulbactam, ceforanide, cefoselis, cefotaxime, cefotaxime/clavulanic acid, cefotaxime/sulbactam, cefotetan, cefotiam, cefotiam hexetil, cefovecin, cefoxitin, cefoxitin screening, cefozopran, cefpimizole, cefpiramide, cefpirome, cefpodoxime, cefpodoxime proxetil, cefpodoxime/clavulanic acid, cefprozil, cefquinome, cefroxadine, cefsulodin, cefsumide, ceftaroline, ceftaroline/avibactam, ceftazidime/avibactam, ceftazidime/clavulanic acid, cefteram, cefteram pivoxil, ceftezole, ceftibuten, ceftiofur, ceftizoxime, ceftizoxime alapivoxil, ceftobiprole, ceftobiprole medocaril, ceftolozane/tazobactam, ceftriaxone, ceftriaxone/beta-lactamase inhibitor, cefuroxime, cefuroxime axetil, cephradine, latamoxef, and loracarbef) -\item fluoroquinolones\cr(besifloxacin, ciprofloxacin, clinafloxacin, danofloxacin, delafloxacin, difloxacin, enoxacin, enrofloxacin, finafloxacin, fleroxacin, garenoxacin, gatifloxacin, gemifloxacin, grepafloxacin, lascufloxacin, levofloxacin, levonadifloxacin, lomefloxacin, marbofloxacin, metioxate, miloxacin, moxifloxacin, nadifloxacin, nifuroquine, norfloxacin, ofloxacin, orbifloxacin, pazufloxacin, pefloxacin, pradofloxacin, premafloxacin, prulifloxacin, rufloxacin, sarafloxacin, sitafloxacin, sparfloxacin, temafloxacin, tilbroquinol, tioxacin, tosufloxacin, and trovafloxacin) -\item glycopeptides\cr(avoparcin, dalbavancin, norvancomycin, oritavancin, ramoplanin, teicoplanin, teicoplanin-macromethod, telavancin, vancomycin, and vancomycin-macromethod) -\item glycopeptides_except_lipo\cr(avoparcin, norvancomycin, ramoplanin, teicoplanin, teicoplanin-macromethod, vancomycin, and vancomycin-macromethod) +\item fluoroquinolones\cr(besifloxacin, ciprofloxacin, ciprofloxacin/metronidazole, ciprofloxacin/ornidazole, ciprofloxacin/tinidazole, clinafloxacin, danofloxacin, delafloxacin, difloxacin, enoxacin, enrofloxacin, finafloxacin, fleroxacin, garenoxacin, gatifloxacin, gemifloxacin, grepafloxacin, lascufloxacin, levofloxacin, levonadifloxacin, lomefloxacin, marbofloxacin, metioxate, miloxacin, moxifloxacin, nadifloxacin, nemonoxacin, nifuroquine, nitroxoline, norfloxacin, ofloxacin, orbifloxacin, pazufloxacin, pefloxacin, pradofloxacin, premafloxacin, prulifloxacin, rufloxacin, sarafloxacin, sitafloxacin, sparfloxacin, temafloxacin, tilbroquinol, tioxacin, tosufloxacin, and trovafloxacin) +\item glycopeptides\cr(avoparcin, bleomycin, dalbavancin, norvancomycin, oritavancin, ramoplanin, teicoplanin, teicoplanin-macromethod, telavancin, vancomycin, and vancomycin-macromethod) +\item glycopeptides_except_lipo\cr(avoparcin, bleomycin, norvancomycin, ramoplanin, teicoplanin, teicoplanin-macromethod, vancomycin, and vancomycin-macromethod) \item isoxazolylpenicillins\cr(cloxacillin, dicloxacillin, flucloxacillin, meticillin, and oxacillin) \item lincosamides\cr(clindamycin, lincomycin, and pirlimycin) \item lipoglycopeptides\cr(dalbavancin, oritavancin, and telavancin) diff --git a/man/eucast_rules.Rd b/man/eucast_rules.Rd index fa6a81ead..f918ec4bb 100644 --- a/man/eucast_rules.Rd +++ b/man/eucast_rules.Rd @@ -99,7 +99,7 @@ To define antimicrobials column names, leave as it is to determine it automatica The following antimicrobials are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://atcddd.fhi.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) +Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), bleomycin (\code{BLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=L01DC01&showdescription=no}{L01DC01}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), ciprofloxacin/metronidazole (\code{CIM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA10&showdescription=no}{J01RA10}), ciprofloxacin/ornidazole (\code{CIO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA12&showdescription=no}{J01RA12}), ciprofloxacin/tinidazole (\code{CIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA11&showdescription=no}{J01RA11}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), nemonoxacin (\code{NEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB08&showdescription=no}{J01MB08}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), nitroxoline (\code{NTR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX07&showdescription=no}{J01XX07}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) } \section{Reference Data Publicly Available}{ diff --git a/man/mdro.Rd b/man/mdro.Rd index b9d4d96de..eee115807 100644 --- a/man/mdro.Rd +++ b/man/mdro.Rd @@ -182,7 +182,7 @@ To define antimicrobials column names, leave as it is to determine it automatica The following antimicrobials are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://atcddd.fhi.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) +Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), bleomycin (\code{BLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=L01DC01&showdescription=no}{L01DC01}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), ciprofloxacin/metronidazole (\code{CIM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA10&showdescription=no}{J01RA10}), ciprofloxacin/ornidazole (\code{CIO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA12&showdescription=no}{J01RA12}), ciprofloxacin/tinidazole (\code{CIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA11&showdescription=no}{J01RA11}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), nemonoxacin (\code{NEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB08&showdescription=no}{J01MB08}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), nitroxoline (\code{NTR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX07&showdescription=no}{J01XX07}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) } \section{Interpretation of SIR}{ diff --git a/tests/testthat/test-amr_selectors.R b/tests/testthat/test-amr_selectors.R index 9c768fff8..73fdf971b 100644 --- a/tests/testthat/test-amr_selectors.R +++ b/tests/testthat/test-amr_selectors.R @@ -29,8 +29,6 @@ test_that("amr selectors works", { # antibiotic class selectors - expect_equal(ncol(example_isolates[, amr_class("antimyco"), drop = FALSE]), 1, tolerance = 0.5) - expect_equal(ncol(example_isolates[, amr_selector(name %like% "trim"), drop = FALSE]), 2, tolerance = 0.5) expect_equal(ncol(example_isolates[, aminoglycosides(), drop = FALSE]), 4, tolerance = 0.5) expect_equal(ncol(example_isolates[, aminopenicillins(), drop = FALSE]), 2, tolerance = 0.5) expect_equal(ncol(example_isolates[, betalactams(), drop = FALSE]), 16, tolerance = 0.5) @@ -53,13 +51,16 @@ test_that("amr selectors works", { expect_equal(ncol(example_isolates[, penicillins(), drop = FALSE]), 7, tolerance = 0.5) expect_equal(ncol(example_isolates[, phenicols(), drop = FALSE]), 1, tolerance = 0.5) expect_equal(ncol(example_isolates[, polymyxins(), drop = FALSE]), 1, tolerance = 0.5) + expect_equal(ncol(example_isolates[, quinolones(), drop = FALSE]), 2, tolerance = 0.5) expect_equal(ncol(example_isolates[, rifamycins(), drop = FALSE]), 1, tolerance = 0.5) expect_equal(ncol(example_isolates[, streptogramins(), drop = FALSE]), 0, tolerance = 0.5) - expect_equal(ncol(example_isolates[, quinolones(), drop = FALSE]), 2, tolerance = 0.5) expect_equal(ncol(example_isolates[, tetracyclines(), drop = FALSE]), 3, tolerance = 0.5) expect_equal(ncol(example_isolates[, trimethoprims(), drop = FALSE]), 2, tolerance = 0.5) expect_equal(ncol(example_isolates[, ureidopenicillins(), drop = FALSE]), 1, tolerance = 0.5) + expect_equal(ncol(example_isolates[, amr_class("antimyco"), drop = FALSE]), 1, tolerance = 0.5) + expect_equal(ncol(example_isolates[, amr_selector(name %like% "trim"), drop = FALSE]), 2, tolerance = 0.5) + expect_message(expect_output(print(carbapenems()))) expect_error(administrable_per_os())